0000950170-24-018765.txt : 20240222 0000950170-24-018765.hdr.sgml : 20240222 20240222161048 ACCESSION NUMBER: 0000950170-24-018765 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 128 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNIVERSAL DISPLAY CORP \PA\ CENTRAL INDEX KEY: 0001005284 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS & ACCESSORIES [3670] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 232372688 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12031 FILM NUMBER: 24664823 BUSINESS ADDRESS: STREET 1: 250 PHILLIPS BOULEVARD CITY: EWING STATE: NJ ZIP: 08618 BUSINESS PHONE: 6096710980 MAIL ADDRESS: STREET 1: 250 PHILLIPS BOULEVARD CITY: EWING STATE: NJ ZIP: 08618 10-K 1 oled-20231231.htm 10-K 10-K
--12-31false00010052841.4trueFYP3Yhttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrentP3Y http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent12-31-203412-31-203812-31-203130001005284oled:InternallyDevelopedIPProcessesAndRecipesMemberoled:AdesisIncMember2023-01-012023-12-310001005284us-gaap:PatentsMemberoled:FujifilmMember2012-07-222012-07-230001005284oled:FujifilmMember2023-12-310001005284us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001005284us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2020-12-310001005284us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-12-310001005284us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001005284oled:CashAccountsInBankingInstitutionsMember2022-12-310001005284us-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMember2022-12-310001005284oled:PerformanceBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2021-01-012021-12-310001005284us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2023-12-3100010052842022-12-310001005284us-gaap:TrademarksAndTradeNamesMemberoled:AdesisIncMember2023-12-310001005284us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001005284us-gaap:PatentsMemberoled:BASFSEMember2016-06-282016-06-280001005284us-gaap:ResearchAndDevelopmentExpenseMemberoled:NonEmployeeMembersOfScientificAdvisoryBoardMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerCMemberus-gaap:AccountsReceivableMember2022-12-310001005284us-gaap:SeriesAPreferredStockMember2023-01-012023-12-3100010052842021-01-012021-12-310001005284srt:MaximumMemberoled:OfficeLabEquipmentAndFurnitureAndFixturesMember2023-12-310001005284oled:OtherNonUSMember2023-01-012023-12-310001005284us-gaap:NonUsMember2022-01-012022-12-310001005284srt:MinimumMemberus-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMember2023-01-012023-12-310001005284oled:AdesisIncMemberus-gaap:CustomerRelationshipsMember2023-12-310001005284oled:BASFSEMember2022-12-310001005284us-gaap:AdditionalPaidInCapitalMember2020-12-310001005284country:KR2022-01-012022-12-310001005284oled:OtherNonUSMember2021-01-012021-12-310001005284us-gaap:OtherIntangibleAssetsMembersrt:MinimumMemberoled:AdesisIncMember2023-01-012023-12-310001005284oled:MotorolaMember2022-12-310001005284us-gaap:ShortTermInvestmentsMember2022-12-310001005284us-gaap:CommonStockMember2023-12-310001005284oled:AdesisIncMemberus-gaap:CustomerRelationshipsMember2023-01-012023-12-310001005284oled:AllocationOfWithholdingToNonKoreanPatentsMember2022-12-310001005284country:KR2023-01-012023-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:PerformanceSharesMember2021-01-012021-12-3100010052842029-12-310001005284us-gaap:AccountingStandardsUpdate201409Memberoled:AdesisIncMember2022-01-012022-12-310001005284oled:MembersOfScientificAdvisoryBoardMember2022-01-012022-12-310001005284us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001005284srt:DirectorMember2021-01-012021-12-310001005284us-gaap:StockCompensationPlanMember2023-12-3100010052842026-12-310001005284us-gaap:PatentedTechnologyMember2021-01-012021-12-310001005284us-gaap:RestrictedStockMember2023-12-310001005284us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001005284oled:CommitmentWithSeniorLevelEmployeesMembersrt:MinimumMember2023-12-310001005284us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001005284country:IE2023-12-310001005284us-gaap:ShortTermInvestmentsMember2023-12-310001005284us-gaap:PatentedTechnologyMember2023-01-012023-12-310001005284us-gaap:NonUsMember2022-12-310001005284us-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMember2023-12-310001005284oled:CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember2023-01-012023-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerCMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310001005284oled:AdditionalFundingAgreement2006Member2023-12-310001005284oled:AdditionalFundingAgreement2006Member2022-01-012022-12-3100010052842022-01-012022-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberoled:MajorCustomerBMember2021-12-310001005284oled:CommitmentWithExecutiveOfficersMember2023-12-310001005284us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberoled:NonEmployeeMembersOfScientificAdvisoryBoardMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001005284oled:EmployeeStockPurchasePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerBMemberus-gaap:SalesRevenueNetMember2021-01-012021-12-310001005284srt:DirectorMember2022-01-012022-12-310001005284us-gaap:TreasuryStockCommonMember2021-12-310001005284oled:EmployeeStockPurchasePlanMember2022-01-012022-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:PerformanceSharesMember2022-01-012022-12-310001005284oled:OneNineNineFiveMemberus-gaap:SeriesAPreferredStockMember2023-12-310001005284us-gaap:AdditionalPaidInCapitalMember2023-12-310001005284oled:BASFSEMember2023-12-310001005284srt:MaximumMember2023-12-310001005284oled:AdesisIncMember2024-12-310001005284us-gaap:SellingGeneralAndAdministrativeExpensesMemberoled:EmployeeStockPurchasePlanMember2022-01-012022-12-310001005284us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2021-01-012021-12-3100010052842023-01-012023-12-310001005284country:KR2021-01-012021-12-310001005284us-gaap:RestrictedStockUnitsRSUMember2022-12-310001005284oled:PerformanceBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2022-01-012022-12-310001005284oled:AdesisIncMember2023-01-012023-12-310001005284us-gaap:CostOfSalesMemberoled:EmployeeStockPurchasePlanMember2023-01-012023-12-310001005284us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001005284country:US2023-12-310001005284oled:EmployeeStockPurchasePlanMember2023-01-012023-12-310001005284us-gaap:RestrictedStockMember2022-12-310001005284srt:DirectorMember2023-01-012023-12-310001005284us-gaap:PatentsMemberoled:MerckKgaaMember2023-04-3000010052842020-12-310001005284us-gaap:PatentsMemberoled:BASFSEMember2016-06-280001005284us-gaap:LicenseAgreementTermsMember2022-01-012022-12-310001005284us-gaap:FurnitureAndFixturesMember2023-12-310001005284us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-01-012022-12-310001005284us-gaap:TreasuryStockCommonMember2020-12-310001005284us-gaap:NonUsMember2023-01-012023-12-310001005284us-gaap:LicenseAgreementTermsMember2021-01-012021-12-310001005284us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2023-12-310001005284oled:AdesisIncMember2022-01-012022-12-310001005284us-gaap:RetainedEarningsMember2023-12-310001005284oled:NewOledMaterialsAgreementAndOledMaterialsAgreementMembersrt:WeightedAverageMember2023-01-012023-12-310001005284us-gaap:BuildingImprovementsMember2023-12-310001005284oled:IncrementalPerformanceBasedMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001005284us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001005284us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001005284us-gaap:ForeignCountryMember2023-12-310001005284oled:OfficeLabEquipmentAndFurnitureAndFixturesMembersrt:MinimumMember2023-12-310001005284us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberoled:MajorCustomerAMember2023-01-012023-12-310001005284oled:IncrementalPerformanceBasedMemberus-gaap:PerformanceSharesMember2022-01-012022-12-310001005284oled:EmployeesAndNonEmployeeMembersOfScientificAdvisoryBoardMember2023-01-012023-12-310001005284us-gaap:PatentedTechnologyMember2022-01-012022-12-3100010052842027-12-310001005284us-gaap:LicenseAgreementTermsMember2023-01-012023-12-310001005284us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateBondSecuritiesMember2023-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerCMemberus-gaap:AccountsReceivableMember2021-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:ExcludingNorthAmericaMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001005284us-gaap:PerformanceSharesMember2022-12-310001005284us-gaap:MoneyMarketFundsMember2023-12-310001005284oled:MaterialSalesMember2023-01-012023-12-310001005284country:US2022-01-012022-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerCMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001005284oled:OtherMember2023-12-310001005284us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2021-12-310001005284oled:FujifilmMember2023-01-012023-12-310001005284oled:AdesisIncMember2023-12-310001005284oled:CompanyPerformanceBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2021-01-012021-12-310001005284oled:ManufacturingExpenseMemberus-gaap:PerformanceSharesMember2022-01-012022-12-310001005284us-gaap:RestrictedStockUnitsRSUMember2023-12-310001005284oled:ContractResearchServicesMember2023-01-012023-12-310001005284us-gaap:SupplierConcentrationRiskMember2023-01-012023-12-3100010052842023-12-310001005284us-gaap:RetainedEarningsMember2021-01-012021-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:ExcludingNorthAmericaMemberus-gaap:SalesRevenueNetMember2021-01-012021-12-310001005284us-gaap:RestrictedStockMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001005284us-gaap:SubsequentEventMember2024-02-202024-02-200001005284us-gaap:FurnitureAndFixturesMember2022-12-310001005284us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001005284us-gaap:BuildingAndBuildingImprovementsMember2023-12-310001005284us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2022-12-310001005284us-gaap:PerformanceSharesMember2021-01-012021-12-310001005284oled:ContractResearchServicesMember2022-01-012022-12-310001005284us-gaap:RestrictedStockMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-12-310001005284oled:FujifilmMemberus-gaap:PatentsMember2012-07-230001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberoled:MajorCustomerBMember2023-12-310001005284oled:AdesisIncMember2021-01-012021-12-310001005284us-gaap:RetainedEarningsMember2020-12-310001005284us-gaap:AccountingStandardsUpdate201409Memberoled:AdesisIncMember2023-01-012023-12-310001005284country:IE2022-12-310001005284oled:PdLdIncMember2023-12-310001005284us-gaap:SeriesAPreferredStockMember2022-12-310001005284us-gaap:CommonStockMember2020-12-310001005284oled:ContractResearchServicesMember2021-01-012021-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberoled:EmployeeStockPurchasePlanMember2022-01-012022-12-310001005284srt:MaximumMemberoled:CommitmentWithSeniorLevelEmployeesMember2023-12-310001005284oled:MotorolaMember2023-12-310001005284srt:MaximumMemberus-gaap:OtherIntangibleAssetsMemberoled:AdesisIncMember2023-01-012023-12-310001005284us-gaap:PerformanceSharesMember2023-01-012023-12-310001005284oled:AdesisIncMember2020-12-310001005284us-gaap:OtherLongTermInvestmentsMember2022-12-310001005284us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001005284oled:MembersOfScientificAdvisoryBoardMember2023-01-012023-12-310001005284oled:VisionoxHefeiTechnologyMember2023-01-012023-12-310001005284us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerBMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001005284us-gaap:PropertyAvailableForOperatingLeaseMember2023-01-012023-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:RestrictedStockMember2021-01-012021-12-310001005284us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001005284us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-12-310001005284us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001005284oled:EmployeeStockPurchasePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-12-310001005284country:JP2022-01-012022-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberoled:MajorCustomerAMember2022-01-012022-12-310001005284us-gaap:TrademarksAndTradeNamesMemberoled:AdesisIncMember2023-01-012023-12-310001005284us-gaap:MoneyMarketFundsMember2022-12-310001005284us-gaap:RetainedEarningsMember2022-12-310001005284us-gaap:CostOfSalesMemberoled:EmployeeStockPurchasePlanMember2022-01-012022-12-310001005284oled:PdLdIncMember2022-12-310001005284us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2023-01-012023-12-310001005284us-gaap:LandMember2023-12-310001005284oled:CompanyPerformanceBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2022-01-012022-12-310001005284oled:AdditionalFundingAgreement2006Member2023-01-012023-12-310001005284us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310001005284us-gaap:RetainedEarningsMember2023-01-012023-12-310001005284us-gaap:TreasuryStockCommonMember2022-12-310001005284oled:OtherMember2022-12-3100010052842021-12-310001005284us-gaap:PerformanceSharesMember2022-01-012022-12-310001005284us-gaap:AccountingStandardsUpdate201409Member2023-01-012023-12-310001005284srt:MaximumMemberus-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMember2023-01-012023-12-310001005284oled:MarketBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2022-01-012022-12-310001005284us-gaap:SeriesAPreferredStockMember2023-12-310001005284us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001005284oled:MaterialSalesMember2022-01-012022-12-310001005284oled:ManufacturingExpenseMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberoled:MajorCustomerAMember2021-12-310001005284oled:ManufacturingExpenseMemberus-gaap:RestrictedStockMember2022-01-012022-12-310001005284us-gaap:ForeignCountryMember2022-12-310001005284oled:InternallyDevelopedIPProcessesAndRecipesMemberoled:AdesisIncMember2023-12-310001005284us-gaap:OtherIntangibleAssetsMemberoled:AdesisIncMember2023-12-310001005284us-gaap:SoftwareDevelopmentMember2023-12-310001005284country:JP2021-01-012021-12-310001005284us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001005284us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-12-310001005284us-gaap:RestrictedStockMember2021-01-012021-12-310001005284oled:RoyaltyAndLicenseFeesMember2021-01-012021-12-310001005284us-gaap:CommonStockMember2023-01-012023-12-310001005284us-gaap:BuildingMember2023-12-310001005284us-gaap:PerformanceSharesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-12-310001005284us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001005284us-gaap:CommonStockMember2021-01-012021-12-310001005284oled:CashAccountsInBankingInstitutionsMember2023-12-310001005284us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-12-310001005284us-gaap:AccountingStandardsUpdate201409Member2022-01-012022-12-310001005284oled:AdesisIncMember2025-12-310001005284us-gaap:AccountingStandardsUpdate201409Member2021-01-012021-12-310001005284oled:EmployeeStockPurchasePlanMember2009-06-250001005284srt:MinimumMember2023-12-310001005284us-gaap:CommonStockMember2022-01-012022-12-310001005284oled:RoyaltyAndLicenseFeesMember2022-01-012022-12-310001005284country:US2021-01-012021-12-310001005284us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001005284us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001005284country:KR2023-01-012023-12-310001005284us-gaap:CommonStockMember2022-12-310001005284us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001005284oled:CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember2021-01-012021-12-310001005284us-gaap:PerformanceSharesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001005284us-gaap:USTreasuryAndGovernmentMemberus-gaap:OtherLongTermInvestmentsMember2023-12-310001005284us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerBMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310001005284us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerCMemberus-gaap:SalesRevenueNetMember2021-01-012021-12-310001005284us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-12-310001005284us-gaap:BuildingAndBuildingImprovementsMember2022-12-310001005284us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-12-3100010052842024-02-220001005284us-gaap:NonUsMember2023-12-310001005284oled:OtherNonUSMember2022-01-012022-12-310001005284us-gaap:MachineryAndEquipmentMember2022-12-310001005284oled:AdesisIncMember2027-12-310001005284oled:MerckKgaaMember2022-12-310001005284us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateBondSecuritiesMember2022-12-310001005284oled:MarketBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberoled:MajorCustomerAMember2022-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:MajorCustomerCMemberus-gaap:AccountsReceivableMember2023-12-310001005284srt:MaximumMemberus-gaap:StockCompensationPlanMember2023-01-012023-12-310001005284oled:ManufacturingExpenseMemberus-gaap:RestrictedStockMember2021-01-012021-12-310001005284country:CN2023-01-012023-12-310001005284us-gaap:PerformanceSharesMember2023-12-310001005284us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001005284us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:RestrictedStockMember2023-01-012023-12-310001005284us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001005284us-gaap:ConstructionInProgressMember2022-12-310001005284us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001005284country:CN2021-01-012021-12-310001005284us-gaap:ForeignCountryMember2023-01-012023-12-310001005284us-gaap:PatentsMemberoled:MerckKgaaMember2023-04-282023-04-280001005284us-gaap:ConstructionInProgressMember2023-12-310001005284us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001005284us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001005284us-gaap:PatentsMemberoled:BASFSEMember2023-12-310001005284oled:ManufacturingExpenseMemberus-gaap:PerformanceSharesMember2021-01-012021-12-310001005284oled:PerformanceBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001005284oled:RoyaltyAndLicenseFeesMember2023-01-012023-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberoled:MajorCustomerAMember2023-12-310001005284us-gaap:AccountingStandardsUpdate201409Memberoled:AdesisIncMember2021-01-012021-12-310001005284us-gaap:RetainedEarningsMember2021-12-310001005284us-gaap:LandMember2022-12-310001005284oled:MaterialSalesMember2021-01-012021-12-310001005284country:CN2022-01-012022-12-310001005284oled:CommitmentWithSeniorLevelEmployeesMember2023-12-310001005284oled:CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember2022-01-012022-12-310001005284oled:AllocationOfWithholdingToNonKoreanPatentsMemberus-gaap:StateAndLocalJurisdictionMember2023-12-310001005284oled:EmployeeStockPurchasePlanMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001005284oled:ManufacturingExpenseMemberus-gaap:RestrictedStockMember2023-01-012023-12-310001005284country:US2023-01-012023-12-310001005284country:US2022-12-310001005284oled:EmployeesAndNonEmployeeMembersOfScientificAdvisoryBoardMember2022-01-012022-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberoled:NonEmployeeMembersOfScientificAdvisoryBoardMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001005284us-gaap:TreasuryStockCommonMember2023-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberoled:EmployeeStockPurchasePlanMember2021-01-012021-12-310001005284us-gaap:RestrictedStockMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310001005284oled:EmployeeStockPurchasePlanMember2021-01-012021-12-310001005284us-gaap:RetainedEarningsMember2022-01-012022-12-310001005284us-gaap:AdditionalPaidInCapitalMember2021-12-310001005284oled:MarketBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2021-01-012021-12-310001005284us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001005284us-gaap:CommonStockMember2021-12-310001005284us-gaap:USTreasuryAndGovernmentMemberus-gaap:OtherLongTermInvestmentsMember2022-12-310001005284us-gaap:RestrictedStockMember2023-01-012023-12-3100010052842028-12-310001005284us-gaap:OtherLongTermInvestmentsMember2023-12-310001005284oled:FujifilmMember2022-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberoled:EmployeeStockPurchasePlanMember2023-01-012023-12-310001005284country:JP2023-01-012023-12-310001005284oled:AllocationOfWithholdingToNonKoreanPatentsMemberus-gaap:StateAndLocalJurisdictionMember2022-12-310001005284oled:AdditionalFundingAgreement2006Member2021-01-012021-12-310001005284us-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMember2023-12-310001005284us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001005284us-gaap:NonUsMember2021-01-012021-12-310001005284us-gaap:PerformanceSharesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310001005284oled:MerckKgaaMember2023-12-310001005284srt:MinimumMember2023-01-012023-12-310001005284oled:AllocationOfWithholdingToNonKoreanPatentsMember2023-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberoled:MajorCustomerAMember2021-01-012021-12-310001005284us-gaap:CustomerConcentrationRiskMemberoled:ExcludingNorthAmericaMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310001005284us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberoled:MajorCustomerBMember2022-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:RestrictedStockMember2022-01-012022-12-310001005284us-gaap:RestrictedStockMember2022-01-012022-12-310001005284us-gaap:AdditionalPaidInCapitalMember2022-12-310001005284us-gaap:CorporateBondSecuritiesMemberus-gaap:OtherLongTermInvestmentsMember2022-12-310001005284oled:IncrementalPerformanceBasedMemberus-gaap:PerformanceSharesMember2021-01-012021-12-310001005284us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:PerformanceSharesMember2023-01-012023-12-3100010052842023-06-300001005284us-gaap:MachineryAndEquipmentMember2023-12-310001005284oled:CompanyPerformanceBasedVestingRequirementMemberus-gaap:PerformanceSharesMember2023-01-012023-12-31iso4217:EURxbrli:pureiso4217:USDxbrli:sharesoled:Investmentoled:Board_memberoled:Participantoled:Employeeoled:Denominatoroled:Patentxbrli:sharesoled:Multipleoled:ExecutiveOfficeriso4217:USDoled:Supplier

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ___________

Commission File Number 1-12031

 

 

img34714927_0.jpg 

UNIVERSAL DISPLAY CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Pennsylvania

 

23-2372688

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

250 Phillips Boulevard, Ewing, New Jersey

 

08618

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (609) 671-0980

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.01 par value

 

OLED

 

The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Non-accelerated filer

☒

☐

Accelerated filer

Smaller reporting company

☐

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant computed by reference to the closing sale price of the registrant’s common stock on the NASDAQ Global Select Market as of June 30, 2023, was $6,320,500,461. Solely for purposes of this calculation, all executive officers and directors of the registrant and all beneficial owners of more than 10% of the registrant’s common stock (and their affiliates) were considered affiliates.

As of February 16, 2024, the registrant had outstanding 47,365,600 shares of common stock.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s Proxy Statement for the 2024 Annual Meeting of Shareholders, which is to be filed with the Securities and Exchange Commission no later than April 29, 2024 (the first business day after the 120th day following the end of the registrant's fiscal year), are incorporated by reference into Part III of this report.

 

Auditor Firm Id:

185

Auditor Name:

KPMG, LLP

Auditor Location:

Philadelphia, PA, USA

 

 

 

TABLE OF CONTENTS

 

 

PART I

 

 

 

 

ITEM 1.

BUSINESS

3

ITEM 1A.

RISK FACTORS

17

ITEM 1B.

UNRESOLVED STAFF COMMENTS

26

ITEM 1C.

CYBERSECURITY

27

ITEM 2.

PROPERTIES

27

ITEM 3.

LEGAL PROCEEDINGS

28

ITEM 4.

MINE SAFETY DISCLOSURES

28

 

 

 

 

PART II

 

 

 

 

ITEM 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

29

ITEM 6.

RESERVED

31

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

32

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

38

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

38

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

38

ITEM 9A.

CONTROLS AND PROCEDURES

38

ITEM 9B.

OTHER INFORMATION.

39

ITEM 9C.

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

39

 

 

 

 

PART III

 

 

 

 

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

40

ITEM 11.

EXECUTIVE COMPENSATION

40

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

40

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

40

ITEM 14.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

40

 

 

 

 

PART IV

 

 

 

 

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

41

ITEM 16.

FORM 10-K SUMMARY

43

 

 

 

 

 

 

i

 

CAUTIONARY STATEMENT

CONCERNING FORWARD-LOOKING STATEMENTS

This report and the documents incorporated by reference in this report contain some “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements concern possible or assumed future events, results and business outcomes. These statements often include words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “project” or similar expressions. These statements are based on assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances.

As you read and consider this report, you should not place undue reliance on any forward-looking statements. You should understand that these statements involve substantial risk and uncertainty and are not guarantees of future performance or results. They depend on many factors that are discussed further under Item 1A (Risk Factors) below, including:

•
successful commercialization by organic light emitting diode (OLED) manufacturers of products incorporating our OLED technologies and materials and their continued willingness to utilize our OLED technologies and materials;
•
the adequacy of protections afforded to us by the patents that we own or license and the cost to us of maintaining, enforcing and defending those patents;
•
our ability to protect our patented and non-patented intellectual property;
•
our exposure to and ability to defend against third-party claims and challenges to our existing and future intellectual property rights;
•
our ability to maintain our competitive position following the expiration of our fundamental phosphorescent organic light-emitting diode (PHOLED) patents;
•
our ability to form and continue strategic relationships with manufacturers of OLED products;
•
the payments that we expect to receive under our existing contracts with OLED manufacturers and the terms of contracts that we expect to enter into with OLED manufacturers in the future;
•
the potential commercial applications of and future demand for our OLED technologies and materials, and of OLED products in general;
•
the stability of the global economy, consumer spending and global supply chains, as well as volatility in and disruption of financial markets;
•
our ability to offer and our customers’ willingness to continue to purchase our materials in the event of substantial increases in tariffs or export restrictions resulting from international trade or geopolitical disputes;
•
our customers' development and use of more efficient manufacturing processes and material processing protocols that result in the more efficient utilization of our materials, and therefore reduce their requirements for our materials;
•
the comparative advantages and disadvantages of our OLED technologies and materials versus existing and future competing technologies and materials;
•
the outcomes of our ongoing and future research and development activities, and those of others, relating to OLED technologies and materials;
•
our ability to acquire and supply OLED materials and technologies at cost competitive pricing;
•
our ability to compete against third parties with resources greater than ours and that are based in countries where our significant customers are located;
•
our ability to respond to and address malicious cybersecurity and IT infrastructure attacks;
•
our quarterly cash dividend policy;
•
our future OLED technology licensing and OLED material revenues and results of operations, including supply and demand for our OLED materials; and
•
general economic and market conditions, including impacts resulting from pandemic outbreaks and geopolitical risks and uncertainties given the international nature of our business.

1

 

Changes or developments in any of these areas could affect our financial results or results of operations and could cause actual results to differ materially from those contemplated by any forward-looking statements.

All forward-looking statements speak only as of the date of this report or the documents incorporated by reference, as the case may be. We do not undertake any duty to update, correct, modify, or supplement any of these forward-looking statements to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events.

2

 

PART I

ITEM 1. BUSINESS

Our Company

We are a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light that can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and as lighting products. OLED displays are capturing a growing share of the display market, especially in the mobile phone, television, monitor, wearable, tablet, notebook and personal computer, augmented reality (AR), virtual reality (VR) and automotive markets. We believe that this is because OLEDs offer potential advantages over competing display technologies with respect to power efficiency, contrast ratio, viewing angle, video response time, form factor and manufacturing cost. We also believe that OLED lighting products have the potential to replace many existing light sources in the future because of their high-power efficiency, excellent color rendering index, low operating temperature and novel form factor. Our technology leadership, our current intellectual property position, and our more than 20 years of experience working closely with leading OLED display manufacturers are some of the competitive advantages that should enable us to continue to share in the revenues from OLED displays and lighting products as they gain wider acceptance.

Our primary business strategy is to (1) develop new OLED materials and sell existing and new materials to product manufacturers for display applications, such as mobile phones, televisions, monitors, wearables, tablets, portable media devices, notebook computers, personal computers and automotive applications, and specialty and general lighting products; and (2) further develop and either license or otherwise commercialize our proprietary OLED material, device design and manufacturing technologies to those manufacturers. We have established a significant portfolio of proprietary OLED technologies and materials, primarily through our internal research and development efforts and acquisitions of patents and patent applications, as well as maintaining long-standing, and establishing new relationships with world-class universities, research institutions and strategic manufacturing partnerships. We currently own, exclusively license or have the sole right to sublicense more than 6,000 patents issued and pending worldwide.

We manufacture and sell our proprietary OLED materials to customers for evaluation and use in commercial OLED products. We also enter into agreements with manufacturers of OLED display and lighting products under which we grant them licenses to practice under our patents and to use our proprietary know-how. At the same time, we work with these and other companies that are evaluating our OLED material, device design and manufacturing technologies for possible use in commercial OLED display and lighting products.

Market Overview

The Display Panel Market

Thin, energy-efficient display panels that can be manufactured on glass or flexible substrates are essential for a wide variety of portable consumer electronics products, such as mobile phones, AR/VR headsets, digital cameras, wearables, tablets and notebook computers. Due to their narrow profile and light weight, flat panel displays are the display of choice for larger product applications, such as computer monitors and televisions.

Liquid crystal displays, or LCDs, continue to dominate the flat panel display market. However, we believe that OLED displays are an attractive alternative to LCDs, and OLED displays are gaining market share, because they offer a number of potential advantages, including:

•
higher power efficiencies, thereby reducing energy consumption;
•
a thinner profile and lighter weight;
•
higher contrast ratios, leading to sharper picture images and graphics;
•
wider viewing angles;
•
deposition on non-rigid substrates which enable conformable and flexible displays;
•
faster response times for video and gaming; and
•
lower cost manufacturing methods and materials.

Based on these characteristics, product manufacturers have adopted small-area OLED displays for use in a wide variety of electronic devices, such as smartphones, wearables and tablets. Manufacturers are increasingly commercializing large-area OLED displays for use in televisions and monitors. We believe that if these efforts are successful, they could result in sizeable markets for OLED displays.

3

 

Organic materials make technically possible the development of flexible displays for use in an entirely new array of product applications. Such applications include display devices that fold in use, or conform to various shapes for wearable, rollable, industrial and ruggedized applications. In addition, due to the inherent transparency of the organic materials and transparent electrode technologies, OLEDs eventually may enable the production of transparent displays for use in products such as automotive windshields and windows with embedded displays.

The Solid-State Lighting Market

Traditional incandescent light bulbs are inefficient because they convert only about 5% of the energy they consume into visible light, with the rest emerging as heat. Fluorescent lamps use excited gases, or plasmas, to achieve a higher energy conversion efficiency of about 20%. However, the color rendering index of most fluorescent lamps – in other words, the quality of their color compared to an ideal light source – is inferior to that of an incandescent bulb. Fluorescent lamps also pose environmental concerns because they typically contain mercury.

Solid-state lighting relies on the direct conversion of electricity to visible light using semiconductor materials. By avoiding the heat and plasma-producing processes of incandescent bulbs and fluorescent lamps, respectively, solid-state lighting products can have substantially higher energy conversion efficiencies.

There are currently two basic types of solid-state lighting devices: inorganic light emitting diodes, or LEDs, and OLEDs. Current LEDs are very small in size (about one square millimeter) and are extremely bright. Having been developed about 25 years before OLEDs, LEDs are already widely employed in a variety of lighting products, such as traffic lights, digital signage and billboards, replacements for incandescent lighting, backlights for smartphones, computer monitors and televisions, and as border or accent lighting. However, most commercial LED offerings are characterized by high operating temperatures and intense brightness which may make them less desirable for many lighting applications.

OLEDs, on the other hand, can be designed to provide improved lighting characteristics because they can be larger in size and can be viewed directly, without using diffusers that are required to temper the intense brightness of LEDs. OLEDs can be fabricated onto any suitable surface, including glass, plastic or metal foil, and could be cost-effective to manufacture in high volume. Given these characteristics, product manufacturers are working on and have introduced limited product applications of OLEDs for diffuse specialty lighting applications and ultimately general illumination. If these efforts are successful, we believe that OLED lighting products could begin to be used for applications currently addressed by other existing lighting technologies, as well as for new applications that take advantage of the OLED form factor. In particular, the ability of OLED technology to produce uniform illumination over arbitrary shapes is making OLED lighting very attractive to the automobile industry as well as the digital signage industry.

Our Competitive Strengths

We believe that we currently are one of the leading technology developers in the OLED industry because we were the first company to develop and commercialize PHOLED emitter technology. Our experienced management and research teams have built an extensive intellectual property portfolio around our OLED technologies and materials, particularly with regard to PHOLED emitter materials, which we continually seek to enhance and grow. We work diligently, through the delivery of high-quality commercial products, superior technical support and customer service, to enable our industry-leading customers, which primarily are large display manufacturers, to adopt our OLED technologies and materials through implementation of long-term commercial material supply and patent and know-how license agreements. Our key competitive strengths include:

Technology Leadership

We are a recognized technology leader in the OLED industry. We, along with world-class academic partners, pioneered the development of our UniversalPHOLED® phosphorescent OLED technologies, which can be used to produce OLEDs that are up to four times more efficient than fluorescent OLEDs and significantly more efficient than current LCDs, which are illuminated using backlights. We believe that our PHOLED technologies and materials will continue to be well-suited for industry usage in the commercial production of OLED displays and lighting products.

Through our internal, innovative research, which has produced the majority of our most critical commercial technologies, our relationships with supplier companies, such as PPG Industries, Inc. (PPG), and our existing and new academic partners, we believe that we can continue to advance the technology we have already developed and commercialized, and that we will continue to discover and develop other important OLED technologies, as well as novel OLED materials, that will facilitate further adoption of our various OLED technologies by product manufacturers. To this end, we operate two state-of-the-art laboratories, or Application Centers, near our larger customers in the Asia-Pacific region. These Application Centers have provided us and our customers with the ability to more quickly evaluate, develop and bring to market our newest OLED materials and technologies. We also are committing significant resources to

4

 

further the development of next-generation emissive layer technologies and dry printing technologies such as organic vapor jet printing (OVJP).

Broad Portfolio of Intellectual Property

Generally, each of our commercial offerings is protected by multiple patents which can help us either to prevent or combat the introduction of counterfeit and/or knock-off products that could potentially impact the market demand for our OLED materials and technologies. Our strong patent and non-patented know-how portfolios in the areas of PHOLED emitter materials, complementary PHOLED materials, OLED device designs, and OLED manufacturing technologies are reflective of our continued commitment to innovate and invest. We believe that our extensive portfolio of patents and non-patented know-how provides us with a competitive advantage in the OLED industry.

Through our internal development efforts, acquisitions, and long-standing relationships with academic partners, research institutions and product manufacturers, we own, exclusively license or have the sole right to sublicense more than 6,000 patents issued and pending worldwide. We continue to enhance and grow our OLED technology and materials patent portfolio organically through internal research and development, partnering with third parties, and by acquisition. We also continue to accumulate valuable non-patented technical know-how relating to our OLED technologies and materials.

Leading Supplier of UniversalPHOLED® Emitter Materials and Related Technology Licensing

We are the leading supplier of PHOLED emitter materials to OLED device manufacturers. The emitter material, which is designed to efficiently convert electrical energy to a desired wavelength of light, is the key component in an OLED device. Our manufacturing partner of over 20 years, PPG, continues to manufacture our materials for us, using proprietary manufacturing processes and know-how, which materials we then qualify to our exacting product specifications and resell on a just-in-time basis to OLED device manufacturers. We record revenues based on our sales of these materials to OLED device manufacturers. Our commercial supply agreements typically require our customers to purchase minimum quantities of our materials, which purchases can be in the form of annual minimum purchase undertakings or as a minimum percentage of their purchase requirements, or a combination of both.

Our commercial supply arrangements allow us to maintain close technical and business relationships with these OLED device manufacturers purchasing our proprietary materials, and thereby further supports our technology licensing business. We do not directly manufacture or sell OLED display or lighting products. Instead, we enter into non-exclusive licensing arrangements with OLED device manufacturers, many of which also purchase our materials, that pay us fixed license fees and/or running royalties based on their sales of licensed commercial products using our proprietary technology and patents. We believe this business model allows us to concentrate on our core strengths of technology development and innovation, while at the same time provides significant operating leverage. We also believe that this approach may reduce potential competitive conflicts with our customers.

Long-Standing Customer Relationships

We have long-standing customer relationships with OLED device manufacturers that are using, or are evaluating for use, our OLED materials in commercial OLED products. We have more than 20 years of experience in working closely with OLED device manufacturers and have provided support to them in their commercialization of OLED technology by delivering customer-specific solutions for red, green, and yellow emitter materials, or dopants.

We have a proven track record of delivering consistent, high-quality OLED material to our customers. We provide just-in-time supply to our customers and serve as a sole source to them for many of our critical materials. We believe that our unparalleled manufacturing partners, namely PPG, our well-established supply chain, our multi-tier quality testing, and our product assurance protocols make us a preferred partner for our customers and for any large-scale OLED display manufacturer that wants to deliver to high-quality international end-customers.

In 2023, our largest customers for our PHOLED materials included Samsung Display Co., Ltd. (SDC), LG Display Co., Ltd. (LG Display), BOE Technology Group Co., Ltd. (BOE), Tianma Micro-electronics Co., Ltd. (Tianma), Visionox Technology, Inc. (Visionox), Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT), Japan Display, Inc., Sharp Corporation, and AU Optronics Corporation (AU Optronics). Other licensed customers of our technology in 2023 included Kaneka Corporation, Pioneer Corporation, and OLEDWorks L.L.C.

5

 

Complementary UniversalPHOLED® Host Material Business

In addition to our proprietary UniversalPHOLED® emitter materials, we continue to develop, supply and offer for sale certain of our proprietary phosphorescent host materials to OLED device manufacturers. In addition, we have entered into a number of host material strategic partnerships through development agreements with OLED material partners that are focused on combining our proprietary PHOLED emitters with hosts and other OLED materials of these companies in order to optimize the performance of our emitters in our customers’ newest product designs. We do not believe that revenue from our host development and third-party collaboration agreements will be significant compared with our emitter business. However, we believe that development and collaborative relationships such as these are important for ensuring the continued success of the OLED industry and the broader adoption of our PHOLED and other OLED technologies in the marketplace.

Experienced Management and Scientific Advisory Team

Our management team has significant experience in developing business models focused on licensing disruptive technologies in high growth industries. The team has strong relationships with, and deep understandings of, our customers and their needs, the commercial marketplace and the OLED industry on the whole. We believe our management team’s experience and long-standing relationships are important to maintaining good and accommodating working relationships with our customers, particularly when we are confronted with challenging technical, regulatory and trade issues given our international reach. In addition, we employ and contract with some of the leading researchers in the industry, and we maintain a long-standing Scientific Advisory Board that includes industry pioneers, namely Professor Stephen R. Forrest of the University of Michigan (Michigan) and Professor Mark E. Thompson of the University of Southern California (USC).

Our Business Strategy

Our current business strategy is to continue to promote and expand our portfolio of OLED technologies and materials for widespread use in OLED displays and lighting products. We generate revenues primarily by selling our proprietary OLED materials and licensing our OLED technologies to display and lighting product manufacturers. We are presently focused on the following steps to implement our business strategy:

Expand Our Collaborative Relationships with Leading Product Manufacturers and Developers

We collaborate and partner with leading manufacturers of displays and lighting products who are commercial licensees of our OLED technologies and purchasers of our OLED materials. We also supply our proprietary OLED materials to manufacturers and developers of OLED displays and lighting products for evaluation and for use in product development and for pre-commercial activities, and we provide technical assistance and support to these manufacturers and developers to foster ongoing relationships and new commercial agreements. We concentrate on working closely with OLED device manufacturers and developers because we believe that the successful incorporation of our technologies and materials into commercial products is critical to their widespread adoption.

Enhance Our Existing Portfolio of PHOLED Technologies and Materials

We believe that a strong portfolio of proprietary OLED technologies and materials for both displays and lighting products is critical to our continued success, particularly as the utilization of PHOLED technologies and materials expands in the marketplace. Consequently, we are continually seeking to expand this portfolio through our internal development efforts, our collaborative relationships with existing and new academic and other research partners, and other strategic opportunities, such as funding early-stage startup companies whose technology may be synergistic to ours. Since the acquisition of the early fundamental research developed by our initial academic partners in the late 1990’s, one of our primary goals has been and continues to be the development of new and improved PHOLED technologies and materials with increased efficiencies, enhanced color gamut and extended lifetimes, which are compatible with different manufacturing methods, so that they can be used by various manufacturers in a broad array of OLED display and lighting products.

Develop Next-Generation Organic Technologies

We continue to conduct research and development activities relating to next-generation OLED technologies for both displays and lighting products, including next generation emissive layer technologies and dry printing technologies such as OVJP, which we discuss in more detail below. We also are funding research by existing and new academic partners and research institutions on the use of OLED and other related technologies in other applications. Our focus on next-generation technologies is designed to enable us to maintain our position as a leading provider of OLED and other organic electronics technologies and materials as new markets emerge.

6

 

Business and Geographic Markets

We derive revenue from the following:

•
sales of OLED materials for evaluation, development and commercial manufacturing;
•
intellectual property and technology licensing;
•
technology development and support, including third-party collaboration efforts and providing support to third parties for commercialization of their OLED products; and
•
contract research services in the areas of chemical synthesis research, development and commercialization for non-OLED applications.

Most manufacturers of displays and lighting products who are or might potentially be interested in our OLED technologies and materials are currently located outside of the United States, particularly in the Asia-Pacific region. To provide on-the-ground support to these manufacturers, we have established wholly-owned subsidiaries in Ireland, Korea, Japan, China and Hong Kong, as well as a representative office in Taiwan. We have Application Centers in Hong Kong and Pangyo, South Korea, which allow our Asia-based display manufacturers to evaluate our technology more quickly and incorporate the technology into their commercial designs. Our wholly-owned subsidiary formed under the laws of the Republic of Ireland, UDC Ireland Ltd. (UDC Ireland), is responsible for all material sales worldwide (excluding the United States) and for licensing and managing intellectual property and undertaking certain other business transactions in all non-U.S. territories.

In 2023, we received a majority of our revenue from three customers domiciled in the Asia-Pacific region, BOE, LG Display and SDC, from each of which we had revenue in excess of 10% of our consolidated revenue. Our business is heavily dependent on our relationships with these customers. Substantially all revenue derived from our customers is denominated in U.S. dollars.

We generally enter into long-term agreements with our customers, which may include (1) a commercial supply agreement for the purchase of specific OLED materials, and (2) patent and know-how license agreements that relate to the manufacture of display and lighting devices. Generally, our commercial material supply agreements provide for multi-year purchase commitments, typically on a price per gram basis, which entitle our customers to certain discounts, technical support on the use of our OLED materials in mass production facilities, and access to certain future OLED materials. In order to secure preferential pricing and technology access, a customer typically agrees to certain minimum purchase obligations which can be in the form of annual minimum purchase undertakings or a percentage of their purchase requirements, or a combination of both. If a customer does not meet its minimum purchase obligations, generally we would have the right to review pricing for future material sales and impose other financial penalties.

Our patent and know-how license agreements generally are made available to our customers for the manufacture of OLED devices. In addition, we also may license to certain material company partners the right to manufacture certain OLED materials that are complementary to our phosphorescent emitter materials. These licenses have included licenses to make host products and certain other non-phosphorescent materials. We believe it is in our, and our customers’ best interests to facilitate the development of materials that are complementary to our offerings and which assist our customers to produce more efficient and manufacturable devices with our materials. These collaboration efforts are likely to generate additional licensing fees for us under our license agreements. Although our customers generally pay us fixed license fees and/or running royalties for OLED licensed products that they manufacture, our material partner licensees generally pay us a portion of their sales for materials that are developed under material collaboration agreements and subsequently commercialized. To date, these material collaboration arrangements have not generated significant revenues for us.

For more information on our revenues, costs and expenses associated with our business, as well as a breakdown of revenues from North America and foreign sources, please see our Consolidated Financial Statements and the notes thereto, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included elsewhere in this report.

Our Technology and its Relation to OLED Technology and Structure

OLED devices are solid-state semiconductor devices made from thin films of organic material that emit light of various wavelengths when electricity is selectively applied to the emissive layer of the device. OLED devices are typically referred to as incorporating an “OLED stack.” OLED stacks vary in specific structure but those commonly used today may include a cathode, an electron injection layer, an electron transport layer, an emissive layer, a hole transport layer, a hole injection layer and an anode, all of which are placed on a substrate which may be made of a number of different materials, including glass, plastic and metal.

Our technology and materials are most commonly utilized in the emissive layer; the materials in the emissive layer are the light-generating component of the OLED stack. Many of our key technologies relate primarily to phosphorescent emitter materials, which we believe are more energy efficient than fluorescent emitter materials that can also be used to generate light within the emissive layer of

7

 

the OLED device. We began selling emitter materials commercially in 2003. A manufacturer will use a small amount of emitter material for each device through a process called “doping” into a host material. The emitter material(s) and the host material(s) together form an emissive layer system. Depending on the nature of the OLED device, the emissive materials and emissive layer system may be designed to emit different colors. We have commercially produced and sold phosphorescent emitter materials that produce red, yellow, green and light-blue light, which are combined in various ways for the display and lighting markets.

Our current materials business, conducted outside the United States by UDC Ireland, is focused primarily on the delivery of such emissive materials. We have also developed host materials for the emissive layer and began selling them commercially in 2011. In addition to our materials, which are generally protected by patents covering various molecular structures, we also have system and process patents that cover various fundamentally important aspects of the OLED device, device architectures, use of materials in devices and OLED manufacturing processes. These patents are important to our licensing business because they enable us to provide our business partners important OLED related technologies.

Our PHOLED Technologies

PHOLED technologies utilize specialized materials and device structures that allow OLEDs to emit light through a process known as phosphorescence. Traditional fluorescent OLEDs emit light through an inherently less efficient process. Theory and experiment show that PHOLEDs exhibit device efficiencies up to four times higher than those exhibited by fluorescent OLEDs. Phosphorescence substantially reduces the power requirements of an OLED and is useful in displays for hand-held devices, such as smartphones, where battery power is often a limiting factor.

Phosphorescence is also important for large-area displays such as televisions, where higher device efficiency and lower heat generation may enable longer product lifetimes and increased energy efficiency.

We have a strong intellectual property portfolio surrounding our existing PHOLED technologies and materials for both displays and lighting products which we market under the UniversalPHOLED® brand. We devote a substantial portion of our efforts to developing new and improved proprietary PHOLED materials and device architectures for red, green, yellow, blue and white OLED devices. In 2023, we continued our commercial supply relationships with companies such as BOE, CSOT, LG Display, SDC, Tianma, and Visionox to use our PHOLED materials to manufacture OLED displays. In addition, we have worked and continue to work closely with customers evaluating and qualifying our proprietary PHOLED materials for commercial usage in both displays and lighting products, and with other material suppliers to combine our PHOLED emitters with their phosphorescent hosts and other OLED materials.

Our Additional Proprietary OLED Technologies

Our intellectual property, research, development and commercialization efforts also encompass a number of other OLED device and manufacturing technologies, including, but not limited to, the following:

FOLED ™ Flexible OLEDs

We are working on a number of technologies required for the fabrication of OLEDs on flexible substrates. Most other flat panel displays are built on rigid glass substrates. In contrast, FOLEDs are OLEDs built on non-rigid substrates such as plastic or metal foil. This has the potential to enhance durability and enable conformation to certain shapes or repeated bending or flexing. Many OLED smartphone displays are built on plastic substrates including those produced by SDC and LG Display. Several of our customers demonstrated different foldable and rollable FOLED displays at recent Consumer Electronics Shows in Las Vegas, NV. The commercial introduction of such FOLED product offerings demonstrates the viability of new display product applications, such as portable, roll-up communications televisions, tablets, notebook computers and smartphones, as well as enhances the usefulness of such devices in ruggedized, industrial and wearable computing systems. Manufacturers also may be able to produce FOLEDs using more efficient continuous, or roll-to-roll, processing methods in the future. Our internal research and development efforts are expected to enhance and promote the future adoption of consumer and industrial FOLED devices.

OVJP® Organic Vapor Jet Printing

OLEDs could be manufactured using other processes as well, including OVJP. As a direct printing technique, OVJP technology has the potential to offer high deposition rates for large-area OLEDs. In addition, OVJP technology reduces OLED material waste associated with use of a shadow mask (i.e., the waste of material that deposits on the shadow mask itself when fabricating an OLED). By comparison to inkjet printing, an OVJP process does not use liquid solvents and therefore the OLED materials utilized are not limited by their viscosity or solvent solubility. OVJP also avoids generation of solvent wastes and eliminates the additional step of removing residual solvent from the OLED device. In 2019, we installed a red-green-blue OVJP pilot tool at our Ewing, New Jersey facility, and we continue to collaborate on OVJP technology development with Professor Forrest of Michigan. In June 2020, we formed a

8

 

wholly-owned subsidiary, OVJP Corporation (OVJP Corp), as a Delaware corporation. Based in California, OVJP Corp was founded to advance the commercialization of our proprietary OVJP technology. As of December 31, 2023, OVJP Corp employed a team of 28 research, mechanical, electrical and software engineers and laboratory technicians. We believe the successful implementation of the OVJP technology has the potential to increase the addressable market for large-size OLED panels while also serving another potential growth market for our proprietary PHOLED materials and technologies.

Our Strategic Relationships with Product Manufacturers

We have established early-stage evaluation programs, development and pre-commercial programs, and commercial arrangements with a substantial number of manufacturers or potential manufacturers of OLED display and lighting products. Many of these relationships are directed towards tailoring our proprietary OLED technologies and materials for use by individual manufacturers. Our ultimate objective is to license our OLED technologies and sell our OLED materials to these manufacturers for their commercial production of OLED products.

Relationships with OLED Display Manufacturers

We license our OLED technologies and patents to display manufacturers for use in commercial products and supply our proprietary OLED materials to these manufacturers for both commercial use and evaluative purposes. We have been collaborating with some of these display manufacturers for over 20 years.

We have been working with SDC and providing our PHOLED materials to SDC for evaluation since 2001. Under the terms of a patent license agreement, we license our patents and technologies to SDC for its manufacture and sale of AMOLED (active-matrix organic light-emitting diode) display products. Under the terms of a supplemental purchase agreement, we supply our proprietary PHOLED materials to SDC for its use in manufacturing licensed products. We also continue to supply SDC with our proprietary UniversalPHOLED materials for use in its development efforts under a 2001 joint development agreement.

On December 2, 2022, we entered into new patent license and supplemental purchase agreements with SDC, both with an effective date of January 1, 2023. These agreements, which cover the manufacture and sale of specified OLED display materials, last through the end of 2027 with an additional two-year extension option for SDC. Under these agreements, we are being paid a license fee, which includes quarterly and annual payments over the agreement term of five years. These agreements convey to SDC the non-exclusive right to use certain of our intellectual property assets for a limited period of time that is less than the estimated life of the assets. The supplemental purchase agreement provides for minimum annual purchase obligations of red and green phosphorescent emitter material from us for use in the manufacture of licensed products. The minimum commitment is subject to SDC’s requirements for phosphorescent emitter materials and our ability to meet these requirements over the term of the supplemental agreement. SDC is currently the largest manufacturer of AMOLED displays for smartphones and other personal electronic devices and produces displays for a number of different smartphone and electronic device manufacturers.

We have been working with LG Display and its affiliates for over 15 years. In 2015, we entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display, which were effective as of January 1, 2015. The terms of these agreements were extended by a January 1, 2021 amendment through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under our patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The OLED commercial supply agreement provides for the sales of materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the life of the agreements as well as minimum royalty revenue. LG Display is currently the largest manufacturer of AMOLED displays for large-area televisions and produces display panels for a number of different television manufacturers.

In 2023, we entered into new long-term, multi-year agreements with BOE. Under these agreements, we have granted BOE non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to BOE for use in its licensed products.

In 2019, we entered into an evaluation and commercial supply relationship with CSOT. In 2020, we entered into long-term, multi-year agreements with CSOT. Under these agreements, we have granted CSOT non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to CSOT for use in its licensed products.

9

 

In 2018, we entered into long-term, multi-year OLED patent license and material purchase agreements with Visionox. Under the license agreement, we have granted certain of Visionox’s affiliates non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, we supply phosphorescent OLED materials to Visionox for use in its licensed products. In 2021, we announced an extension of the Visionox agreement by entering into new five-year OLED material supply and license agreements with a new affiliate of Visionox, Visionox Hefei Technology Co. Ltd.

In 2016, we entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma. Under the license agreement, we have granted Tianma non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on Tianma’s sales of licensed products. Additionally, we supply phosphorescent OLED materials to Tianma for use in its licensed products. In 2021, we mutually agreed to extend the terms of both the patent license and material purchase agreements for an additional multi-year term.

We have been collaborating with AU Optronics since 2001, and we continue to provide our proprietary PHOLED materials to AU Optronics under a 2016 commercial supply agreement through which AU Optronics also has certain license rights.

We also continue to support numerous display manufacturers in their evaluation of our technologies and proprietary OLED materials, through evaluation arrangements in which we provide our proprietary OLED materials to such manufacturers for limited scale commercial production, evaluation and for purposes of development, manufacturing qualification and product testing. Many of these strategic relationships have been in place for longer than a decade, and we continue to establish new relationships.

Relationships with OLED Lighting Manufacturers

We license our OLED technologies and patents to lighting manufacturers for use in commercial products and supply our proprietary OLED materials to these manufacturers for both commercial use and evaluative purposes. Some of these strategic relationships have also been in place for longer than a decade.

We continue to license our OLED patents, and to provide our OLED materials, to OLEDWorks for use in OLED lighting products under patent license and commercial supply agreements signed in 2015. We have also extended the rights under these agreements to OLEDWorks GmbH, the German company and facility that OLEDWorks acquired in 2015 from Philips Technologie GmbH.

We also have strategic relationships with Kaneka, Konica Minolta and Sumitomo, and continue to license our OLED patents and technologies to these customers.

Similar to our arrangements with display manufacturers, we continue to support numerous lighting manufacturers in their evaluation of our technologies and proprietary OLED materials, typically through evaluation agreements under which we provide our proprietary OLED materials to such manufacturers for evaluation and potential commercial application.

Relationships with Manufacturers for Other Commercial Products

In addition to our relationships with lighting and display manufacturers, we have agreements and arrangements with manufacturers or potential manufacturers to use our proprietary OLED technologies and materials in other commercial products, such as in automotive interiors and exteriors.

Our OLED Materials Manufacturing Business

We supply our proprietary UniversalPHOLED® materials to display manufacturers, lighting manufacturers and others. These materials are produced in batch quantities by PPG to our exacting product specifications using our manufacturing process and know-how. We qualify each batch of emitters at our device qualification facilities to ensure that they meet required specifications, and we store qualified product inventory for delivery to our customers. We believe that our inventory-carrying practices, along with the terms under which we sell our OLED materials (including payment terms), are typical for the markets in which we operate. In 2023, we completed successful Surveillance Audits on our ISO 9001:2015 Quality Management Systems, our ISO 14001:2015 Environmental Management Systems, and our ISO 45001:2018 Occupational Health and Safety Management Systems.

10

 

PPG

We have maintained a close working relationship with PPG since 2000. In 2011, we entered into an agreement with PPG, the term of which, by amendment in February 2021, continues through December 31, 2024, and thereafter is automatically renewed for additional one-year terms, unless terminated by us with prior notice of one year or terminated by PPG with prior notice of two years. Under that agreement, PPG is responsible, under our direction, for manufacturing scale-up of our proprietary OLED materials, and for supplying us with those materials. We use these materials for our own research and development as well as for resale to our customers, both for their evaluation and for use in commercial OLED products. Through our collaboration with PPG, key raw materials are sourced from multiple suppliers to ensure that we are able to meet the needs of our customers on a timely basis. We have not had any issues with obtaining access to adequate amounts of any key raw materials.

In February 2021, we entered into an amendment to the PPG agreement extending the term of the agreement and specifying operation and maintenance services that will be provided by PPG affiliate, PPG SCM Ireland Limited (PPG SCM), to UDC Ireland at our manufacturing site in Shannon, Ireland, which we began leasing at such time for the production of our OLED materials. We purchased the site in September 2023 and amended and restated the February 2021 amendment to the PPG agreement to reflect our ownership and PPG SCM’s updated operation and maintenance services after such purchase. When fully operational, the facility is expected to double our production capacity and allow for the diversification of our manufacturing base for phosphorescent emitters. The first phase of facility improvements has been completed and operations commenced in June 2022. As with our initial agreement with PPG, under our amended and restated 2021 amendment we compensate PPG on a cost-plus basis for the services provided at the Shannon manufacturing facility.

Collaborations with Other OLED Material Manufacturers

We continued our non-exclusive collaborative relationships with OLED material manufacturing customers during 2023. Most of these relationships are focused on combining our proprietary PHOLED emitters with hosts and other OLED materials of these companies in an effort to optimize our PHOLED emitter products and deliver a high-performance system to the end customer. Our product manufacturing customers are not required to purchase host materials from us. As a result, we do not believe these collaboration efforts will generate significant revenue for us as compared to our emitter and licensing businesses. We believe, however, that collaborative relationships such as these are important for ensuring success of the OLED industry and broader adoption of our PHOLED and other OLED technologies.

Research and Development

Our research and development activities are focused on the advancement of our OLED technologies and materials for displays, lighting and other applications. We conduct this research and development primarily internally and also through various relationships with commercial business partners, academic partners, and research institutions. Our venture capital company, UDC Ventures LLC, continues to seek to invest in companies that we believe are developing synergistic or complementary technologies to ours.

Internal Development Efforts

Ewing, New Jersey Facility

We conduct a substantial portion of our OLED development activities at our state-of-the-art development and testing facility in Ewing, New Jersey. At this expanded facility, which now exceeds 50,000 square feet, we perform technology development, including device and process optimization, prototype fabrication, manufacturing scale-up studies, process and product testing, characterization and reliability studies, and technology transfer with our business partners.

Our Ewing facility houses multiple OLED deposition systems, including numerous display fabrication tools and OVJP systems. In addition, the facility contains equipment for substrate patterning, organic material deposition, display packaging, module assembly and extensive testing in Class 100 and 100,000 clean rooms and opto-electronic test laboratories. Our facility also includes state-of-the-art synthetic and analytical chemistry laboratories in which we conduct OLED materials research and make small quantities of new materials that we then test in OLED devices.

Application Centers

In addition to our laboratory facilities in Ewing, New Jersey, we have Application Centers in Hong Kong and Pangyo, South Korea. These centers, which include state-of-the-art OLED laboratories, better assist our Asia-based customers in their timely evaluation and adoption of our proprietary PHOLED materials, know-how and technologies in their respective PHOLED designs. We purchased the real estate housing our Application Center in Pangyo, South Korea in May 2023.

11

 

Our Contract Development and Manufacturing Organization: Adesis, Inc.

In 2016, we acquired Adesis, Inc. (Adesis), a contract development and manufacturing organization (CDMO) that provides support services to the OLED, pharma, biotech, catalysis and other industries. Adesis currently operates in its headquarters facility, which it purchased in 2017 and consists of over 47,500 square feet in New Castle, Delaware, and in another, leased, over 40,000 square foot facility in Wilmington, Delaware. As of December 31, 2023, Adesis employed a team of 138 research scientists, chemists, engineers and laboratory technicians.

Although we expect to continue to utilize the majority of its technology research capacity for the benefit of our OLED technology development, Adesis is expected to continue operating as a CDMO in the above-mentioned industries.

University-Sponsored Research

Original Academic Partners

We have long-standing relationships with Princeton University (Princeton) and USC for the conduct of research relating to our OLED and other organic thin-film technologies and materials for applications such as displays and lighting. This research, subject to an agreement entered into by the parties (as amended, the 1997 Amended License Agreement) had been performed at Princeton under the direction of Professor Forrest and at USC under the direction of Professor Thompson. In 2006, Professor Forrest transferred to Michigan, where we continue to fund his research.

Since 2006, in connection with Dr. Forrest’s transfer, we entered into a new sponsored research agreement with USC under which we are funding organic electronics research being conducted by Drs. Forrest and Thompson (the 2006 Research Agreement). Work by Professor Forrest is being funded through a subcontract between USC and Michigan.

The 2006 Research Agreement extends through April 2024 with an option to further extend for an additional one-year period. We make payments under the 2006 Research Agreement to USC on a quarterly basis as actual expenses are incurred. As of December 31, 2023, we were obligated to pay USC up to $2.0 million for work to be performed during the remaining extended term.

Other Academic Relationships

Over the years, we have also entered into research agreements with various universities and research institutions that have been able to provide tailored research capabilities and insights relating to our PHOLED technology. As the utilization of PHOLED technology continues to expand, we intend to further engage key researchers at other universities and research institutions to help identify additional fundamental technologies that could benefit PHOLED technology implementation.

Intellectual Property

Along with our personnel, our primary and most fundamental assets are patents and other intellectual property. This includes more than 6,000 U.S. and foreign patents and patent applications that we own, exclusively license or have the sole right to sublicense. It also includes a substantial body of non-patented technical know-how that we have accumulated over time.

Our Patents

Our research and development activities, conducted both internally and through collaborative programs with third parties, have resulted in our filing of a substantial number of patent applications relating to our OLED technologies and materials. These patents that we own represent, among other things, innovations beyond the original fundamental PHOLED conceptual patents that we license from our university research partners, described below. Although many of these licensed fundamental conceptual patents have expired, our internal research efforts include essential innovations that have generated commercially viable implementations of the original PHOLED concepts and patents.

As of December 31, 2023, we owned more than 6,000 unexpired issued patents and pending patent applications around the world in addition to the hundreds of patents and patent applications we exclusively license from our research partners, as discussed below.

Patents We License from Research Partners

We exclusively license patent rights from a number of university research partners. Generally, we sponsor scientific researchers at universities to undertake pre-defined research programs, and in exchange we receive license rights to patents that may be developed under the programs. As part of these programs, we may provide compensation in the form of support for research program-related

12

 

activities, reimbursement for patent related costs, as well as providing for some forms of licensing and/or sublicensing fees for licensed technology that is commercialized by us or our customers. We have expanded our sponsored research programs over the past 10 years to include additional scientific researchers at a number of different institutions that we believe can provide breakthroughs in promising new fields of research that may benefit the OLED marketplace. As of December 31, 2023, the patent rights we exclusively license from all our university research partners included more than 626 issued patents and pending patent applications in jurisdictions around the world. Under our university patent license agreements, we are generally free to sublicense to third parties all or any portion of the licensed patent rights for the life of the licensed patents, though our rights are subject to termination for an uncured material breach or default by us, or if we become bankrupt or insolvent.

As part of our university license agreements, we may be required to compensate the universities to the extent we, or our sublicensees, utilize the licensed technology in commercial products. Under the 1997 Amended License Agreement we are required to pay Princeton royalties for licensed products sold by us or our sublicensees. These royalties amount to 3% of the net sales price for licensed products sold by us and 3% of the revenues we receive for licensed patents used by our sublicensees. We owed royalties under the 1997 Amended License Agreement of $575,000 for 2023.

Acquired Patents and Other Intellectual Property

From time to time we acquire patents and other intellectual property that we believe provide strategic business opportunities, such as the patent and technology portfolio we acquired from Motorola Solutions, Inc. (f/k/a Motorola, Inc.) (Motorola) in 2011, and the following portfolios from Fujifilm Corporation, BASF, and Merck KGaA:

Patents We Acquired from Fujifilm Corporation

In 2012, we entered into a Patent Sale Agreement (the Fujifilm Agreement) with Fujifilm. Under the Fujifilm Agreement, Fujifilm sold more than 1,200 OLED-related patents and patent applications for a total cost of $109.5 million. The Fujifilm Agreement contains customary representations and warranties and covenants, including respective covenants not to sue by both parties thereto. The Fujifilm Agreement permitted us to assign all of our rights and obligations under the Fujifilm Agreement to our affiliates, and we assigned, prior to the consummation of the transactions contemplated by the Fujifilm Agreement, our rights and obligations to UDC Ireland. The transactions contemplated by the Fujifilm Agreement were consummated on July 26, 2012.

Patents We Acquired from BASF

In 2016, UDC Ireland entered into an IP Transfer Agreement (the BASF Agreement) with BASF. Under the BASF Agreement, BASF sold us more than 500 OLED-related patents and patent applications for a total cost of $96.0 million. The transactions contemplated by the BASF Agreement were consummated on June 28, 2016.

Patents We Acquired from Merck KGaA

In 2023, UDC Ireland entered into a Patent Sale and License Agreement with Merck KGaA. Under this agreement, Merck KGaA sold to UDC Ireland all of its rights, title and interest to over 550 of its owned and licensed OLED-related patents and patent applications in exchange for a cash payment of $66.0 million. The Patent Sale and License Agreement contains customary representations, warranties and covenants of the parties. UDC Ireland recorded the payment of $66.0 million as acquired technology, which is being amortized over a period of 10 years. The transactions contemplated by the Merck KGaA Agreement were consummated on April 28, 2023.

Non-patented Technical Know-How

We have accumulated, and continue to accumulate, a substantial amount of non-patented technical know-how relating to OLED technologies and materials. Where practicable, we share portions of this information with display manufacturers and other business partners on a confidential basis. We also employ various methods to protect this information from unauthorized use or disclosure, although no such methods can afford complete protection. Moreover, because we derive some of this information and know-how from academic institutions, there is an increased potential for public disclosure. We also cannot prevent the actual independent development of the same or similar information and know-how by third parties.

Competition

The industry in which we operate is highly competitive. We compete against alternative display technologies, in particular LCDs, as well as other OLED technologies. We also compete in the lighting market against incumbent technologies, such as incandescent and fluorescent bulbs, and inorganic LEDs, and against emerging technologies, such as other OLED technologies.

13

 

Display Panel Industry Competitors

Numerous domestic and foreign companies have developed or are developing and improving LCD, which includes quantum dot LCDs (which are sometimes referred to as QLEDs), and other early-stage display technologies, including microLED technologies, that are attempting to compete with our OLED display technologies. OLED display technologies compete with LCDs, QLEDs and other display technologies for many product applications on the basis of lower power consumption, better contrast ratios, faster video rates, form factor and lower manufacturing cost. However, other companies may succeed in continuing to improve these competing display technologies, or in developing new display technologies, that are superior to OLED display technologies in various respects. We cannot predict the timing or extent to which such improvements or developments may occur.

Lighting Industry Competitors

Although there has been a movement to phase out traditional incandescent bulbs throughout many countries, traditional incandescent bulbs and fluorescent lamps remain well-entrenched products in the lighting industry. In addition, compact fluorescent lamps and solid-state LEDs have been introduced into the market and would compete with OLED lighting products. LEDs have realized significant market adoption in the general lighting market. Having attributes different from fluorescent lamps and LEDs, OLEDs may compete directly with these products for certain lighting applications. However, manufacturers of LEDs and compact fluorescent lamps may succeed in more broadly adapting their products to various lighting applications, or others may develop competing solid-state lighting technologies that are superior to OLEDs. Again, we cannot predict whether or when this might occur.

OLED Technologies and Materials Competitors

Eastman Kodak Company (Kodak) developed and patented the original fluorescent OLED technology in 1987. Cambridge Display Technology, Ltd. (CDT), which was acquired by Sumitomo Chemical Company in 2007, developed and patented polymer OLED technology in 1989. Display and lighting manufacturers, including customers of ours, are engaged in their own OLED research, development and commercialization activities, and have developed and may continue to develop proprietary OLED technologies and materials that are necessary or useful for commercial OLED devices. In addition, other material manufacturers, such as Sumitomo, Idemitsu Kosan Co., Ltd. (Idemitsu Kosan), Merck KGaA, Kyulux Inc., Summer Sprout Technology, UIV OLED, Aglaia Tech, Jilin OLED Photoelectric Materials Co., Ltd., and Nanjing Topto Semiconductor Materials Co., Ltd. are selling or sampling competing OLED materials to customers, including companies to which we sell our proprietary PHOLED materials.

Our licensing business is based on our control of a broad portfolio of OLED-related device patents and technologies. We believe this portfolio includes fundamental patents in the field of phosphorescent OLED materials and devices, as well as certain additional complementary OLED technologies. As discussed above, alternative technologies, such as fluorescent OLED emitter materials, exist and could be competitive to our phosphorescent OLED material solutions. However, fluorescent materials have characteristics that we believe many market participants consider less desirable than those of phosphorescent materials. Suppliers of fluorescent emitter materials include Solus Advanced Materials Co., Ltd., Dow Chemical (previously Gracel Display), Idemitsu Kosan and SFC Co. Ltd. Fluorescent materials may also be viewed as complementary in that they can be used in the same OLED stack as phosphorescent materials.

The competitive landscape with respect to our host materials business is characterized by a larger number of established chemical material suppliers who have long-term relationships with many of our existing customers and licensees. We have elected to partner with certain of these companies to manufacture and deliver host solutions to our customers, as well as selling our host materials directly to device manufacturers. We believe our competitive advantage stems, in part, from our deep knowledge of our phosphorescent emitter materials, which are complementary with the host solutions. We believe that our understanding of phosphorescent emitter materials enables us to create host material solutions that are especially well suited for use with a certain class of emitter materials that are implemented commercially today. However, we note that many of our technology partners have their own host solutions and the competitive landscape includes many well-established companies such as Solus Advanced Materials Co., Ltd., Dow Chemical, Duksan Neolux Co., Ltd., Idemitsu Kosan, Merck KGaA, NSCC, Beijing Sineva Technology Co., Ltd., China Ray, Lumilan, Eternal Material Technology (EMT) and Samsung SDI Co. Ltd. These companies have significant resources, and some may aggressively pursue such business in the future.

Our existing business relationships with SDC and other product manufacturers suggest that our OLED technologies and materials, particularly our PHOLED technologies and materials, may achieve a significant level of market penetration in the display and lighting industries. However, others, such as those working to develop thermally activated delayed fluorescence (TADF), may succeed in developing new OLED technologies, materials and alternative solutions that may supplement or be utilized in place of ours. We cannot be sure of the extent to which product manufacturers will adopt and continue to utilize our OLED technologies and materials for the production of commercial displays and lighting products.

14

 

Our Venture Capital Business: UDC Ventures LLC

Our wholly-owned subsidiary, UDC Ventures LLC, is a corporate venture capital entity that funds companies we believe are developing innovative products and technologies that may be synergistic or complementary to our business and/or business strategies or which may otherwise provide favorable investment opportunities.

Human Capital

As of December 31, 2023, we had 456 active employees, none of whom are unionized. Of these employees, 321 are research scientists, engineers and laboratory technicians at our domestic and international facilities. This team includes chemists, physicists, engineers and technicians with physics, electrical engineering, mechanical engineering and organic/inorganic chemistry backgrounds, and highly-trained theoreticians and experimentalists. We believe that relations with our employees are good.

Our goal is to be a diverse and inclusive company. Guided by our values, we are committed to creating a company where everyone is included and respected, and where we support each other in reaching our full potential. We are committed to diverse representation across all levels of our workforce to reflect the vibrant and thriving diversity of the communities in which we live and work. Women represent 40% of our executive management team, 21% of our leadership (Director level and above) and 22% of our total workforce, as well as 38% of our Board of Directors. We have employees from over 25 countries in our workforce, and we believe that a diverse workforce made up of people with different ideas, strengths, interests and cultural backgrounds drives employee and business success. In 2023 our voluntary turnover rate was 9%, and we had overall employee growth rate of 2%. Additional data, including historical turnover and diversity information, as well as our corporate policies relating to our employee engagement and human capital, are updated on our website www.oled.com, and included in our annual Corporate Responsibility Report.

Our Company History

Our corporation was organized under the laws of the Commonwealth of Pennsylvania in 1985. Our business was commenced in 1994 by a company then known as Universal Display Corporation, which had been incorporated under the laws of the State of New Jersey. In 1995, a wholly-owned subsidiary of ours merged into this New Jersey corporation. The surviving corporation in this merger became a wholly-owned subsidiary of ours and changed its name to UDC, Inc. Simultaneously with the consummation of this merger, we changed our name to Universal Display Corporation. UDC, Inc. functions as an operating subsidiary of ours and has certain overlapping officers and directors. We have also formed or acquired other wholly-owned subsidiaries, including Universal Display Corporation Hong Kong, Limited (2008), Universal Display Corporation Korea, Y.H. (2010), Universal Display Corporation Japan GK (2011), UDC Ireland Limited (2012), Universal Display Corporation China, Ltd. (2016), Adesis, Inc. (2016), UDC Ventures LLC (2019), OLED Material Manufacturing Limited (2020), and OVJP Corporation (2020), and we established a representative office in Taiwan (2011).

Our Compliance with Environmental Protection Laws

We are not aware of any material effects that compliance with Federal, state or local environmental protection laws or regulations will have on our business. We have not incurred substantial costs to comply with any environmental protection laws or regulations, and we do not anticipate having to do so in the foreseeable future.

Our Internet Site

Our Internet address is www.oled.com. We make available through our Internet website, free of charge, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after we file such material with the U.S. Securities and Exchange Commission (the SEC). The SEC maintains a website that contains these reports as well as proxy statements and information regarding issuers who file electronically, with the address www.sec.gov. In addition, we have made available on our Internet website under the heading “Corporate Governance” the charter for the Audit Committee of our Board of Directors, the charter for the Human Capital Committee of our Board of Directors, the charter for the Nominating & Corporate Governance Committee of our Board of Directors, our Code of Ethics & Business Conduct for Employees, our Code of Conduct for Directors, and our Corporate Governance Guidelines. We intend to make available on our Internet website any future amendments or waivers to our Code of Ethics & Business Conduct for Employees and our Code of Conduct for Directors. The information on our Internet website is not part of this report.

15

 

INFORMATION ABOUT OUR EXECUTIVE OFFICERS

The following table sets forth certain information with respect to our executive officers as of February 22, 2024:

 

Name

 

Age

 

 

Position

Steven V. Abramson

 

 

72

 

 

President, Chief Executive Officer and Director

Julia J. Brown

 

 

62

 

 

Executive Vice President and Chief Technical Officer

Janice K. Mahon

 

 

66

 

 

Senior Vice President of Technology Commercialization and General Manager, Commercial Sales Business

Brian Millard

 

 

41

 

 

Vice President, Chief Financial Officer and Treasurer

Mauro Premutico

 

 

58

 

 

Senior Vice President, Planning, Chief Legal Officer and Secretary

 

Our Board of Directors has appointed these executive officers to hold office until their successors are duly appointed.

Steven V. Abramson is our President and Chief Executive Officer, and has been a member of our Board of Directors since May 1996. Mr. Abramson served as our President and Chief Operating Officer from May 1996 through December 2007. From March 1992 to May 1996, Mr. Abramson was Vice President, General Counsel, Secretary and Treasurer of Roy F. Weston, Inc., a worldwide environmental consulting and engineering firm. From December 1982 to December 1991, Mr. Abramson held various positions at InterDigital, Inc., including General Counsel, Executive Vice President and General Manager of the Technology Licensing Division.

Julia J. Brown, Ph.D. became our Executive Vice President in April 2021, prior to which she served as a Senior Vice President since June 2008. She has been our Chief Technical Officer since June 2002 and joined us in June 1998 as our Vice President of Technology Development. From 1991 to 1998, Dr. Brown was a Research Department Manager at Hughes Research Laboratories where she directed the pilot line production of high-speed Indium Phosphide-based integrated circuits for insertion into advanced airborne radar and satellite communication systems. Dr. Brown received an M.S. and Ph.D. in Electrical Engineering/Electrophysics at USC and a B.S.E.E. from Cornell University. Dr. Brown holds a number of distinguished elected awards including Fellow of the Institute of Electrical and Electronics Engineers (IEEE), Fellow of the Society of Information Display (SID), and the National Academy of Engineers (NAE).

Janice K. Mahon became our Senior Vice President, Technology Commercialization and General Manager, Commercial Sales Business in April 2021, and previously served as our Vice President of Technology Commercialization since January 1997, and General Manager of our PHOLED Material Sales Business since January 2007. From 1992 to 1996, Ms. Mahon was Vice President of SAGE Electrochromics, Inc., a thin-film electrochromic technology company, where she oversaw a variety of business development, marketing, finance and administrative activities. From 1984 to 1989, Ms. Mahon was a Vice President and General Manager for Chronar Corporation, a leading developer and manufacturer of amorphous silicon photovoltaic (PV) panels. Prior to that, Ms. Mahon worked as Senior Engineer for the Industrial Chemicals Division of FMC Corporation. Ms. Mahon received her B.S. in Chemical Engineering from Rensselaer Polytechnic Institute in 1979, and an M.B.A. from Harvard University in 1984. Ms. Mahon was a member of the Technical Council of the FlexTech Alliance from 1997 through 2010, and a member of its Governing Board from 2008 through 2010. Ms. Mahon was a member of the Board of Directors and Marketing Committee Chairperson of the OLED Association from 2009-2014.

Brian Millard is our Vice President, Chief Financial Officer and Treasurer. Mr. Millard joined us in September 2022 with more than 15 years of financial, operational and strategic experience across several industries. Prior to joining us, Mr. Millard served as Senior Vice President, Finance and Corporate Controller at Emergent BioSolutions from January 2020 to September 2022 and as Vice President, Corporate Controller from October 2017 to January 2020. Previously, Mr. Millard served as Vice President, Corporate Controller at Hertz Global Holdings, Inc., from August 2015 to October 2017 and Assistant Corporate Controller from March 2014 to August 2015. Mr. Millard also served in financial reporting leadership roles at Hilton Worldwide Holdings, Inc. Mr. Millard began his career at Deloitte & Touche LLP. He received his M.S. and B.B.A. degrees in accounting from James Madison University and is a licensed certified public accountant.

Mauro Premutico has served as our Secretary since September 2022, and our Senior Vice President, Planning, and Chief Legal Officer since April 2021. He previously served as our Vice President of Legal and General Manager of Patents and Licensing since April 2012. Prior to joining us, Mr. Premutico was the Managing Vice President and Chief Patent Counsel for The Walt Disney Company from 2009 to 2012, and Vice President of Intellectual Property and Associate General Counsel for Lenovo Group Ltd. from 2005 to 2009. Mr. Premutico received a J.D. from Boston University School of Law, an M.B.A. from Yale University, and a B.S.E.E. from Worcester Polytechnic Institute.

16

 

ITEM 1A. RISK FACTORS

You should carefully consider the following risks and uncertainties when reading this Annual Report on Form 10-K. The following factors, as well as other factors affecting our operating results and financial condition, could cause our actual future results and financial condition to differ materially from those projected.

Risks Related to Our Intellectual Property

If we cannot obtain and maintain appropriate patent and other intellectual property protection for our OLED technologies and materials, our business will suffer.

The value of our OLED technologies and materials is dependent on our ability to secure and maintain appropriate patent and other intellectual property rights protection. Although we own or license many patents respecting our OLED technologies and materials that have already been issued, there can be no assurance that additional patents applied for will be obtained, or that any of these patents, once issued, will afford commercially significant protection for our OLED technologies and materials, or will be found valid if challenged. Also, there is no assurance that we will be successful in defending the validity of our current or future patents in pending and future patent oppositions, invalidation trials, interferences, reexaminations, reissues, or other administrative or court proceedings. Moreover, we have not obtained patent protection for some of our OLED technologies and materials in all foreign countries in which OLED products or materials might be manufactured or sold.

We believe that the strength of our current intellectual property position results primarily from the essential nature of our fundamental patents covering phosphorescent OLED devices and certain materials utilized in these devices. Certain of our existing fundamental phosphorescent OLED patents expired in the United States in 2017 and 2019; and expired in other countries of the world in 2018 and 2020. While we hold a wide range of additional patents and patent applications relating to our commercial OLED materials and technologies whose expiration dates extend (and in the case of patent applications, will extend) beyond 2023, many of which are also of importance in the OLED industry, none may be of an equally essential nature as our original fundamental patents, and therefore our competitive position may be less certain as a result of the expiration of these patents.

We have more than 6,000 issued and pending patents relating to our OLED technologies. There is no assurance that these patents and applications will not be challenged prior to their respective expirations in any of the jurisdictions in which they are utilized, or that if challenged, we will be able to secure sufficient breadth of protection, and monetary and injunctive relief for the violation of our rights to make up for the business harm resulting from such activities. Moreover, there can be no assurance that competitors will not develop or produce competing PHOLED material designs that may be outside of our existing patents. There may also be fundamental new advancements in the field of OLED technology that could enable the commercial use of older and unpatented PHOLED materials or the adoption of new OLED materials that do not require the utilization of our proprietary PHOLED materials to achieve superior performance characteristics.

We may become engaged in litigation to protect or enforce our patent and other intellectual property rights, or in International Trade Commission proceedings to abate the importation of goods that would compete unfairly with those of our licensees. In addition, we are participating in or have participated in, and in the future will likely have to participate in, interference, reissue, or reexamination proceedings before the U.S. Patent and Trademark Office, and opposition, nullity or other proceedings before foreign patent offices, with respect to some of our patents or patent applications. All of these actions place our patents and other intellectual property rights at risk and may result in substantial costs to us as well as a diversion of management attention from our business and operations. Moreover, if successful, these actions could result in the loss of patent or other intellectual property rights protection for the key OLED technologies and materials on which our business depends.

We rely, in part, on several non-patented proprietary technologies to operate our business. Others may independently develop the same or similar technologies or otherwise obtain access to our unpatented technologies. Furthermore, these parties may obtain patent protection for such technology, inhibiting or preventing us from practicing the technology. To protect our trade secrets, know-how and other non-patented proprietary information, we require employees, consultants, financial advisors and strategic partners to enter into confidentiality agreements. These agreements may not ultimately provide meaningful protection for our trade secrets, know-how or other non-patented proprietary information. In particular, we may not be able to fully or adequately protect our proprietary information as we conduct discussions with potential strategic partners.

Additionally, although we take many measures and implement safeguards to prevent unauthorized use, including by theft and misuse, of our intellectual property and proprietary information, third parties may attempt to obtain, copy, reverse-engineer, use or disclose, illegally or otherwise, such intellectual property and proprietary information. We also may face attempts by others to gain unauthorized access through the Internet to our information technology systems or to our intellectual property, which might be the result of industrial or other espionage or actions by hackers seeking to harm our company or its products. If we are unable to protect the proprietary nature of our intellectual property and proprietary information, it will harm our business.

17

 

We or our customers may incur substantial costs or lose important rights as a result of litigation or other proceedings relating to our patent and other intellectual property rights or with respect to our OLED materials business.

There are a number of other companies and organizations that have been issued patents and are filing patent applications relating to OLED technologies and materials, including, without limitation, Kodak (substantially all of whose OLED assets were sold to a group of LG companies in 2009), CDT (acquired by Sumitomo in 2007), Canon, Inc., Semiconductor Energy Laboratories Co., Idemitsu Kosan and Mitsubishi Chemical Corporation. In addition, some of our customers such as SDC and LG Display have been issued patents and are filing patent applications relating to OLED technologies and materials. As a result, there may be issued patents or pending patent applications of third parties that would be infringed by the use of our OLED technologies or materials, thus subjecting our customers to possible suits for patent infringement in the future. Such lawsuits could result in our customers being liable for damages or require our customers to obtain additional licenses that could increase the cost of their products. This, in turn, could have an adverse effect on our customers’ sales and thus our royalties or material sales revenues, or cause our customers to seek to renegotiate our royalty rates or pricing. In addition, we have agreed to indemnify customers purchasing our OLED materials for commercial usage against certain claims of patent infringement by third parties, as a result of which we may incur substantial legal costs in connection with defending these customers from such claims.

Our licensees may also seek to avoid paying future royalties by attempting to have our patents declared invalid and unenforceable by a court. Our licensees may be more likely to file such declaratory actions in light of the U.S. Supreme Court’s decision in MedImmune, Inc. v. Genentech, Inc. (2007), in which the Court found that a licensee need not refuse to pay royalties and commit material breach of the license agreement before bringing an action to declare a licensed U. S. patent invalid and unenforceable.

In addition, we may be required, from time-to-time, to assert our intellectual property rights by instituting legal proceedings against others. We cannot be assured that we will be successful in enforcing our patents in any lawsuits we may commence. Defendants in any litigation we may commence to enforce our patents may attempt to establish that our patents are invalid or are unenforceable. Thus, any patent litigation we commence could lead to a determination that one or more of our patents are invalid or unenforceable. If a third party succeeds in invalidating one or more of our patents, that party and others could compete more effectively against us. Our ability to derive licensing revenues from products or technologies covered by these patents would also be adversely affected.

Whether our customers are defending the assertion of third-party intellectual property rights against their businesses arising as a result of the use of our technology, or we are asserting our own intellectual property rights against others, such litigation can be complex, costly, protracted and highly disruptive to our or our customers’ business operations by diverting the attention and energies of management and key technical personnel. As a result, the pendency or adverse outcome of any intellectual property litigation to which we or our customers are subject could disrupt business operations, require the incurrence of substantial costs and subject us or our customers to significant liabilities, each of which could severely harm our business. Costs associated with these actions are likely to increase as AMOLED products using our PHOLED and other OLED technologies and materials continue to enter the consumer marketplace.

Plaintiffs in intellectual property cases often seek injunctive relief in addition to money damages. Any intellectual property litigation commenced against our customers may force them to take actions that could be harmful to their businesses and thus to revenues, including the halting of sales of products that incorporate or otherwise use our technology or materials.

Furthermore, the measure of damages in intellectual property litigation can be complex and is often subjective or uncertain. If our customers were to be found liable for infringement of proprietary rights of a third party, the amount of damages they might have to pay could be substantial and is difficult to predict. Decreased sales of our customers’ products incorporating our technology or materials would have an adverse effect on our royalty revenues under existing licenses and material sales under our existing sales agreements. Were this to occur, it would likely harm our ability to (i) obtain new licensees which would have an adverse effect on the terms of the royalty arrangements we could enter into with any new licensees, and (ii) sell our UniversalPHOLED® materials to existing and new customers. Moreover, to the extent any third party claims are directed specifically to materials supplied by us to our customers, we may be required to incur significant costs associated with the defense of such claims and potential damages associated with such claims that may be awarded against our customers.

As is commonplace in technology companies, we employ individuals who were previously employed at other technology companies. To the extent our employees are involved in research areas that are similar to those areas in which they were involved at their former employers, we may be subject to claims that such employees or we have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of the former employers. Litigation may be necessary to defend against such claims. The costs associated with these actions or the loss of rights critical to our or our customers’ businesses could negatively impact our revenues or cause our business to fail.

18

 

Recent court decisions in various patent cases may make it more difficult for us to obtain future patents, enforce our patents against third parties or obtain favorable judgments in cases where the patents are enforced.

Recent case law may make it more difficult for patent holders to secure future patents and/or enforce existing patents. For example, in KSR International Co. vs. Teleflex, Inc. (2007), the U.S. Supreme Court mandated a more expansive and flexible approach to determine whether a patent is obvious and invalid. As a result of the less rigid approach to assessing obviousness, defending the validity of or obtaining patents may be more difficult.

Recent court decisions may also impact the enforcement of our patents. For example, we may not be able to enjoin certain third party uses of products or methods covered by our patents following the initial authorized sale, even where those uses are expressly proscribed in an agreement with the buyer. Also, we may face increased difficulty enjoining infringement of our patents. The U.S. Supreme Court has held that an injunction should not automatically issue based on a finding of patent infringement, but should be determined based on a test balancing considerations of the patentee’s interest, the infringer’s interest, and the public’s interest. Obtaining enhanced damages for willful infringement of our patents may also be more difficult even in those cases where we successfully prove a third party has infringed our patents, as a recent case set a more stringent standard for proving willful infringement.

Therefore, as a result of such rulings, it may be more difficult for us to defend our currently issued patents, obtain additional patents in the future or achieve the desired competitive effect even when our patents are enforced. If we are unable to so defend our currently issued patents, or to obtain new patents for any reason, our business would suffer.

Risks Related to Our Business and Operations

If we cannot form and maintain lasting business relationships with OLED product manufacturers, our business strategy will fail.

Our business strategy ultimately depends upon our development and maintenance of commercial licensing and material supply relationships with high-volume manufacturers of OLED products. We have entered into a limited number of such relationships from which most of our material sales and licensing revenue are generated. Our other relationships with product manufacturers currently are limited to technology development and the evaluation of our OLED technologies and materials for possible use in commercial products. Some or all of these relationships may not succeed or, even if they are successful, may not result in the product manufacturers entering into commercial licensing and material supply relationships with us.

Many of our agreements with product manufacturers last for only limited periods of time, such that our relationships with these manufacturers will expire unless they are renewed. These product manufacturers may not agree to renew their relationships with us on a continuing basis or may agree to do so on terms that are less favorable to us. In addition, we regularly continue working with product manufacturers after our existing agreements with them have expired while we are attempting to negotiate contract extensions or new agreements with them. Should our relationships with the various product manufacturers not continue or be renewed on less favorable terms, or if we are not able to identify other product manufacturers and enter into contracts with them, our business may materially suffer.

Our ability to enter into additional commercial licensing and material supply relationships, or to maintain our existing relationships, may depend on our ability to make certain financial or other commitments. We might not be able, for financial or other reasons, to enter into or continue these relationships on commercially acceptable terms, or at all. Failure to do so may cause our business strategy to fail.

If we fail to continue to make advances in our OLED research and development activities, we might not succeed in continuing to commercialize our OLED technologies and materials.

Further advances in our OLED technologies and materials depend, in part, on the success of the research and development work we conduct, both alone and with our research partners. We cannot be certain that this work will yield additional advances in the research and development of these technologies and materials.

Our research and development efforts remain subject to all of the risks associated with the development of new products based on emerging and innovative technologies, including, without limitation, unanticipated technical or other problems and the possible insufficiency of funds for completing development of these products. Technical problems may result in delays and cause us to incur additional expenses that would increase our losses. If we cannot complete research and development of our OLED technologies and materials successfully, or if we experience delays in completing research and development of our OLED technologies and materials for use in potential commercial applications, particularly after incurring significant expenditures, our business may fail.

19

 

Conflicts or other problems may arise with our customers or joint development partners, resulting in renegotiation, breach or termination of, or litigation related to, our agreements with them. This would adversely affect our revenues.

Conflicts or other problems could arise between us and our customers or joint development partners, some of which we have made strategic investments in, as to royalty rates, milestone payments or other commercial terms. Similarly, we may disagree with our customers or joint development partners as to which party owns or has the right to commercialize intellectual property that is developed during the course of the relationship or as to other non-commercial terms. If such a conflict were to arise, a customer or joint development partner might attempt to compel renegotiation of certain terms of their agreement or terminate their agreement entirely, and we might lose the royalty revenues, material sales revenues and other benefits of the agreement. Either we or the customer or joint development partner might initiate litigation to determine commercial obligations, establish intellectual property rights or resolve other disputes under the agreement. Such litigation could be costly to us and require substantial attention of management. If we were unsuccessful in such litigation, we could lose the commercial benefits of the agreement, be liable for financial damages and suffer losses of intellectual property or other rights that are the subject of dispute.

If our OLED technologies and materials are not feasible for broad-based product applications, we may not be able to continue to generate revenues sufficient to support ongoing operations.

Our main business strategy is to sell our OLED materials and license our OLED technologies to manufacturers for incorporation into the display and lighting products that they sell. Consequently, our success depends on the ability and willingness of manufacturers to continue to develop, manufacture and sell commercial products integrating our technologies and materials.

Before product manufacturers will agree to expand the use of our OLED technologies and materials for wider scale commercial production, they will likely require us to demonstrate to their satisfaction that our OLED technologies and materials are feasible for broad-based product applications beyond current commercial application, such as smartphones, wearables and television displays. This, in turn, may require additional advances in our technologies and materials, as well as those of others, for applications in a number of areas, including, without limitation, advances with respect to the development of:

•
OLED materials with improved lifetimes, efficiencies and color coordinates for larger area full-color OLED displays and general lighting products;
•
more robust OLED materials for use in more demanding large-scale manufacturing environments; and
•
scalable and cost-effective methods and technologies for the fabrication of large volume OLED materials and products.

We cannot be certain that these advances will occur, and hence our OLED technologies and materials may not be feasible for additional broad-based product applications and expansion.

Even if our OLED materials and technologies are technically feasible, they may not be further adopted by product manufacturers for broad-based product applications.

The potential size, timing and viability of market opportunities targeted by us remain uncertain. Market acceptance of our OLED materials and technologies beyond current product offerings and sales volumes will depend, in part, upon these materials and technologies providing benefits comparable or superior to competing display and lighting technologies at an advantageous cost to manufacturers, and the adoption of products incorporating these technologies by consumers. Many current and potential customers for our OLED technologies utilize and have invested significant resources in competing technologies, and may, therefore, be reluctant to redesign their products or manufacturing processes to incorporate our OLED technologies.

During the entire product development process for a new product, we face the risk that our materials or technologies will fail to meet the manufacturer’s technical, performance or cost requirements or will be replaced by a competing product or alternative technology. Even if we offer materials and technologies that are satisfactory to a product manufacturer, the manufacturer may choose to delay or terminate its product development efforts for reasons unrelated to our materials or technologies. In addition, our agreements with our customers do not require them to purchase our host materials to utilize our phosphorescent emitter materials, and those customers may elect not to purchase our host materials.

Mass production of new mass market OLED products will require the availability of suitable manufacturing equipment, components and materials, many of which are available only from a limited number of suppliers. In addition, there may be a number of other technologies that manufacturers need to utilize in conjunction with our OLED technologies in order to bring these new OLED products to the market. Thus, even if our OLED technologies are a viable alternative to competing approaches, if product manufacturers are unable to obtain access to this equipment and these components, materials and other technologies, they may not utilize our OLED technologies.

20

 

There are numerous potential alternatives to OLEDs, which may limit our ability to commercialize our OLED technologies and materials.

The display market remains dominated by displays based on LCD technology. Numerous companies are making substantial investments in, and conducting research to improve characteristics of, LCDs; additionally, other competing display technologies have been, or are being, developed, like microLED. A similar situation exists in the solid-state lighting market, which is currently dominated by LED products. Advances in any of these various technologies may overcome their current limitations and permit them to become the leading technologies in their field, either of which could limit the potential market for products utilizing our OLED technologies and materials. This, in turn, would cause product manufacturers to avoid entering into commercial relationships with us, or to terminate or not renew their existing relationships with us.

Other OLED technologies may be more successful or cost-effective than ours, which may limit the commercial adoption of our OLED technologies and materials.

Our competitors have developed and continue to develop OLED technologies that differ from or compete with our OLED technologies. In particular, competing fluorescent and thermally activated delayed fluorescence OLED technology may become a viable alternative to our phosphorescent OLED technology. Moreover, our competitors may succeed in developing new OLED technologies that may become more cost-effective or have fewer limitations than our OLED technologies. If our OLED technologies, and particularly our phosphorescent OLED technology, are unable to continue to capture a substantial portion of the OLED product market, our business strategy may fail.

The consumer electronics industry experiences significant downturns from time to time, any of which may adversely affect the demand for and pricing of our OLED technologies and materials.

Our success depends upon the ability and continuing willingness of our customers to manufacture and sell products utilizing our technologies and materials, specifically our phosphorescent emitters and host materials, and the widespread acceptance of our customers’ products in the consumer marketplace. Any slowdown in the demand for our customers’ products or a decrease in our customers’ use of or demand for our materials would adversely affect our material sales and royalty revenues and thus our business. Our customers’ decrease in the use of or demand for our materials may depend on several factors, including pricing, availability, continued technical improvements and competitive product offerings. The markets for flat panel displays and lighting products are highly competitive. Success in the market for end-user products that may integrate our OLED technologies and materials also depends on factors beyond the control of our customers and us, including the cyclical and seasonal nature of the end-user markets that our customers serve, as well as industry and general economic conditions.

The markets that we hope to penetrate have experienced significant periodic downturns, often in connection with, or in anticipation of, declines in general economic conditions. These downturns have been characterized by lower product demand, production overcapacity and erosion of average selling prices. Our business strategy is dependent on manufacturers building and selling products that incorporate our OLED technologies and materials. Industry-wide fluctuations and downturns in the demand for displays and solid-state lighting products could cause significant harm to our business.

Our customers may develop new or more efficient manufacturing processes, which may adversely affect demand for our OLED materials.

By developing enhanced material processing methods and more efficient manufacturing techniques, our customers who purchase our phosphorescent emitter and host materials could become more efficient in the utilization of our materials by developing designs that require less materials on a per square meter basis, or by modifying their manufacturing process to make more efficient use of our materials, which could limit or reduce the amount of materials they purchase from us. Thus, demand for our materials may not expand in proportion to the number of OLED related products manufactured by our customers, and may result in reduced demand for our materials and technologies relative to our customers' manufacture and sale of products made with such materials.

Epidemics, pandemics, disease outbreaks and other public health crises could have a material adverse effect on our operations and business.

As we experienced in the past during the COVID-19 epidemic and pandemic, such events could negatively impact the global economy, disrupt consumer spending and global supply chains, and create significant volatility and disruption of financial markets, which in turn could have a material adverse effect on our business, financial condition and results of operations. The extent of such impact would depend on factors such as the duration and severity of the event, which would likely be difficult to predict.

21

 

Any downturn in U.S. or global economic conditions may have a significant adverse effect on our business.

There have been significant and sustained economic downturns in the U.S. and globally in the past. These downturns have placed pressure on consumer demand, and the resulting impact on consumer spending has had a material adverse effect on the demand for consumer electronic products. Similar downturns in the future may have a significant adverse effect on one or more of our licensees as an enterprise, which could result in those licensees reducing their efforts to commercialize products that incorporate our OLED technologies and materials. Consumer demand and the condition of the display and lighting industries may also be impacted by other external factors such as war, terrorism, geopolitical uncertainties, epidemics and other business interruptions. The impact of these external factors is difficult to predict, and one or more of these factors could adversely impact the demand for our customers’ products, and thus our business.

Heightened levels of inflation and the potential worsening of macro-economic conditions, including slower growth or recession, changes to fiscal and monetary policy, tighter credit, higher interest rates and currency fluctuations, present a risk for us, our suppliers and the display and lighting industries in general. If inflation remains at current levels for an extended period, or increases, and we are unable to successfully mitigate the impact, our costs are likely to increase, resulting in pressure on our profits, margins and cash flows, particularly for existing fixed-price contracts. In addition, our business could be adversely impacted if our customers experience budget, inflationary or other pressures, such as increases in the cost of borrowing from rising interest rates.

Many of our competitors have greater resources and are based in the same Asia-Pacific countries where our significant customers are located, which may make it difficult for us to compete successfully against them.

The display and solid-state lighting industries are characterized by increasingly intense competition. Many of our competitors have better name recognition and greater financial, technical, marketing, personnel and research capabilities than we do. Also, many of them are based in the same Asia-Pacific countries where our customers’ operations are located, and as such they may receive preference from such countries and/or not be subject to the same laws, regulations and requirements as we are. Because of these differences, we may never be able to compete successfully in these markets or maintain any competitive advantages we are able to achieve over time.

If we cannot keep our key employees or hire other talented persons as we grow, our business might not succeed.

Our performance is substantially dependent on the continued services of our executive officers and other key technical and managerial personnel, and on our ability to offer competitive salaries and benefits to these and our other employees. We do not have employment agreements with any of our executive officers or other key technical or managerial personnel that require them to continue to work for us for any specified period and, therefore, they could terminate their employment with us at any time. Additionally, competition for highly skilled technical and managerial personnel is intense. We might not be able to attract, hire, train, retain and motivate the highly skilled employees we need to be successful. If we fail to attract and retain the necessary technical and managerial personnel, our business will suffer and might fail.

We rely solely on PPG to manufacture the OLED materials we use and sell to product manufacturers.

Our business prospects depend significantly on our ability to obtain proprietary OLED materials for our own use and for sale to product manufacturers. Our agreement with PPG provides us with a source for these materials for development, evaluation and commercial purposes. Our agreement with PPG currently runs through the end of 2024 and shall be automatically renewed for additional one-year terms, unless terminated by us with prior notice of one year or terminated by PPG with prior notice of two years. Our inability to continue obtaining these OLED materials from PPG or another source at cost-competitive prices and to continue obtaining these OLED materials in sufficient quantities to meet our product manufacturers' current and future demands and timetables would have a material adverse effect on our revenues and cost of goods sold relating to sales of these materials to OLED product manufacturers, as well as on our ability to perform future development work.

Additionally, PPG manufactures our materials at facilities based in the United States and Ireland, which materials we then predominantly export to our customers that have manufacturing locations in countries in the Asia-Pacific region. As a result, such materials may be subject to tariffs, export restrictions or other barriers from or to these countries and/or customers.

Inflationary pressures and persistently high prices and uncertain availability of raw materials or other inputs used by us and our suppliers, or instability in logistics and related costs, could negatively impact our profitability.

Increases in prices, including as a result of inflation and rising interest rates, for raw materials or other inputs that we and our suppliers use in manufacturing our OLED materials, or increases in logistics and related costs, have led and may continue to lead to higher production costs for our materials. In addition, any increase in the cost or reduced availability of critical materials for our OLED materials could lead to higher production costs. Further, uncertain supply of such materials could disrupt our or our suppliers’ ability to

22

 

obtain such materials in a timely manner and/or could lead to increased costs. Geopolitical risks and crises, fluctuations in supply and demand, fluctuations in interest rates, any weakening of the U.S. dollar, and other economic and political factors have created and may continue to create pricing pressure for raw materials and other inputs. These inflationary pressures could, in turn, negatively impact our profitability because we may not be able to pass these costs on to our customers or require our suppliers to absorb such costs.

We strive to maintain sufficient levels of inventory to accommodate our manufacturing customers. Inventory management relating to our material sales is complex, and excess inventory may harm our business and cause it to suffer.

Inventory management remains an area of focus as we balance the need to maintain strategic inventory levels of our OLED materials to ensure competitive lead times against the risk of inventory obsolescence because of rapidly changing technology and customer requirements. As a just-in-time supplier to our customers, we carry sufficient inventory to accommodate their capacity requirements, sometimes without firm purchase commitments. Our dependence on third-party manufacturers to provide our materials to us exposes us to longer lead times than if we were a direct manufacturer, increasing our risk of inventory obsolescence comparatively. Our customers may increase orders during periods of product shortages, cancel orders if their inventory is too high, or delay orders in anticipation of new products. They also may adjust their orders in response to the supply and demand of their products by end-users, or the supply and demand of our products and the products of our competitors that are available to them.

Inventory management risks are heightened when our largest customers launch new products and retire existing products. At such times, these customers tend to change product designs and may introduce some of our new materials into new designs. The production of these materials requires us to purchase essential raw material and commence manufacturing well in advance of receiving firm customer orders for such materials. Accordingly, we are subject to the risk of unanticipated changes in our customers’ manufacturing plans and designs. Unanticipated product cessation and product introduction delays or cancellation may cause us to order or produce excess or insufficient inventory. Excess inventory of our OLED materials is subject to the risk of inventory obsolescence. In the event that a substantial portion of our inventory becomes obsolete, it could have a material adverse effect on earnings due to the resulting costs associated with the inventory impairment charges and inventory write-downs.

We are the sole source supplier for certain critical components used in OLED technologies, which subjects customers to risk if we are unable to meet the demand for such components.

Our customers depend on us as the sole source for certain proprietary PHOLED materials used in manufacturing OLED products, which makes them susceptible to supply shortages if we are unable to meet their demand for such components. A potential customer could be hesitant to adopt OLED technology given the risks inherent in depending on a sole source for critical components and the inability to establish alternate supply relationships. If we are unable to supply the components needed by our existing customers in a timely manner, or if potential customers do not utilize OLED technology because of concerns about our ability to meet supply demands, our business may materially suffer.

Because the vast majority of OLED product manufacturers are located in the Asia-Pacific region, we are subject to international operational, financial, legal and political risks which may negatively impact our operations.

Many of our customers and prospective customers have a majority of their operations in countries other than the United States, particularly in the Asia-Pacific region, and revenue outside the United States represents a majority of our total net revenue. We also have offices in various countries located outside of the United States. Risks associated with our doing business outside of the United States include, without limitation:

•
compliance with a wide variety of U.S. and foreign laws and regulations, including foreign anti-corruption and export laws, and certain registration and licensing requirements for the OLED materials we sell;
•
legal uncertainties on doing business in certain countries or with certain parties regarding taxes, tariffs, quotas, export controls, export licenses and other trade barriers;
•
economic instability in the countries of our customers, causing delays or reductions in orders for their products and therefore our royalties;
•
political instability in the countries in which we and/or our customers operate, particularly in South Korea relating to its disputes with and proximity to North Korea, in Hong Kong relating to anti-government protests and in Taiwan relating to its disputes with China;
•
third party theft or compromise of our products, technology, data or intellectual property, including by means of counterfeiting or reverse-engineering;
•
difficulties in collecting accounts receivable and longer accounts receivable payment cycles;

23

 

•
fluctuations in foreign currency exchange rates for any revenues or expenses not denominated in U.S. dollars;
•
potentially adverse tax and tariff consequences; and
•
trade conflicts between and among various geopolitical factions that could result in trade restrictions being placed on our business and sale of OLED materials.

Any of these factors could impair our ability to license our OLED technologies and sell our OLED materials, thereby harming our business. Compliance with changing laws and regulations may involve significant costs or require changes in business practice that could result in reduced profitability.

We rely on information technology systems to operate various elements of our business and a cyber-attack or other breach of our systems, or those of third parties on whom we may rely, could subject us to liability or interrupt the operation of our business.

We are dependent on information technology systems to operate various elements of our business. A breakdown, invasion, corruption, destruction or interruption of critical information technology systems by employees, others with authorized access to our systems or unauthorized persons could negatively impact operations. In the ordinary course of business, we collect, store and transmit important data and it is critical that we do so in a secure manner to maintain the confidentiality and integrity of such information. Additionally, we outsource certain elements of our information technology systems to third parties. As a result of this outsourcing, our third-party vendors may or could have access to our confidential information making such systems vulnerable. Data breaches of our information technology systems, or those of our third-party vendors, may pose a risk that sensitive data may be exposed to unauthorized persons or to the public. While we believe that we have taken appropriate security measures to protect our data and information technology systems, and have been informed by our third-party vendors that they have as well, there can be no assurance that our efforts will prevent breakdowns or breaches in our systems, or those of our third-party vendors, that could adversely affect our business.

Natural disasters or other unforeseen catastrophic events could unfavorably affect our business.

Natural disasters, such as hurricanes, tsunamis, or earthquakes, particularly in Asia-Pacific region, where many of our customers are located, or the occurrence of other unforeseen catastrophic events, such a fire or flood, could unfavorably affect our business and financial performance. Such events could unfavorably affect our customers in many ways, such as causing physical damage to one or more of their properties, the temporary or permanent closure of one or more plants, the disruption or cessation of manufacturing of product lines, and the temporary or long-term disruption in the supply or demand for their products. A resulting by-product of such natural disasters or other unforeseen catastrophic events could be a temporary or long-term disruption in the supply of or demand for our products.

Risks Related to Legal, Regulatory and Tax Matters

We may be subject to environmental and export laws and regulations, including without limitation those associated with the effects of climate change, that impose additional compliance costs and that could negatively impact our business.

Changes in environmental and export laws or regulations of our products could result in higher operating and compliance expenses and limit the markets in which we can manufacture and to which markets and customers we can export and sell our products. Changes in environmental and export laws or regulations, including laws relating to manufacturing operations and export restrictions, also could lead to new or additional investment in product designs and an increase in raw materials costs, and could increase our environmental and export compliance expenditures. Some of these laws and regulations may be changed or augmented as governments and regulatory bodies seek to address the effects of climate change and export compliance. If environmental and/or export laws or regulations are either changed or adopted and impose additional operational restrictions and compliance requirements upon us or our products, they could negatively impact our business, capital expenditures, results of operations and financial condition.

Our effective tax rate may increase or decrease.

We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in determining our worldwide provision for income taxes. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. We are subject to audit by tax authorities where we do business. Although we believe that our tax estimates and tax positions are reasonable, they could be materially affected by many factors including the final outcome of tax audits and related litigation, the introduction of new tax accounting standards, legislation, regulations, and related interpretations, our global mix of earnings and the realizability of deferred tax assets. An increase or decrease in our effective tax rate could have a material adverse impact on our financial condition and results of operations.

24

 

In addition, at any time, U.S. federal tax laws or the administrative interpretations of those laws may be changed. We also cannot predict whether, when or to what extent other new U.S. federal tax laws, regulations, interpretations or rulings will be issued. As a result, changes in U.S. federal tax laws could negatively impact our operating results, financial condition and business operations, and adversely impact our shareholders.

Occasionally, changes in state and local tax laws or regulations are enacted that may result in an increase in our tax liability. Shortfalls in tax revenues for states and municipalities in recent years may lead to an increase in the frequency and size of such changes. If such changes occur, we may be required to pay additional taxes on our assets or income.

The Organization for Economic Development’s Base Erosion Profit Shifting Pillar 2.0 (BEPS Pillar 2.0) initiative provides a minimum global tax rate of 15% for multinational organizations with a global turnover of €750 million or more. The Company is not expected to reach this threshold in the coming year. Rules and regulations surrounding the BEPS Pillar 2.0 initiative are continually evolving. At the current time, the impact and timing of BEPS Pillar II cannot be estimated.

Risks Related to Our Stock and Capitalization

We may require additional funding in the future in order to continue our business.

Our capital requirements have been and will continue to be significant. We may require additional funding in the future for the research, development and commercialization of our OLED technologies and materials, to obtain and maintain patents and other intellectual property rights in these technologies and materials, and for working capital and other purposes, the timing and amount of which are difficult to ascertain. Our cash on hand may not be sufficient to meet all our future needs. When we need additional funds, such funds may not be available on commercially reasonable terms or at all. If we cannot obtain more money when needed, our business might fail. Additionally, if we attempt to raise money in an offering of shares of our common stock, preferred stock, warrants or depositary shares, or if we engage in acquisitions involving the issuance of such securities, the issuance of these shares will dilute our then-existing shareholders.

The market price of our common stock may be highly volatile.

The market price of our common stock may be highly volatile, as has been the case with our common stock in the past as well as the securities of many companies, particularly other emerging-growth companies in the technology industry. Factors such as the following may have a significant impact on the market price of our common stock in the future:

•
our revenues, expenses and operating results;
•
announcements by us, by our licensors, customers, or our competitors of technological developments, new product applications or contractual arrangements;
•
announcements relating to dividends and share repurchases; and
•
other factors affecting the display and solid-state lighting industries in general.

Our operating results may have significant period-to-period fluctuations, which would make it difficult to predict our future performance.

Due to the current stage of commercialization of our OLED technologies and materials, current geopolitical risks, the limited number of commercially successful consumer products utilizing our OLED technologies that customers have introduced in the marketplace, the relatively short product lifetimes of these consumer products, and the significant development and manufacturing objectives that we and our customers must achieve for the widespread inclusion of our OLED technologies in consumer products such as mobile phones, tablets, television displays and lighting products, our quarterly operating results are difficult to predict and may vary significantly from quarter to quarter.

We believe that period-to-period comparisons of our operating results are not a reliable indicator of our future performance at this time. Among other factors affecting our period-to-period results, our license and technology development fees often consist of large one-time, annual, semi-annual or quarterly payments, which may result in significant fluctuations in our revenues. In addition, our reliance on a relatively small number of licensees with large volumes of consumer product sales makes our quarterly operating results subject to our licensees’ specific plans and the success of their specific product offerings.

25

 

With respect to material sales, our sales are primarily dependent on purchases made by a relatively small number of customers. In addition to the other factors described above relating to our customers’ sales opportunities, our quarter-to-quarter sales may be materially impacted by our customers’ inventory management plans, which may vary substantially based on financial management considerations, changes in their product mix plans, modified material processing techniques and manufacturing line modifications.

If, in some future period, our operating results or business outlook fall below the expectations of securities analysts or investors, our stock price would be likely to decline and investors in our common stock may not be able to resell their shares at or above their purchase price. Broad market, industry and global economic factors may also materially reduce the market price of our common stock, regardless of our operating performance.

The issuance of additional shares of our common stock could drive down the price of our stock.

The price of our common stock could decrease if:

•
shares of our common stock that are currently subject to restriction on sale become freely salable, whether through an effective registration statement or based on Rule 144 under the Securities Act of 1933, as amended; or
•
we issue additional shares of our common stock that might be or become freely salable, including shares that would be issued upon conversion of our preferred stock or the exercise of outstanding stock options.

We can issue shares of preferred stock that may adversely affect the rights of shareholders of our common stock.

Our Articles of Incorporation authorize us to issue up to 5,000,000 shares of preferred stock with designations, rights and preferences determined from time-to-time by our Board of Directors. Accordingly, our Board of Directors is empowered, without shareholder approval, to issue preferred stock with dividend, liquidation, conversion, voting or other rights superior to those of shareholders of our common stock. For example, an issuance of shares of preferred stock could:

•
adversely affect the voting power of the shareholders of our common stock;
•
make it more difficult for a third party to gain control of us;
•
discourage bids for our common stock at a premium; or
•
otherwise adversely affect the market price of our common stock.

As of February 22, 2024, we have issued and outstanding 200,000 shares of Series A Nonconvertible Preferred Stock, all of which are held by an entity controlled by members of the family of Sherwin I. Seligsohn, our late founder and former Chairman of the Board of Directors. Our Board of Directors has authorized and issued other shares of preferred stock in the past, none of which are currently outstanding, and may do so again at any time in the future.

Any decisions to reduce or discontinue paying cash dividends to our shareholders could cause the market price for our common stock to decline.

In 2017, our Board of Directors began declaring quarterly cash dividends on our common stock, which we have consistently paid since then and we intend to continue to pay in the future. However, payment of future cash dividends will be at the discretion of our Board of Directors and will depend upon our results of operations, earnings, capital requirements, contractual restrictions and other factors deemed relevant by our Board of Directors. As such, we may modify, suspend or cancel our cash dividend policy in any manner and at any time. Any reduction or discontinuance by us of the payment of quarterly cash dividends could cause the market price of our common stock to decline. Moreover, in the event our payment of quarterly cash dividends are reduced or discontinued, our failure or inability to resume paying cash dividends at historical levels could cause the market price of our common stock to decline. There is no guarantee that our common stock will appreciate in value or even maintain the price at which current shareholders purchased their shares.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

26

 

ITEM 1C. CYBERSECURITY

Recognizing the importance of assessing, identifying, and managing material risks from cybersecurity threats, we maintain a cybersecurity program that is led by our management team and overseen by the Audit Committee of our Board of Directors. Material risks from cybersecurity threats to our company may include, among other things, operational risks, intellectual property theft, fraud, extortion, harm to employees or customers and violation of data privacy or security laws.

To identify and manage the risks from cybersecurity threats, our cybersecurity program includes various preventative, detection and responsive measures, including without limitation the following: use of monitoring and detection software applications, ongoing employee education and certification about cybersecurity threats, routine security access reviews, and the implementation of physical security measures. As standard practice, we require third-party service providers that may electronically interact with or handle our sensitive information to maintain an effective security management program and to notify us in the event of any known or suspected cyber incident.

Members of our management team, most notably our Chief Financial Officer, who has responsibility for managing our Information Technology and Security functions, are responsible for leading our cybersecurity program. Our management team meets regularly with our information technology leadership personnel, including our Head of Information Technology, who reports to our Chief Financial Officer, to receive updates and data on cybersecurity management activities, including assessments on emerging technologies and evaluations of recommended practices related to cybersecurity measures. Our Head of Information Technology, who has managed information technology services and security for over 25 years, and our Chief Financial Officer maintain their expertise through participating in events such as continuing education and training, and information-sharing collaborations. We also retain a third-party Information Security consulting firm to advise on and assess our cybersecurity processes on an ongoing basis.

The Audit Committee of our Board of Directors has oversight responsibility for our cybersecurity program. Our Chief Financial Officer and Head of Information Technology provide periodic updates regarding our cybersecurity risk management strategy and related activities to the Audit Committee, and provide other information as needed or requested to facilitate the committee’s oversight of our cybersecurity risk. The chair of our Audit Committee, who previously founded and for 19 years led an information technology consulting company that specialized in providing software and systems integration, business process and technical consulting to multinational companies, holds a certification in Systemic Cyber Risk Governance for Corporate Directors. Other members of our full Board of Directors, which also receives periodic briefings on cybersecurity matters, also have received professional education and training related to cybersecurity.

Despite our efforts to manage the risk from cybersecurity threats, we may not be successful in preventing or mitigating a cybersecurity incident that could have a material adverse effect on us. See Item 1A. “Risk Factors” for a further discussion of our cybersecurity risks.

ITEM 2. PROPERTIES

As of December 31, 2023, we operated facilities at the following locations:

 

Location

 

Description of Use

 

Country

375 Phillips Blvd. Ewing, New Jersey

 

Corporate Offices and Research & Development Laboratories

 

United States

250 Phillips Blvd. Ewing, New Jersey (1)

 

Corporate Offices and Manufacturing Logistics

 

United States

300 Phillips Blvd. Ewing, New Jersey (1)

 

Corporate and Collaboration Offices

 

United States

27 McCullough Drive New Castle, Delaware

 

Adesis Offices and Manufacturing Laboratories

 

United States

Shannon Industrial Estate, Shannon, County Clare (2)

 

Manufacturing Facility

 

Ireland

Block A, 7F. Korea Bio Park
700 Daewangpangyo-ro, Bundang-gu
Seongnam-si, Gyeonggi-do, 13488, South Korea (3)

 

Application Center

 

South Korea
(1)
Approximately 88,000 square feet for the expansion of research and development activities, collaboration, manufacturing logistics and other corporate functions.
(2)
Leased beginning in 2021 for production by PPG of our PHOLED materials and purchased in September 2023.
(3)
Leased beginning in 2017 and purchased in May 2023.

27

 

Patent Related Challenges and Oppositions

Each major jurisdiction in the world that issues patents provides both third parties and applicants an opportunity to seek a further review of an issued patent. The process for requesting and considering such reviews is specific to the jurisdiction that issued the patent in question, and generally does not provide for claims of monetary damages or a review of specific claims of infringement. The conclusions made by the reviewing administrative bodies tend to be appealable and generally are limited in scope and applicability to the specific claims and jurisdiction in question.

We believe that opposition proceedings are frequently commenced in the ordinary course of business by third parties who may believe that one or more claims in a patent do not comply with the technical or legal requirements of the specific jurisdiction in which the patent was issued. We view these proceedings as reflective of its goal of obtaining the broadest legally permissible patent coverage permitted in each jurisdiction. Once a proceeding is initiated, as a general matter, the issued patent continues to be presumed valid until the jurisdiction’s applicable administrative body issues a final non-appealable decision. Depending on the jurisdiction, the outcome of these proceedings could include affirmation, denial or modification of some or all of the originally issued claims. We believe that as OLED technology becomes more established and its patent portfolio increases in size, so will the number of these proceedings.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

28

 

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our Common Stock

Our common stock is quoted on the NASDAQ Global Select Market website under the symbol “OLED.” As of February 16, 2024, there were approximately 261 holders of record of our common stock.

During 2021, 2022 and 2023, we declared and paid cash dividends on our common stock. While we intend to pay regular quarterly dividends in the future, payment of future cash dividends will be at the discretion of our Board of Directors and will depend upon our results of operations, earnings, capital requirements, contractual restrictions and other factors deemed relevant by our Board of Directors. As such, we may modify, suspend or cancel our cash dividend policy in any manner and at any time.

29

 

Performance Graph

The performance graph below compares the change in the cumulative shareholder return of our common stock from December 31, 2018 to December 31, 2023, with the percentage change in the cumulative total return over the same period on (i) the Russell 2000 Index, and (ii) the S&P 500 Electronics Components Index. This performance graph assumes an initial investment of $100 on December 31, 2018 in each of our common stock, the Russell 2000 Index and the S&P 500 Electronics Components Index. For the year-ended December 31, 2023, the NASDAQ Electronics Components Index was no longer publicly accessible to shareholders and was replaced with the S&P 500 Electronics Components Index, which management considers a closely-related index.

 

img34714927_1.jpg 

 

 

 

Cumulative Total Return

 

 

 

12/18

 

 

12/19

 

 

12/20

 

 

12/21

 

 

12/22

 

 

12/23

 

Universal Display Corp.

 

$

100.00

 

 

$

220.73

 

 

$

247.08

 

 

$

178.17

 

 

$

117.83

 

 

$

210.46

 

Russell 2000

 

 

100.00

 

 

 

125.52

 

 

 

150.58

 

 

 

172.90

 

 

 

137.56

 

 

 

160.85

 

S&P 500 Electronic Components

 

 

100.00

 

 

 

117.20

 

 

 

145.76

 

 

 

179.27

 

 

 

158.18

 

 

 

190.05

 

Securities Authorized for Issuance under Equity Compensation Plans

The information required by this item with respect to our equity compensation plans will be set forth in our definitive Proxy Statement for the 2024 Annual Meeting of Shareholders, and herein by reference.

30

 

ITEM 6. [RESERVED]

None.

31

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the section entitled “Selected Financial Data” in this report and our Consolidated Financial Statements and related notes to this report. This discussion and analysis contains forward-looking statements based on our current expectations, assumptions, estimates and projections. These forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those indicated in these forward-looking statements as a result of certain factors, as more fully discussed in Item 1A of this report, entitled “Risk Factors.”

OVERVIEW

We are a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display applications, such as mobile phones, televisions, monitors, wearables, tablets, portable media devices, notebook computers, personal computers and automotive applications, as well as specialty and general lighting products. Since 1994, we have been engaged and expect to continue to be primarily engaged, in funding and performing research and development activities relating to OLED technologies and materials, and commercializing these technologies and materials. We derive our revenue primarily from the following:

•
sales of OLED materials for evaluation, development and commercial manufacturing;
•
intellectual property and technology licensing;
•
technology development and support, including third-party collaboration efforts and providing support to third parties for commercialization of their OLED products; and
•
contract research services in the areas of chemical materials synthesis research, development and commercialization for non-OLED applications.

Material sales relate to our sale of OLED materials for incorporation into our customers’ commercial OLED products or for their OLED development and evaluation activities. Material sales are generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties.

We receive license and royalty payments under certain commercial, development and technology evaluation agreements, some of which are non-refundable advances. These payments may include royalty and license fees made pursuant to license agreements and also license fees included as part of certain commercial supply agreements. These payments are included in the estimate of total contract consideration by customer and recognized as revenue over the contract term based on material units sold at the estimated per unit fee over the life of the contract.

On December 2, 2022, we entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, we are being paid a license fee, which includes quarterly and annual payments over the agreement term of five years. The agreement conveys to SDC the non-exclusive right to use certain of our intellectual property assets for a limited period of time that is less than the estimated life of the assets.

At the same time that we entered into the current commercial license agreement with SDC, we also entered into a material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the material purchase agreement, SDC agrees to purchase from us a minimum amount of red and green phosphorescent emitter materials for use in the manufacture of licensed products. This minimum commitment is subject to SDC’s requirements for phosphorescent emitter materials and our ability to meet these requirements over the term of the supplemental agreement.

In 2015, we entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display), which were effective as of January 1, 2015. The terms of these agreements were extended by a January 1, 2021 amendment through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under our patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The OLED commercial supply agreement provides for the sales of materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the life of the agreements as well as minimum royalty revenue.

32

 

In 2023, we entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, we have granted BOE non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to BOE for use in its licensed products.

In 2019, we entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, we entered into long-term, multi-year agreements with CSOT. Under these agreements, we have granted CSOT non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to CSOT for use in its licensed products.

In 2018, we entered into long-term, multi-year OLED patent license and material purchase agreements with Visionox Technology, Inc. (Visionox). Under the license agreement, we have granted certain of Visionox’s affiliates non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, we supply phosphorescent OLED materials to Visionox for use in its licensed products. In 2021, we announced an extension of the Visionox agreement by entering into new five-year OLED material supply and license agreements with a new affiliate of Visionox, Visionox Hefei Technology Co. Ltd.

In 2016, we entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Micro-electronics Co., Ltd. (Tianma). Under the license agreement, we have granted Tianma non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on Tianma’s sales of licensed products. Additionally, we supply phosphorescent OLED materials to Tianma for use in its licensed products. In 2021, we mutually agreed to extend the terms of both the patent license and material purchase agreements for an additional multi-year term.

In 2016, we acquired Adesis, Inc. (Adesis) which has operations in New Castle and Wilmington, Delaware. Adesis is a contract development and manufacturing organization (CDMO) that provides support services on a contractual basis to third-party customers in the OLED, pharma, biotech, catalysis and other industries. As of December 31, 2023, Adesis employed a team of 138 research scientists, chemists, engineers and laboratory technicians. Prior to our acquisition of Adesis, we utilized more than 50% of Adesis’ technology service and production output. We continue to utilize a significant portion of its technology research capacity for the benefit of our OLED technology development, and Adesis uses the remaining capacity to operate as a CDMO by providing contract research services for non-OLED applications to third-party customers in the above-mentioned industries. Contract research services revenue is earned by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis for those third-party customers.

In June 2020, a wholly-owned subsidiary, OVJP Corporation (OVJP Corp), was formed as a Delaware corporation. Based in California, OVJP Corp was founded to advance the commercialization of our proprietary Organic Vapor Jet Printing (OVJP) technology. As of December 31, 2023, OVJP Corp employed a team of 28 research, mechanical, electrical and software engineers and laboratory technicians. As a direct printing technique, OVJP technology has the potential to offer high deposition rates for large-area OLEDs. In addition, OVJP technology reduces OLED material waste associated with use of a shadow mask (i.e., the waste of material that deposits on the shadow mask itself when fabricating an OLED). By comparison to inkjet printing, an OVJP process does not use liquid solvents and therefore the OLED materials utilized are not limited by their viscosity or solvent solubility. OVJP also avoids generation of solvent wastes and eliminates the additional step of removing residual solvent from the OLED device. We believe the successful implementation of the OVJP technology has the potential to increase the addressable market for large-size OLED panels while also serving another potential growth market for our proprietary PHOLED materials and technologies.

In February 2021, we announced the establishment of a new manufacturing site in Shannon, Ireland and an agreement between UDC Ireland Limited and PPG for the production of our OLED materials. We purchased the site during September 2023. When fully operational, the new facility is expected to double our production capacity and allow for the diversification of our manufacturing base for phosphorescent emitters. The first phase of facility improvements has been completed and operations commenced in June 2022.

We also generate technology development and support revenue earned from development and technology evaluation agreements and commercialization assistance fees.

We anticipate fluctuations in our annual and quarterly results of operations due to uncertainty regarding, among other factors:

•
the timing, cost and volume of sales of our OLED materials;
•
the timing of our receipt of license fees and royalties, as well as fees for future technology development and evaluation;

33

 

•
the timing and magnitude of expenditures we may incur in connection with our ongoing research and development and patent-related activities; and
•
the timing and financial consequences of our formation of new business relationships and alliances.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations is based on our Consolidated Financial Statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect our reported assets and liabilities, revenues and expenses, and other financial information. Actual results may differ significantly from our estimates under other assumptions and conditions.

We believe that our accounting policies related to revenue recognition and deferred revenue and income taxes, as described below, are our “critical accounting policies” as contemplated by the SEC. These policies, which have been reviewed with our Audit Committee, are discussed in greater detail below.

Revenue Recognition and Deferred Revenue

Material sales relate to the sale of our OLED materials for incorporation into our customers’ commercial OLED products or for their OLED development and evaluation activities. Revenue associated with material sales is generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties. Revenue may be recognized after control of the material passes in the event the transaction price includes variable consideration. For example, a customer may be provided an extended opportunity to stock materials prior to use in mass production and given a general right of return not conditioned on breaches of warranties associated with the specific product. In such circumstances, revenue will be recognized at the earlier of the expiration of the customer’s general right of return or once it becomes unlikely that the customer will exercise its right of return.

The vast majority of revenue attributed to material sales is determined through technology license agreements and material supply agreements the terms of which are jointly agreed upon with our customers. The remaining revenue recognized is in the form of contract research services revenue earned by our subsidiary, Adesis, Inc., and our occasional material sales to smaller customers. None of the revenue recognized during the years ended December 31, 2023, 2022 or 2021 resulted solely from royalty or license fee arrangements as to which there were not associated material sales.

The rights and benefits to our OLED technologies are conveyed to the customer through technology license agreements and material supply agreements. We believe that the licenses and materials sold under these combined agreements are not distinct from each other for financial reporting purposes and as such, are accounted for as a single performance obligation. Accordingly, total contract consideration is estimated and recognized over the contract term based on material units sold at the estimated per unit fee over the life of the contract. Total contract consideration is allocated to material sales and royalty and licensing fees on the Consolidated Statements of Income based on contract pricing.

Various estimates are relied upon to recognize revenue. We estimate total material units to be purchased by our customers over the contract term based on historical trends, industry estimates and our forecast process. Our management uses the expected value method to estimate the material per unit fee. Additionally, our management estimates the sales-based portion of royalty revenue based on the estimated net sales revenue of our customers over the contract term.

Accounting for Income Taxes

We are subject to income taxes in both the U.S. and foreign jurisdictions. Significant judgments and estimates are required in evaluating our tax positions for future realization and determining our provision for income taxes. Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management's best assessment of estimated future taxes to be paid.

In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion or all of our deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent on our ability to generate future taxable income to obtain benefit from the reversal of temporary differences, net operating loss carryforwards and tax credits. As part of our assessment, we consider the scheduled reversal of deferred tax assets and liabilities, projected future taxable income, and tax planning strategies.

34

 

During the year ended December 31, 2023, based on our previous earnings history, a current evaluation of expected future taxable income and other evidence, we determined to retain the valuation allowance that relates to New Jersey research and development credits and unrealized loss on investments. Actual results could differ from our assessments if adequate taxable income is generated in future periods. To the extent we establish a new valuation allowance or change a previously established valuation allowance in a future period, income tax expense will be impacted.

RESULTS OF OPERATIONS

For a discussion of our results of operations comparison for the years ended December 31, 2022 and 2021, refer to our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed on February 23, 2023.

Comparison of the Years Ended December 31, 2023 and 2022

 

 

 

Year Ended December 31,

 

 

 

 

 

 

2023

 

 

2022

 

 

(Decrease) Increase

 

REVENUE:

 

 

 

 

 

 

 

 

 

Material sales

 

$

322,029

 

 

$

331,081

 

 

$

(9,052

)

Royalty and license fees

 

 

238,389

 

 

 

267,115

 

 

 

(28,726

)

Contract research services

 

 

16,011

 

 

 

18,423

 

 

 

(2,412

)

Total revenue

 

 

576,429

 

 

 

616,619

 

 

 

(40,190

)

COST OF SALES

 

 

135,376

 

 

 

127,896

 

 

 

7,480

 

Gross margin

 

 

441,053

 

 

 

488,723

 

 

 

(47,670

)

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

Research and development

 

 

130,481

 

 

 

117,062

 

 

 

13,419

 

Selling, general and administrative

 

 

67,387

 

 

 

77,886

 

 

 

(10,499

)

Amortization of acquired technology and other intangible assets

 

 

15,993

 

 

 

17,459

 

 

 

(1,466

)

Patent costs

 

 

9,356

 

 

 

8,329

 

 

 

1,027

 

Royalty and license expense

 

 

647

 

 

 

877

 

 

 

(230

)

Total operating expenses

 

 

223,864

 

 

 

221,613

 

 

 

2,251

 

OPERATING INCOME

 

 

217,189

 

 

 

267,110

 

 

 

(49,921

)

Interest income, net

 

 

28,166

 

 

 

7,811

 

 

 

20,355

 

Other loss, net

 

 

(184

)

 

 

(6,691

)

 

 

6,507

 

Interest and other loss, net

 

 

27,982

 

 

 

1,120

 

 

 

26,862

 

INCOME BEFORE INCOME TAXES

 

 

245,171

 

 

 

268,230

 

 

 

(23,059

)

INCOME TAX EXPENSE

 

 

(42,160

)

 

 

(58,169

)

 

 

16,009

 

NET INCOME

 

$

203,011

 

 

$

210,061

 

 

$

(7,050

)

Revenue

Our total material sales were $322.0 million for the year ended December 31, 2023, as compared to $331.1 million for the year ended December 31, 2022, a decrease of 3% with a decrease in unit material volume of less than 1%. The decline in material sales was primarily due to reduced demand for our emitter material during 2023, partially offset by the introduction of blue emitter and host sales. This weakness resulted from the continuation of unfavorable macroeconomic conditions that have negatively impacted the OLED display market segment.

•
Green emitter sales for the year ended December 31, 2023, which include our yellow-green emitters, were $243.2 million as compared to $251.6 million for the year ended December 31, 2022, with unit material volumes decreasing by 2%.
•
Red emitter sales for the year ended December 31, 2023, were $73.2 million as compared to $79.0 million for the year ended December 31, 2022, with unit material volumes increasing by less than 1%.

Revenue from royalty and license fees was $238.4 million for the year ended December 31, 2023 as compared to $267.1 million for the year ended December 31, 2022, a decrease of 11%. The decrease in royalty and license fees was primarily the result of higher estimated future demand for several of our customers over the remaining lives of their contracts, as well as the impact of the cumulative catch-up adjustments noted below.

35

 

The cumulative catch-up adjustment arising from changes in estimates of transaction price, net was an increase of $10.6 million for the year ended December 31, 2023 as compared to an increase of $30.3 million for the year ended December 31, 2022, resulting in a net reduction in revenue between periods of $19.7 million, the majority of which was recorded to royalty and license fees. These adjustments resulted from an increase in the average price per gram that was primarily due to the decrease in anticipated OLED materials demand by several of our customers over the remaining lives of their contracts.

Contract research services revenue was $16.0 million for the year ended December 31, 2023 as compared to $18.4 million for the year ended December 31, 2022, a decrease of 13%. The decrease in contract research services revenue was primarily due to reduced demand from several CDMO customers of our subsidiary, Adesis, during the year ended December 31, 2023. Revenue from contract research services consists of revenue earned by Adesis, which provides support services on a contractual basis to third-party customers in the pharma, biotech, catalysis and other industries.

Cost of Sales

Cost of sales for the year ended December 31, 2023 increased by $7.5 million as compared to the year ended December 31, 2022, primarily due to a $5.1 million increase in expenses related to the Shannon manufacturing facility due to pre-production costs being classified as SG&A in the prior year, a $4.9 million increase in inventory reserves, and changes in product mix. As a result of the decrease in revenue from royalty and licenses fees and material sales, gross margin for the year ended December 31, 2023 decreased by $47.7 million as compared to the year ended December 31, 2022, with gross margin as a percentage of revenue decreasing to 77% from 79%.

Research and development

Research and development expenses increased to $130.5 million for the year ended December 31, 2023, as compared to $117.1 million for the year ended December 31, 2022. The increase in research and development expenses was primarily due to higher operating costs, including increased contract research costs, employee-related expenses and those costs associated with PPG development activity.

Selling, general and administrative

Selling, general and administrative expenses decreased to $67.4 million for the year ended December 31, 2023, as compared to $77.9 million for the year ended December 31, 2022. The decrease in selling, general and administrative expenses was primarily due to lower stock-based compensation expenses and a decrease in pre-production costs associated with the Shannon facility. The Shannon facility became operational during June 2022 and the costs associated with this facility have since been included in cost of sales.

Amortization of acquired technology and other intangible assets

Amortization of acquired technology and other intangible assets was $16.0 million for the year ended December 31, 2023, as compared to $17.5 million for the year ended December 31, 2022. The decrease was due to the Fujifilm patents becoming fully amortized during July 2022, partially offset by the commencement of amortization expense associated with the Merck KGaA patent acquisition that was completed in April 2023. See Note 7 in Notes to Consolidated Financial Statements for further discussion.

Patent costs

Patent costs increased to $9.4 million for the year ended December 31, 2023, as compared to $8.3 million for the year ended December 31, 2022. The results in the current year reflected higher internal prosecution related costs.

Royalty and license expense

Royalty and license expense decreased to $647,000 for the year ended December 31, 2023, as compared to $877,000 for the year ended December 31, 2022.

Interest and other loss, net

Interest income, net was $28.2 million for the year ended December 31, 2023, as compared to $7.8 million for the year ended December 31, 2022. The increase in interest income, net was primarily due to an increase in bond yields on available-for-sale investments held during the year ended December 31, 2023 compared to the prior year as well as higher available-for-sale investment balances. Other loss, net primarily consisted of impairment of minority investments, net exchange gains and losses on foreign currency transactions

36

 

and rental income. We recorded other loss, net of $184,000 for the year ended December 31, 2023 as compared to $6.7 million for the year ended December 31, 2022.

Income tax expense

We are subject to income taxes in both the United States and foreign jurisdictions. The effective income tax rate was an expense of 17.2% and 21.7% for the years ended December 31, 2023 and 2022, respectively, and we recorded income tax expense of $42.2 million and $58.2 million, respectively, for those periods. The effective income tax rate decreased due to a change in U.S. tax regulations associated with the ability to credit Chinese withholding taxes, as well as a change in the capitalization rules for research and development expenses.

Liquidity and Capital Resources

Our principal sources of liquidity are our cash and cash equivalents and short-term investments. As of December 31, 2023, we had cash and cash equivalents of $92.0 million, short-term investments of $422.1 million, and long-term U.S. Government bond investments of $285.5 million for a total of $799.6 million. This compares to cash and cash equivalents of $93.4 million, short-term investments of $484.3 million, and long-term corporate bond and U.S. Government bond investments of $247.9 million for a total of $825.6 million as of December 31, 2022.

Cash provided by operating activities for the year ended December 31, 2023 was $154.8 million resulting from $203.0 million of net income and an increase of $55.3 million due to non-cash items including depreciation, stock-based compensation, and amortization of intangibles, partially offset by a $103.5 million reduction due to changes in our operating assets and liabilities. Changes in our operating assets and liabilities related to an increase in accounts receivable of $47.2 million, an increase in other assets of $37.1 million, a decrease in other liabilities of $26.5 million and a decrease in deferred revenue of $4.2 million, partially offset by a decrease in inventory of $7.4 million and an increase in accounts payable and accrued expenses of $4.1 million.

Cash provided by operating activities for the year ended December 31, 2022 was $126.8 million resulting from $210.1 million of net income and an increase of $51.0 million due to non-cash items including stock-based compensation, depreciation, amortization of intangibles and deferred income taxes, partially offset by a $134.3 million reduction due to changes in our operating assets and liabilities. Changes in our operating assets and liabilities related to a decrease in deferred revenue of $93.2 million, an increase in inventory of $49.1 million and a decrease in other liabilities of $11.4 million, partially offset by a decrease in accounts receivable of $15.0 million, an increase in accounts payable and accrued expenses of $3.3 million and a decrease in other assets of $1.1 million.

Cash used in investing activities was $83.3 million for the year ended December 31, 2023, as compared to $280.7 million for the year ended December 31, 2022. The decrease was due to the timing of maturities and purchases of investments resulting in net sales and maturities of $43.1 million for the year ended December 31, 2023, as compared to net purchases $233.5 million for the year ended December 31, 2022, partially offset by an increase in purchases of intangibles and property, plant and equipment of $79.1 million for the year ended December 31, 2023 as compared to the year ended December 31, 2022. The increase in property, plant and equipment and intangibles during the year ended December 31, 2023 was primarily due to the Merck KGaA patent acquisition and the purchases of the Shannon facility and the South Korea application center.

Cash used in financing activities was $72.9 million for the year ended December 31, 2023, as compared to $64.6 million for the year ended December 31, 2022. The increase was due to an increase in the cash payment of dividends in the current year of $9.7 million, partially offset by a decrease in the payment of withholding taxes related to stock-based compensation to employees of $1.0 million and an increase in the proceeds from issuance of common stock of $442,000.

Working capital was $798.3 million as of December 31, 2023, as compared to $763.8 million as of December 31, 2022. The increase was primarily due to increases in accounts receivable and other current assets and a decrease in other current liabilities, partially offset by a decrease in short-term investments.

Several significant contractual obligations are anticipated to be incurred in future periods and include payments for retirement benefit plan obligations, lease obligations and PPG inventory commitments. Payments towards the retirement plan obligations commenced during fiscal year 2023 and are expected to total $75.6 million over the remaining life of the plan. Existing lease obligations are $4.3 million for fiscal years 2024 and 2025, $4.4 million for fiscal year 2026 and $16.4 million thereafter. Existing PPG inventory commitments are $29.8 million and will fluctuate based on PPG production needs to fulfill to our demand for commercial emitter material.

37

 

We anticipate, based on our internal forecasts and assumptions relating to our operations (including, among others, assumptions regarding our working capital requirements, the progress of our research and development efforts, the availability of sources of funding for our research and development work, and the timing and costs associated with the preparation, filing, prosecution, maintenance, defense and enforcement of our patents and patent applications), that we have sufficient cash, cash equivalents and short-term investments to meet our obligations for at least the next twelve months.

We believe that potential additional financing sources for us include long-term and short-term borrowings and public and private sales of our equity and debt securities. It should be noted, however, that additional funding may be required in the future for research, development and commercialization of our OLED technologies and materials, to obtain, maintain and enforce patents respecting these technologies and materials, and for working capital and other purposes, the timing and amount of which are difficult to ascertain. There can be no assurance that additional funds will be available to us when needed, on commercially reasonable terms or at all, particularly in the current economic environment.

Recently Issued Accounting Pronouncements

Recently issued accounting pronouncements are addressed in Note 2 in the Notes to the Consolidated Financial Statements included herein.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We do not utilize financial instruments for trading purposes and hold no derivative financial instruments, other financial instruments or derivative commodity instruments that could expose us to significant market risk other than our investments disclosed in “Fair Value Measurements” in Note 4 to the Consolidated Financial Statements included herein. We generally invest in investment grade financial instruments to reduce our exposure related to investments. Our primary market risk exposure with regard to such financial instruments is to changes in interest rates, which would impact interest income earned on investments. However, based upon the conservative nature of our investment portfolio and current experience, we do not believe a decrease in investment yields would have a material negative effect on our interest income.

Substantially all our revenue is derived from outside of North America. All revenue is primarily denominated in U.S. dollars and therefore we bear no significant foreign exchange risk.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Our Consolidated Financial Statements and the related notes to those statements are attached to this report beginning on page F-1.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2023. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by us in reports filed or submitted under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure. However, a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Management’s Report on Internal Control over Financial Reporting and Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting

The report of management on our internal control over financial reporting and the associated attestation report of our independent registered public accounting firm are set forth in Item 8 of this report.

38

 

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

On February 20, 2024, we amended and restated the February 2021 amendment to our agreement with PPG, to be effective in September 2023 to coincide with our purchase and ownership of the Shannon manufacturing facility, to reflect such purchase and PPG’s updated operation and maintenance services after such purchase. The term of our PPG agreement and the compensation arrangement for PPG’s services at the Shannon facility remain the same as set forth in the February 2021 amendment.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None.

39

 

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information with respect to this item is set forth in our definitive Proxy Statement for the 2024 Annual Meeting of Shareholders, which is to be filed with the U.S. Securities and Exchange Commission no later than April 29, 2024 (the first business day after the 120th day following the end of our fiscal year) (our Proxy Statement), and which is incorporated herein by reference. Information regarding our executive officers is included at the end of Item 1 in Part I of this report.

ITEM 11. EXECUTIVE COMPENSATION

Information with respect to this item will be set forth in our Proxy Statement, and is incorporated herein by reference.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Information with respect to this item will be set forth in our Proxy Statement, and is incorporated herein by reference.

Information with respect to this item will be set forth in our Proxy Statement, and is incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Information with respect to this item will be set forth in our Proxy Statement, and is incorporated herein by reference.

40

 

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) The following documents are filed as part of this report:

(1) Financial Statements:

Management’s Report on Internal Control Over Financial Reporting

F-2

Reports of Independent Registered Public Accounting Firm

F-3

Consolidated Balance Sheets

F-6

Consolidated Statements of Income

F-7

Consolidated Statements of Comprehensive Income

F-8

Consolidated Statements of Shareholders’ Equity

F-9

Consolidated Statements of Cash Flows

F-10

Notes to Consolidated Financial Statements

F-11

 

(2) Financial Statement Schedules:

None.

(3) Exhibits:

The following is a list of the exhibits filed as part of this report. Where so indicated by footnote, exhibits that were previously filed are incorporated by reference. For exhibits incorporated by reference, the location of the exhibit in the previous filing is indicated parenthetically, together with a reference to the filing indicated by footnote.

Exhibit
Number

Description

3.1

Amended and Restated Articles of Incorporation of the registrant (1)

3.2

Amended and Restated Bylaws of the registrant (2)

4

Description of Securities (3)

10.1#

 

Amended and Restated Change in Control Agreement between the registrant and Steven V. Abramson, dated as of November 4, 2008 (4)

10.2#

 

Amended and Restated Change in Control Agreement between the registrant and Julia J. Brown, dated as of November 4, 2008 (4)

10.3#

 

Amended and Restated Change in Control Agreement between the registrant and Janice K. Mahon, dated as of November 4, 2008 (4)

10.4#

Amended and Restated Change in Control Agreement between the registrant and Mauro Premutico, dated April 16, 2012 (5)

10.5#

Supplemental Executive Retirement Plan, dated as of April 1, 2010 (6)

10.6

1997 Amended License Agreement among the registrant, The Trustees of Princeton University and the University of Southern California, dated as of October 9, 1997 (7)

10.7

Amendment #1 to the Amended License Agreement among the registrant, the Trustees of Princeton University and the University of Southern California, dated as of August 7, 2003 (8)

10.8

Amendment #2 to the Amended License Agreement among the registrant, the Trustees of Princeton University, the University of Southern California and the Regents of the University of Michigan, dated as of January 1, 2006 (9)

10.9

 

Amended and Restated OLED Materials Supply and Service Agreement between the registrant and PPG Industries, Inc., dated as of October 1, 2011 (10)

10.10+*

 

Amended and Restated Amendment, dated February 20, 2024, to Amended and Restated OLED Materials Supply and Service Agreement, dated as of October 1, 2011, between the Registrant and PPG Industries, Inc.

10.11#

Universal Display Corporation Annual Incentive Plan (11)

10.12#*

Form Agreement - Restricted Stock Unit Grant Letter

41

 

10.13#*

Form Agreement - Performance Stock Unit Grant Letter

10.14#

Universal Display Corporation 2014 Equity Compensation Plan (12)

10.15#

Amendment 2015-1, dated March 3, 2015, to Universal Display Corporation Supplemental Executive Retirement Plan (13)

10.16+

 

IP Transfer Agreement, dated June 28, 2016 by and between UDC Ireland Limited and BASF SE (14)

10.17#

 

Amended and Restated Change in Control Agreement between the registrant and Brian Millard, dated as of September 6, 2022 (11)

10.18#

 

Amendment to Amended and Restated Change in Control Agreement, dated May 31, 2023, between the registrant and Brian Millard (15)

10.19#

 

Restricted Stock Grant Unit Agreement between the registrant and Brian Millard, dated as of September 6, 2022 (11)

10.20+

 

OLED Patent License Agreement between UDC Ireland Limited and Samsung Display Co., Ltd., dated as of December 2, 2022 (11)

10.21+

 

Supplemental OLED Material Purchase Agreement between UDC Ireland Limited and Samsung Display Co., Ltd., dated as of December 2, 2022 (11)

10.22#

 

Universal Display Corporation 2023 Equity Compensation Plan (16)

10.23#

 

UDC, Inc. Deferred Compensation Plan (17)

21*

Subsidiaries of the registrant

23.1*

Consent of KPMG LLP

31.1*

Certifications of Steven V. Abramson, Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a)

31.2*

Certifications of Brian Millard, Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a)

32.1**

Certifications of Steven V. Abramson, Chief Executive Officer, as required by Rule 13a-14(b) or Rule 15d-14(b), and by 18 U.S.C. Section 1350. (This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)

32.2**

Certifications of Brian Millard, Chief Financial Officer, as required by Rule 13a-14(b) or Rule 15d-14(b), and by 18 U.S.C. Section 1350. (This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)

97#*

 

Universal Display Corporation Compensation Recoupment Policy

101.INS*

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH*

Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents (Calculation; Definition; Label; Presentation)

104

 

The cover page of this Annual Report on Form 10-K for the year ended December 31, 2023, formatted in Inline XBRL (included in Item 101.INS)

 

Explanation of footnotes to listing of exhibits:

 

* Filed herewith.

** Furnished herewith.

# Management contract or compensatory plan or arrangement.

+ Either (1) confidential treatment has been accorded to certain portions of this exhibit pursuant to Rule 406 under the Securities Act of 1933, as amended, or Rule 24b-2 under the Securities Exchange Act of 1934, as amended, or (2) portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the SEC.

(1)
Filed as an Exhibit to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, filed with the SEC on August 9, 2018.

42

 

(2)
Filed as an Exhibit to the Annual Report on Form 10-K for the year ended December 31, 2003, filed with the SEC on March 1, 2004.
(3)
Filed as an Exhibit to the Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on February 20, 2020.
(4)
Filed as an Exhibit to the Annual Report on Form 10-K for the year ended December 31, 2008, filed with the SEC on March 12, 2009.
(5)
Filed as an Exhibit to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, filed with the SEC on August 8, 2012.
(6)
Filed as an Exhibit to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, filed with the SEC on May 10, 2010.
(7)
Filed as an Exhibit to the Annual Report on Form 10K-SB for the year ended December 31, 1997, filed with the SEC on March 31, 1998.
(8)
Filed as an Exhibit to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2003, filed with the SEC on November 10, 2003.
(9)
Filed as an Exhibit to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2006, filed with the SEC on August 9, 2006.
(10)
Filed as an Exhibit to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, filed with the SEC on November 8, 2011.
(11)
Filed as an Exhibit to the Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 23, 2023.
(12)
Filed as Exhibit A to the Company's Definitive Proxy Statement for the 2014 Annual Meeting filed with the SEC on April 25, 2014.
(13)
Filed as an Exhibit to the Current Report on Form 8-K filed with the SEC on March 9, 2015.
(14)
Filed as an Exhibit to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, filed with the SEC on August 4, 2016.
(15)
Filed as an Exhibit to the Current Report on Form 8-K filed with the SEC on June 1, 2023.
(16)
Filed as Annex A to the Company's Definitive Proxy Statement for the 2023 Annual Meeting filed with the SEC on April 20, 2023.
(17)
Filed as an Exhibit to the Current Report on Form 8-K filed with the SEC on November 2, 2023.

Note: Any of the exhibits listed in the foregoing index not included with this report may be obtained, without charge, by writing to Mauro Premutico, Secretary, Universal Display Corporation, 250 Phillips Boulevard, Ewing, New Jersey 08618.

(b) The exhibits required to be filed by us with this report are listed above.

(c) The Consolidated Financial Statement schedules required to be filed by us with this report are listed above.

ITEM 16. FORM 10-K SUMMARY

None.

43

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UNIVERSAL DISPLAY CORPORATION

By: /s/ Brian Millard

Brian Millard

Vice President, Chief Financial Officer and Treasurer

Date: February 22, 2024

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name

Title

Date

/s/ Steven V. Abramson

President, Chief Executive Officer and Director (principal executive officer)

February 22, 2024

Steven V. Abramson

 

/s/ Brian Millard

 

Vice President, Chief Financial Officer and Treasurer

 

February 22, 2024

Brian Millard

 

(principal financial and accounting officer)

 

 

 

 

 

 

 

/s/ Sidney D. Rosenblatt

 

Chair of the Board of Directors

 

February 22, 2024

Sidney D. Rosenblatt

 

 

 

 

 

 

 

 

 

/s/ Elizabeth H. Gemmill

Lead Independent Director

February 22, 2024

Elizabeth H. Gemmill

 

/s/ Cynthia J. Comparin

Director

February 22, 2024

Cynthia J. Comparin

 

/s/ Richard C. Elias

Director

February 22, 2024

Richard C. Elias

 

 

/s/ C. Keith Hartley

 

Director

 

February 22, 2024

C. Keith Hartley

 

 

 

 

 

 

 

 

 

/s/ Celia M. Joseph

Director

February 22, 2024

Celia M. Joseph

 

 

 

 

 

 

/s/ Lawrence Lacerte

 

Director

 

February 22, 2024

Lawrence Lacerte

 

 

 

 

 

44

 

UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Consolidated Financial Statements:

Management’s Report on Internal Control Over Financial Reporting

F-2

Reports of Independent Registered Public Accounting Firm

F-3

Consolidated Balance Sheets

F-6

Consolidated Statements of Income

F-7

Consolidated Statements of Comprehensive Income

F-8

Consolidated Statements of Shareholders’ Equity

F-9

Consolidated Statements of Cash Flows

F-10

Notes to Consolidated Financial Statements

F-11

 

 

F-1

 

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for Universal Display Corporation and its subsidiaries (the Company). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of Consolidated Financial Statements for external purposes in accordance with generally accepted accounting principles. Our system of internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management performed an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2023 based upon criteria in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, management determined that the Company’s internal control over financial reporting was effective as of December 31, 2023, based on the criteria in Internal Control-Integrated Framework (2013) issued by COSO.

The effectiveness of our internal control over financial reporting as of December 31, 2023, has been attested to by KPMG LLP, an independent registered public accounting firm, as stated in its report which appears on the following page.

Steven V. Abramson

President and Chief Executive Officer

Brian Millard

Vice President, Chief Financial Officer and Treasurer

 

February 22, 2024

F-2

 

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors

Universal Display Corporation:

Opinion on Internal Control Over Financial Reporting

We have audited Universal Display Corporation and subsidiaries' (the Company) internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes (collectively, the consolidated financial statements), and our report dated February 22, 2024 expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Philadelphia, Pennsylvania

February 22, 2024

F-3

 

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors

Universal Display Corporation:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Universal Display Corporation and subsidiaries (the Company) as of December 31, 2023 and 2022, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 22, 2024 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Estimated per unit fee for long-term OLED contracts

As discussed in Notes 2 and 21 to the consolidated financial statements, the Company recognizes revenue for organic light emitting diode (OLED) sales to customers with long-term contracts (i.e., over 1 year in length) using certain estimates. Revenue is determined by estimating total contract consideration expected to be received over the term of the contract and recognized based on material units sold during the period at their estimated per unit fee. The estimated per unit fee includes fixed amounts designated in contracts with customers as license fees and royalty fees, as well as estimates of material units to be sold . The Company uses internal and external data to estimate material units to be sold over the contract terms.

We identified the assessment of the estimated per unit fee for long-term OLED contracts as a critical audit matter. The estimated per unit fee was dependent upon the estimates of total material units to be sold. Significant auditor judgment was required in evaluating the forecasted material unit sales, as changes in the estimates could significantly affect the estimated per unit fee.

F-4

 

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the critical audit matter. This included controls related to the Company’s revenue recognition process, including the Company’s review and approval of forecasted quantities of material unit sales of OLED products. We assessed the Company’s forecasting policies and procedures and the inputs used in the estimation process. This assessment included considering the availability of other relevant sources of data used for developing the estimate and evaluating any potential management bias. Additionally, we inspected the forecast calculations for a selection of OLED contracts and compared the per-material unit prices used against the respective contract terms. We compared the OLED material unit sales forecast to internal operating and production budgets, and we compared the forecasted OLED material unit sales to the results of inquiries of Company personnel, third party market data, and analyst reports. We assessed the Company’s ability to accurately forecast OLED material unit sales by comparing recent historical forecasts to actual results and evaluating the Company’s conclusions regarding the reasons for changes in the current year’s estimates as compared to prior estimates.

/s/ KPMG LLP

We have served as the Company’s auditor since 2002.

Philadelphia, Pennsylvania

February 22, 2024

F-5

 

UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

 

 

December 31, 2023

 

 

December 31, 2022

 

ASSETS

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

Cash and cash equivalents

 

$

91,985

 

 

$

93,430

 

Short-term investments

 

 

422,137

 

 

 

484,345

 

Accounts receivable

 

 

139,850

 

 

 

92,664

 

Inventory

 

 

175,795

 

 

 

183,220

 

Other current assets

 

 

87,365

 

 

 

45,791

 

Total current assets

 

 

917,132

 

 

 

899,450

 

PROPERTY AND EQUIPMENT, net of accumulated depreciation of $143,908 and $117,118

 

 

175,150

 

 

 

143,445

 

ACQUIRED TECHNOLOGY, net of accumulated amortization of $186,850 and $189,671

 

 

90,325

 

 

 

38,382

 

OTHER INTANGIBLE ASSETS, net of accumulated amortization of $10,414 and $8,989

 

 

6,874

 

 

 

8,247

 

GOODWILL

 

 

15,535

 

 

 

15,535

 

INVESTMENTS

 

 

299,548

 

 

 

259,861

 

DEFERRED INCOME TAXES

 

 

59,108

 

 

 

58,161

 

OTHER ASSETS

 

 

105,289

 

 

 

109,739

 

TOTAL ASSETS

 

$

1,668,961

 

 

$

1,532,820

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

Accounts payable

 

$

10,933

 

 

$

9,519

 

Accrued expenses

 

 

52,080

 

 

 

51,002

 

Deferred revenue

 

 

47,713

 

 

 

45,599

 

Other current liabilities

 

 

8,096

 

 

 

29,577

 

Total current liabilities

 

 

118,822

 

 

 

135,697

 

DEFERRED REVENUE

 

 

12,006

 

 

 

18,279

 

RETIREMENT PLAN BENEFIT LIABILITY

 

 

52,249

 

 

 

59,790

 

OTHER LIABILITIES

 

 

38,658

 

 

 

43,685

 

Total liabilities

 

 

221,735

 

 

 

257,451

 

COMMITMENTS AND CONTINGENCIES (Note 18)

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY:

 

 

 

 

 

 

Preferred Stock, par value $0.01 per share, 5,000,000 shares authorized, 200,000 
   shares of Series A Nonconvertible Preferred Stock issued and outstanding
   (liquidation value of $7.50 per share or $1,500)

 

 

2

 

 

 

2

 

Common Stock, par value $0.01 per share, 200,000,000 shares authorized, 48,731,026
   and 49,136,030 shares issued, and 47,365,378 and 47,770,382 shares outstanding at
   December 31, 2023 and December 31, 2022, respectively

 

 

487

 

 

 

491

 

Additional paid-in capital

 

 

699,554

 

 

 

681,335

 

Retained earnings

 

 

789,553

 

 

 

653,277

 

Accumulated other comprehensive loss

 

 

(1,086

)

 

 

(18,452

)

Treasury stock, at cost (1,365,648 shares at December 31, 2023 and December 31, 2022)

 

 

(41,284

)

 

 

(41,284

)

Total shareholders’ equity

 

 

1,447,226

 

 

 

1,275,369

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

1,668,961

 

 

$

1,532,820

 

 

The accompanying notes are an integral part of these Consolidated Financial Statements.

F-6

 

UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except share and per share data)

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

REVENUE:

 

 

 

 

 

 

 

 

 

Material sales

 

$

322,029

 

 

$

331,081

 

 

$

318,623

 

Royalty and license fees

 

 

238,389

 

 

 

267,115

 

 

 

219,032

 

Contract research services

 

 

16,011

 

 

 

18,423

 

 

 

15,870

 

Total revenue

 

 

576,429

 

 

 

616,619

 

 

 

553,525

 

COST OF SALES

 

 

135,376

 

 

 

127,896

 

 

 

114,991

 

Gross margin

 

441,053

 

 

 

488,723

 

 

 

438,534

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

Research and development

 

 

130,481

 

 

 

117,062

 

 

 

99,673

 

Selling, general and administrative

 

 

67,387

 

 

 

77,886

 

 

 

80,372

 

Amortization of acquired technology and other intangible assets

 

 

15,993

 

 

 

17,459

 

 

 

21,994

 

Patent costs

 

 

9,356

 

 

 

8,329

 

 

 

8,160

 

Royalty and license expense

 

 

647

 

 

 

877

 

 

 

691

 

Total operating expenses

 

 

223,864

 

 

 

221,613

 

 

 

210,890

 

OPERATING INCOME

 

 

217,189

 

 

 

267,110

 

 

 

227,644

 

Interest income, net

 

 

28,166

 

 

 

7,811

 

 

 

505

 

Other (loss) income, net

 

 

(184

)

 

 

(6,691

)

 

 

98

 

Interest and other income, net

 

 

27,982

 

 

 

1,120

 

 

 

603

 

INCOME BEFORE INCOME TAXES

 

 

245,171

 

 

 

268,230

 

 

 

228,247

 

INCOME TAX EXPENSE

 

 

(42,160

)

 

 

(58,169

)

 

 

(44,034

)

NET INCOME

 

$

203,011

 

 

$

210,061

 

 

$

184,213

 

NET INCOME PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

BASIC

 

$

4.25

 

 

$

4.41

 

 

$

3.87

 

DILUTED

 

$

4.24

 

 

$

4.40

 

 

$

3.87

 

WEIGHTED AVERAGE SHARES USED IN COMPUTING NET
   INCOME PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

BASIC

 

 

47,559,669

 

 

 

47,390,352

 

 

 

47,296,447

 

DILUTED

 

 

47,622,763

 

 

 

47,468,507

 

 

 

47,365,435

 

CASH DIVIDEND DECLARED PER COMMON SHARE

 

$

1.40

 

 

$

1.20

 

 

$

0.80

 

The accompanying notes are an integral part of these Consolidated Financial Statements.

F-7

 

UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

NET INCOME

 

$

203,011

 

 

$

210,061

 

 

$

184,213

 

OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) on available-for-sale securities, net of tax
   of ($351), none and $65, respectively

 

 

8,745

 

 

 

(7,745

)

 

 

(233

)

Employee benefit plan:

 

 

 

 

 

 

 

 

 

Actuarial gain on retirement plan, net of tax of ($2,168), ($1,667)
   and ($1,336), respectively

 

 

7,207

 

 

 

5,971

 

 

 

13,620

 

Plan amendment cost, net of tax of none, none and $79, respectively

 

 

—

 

 

 

—

 

 

 

(283

)

Amortization of prior service cost and actuarial loss for
   retirement plan included in net periodic pension costs,
   net of tax of ($299), ($569) and ($1,316), respectively

 

 

996

 

 

 

2,037

 

 

 

4,719

 

Net change in employee benefit plan

 

 

8,203

 

 

 

8,008

 

 

 

18,056

 

Change in cumulative foreign currency translation adjustment

 

 

418

 

 

 

(480

)

 

 

(39

)

TOTAL OTHER COMPREHENSIVE INCOME (LOSS)

 

 

17,366

 

 

 

(217

)

 

 

17,784

 

COMPREHENSIVE INCOME

 

$

220,377

 

 

$

209,844

 

 

$

201,997

 

 

The accompanying notes are an integral part of these Consolidated Financial Statements.

F-8

 

UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands, except for share data)

 

 

 

Series A
Nonconvertible

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Accumulated
Other

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Retained

 

 

Comprehensive

 

 

Treasury Stock

 

 

Shareholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Loss

 

 

Shares

 

 

Amount

 

 

Equity

 

BALANCE, DECEMBER 31, 2020

 

 

200,000

 

 

$

2

 

 

 

49,013,476

 

 

$

490

 

 

$

635,595

 

 

$

353,930

 

 

$

(36,019

)

 

 

1,365,648

 

 

$

(41,284

)

 

$

912,714

 

Net income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

184,213

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

184,213

 

Other comprehensive income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

17,784

 

 

 

—

 

 

 

—

 

 

 

17,784

 

Cash dividend

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(37,931

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(37,931

)

Issuance of common stock to employees

 

 

—

 

 

 

—

 

 

 

63,969

 

 

 

1

 

 

 

34,471

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

34,472

 

Shares withheld for employee taxes

 

 

—

 

 

 

—

 

 

 

(29,179

)

 

 

—

 

 

 

(14,949

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(14,949

)

Issuance of common stock to Board of
    Directors and Scientific Advisory Board

 

 

—

 

 

 

—

 

 

 

8,502

 

 

 

—

 

 

 

1,704

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

1,704

 

Issuance of common stock to employees
   under an ESPP

 

 

—

 

 

 

—

 

 

 

9,156

 

 

 

—

 

 

 

1,907

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

1,907

 

BALANCE, DECEMBER 31, 2021

 

 

200,000

 

 

 

2

 

 

 

49,065,924

 

 

 

491

 

 

 

658,728

 

 

 

500,212

 

 

 

(18,235

)

 

 

1,365,648

 

 

 

(41,284

)

 

 

1,099,914

 

Net income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

210,061

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

210,061

 

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(217

)

 

 

—

 

 

 

—

 

 

 

(217

)

Cash dividend

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(56,996

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(56,996

)

Issuance of common stock to employees

 

 

—

 

 

 

—

 

 

 

72,769

 

 

 

—

 

 

 

27,907

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

27,907

 

Shares withheld for employee taxes

 

 

—

 

 

 

—

 

 

 

(31,938

)

 

 

—

 

 

 

(9,209

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(9,209

)

Issuance of common stock to Board of
   Directors and Scientific Advisory Board

 

 

—

 

 

 

—

 

 

 

12,218

 

 

 

—

 

 

 

1,866

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

1,866

 

Issuance of common stock to employees
   under an ESPP

 

 

—

 

 

 

—

 

 

 

17,057

 

 

 

—

 

 

 

2,043

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,043

 

BALANCE, DECEMBER 31, 2022

 

 

200,000

 

 

 

2

 

 

 

49,136,030

 

 

 

491

 

 

 

681,335

 

 

 

653,277

 

 

 

(18,452

)

 

 

1,365,648

 

 

 

(41,284

)

 

 

1,275,369

 

Net income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

203,011

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

203,011

 

Other comprehensive income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

17,366

 

 

 

—

 

 

 

—

 

 

 

17,366

 

Cash dividend

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(66,735

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(66,735

)

Issuance of common stock to employees

 

 

—

 

 

 

—

 

 

 

145,428

 

 

 

1

 

 

 

21,792

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

21,793

 

Shares withheld for employee taxes

 

 

—

 

 

 

—

 

 

 

(58,512

)

 

 

—

 

 

 

(8,206

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(8,206

)

Cancellation of restricted stock awards

 

 

—

 

 

 

—

 

 

 

(526,241

)

 

 

(5

)

 

 

5

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Issuance of common stock to Board of
   Directors and Scientific Advisory Board

 

 

—

 

 

 

—

 

 

 

16,808

 

 

 

—

 

 

 

2,074

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,074

 

Issuance of common stock to employees
   under an ESPP

 

 

—

 

 

 

—

 

 

 

17,513

 

 

 

—

 

 

 

2,554

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,554

 

BALANCE, DECEMBER 31, 2023

 

 

200,000

 

 

$

2

 

 

 

48,731,026

 

 

$

487

 

 

$

699,554

 

 

$

789,553

 

 

$

(1,086

)

 

 

1,365,648

 

 

$

(41,284

)

 

$

1,447,226

 

The accompanying notes are an integral part of these Consolidated Financial Statements.

F-9

 

UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Net income

 

$

203,011

 

 

$

210,061

 

 

$

184,213

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

Depreciation

 

 

27,409

 

 

 

24,815

 

 

 

19,968

 

Amortization of intangibles

 

 

15,993

 

 

 

17,459

 

 

 

21,994

 

Amortization of premium and discount on investments, net

 

 

(11,603

)

 

 

(6,461

)

 

 

(373

)

Impairment of minority investments

 

 

—

 

 

 

6,962

 

 

 

—

 

Stock-based compensation to employees

 

 

22,335

 

 

 

28,380

 

 

 

34,871

 

Stock-based compensation to Board of Directors and Scientific Advisory Board

 

 

1,774

 

 

 

1,566

 

 

 

1,404

 

Deferred income tax (benefit) expense

 

 

(3,766

)

 

 

(26,946

)

 

 

1,748

 

Retirement plan expense, net of benefit payments

 

 

3,129

 

 

 

5,276

 

 

 

8,875

 

Decrease (increase) in assets:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(47,186

)

 

 

14,975

 

 

 

(25,378

)

Inventory

 

 

7,425

 

 

 

(49,060

)

 

 

(42,569

)

Other current assets

 

 

(41,574

)

 

 

(24,843

)

 

 

(202

)

Other assets

 

 

4,450

 

 

 

25,971

 

 

 

(32,369

)

Increase (decrease) in liabilities:

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

4,047

 

 

 

3,338

 

 

 

1,902

 

Other current liabilities

 

 

(21,481

)

 

 

20,917

 

 

 

2,105

 

Deferred revenue

 

 

(4,159

)

 

 

(93,203

)

 

 

(5,220

)

Other liabilities

 

 

(5,027

)

 

 

(32,392

)

 

 

20,136

 

Net cash provided by operating activities

 

 

154,777

 

 

 

126,815

 

 

 

191,105

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(59,792

)

 

 

(42,497

)

 

 

(43,161

)

Purchase of intangibles

 

 

(66,563

)

 

 

(4,709

)

 

 

(394

)

Purchases of investments

 

 

(531,103

)

 

 

(701,993

)

 

 

(642,180

)

Proceeds from sale and maturity of investments

 

 

574,165

 

 

 

468,456

 

 

 

227,984

 

Net cash used in investing activities

 

 

(83,293

)

 

 

(280,743

)

 

 

(457,751

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Proceeds from issuance of common stock

 

 

2,012

 

 

 

1,570

 

 

 

1,507

 

Payment of withholding taxes related to stock-based compensation to employees

 

 

(8,206

)

 

 

(9,209

)

 

 

(14,949

)

Cash dividends paid

 

 

(66,735

)

 

 

(56,996

)

 

 

(37,931

)

Net cash used in financing activities

 

 

(72,929

)

 

 

(64,635

)

 

 

(51,373

)

DECREASE IN CASH AND CASH EQUIVALENTS

 

 

(1,445

)

 

 

(218,563

)

 

 

(318,019

)

CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR

 

 

93,430

 

 

 

311,993

 

 

 

630,012

 

CASH AND CASH EQUIVALENTS, END OF YEAR

 

$

91,985

 

 

$

93,430

 

 

$

311,993

 

The following non-cash activities occurred:

 

 

 

 

 

 

 

 

 

Unrealized loss on available-for-sale securities

 

$

(8,938

)

 

$

(8,100

)

 

$

(295

)

Common stock issued to Board of Directors and Scientific Advisory Board
   that was earned and accrued for in a previous period

 

 

300

 

 

 

300

 

 

 

300

 

Net change in accounts payable and accrued expenses related to purchases
   of property and equipment

 

 

678

 

 

 

3,069

 

 

 

(3,526

)

Cash paid for income taxes, net of refunds

 

 

96,176

 

 

 

72,347

 

 

 

52,650

 

 

The accompanying notes are an integral part of these Consolidated Financial Statements.

F-10

 

UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.
BUSINESS:

Universal Display Corporation and its subsidiaries (the Company) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light and can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and as lighting products. OLED displays are capturing a growing share of the display market, especially in the mobile phone, television, monitor, wearable, tablet, notebook and personal computer, augmented reality (AR), virtual reality (VR) and automotive markets. The Company believes this is because OLEDs offer potential advantages over competing display technologies with respect to power efficiency, contrast ratio, viewing angle, video response time, form factor and manufacturing cost. The Company also believes that OLED lighting products have the potential to replace many existing light sources in the future because of their high-power efficiency, excellent color rendering index, low operating temperature and novel form factor. The Company’s technology leadership, intellectual property position, and more than 20 years of experience working closely with leading OLED display manufacturers are some of the competitive advantages that should enable the Company to continue to share in the revenues from OLED displays and lighting products as they gain wider acceptance.

The Company’s primary business strategy is to (1) develop new OLED materials and sell existing and new materials to product manufacturers of products for display applications, such as mobile phones, televisions, monitors, wearables, tablets, portable media devices, notebook computers, personal computers and automotive applications, and specialty and general lighting products; and (2) further develop and either license or otherwise commercialize the Company’s proprietary OLED material, device design and manufacturing technologies to those manufacturers. The Company has established a significant portfolio of proprietary OLED technologies and materials, primarily through internal research and development efforts and acquisitions of patents and patent applications, as well as maintaining long-standing, and establishing new relationships with world-class universities, research institutions and strategic manufacturing partnerships. The Company currently owns, exclusively licenses or has the sole right to sublicense more than 6,000 patents issued and pending worldwide.

The Company manufactures and sells its proprietary OLED materials to customers for evaluation and use in commercial OLED products. The Company also enters into agreements with manufacturers of OLED display and lighting products under which it grants them licenses to practice under the Company’s patents and to use the Company's proprietary know-how. At the same time, the Company works with these and other companies that are evaluating the Company's OLED material, device design and manufacturing technologies for possible use in commercial OLED display and lighting products.

2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

Principles of Consolidation

The Consolidated Financial Statements include the accounts of Universal Display Corporation and its wholly owned subsidiaries, UDC, Inc., UDC Ireland Limited (UDC Ireland), Universal Display Corporation Hong Kong, Limited, Universal Display Corporation Korea, Y.H. (UDC Korea), Universal Display Corporation Japan GK, Universal Display Corporation China, Ltd., Adesis, Inc. (Adesis), UDC Ventures LLC, OVJP Corporation (OVJP Corp) and OLED Material Manufacturing Limited (OMM). All intercompany transactions and accounts have been eliminated.

Reclassification of Prior Year Presentation

Certain prior year adjustments to reconcile net income to net cash provided by operating activities have been reclassified on the Consolidated Statements of Cash Flows to conform to the current year presentation. These adjustments have been consolidated into their respective operating assets and liabilities accounts, specifically, inventory, other current assets, other assets and deferred revenue.

Management’s Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The estimates made are principally in the areas of revenue recognition including estimates of material unit sales and royalties, the useful life of acquired intangibles, lease liabilities, right-of-use assets, the use and recoverability of inventories, intangibles, investments and income taxes including realization of deferred tax assets, stock-based compensation and retirement benefit plan liabilities. Actual results could differ from those estimates.

F-11

 

Cash, Cash Equivalents and Investments

The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of three months or less to be cash equivalents. The Company classifies its remaining investments as available-for-sale. These securities (excluding minority equity investments) are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.

Trade Accounts Receivable

Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. The Company’s accounts receivable balance is a result of chemical sales, royalties and license fees. These receivables have historically been paid timely. Due to the nature of the accounts receivable balance, the Company believes there is no significant collection risk. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their ability to make payments, allowances for credit losses would be required. As of December 31, 2023 and 2022, the allowance for credit losses was $166,000 and $279,000, respectively.

Inventories

Inventories consist of raw materials, work-in-process and finished goods, and are stated at the lower of cost, determined on a first-in, first-out basis, or net realizable value. Inventory valuation and firm committed purchase order assessments are performed on a quarterly basis and those items that are identified to be obsolete or in excess of forecasted usage are written down to their estimated realizable value. Estimates of realizable value are based upon management’s analyses and assumptions, including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. A 12-month rolling forecast based on factors, including, but not limited to, production cycles, anticipated product orders, marketing forecasts, backlog, and shipment activities is used in the inventory analysis. If market conditions are less favorable than forecasts or actual demand from customers is lower than estimates, additional inventory write-downs may be required. If demand is higher than expected, inventories that had previously been written down may be sold.

Property and Equipment

Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful life of 30 years for buildings, 15 years for building improvements, and three to seven years for office and lab equipment and furniture and fixtures. Repair and maintenance costs are charged to expense as incurred. Additions and betterments are capitalized.

Major renewals and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to current operations as incurred. Upon retirement or disposal of assets, the cost and related accumulated depreciation are removed from the Consolidated Balance Sheets and any gain or loss is reflected in other operating expenses.

Certain costs of computer software obtained for internal use are capitalized and amortized on a straight-line basis over three years. Costs for maintenance and training, as well as the cost of software that does not add functionality to an existing system, are expensed as incurred.

Impairment of Long-Lived Assets

Company management continually evaluates whether events or changes in circumstances might indicate that the remaining estimated useful life of long-lived assets may warrant revision, or that the remaining balance may not be recoverable. When factors indicate that long-lived assets should be evaluated for possible impairment, the Company uses an estimate of the related undiscounted cash flows in measuring whether the long-lived asset should be written down to fair value. Measurement of the amount of impairment would be based on generally accepted valuation methodologies, as deemed appropriate. As of December 31, 2023, Company management believed that no revision to the remaining useful lives or write-down of the Company’s long-lived assets was required, and similarly, no such revisions were required for the years ended December 31, 2022 or 2021.

Goodwill and Purchased Intangible Assets

Goodwill is tested for impairment in the fourth fiscal quarter and, when specific circumstances dictate, between annual tests. If after assessing the totality of events or circumstances as those described in the qualitative assessment, it is determined that it is more likely than not the fair value of a reporting unit is less than its carrying amount, then a quantitative goodwill impairment test will be performed. Under the quantitative test, the fair value of the reporting unit is compared to its carrying amount including goodwill. If the

F-12

 

fair value of the reporting unit exceeds its carrying amount, goodwill of the reporting unit would be considered not impaired. However, if the carrying amount of the reporting unit exceeds its fair value, an impairment loss would be recognized in the amount equal to the excess, limited to the total amount of goodwill allocated to that reporting unit. The Company performed its annual impairment assessment as of December 31, 2023 utilizing a qualitative assessment and concluded that it was more likely than not that the fair value of Adesis is greater than its carrying value. Future impairment tests will continue to be performed annually in the fiscal fourth quarter, or sooner if a triggering event occurs. As of December 31, 2023, no indications of impairment existed.

Purchased intangible assets with finite lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets.

Fair Value of Financial Instruments

The carrying values of accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value in the accompanying Consolidated Financial Statements due to the short-term nature of those instruments. The Company’s other financial instruments, which include cash equivalents and investments (excluding minority equity investments) are carried at fair value.

Fair Value Measurements

Fair value is defined as an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. The Company uses valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. Observable inputs are inputs that market participants would use in pricing the asset or liability and are based on market data obtained from sources independent of the Company. Unobservable inputs reflect assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.

Minority Equity Investments

The Company accounts for minority equity investments in companies that are not accounted for under the equity method as equity securities without readily determinable fair values. The value of these securities is based on original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment in the same issuer. Under this method, the share of income or loss of such companies is not included in the Consolidated Statements of Income. The carrying value of these investments is included in investments on the Consolidated Balance Sheets.

The Company’s policy is to recognize an impairment in the value of its minority equity investments when evidence of an impairment exists. Factors considered in the assessment include a significant adverse change in the regulatory, economic, or technological environment, the completion of new equity financing that may indicate a decrease in value, the failure to complete new equity financing arrangements after seeking to raise additional funds, or the commencement of proceedings under which the assets of the business may be placed in receivership or liquidated to satisfy the claims of debt and equity stakeholders. The impairment in the value of minority equity investments is included in the other (loss) income, net line item on the Consolidated Statements of Income.

Leases

The Company is a lessee in operating leases primarily incurred to facilitate manufacturing, research and development, and selling, general and administrative activities. At contract inception, the Company determines if an arrangement is or contains a lease, and if so recognizes a right-of-use asset and lease liability at the lease commencement date. For operating leases, the lease liability is measured at the present value of the unpaid lease payments at the lease commencement date, whereas for finance leases, the lease liability is initially measured at the present value of the unpaid lease payments and subsequently measured at amortized cost using the interest method. Operating lease right-of-use assets are included in other assets on the Consolidated Balance Sheets. The short-term portion of operating lease liabilities is included in other current liabilities on the Consolidated Balance Sheets and the long-term portion is included in other liabilities on the Consolidated Balance Sheets. As of December 31, 2023, the Company had no leases that qualified as financing arrangements.

Key estimates and judgments include how the Company determines the discount rate used to discount the unpaid lease payments to present value and the lease term. The Company monitors for events or changes in circumstances that could potentially require recognizing an impairment loss.

F-13

 

Revenue Recognition and Deferred Revenue

Material sales relate to the Company’s sale of its OLED materials for incorporation into its customers’ commercial OLED products or for their OLED development and evaluation activities. Revenue associated with material sales is generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties. Revenue may be recognized after control of the material passes in the event the transaction price includes variable consideration. For example, a customer may be provided an extended opportunity to stock materials prior to use in mass production and given a general right of return not conditioned on breaches of warranties associated with the specific product. In such circumstances, revenue will be recognized at the earlier of the expiration of the customer’s general right of return or once it becomes unlikely that the customer will exercise its right of return.

The vast majority of revenue attributed to material sales is determined through technology license agreements and material supply agreements the terms of which are jointly agreed upon with the Company’s customers. The remaining revenue recognized is in the form of contract research services revenue earned by the Company’s subsidiary, Adesis, Inc., and the Company’s occasional material sales to smaller customers. None of the revenue recognized during the years ended December 31, 2023, 2022 or 2021 resulted solely from royalty or license fee arrangements as to which there were not associated material sales.

The rights and benefits to the Company’s OLED technologies are conveyed to the customer through technology license agreements and material supply agreements. The Company believes that the licenses and materials sold under these combined agreements are not distinct from each other for financial reporting purposes and as such, they are accounted for as a single performance obligation. Accordingly, total contract consideration is estimated and recognized over the contract term based on material units sold at the estimated per unit fee over the life of the contract. Total contract consideration is allocated to material sales and royalty and licensing fees on the Consolidated Statements of Income based on contract pricing.

Various estimates are relied upon to recognize revenue. The Company estimates total material units to be purchased by its customers over the contract term based on historical trends, industry estimates and its forecast process. Management uses the expected value method to estimate the material per unit fee. Additionally, management estimates the sales-based portion of royalty revenue based on the estimated net sales revenue of its customers over the contract term.

Contract research services revenue is revenue earned by Adesis by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis. These services range from intermediates for structure-activity relationship studies, reference agents and building blocks for combinatorial synthesis, re-synthesis of key intermediates, specialty organic chemistry needs, and selective toll manufacturing. These services are provided to third-party pharmaceutical and life sciences firms and other technology firms at fixed costs or predetermined rates on a contract basis. Revenue is recognized as services are performed with billing schedules and payment terms negotiated on a contract-by-contract basis. Payments received in excess of revenue recognized are recorded as deferred revenue. In other cases, services may be provided and revenue is recognized before the customer is invoiced. In these cases, revenue recognized will exceed amounts billed and the difference, representing amounts which are currently unbillable to the customer pursuant to contractual terms, is recorded as an unbilled receivable.

Technology development and support revenue is revenue earned from development and technology evaluation agreements and commercialization assistance fees. Technology development and support revenue is included in contract research services on the Consolidated Statements of Income.

On December 2, 2022, the Company entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, the Company is being paid a license fee, which includes quarterly and annual payments over the agreement term of five years. The agreement conveys to SDC the non-exclusive right to use certain of the Company's intellectual property assets for a limited period of time that is less than the estimated life of the assets.

At the same time the Company entered into the current commercial license agreement with SDC, the Company also entered into a new supplemental material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the supplemental material purchase agreement, SDC agrees to purchase red and green phosphorescent emitter materials from the Company for use in the manufacture of licensed products. This amount purchased is subject to SDC’s requirements for phosphorescent emitter materials and the Company’s ability to meet these requirements over the term of the supplemental agreement.

F-14

 

In 2015, the Company entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display), which were effective as of January 1, 2015. The terms of these agreements were extended by a January 1, 2021 amendment through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under the Company's patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The OLED commercial supply agreement provides for the sale of materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the lives of the agreements as well as minimum royalty revenue.

In 2023, the Company entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, the Company has granted BOE non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company supplies phosphorescent OLED materials to BOE for use in its licensed products.

In 2019, the Company entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, the Company entered into long-term, multi-year agreements with CSOT. Under these agreements, the Company has granted CSOT non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company also supplies phosphorescent OLED materials to CSOT for use in its licensed products.

In 2018, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Visionox Technology, Inc. (Visionox). Under the license agreement, the Company granted certain of Visionox’s affiliates non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Visionox for use in its licensed products. In 2021, the Company announced that it had extended the Visionox agreement by entering into new five-year OLED material supply and license agreements with a new affiliate of Visionox, Visionox Hefei Technology Co. Ltd.

In 2016, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Micro-electronics Co., Ltd. (Tianma). Under the license agreement, the Company has granted Tianma non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Tianma for use in its licensed products. In 2021, the parties extended the terms of both the patent license and material purchase agreements for an additional multi-year-term.

All material sales transactions that are not variable consideration transactions are billed and due within 90 days and substantially all are transacted in U.S. dollars.

Cost of Sales

Cost of sales consists of labor and material costs associated with the production of materials processed at the facilities of the Company's manufacturing partner, PPG Industries, Inc. (PPG) and at the Company's internal facilities. The Company’s portion of cost of sales also includes depreciation of manufacturing equipment, as well as manufacturing overhead costs and inventory adjustments for excess and obsolete inventory.

Research and Development

Expenditures for research and development are charged to expense as incurred.

Patent Costs

Costs associated with patent applications, patent prosecution, patent defense and the maintenance of patents are charged to expense as incurred. Costs to successfully defend a challenge to a patent are capitalized to the extent of an evident increase in the value of the patent. Costs that relate to an unsuccessful outcome are charged to expense.

Amortization of Acquired Technology

Amortization costs primarily relate to technology acquired from Merck KGaA, Darmstadt, Germany (Merck KGaA), BASF SE (BASF) and Fujifilm Corporation (Fujifilm). The Merck KGaA acquisition was completed on April 28, 2023. The BASF and Fujifilm acquisitions were completed in the years ended December 31, 2016 and 2012, respectively. Acquisition costs are being amortized over

F-15

 

a period of 10 years for the Merck KGaA and BASF patents. The Fujifilm acquired technology was fully amortized over a period of 10 years that ended in July 2022.

Amortization of Other Intangible Assets

Other intangible assets from the Adesis acquisition are being amortized over a period of 10 to 15 years. See Note 7 for further discussion.

Translation of Foreign Currency Financial Statements and Foreign Currency Transactions

The Company’s reporting currency is the U.S. dollar. The functional currency for the UDC Ireland and UDC Korea subsidiaries are also the U.S. dollar and the functional currency for the OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries is its respective local currency. The Company translates the amounts included in the Consolidated Statements of Income from OMM and its Asia-Pacific foreign subsidiaries into U.S. dollars at weighted-average exchange rates, which the Company believes are representative of the actual exchange rates on the dates of the transactions. The Company's OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries' assets and liabilities are translated into U.S. dollars from the local currency at the actual exchange rates as of the end of each reporting date, and the Company records the resulting foreign exchange translation adjustments in the Consolidated Balance Sheets as a component of accumulated other comprehensive loss. The overall effect of the translation of foreign currency and foreign currency transactions to date has been insignificant.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than 50%. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties, if any, related to unrecognized tax benefits as a component of tax expense.

Share-Based Payment Awards

The Company recognizes in the Consolidated Statements of Income the grant-date fair value of equity-based awards such as shares issued under employee stock purchase plans, restricted stock awards, restricted stock units and performance unit awards issued to employees and directors.

The grant-date fair value of stock awards is based on the closing price of the stock on the date of grant. The fair value of share-based awards is recognized as compensation expense on a straight-line basis over the requisite service period, net of forfeitures. The Company issues new shares upon the respective grant, exercise or vesting of the share-based payment awards, as applicable.

Performance unit awards are subject to either a performance-based or market-based vesting requirement. For performance-based vesting, the grant-date fair value of the award, based on fair value of the Company's common stock, is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved, and compensation expense is periodically adjusted based on actual and expected performance. Compensation expense for performance unit awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.

Recent Accounting Pronouncements

Adoption of New Accounting Standards

In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with FASB ASC 606. The adoption of ASU 2021-08, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.

F-16

 

In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, Liabilities—Supplier Finance Programs (Subtopic 450-50): Disclosure of Supplier Finance Program Obligations, which require disclosures about a buyer's supplier finance program. The adoption of ASU 2022-04, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.

Accounting Standards Issued But Not Yet Adopted

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. Under this standard, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. The standard also requires certain disclosures for equity securities that are subject to contractual restrictions. ASU 2022-03 becomes effective January 1, 2024, and will not have a significant impact on the Consolidated Financial Statements and related disclosures.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard improves the reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 becomes effective January 1, 2024, and the Company is evaluating the potential impact of this standard on the Consolidated Financial Statements and related disclosures.

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The standard enhances to the annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity's worldwide operations. ASU 2023-09 becomes effective January 1, 2025, and the Company is evaluating the potential impact of this standard on its income tax disclosures.

3.
CASH, CASH EQUIVALENTS AND INVESTMENTS:

The Company’s portfolio of marketable fixed income securities consists of U.S. Government bonds and corporate bonds. The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of three months or less to be cash equivalents. The Company classifies its remaining debt security investments as available-for-sale. These debt securities are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.

Cash and Cash Equivalents

The following table provides details regarding the Company’s portfolio of cash and cash equivalents (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Cash and Cash Equivalents Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Cash accounts in banking institutions

 

$

91,717

 

 

$

—

 

 

$

—

 

 

$

91,717

 

Money market accounts

 

 

268

 

 

 

—

 

 

 

—

 

 

 

268

 

 

 

$

91,985

 

 

$

—

 

 

$

—

 

 

$

91,985

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Cash accounts in banking institutions

 

$

86,268

 

 

$

—

 

 

$

—

 

 

$

86,268

 

Money market accounts

 

 

7,162

 

 

 

—

 

 

 

—

 

 

 

7,162

 

 

 

$

93,430

 

 

$

—

 

 

$

—

 

 

$

93,430

 

Short-term Investments

The following table provides details regarding the Company’s portfolio of short-term investments (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Short-term Investments Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

1,763

 

 

$

1

 

 

$

(5

)

 

$

1,759

 

U.S. Government bonds

 

 

420,769

 

 

 

303

 

 

 

(694

)

 

 

420,378

 

 

 

$

422,532

 

 

$

304

 

 

$

(699

)

 

$

422,137

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

150,698

 

 

$

—

 

 

$

(910

)

 

$

149,788

 

U.S. Government bonds

 

 

339,472

 

 

 

32

 

 

 

(4,947

)

 

 

334,557

 

 

 

$

490,170

 

 

$

32

 

 

$

(5,857

)

 

$

484,345

 

 

F-17

 

Long-term Corporate Bond and U.S. Government Bond Investments

The following table provides details regarding the Company’s portfolio of long-term investments (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Long-term Investments Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Government bonds

 

$

284,053

 

 

$

1,457

 

 

$

(8

)

 

$

285,502

 

 

 

$

284,053

 

 

$

1,457

 

 

$

(8

)

 

$

285,502

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

2,479

 

 

$

—

 

 

$

(28

)

 

$

2,451

 

U.S. Government bonds

 

 

247,464

 

 

 

52

 

 

 

(2,152

)

 

$

245,364

 

 

 

$

249,943

 

 

$

52

 

 

$

(2,180

)

 

$

247,815

 

Minority Equity Investments

The Company’s portfolio of minority equity investments consists of investments in privately held early-stage companies primarily motivated for the Company to gain early access to new technology and are passive in nature in that the Company typically does not seek to obtain representation on the boards of directors of the companies in which it invests. Minority equity investments are included in investments on the Consolidated Balance Sheets. As of December 31, 2023, the Company had minority equity investments in five entities with a total carrying value of $14.0 million accounted for as equity securities without readily determinable fair values as compared to four minority equity investments with a total carrying value of $12.0 million as of December 31, 2022.

During the year ended December 31, 2022, the Company recognized an impairment in the value of two of its minority equity investments, an impairment of an equity security investment in the amount of $3.0 million and an impairment of a long-term convertible note investment of $4.0 million which had been acquired during the year ended December 31, 2022. During the year ended December 31, 2023, the Company did not recognize an impairment in the value of its minority equity investments. The impairment in the value of minority equity investments are included in the other (loss) income, net line item on the Consolidated Statements of Income.

4.
FAIR VALUE MEASUREMENTS:

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2023 (in thousands):

 

 

 

 

 

Fair Value Measurements, Using

 

 

 

Total Carrying Value
as of December 31,
 2023

 

 

Quoted Prices in
Active Markets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant Unobservable
Inputs
(Level 3)

 

Cash equivalents

 

$

268

 

 

$

268

 

 

$

—

 

 

$

—

 

Short-term Corporate bonds

 

 

1,759

 

 

 

1,759

 

 

 

—

 

 

 

—

 

Short-term U.S. Government bonds

 

 

420,378

 

 

 

420,378

 

 

 

—

 

 

 

—

 

Long-term U.S. Government bonds

 

 

285,502

 

 

 

285,502

 

 

 

—

 

 

 

—

 

 

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2022 (in thousands):

 

 

 

 

 

 

Fair Value Measurements, Using

 

 

 

Total Carrying Value
as of December 31,
 2022

 

 

Quoted Prices in
Active Markets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant Unobservable
Inputs
(Level 3)

 

Cash equivalents

 

$

7,162

 

 

$

7,162

 

 

$

—

 

 

$

—

 

Short-term Corporate bonds

 

 

149,788

 

 

 

149,788

 

 

 

—

 

 

 

—

 

Short-term U.S. Government bonds

 

 

334,557

 

 

 

334,557

 

 

 

—

 

 

 

—

 

Long-term Corporate bonds

 

 

2,451

 

 

 

2,451

 

 

 

—

 

 

 

—

 

Long-term U.S. Government bonds

 

 

245,364

 

 

 

245,364

 

 

 

—

 

 

 

—

 

 

F-18

 

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on management’s own assumptions used to measure assets and liabilities at fair value. A financial asset’s or liability’s classification is determined based on the lowest level input that is significant to the fair value measurement.

Changes in fair value of the debt investments are recorded as unrealized gains and losses in accumulated other comprehensive loss on the Consolidated Balance Sheets and any credit losses on debt investments are recorded as an allowance for credit losses with an offset recognized in other (loss) income, net on the Consolidated Statements of Income. There were no credit losses on debt investments as of December 31, 2023 or December 31, 2022.

5.
INVENTORY:

Inventory consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Raw materials

 

$

113,400

 

 

$

115,448

 

Work-in-process

 

 

9,433

 

 

 

7,626

 

Finished goods

 

 

52,962

 

 

 

60,146

 

Inventory

 

$

175,795

 

 

$

183,220

 

 

The Company recorded an inventory reserve of $8.5 million, $3.6 million and $3.6 million for the years ended December 31, 2023, 2022 and 2021, respectively, due to excess inventory levels in certain products.

6.
PROPERTY AND EQUIPMENT:

Property and equipment, net consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Land

 

$

12,230

 

 

$

2,642

 

Building and improvements

 

 

116,903

 

 

 

99,586

 

Office and lab equipment

 

 

148,465

 

 

 

129,697

 

Furniture, fixtures and computer related assets

 

 

18,970

 

 

 

18,071

 

Construction-in-progress

 

 

22,490

 

 

 

10,567

 

 

 

 

319,058

 

 

 

260,563

 

Less: Accumulated depreciation

 

 

(143,908

)

 

 

(117,118

)

Property and equipment, net

 

$

175,150

 

 

$

143,445

 

Depreciation expense was $27.4 million, $24.8 million and $20.0 million for the years ended December 31, 2023, 2022 and 2021, respectively. The increase in property and equipment, net for the year ended December 31, 2023 is primarily due to the purchases of two previously leased facilities for an aggregate cost of $23.4 million and ongoing renovation activities at our research and development center in Ewing, New Jersey.

7.
GOODWILL AND INTANGIBLE ASSETS:

The Company monitors the recoverability of goodwill annually or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Purchased intangible assets subject to amortization consist of acquired technology and other intangible assets that include trade names, customer relationships and developed intellectual property (IP) processes.

F-19

 

Acquired Technology

Acquired technology primarily consists of acquired license rights for patents and know-how obtained from Merck KGaA, BASF and Fujifilm. These intangible assets consist of the following (in thousands):

 

 

December 31,

 

 

 

2023 (1)

 

 

2022

 

PD-LD, Inc.

 

$

—

 

 

$

1,481

 

Motorola

 

 

—

 

 

 

15,909

 

Merck KGaA

 

 

66,012

 

 

 

—

 

BASF

 

 

95,989

 

 

 

95,989

 

Fujifilm

 

 

109,462

 

 

 

109,462

 

Other

 

 

5,712

 

 

 

5,212

 

 

 

 

277,175

 

 

 

228,053

 

Less: Accumulated amortization

 

 

(186,850

)

 

 

(189,671

)

Acquired technology, net

 

$

90,325

 

 

$

38,382

 

 

(1)
During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.

Amortization expense related to acquired technology was $14.6 million, $16.0 million and $20.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. Amortization expense is included in amortization of acquired technology and other intangible assets expense line item on the Consolidated Statements of Income and is expected to be $16.8 million in each of the years ending December 31, 2024 and 2025, $12.0 million in the year ending December 31, 2026, $7.2 million in each of the years ending December 2027 and 2028, and $30.3 million in total thereafter.

Merck KGaA Patent Acquisition

In April 2023, UDC Ireland entered into a Patent Sale and License Agreement with Merck KGaA. Under this agreement, Merck KGaA sold to UDC Ireland all of its rights, title and interest to over 550 of its owned and licensed OLED-related patents and patent applications in exchange for a cash payment of $66.0 million. The Patent Sale and License Agreement contains customary representations, warranties and covenants of the parties. UDC Ireland recorded the payment of $66.0 million as acquired technology, which is being amortized over a period of 10 years.

BASF Patent Acquisition

On June 28, 2016, UDC Ireland entered into and consummated an IP Transfer Agreement with BASF. Under the IP Transfer Agreement, BASF sold to UDC Ireland all of its rights, title and interest to certain of its owned and co-owned intellectual property rights relating to the composition, development, manufacture and use of OLED materials, including OLED lighting and display stack technology, as well as certain tangible assets. The intellectual property includes knowhow and more than 500 issued and pending patents in the area of phosphorescent materials and technologies. These assets were acquired in exchange for a cash payment of €86.8 million ($95.8 million). In addition, UDC Ireland also took on certain rights and obligations under three joint research and development agreements to which BASF was a party. The IP Transfer Agreement also contains customary representations, warranties and covenants of the parties. UDC Ireland recorded the payment of €86.8 million ($95.8 million) and acquisition costs incurred of $217,000 as acquired technology, which is being amortized over a period of 10 years.

Fujifilm Patent Acquisition

On July 23, 2012, the Company entered into a Patent Sale Agreement with Fujifilm. Under the agreement, Fujifilm sold more than 1,200 OLED-related patents and patent applications in exchange for a cash payment of $105.0 million, plus $4.5 million in costs incurred in connection with the purchase. The agreement contains customary representations and warranties and covenants, including respective covenants not to sue by both parties thereto. The agreement permitted the Company to assign all of its rights and obligations under the agreement to its affiliates, and the Company assigned, prior to the consummation of the transactions contemplated by the agreement, its rights and obligations to UDC Ireland. The transactions contemplated by the agreement were consummated on July 26, 2012. The Company recorded the $105.0 million plus $4.5 million of purchase costs as acquired technology, which was amortized over a period of 10 years that ended in July 2022.

F-20

 

Other Intangible Assets

As a result of the Adesis acquisition in June 2016, the Company recorded $16.8 million of other intangible assets, including $10.5 million assigned to customer relationships with a weighted average life of 11.5 years, $4.8 million to internally developed IP, processes and recipes with a weighted average life of 15 years, and $1.5 million to trade name and trademarks with a weighted average life of 10 years.

At December 31, 2023, these other intangible assets consist of the following (in thousands):

 

 

 

December 31, 2023

 

 

 

Gross Carrying
Amount

 

 

Accumulated
Amortization

 

 

Net Carrying
Amount

 

Customer relationships

 

$

10,520

 

 

$

(6,801

)

 

$

3,719

 

Developed IP, processes and recipes

 

 

4,820

 

 

 

(2,388

)

 

 

2,432

 

Trade name/Trademarks

 

 

1,500

 

 

 

(1,118

)

 

 

382

 

Other

 

 

448

 

 

 

(107

)

 

 

341

 

Total identifiable other intangible assets

 

$

17,288

 

 

$

(10,414

)

 

$

6,874

 

 

Amortization expense related to other intangible assets was $1.4 million for each of the years ended December 31, 2023, 2022, and 2021. Amortization expense is included in amortization of acquired technology and other intangible assets expense line item on the Consolidated Statements of Income and is expected to be $1.4 million for each of the next three fiscal years (2024 - 2026), $1.3 million for the year ending December 31, 2027, $422,000 for the year ending December 31, 2028, and $1.0 million in total thereafter.

Goodwill

As a result of the Adesis acquisition, the Company recorded $15.5 million of goodwill. The Company performs its annual assessment of goodwill during the fourth quarter of the fiscal year unless events suggest an impairment may have been incurred in an interim period using Adesis’ standalone financial operating performance information. Application of the goodwill impairment test requires the exercise of judgment, including the determination of the fair value of each reporting unit, as Adesis is considered to be the reporting unit. As part of the annual assessment of goodwill completed during the fourth quarter ended December 31, 2023, there were no significant indicators to conclude that an impairment of the goodwill associated with the acquisition of Adesis had occurred.

8.
OTHER ASSETS:

Other assets consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Long-term taxes receivable

 

$

60,146

 

 

$

63,915

 

Right-of-use assets

 

 

24,910

 

 

 

31,486

 

Long-term unbilled receivables

 

 

9,074

 

 

 

—

 

Long-term contract assets

 

 

9,278

 

 

 

11,651

 

Other long-term assets

 

 

1,881

 

 

 

2,687

 

Other assets

 

$

105,289

 

 

$

109,739

 

See Notes 9 and 20 for further explanation on right-of-use assets and long-term taxes receivable, respectively.

9.
LEASES:

The Company has entered into operating leases to facilitate the expansion of its manufacturing, research and development, and selling, general and administrative activities. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend or terminate the lease when those events are reasonably certain to occur. The interest rate implicit in lease contracts is typically not readily determinable and as such the Company uses the appropriate incremental borrowing rate based on information available at the lease commencement date in determining the present value of the lease payments. Current lease agreements do not contain any residual value guarantees or material restrictive covenants. As of December 31, 2023, the Company did not have any finance leases and no additional operating leases that have not yet commenced.

F-21

 

The following table presents the Company’s operating lease cost and supplemental cash flow information related to the Company’s operating leases (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Operating lease cost

 

$

4,639

 

 

$

4,436

 

 

$

3,637

 

Non-cash activity:

 

 

 

 

 

 

 

 

 

Right-of-use assets obtained in exchange for lease obligations

 

$

1,072

 

 

$

4,750

 

 

$

26,174

 

The following table presents the Company’s operating lease right-of-use assets and liabilities (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Right-of-use assets

 

$

24,910

 

 

$

31,486

 

Short-term lease liabilities

 

 

3,533

 

 

 

3,737

 

Long-term lease liabilities

 

 

22,855

 

 

 

29,039

 

 

The following table presents weighted average assumptions used to compute the Company’s right-of-use assets and lease liabilities:

 

 

 

December 31, 2023

 

Weighted average remaining lease term (in years)

 

 

6.7

 

Weighted average discount rate

 

 

3.7

%

As of December 31, 2023, current operating leases had remaining terms between three and eight years with options to extend the lease terms.

Undiscounted future minimum lease payments as of December 31, 2023, by year and in the aggregate, having non-cancelable lease terms in excess of one year were as follows (in thousands):

 

 

 

Maturities of

 

 

 

Operating Lease Liabilities

 

2024

 

$

4,267

 

2025

 

 

4,321

 

2026

 

 

4,401

 

2027

 

 

4,323

 

2028

 

 

3,996

 

Thereafter

 

 

8,083

 

Total lease payments

 

 

29,391

 

Less: imputed interest

 

 

(3,003

)

Present value of lease payments

 

$

26,388

 

 

10.
ACCRUED EXPENSES:

Accrued expenses consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Compensation

 

$

29,456

 

 

$

31,751

 

PPG Industries, Inc. agreement

 

 

11,962

 

 

 

9,864

 

Consulting

 

 

2,121

 

 

 

910

 

Professional fees

 

 

1,124

 

 

 

906

 

Research and development agreements

 

 

822

 

 

 

662

 

Royalties

 

 

647

 

 

 

877

 

Other

 

 

5,948

 

 

 

6,032

 

Accrued expenses

 

$

52,080

 

 

$

51,002

 

 

F-22

 

11.
RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS:

The Company has long-standing relationships with a number of academic institutions that undertake funded research projects, including Princeton University (Princeton) and the University of Southern California (USC).

Under the current license agreement among the Company, Princeton and USC, the universities have granted the Company worldwide, exclusive license rights, with rights to sublicense, to make, have made, use, lease and/or sell products and to practice processes based on patent applications and issued patents arising out of research performed by the universities for the Company. The Company recorded royalty expense in connection with this agreement of $575,000, $853,000 and $691,000 for the years ended December 31, 2023, 2022 and 2021, respectively.

The Company also makes payments under the current research agreement with USC on a quarterly basis as actual expenses are incurred. As of December 31, 2023, the Company was obligated to pay USC up to $2.0 million for work to be performed during the remaining extended term. The Company recorded research and development expense in connection with work performed under the agreement of $1.1 million, $905,000 and $1.3 million for the years ended December 31, 2023, 2022 and 2021, respectively.

12.
OTHER LIABILITIES:

Other liabilities consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Long-term lease liabilities

 

$

22,855

 

 

$

29,039

 

Long-term taxes payable

 

 

15,749

 

 

 

14,592

 

Other long-term liabilities

 

 

54

 

 

 

54

 

Other liabilities

 

$

38,658

 

 

$

43,685

 

See Notes 9 and 20 for further explanation on long-term lease liabilities and long-term taxes payable, respectively.

13.
EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS:

On September 22, 2011, the Company entered into an Amended and Restated OLED Materials Supply and Service Agreement with PPG (the New OLED Materials Agreement), which, effective as of October 1, 2011, replaced the original OLED Materials Agreement with PPG. The term of the New OLED Materials Agreement, by amendment in February 2021, runs through December 31, 2024, and thereafter is automatically renewed for additional one-year terms, unless terminated by the Company by providing prior notice of one year or terminated by PPG by providing prior notice of two years. The New OLED Materials Agreement contains provisions that are substantially similar to those of the original OLED Materials Agreement. Under the New OLED Materials Agreement, PPG continues to assist the Company in developing its proprietary OLED materials and supplying the Company with those materials for evaluation purposes and for resale to its customers.

Under the New OLED Materials Agreement, the Company compensates PPG on a cost-plus basis for the services provided during each calendar quarter. The Company is required to pay for some of these services in all cash. Up to 50% of the remaining services are payable, at the Company’s sole discretion, in cash or shares of the Company’s common stock, with the balance payable in cash. The actual number of shares of common stock issuable to PPG is determined based on the average closing price for the Company’s common stock during a specified number of days prior to the end of each calendar half-year period ending on March 31 and September 30. If, however, this average closing price is less than $20.00, the Company is required to compensate PPG in cash. No shares have been issued for services rendered by PPG since the inception of the contract.

The Company is also required to reimburse PPG for raw materials used for research and development. The Company records the purchases of these raw materials as a current asset until such materials are used for research and development efforts.

In February 2021, the Company entered into an amendment to the New OLED Materials Agreement extending the term of the agreement and specifying operation and maintenance services to be provided by PPG affiliate, PPG SCM Ireland Limited (PPG SCM), to UDC Ireland, at the Company’s manufacturing site in Shannon, Ireland that UDC Ireland’s wholly-owned subsidiary, OLED Material Manufacturing Limited (OMM), began leasing at such time for the production of OLED materials. OMM purchased the site in September 2023 and the Company amended and restated the February 2021 amendment to reflect OMM’s ownership and PPG SCM’s updated operation and maintenance services after such purchase. Facility improvements have been completed and operations commenced in June 2022. As with the initial New OLED Materials Agreement, the Company compensates PPG on a cost-plus basis for the services provided at the Shannon manufacturing facility.

F-23

 

The Company recorded research and development expense of $9.1 million, $7.3 million and $3.6 million for the years ended December 31, 2023, 2022 and 2021, respectively, in relation to the cash portion of the reimbursement of expenses and work performed by PPG, excluding amounts paid for commercial chemicals.

14.
SHAREHOLDERS' EQUITY:

Preferred Stock

The Company’s Amended and Restated Articles of Incorporation authorize it to issue up to 5,000,000 shares of $0.01 par value preferred stock with designations, rights and preferences determined from time-to-time by the Company’s Board of Directors. Accordingly, the Company’s Board of Directors is empowered, without shareholder approval, to issue preferred stock with dividend, liquidation, conversion, voting or other rights superior to those of shareholders of the Company’s common stock.

 

In 1995, the Company issued 200,000 shares of Series A Nonconvertible Preferred Stock (Series A) to American Biomimetics Corporation (ABC) pursuant to a certain Technology Transfer Agreement between the Company and ABC. The Series A shares have a liquidation value of $7.50 per share. Series A shareholders, as a single class, have the right to elect two members of the Company’s Board of Directors. This right has never been exercised. Holders of the Series A shares are entitled to one vote per share on matters which shareholders are generally entitled to vote. The Series A shareholders are not entitled to any dividends.

 

As of December 31, 2023, the Company had issued 200,000 shares of preferred stock, all of which were outstanding.

Common Stock

The Company’s Amended and Restated Articles of Incorporation authorize it to issue up to 200,000,000 shares of $0.01 par value common stock. Each share of the Company’s common stock entitles the holder to one vote on all matters to be voted upon by the shareholders.

As of December 31, 2023, the Company had issued 48,731,026 shares of common stock, of which 47,365,378 were outstanding. During the years ended December 31, 2023 and 2022, the Company repurchased no shares of common stock.

Dividends

During the year ended December 31, 2023, the Company declared and paid cash dividends of $1.40 per common share, or $66.7 million, on the Company’s outstanding common stock.

 

On February 20, 2024, the Company’s Board of Directors declared a first quarter dividend of $0.40 per share to be paid on March 29, 2024 to all shareholders of record of the Company's common stock as of the close of business on March 15, 2024. All future dividends will be subject to the approval of the Company’s Board of Directors.

F-24

 

15.
ACCUMULATED OTHER COMPREHENSIVE LOSS:

Amounts related to the changes in accumulated other comprehensive loss were as follows (in thousands):

 

 

Unrealized
Gain (Loss) on
Available-for-
Sale-Securities

 

 

Net Unrealized
Gain (Loss) on
Retirement Plan (2)

 

 

Change in Cumulative
Foreign Currency
Translation Adjustment

 

 

Total

 

 

Affected Line items in the
Consolidated Statements of
Income

Balance January 1, 2021, net of tax

 

$

91

 

 

$

(36,075

)

 

$

(35

)

 

$

(36,019

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

(233

)

 

 

13,620

 

 

 

(39

)

 

 

13,348

 

 

 

Plan amendment cost

 

 

—

 

 

 

(283

)

 

 

—

 

 

 

(283

)

 

 


Reclassification to net income (1)

 

 

—

 

 

 

4,719

 

 

 

—

 

 

 

4,719

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

(233

)

 

 

18,056

 

 

 

(39

)

 

 

17,784

 

 

 

Balance December 31, 2021, net of tax

 

 

(142

)

 

 

(18,019

)

 

 

(74

)

 

 

(18,235

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

(7,745

)

 

 

5,971

 

 

 

(480

)

 

 

(2,254

)

 

 



Reclassification to net income (1)

 

 

—

 

 

 

2,037

 

 

 

—

 

 

 

2,037

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

(7,745

)

 

 

8,008

 

 

 

(480

)

 

 

(217

)

 

 

Balance December 31, 2022, net of tax

 

 

(7,887

)

 

 

(10,011

)

 

 

(554

)

 

 

(18,452

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

8,745

 

 

 

7,207

 

 

 

418

 

 

 

16,370

 

 

 



Reclassification to net income (1)

 

 

—

 

 

 

996

 

 

 

—

 

 

 

996

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

8,745

 

 

 

8,203

 

 

 

418

 

 

 

17,366

 

 

 

Balance December 31, 2023, net of tax

 

$

858

 

 

$

(1,808

)

 

$

(136

)

 

$

(1,086

)

 

 

 

(1)
The Company reclassified amortization of prior service cost, actuarial loss and plan amendment cost for its retirement plan from accumulated other comprehensive loss to net income of $1.0 million, $2.0 million and $4.7 million for the years ended December 31, 2023, 2022 and 2021, respectively.
(2)
Refer to Note 17: Employee Retirement Plans
16.
STOCK-BASED COMPENSATION:

Equity Compensation Plan

On June 15, 2023, the shareholders of the Company voted to approve the Universal Display Corporation 2023 Equity Compensation Plan (the “Equity Compensation Plan”), which replaced the Universal Display Corporation 2014 Equity Compensation Plan. The Equity Compensation Plan provides for the granting of incentive and nonqualified stock options, shares of common stock, stock appreciation rights and performance units to employees, directors and consultants of the Company. Stock options are exercisable over periods determined by the Company’s Human Capital Committee, but for no longer than 10 years from the grant date. The total number of shares that may be subject to awards under the Equity Compensation Plan is equal to the shares that were available for issuance and not subject to an award under the 2014 Equity Compensation Plan at the time it was replaced by the Equity Compensation Plan, subject to adjustment with respect to shares underlying any outstanding award granted under the Equity Compensation Plan or the 2014 Equity Compensation Plan that may expire, or be terminated, surrendered or forfeited for any reason, without issuance of such

F-25

 

shares. As of December 31, 2023, there were 1,519,235 shares that remained available to be granted under the Equity Compensation Plan. The Equity Compensation Plan will terminate on June 15, 2033.

Restricted Stock Award and Units

The Company has issued restricted stock awards and units to employees and non-employees with vesting terms of one to five years. The fair value is equal to the market price of the Company’s common stock on the date of grant for awards granted to employees. Consistent with the accounting for equity-classified awards issued to employees, our equity-classified nonemployee share-based awards are measured at the grant date fair value. Expense for restricted stock awards and units is amortized ratably over the vesting period for the awards issued to employees and using a graded vesting method for the awards issued to non-employees.

The following table summarizes the activity related to restricted stock unit (RSU) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

230,223

 

 

$

165.13

 

Granted

 

 

121,896

 

 

 

136.22

 

Vested

 

 

(132,010

)

 

 

163.85

 

Forfeited

 

 

(3,623

)

 

 

152.21

 

Unvested, December 31, 2023

 

 

216,486

 

 

$

149.68

 

The weighted average grant-date fair value per unit of RSU awards granted was $136.22, $140.37 and $208.67 during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSUs that vested during the year was $21.6 million for the year ended December 31, 2023, $18.0 million for the year ended December 31, 2022 and $12.5 million for the year ended December 31, 2021. The fair value of RSUs as of their respective vesting dates was $18.6 million for the year ended December 31, 2023, $15.3 million for the year ended December 31, 2022 and $15.1 million for the year ended December 31, 2021.

The following table summarizes the activity related to restricted stock award (RSA) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

33,637

 

 

$

178.37

 

Granted

 

 

2,366

 

 

 

126.87

 

Vested

 

 

(18,456

)

 

 

178.82

 

Unvested, December 31, 2023

 

 

17,547

 

 

$

170.96

 

The weighted average grant-date fair value per award of RSA awards granted was $126.87, $148.35 and $172.95 during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSAs that vested during the year was $3.3 million for the year ended December 31, 2023, $8.3 million for the year ended December 31, 2022 and $9.3 million for the year ended December 31, 2021. The fair value of RSAs as of their respective vesting dates was $2.6 million for the year ended December 31, 2023, $6.5 million for the year ended December 31, 2022 and $20.0 million for the year ended December 31, 2021.

For the years ended December 31, 2023, 2022 and 2021, the Company recorded, as compensation charges related to restricted stock awards and units issued to employees and non-employees, selling, general and administrative expense of $9.5 million, $14.3 million and $15.4 million, respectively, cost of sales of $1.9 million, $2.2 million and $2.5 million, respectively, and research and development expense of $5.8 million, $6.1 million and $5.2 million, respectively.

In connection with the vesting of restricted stock awards and units during the years ended December 31, 2023, 2022 and 2021, 53,162, 54,856 and 67,798 shares, respectively, with aggregate fair values of $7.4 million, $8.4 million and $14.1 million, respectively, were withheld in satisfaction of tax withholding obligations and are reflected as a financing activity within the Consolidated Statements of Cash Flows.

For the years ended December 31, 2023, 2022 and 2021, the Company recorded as compensation charges related to all restricted stock units to non-employee members of the Scientific Advisory Board, whose unvested shares are marked-to-market each reporting period, research and development expense of $248,000, $234,000 and $220,000, respectively.

F-26

 

The Company has granted restricted stock units to non-employee members of the Board of Directors with quarterly vesting over a period of approximately one year. The fair value is equal to the market price of the Company's common stock on the date of grant. The restricted stock units are issued and expense is recognized ratably over the vesting period. For the years ended December 31, 2023, 2022 and 2021, the Company recorded compensation charges for services performed, related to all restricted stock units granted to non-employee members of the Board of Directors, selling, general and administrative expense of $1.5 million, $1.3 million and $1.2 million, respectively. In connection with the vesting of the restricted stock, the Company issued to non-employee members of the Board of Directors 13,016, 8,784 and 5,412 shares during the years ended December 31, 2023, 2022 and 2021, respectively.

As of December 31, 2023, the total unrecognized expense related to all restricted stock awards and units was $21.7 million, which the Company expects to recognize over a weighted average period of 1.80 years.

Performance Unit Awards

Each performance unit award is subject to both a performance-vesting requirement (either performance-based or market-based) and a service-vesting requirement. The performance-based vesting requirement is tied to EBITDA and cash flow achievement, as measured over a specific performance period. The market-based vesting requirement is tied to the Company's total shareholder return (TSR) relative to the TSR of companies comprising the Nasdaq Electronics Components Index, as measured over a three-year performance period. The maximum number of performance units that may vest based on performance is three times the shares granted. Further, if the Company's performance falls below certain thresholds, the performance units will not vest at all.

The following table summarizes the activity related to performance unit awards (PSU) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

227,866

 

 

$

185.57

 

Granted

 

 

84,448

 

 

 

165.72

 

Vested

 

 

(11,970

)

 

 

155.85

 

Forfeited

 

 

(91,791

)

 

 

170.96

 

Unvested, December 31, 2023

 

 

208,553

 

 

$

185.86

 

During the years ended December 31, 2023, 2022 and 2021, the Company granted 84,448, 100,621 and 77,086 performance units, respectively, of which 63,335, 75,465 and 42,291 units, respectively, are subject to performance-based vesting requirements and 21,113, 25,156 and 34,795 units, respectively, are subject to market-based vesting requirements, and which will vest over the terms described above. During the years ended December 31, 2023, 2022 and 2021, there were none, 1,268, and none incremental performance-based shares, respectively, that vested resulting from an increased vesting factor based on Company performance. The weighted average grant date fair value per unit of the performance unit awards granted was $165.72, $186.66 and $214.70 during the years ended December 31, 2023, 2022 and 2021, respectively, as determined by the Company’s common stock on date of grant for the units with performance-based vesting and a Monte-Carlo simulation for the units with market-based vesting. The grant date fair value of PSUs that vested during the year was $1.9 million for the year ended December 31, 2023, $1.9 million for the year ended December 31, 2022 and $1.1 million for the year ended December 31, 2021. The fair value of PSUs as of their respective vesting dates was $1.7 million for the year ended December 31, 2023, $1.8 million for the year ended December 31, 2021 and $2.0 million for the year ended December 31, 2021.

For the years ended December 31, 2023, 2022 and 2021, the Company recorded, as compensation charges related to all performance stock units, selling, general and administrative expense of $2.6 million, $2.8 million and $8.0 million, respectively, cost of sales of $770,000, $940,000 and $1.3 million, respectively, and research and development expense of $1.2 million, $1.5 million and $2.1 million, respectively.

In connection with the vesting of performance units during the years ended December 31, 2023, 2022 and 2021, 5,350, 5,082 and 3,881 shares, respectively, with aggregate fair values of $775,000, $826,000 and $875,000, respectively, were withheld in satisfaction of tax withholding obligations and are reflected as a financing activity within the Consolidated Statements of Cash Flows.

As of December 31, 2023, the total unrecognized compensation expense related to performance unit awards was $12.9 million, which the Company expects to recognize over a weighted average period of 1.98 years.

F-27

 

Employee Stock Purchase Plan

On April 7, 2009, the Board of Directors of the Company adopted an Employee Stock Purchase Plan (ESPP). The ESPP was approved by the Company’s shareholders and became effective on June 25, 2009. The Company has reserved 1,000,000 shares of common stock for issuance under the ESPP. Unless terminated by the Board of Directors, the ESPP will expire when all reserved shares have been issued.

Eligible employees may elect to contribute to the ESPP through payroll deductions during consecutive three-month purchase periods, the first of which began on July 1, 2009. Each employee who elects to participate will be deemed to have been granted an option to purchase shares of the Company’s common stock on the first day of the purchase period. Unless the employee opts out during the purchase period, the option will automatically be exercised on the last day of the period, which is the purchase date, based on the employee’s accumulated contributions to the ESPP. The purchase price will equal 85% of the lesser of the closing price per share of common stock on the first day of the period or the last business day of the period.

Employees may allocate up to 10% of their base compensation to purchase shares of common stock under the ESPP; however, each employee may purchase no more than 12,500 shares on a given purchase date, and no employee may purchase more than $25,000 of common stock under the ESPP during a given calendar year.

For the years ended December 31, 2023, 2022 and 2021, the Company issued 17,513, 17,057 and 9,156 shares, respectively, of its common stock under the ESPP, resulting in proceeds of $2.0 million, $1.6 million and $1.5 million, respectively. For the years ended December 31, 2023, 2022 and 2021, the Company recorded charges of $136,000, $107,000 and $93,000, respectively, to selling, general and administrative expense, $167,000, $141,000, $119,000, respectively, to cost of sales and $240,000, $224,000 and $188,000, respectively, to research and development expense, related to the ESPP equal to the amount of the discount and the value of the look-back feature.

Scientific Advisory Board Awards

During the years ended December 31, 2023 and 2022, the Company granted a total of 2,366 and 2,024 shares, respectively, of fully vested common stock to non-employee members of the Scientific Advisory Board for services performed in 2022 and 2021, respectively. The fair value of the shares issued to members of the Scientific Advisory Board was $300,000 for both years ended December 31, 2023 and 2022.

17.
EMPLOYEE RETIREMENT PLANS:

Defined Contribution Plan

The Company maintains the Universal Display Corporation 401(k) Plan (the Plan) in accordance with the provisions of Section 401(k) of the Internal Revenue Code (the Code). The Plan covers substantially all full-time employees of the Company. Participants may contribute up to 90% of their total compensation to the Plan, not to exceed the limit as defined in the Code. Once an employee is eligible to participate in the Plan, the Company will make a non-elective contribution equal to 3% of the employee’s total compensation. For the years ended December 31, 2023, 2022 and 2021, the Company contributed $1.5 million, $1.4 million and $1.3 million, respectively, to the Plan.

Defined Benefit Plan

On March 18, 2010, the Human Capital Committee and the Board of Directors of the Company approved and adopted the Universal Display Corporation Supplemental Executive Retirement Plan (SERP), effective as of April 1, 2010. On March 3, 2015, the Human Capital Committee and the Board of Directors amended the SERP to include salary and bonus as part of the plan. Prior to this amendment, the SERP benefit did not take into account any bonuses. The purpose of the SERP, which is unfunded, is to provide certain of the Company’s key employees with supplemental pension benefits following a cessation of their employment and to encourage their continued employment with the Company. As of December 31, 2023 there were eight participants in the SERP.

The SERP benefit is based on a percentage of the participant’s annual base salary and in certain cases, the participant's average annual bonus for the most recent three fiscal years ending prior to the participant's date of termination of employment with the Company for the life of the participant. For this purpose, annual base salary means 12 times the average monthly base salary paid or payable to the participant during the 24-month period immediately preceding the participant’s date of termination of employment, or, if required, the date of a change in control of the Company.

F-28

 

Under the SERP, if a participant resigns or is terminated without cause at or after age 65 and with at least 20 years of service, he or she will be eligible to receive a SERP benefit. The benefit is based on a percentage of the participant’s annual base salary and bonus for the life of the participant. This percentage is 50%, 25% or 15%, depending on the participant’s benefit class.

If a participant resigns at or after age 65 and with at least 15 years of service, he or she will be eligible to receive a prorated SERP benefit. If a participant is terminated without cause or on account of a disability after at least 15 years of service, he or she will be eligible to receive a prorated SERP benefit regardless of age. The prorated benefit in either case would be based on the participant’s number of years of service (up to 20), divided by 20. In the event a participant is terminated for cause, his or her SERP benefit and any future benefit payments are subject to immediate forfeiture.

The SERP benefit is payable in installments over 10 years, beginning at the later of age 65 or the date of the participant’s separation from service. Payments are based on a present value calculation of the benefit amount for the actuarial remaining life expectancy of the participant. This calculation is made as of the date benefit payments are to begin (later of age 65 or separation from service). If the participant dies after reaching age 65, any future or remaining benefit payments are made to the participant’s beneficiary or estate. If the participant dies before reaching age 65, the benefit is forfeited.

In the event of a change in control of the Company, each participant will become immediately vested in his or her SERP benefit. Unless the participant’s benefit has already fully vested, if the participant has less than 20 years of service at the time of the change in control, he or she will receive a prorated benefit based on his or her number of years of service (up to 20), divided by 20. If the change in control qualifies as a “change in control event” for purposes of Section 409A of the Internal Revenue Code, then each participant (including former employees who are entitled to SERP benefits) will receive a lump sum cash payment equal to the present value of the benefit immediately upon the change in control.

Certain of the Company’s executive officers are designated as special participants under the SERP. If these participants resign or are terminated without cause after 20 years of service, or at or after age 65 and with at least 15 years of service, they will be eligible to receive a SERP benefit. If they are terminated without cause or on account of a disability, they will be eligible to receive a prorated SERP benefit regardless of age. The prorated benefit would be based on the participant’s number of years of service (up to 20), divided by 20.

The SERP benefit for special participants is based on 50% of their annual base salary and bonus for their life and the life of their surviving spouse, if any. Payments are based on a present value calculation of the benefit amount for the actuarial remaining life expectancies of the participant and their surviving spouse, if any. If they die before reaching age 65, the benefit is not forfeited if the surviving spouse, if any, lives until the participant would have reached age 65. If their spouse also dies before the participant would have reached age 65, the benefit is forfeited.

The Company records amounts relating to the SERP based on calculations that incorporate various actuarial and other assumptions, including discount rates, rate of compensation increases, retirement dates, and life expectancies. The net periodic costs are recognized as employees render the services necessary to earn the SERP benefits.

In connection with the initiation and subsequent amendments of the SERP, the Company recorded cost related to prior service of $1.9 million as accumulated other comprehensive loss as of December 31, 2023. The prior service cost is being amortized as a component of net periodic pension cost over the average of the remaining service period of the employees expected to receive benefits under the plan. The prior service cost expected to be amortized for the year ending December 31, 2024 is $43,000. In December 2022, one of the participants retired and monthly SERP benefit payments commenced in January 2023. The total SERP benefit payments for the year ended December 31, 2023 were $2.0 million.

F-29

 

Information relating to the Company’s plan is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Change in benefit obligation:

 

 

 

 

 

 

Benefit obligation, beginning of year

 

$

61,804

 

 

$

66,773

 

Service cost

 

 

951

 

 

 

1,287

 

Interest cost

 

 

2,898

 

 

 

1,383

 

Actuarial gain

 

 

(9,375

)

 

 

(7,639

)

Benefit payments

 

 

(2,015

)

 

 

—

 

Benefit obligation, end of year

 

 

54,263

 

 

 

61,804

 

Fair value of plan assets

 

 

—

 

 

 

—

 

Unfunded status of the plan, end of year

 

$

54,263

 

 

$

61,804

 

Current liability

 

$

2,014

 

 

$

2,014

 

Non-current liability

 

$

52,249

 

 

$

59,790

 

 

The accumulated benefit obligation for the plan was $52.5 million and $59.5 million as of December 31, 2023 and 2022, respectively. The actuarial gain of $9.4 million for the year ended December 31, 2023 was primarily due to a decrease in the total average annual bonus for each of the participants during the most recent three fiscal years. The actuarial gain of $7.6 million for the year ended December 31, 2022 was primarily due to an increase in the discount rate.

The components of net periodic pension cost were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Service cost

 

$

951

 

 

$

1,287

 

 

$

1,675

 

Interest cost

 

 

2,898

 

 

 

1,383

 

 

 

1,165

 

Amortization of prior service cost

 

 

815

 

 

 

1,119

 

 

 

1,099

 

Amortization of loss

 

 

480

 

 

 

1,487

 

 

 

4,936

 

Total net periodic benefit cost

 

$

5,144

 

 

$

5,276

 

 

$

8,875

 

 

The measurement date is the Company’s fiscal year end. The net periodic pension cost is based on assumptions determined at the prior year end measurement date.

Assumptions used to determine the year end benefit obligation were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Discount rate

 

 

4.74

%

 

 

4.94

%

Rate of compensation increases

 

 

3.50

%

 

 

3.50

%

 

Assumptions used to determine the net periodic pension cost were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Discount rate

 

 

4.94

%

 

 

2.16

%

 

 

1.54

%

Rate of compensation increases

 

 

3.50

%

 

 

3.50

%

 

 

3.50

%

 

Actuarial gains and losses are amortized from accumulated other comprehensive loss into net periodic pension cost over future years based upon the average remaining service period of active plan participants, when the accumulation of such gains or losses exceeds 10% of the year end benefit obligation. The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost or credit) is included in the Company’s results of income on a straight-line basis over the average remaining service period of active plan participants.

F-30

 

The estimated amounts to be amortized from accumulated other comprehensive loss into the net periodic pension cost in 2024 are as follows (in thousands):

 

Amortization of prior service cost

 

$

43

 

Amortization of loss

 

 

—

 

Total

 

$

43

 

 

Benefit payments, which reflect estimated future service, are currently expected to be paid as follows (in thousands):

 

Year

 

Projected
Benefits

 

2024

 

$

2,014

 

2025

 

 

5,097

 

2026

 

 

6,141

 

2027

 

 

6,489

 

2028

 

 

6,489

 

2029-2033

 

 

34,503

 

Thereafter

 

 

14,855

 

 

18.
COMMITMENTS AND CONTINGENCIES:

Commitments

Under the current research agreement with USC, the Company is obligated to make certain payments to USC based on work performed by it under that agreement, and by the University of Michigan (Michigan) under a subcontractor agreement that Michigan has with USC.

Under the terms of the current license agreement among the Company, Princeton and USC, the Company makes royalty payments to Princeton. See Note 11 for further explanation.

The Company has agreements with five executive officers and 13 senior level employees which provide for certain cash and other benefits upon termination of employment of the officer or employee in connection with a change in control of the Company. If a covered person’s employment is terminated in connection with the change in control, the person is entitled to a lump-sum cash payment equal to two times (in the case of the executive officers) or either one or two times (in the case of the senior level employees) the sum of the average annual base salary and bonus of the person and immediate vesting of all stock options and other equity awards that may be outstanding at the date of the change in control, among other items.

In order to manage manufacturing lead times and help ensure adequate material supply, the Company entered into the New OLED Materials Agreement (see Note 13) that allows PPG to procure and produce inventory based upon criteria as defined by the Company. These purchase commitments consist of firm, noncancelable and unconditional commitments. In certain instances, this agreement allows the Company the option to reschedule and adjust the Company’s requirements based on its business needs prior to firm orders being placed. As of December 31, 2023, 2022 and 2021, the Company had purchase commitments for inventory of $29.8 million, $31.9 million and $25.7 million, respectively.

Patent Related Challenges and Oppositions

Each major jurisdiction in the world that issues patents provides both third parties and applicants an opportunity to seek a further review of an issued patent. The process for requesting and considering such reviews is specific to the jurisdiction that issued the patent in question, and generally does not provide for claims of monetary damages or a review of specific claims of infringement. The conclusions made by the reviewing administrative bodies tend to be appealable and generally are limited in scope and applicability to the specific claims and jurisdiction in question.

The Company believes that opposition proceedings are frequently commenced in the ordinary course of business by third parties who may believe that one or more claims in a patent do not comply with the technical or legal requirements of the specific jurisdiction in which the patent was issued. The Company views these proceedings as reflective of its goal of obtaining the broadest legally permissible patent coverage permitted in each jurisdiction. Once a proceeding is initiated, as a general matter, the issued patent continues to be presumed valid until the jurisdiction’s applicable administrative body issues a final non-appealable decision. Depending on the jurisdiction, the outcome of these proceedings could include affirmation, denial or modification of some or all of the originally issued claims. The Company believes that as OLED technology becomes more established and its patent portfolio increases in size, so will the number of these proceedings.

F-31

 

19.
CONCENTRATION OF RISK:

Revenues and accounts receivable from the Company's largest customers for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands):

 

 

2023

 

 

2022

 

 

2021

 

Customer

 

% of Total Revenue

 

Accounts Receivable

 

 

% of Total Revenue

 

Accounts Receivable

 

 

% of Total Revenue

 

Accounts Receivable

 

A

 

36%

 

$

38,105

 

 

41%

 

$

11,425

 

 

44%

 

$

10,850

 

B

 

23%

 

 

30,142

 

 

25%

 

 

24,440

 

 

26%

 

 

45,867

 

C

 

17%

 

 

38,529

 

 

16%

 

 

22,291

 

 

14%

 

 

18,557

 

Revenues from outside of North America represented approximately 98%, 97%, and 97% of consolidated revenue for each of the years ended December 31, 2023, 2022 and 2021, respectively. Revenues by geographic area are as follows (in thousands):

 

 

 

Year Ended December 31,

 

Country

 

2023

 

 

2022

 

 

2021

 

South Korea

 

$

322,509

 

 

$

360,640

 

 

$

334,835

 

China

 

 

229,727

 

 

 

230,582

 

 

 

192,079

 

Japan

 

 

6,971

 

 

 

5,579

 

 

 

7,358

 

Other non-U.S. locations

 

 

4,411

 

 

 

3,829

 

 

 

3,137

 

Total non-U.S. locations

 

 

563,618

 

 

 

600,630

 

 

 

537,409

 

United States

 

 

12,811

 

 

 

15,989

 

 

 

16,116

 

Total revenue

 

$

576,429

 

 

$

616,619

 

 

$

553,525

 

 

The Company attributes revenue to different geographic areas on the basis of the location of the customer.

Property and equipment, net by geographic area are as follows (in thousands):

 

 

 

December 31,

 

Country

 

2023

 

 

2022

 

United States

 

$

118,250

 

 

$

117,255

 

Ireland

 

 

42,203

 

 

 

20,270

 

Other

 

 

14,697

 

 

 

5,920

 

Total long-lived assets

 

$

175,150

 

 

$

143,445

 

Substantially all chemical materials were purchased from one supplier. See Note 13.

20.
INCOME TAXES:

The components of income before income taxes are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

United States

 

$

71,514

 

 

$

77,205

 

 

$

60,066

 

Foreign

 

 

173,657

 

 

 

191,025

 

 

 

168,181

 

Income before income taxes

 

$

245,171

 

 

$

268,230

 

 

$

228,247

 

 

F-32

 

The components of the income tax expense are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Current income tax (expense) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

$

(15,848

)

 

$

(51,980

)

 

$

(16,433

)

State

 

 

(3,048

)

 

 

(1,833

)

 

 

(641

)

Foreign

 

 

(27,030

)

 

 

(31,302

)

 

 

(25,212

)

 

 

 

(45,926

)

 

 

(85,115

)

 

 

(42,286

)

Deferred income tax (expense) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

 

(460

)

 

 

25,916

 

 

 

(844

)

State

 

 

3,936

 

 

 

1,216

 

 

 

(734

)

Foreign

 

 

290

 

 

 

(186

)

 

 

(170

)

 

 

 

3,766

 

 

 

26,946

 

 

 

(1,748

)

Income tax expense

 

$

(42,160

)

 

$

(58,169

)

 

$

(44,034

)

 

Reconciliation of the statutory U.S. federal tax rate to the Company's effective tax rate is as follows:

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Statutory U.S. federal income tax rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

Effect of foreign operations

 

 

(4.0

)

 

 

(4.9

)

 

 

(5.0

)

U.S. International Tax (Sub F, GILTI, FDII)

 

 

2.9

 

 

 

4.2

 

 

 

2.1

 

Research tax credits

 

 

(2.4

)

 

 

(1.9

)

 

 

(1.4

)

Redetermination of foreign tax credit utilization

 

 

(2.0

)

 

 

—

 

 

 

—

 

Nondeductible employee compensation

 

 

1.7

 

 

 

1.9

 

 

 

3.0

 

State income taxes, net of federal benefit

 

 

(0.2

)

 

 

0.1

 

 

 

0.2

 

Stock based compensation

 

 

0.1

 

 

 

0.2

 

 

 

(0.3

)

Accruals and reserves

 

 

—

 

 

 

—

 

 

 

(0.8

)

Other

 

 

0.1

 

 

 

1.1

 

 

 

0.5

 

Effective tax rate

 

 

17.2

%

 

 

21.7

%

 

 

19.3

%

 

The following table summarizes Company tax credit carry forwards for tax return purposes as of December 31, 2023 (in thousands):

 

 

 

Tax Benefit

 

 

Expiration Date

Tax credit carry forwards:

 

 

 

 

 

State research tax credits

 

$

8,752

 

 

2034-2038

Foreign tax credits

 

$

186

 

 

2031

Total credit carry forwards

 

$

8,938

 

 

 

 

F-33

 

Significant components of the Company's net deferred tax assets and liabilities are as follows (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Deferred tax asset:

 

 

 

 

 

 

Capitalized research expenditures

 

$

39,459

 

 

$

38,485

 

Retirement plan

 

 

12,555

 

 

 

13,495

 

Tax credit carry forwards

 

 

8,938

 

 

 

8,100

 

Accruals and reserves

 

 

7,180

 

 

 

6,944

 

Lease Liabilities

 

 

6,671

 

 

 

7,230

 

Deferred revenue

 

 

1,741

 

 

 

2,077

 

Stock-based compensation

 

 

1,498

 

 

 

1,454

 

Other

 

 

1,362

 

 

 

3,400

 

 

 

 

79,404

 

 

 

81,185

 

Valuation allowance

 

 

(9,551

)

 

 

(11,087

)

Deferred tax assets

 

 

69,853

 

 

 

70,098

 

Deferred tax liability:

 

 

 

 

 

 

Lease Assets

 

 

(6,302

)

 

 

(6,944

)

Acquisition Goodwill

 

 

(1,549

)

 

 

(1,283

)

Other

 

 

(2,894

)

 

 

(3,710

)

Deferred tax liabilities

 

 

(10,745

)

 

 

(11,937

)

Net deferred tax assets

 

$

59,108

 

 

$

58,161

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent on the Company's ability to generate future taxable income to obtain benefit from the reversal of temporary differences, net operating loss carryforwards and tax credits. As part of its assessment, management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. At this time there is not sufficient evidence to release the valuation allowance that has been recorded for the New Jersey research and development credits and unrealized loss on investments. There are no indicators against the realizability of the remaining net deferred tax asset.

The U.S.-Korean Mutual Agreement Procedure (MAP) for the years ended December 31, 2010, to December 31, 2017, was closed in September 2022, resulting in a refund of the Korean withholding taxes previously withheld. The Company filed amended U.S. federal tax returns to reflect the refund and to redetermine the foreign tax credit amount. As a result, the Company has recorded a long-term asset of $3.0 million in the year ended December 31, 2022. There was no long-term asset recorded for the year ended December 31, 2023.

On December 27, 2018, the Korean Supreme Court, citing prior cases, held that only royalties paid with respect to Korean registered patents are considered Korean source income and subject to Korean withholding tax under the applicable law and interpretation of the Korea-U.S. Tax Treaty. The Company has incurred Korean withholding tax of $14.9 million for each of the years ended December 31, 2018, through December 31, 2022. Based on the Korean Supreme Court decision, a tax refund request on behalf of the Company was or will be filed with the Korean National Tax Service (KNTS) for the entire period from January 1, 2018, to December 31, 2022. The Company received a formal rejection from the KNTS; and in May 2022 filed an appeal with the Korean Tax Tribunal. On December 18th, 2023, the Company received a formal rejection from the Tax Tribunal. Anticipating the rejection of the appeal, in September 2023 the Company filed a petition to the District Court and is awaiting its decision. The Company has been advised by a prominent Korean law firm that there is a more-likely-than-not chance of success. As a result, the Company has recorded a long-term asset of $60.1 million and $60.9 million as of December 31, 2023, and December 31, 2022, respectively for the receipt of the Korean withholding tax. The Company also recorded foreign exchange loss of $732,000 during the year ended December 31, 2023, due to the fluctuation of the Korean Won to the U.S. Dollar and resulting remeasurement of this Won-denominated receivable. The Company will amend U.S. federal tax returns for the 2018 to 2022 years when the anticipated refund from KNTS is received to offset the additional tax liability. The Company has recorded a long-term liability of $15.7 million and $14.6 million as of December 31, 2023, and December 31, 2022, respectively, for the estimated amounts due to the U.S. federal government based on the amendment of the Company's U.S. tax returns, indicating that lower withholding amounts were required.

The Company is not subject to examinations by the federal tax authority for the years prior to 2017. The Company's state and foreign tax returns are open for a period of generally three to four years. The Company is under California tax audit for 2019 and 2020 years, which is in the information-collecting stage.

The above estimates may change in the future and upon settlement.

F-34

 

21.
REVENUE RECOGNITION:

The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (Topic 606). The standard establishes the principles that an entity shall apply to report useful information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows from a contract with a customer.

For each of the years ended December 31, 2023, 2022 and 2021, the Company recorded 97% of its revenue from OLED related sales and 3% from the providing of services through Adesis, respectively.

Contract Balances

The following table provides information about assets and liabilities associated with the Company's contracts from customers (in thousands):

 

 

 

As of December 31, 2023

 

Accounts receivable

 

$

139,850

 

Short-term unbilled receivables

 

 

21,084

 

Short-term contract assets

 

 

2,698

 

Long-term unbilled receivables

 

 

9,074

 

Long-term contract assets

 

 

9,278

 

Short-term deferred revenue

 

 

47,713

 

Long-term deferred revenue

 

 

12,006

 

Short-term and long-term unbilled receivables and contract assets are classified as other current assets and other assets, respectively, on the Consolidated Balance Sheets. Contract assets represent consideration related to the renewal of customer contracts which is recognized over the contract term based on material units sold. The deferred revenue balance as of December 31, 2023 will be recognized as materials are shipped to customers over the remaining contract periods. As of December 31, 2023, the Company had $25.2 million of backlog associated with committed purchase orders from its customers for phosphorescent emitter material. These orders are anticipated to be fulfilled within the next 90 days.

Significant changes in the assets and liabilities balances associated with the Company's contracts from customers for the years ended December 31, 2023 and 2022, are as follows (in thousands):

 

 

Year Ended December 31, 2023

 

 

 

Assets

 

 

Liabilities

 

Balance at December 31, 2022

 

$

38,457

 

 

$

(63,878

)

Revenue recognized that was previously included in deferred revenue, net

 

 

—

 

 

 

195,703

 

Increases due to cash received

 

 

—

 

 

 

(202,100

)

Cumulative catch-up adjustment arising from changes in estimates of
   transaction price, net

 

 

—

 

 

 

10,556

 

Unbilled receivables recorded, net

 

 

41,659

 

 

 

—

 

Contract assets recorded, net

 

 

(2,407

)

 

 

—

 

Transferred to receivables from unbilled receivables

 

 

(35,575

)

 

 

—

 

Net change

 

 

3,677

 

 

 

4,159

 

Balance at December 31, 2023

 

$

42,134

 

 

$

(59,719

)

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2022

 

 

 

Assets

 

 

Liabilities

 

Balance at December 31, 2021

 

$

8,127

 

 

$

(157,081

)

Revenue recognized that was previously included in deferred revenue, net

 

 

—

 

 

 

239,608

 

Increases due to cash received

 

 

—

 

 

 

(176,667

)

Cumulative catch-up adjustment arising from changes in estimates of
   transaction price, net

 

 

—

 

 

 

30,262

 

Unbilled receivables recorded, net

 

 

15,946

 

 

 

—

 

Contract assets recorded, net

 

 

14,384

 

 

 

—

 

Net change

 

 

30,330

 

 

 

93,203

 

Balance at December 31, 2022

 

$

38,457

 

 

$

(63,878

)

 

F-35

 

The cumulative catch-up adjustment arising from changes in estimates of transaction price, net was $10.6 million for the year ended December 31, 2023 as compared to $30.3 million for the year ended December 31, 2022. These adjustments resulted from an increase in the average price per gram that was primarily due to the decrease in anticipated demand by several of the Company's customers over the remaining lives of their contracts, resulting from changes in global macroeconomic factors.

22.
NET INCOME PER COMMON SHARE:

The Company computes earnings per share in accordance with ASC Topic 260, Earnings per Share, which requires earnings per share (EPS) for each class of stock to be calculated using the two-class method. The two-class method is an allocation of income between the holders of common stock and the Company's participating security holders. Under the two-class method, income for the reporting period is allocated between common shareholders and other security holders based on their respective participation rights in undistributed income. Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and, therefore, are included in computing earnings per share pursuant to the two-class method.

Basic net income per common share is computed by dividing net income allocated to common shareholders by the weighted-average number of shares of common stock outstanding for the period excluding unvested restricted stock units and performance units. Net income allocated to the holders of the Company's unvested restricted stock awards is calculated based on the shareholders proportionate share of weighted average shares of common stock outstanding on an if-converted basis.

For purposes of determining diluted net income per common share, basic net income per share is further adjusted to include the effect of potential dilutive common shares outstanding, including restricted stock units, performance units and the impact of shares to be issued under the Company's Employee Stock Purchase Plan.

The following table is a reconciliation of net income and the shares used in calculating basic and diluted net income per common share for the years ended December 31, 2023, 2022 and 2021 (in thousands, except share and per share data):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income

 

$

203,011

 

 

$

210,061

 

 

$

184,213

 

Adjustment for Basic EPS:

 

 

 

 

 

 

 

 

 

Earnings allocated to unvested shareholders

 

 

(993

)

 

 

(1,215

)

 

 

(1,137

)

Adjusted net income

 

$

202,018

 

 

$

208,846

 

 

$

183,076

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – Basic

 

 

47,559,669

 

 

 

47,390,352

 

 

 

47,296,447

 

Effect of dilutive shares:

 

 

 

 

 

 

 

 

 

Common stock equivalents arising from stock options and ESPP

 

 

2,173

 

 

 

2,340

 

 

 

1,010

 

Restricted stock awards and units and performance units

 

 

60,921

 

 

 

75,815

 

 

 

67,978

 

Weighted average common shares outstanding – Diluted

 

 

47,622,763

 

 

 

47,468,507

 

 

 

47,365,435

 

Net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

4.25

 

 

$

4.41

 

 

$

3.87

 

Diluted

 

$

4.24

 

 

$

4.40

 

 

$

3.87

 

For the years ended December 31, 2023, 2022, and 2021, the combined effects of unvested restricted stock awards, restricted stock units, performance unit awards and stock options of 36,345, 122,843 and none, respectively, were excluded from the calculation of diluted EPS as their impact would have been antidilutive.

F-36

 EX-10.10 2 oled-ex10_10.htm EX-10.10 EX-10.10

 

Exhibit 10.10

UDC IRELAND LIMITED

Suite 14, Plaza 256, Blanchardstown Corporate Park 2,

Ballycoolin, Dublin 15, Ireland

 

 

February 20, 2024

 

[***]

PPG Industries, Inc.

One PPG Place

Pittsburgh, PA 15272

 

Re: Amended and Restated Amendment to that certain Amended and Restated OLED Materials Supply and Service Agreement, effective as of October 1, 2011, as amended (the “Supply Agreement”), by and between PPG Industries, Inc. (“PPG”) and Universal Display Corporation (“UDC”)

 

Dear [***]:

 

This amended and restated letter agreement (this “Amendment”), as of the Effective Date (defined below) supersedes the terms of the prior letter agreement, dated February 23, 2021, between the parties hereto (the “Prior Amendment”) and, as of the Effective Date amends the terms of the Supply Agreement, providing for PPG SCM Ireland Limited’s (“SCMI”) (1) provision of operation and maintenance services as set forth on Exhibit A (the “Operating Services”) for that certain manufacturing facility located in the northwest corner of the Shannon Industrial Estate, adjacent to the Shannon International Airport, with an address of Shannon Industrial Estate, Shannon, County Clare, V14FX09, Ireland (the “Facility”) and (2) manufacture of the Products at the Facility (the “Manufacturing Services” and, together with the Operating Services, the “Services”) for UDC’s affiliate, UDC Ireland Limited (“UDC Ireland”). UDC Ireland’s affiliate, OLED Material Manufacturing Limited (“OM2”) entered into a commercial lease of the Facility with an option to purchase the Facility effective as of February 23, 2021, and exercised its option and purchased the Facility effective as of September 8, 2023 which effective date of purchase is also the effective date of this Amendment (the “Effective Date”).

 

As of the Effective Date, PPG, SCMI, UDC and UDC Ireland hereby agree to amend the Supply Agreement as follows:

 

1)
UDC Ireland and SCMI are each added as a “Party” to the Supply Agreement with respect to the Services at the Facility. Each Party’s signature on this Amendment indicates its acceptance of UDC Ireland and SCMI each becoming a Party to the Supply Agreement in such manner, and UDC Ireland and SCMI being the contracting entities and being assigned and assuming, where applicable, UDC’s and PPG’s respective rights and obligations with respect to the Services. For the avoidance of doubt, UDC hereby grants SCMI the same licenses that are granted to PPG to the extent set forth in Section 3.3 of the Supply Agreement.

 

2)
UDC Ireland agrees to contract with SCMI for the provision of the Services and SCMI agrees to contract with UDC Ireland to provide the Services, in each case, in accordance with the terms and conditions of the Supply Agreement and this Amendment. On the date hereof OM2 grants SCMI, SCMI’s affiliates, and its and their employees a license for SCMI, SCMI’s affiliates, and its and their employees’ to access the Facility and occupy certain portions of the Facility as described herein at [***] to perform the Services. SCMI agrees that its occupation is a license, not a lease and, if requested, it agrees to sign a deed of renunciation disclaiming any renewal rights in a form deed mutually agreed by SCMI and OM2. That certain Letter Agreement Regarding License for Use of Commercial Real Estate, dated February 23, 2021, by and between OM2 and SCMI, is terminated and is of no further force and effect.

 

 

 

 

 

 

3)
The primary roles and responsibilities of SCMI and UDC Ireland with respect to the Services and the Facility will be performed in accordance with the provisions of the Supply Agreement and Exhibit A, attached hereto and incorporated by reference herein. Any questions that may arise regarding roles and responsibilities in connection with the Services that are not addressed in the Supply Agreement or on Exhibit A will be determined in good faith by authorized representatives of SCMI and UDC Ireland.

 

4)
SCMI will be compensated for its provision of the Services to UDC Ireland in accordance with the provisions of the Supply Agreement and Exhibit B, attached hereto and incorporated by reference herein.

 

5)
Section 18.2 of the Supply Agreement is amended to extend the term of such agreement through December 31, 2024 (the “Extension Period”). Through November 30, 2024 of the Extension Period no Party may provide a notice of non-renewal or terminate the Supply Agreement except for a material breach or bankruptcy of another Party in accordance with Sections 18.3 or 18.4 of such agreement, respectively. On December 1, 2024 or at any time thereafter, the automatic renewal and notice of non-renewal terms in Section 18.2 of the Supply Agreement will apply to the Supply Agreement and any amendments thereto including this Amendment along with, for the avoidance of doubt, other provisions of Article 18 (it being understood that SCMI may not be able to include [***] in the reconciliation statements contemplated by Section 18.7 and SCMI’s failure to do so will not prejudice its right [***]; provided that SCMI will (a) use commercially reasonable efforts to include [***] in the reconciliation statements contemplated by Section 18.7 or (b) at the time it provides such reconciliation statements, also provide UDC Ireland with a [***]). Upon termination of this Amendment with respect to the Facility and SCMI’s wind-down of its operations at the Facility, UDC Ireland will [***]. As soon as practical after notice of the termination of this Amendment with respect to the Facility, SCMI will provide UDC Ireland with [***]. UDC Ireland reserves the right to ask questions of and seek clarification from SCMI on [***]. For the avoidance of doubt, SCMI agrees that it will wind-down its operations in reasonable cooperation with UDC Ireland, and SCMI also agrees to provide termination assistance to UDC Ireland pursuant to Section 18.6 of the Supply Agreement [***].

 

 

[***]

 

The Services will be performed in accordance with the Supply Agreement and terms contained in this Amendment. Except as modified by this Amendment, the Supply Agreement and its terms will remain in full force and effect and such terms will be incorporated into this Amendment and govern the provision of the Services to the extent not addressed in this Amendment. Any conflict in terms contained in the Supply Agreement and this Amendment will be governed by the terms contained in this Amendment.

 

The terms of this Amendment will be deemed to be Confidential Information. Capitalized terms used but not otherwise defined in this Amendment will have the meanings given to them in the Supply Agreement. Each individual signing this Amendment on behalf of a Party represents that they have the authority to enter into this Amendment and bind such entity in accordance with its terms. This Amendment may be executed in counterparts, in which event all executed copies taken together or a copy with all the signature pages attached thereto, will constitute one and same instrument. The facsimile or electronic transmission of signatures to this Amendment will be valid, legal and binding on all parties hereto.

 

[Signed on Next Page]

 

2

 

 

 

 

 

 

Please acknowledge your understanding and acceptance by signing below and returning one fully-executed copy to our attention.

 

Sincerely,

With respect to amending the Supply Agreement:

UDC Ireland Limited Universal Display Corporation

 

 

 

Janice Mahon Steven V. Abramson

Director President & CEO

 

Acknowledged and agreed to this 20th day of February, 2024.

PPG Industries, Inc.

By:

Name:

Title:

 

 

 

PPG SCM Ireland Limited

By:

Name:

Title:

3

 

 

Exhibit A

 

Roles and Responsibilities of the Parties Related to the

Services and the Facility

 

1)
The Facility:

 

A map of the Facility and the buildings and structures set forth thereon is contained on Schedule 1 to this Exhibit A (the “Facility Map”). [***]

 

2)
Environment, Health and Safety (“EHS”) and Regulatory Management:

 

UDC Ireland and SCMI agree upon the assignment of EHS roles and responsibilities, including, but not limited to, site health and safety management, EPA licensing and monitoring, other site and operating licensing (if any), ISO certification maintenance, and contact with various Irish regulatory authorities that UDC Ireland and SCMI will be responsible for as set forth in this Exhibit A and further detailed in Schedule 2 attached to this Exhibit A (the “EHS Services Schedule”). The EHS Services Schedule will define (a) the EHS services performed by (or contracted out by) SCMI at the Facility (the “EHS Services”, which shall be a part of the Operating Services), including those EHS services that SCMI will perform for or on behalf of UDC Ireland and (b) the EHS roles and responsibilities that will be the obligation of UDC Ireland.

 

3)
SCMI’s General Responsibilities:

 

SCMI will perform the Services at the Facility in accordance with the Supply Agreement and this Amendment, as may be more detailed in the Operating Services Schedule (defined below) and EHS Services Schedule, as follows:

 

[***]

 

4)
UDC Ireland’s General Responsibilities:

 

UDC Ireland will serve in roles and responsibilities at the Facility in accordance with the Supply Agreement and this Amendment, as may be more detailed in the Operating Services Schedule and EHS Services Schedule, as follows:

 

[***]

 

 

5)
IT Systems and Software.

 

Except as otherwise agreed by the Parties, all information technology and software, including any upgrades, used for the Facility’s operations and the provision of the Services will be handled as set forth on the Operating Services Schedule.

 

6)
External Communications.

 

Any communications regarding the Services, the Facility, or the EPA License with any governmental or regulatory agencies will be [***].

7)
Capital Investments:

 

 

4

 

 

a)
Capital Investments. [***]

 

b)
Implementation of Capital Investments. [***]

 

c)
Payment. Each Capital Investment will be paid for [***].

 

d)
[***]

 

8)
Warranties, Disclaimers and Limitations of Liability:

 

a)
For the avoidance of doubt, except as modified by Section 6(b), the Services will be provided and the Products will be sold subject to the same warranties, disclaimers, and limitations on liability set forth in the Supply Agreement including, without limitation, those set forth in Article 11 of the Supply Agreement, including for the avoidance of doubt Section 11.5 (Additional PPG Disclaimer; Indemnity), Section 11.6 (Disclaimer of Additional Warranties) and Section 11.7 (Limitation on Certain Damages).

 

b)
[***]

 

 

9)
Mitigation:

 

Each Party will, and UDC Ireland will cause OM2 to, use commercially reasonable efforts to mitigate the extent of any damages they may suffer in connection with this Amendment and/or the License. Additionally, each Party will, and UDC Ireland will cause OM2 to, [***].

 

10)
Affiliates:

 

The Parties acknowledge and agree that Manufacturing Services and Operating Services may be provided by affiliates that own, are owned by or under common ownership of SCMI. SCMI will provide prior notice to UDC Ireland of any affiliates that will be providing such Services and the nature of the Services to be provided; provided, that, such notice will not be required if PPG will be providing such Services. SCMI will be responsible for the Manufacturing Services and/or Operating Services provided by its affiliates to the same extent that it would be responsible if it provided the Manufacturing Services and/or Operating Services.

 

11)
Insurance:

 

a)
SCMI and UDC Ireland shall each, and each shall cause its affiliates that have personnel at the Facility to, maintain standard general liability insurance or self-insurance practices to protect against covered damages, costs or fees (including reasonable attorney’s fees) arising out of or relating to any property damage, bodily injury, sickness, disease or death, caused directly by any negligent act or omission of such Party’s (or its affiliate’s) personnel while at the Facility. Each such policy of SCMI or its affiliates will name UDC Ireland as an additional insured and each such policy of UDC Ireland or its affiliates will name SCMI as an additional insured.

b)
SCMI will maintain (or maintain a program of self-insurance for) property damage coverage for all equipment owned by SCMI at the Facility. UDC Ireland will, and will require OM2 to, maintain property damage coverage for all equipment owned by UDC Ireland or OM2, as applicable, at the Facility in an amount sufficient to cover the replacement value of such equipment.

 

c)
SCMI and UDC Ireland shall each, and each shall cause its affiliates that have personnel at the Facility to, maintain Employer’s Liability insurance in an amount not less than [***].

5

 

 

 

d)
With respect to all insurance maintained by UDC Ireland or its affiliates in accordance with this Section 11, UDC Ireland will or will cause the insured to (i) provide SCMI with a certificate of such insurance, (ii) notify SCMI of any material changes to the relevant insurance policies, and (iii) include a waiver of subrogation in favor of SCMI and any additional insureds. With respect to all insurance maintained by SCMI or its affiliates in accordance with this Section 11, SCMI will or will cause the insured to (x) provide UDC Ireland with a certificate of such insurance, (y) notify UDC Ireland of any material changes to the relevant insurance policies, and (z) include a waiver of subrogation in favor of UDC Ireland and any additional insureds.

 

 

12)
Amendment:

 

The Parties anticipate that this Exhibit A and Schedules hereto, including the Facility Map, will need to be amended from time to time as the engagement contemplated by this Amendment progresses and upon their mutual written agreement.

 

 

6

 

 

Schedule 1 to Exhibit A

 

The Facility Map

 

 

[***]

7

 

 

Schedule 2 to Exhibit A

 

EHS Services Schedule

 

[***]

 

 

 

8

 

 

Schedule 3 to Exhibit A

 

Operating Services Schedule

 

[***]

 

 

 

9

 

 

Exhibit B

 

Compensation

 

SCMI’s projected operating costs with respect to the Services will be captured in [***]. UDC Ireland or an affiliate of UDC Ireland will pay SCMI or an affiliate of SCMI for the provision of the Services in accordance with the terms and rates as set forth in the Supply Agreement (as currently implemented by the Parties as of the Effective Date [***]), it being understood that prior to the date when Commercial OLED Chemicals begin to be manufactured at the Facility, Services [***] and SCMI’s costs and expenses will be treated as [***], consistent with how such costs and expenses were handled by PPG and UDC [***], and the applicable multipliers will be applied accordingly. Notwithstanding the foregoing, consistent with [***] none of the services, expense items or capital goods which are paid for by UDC Ireland as [***]. For Commercial OLED Chemicals manufactured at the Facility, the multipliers used for the Services will be determined in the same manner that multipliers are determined for the production of Commercial OLED Chemicals and Development Chemicals at [***]. For the avoidance of doubt, costs and expenses associated with [***] will both be included in [***]. In the event SCMI incurs any cost or expense related to the Services or the Facility for which it is not compensated or reimbursed, then SCMI will make UDC Ireland aware of such cost or expense and the Parties will discuss and, upon mutual agreement, not to be unreasonably withheld, [***]. It is understood that the intent is for [***].

 

For any project-work or other services to be provided by SCMI to UDC Ireland in connection with the Services and not addressed in the Supply Agreement or above (the “Other Services”), SCMI and UDC Ireland will [***].

 

SCMI may pay for its costs to provide the Services in [***]. All payments made by UDC Ireland or a UDC Ireland affiliate on behalf of UDC Ireland to SCMI will be paid [***] in accordance with the payment terms set forth in the Supply Agreement. SCMI and UDC Ireland intend that, when [***].

 

UDC Ireland or an affiliate of UDC Ireland will pay SCMI for [***] on SCMI’s provision of the [***] other activities for which UDC Ireland is obligated to compensate or reimburse SCMI hereunder, [***].

10

 

 EX-10.12 3 oled-ex10_12.htm EX-10.12 EX-10.12

Exhibit 10.12

universal display corporation

EQUITY COMPENSATION PLAN

RESTRICTED STOCK UNIT GRANT LETTER

THIS RESTRICTED STOCK UNIT GRANT LETTER (the “Grant Letter”), dated as of [ ] (the “Grant Date”), is delivered by Universal Display Corporation (the “Company”), to [ ] a key employee of the Company or one of its subsidiaries (the “Grantee”).

RECITALS

WHEREAS, the Universal Display Corporation Equity Compensation Plan, effective as of June 15, 2023 (the “Plan”) permits the grant of Restricted Stock Units to employees, non-employee directors, or consultants of the Company and its subsidiaries, in accordance with the terms and provisions of the Plan;

 

WHEREAS, the Company desires to grant Restricted Stock Units to the Grantee, and the Grantee desires to accept such Restricted Stock Units, on the terms and conditions set forth herein and in the Plan; and

WHEREAS, the applicable provisions of the Plan are incorporated into this Grant Letter by reference, including the definitions of terms contained in the Plan (unless such terms are otherwise defined herein).

NOW, THEREFORE, the parties hereto, intending to be legally bound hereby, agree as follows:

1.
Grant of Restricted Stock Units.

Subject to the terms and vesting conditions hereinafter set forth, the Company hereby awards to the Grantee [ ] restricted stock units under the Plan (hereinafter, the “Restricted Stock Units”), subject to the vesting and other conditions of this Grant Letter.

2.
Vesting.
(a)
General Vesting Terms. Provided the Grantee remains employed by the Company or a subsidiary through the vesting dates set forth in this Section 2 (the “Vesting Dates”) and meets any applicable vesting requirements set forth in this Grant Letter, except as set forth in Section 2(b) and 2(c) below, the Restricted Stock Units awarded under this Grant Letter shall vest pro-rata over a [ ] period from the Grant Date as follows (the period over which the Restricted Stock Units vest is referred to as the “Vesting Period”):

Vesting Date

Number of Vested Restricted Stock Units

[ ]

[ ] Restricted Stock Units

 

[ ]

[ ]

[ ] Restricted Stock Units

[ ] Restricted Stock Units

 

 

(b)
Death or Disability. If the Grantee terminates employment during the Vesting Period because of the Grantee’s death or “Disability” (as defined below), the Grantee shall vest in a portion of the Restricted Stock Units. Such pro-ration shall be applied by multiplying the number of Restricted Stock Units by a fraction, the numerator of which is the number of months of service actually completed by the Grantee during the applicable Vesting Period prior to such termination of employment (rounded up to the next whole month), and the denominator of which is 12 (i.e., the number of months in the applicable Vesting Period). “Disability” shall mean that the Grantee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months, as determined by the Committee in its discretion.
(c)
Corporate Changes. In the event of a corporate change under Section 13 of the Plan, the Restricted Stock Units may vest as set forth in Section 13 of the Plan.
(d)
Termination other than due to Death or Disability. Except as provided in Section 2(b), in the event of a termination of employment, the Grantee will forfeit all Restricted Stock Units that do not vest either before the termination date or on the termination date associated with such termination. No Restricted Stock Units will vest after the Grantee’s employment with the Company, or a subsidiary has terminated for any reason. In the event a Grantee’s employment is terminated by the Company or a subsidiary for cause, as determined by the Committee, all outstanding Restricted Stock Units held by such Grantee shall immediately terminate and be of no further force or effect.
3.
Restricted Stock Units Account.

The Company shall establish a bookkeeping account on its records for the Grantee and shall credit the Grantee’s Restricted Stock Units to the bookkeeping account.

4.
Payment of Restricted Stock Units.
(a)
If the Restricted Stock Units vest in accordance with Section 2(a), the Grantee shall be entitled to receive the equivalent number of shares of common stock of the Company (“Common Stock”) corresponding to the vested Restricted Stock Units as of the Vesting Date.
(b)
If the Restricted Stock Units vest in accordance with Section 2(b), the Grantee shall be entitled to receive the equivalent number of shares of Common Stock corresponding to the vested Restricted Stock Units as of the date of the Grantee’s termination of employment on account of death or Disability, as applicable.
(c)
If the Restricted Stock Units vest in accordance with Section 2(c) due to a corporate change as set forth in Section 13 of the Plan that qualifies as a “change in control event” under section 409A of the Code, the Grantee shall be entitled to receive the equivalent number of shares of Common Stock corresponding to the vested Restricted Stock Units as of the

2

 

corporate change under Section 13 of the Plan. If the corporate change as set forth in Section 13 of the Plan is not a “change in control event” under section 409A of the Code, distribution of the shares of Common Stock shall be made on the regular schedule set forth in Section 4(a) or (b) above, as applicable, to the extent required under section 409A of the Code.
(d)
Within 30 days after the Vesting Date (for distributions under Section 4(a)), within 30 days after the date of termination of employment (for distributions under Section 4(b)), or upon closing of a corporate event under Section 4(c), as applicable, each vested Restricted Stock Unit shall be settled in stock as one share of Common Stock for every vested Restricted Stock Unit, and the Company shall deliver to the Grantee a stock certificate (or make an appropriate book entry for such shares) for the number of shares of Common Stock equal to the number of vested Restricted Stock Units being settled, subject to payment of any federal, state, local, or foreign withholding taxes as described in Section 12 below, and subject to compliance with section 409A of the Code, if applicable. The obligation of the Company to deliver the shares upon vesting shall be subject to the rights of the Company as set forth in the Plan and to all applicable laws, rules, regulations, and such approvals by governmental agencies as may be deemed appropriate by the Committee.
5.
Certain Corporate Changes.

If there is any change made to the Common Stock (whether by reason of a stock dividend, extraordinary dividend or distribution, recapitalization, stock split, combination of shares, exchange of shares, merger, reorganization, consolidation, reclassification, change in par value, or any other change in capital structure made without receipt of consideration), then unless such event or change results in the termination of all the Restricted Stock Units granted under this Grant Letter, the Committee shall proportionately adjust, as provided in the Plan, the number and class of shares underlying the Restricted Stock Units held by the Grantee to reflect the effect of such event or change in the Company’s capital structure in such a way as to prevent the enlargement or dilution of rights and benefits under the Restricted Stock Units. Any adjustment that occurs under the terms of this Section 5 or the Plan will not change the timing or form of payment with respect to any Restricted Stock Units.

6.
No Stockholder Rights.

The Grantee has no voting rights, no rights to receive dividends, and no other ownership rights and privileges of a stockholder with respect to the shares of Common Stock subject to the Restricted Stock Units prior to the delivery of shares of Common Stock after vesting. Notwithstanding the foregoing, should any dividend or other distribution payable in cash be declared and paid on the outstanding Common Stock while one or more Restricted Stock Units remain subject to this award (i.e., those shares of Common Stock are not otherwise issued and outstanding for purposes of entitlement to the dividend or distribution), then a special book account shall be established for the Grantee and credited with a dividend equivalent to the actual dividend or distribution which would have been paid on those shares of Common Stock had they been issued and outstanding and entitled to that dividend or distribution. No interest will be credited to any such account. The dividend equivalents shall vest in accordance with the vesting provisions in effect hereunder for the particular shares of Common Stock to which they relate and shall be distributed to the Grantee (in cash or such other form as the Committee may deem

3

 

appropriate) concurrently with the issuance of those vested shares of Common Stock, subject to applicable tax withholding. In no event shall any dividend equivalents vest or become distributable unless the shares of Common Stock to which they relate vest in accordance with the terms of this Grant Letter.

7.
Retention Rights.

Neither the award of Restricted Stock Units, nor any other action taken with respect to the Restricted Stock Units, shall confer upon the Grantee any right to continue in the employ or service of the Company or a subsidiary or shall interfere in any way with the right of the Company or a subsidiary to terminate Grantee’s employment or service at any time.

8.
Restrictive Covenants.

(a) The Grantee acknowledges and agrees that, during the Grantee’s employment with the Company and its affiliates, and for the twelve (12) month period following the Grantee’s termination of employment for any reason, the Grantee will not be employed for, engaged as a consultant or researcher for, or otherwise perform services for any business or enterprise directly engaged in, or with affiliates directly engaged in, the business of researching, developing, licensing, selling, distributing, marketing or otherwise commercializing organic light emitting device (“OLED”) technology, chemicals or manufacturing equipment. The Grantee further agrees that, given the nature of the Company’s business and the locations of its clients, a worldwide geographic scope is appropriate and reasonable.

(b) For purposes of this Agreement, the Grantee acknowledges and agrees that the terms “Confidential Information” and “Trade Secrets” shall mean information that the Company or any of its affiliates owns or possesses, that the Company or its affiliates have developed at significant expense and effort, that they use or that is potentially useful in the business of the Company or its affiliates, that the Company or its affiliates treat as proprietary, private or confidential, and that is not generally known to the public. The Grantee further acknowledges that the Grantee’s relationship with the Company is one of confidence and trust such that the Grantee has in the past been, and may in the future be, privy to Confidential Information and Trade Secrets of the Company or any of its affiliates.

(c) The Grantee covenants and agrees that during the term of the Grantee’s employment by the Company and for a period to two (2) years following termination of employment for any reason, the Grantee shall not, directly or indirectly through others, (i) hire or attempt to hire any employee of the Company or any of its affiliates, (ii) solicit or attempt to solicit any employee of the Company or its affiliates to become an employee, consultant, or independent contractor to, for, or of any other person or business entity, or (iii) solicit or attempt to solicit any employee, or any consultant or independent contractor of the Company or any of its affiliates to change or terminate his or her relationship with the Company or any of its affiliates, unless in each case more than three months shall have elapsed between the last day of such person’s employment or service with the Company or any of its affiliates and the first date of such solicitation or hiring or attempt to solicit or hire. If any employee, consultant, or independent contractor is hired or solicited by any entity that has hired or agreed to hire the Grantee, such hiring or solicitation shall be conclusively presumed to be a violation of this Grant Letter; provided, however, that any hiring or solicitation pursuant to a general solicitation

4

 

conducted by an entity that has hired or agreed to hire the Grantee, or by a headhunter employed by such entity, which does not involve the Grantee, shall not be a violation of this Section 8(c).

(d) The Grantee covenants and agrees that during the term of the Grantee’s employment by the Company or its affiliates and for a period to two (2) years following termination of employment for any reason, the Grantee shall not, either directly or indirectly through others:

(i) solicit, divert, appropriate, or do business with, or attempt to solicit, divert, appropriate, or do business with, any customer for whom the Company or any of its affiliates provided goods or services within 12 months prior to the Grantee’s date of termination or any actively sought prospective customer of the Company or any of its affiliates for the purpose of providing such customer or actively sought prospective customer with services or products competitive with those offered by the Company or any of its affiliates during the Grantee’s employment with the Company or any of its affiliates, or

(ii) encourage any customer for whom the Company or any of its affiliates provided goods or services within 12 months prior to the Grantee’s date of termination to reduce the level or amount of business such customer conducts with the Company or any of its affiliates.

(e) The Grantee acknowledges and agrees that the business of the Company and its affiliates is highly competitive, that the Confidential Information and Trade Secrets have been developed by the Company at significant expense and effort, and that the restrictions contained in this Section 8 are reasonable and necessary to protect the legitimate business interests of the Company and its affiliates.

(f) Because the Grantee’s services are personal and unique and the Grantee has had and will continue to have access to and has become and will continue to become acquainted with Confidential Information and Trade Secrets, the parties to this Grant Letter acknowledge and agree that any breach by the Grantee of any of the covenants or agreements contained in Section 8 will result in irreparable injury to the Company or any of its affiliates, as the case may be, for which money damages could not adequately compensate such entity. Therefore, the Company or any of its affiliates shall have the right (in addition to any other rights and remedies which it may have at law or in equity and in addition to the forfeiture requirements set forth in Section 8(g) below) to seek to enforce Section 8 and any of its provisions by injunction, specific performance, or other equitable relief, without bond and without prejudice to any other rights and remedies that the Company or any of its affiliates may have for a breach, or threatened breach, of the restrictive covenants set forth in Section 8. The Grantee agrees that in any action in which the Company or any of its affiliates seeks injunction, specific performance, or other equitable relief, the Grantee will not assert or contend that any of the provisions of Section 8 are unreasonable or otherwise unenforceable. The Grantee irrevocably and unconditionally (i) agrees that any legal proceeding arising out of this paragraph or the obligations set forth in this Agreement may be brought in the State Courts of the Commonwealth of Pennsylvania or the United States District Court for the Eastern District of Pennsylvania, (ii) consents to the non-exclusive jurisdiction of such court in any such proceeding, and (iii) waives any objection to the laying of venue of any such proceeding in any such court. The Grantee also irrevocably and unconditionally consents to the service of any process, pleadings, notices, or other papers.

(g) The Grantee acknowledges and agrees that in the event the Grantee breaches any of the covenants or agreements contained in this Section 8:

(i) The Committee may in its discretion determine that the Grantee shall forfeit all of the outstanding Restricted Stock Units, and the outstanding Restricted Stock Units shall immediately terminate, and

5

 

(ii) The Committee may in its discretion require the Grantee to return to the Company any shares of Common Stock received in settlement of the Restricted Stock Units; provided, that if the Grantee has disposed of any shares of Common Stock received in settlement of the Restricted Stock Units, then the Committee may require the Grantee to pay to the Company, in cash, the fair market value of such shares of Common Stock as of the date of disposition. The Committee shall exercise the right of recoupment provided in this Section 8(g)(ii) within 180 days after the Committee’s discovery of the Grantee’s breach of any of the covenants or agreements contained in this Section 8.

(h) If any portion of the covenants or agreements contained in this Section 8, or the application hereof, is construed to be invalid or unenforceable, the other portions of such covenants or agreements or the application thereof shall not be affected and shall be given full force and effect without regard to the invalid or unenforceable portions to the fullest extent possible. If any covenant or agreement in this Section 8 is held to be unenforceable because of the duration thereof or the scope thereof, then the court making such determination shall have the power to reduce the duration and limit the scope thereof, and the covenant or agreement shall then be enforceable in its reduced form. The covenants and agreements contained in this Section 8 shall survive the termination of this Agreement.

9.
Amendment.

This award may be amended by the Committee, in whole or in part, in accordance with the applicable terms of the Plan.

10.
Notice.

Any notice to the Company provided for in this Grant Letter shall be addressed to it in care of the Corporate Secretary of the Company, 250 Phillips Boulevard, Ewing, New Jersey 08618, and any notice to the Grantee shall be addressed to such Grantee at the current address shown on the payroll system of the Company or a subsidiary thereof, or to such other address as the Grantee may designate to the Company in writing. Any notice provided for hereunder shall be delivered by hand, sent by telecopy or electronic mail, or enclosed in a properly sealed envelope addressed as stated above, registered and deposited, postage and registry fee prepaid in the United States mail or other mail delivery service. Notice to the Company shall be deemed effective upon receipt. By receipt of this Grant Letter, Grantee hereby consents to the delivery of information (including without limitation, information required to be delivered to the Grantee pursuant to the applicable securities laws) regarding the Company, the Plan, and the Restricted Stock Units via the Company’s electronic mail system or other electronic delivery system.

11.
Incorporation of Plan by Reference.

This Grant Letter is made pursuant to the terms of the Plan, the terms of which are incorporated herein by reference, and shall in all respects be interpreted in accordance therewith. The decisions of the Committee shall be conclusive upon any question arising hereunder. The Grantee’s receipt of the Restricted Stock Units awarded under this Grant Letter constitutes such Grantee’s acknowledgment that all decisions and determinations of the Committee with respect to the Plan, this Grant Letter, and/or the Restricted Stock Units shall be final and binding on the Grantee, his or her beneficiaries, and any other person having or claiming an interest in such Restricted Stock Units. The settlement of any award with respect to Restricted Stock Units is

6

 

subject to the provisions of the Plan and to interpretations, regulations, and determinations concerning the Plan as established from time to time by the Committee in accordance with the provisions of the Plan. A copy of the Plan will be furnished to each Grantee upon request.

12.
Income Taxes; Withholding Taxes.

The Grantee is solely responsible for the satisfaction of taxes and penalties that may arise in connection with the Restricted Stock Units pursuant to this Grant Letter. At the time of taxation, the Company shall have the right to deduct from other compensation, or to withhold from the amounts payable under the Restricted Stock Unit, including from shares of Common Stock, an amount equal to the federal (including FICA), state, local, and foreign income taxes and other amounts as may be required by law to be withheld with respect to the taxation of the Restricted Stock Units, provided that any share withholding shall not exceed the Grantee’s minimum applicable withholding tax rate for federal (including FICA), state, local, and foreign tax liabilities.

 

13.
Governing Law.

The validity, construction, interpretation, and effect of this instrument shall exclusively be governed by, and determined in accordance with, the applicable laws of the Commonwealth of Pennsylvania, excluding any conflicts or choice of law rule or principle.

14.
Assignment.

This Grant Letter shall bind and inure to the benefit of the successors and assignees of the Company. The Grantee may not sell, assign, transfer, pledge, or otherwise dispose of the Restricted Stock Units, except to a successor Grantee in the event of the Grantee’s death.

15.
Section 409A.

This Grant Letter is intended to comply with the applicable requirements of section 409A of the Code, as set forth in Section 19(f) of the Plan.

16.
Company Policies.

All Restricted Stock Units under this Grant Letter shall be subject to any applicable clawback or recoupment policies, share trading policies, and other policies that may be implemented by the Board from time to time.

IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute and attest this instrument, and the Grantee has placed his or her signature hereon, effective as of the date of the grant set forth above.

UNiversal Display Corporation

7

 

 

By: _________________________________

Name:

Title:

 

I, [ ], hereby accept the award of the Restricted Stock Units described in this Grant Letter pursuant to the terms and conditions described herein, and I agree to be bound by all terms of the Plan and this Grant Letter. I hereby agree that all decisions and determinations of the Committee with respect to the Restricted Stock Units shall be final and binding.

Acknowledged and Agreed by the Grantee:

 

 

By: _______________________________

[ ]

 

Date: ______________________________

 

 

 

8

 

 EX-10.13 4 oled-ex10_13.htm EX-10.13 EX-10.13

 

Exhibit 10.13

Universal Display Corporation

EQUITY COMPENSATION PLAN

 

PERFORMANCE UNIT GRANT LETTER

 

 

THIS PERFORMANCE UNIT GRANT LETTER (the “Grant Letter”), dated as of [ ] (the “Grant Date”), is delivered by Universal Display Corporation (the “Company”), to [ ], a key employee of the Company or one of its subsidiaries (the “Grantee”).

RECITALS

WHEREAS, the Universal Display Corporation Equity Compensation Plan, effective as of June 15, 2023 (the “Plan”) permits the grant of stock units based on the achievement of certain performance goals (“Performance Units”) to employees, non-employee directors, or consultants of the Company and its subsidiaries, in accordance with the terms and provisions of the Plan;

WHEREAS, the Company desires to grant Performance Units to the Grantee, and the Grantee desires to accept such Performance Units, on the terms and conditions set forth herein and in the Plan;

WHEREAS, the Performance Units granted pursuant to this Grant Letter shall vest based on the attainment of performance goals related to [ ], as described in Schedule A (“Performance Goals”); and

WHEREAS, the applicable provisions of the Plan are incorporated into this Grant Letter by reference, including the definitions of terms contained in the Plan (unless such terms are otherwise defined herein).

NOW, THEREFORE, the parties hereto, intending to be legally bound hereby, agree as follows:

Grant of Performance Units.

Subject to the terms and vesting conditions hereinafter set forth, the Company hereby awards to the Grantee a target award of [ ] Performance Units (hereinafter, the “Target Award”) under the Plan.

Vesting.

(a)
General Vesting Terms. Except as set forth in Sections 2(b) and 2(c) below, the Grantee shall vest in a number of Performance Units based on the attainment of the Performance Goals as of the end of the Performance Period (defined below), provided that the Grantee remains employed by the Company or a subsidiary through [ ] (the “Vesting Date”). The performance period shall begin [ ] (the “Performance Period Start Date”) and

 

 

shall end [ ] (the “Performance Period End Date” and, together with the Performance Period Start Date, the “Performance Period”). The period beginning on the Performance Period Start Date and ending on the Vesting Date shall be referred to as the “Vesting Period.” Except as specifically provided for below in this Section 2, no Performance Units will vest for any reason prior to the Vesting Date, and in the event of a termination of the Grantee’s employment prior to the Vesting Date, the Grantee will forfeit all Performance Units that have not yet vested as of the termination date. Except as provided in Section 2(c) below, if the Performance Goals are not attained at the end of the Performance Period, the Performance Units will be immediately forfeited. Except as otherwise set forth in this Grant Letter, at the end of the Performance Period, the Human Capital Committee of the Board of Directors or such other persons as they may properly delegate (the “Committee”) will determine whether and to what extent the Performance Goals have been met and the amount earned with respect to the Performance Units, and will certify such attainment of the Performance Goals (“Performance Goal Certification”). The Grantee may earn up to [ ] percent ([ ]%) of the Target Award based on the attainment of the Performance Goals.
(b)
Death or Disability. If the Grantee terminates employment during the Vesting Period because of the Grantee’s death or “Disability” (as defined below), the Grantee shall earn a pro-rata portion of the outstanding Performance Units based on attainment of the Performance Goals described on Schedule A, as determined following the end of the Performance Period (or as determined under Section 2(c), if applicable). The pro-rated portion shall be determined based on the number of Performance Units earned based on the attainment of the Performance Goals during the Performance Period, multiplied by a fraction, the numerator of which is the number of days of service actually completed by the Grantee during the Vesting Period prior to such termination of employment, and the denominator of which is the number of days from the commencement of the Performance Period through the Vesting Date, inclusive, as determined by the Committee). “Disability” shall mean that the Grantee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months, as determined by the Committee in its discretion.
(c)
Corporate Changes. In the event of a corporate change under Section 13 of the Plan, the Performance Units shall vest and the Performance Goals shall be deemed to have been attained at such a level that the Grantee shall have earned one hundred percent (100%) of the Target Award.
(d)
Termination other than due to Death or Disability. Except as provided in Section 2(b), in the event of a termination of employment, the Grantee will forfeit all Performance Units that do not vest either before the termination date or on the termination date associated with such termination. Except as provided in Section 2(b), no Performance Units will vest after the Grantee’s employment with the Company or a subsidiary has terminated for any reason. In the event a Grantee’s employment is terminated by the Company or a subsidiary for cause, as determined by the Committee, all outstanding Performance Units held by such Grantee shall immediately terminate and be of no further force or effect.

2

 

 

Performance Units Account.

The Company shall establish a bookkeeping account on its records for the Grantee and shall credit the Grantee’s Performance Units to the bookkeeping account.

Payment of Performance Units.

(e)
If the Performance Units vest in accordance with Section 2(a) or Section 2(b), the Grantee shall be entitled to receive upon vesting the equivalent number of shares of common stock of the Company (“Common Stock”) corresponding to the vested Performance Units. The shares of Common Stock shall be distributed as soon as reasonably possible after the Performance Goal Certification is completed and shall not be subject to any holding requirement.
(f)
If the Performance Units vest in accordance with Section 2(c) due to a corporate change as set forth in Section 13 of the Plan that qualifies as a “change in control event” under section 409A of the Code, the Grantee shall be entitled to receive the equivalent number of shares of Common Stock corresponding to the vested Performance Units as of the corporate change under Section 13 of the Plan. If the corporate change as set forth in Section 13 of the Plan is not a “change in control event” under section 409A of the Code, distribution of the shares of Common Stock shall be made on the regular schedule set forth in Section 4(a), to the extent required under section 409A of the Code.
(g)
For distributions under Section 4(a), or upon the closing date of the corporate change as set forth in Section 13 of the Plan, for distributions under Section 4(b), as applicable, each vested Performance Unit credited to the Grantee’s account shall be settled in stock as one share of Common Stock for every vested Performance Unit, and the Company shall deliver to the Grantee a stock certificate (which shall not restrict the transfer, pledge, or assignment of the shares), or make an appropriate book entry for such shares, for the number of shares of Common Stock equal to the number of vested Performance Units being settled, subject to payment of any federal, state, local, or foreign withholding taxes as described in Section 12 below, and subject to compliance with section 409A of the Code, if applicable. The obligation of the Company to deliver the shares upon vesting shall be subject to the rights of the Company as set forth in the Plan and to all applicable laws, rules, regulations, and such approvals by governmental agencies as may be deemed appropriate by the Committee.

Certain Corporate Changes.

If there is any change made to the Common Stock (whether by reason of a stock dividend, extraordinary dividend or distribution, recapitalization, stock split, combination of shares, exchange of shares, merger, reorganization, consolidation, reclassification, change in par value, or any other change in capital structure made without receipt of consideration), then unless such event or change results in the termination of all the Performance Units granted under this Grant Letter, the Committee shall proportionately adjust, as provided in the Plan, the number and class of shares underlying the Performance Units held by the Grantee to reflect the effect of such event or change in the Company’s capital structure in such a way as to prevent the enlargement or dilution of rights and benefits under the Performance Units. Any adjustment that occurs under

3

 

 

the terms of this Section 5 or the Plan will not change the timing or form of payment with respect to any Performance Units.

No Stockholder Rights.

The Grantee has no voting rights, no rights to receive dividends, and no other ownership rights and privileges of a stockholder with respect to the shares of Common Stock subject to the Performance Units prior to the delivery of shares of Common Stock after vesting. Notwithstanding the foregoing, should any dividend or other distribution payable in cash be declared and paid on the outstanding Common Stock while one or more Performance Units remain subject to this award (i.e., those shares of Common Stock are not otherwise issued and outstanding for purposes of entitlement to the dividend or distribution), then a special book account shall be established for the Grantee and credited with a dividend equivalent to the actual dividend or distribution which would have been paid on those shares of Common Stock had they been issued and outstanding and entitled to that dividend or distribution. No interest will be credited to any such account. The dividend equivalents shall vest for each Performance Unit that vests pursuant to Section 2 hereof in accordance with the vesting provisions in effect hereunder for the particular shares of Common Stock to which they relate and shall be distributed to the Grantee (in cash or such other form as the Committee may deem appropriate) concurrently with the issuance of those vested shares of Common Stock, subject to applicable tax withholding. In no event shall any dividend equivalents vest or become distributable unless the shares of Common Stock to which they relate vest in accordance with the terms of this Grant Letter.

Retention Rights.

Neither the award of Performance Units, nor any other action taken with respect to the Performance Units, shall confer upon the Grantee any right to continue in the employ or service of the Company or a subsidiary or shall interfere in any way with the right of the Company or a subsidiary to terminate Grantee’s employment or service at any time.

Restrictive Covenants.

(a) The Grantee acknowledges and agrees that, during the Grantee’s employment with the Company and its affiliates, and for the twelve (12) month period following the Grantee’s termination of employment for any reason, the Grantee will not be employed for, engaged as a consultant or researcher for, or otherwise perform services for any business or enterprise directly engaged in, or with affiliates directly engaged in, the business of researching, developing, licensing, selling, distributing, marketing or otherwise commercializing organic light emitting device (“OLED”) technology, chemicals or manufacturing equipment. The Grantee further agrees that, given the nature of the Company’s business and the locations of its clients, a worldwide geographic scope is appropriate and reasonable.

(b) For purposes of this Agreement, the Grantee acknowledges and agrees that the terms “Confidential Information” and “Trade Secrets” shall mean information that the Company or any of its affiliates owns or possesses, that the Company or its affiliates have developed at significant expense and effort, that they use or that is potentially useful in the business of the Company or its affiliates, that the Company or its affiliates treat as proprietary, private or confidential, and that is not generally known to the public. The Grantee further

4

 

 

acknowledges that the Grantee’s relationship with the Company is one of confidence and trust such that the Grantee has in the past been, and may in the future be, privy to Confidential Information and Trade Secrets of the Company or any of its affiliates.

(c) The Grantee covenants and agrees that during the term of the Grantee’s employment by the Company and for a period to two (2) years following termination of employment for any reason, the Grantee shall not, directly or indirectly through others, (i) hire or attempt to hire any employee of the Company or any of its affiliates, (ii) solicit or attempt to solicit any employee of the Company or its affiliates to become an employee, consultant, or independent contractor to, for, or of any other person or business entity, or (iii) solicit or attempt to solicit any employee, or any consultant or independent contractor of the Company or any of its affiliates to change or terminate his or her relationship with the Company or any of its affiliates, unless in each case more than three months shall have elapsed between the last day of such person’s employment or service with the Company or any of its affiliates and the first date of such solicitation or hiring or attempt to solicit or hire. If any employee, consultant, or independent contractor is hired or solicited by any entity that has hired or agreed to hire the Grantee, such hiring or solicitation shall be conclusively presumed to be a violation of this Grant Letter; provided, however, that any hiring or solicitation pursuant to a general solicitation conducted by an entity that has hired or agreed to hire the Grantee, or by a headhunter employed by such entity, which does not involve the Grantee, shall not be a violation of this Section 8(c).

(d) The Grantee covenants and agrees that during the term of the Grantee’s employment by the Company or its affiliates and for a period to two (2) years following termination of employment for any reason, the Grantee shall not, either directly or indirectly through others:

(i) solicit, divert, appropriate, or do business with, or attempt to solicit, divert, appropriate, or do business with, any customer for whom the Company or any of its affiliates provided goods or services within 12 months prior to the Grantee’s date of termination or any actively sought prospective customer of the Company or any of its affiliates for the purpose of providing such customer or actively sought prospective customer with services or products competitive with those offered by the Company or any of its affiliates during the Grantee’s employment with the Company or any of its affiliates, or

(ii) encourage any customer for whom the Company or any of its affiliates provided goods or services within 12 months prior to the Grantee’s date of termination to reduce the level or amount of business such customer conducts with the Company or any of its affiliates.

(e) The Grantee acknowledges and agrees that the business of the Company and its affiliates is highly competitive, that the Confidential Information and Trade Secrets have been developed by the Company at significant expense and effort, and that the restrictions contained in this Section 8 are reasonable and necessary to protect the legitimate business interests of the Company and its affiliates.

(f) Because the Grantee’s services are personal and unique and the Grantee has had and will continue to have access to and has become and will continue to become acquainted with Confidential Information and Trade Secrets, the parties to this Grant Letter acknowledge and agree that any breach by the Grantee of any of the covenants or agreements contained in Section 8 will result in irreparable injury to the Company or any of its affiliates, as the case may be, for which money damages could not adequately compensate such entity. Therefore, the Company or any of its affiliates shall have the right (in addition to any other rights and remedies which it may have at law or in equity and in addition to the forfeiture requirements set forth in Section 8(g)

5

 

 

below) to seek to enforce Section 8 and any of its provisions by injunction, specific performance, or other equitable relief, without bond and without prejudice to any other rights and remedies that the Company or any of its affiliates may have for a breach, or threatened breach, of the restrictive covenants set forth in Section 8. The Grantee agrees that in any action in which the Company or any of its affiliates seeks injunction, specific performance, or other equitable relief, the Grantee will not assert or contend that any of the provisions of Section 8 are unreasonable or otherwise unenforceable. The Grantee irrevocably and unconditionally (i) agrees that any legal proceeding arising out of this paragraph or the obligations set forth in this Agreement may be brought in the State Courts of the Commonwealth of Pennsylvania or the United States District Court for the Eastern District of Pennsylvania, (ii) consents to the non-exclusive jurisdiction of such court in any such proceeding, and (iii) waives any objection to the laying of venue of any such proceeding in any such court. The Grantee also irrevocably and unconditionally consents to the service of any process, pleadings, notices, or other papers.

(g) The Grantee acknowledges and agrees that in the event the Grantee breaches any of the covenants or agreements contained in this Section 8:

(i) The Committee may in its discretion determine that the Grantee shall forfeit all of the outstanding Performance Units, and the outstanding Performance Units shall immediately terminate, and

(ii) The Committee may in its discretion require the Grantee to return to the Company any shares of Common Stock received in settlement of the Performance Units; provided, that if the Grantee has disposed of any shares of Common Stock received in settlement of the Performance Units, then the Committee may require the Grantee to pay to the Company, in cash, the fair market value of such shares of Common Stock as of the date of disposition. The Committee shall exercise the right of recoupment provided in this Section 8(g)(ii) within 180 days after the Committee’s discovery of the Grantee’s breach of any of the covenants or agreements contained in this Section 8.

(h) If any portion of the covenants or agreements contained in this Section 8, or the application hereof, is construed to be invalid or unenforceable, the other portions of such covenants or agreements or the application thereof shall not be affected and shall be given full force and effect without regard to the invalid or unenforceable portions to the fullest extent possible. If any covenant or agreement in this Section 8 is held to be unenforceable because of the duration thereof or the scope thereof, then the court making such determination shall have the power to reduce the duration and limit the scope thereof, and the covenant or agreement shall then be enforceable in its reduced form. The covenants and agreements contained in this Section 8 shall survive the termination of this Agreement.

Amendment.

This award may be amended by the Committee, in whole or in part, in accordance with the applicable terms of the Plan.

Notice.

Any notice to the Company provided for in this Grant Letter shall be addressed to it in care of the Corporate Secretary of the Company, 250 Phillips Boulevard, Ewing, New Jersey 08618, and any notice to the Grantee shall be addressed to such Grantee at the current address shown on the payroll system of the Company or a subsidiary thereof, or to such other address as

6

 

 

the Grantee may designate to the Company in writing. Any notice provided for hereunder shall be delivered by hand, sent by telecopy or electronic mail, or enclosed in a properly sealed envelope addressed as stated above, registered and deposited, postage and registry fee prepaid in the United States mail or other mail delivery service. Notice to the Company shall be deemed effective upon receipt. By receipt of this Grant Letter, Grantee hereby consents to the delivery of information (including without limitation, information required to be delivered to the Grantee pursuant to the applicable securities laws) regarding the Company, the Plan, and the Performance Units via the Company’s electronic mail system or other electronic delivery system.

Incorporation of Plan by Reference.

This Grant Letter is made pursuant to the terms of the Plan, the terms of which are incorporated herein by reference, and shall in all respects be interpreted in accordance therewith. The decisions of the Committee shall be conclusive upon any question arising hereunder. The Grantee’s receipt of the Performance Units awarded under this Grant Letter constitutes such Grantee’s acknowledgment that all decisions and determinations of the Committee with respect to the Plan, this Grant Letter, and/or the Performance Units shall be final and binding on the Grantee, his or her beneficiaries, and any other person having or claiming an interest in such Performance Units. The settlement of any award with respect to Performance Units is subject to the provisions of the Plan and to interpretations, regulations, and determinations concerning the Plan as established from time to time by the Committee in accordance with the provisions of the Plan. A copy of the Plan will be furnished to each Grantee upon request.

Income Taxes; Withholding Taxes.

The Grantee is solely responsible for the satisfaction of taxes and penalties that may arise in connection with the Performance Units pursuant to this Grant Letter. At the time of taxation, the Company shall have the right to deduct from other compensation, or to withhold from the amounts payable under the Performance Units, including from shares of Common Stock, an amount equal to the federal (including FICA), state, local, and foreign income taxes and other amounts as may be required by law to be withheld with respect to the taxation of the Performance Units, provided that any share withholding shall not exceed the Grantee’s minimum applicable withholding tax rate for federal (including FICA), state, local, and foreign tax liabilities.

Governing Law.

The validity, construction, interpretation, and effect of this instrument shall exclusively be governed by, and determined in accordance with, the applicable laws of the Commonwealth of Pennsylvania, excluding any conflicts or choice of law rule or principle.

Assignment.

This Grant Letter shall bind and inure to the benefit of the successors and assignees of the Company. The Grantee may not sell, assign, transfer, pledge, or otherwise dispose of the Performance Units, except to a successor Grantee in the event of the Grantee’s death.

7

 

 

Section 409A.

This Grant Letter is intended to comply with the applicable requirements of section 409A of the Code, as set forth in Section 19(f) of the Plan.

Company Policies.

All Performance Units under this Grant Letter shall be subject to any applicable clawback or recoupment policies, share trading policies, and other policies that may be implemented by the Board from time to time.

IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute and attest this instrument, and the Grantee has placed his or her signature hereon, effective as of the date of the grant set forth above.

 

Universal Display Corporation

 

 

By: ________________________________

Name: Steven V. Abramson

Title: President and CEO

 

 

I, [ ], hereby accept the award of the Performance Units described in this Grant Letter pursuant to the terms and conditions described herein, and I agree to be bound by all terms of the Plan and this Grant Letter. I hereby agree that all decisions and determinations of the Committee with respect to the Performance Units shall be final and binding.

 

Acknowledged and Agreed by the Grantee:

 

 

By: _______________________________

[ ]

 

Date: _____________________________

 

8

 

 

Schedule A

Performance Goals

1. Performance Goals. The Performance Units shall vest based on continual employment (as described in the Grant Letter) and based on the Company’s achievement of [ ]

2. General Vesting Terms. [ ] No vesting shall occur unless and until the Committee certifies that the Performance Goals have been achieved. Any fractional Performance Unit resulting from the vesting of the Performance Units shall be rounded down to the nearest whole number. Any portion of the Performance Units that does not vest as of the end of the Performance Period shall be forfeited as of the end of the Performance Period. In no event shall the maximum number of Performance Units that may be payable pursuant to this Grant Letter exceed [ ] of the Target Award.

 

9

 

 EX-21 5 oled-ex21.htm EX-21 EX-21

 

Exhibit 21

 

SUBSIDIARIES OF THE REGISTRANT

UDC, Inc., a New Jersey corporation.

Adesis, Inc., a Delaware corporation.

Universal Display Corporation Hong Kong, Limited, a Hong Kong limited liability entity.

Universal Display Corporation Korea, Y.H., a limited liability entity organized under the laws of the Republic of Korea.

Universal Display Corporation Japan GK, a limited liability entity organized under the laws of Japan.

UDC Ireland Limited, a private company limited by shares, organized under the laws of Ireland.

Universal Display Corporation China, Ltd., a wholly foreign-owned limited liability company organized under the laws of China.

 

UDC Ventures LLC, a Delaware limited liability company.

 

OVJP Corporation, a Delaware corporation.

 

OLED Material Manufacturing Limited, a private company limited by shares, organized under the laws of Ireland.

 

 

 EX-23.1 6 oled-ex23_1.htm EX-23.1 EX-23.1

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the registration statements (Nos. 333-159081, 333-131515, 333-120737, 333-112077, 333-101733, 333-74854, 333-72846, 333-60856, 333-50990, 333-40760, and 333-27901) on Form S-3 and (Nos. 333-198060, 333-159083, 333-159082 and 333-273656) on Form S-8 of our reports dated February 22, 2024, with respect to the consolidated financial statements of Universal Display Corporation and the effectiveness of internal control over financial reporting.

 

/s/ KPMG LLP

 

Philadelphia, Pennsylvania

February 22, 2024

 

 

 EX-31.1 7 oled-ex31_1.htm EX-31.1 EX-31.1

 

Exhibit 31.1

CERTIFICATIONS REQUIRED BY

RULE 13a-14(a)/15d-14(a)

I, Steven V. Abramson, certify that:

1. I have reviewed this annual report on Form 10-K of Universal Display Corporation (the “registrant”) for the year ended December 31, 2023;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:

 

February 22, 2024

By:

 

/s/ Steven V. Abramson

 

 

Steven V. Abramson

 

 

President and Chief Executive Officer

 

 

 EX-31.2 8 oled-ex31_2.htm EX-31.2 EX-31.2

 

Exhibit 31.2

CERTIFICATIONS REQUIRED BY

RULE 13a-14(a)/15d-14(a)

I, Brian Millard, certify that:

1. I have reviewed this annual report on Form 10-K of Universal Display Corporation (the “registrant”) for the year ended December 31, 2023;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:

 

February 22, 2024

By:

 

/s/ Brian Millard

 

 

Brian Millard

 

 

 

 

 

Vice President, Chief Financial Officer and Treasurer

 

 

 EX-32.1 9 oled-ex32_1.htm EX-32.1 EX-32.1

 

Exhibit 32.1

CERTIFICATIONS REQUIRED BY

RULE 13a-14(b)/15d-14(b) AND 18 U.S.C. SECTION 1350

In connection with the annual report of Universal Display Corporation (the “Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven V. Abramson, President and Chief Executive Officer of the Company, hereby certify, based on my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:

February 22, 2024

By:

 

/s/ Steven V. Abramson

 

Steven V. Abramson

 

President and Chief Executive Officer

 

 

 EX-32.2 10 oled-ex32_2.htm EX-32.2 EX-32.2

 

Exhibit 32.2

CERTIFICATIONS REQUIRED BY

RULE 13a-14(b)/15d-14(b) AND 18 U.S.C. SECTION 1350

In connection with the annual report of Universal Display Corporation (the “Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian Millard, Vice President, Chief Financial Officer and Treasurer of the Company, hereby certify, based on my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:

February 22, 2024

By:

 

/s/ Brian Millard

 

Brian Millard

 

Vice President, Chief Financial Officer and Treasurer

 

 

 EX-97 11 oled-ex97.htm EX-97 EX-97

Exhibit 97

UNIVERSAL DISPLAY CORPORATION

COMPENSATION RECOUPMENT POLICY

I.
Purpose

The Board of Directors (“Board”) of Universal Display Corporation (the “Company”), based on the recommendation of its Human Capital Committee (the “Committee”), has adopted this Compensation Recoupment Policy (this “Policy) to implement a mandatory clawback policy if a Restatement in compliance with the Applicable Rules (each as defined below) occurs. This Policy is in addition to the discretionary clawback policies that have been previously adopted in connection with Senior Officers grants of incentive and performance based awards.

Any capitalized terms used but not immediately defined in this Policy shall have the meanings set forth in Section II.

II.
Defined Terms
a.
“Applicable Rules” means Section 10D of the Exchange Act and Rule 10D-1 promulgated thereunder, Listing Rule 5608 of the Listing Rules of The Nasdaq Stock Market (“Nasdaq”), and any other national stock exchange rules to which the Company is or may become subject.
b.
“Clawback Compensation” means Incentive-Based Compensation or any other recovered incentive compensation, in each case determined to be subject to recoupment under this Policy.
c.
“Clawback Event” means a required recoupment of Incentive-Based Compensation in the event of a Restatement.
d.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
e.
“Financial Reporting Measures” mean (i) measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures, (ii) the Company’s stock price, and (iii) total stockholder return in respect of the Company. A “Financial Reporting Measure” need not be presented within the financial statements or included in a filing with the SEC.
f.
“Incentive-Based Compensation” means any compensation that is granted, earned, paid, received, or vested, based wholly or in part upon the attainment of a Financial Reporting Measure. Incentive-Based Compensation does not include, among other forms of compensation, Time-Based/Bonus Compensation. Incentive-Based Compensation is deemed to be “Received” for the purposes of this Policy in the fiscal period during which the Financial Reporting Measure applicable to the Incentive-Based Compensation award is attained, even if the

 

payment or grant of the Incentive-Based Compensation occurs after the end of that period.
g.
“Recovery Period” means the three completed fiscal years immediately before the date that the Company is required to prepare a Restatement, which date is the earlier of (i) the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare a Restatement or (ii) a date that a court, regulator, or other legally authorized body directs the Company to prepare a Restatement.
h.
“Regulators” means, as applicable, the SEC and Nasdaq.
i.
“Restatement” means an accounting restatement that the Company is required to prepare due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including (i) an error in previously issued financial statements that is material to the previously issued financial statements, or (ii) an error that would result in a material misstatement if it were corrected in the current period or left uncorrected in the current period.
j.
“SEC” means the U.S. Securities and Exchange Commission.
k.
“Senior Officer” means any person designated by the Board as an “officer” in accordance with Rule 16a-1(f) promulgated under Section 16 of the Exchange Act.
l.
“Time-Based/Bonus Compensation” means equity awards that vest exclusively upon completion of a specified employment period, without any performance condition, and bonus awards that are discretionary or based on goals unrelated to Financial Reporting Measures.
III.
Administration

The Committee shall administer this Policy and make all related determinations, in its sole discretion, with respect to this Policy, provided that the Committee interprets this Policy in a manner consistent with the requirements of the Applicable Rules.

Notwithstanding the foregoing, subject to the Applicable Rules, the Board, in its discretion, may assume any or all powers and authority of the Committee with respect to administration of Section VIII of this Policy, in which case references to the Committee shall be deemed to include the Board, as applicable.

2

 

IV.
Recovery on a Restatement

If the Company is required to prepare a Restatement, the Company shall reasonably promptly recover the amount, as calculated pursuant to this Section IV, of any erroneously awarded Incentive-Based Compensation that is Received by any Senior Officer during the Recovery Period. The amount of erroneously awarded Incentive-Based Compensation subject to this Policy will be the excess of the amount of Incentive-Based Compensation that is Received by the Senior Officer (whether in cash or shares) based on the erroneous data in the original financial statements over the amount of Incentive-Based Compensation (whether in cash or in shares) that the Senior Officer would have Received had such Incentive-Based Compensation been based on the restated results, without respect to any tax liabilities that the Senior Officer incurred or paid in respect of such Incentive-Based Compensation.

Other than as set forth in Section VIII, recovery of any erroneously awarded compensation under this Policy is not dependent on fraud or misconduct by any Senior Officer in connection with a Restatement.

Without limiting the foregoing, for Incentive-Based Compensation based on the Company’s stock price or total stockholder return, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in the Restatement, (i) the amount shall be based on the Company’s reasonable estimate of the effect of the Restatement on the stock price or total stockholder return upon which the Incentive-Based Compensation was Received and (ii) the Company shall maintain documentation of the determination of that reasonable estimate and provide such estimate to Nasdaq.

In addition to the foregoing, in the event that a Senior Officer fails to repay or reimburse erroneously awarded compensation that is subject to recovery, the Committee may require a Senior Officer to reimburse the Company for any and all expenses reasonably incurred (including legal fees) by the Company in recovering erroneously awarded compensation under this Policy.

V.
Coverage and Application

This Policy covers all Senior Officers at any time during the Recovery Period who have Received Incentive-Based Compensation. Incentive-Based Compensation shall not be recovered under this Policy to the extent Received by any person before the date the person served as a Senior Officer. Subsequent changes in a Senior Officer’s employment status, including retirement or termination of employment, do not affect the Company’s right or obligation to recover Incentive-Based Compensation under this Policy.

For the avoidance of doubt, and subject to Section VIII hereof, this Policy shall apply to Incentive-Based Compensation that is Received by any Senior Officer on or after October 2, 2023 (the “Nasdaq Rule Effective Date”) and that results from the attainment of a Financial Reporting Measure based on or derived from financial information for any fiscal period ending on or after the Nasdaq Rule Effective Date. For the avoidance of

3

 

doubt, this will include Incentive-Based Compensation that may have been approved, awarded, or granted to a Senior Officer on or before the Nasdaq Rule Effective Date if such Incentive-Based Compensation is Received after the Nasdaq Rule Effective Date.

VI.
Exceptions to Policy

No recovery of Incentive-Based Compensation shall be required if any of the following conditions are met, and the Committee determines that recovery would be impracticable on such basis:

a.
the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered; provided that before determining that it would be impracticable to recover any Incentive-Based Compensation based on the expense of enforcement, the Company shall (i) have made a reasonable attempt to recover the Incentive-Based Compensation, (ii) have documented such reasonable attempts to recover, and (iii) provide the documentation to Nasdaq;
b.
recovery would violate the home country law where that law was adopted before November 28, 2022; or
c.
recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended (the “Code”), and U.S. Treasury regulations promulgated thereunder.
VII.
Public Disclosure

The Company shall make all required disclosures and filings with the Regulators with respect to this Policy in accordance with the requirements of the Applicable Rules, and any other requirements applicable to the Company, including any disclosures required in connection with SEC filings.

VIII.
Methods of Recovery

In a Clawback Event, subject to applicable law, the Committee may take any such actions as it deems necessary or appropriate, including, without limitation:

a.
The reduction or cancellation of any Clawback Compensation in the form of vested or unvested equity or equity-based awards that have not been distributed or otherwise settled before the date of determination;
b.
The recovery of any Clawback Compensation that was previously paid to the Senior Officer;
c.
The recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any Clawback Compensation in the form of equity or equity-based awards;

4

 

d.
The offset, withholding, or elimination of any amount that could be paid or awarded to the Senior Officer after the date of determination;
e.
The recoupment of any amount in respect of Clawback Compensation contributed to a plan that takes into account Clawback Compensation (excluding certain tax-qualified plans, but including long-term disability, life insurance, supplemental executive retirement plans and deferred compensation plans, in each case to the extent permitted by applicable law, including Section 409A of the Code) and any earnings accrued to date on any such amount; and
f.
The taking of any other remedial and recovery action permitted by law, as determined by the Committee.

In addition, the Committee may authorize legal action for breach of fiduciary duty or other violation of law and take such other actions to enforce the Senior Officer’s obligations to the Company as the Committee deems appropriate.

IX.
No Indemnification

The Company shall not indemnify any current or former Senior Officer against the loss of erroneously awarded compensation and shall not pay or reimburse any Senior Officer for premiums incurred or paid for any insurance policy to fund such Senior Officer’s potential recovery obligations.

X.
No Substitution of Rights; Non-Exhaustive Rights; Discretionary Recoveries

Any right of recoupment under this Policy is in addition to, and not instead of, any other remedies or rights of recoupment that may be available to the Company under (a) the Universal Display Corporation Equity Compensation Plan, as amended, any other incentive plan of the Company or any of its subsidiaries or affiliates, and any amendments or successor plans to the foregoing; and (b) the terms of any similar policy or provision in any employment agreement, compensation agreement or arrangement, or similar agreement and any other legal remedies available to the Company.

In addition to recovery of compensation as provided for in this Policy:

The Company may take any and all other actions as it deems necessary, appropriate, and in the Company’s best interest in connection with a Clawback Event, including termination of a Senior Officer’s employment and initiating legal action against a Senior Officer, and nothing in this Policy limits the Company’s rights to take any such or other appropriate actions.

Nothing herein shall restrict or limit the Committee’s discretion to require the return, repayment, recoupment, or forfeiture of any equity-based performance and incentive compensation payment or award, including, without limitation, Time-Based/Bonus Compensation, made or granted to any current or former Senior Officer under the Universal Display Corporation Equity Compensation Plan, as

5

 

amended, any other incentive plan of the Company or any of its subsidiaries or affiliates, and any amendments or successor plans to the foregoing.

XI.
Amendment

The Board, based on the recommendation of the Committee, may amend this Policy at any time for any reason, subject to any limitations under the Applicable Rules. The Board may terminate this Policy at any time that the Applicable Rules are no longer applicable to the Company.

XII.
Successors

This Policy shall be binding and enforceable against all Senior Officers and their beneficiaries, heirs, executors, administrators, or other legal representatives.

XIII.
Effective Date of Policy

This Policy shall be effective as of December 1, 2023 (the “Policy Effective Date”). For the avoidance of doubt, the terms of this Policy shall apply to any Incentive-Based Compensation that is Received by any Senior Officer on or after the Nasdaq Rule Effective Date, even if such Incentive-Based Compensation was approved, awarded, granted, or paid to such Senior Officer prior to the Policy Effective Date. Without limiting the generality of Section IX hereof, and subject to applicable law, the Committee may effect recovery under this Policy from any amount of compensation approved, awarded, granted, payable, or paid to any Senior Officer prior to, on, or after the Policy Effective Date.

6

 

 GRAPHIC 12 img34714927_0.jpg GRAPHIC begin 644 img34714927_0.jpg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img34714927_1.jpg GRAPHIC begin 644 img34714927_1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X0+Z17AI9@ 34T *@ @ ! $[ ( M 0 !2H=I 0 ! !6IR= $ @ "TNH< < $, /@ M 2!(;W!K:6YS %D , @ !0 *HD 0 @ !0 *\DI$ M @ ,U.0 DI( @ ,U.0 ZAP !P 0P &< !SJ 0 M M M M M M R,#(T.C R.C Q M(#$Q.C(X.C$Y #(P,C0Z,#(Z,#$@,3$Z,C@Z,3D !, &D ;@!D ', 80!Y M " 2 !O ' :P!I &X

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end EX-101.SCH 14 oled-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - LEASES - Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Disclosure - NET INCOME PER COMMON SHARE - Schedule of Earnings Per Share (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100040 - Disclosure - REVENUE RECOGNITION - Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 100080 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100090 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 100100 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 100110 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Non-Cash Activities link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - BUSINESS link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - OTHER ASSETS link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - OTHER LIABILITIES link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - EMPLOYEE RETIREMENT PLANS link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - CONCENTRATION OF RISK link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - REVENUE RECOGNITION link:presentationLink link:calculationLink link:definitionLink 100330 - Disclosure - NET INCOME PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 100340 - Disclosure - QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 100350 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 100360 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 100370 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 100380 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 100390 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 100400 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 100410 - Disclosure - OTHER ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 100420 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 100430 - Disclosure - ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 100440 - Disclosure - OTHER LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 100450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) link:presentationLink link:calculationLink link:definitionLink 100460 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 100470 - Disclosure - EMPLOYEE RETIREMENT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 100480 - Disclosure - CONCENTRATION OF RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 100490 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 100500 - Disclosure - REVENUE RECOGNITION (Tables) link:presentationLink link:calculationLink link:definitionLink 100510 - Disclosure - NET INCOME PER COMMON SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 100520 - Disclosure - QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) (Tables) link:presentationLink link:calculationLink link:definitionLink 100530 - Disclosure - BUSINESS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100540 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100550 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Cash, Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 100560 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Investments (Details) link:presentationLink link:calculationLink link:definitionLink 100570 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100580 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 100590 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100600 - Disclosure - INVENTORY - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 100610 - Disclosure - INVENTORY - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100620 - Disclosure - PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 100630 - Disclosure - PROPERTY AND EQUIPMENT - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100640 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Acquired Technology (Details) link:presentationLink link:calculationLink link:definitionLink 100650 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Acquired Technology - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100660 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Other Intangible Assets - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100670 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 100680 - Disclosure - OTHER ASSETS - Schedule of Other Assets (Details) link:presentationLink link:calculationLink link:definitionLink 100690 - Disclosure - LEASES- Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100700 - Disclosure - LEASES - Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 100710 - Disclosure - LEASES - Schedule Of Operating Lease Right of Use Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 100720 - Disclosure - LEASES - Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 100730 - Disclosure - LEASES - Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms (Details) link:presentationLink link:calculationLink link:definitionLink 100740 - Disclosure - ACCRUED EXPENSES - Schedule of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 100750 - Disclosure - RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS- Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100760 - Disclosure - OTHER LIABILITIES - Summary of Other liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 100770 - Disclosure - EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100780 - Disclosure - SHAREHOLDERS' EQUITY - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100790 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 100800 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 100810 - Disclosure - STOCK-BASED COMPENSATION - Equity Compensation Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100820 - Disclosure - STOCK-BASED COMPENSATION - Equity Instruments Other Than Options (Details) link:presentationLink link:calculationLink link:definitionLink 100830 - Disclosure - STOCK-BASED COMPENSATION - Equity Instruments Other Than Options - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100840 - Disclosure - STOCK-BASED COMPENSATION - Employee Stock Purchase Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100850 - Disclosure - STOCK-BASED COMPENSATION - Deferred Compensation Arrangement - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100860 - Disclosure - EMPLOYEE RETIREMENT PLANS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100870 - Disclosure - EMPLOYEE RETIREMENT PLANS - Information Relating to the Company's Plan (Details) link:presentationLink link:calculationLink link:definitionLink 100880 - Disclosure - EMPLOYEE RETIREMENT PLANS - Components of Net Periodic Pension Cost (Details) link:presentationLink link:calculationLink link:definitionLink 100890 - Disclosure - EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Benefit Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 100900 - Disclosure - EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Net Periodic Pension Cost (Details) link:presentationLink link:calculationLink link:definitionLink 100910 - Disclosure - EMPLOYEE RETIREMENT PLANS - Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year (Details) link:presentationLink link:calculationLink link:definitionLink 100920 - Disclosure - EMPLOYEE RETIREMENT PLANS - Benefit Payments Expected to be Paid (Details) link:presentationLink link:calculationLink link:definitionLink 100930 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100940 - Disclosure - CONCENTRATION OF RISK - Revenues and Accounts Receivable From Our Largest Customers (Details) link:presentationLink link:calculationLink link:definitionLink 100950 - Disclosure - CONCENTRATION OF RISK - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100960 - Disclosure - CONCENTRATION OF RISK - Revenues by Geographic Area (Details) link:presentationLink link:calculationLink link:definitionLink 100970 - Disclosure - CONCENTRATION OF RISK - Long-Lived Assets (Net) by Geographic Area (Details) link:presentationLink link:calculationLink link:definitionLink 100980 - Disclosure - INCOME TAXES - Components of Income (Loss) before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 100990 - Disclosure - INCOME TAXES - Components of Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 101000 - Disclosure - INCOME TAXES - Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 101010 - Disclosure - INCOME TAXES - Tax Loss and Tax Credit Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 101020 - Disclosure - INCOME TAXES - Significant Components of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 101030 - Disclosure - INCOME TAXES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 101040 - Disclosure - REVENUE RECOGNITION - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 101050 - Disclosure - REVENUE RECOGNITION - Schedule of Assets and Liabilities Associated with Contracts from Customers (Details) link:presentationLink link:calculationLink link:definitionLink 101060 - Disclosure - REVENUE RECOGNITION - Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances (Details) link:presentationLink link:calculationLink link:definitionLink 101070 - Disclosure - NET INCOME PER COMMON SHARE - Schedule of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 101080 - Disclosure - NET INCOME PER COMMON SHARE - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 101090 - Disclosure - QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) (Details) link:presentationLink link:calculationLink link:definitionLink Auditor Firm ID Auditor Firm ID Benefit Payments Expected to be Paid Schedule of Expected Benefit Payments [Table Text Block] 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Major Customer A [Member] Major Customer A [Member] Single non-government external Customer A that accounts for 10 percent or more of the entity's revenues. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Document Transition Report Document Transition Report Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Schedule of Nonvested Performance-Based Units Activity Schedule of Nonvested Performance-Based Units Activity [Table Text Block] Money Market Accounts [Member] Money Market Funds [Member] Assumptions used to determine the year end benefit obligation [Abstract] Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax, Total Unrealized (loss) gain on available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Geographical Geographical [Axis] Percentage of market value (in hundredths) Employee Stock Purchase Plan E S P P Percentage Of Market Value The percentage of the lesser of the price per share of common stock on the first day of the purchase period, or the last day of the purchase period, at which eligible employees may purchase shares under the plan. Revenue from Contracts with Customers - ASU No. 2014-09 [Member] Accounting Standards Update 2014-09 [Member] Restricted stock awards and units vesting terms Expiration term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Debt Securities, Available-for-sale, Total Available-for-sale Securities, Fair Value Disclosure Debt Securities, Available-for-Sale Other Current Assets [Member] Other Current Assets [Member] Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held, Ending Balance Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held, Beginning Balance Credit losses on debt investments Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) Quarterly Financial Information [Text Block] Other Liabilities, Noncurrent, Total OTHER LIABILITIES Other Liabilities, Noncurrent Gain Contingencies, Nature Gain Contingencies, Nature [Axis] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Finite-Lived Intangible Asset, Expected Amortization, Year Two Future amortization expense, 2024 Components of net periodic pension cost [Abstract] Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Additional agreement duration Additional Agreement Duration Additional agreement duration. Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Defined Benefit Pension Plans And Defined Benefit Postretirement Plans [Abstract] Defined Benefit Pension Plans and Defined Benefit Postretirement Plans. Entity Public Float Entity Public Float 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four CONCENTRATION OF RISK Concentration Risk Disclosure [Text Block] Weighted Average Weighted Average [Member] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Estimated useful life (in years) Property, Plant and Equipment, Useful Life Revenue from Contract with Customer, Excluding Assessed Tax, Total Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Other current liabilities Increase (Decrease) in Other Current Liabilities Backlog associated with committed purchase orders from customers Backlog Associated With Committed Purchase Orders From Customers Backlog associated with committed purchase orders from its customers. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized compensation expense related to performance unit awards Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Customer Concentration Risk [Member] Concentration Risk Type [Axis] Material sales Material Sales [Member] Material sales. Long-term taxes receivable Income Taxes Receivable, Noncurrent ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Title of Individual Title of Individual [Domain] Disclosure Text Block [Abstract] Dividend record date Dividends Payable, Date of Record Research and Development [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Long-term lease liabilities Operating Lease, Liability, Noncurrent Common stock dividends paid per share Common Stock, Dividends, Per Share, Cash Paid Schedule Of Stock By Class [Table] Schedule of Stock by Class [Table] Fair Value Measurement Fair Value Measurement [Domain] Debt Securities Available For Sale [Table] Debt Securities, Available-for-Sale [Table] Long-term lease liabilities Finance Lease, Liability, Noncurrent Class Of Stock [Line Items] Class of Stock [Line Items] Balance Sheet Location Balance Sheet Location [Axis] Shares issued (in shares) Deferred Compensation Arrangement with Individual, Shares Issued Total current assets Assets, Current Vesting Vesting [Domain] TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity Entity Address, State or Province Entity Address, State or Province Other Deferred Tax Assets, Other Deferred income tax (expense) benefit: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred Income Tax Assets, Net, Total DEFERRED INCOME TAXES Deferred Income Tax Assets, Net Amortization of prior service cost and actuarial loss for retirement plan included in net periodic pension costs net of tax of ($299), ($569) and ($1,316), respectively Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Defined benefit plan threshold of benefit obligation at which actuarial losses are amortized (in hundredths) Defined Benefit Plans Threshold Of Benefit Obligation At Which Actuarial Losses Are Amortized The threshold percentage of year end benefit obligation for which accumulation of actuarial losses in excess of this threshold are amortized from accumulated other comprehensive loss into net periodic pension cost over future years, based upon the average remaining service period of active plan participants. COMPREHENSIVE INCOME Comprehensive Income (Loss), Net of Tax, Attributable to Parent INVENTORY Inventory Disclosure [Text Block] Goodwill and Purchased Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Lease Liabilities Lease Liabilities Lease liabilities Trading Symbol Trading Symbol Deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Transferred to receivables from unbilled receivables Transferred To Receivables From Unbilled Receivables Transferred to receivables from unbilled receivables. Common Stock, Shares, Issued, Total Common Stock, shares issued (in shares) Common Stock, Shares, Issued Nondeductible employee compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Schedule Of Available For Sale Securities [Line Items] Debt Securities, Available-for-Sale [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Fair value granted as of the respective vesting dates Other Non-U.S. Locations [Member] Other Non U S [Member] Other Non US. Preferred stock voting rights Preferred Stock, Voting Rights Contract Assets Recorded Contract Assets Recorded Contract Assets Recorded Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Treasury Stock, Preferred, Shares 2029-2033 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Korean Government [Member] Foreign Tax Authority [Member] BALANCE (in shares) BALANCE (in shares) Shares, Outstanding 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Accumulated Other Comprehensive Loss [Member] AOCI Attributable to Parent [Member] Other comprehensive income (loss) TOTAL OTHER COMPREHENSIVE INCOME (LOSS) Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Translation of Foreign Currency Financial Statements and Foreign Currency Transactions Foreign Currency Transactions and Translations Policy [Policy Text Block] Accumulated Other Comprehensive Income (Loss) [Roll Forward] Accumulated Other Comprehensive Income (Loss) [Line Items] Entity Address, City or Town Entity Address, City or Town Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Benefit obligation, beginning of year Benefit obligation, end of year Defined Benefit Plan, Benefit Obligation Property and Equipment Property, Plant and Equipment [Table Text Block] Unrealized gain (loss) on available-for-sale securities, tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Common stock dividends paid Payments of Ordinary Dividends, Common Stock Manufacturing Expense [Member] Manufacturing Expense [Member] Manufacturing expense. Subsequent Event [Member] Subsequent Event [Member] Subsequent Event Type Subsequent Event Type [Axis] Future amortization expense of other intangible assets, fiscal year 2024 Other Finite Lived Intangible Assets Amortization Expense Next Twelve Months Other finite lived intangible assets amortization expense next twelve months. Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Components of Income Tax Expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Other [Member] Total Non-U.S. Locations [Member] Non-US [Member] Charges to expense Employee Stock Purchase Plan E S P P Compensation Expense Employee stock purchase plan ESPP compensation expense. CURRENT LIABILITIES: Liabilities, Current [Abstract] Annual base salary period (in months) Defined Benefit Plans Annual Base Salary Period The period (in months) immediately preceding the participant's date of termination of employment, or, if required, the date of a change in control of the Company, used to determine the participant's annual base salary. CURRENT ASSETS: Assets, Current [Abstract] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Preferred Stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share CASH, CASH EQUIVALENTS AND INVESTMENTS Cash and Cash Equivalents Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Major Customer C [Member] Major Customer C [Member] Single non-government external Customer C that accounts for 10 percent or more of the entity's revenues. Short-term lease liabilities Operating Lease, Liability, Current Earnings Per Share, Basic, Other Disclosure [Abstract] WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME PER COMMON SHARE: Employee Stock Purchase Plan ESPP Purchase Period1 Employee Stock Purchase Plan ESPP Purchase Period1 PROPERTY AND EQUIPMENT, net of accumulated depreciation of $143,908 and $117,118 Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property and equipment, net Property, Plant and Equipment, Net Series A Nonconvertible Preferred Stock [Member] Series A Preferred Stock [Member] Contract expiration year Contract Expiration Year Contract expiration year. Class of Stock Class of Stock [Domain] Accumulated Amortization Other Finite-Lived Intangible Assets, Accumulated Amortization Other Finite Lived Intangible Assets Accumulated Amortization Other finite lived intangible assets accumulated amortization. Dividend declared date Dividends Payable, Date Declared State and foreign income tax returns subject to examination period minimum (in years) State And Foreign Income Tax Returns Subject To Examination Period Minimum State and foreign income tax returns subject to examination period minimum. Statutory U.S. federal income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Statement of Comprehensive Income [Abstract] Scenario Scenario [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Treasury Stock, Common, Shares Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Discount rate Entity Central Index Key Entity Central Index Key Other Intangible Assets [Member] Other Intangible Assets [Member] Charges to expense for cash portion of reimbursement of expenses Research And Development Expense Credit Research and development expense (credit). Amortization of loss Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year Plan Name Plan Name [Domain] Other current assets Increase (Decrease) in Other Current Assets Schedule Of Operating Lease Right of Use Assets and Liabilities Schedule of Operating Lease Right of Use Assets and Liabilities [Table Text Block] Schedule of operating lease right-of-use assets and liabilities. U.S. Government Bonds [Member] US Treasury and Government [Member] Risks and Uncertainties [Abstract] Components of income before income taxes [Abstract] Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] ADJUSTED BALANCE ADJUSTED BALANCE Adjusted Balance Stockholder Equity Adjusted balance stockholder equity. Operating lease, option to extend Lessee, Operating Lease, Option to Extend Percent of services payable in cash or shares Long Term Purchase Commitment Percent Of Services Payable In Cash Or Shares Long-Term Purchase Commitment, Percent Of Services Payable In Cash Or Shares Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Foreign Current income tax expense Current Foreign Tax Expense (Benefit) Total current liabilities Liabilities, Current Entity Tax Identification Number Entity Tax Identification Number Stock based compensation Effective Income Tax Rate Reconciliation Deduction Share Based Compensation Cost Percent Effective income tax rate reconciliation deduction share based compensation cost percent. Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Finished goods Inventory, Finished Goods, Net of Reserves Thereafter Defined Benefit Plans Expected Future Benefit Payments After Five Fiscal Years Thereafter The amount of the aggregate benefits expected to be paid in total, subsequent to the five fiscal years thereafter (the aggregate amount of benefits expected to be paid after years 6 through 10 after the date of the latest statement of financial position). Recognized income tax positions measured at likelihood of realization description Income Tax Examination, Likelihood of Unfavorable Settlement Compensation plan extended term description Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms Financial Instruments Financial Instruments [Domain] Amortization of acquired technology and other intangible assets Amortization Of Acquired Technology And Other Intangible Assets Amortization of acquired technology and other intangible assets. Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Unrealized gain (loss) on available-for-sale securities [Member] AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Benefit percentage for special participants (in hundredths) Defined Benefit Plans Benefit Percentage For Special Participants The percentage of a special participant's annual base salary for the life of the participant (and their surviving spouse, if any), on which the benefit is based. Adjusted balance on January 1, 2018 Adjusted Balance Deferred Revenue Adjusted balance deferred revenue. Capitalized research expenditures Deferred Tax Assets Capitalized Research Expenditures The tax effect as of the balance sheet date of the amount of the estimated future tax deductions attributable to capitalized research expenditures. Total Defined Benefit Plan, Expected Amortization, Next Fiscal Year Construction-in-progress [Member] Construction in Progress [Member] Proceeds from common stock issued Issuance of common stock to employees under an ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Other Liabilities [Member] Other Liabilities [Member] Long-term unbilled receivables Long-term unbilled receivables Award Type Award Type [Axis] LEASES Lessee, Operating Leases [Text Block] Restricted Stock [Member] Restricted Stock [Member] Cash and Cash Equivalents [Abstract] RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS RESEARCH AND LICENSE AGREEMENTS WITH PRINCETON UNIVERSITY, UNIVERSITY OF SOUTHERN CALIFORNIA AND THE UNIVERSITY OF MICHIGAN Research, Development, and Computer Software Disclosure [Text Block] Plan Name Plan Name [Axis] Maximum obligation Research And Development Arrangement Maximum Obligation The maximum amount the Company is obligated to pay under the specified research agreement, as of the balance sheet date. Geographical Geographical [Domain] Operating leases remaining term Lessee, Operating Lease, Term of Contract TOTAL ASSETS Assets Cash paid for OLED patents Finite Lived Intangible Assets Acquired Other Acquisition Costs Finite lived intangible assets acquired, other acquisition costs. Long-Lived Assets (Net) by Geographic Area Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] United States [Member] UNITED STATES Investment Income, Net, Total Interest income, net Investment Income, Net Right-of-use assets Operating Lease, Right-of-Use Asset Accruals and reserves Effective Income Tax Rate Reconciliation Change In Accruals And Reserves Percent Effective income tax rate reconciliation change in accruals and reserves percent. Entity Registrant Name Entity Registrant Name Lessee Lease Description [Line Items] Lessee, Lease, Description [Line Items] Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained earnings Retained Earnings (Accumulated Deficit) Property Subject to or Available for Operating Lease [Axis] Future amortization expense of other intangible assets, fiscal year 2028 Other Finite Lived Intangible Assets Amortization Expense Year Five Other finite lived intangible assets amortization expense year five. Retained Earnings [Member] Retained Earnings [Member] Class of Stock Class of Stock [Axis] Raw materials Inventory, Raw Materials, Net of Reserves Number of Shares, Unvested, December 31, 2023 Number of Shares, Unvested, January 1, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Total Cumulative effect adjustment to reduction of retained earnings ASC Topic 606 Adoption ASC Topic 606 Adoption Equity, Including Portion Attributable to Noncontrolling Interest Common stock issued (in shares) Issuance of common stock to employees under an ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Minimum [Member] Minimum [Member] Tax Credit And Operating Loss Carryforwards [Line Items] Tax Credit And Operating Loss Carryforwards [Line Items] Tax credit and operating loss carry forwards line items. Revenues, Total Revenues Revenues Treasury Stock, Number of Shares and Restriction Disclosures [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Operating Lease, Liability, Total Present value of lease payments Operating Lease, Liability Forecast [Member] Forecast [Member] Information Relating to the Company's Plan Schedule of Net Funded Status [Table Text Block] Revenue Recognition and Deferred Revenue Revenue [Policy Text Block] Equity Component Equity Component [Domain] Contributions to the 401(k) Plan Defined Contribution Plan, Cost Long-term Corporate bonds Long-Term Transition Bond, Current Land [Member] Land [Member] 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Computer Software [Member] Software Development [Member] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Measurement Frequency Measurement Frequency [Axis] Shares withheld for employee taxes Fair value of shares withheld for tax withholding obligations Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Building and improvements [Member] Building and Building Improvements [Member] Entity Current Reporting Status Entity Current Reporting Status Common Stock, shares authorized (in shares) Common Stock, Shares Authorized Research and Development Expense, Total Research and development Research and Development Expense Cash And Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Income taxes. IRELAND Ireland [Member] OTHER INTANGIBLE ASSETS, net of accumulated amortization of $10,414 and $8,989 Net Carrying Amount Other Finite Lived Intangible Assets Net Other finite lived intangible assets net. Deferred Tax Liabilities, Gross, Total Deferred tax liabilities Deferred Tax Liabilities, Gross Foreign Deferred Foreign Income Tax Expense (Benefit) ASSETS Assets [Abstract] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Assumptions used to determine the net periodic pension cost [Abstract] Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Amortization of Intangible Assets, Total Amortization of intangibles Amortization of Intangible Assets Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Lease Assets Deferred Tax Liabilities, Leasing Arrangements Common Stock, par value $0.01 per share, 200,000,000 shares authorized, 48,731,026and 49,136,030 shares issued, and 47,365,378 and 47,770,382 share outstanding at December 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued SHAREHOLDERS' EQUITY Shareholders' Equity and Share-Based Payments [Text Block] Company Performance-Based Vesting Requirement [Member] Company Performance Based Vesting Requirement [Member] Company performance-based vesting requirement. Revenue recognized that was previously included in deferred revenue Contract with Customer, Liability, Revenue Recognized Long-term contract assets Long-term contract assets Furniture and fixtures [Member] Furniture and Fixtures [Member] Furniture, fixtures and computer related assets [Member] Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities Schedule Of Weighted Average Assumptions Used To Compute Right Of Use Assets And Lease Liabilities Table [Text Block] Schedule of weighted average assumptions used to compute right-of-use assets and lease liabilities. Preferred Stock, liquidation value Preferred Stock, Liquidation Preference, Value Accrued Expenses Accrued expenses Accrued Liabilities, Current Current Fiscal Year End Date Current Fiscal Year End Date Share-based Payment Arrangement, Noncash Expense, Total Stock-based compensation to employees Share-Based Payment Arrangement, Noncash Expense Auditor Name Auditor Name OPERATING INCOME Operating Income (Loss) Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit), Total Deferred Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Income tax expense INCOME TAX EXPENSE Income Tax Expense (Benefit) Research and Development Expense [Member] Research and Development Expense [Member] Non-current liability Liability, Defined Benefit Plan, Noncurrent, Total RETIREMENT PLAN BENEFIT LIABILITY Liability, Defined Benefit Plan, Noncurrent Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] BUSINESS Nature of Operations [Text Block] Leases Lessee, Leases [Policy Text Block] Developed IP, Processes and Recipes [Member] Internally-developed IP, Processes and Recipes [Member] Internally Developed I P Processes And Recipes [Member] Internally-developed IP, processes and recipes. License agreement, extended option term License Agreement Extended Option Term License agreement extended option term. Reclassification to net income Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Foreign exchange loss Unrealized Loss on Foreign Currency Derivatives, before Tax Concentration risk, percentage (less than 1% for contracts with U.S. government agencies) % of Total Revenue Concentration Risk, Percentage Research and development arrangement, new amendment expiration date. Research And Development Arrangement New Amendment Expiration Date Research agreement, new amendment expiration date Compensation expense Share-Based Payment Arrangement, Expense Payment of withholding taxes related to stock-based compensation to employees Payment, Tax Withholding, Share-Based Payment Arrangement Effect of dilutive shares: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Benefit percentage, tier three (in hundredths) Defined Benefit Plans Benefit Percentage Tier Three The lowest level of percentage of the participant's annual base salary for the life of the participant, on which the benefit is based, depending on the participant's benefit class. The aggregation of information pertaining to both the OLED Materials Supply and Service Agreement (OLED Materials Agreement), and the Amended and Restated OLED Materials Supply and Service Agreement (the New OLED Materials Agreement), with PPG Industries. New Oled Materials Agreement And Oled Materials Agreement [Member] New OLED Materials Agreement and OLED Materials Agreement [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] ACQUIRED TECHNOLOGY, net of accumulated amortization of $186,850 and $189,671 Finite-Lived Intangible Assets, Net, Ending Balance Finite-Lived Intangible Assets, Net, Beginning Balance Acquired technology, net Finite-Lived Intangible Assets, Net Cash Accounts in Banking Institutions [Member] Cash Accounts In Banking Institutions [Member] Cash accounts in banking institutions. Balance Balance Deferred Revenue, Total Deferred Revenue REVENUE RECOGNITION Revenue from Contract with Customer [Text Block] BALANCE ADJUSTED (in shares) BALANCE ADJUSTED (in shares) Adjusted Shares Outstanding Adjusted shares outstanding. Dividends, Cash, Total Cash dividend Dividends, Cash Cumulative Effect Period Of Adoption Adjustment [Member] Cumulative Effect, Period of Adoption, Adjustment [Member] Cash and cash equivalents maturity period Cash And Cash Equivalents Maturity Period Cash and cash equivalents maturity period. Amortization of prior service cost and actuarial loss for retirement plan included in net periodic pension costs, tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax Measurement Basis Measurement Basis [Axis] Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Other Nonoperating Income (Expense), Total Other Nonoperating Income (Expense) Other income (loss), net Other (loss) income, net Adjusted balance on January 1, 2018 Adjusted Balance Unbilled Receivables Adjusted balance unbilled receivables. OPERATING EXPENSES: Operating Expenses [Abstract] Property, Plant and Equipment [Abstract] Number of participants Defined Benefit Plans Number Of Participants The number of participants in the defined benefit plan. Members of Scientific Advisory Board [Member] Members Of Scientific Advisory Board [Member] Members of scientific advisory board. Excluding North America [Member] Excluding North America [Member] Excluding North America. Entity Voluntary Filers Entity Voluntary Filers OTHER COMPREHENSIVEINCOME (LOSS), NET OF TAX: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Schedule of Investments Debt Securities, Available-for-Sale [Table Text Block] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Commitments and Contingencies Disclosure [Abstract] Other Assets, Noncurrent, Total Long-term asset OTHER ASSETS Other Assets, Noncurrent FUJIFILM [Member] Fujifilm [Member] Fujifilm. Other Other Accrued Liabilities, Current Depreciation, Total Depreciation expense Depreciation Depreciation Compensation Accrued Salaries, Current Finite-Lived Intangible Asset, Expected Amortization, Year Four Future amortization expense, 2026 Finite-Lived Intangible Asset, Expected Amortization, Year One Future amortization expense, 2023 Retirement Plan Type Retirement Plan Type [Domain] Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Total Additional paid-in capital Additional Paid in Capital Other Significant Noncash Transactions [Line Items] Other Significant Noncash Transactions [Line Items] Available-for-sale Securities, Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Long-Term Commitment (Excluding Unconditional Purchase Obligation) [Abstract] SHAREHOLDERS' EQUITY: Equity, Attributable to Parent [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Distribution Type Distribution Type [Domain] Interest cost Defined Benefit Plan, Interest Cost Loss Contingency Nature Loss Contingency Nature [Axis] Cost of Goods and Services Sold, Total COST OF SALES Cost of Goods and Services Sold Plan amendment cost Other Comprehensive Income Plan Amendment Cost Other comprehensive income plan amendment cost. Net income per common share: NET INCOME PER COMMON SHARE: Earnings Per Share [Abstract] Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Property Available for Operating Lease [Member] Accounting Policies [Abstract] One Nine Nine Five [Member] One Nine Nine Five [Member] Finite-Lived Intangible Asset, Expected Amortization, Year Five Future amortization expense, 2027 Cumulative catch-up adjustment arising from changes in estimates of transaction price Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price Lessee Lease Description [Table] Lessee, Lease, Description [Table] Estimated amounts to be amortized from accumulated other comprehensive loss in next fiscal year [Abstract] Defined Benefit Plan, Expected Amortization, Next Fiscal Year [Abstract] Long-term taxes payable Taxes Payable Taxes Payable, Total Other comprehensive gain (loss) before reclassification Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Scenario Scenario [Axis] Allocation of Withholding to Non-Korean Patents [Member] Allocation Of Withholding To Non Korean Patents [Member] Allocation of withholding to non-Korean patents. Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Other Assets [Member] Other Noncurrent Assets [Member] Non Employee Members of Scientific Advisory Board [Member] Non Employee Members Of Scientific Advisory Board [Member] Non-employee members of the Scientific Advisory Board. Benefit payments currently expected to be paid [Abstract] Defined Benefit Plan, Expected Future Benefit Payment [Abstract] Long Term Purchase Commitment [Table] Long-Term Purchase Commitment [Table] Document Financial Statement Restatement Recovery Analysis [Flag] Number Of Executive Officers Under Agreement The number of executive officers under agreement. Number of executive officers under agreement Maximum allocation of base compensation (in hundredths) Employee Stock Purchase Plan E S P P Maximum Allocation Of Base Compensation The maximum percentage of employees' base compensation that can be allocated under the plan. Other [Member] Other [Member] Other [Member]. Equity Method Investment, Other than Temporary Impairment Impairment in minority investment Non-cash activity: Cash Flow, Operating Activities, Lessee [Abstract] Other Finite Lived Intangible Assets Amortization Expense Year Three Other finite lived intangible assets amortization expense year three. Future amortization expense of other intangible assets, fiscal year 2025 Earnings Per Share, Basic, Total Basic BASIC Earnings Per Share, Basic Cash Equivalents, at Carrying Value Cash Equivalents, at Carrying Value Schedule Of Cash And Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Recognized income tax positions measured at percentage of likelihood of realization Recognized Income Tax Positions Measured At Percentage Of Likelihood Of Realization Recognized income tax positions measured at percentage of likelihood of realization. Schedule of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances Summary Of Significant Changes In Unbilled Receivables And Deferred Liabilities Balances Table [Text Block] Summary of significant changes in unbilled receivables and deferred liabilities balances. Change in inventory reserve Change in excess inventory reserve Inventory Write-down COMMITMENTS AND CONTINGENCIES (Note 18) Commitments and Contingencies Income Statement [Abstract] Other Finite Lived Intangible Assets Amortization Thereafter Other Finite Lived Intangible Assets Amortization Thereafter Future amortization expense of other intangible assets, thereafter Amortization of loss Defined Benefit Plan, Amortization of Gain (Loss) PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Performance Shares [Member] Performance Shares [Member] Schedule of Assets and Liabilities Associated with Contracts from Customers Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Multiple of sum of average annual base salary and bonus agreement terms Multiple Of Sum Of Average Annual Base Salary And Bonus Agreement Terms The multiple of the sum of the average annual base salary and bonus of the officer, which comprises the lump-sum cash payment to which each executive is entitled, under the agreement. Operating lease cost Operating Lease, Cost Statistical Measurement Statistical Measurement [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Short-term unbilled receivables Unbilled Receivables, Current Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Deferred income tax expense, gross Deferred Income Tax Expense Benefit Before Changein Valuation Allowance Deferred income tax expense (benefit) before change in valuation allowance. Assigned value of acquired intangible assets Finite-Lived Intangible Assets Acquired Distribution Type Distribution Type [Axis] Award Type All Award Types Document Period End Date Document Period End Date Statistical Measurement Statistical Measurement [Axis] Acquisition Costs, Period Cost Tax Credit And Operating Loss Carryforwards [Table] Tax Credit And Operating Loss Carryforwards [Table] Tax Credit And Operating Loss Carryforwards. COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Revenue recognition Recognition of Deferred Revenue Earnings Per Share, Diluted, Total Diluted DILUTED Earnings Per Share, Diluted Product and Service Product and Service [Domain] Other long-term assets Other Long-Term Investments Cost of Sales [Member] Cost of Sales [Member] Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Research tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent REVENUE: Revenue from Contract with Customer [Abstract] Number of suppliers from which chemical materials were purchased Number Of Suppliers From Which Chemical Materials Were Purchased The number of suppliers from which all chemical materials were purchased. Amortization of Other Intangible Assets Amortization Of Other Intangible Assets Policy [Text Block] Amortization of other intangible assets. Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Reserved for issuance (in shares) Employee Stock Purchase Plan E S P P Shares In E S P P Employee stock purchase plan ESPP shares in ESPP. Factor used to determine annual base salary Defined Benefit Plans Factor Used To Determine Annual Base Salary The multiple of the highest monthly base salary paid or payable to the participant during the defined period immediately preceding the participant's date of termination or employment, or, if required, the date of a change in control of the Company. This multiple is used to determine the participant's annual base salary. Other liabilities Increase (Decrease) in Other Noncurrent Liabilities Prepaid Expense and Other Assets [Abstract] Loss Contingency, Nature Loss Contingency, Nature [Domain] Percentage of revenue recorded from provision of services Percentage Of Revenue Recorded From Provision Of Services Percentage of revenue recorded from provision of services. Common Stock Issued to Board of Directors and Scientific Advisory Board that was Earned and Accrued for in Previous Period [Member] Common Stock Issued To Board Of Directors And Scientific Advisory Board That Was Earned And Accrued For In Previous Period [Member] The fair value of stock, restricted stock or stock options granted to the Board of Directors and Scientific Advisory Board as payment for services rendered or acknowledged claims in a previous period. China [Member] CHINA Fair Value, Measurements, Recurring [Member] Fair Value, Recurring [Member] Net unrealized gain (loss) on retirement plan [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Reduction of Korean Withholding Taxes [Member] Reduction in Taxes [Member] Inventories Inventory, Policy [Policy Text Block] Net deferred tax assets Deferred Tax Assets, Net U.S. Government Bonds [Member] US Treasury Securities [Member] Matching contribution limit (in hundredths) Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Long-term unbilled receivables Unbilled Receivables, Not Billable Repurchase of common stock Payments for Repurchase of Common Stock Minority Equity Investments Minority Equity Investments Policy [Text Block] Minority equity investments. Finite-Lived Intangible Assets, Major Class Name Finite-Lived Intangible Assets, Major Class Name [Domain] Principles of Consolidation Consolidation, Policy [Policy Text Block] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Benefit percentage, tier one (in hundredths) Defined Benefit Plans Benefit Percentage Tier One The highest level of percentage of the participant's annual base salary for the life of the participant, on which the benefit is based, depending on the participant's benefit class. LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity [Abstract] Stock Issued During Period, Value, Restricted Stock Award, Forfeitures Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Amortization expense related to other intangible assets Other Finite Lived Amortization Of Intangible Assets Other finite lived amortization of intangible assets. Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Amortization of Acquired Technology Amortization Of Acquired Technology Policy Policy [Text Block] Amortization of acquired technology. Finite-Lived Intangible Asset, Expected Amortization, Year Three Future amortization expense, 2025 Other Liabilities [Abstract] Equity [Abstract] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Grants in period (shares) Number of Shares, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer South Korea [Member] KOREA, REPUBLIC OF Other significant noncash transaction, value of consideration received Other Significant Noncash Transaction, Value of Consideration Received Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Cash, Cash Equivalents and Investments Cash and Cash Equivalents, Policy [Policy Text Block] Adjustment for Basic EPS: Earnings Per Share, Basic [Abstract] PD LD, Inc [Member] Pd Ld Inc [Member] Information pertaining to the PD-LD, Inc acquisition. Equity Components Equity Components [Axis] OTHER LIABILITIES Other Liabilities Disclosure [Text Block] Shareholders' Equity A Nonconvertible Preferred Stock Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Defined Benefit Plan, Plan Assets, Amount, Ending Balance Defined Benefit Plan, Plan Assets, Amount, Beginning Balance Defined Benefit Plan, Plan Assets, Amount, Total Fair value of plan assets Defined Benefit Plan, Plan Assets, Amount EMPLOYEE RETIREMENT PLANS Retirement Benefits [Text Block] Number of minority investments Number Of Minority Investments Number of minority investments. Inventory Disclosure [Abstract] Future amortization expense of other intangible assets, fiscal year 2027 Other Finite Lived Intangible Assets Amortization Expense Year Four Other finite lived intangible assets amortization expense year four. Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block] Finite-Lived Intangible Assets, Net [Abstract] Amortization of prior service cost Prior service cost expected to be amortized in next fiscal year Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year Unbilled receivables recognized Increase (Decrease) in Contract with Customer, Asset Shares withheld for employee taxes Stock Issued During Period Value Share Based Compensation Shares Withheld For Employee Taxes Stock issued during period value share based compensation shares Withheld for employee taxes. Weighted-Average Grant-Date Fair Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Local Phone Number Local Phone Number Building Improvements [Member] Building Improvements [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Issuance of common stock in connection with materials and license agreements (in shares) Debt Conversion, Converted Instrument, Shares Issued Federal Current Federal Tax Expense (Benefit) Research Tax Credit [Member] Research Tax Credit Carryforward [Member] Goodwill, Ending Balance Goodwill, Beginning Balance Goodwill, Total Goodwill GOODWILL Goodwill Number of employees under agreement Number Of Employees Under Agreement Number of employees under agreement. Visionox Hefei Technology Co. Ltd [Member] Visionox Hefei Technology [Member] Visionox Hefei Technology. Statement of Cash Flows [Abstract] Acquisition Goodwill Acquisition Goodwill Deferred Tax Liabilities, Goodwill Director [Member] Director [Member] Tax credit carryforwards, Expiration Date Tax Credit Carryforward, Expiration Date Income Tax Authority Income Tax Authority [Domain] Employee benefit plan: Employee Benefit Plans [Abstract] Employee Benefit Plans [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Gross margin Gross Profit Change in cumulative foreign currency translation adjustment [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accounts Receivable [Member] Concentration Risk Benchmark [Axis] Document Annual Report Document Annual Report Common Stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Deferred Revenue, Noncurrent, Total Long-term deferred revenue DEFERRED REVENUE Deferred Revenue, Noncurrent Number of patents issued and pending application Number Of Patents Issued And Pending Application Number of Patents Issued And Pending Application Cumulative Effect, Period of Adoption Cumulative Effect, Period of Adoption [Axis] Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Royalty and license fees Royalty And License Fees [Member] Royalty and license fees. Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Effective Income Tax Rate Reconciliation, Percent [Abstract] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Maximum [Member] Maximum [Member] Weighted-Average Grant-Date Fair Value, Unvested, December 31, 2023 Weighted-Average Grant-Date Fair Value, Unvested, January 1, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value Cost of Sales Cost of Goods and Service [Policy Text Block] Patent costs Patent Costs Patent costs. Payments of Dividends, Total Cash dividends paid Payments of Dividends Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Research And Development Arrangement Contract To Perform For Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] DECREASE IN CASH AND CASH EQUIVALENTS Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Service cost Defined Benefit Plan, Service Cost Work-in-process Inventory, Work in Process, Net of Reserves Deferred Compensation Arrangement with Employees and Non-Employees, Share-Based Payments [Line Items] Deferred Compensation Arrangement With Employees And Non Employees Share Based Payments [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Payables and Accruals [Abstract] Unbilled Receivables Increase (Decrease) Increase Decrease In Unbilled Receivables [Abstract] Increase (decrease) in unbilled receivables. Initial prior service cost for retirement plan Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax 2027 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Document Financial Statement Error Correction [Flag] LEASES Leases of Lessee Disclosure [Text Block] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Supplemental Executive Retirement Plan [Member] Supplemental Employee Retirement Plan [Member] City Area Code City Area Code Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Axis] State Deferred State and Local Income Tax Expense (Benefit) Inventory Inventory Inventory, Net CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Net change Unbilled Receivables Increase Decrease Net Unbilled receivables increase (decrease), net. Plan amendment cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Increase (Decrease) for Plan Amendment Quarterly Supplemental Financial Data (Unaudited) Quarterly Financial Information [Table Text Block] Contract with customer liability, transaction price Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Changes In Estimate Of Transaction Price Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Changes In Estimate Of Transaction Price Actuarial gain on retirement plan, tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax Rate of compensation increases Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Change in benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Customer Customer [Domain] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Japan [Member] JAPAN Selling, General and Administrative Expense [Member] Selling, General and Administrative Expenses [Member] Weighted Average Number of Shares Outstanding, Basic, Total Weighted average common shares outstanding – Basic BASIC Weighted Average Number of Shares Outstanding, Basic Cumulative catch-up adjustment arising from decrease in estimates of transaction price Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Decrease in Estimate of Transaction Price Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Decrease in Estimate of Transaction Price Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Domain] CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Research and Development Research and Development Expense, Policy [Policy Text Block] Retirement plan Deferred Tax Assets Retirement Plan The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from all currently nondeductible expenses reflected in retirement plan, which can only be deducted for tax purposes when benefit is paid, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. Future amortization expense of other intangible assets, fiscal year 2026 Other Finite Lived Intangible Assets Amortization Expense Year Two Other finite lived intangible assets amortization expense year two. Operating lease description Lessee, Operating Lease, Description Share-Based Compensation Arrangement by Share-Based Payment Award Options Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award Options Weighted Average Grant Date Fair Value Fair value as of the respective vesting dates Issuance of common stock to Board of Directors and Scientific Advisory Board (in shares) Issuance Of Common Stock To Board Of Directors And Scientific Advisory Board Shares Number of new stock issued during the period to the Board of Directors and Scientific Advisory Board. Consulting Accrued Consulting Fees Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for consulting fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Statement [Table] Statement [Table] Accounts Receivable [Member] Accounts Receivable [Member] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Document Fiscal Period Focus Document Fiscal Period Focus Total lease payments Lessee, Operating Lease, Liability, to be Paid Market-Based Vesting Requirement [Member] Market Based Vesting Requirement [Member] Market-based vesting requirement. Employee Stock Purchase Plan (ESPP) [Member] Employee Stock Purchase Plan [Member] Employee stock purchase plan. Rate of compensation increases Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Adoption of Topic 606 on January 1, 2018 Cumulative Effect Of New Accounting Principle In Period Of Adoption For Unbilled Receivables Cumulative effect of new accounting principle in period of adoption for unbilled receivables. 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Professional Fees Accrued Professional Fees, Current Statement [Line Items] Statement [Line Items] Other Assets [Abstract] Age of participant (in years) Defined Benefit Plans Age Of Participant The threshold age of the employee, at which the participant may be eligible to receive a benefit, if the participant resigns or is terminated without cause at or after this age, and with a defined period of service. Antidilutive securities excluded from calculation of diluted EPS Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Office and lab equipment [Member] Machinery and Equipment [Member] Non-Employee Members of Scientific Advisory Board [Member] Non-Employee Members of Scientific Advisory Board [Member] Employees And Non Employee Members Of Scientific Advisory Board [Member] Individuals employed by the entity, and non-employee members of the Scientific Advisory Board. Schedule of Revenues from External Customers and Long-Lived Assets [Table] Estimated settlement amounts due (refunds) from withholding taxes Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Royalty expense Royalty and license expense Royalty Expense Significant Components of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts Receivable Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Cumulative Effect, Period of Adoption Cumulative Effect, Period of Adoption [Domain] Customer Customer [Axis] Research and development expense incurred Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Common Stock [Member] Common Stock [Member] Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other current assets Other Assets, Current Corporate Bond Securities [Member] Corporate Bond Securities [Member] Corporate Bonds [Member] Building [Member] Building [Member] Plan amendment cost, net of tax of none, none and $79, respectively Other Comprehensive Income Plan Amendment Cost Net Of Tax Other comprehensive income plan amendment cost net of tax. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding License fee agreement, term of agreement License fee agreement, term of agreement. License Fee Agreement Term Of Agreement Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Number of convertible note investments Number Of Convertible Note Investments Number Of Convertible Note Investments Earnings allocated to unvested shareholders Participating Securities, Distributed and Undistributed Earnings (Loss), Basic Treasury stock, at cost (1,365,648 shares at December 31, 2023 and December 31, 2022) Treasury Stock, Value, Ending Balance Treasury Stock, Value, Beginning Balance Treasury Stock, Value, Total Treasury Stock, Value Cover [Abstract] Selling, General and Administrative Expense, Total Selling, general and administrative Selling, General and Administrative Expense Long-Term Purchase Commitment, Category of Item Purchased [Domain] Vesting Vesting [Axis] Current income tax (expense) benefit: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Redetermination of foreign tax credit utilization Redetermination of foreign tax credit utilization Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent ACCUMULATED OTHER COMPREHENSIVE LOSS Comprehensive Income (Loss) Note [Text Block] Income Taxes Paid, Net, Total Cash paid for income tax Income Taxes Paid, Net Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Preferred Stock [Member] Preferred Stock [Member] 2028 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Share-Based Payment Awards Share-Based Payment Arrangement [Policy Text Block] Weighted average grant-date fair value of RSU awards granted (in dollars per share) Weighted-Average Grant-Date Fair Value, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Patents [Member] Patents [Member] Security Exchange Name Security Exchange Name Long-term U.S. Government bonds Long-term Investments, Total INVESTMENTS Long-Term Investments Gross Carrying Amount Other intangible assets Other Finite-Lived Intangible Assets, Gross Trade Accounts Receivable Accounts Receivable [Policy Text Block] Schedule of Cash, Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Revenues by Geographic Area Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Preferred Stock, Shares Issued, Total Preferred Stock, shares issued (in shares) Preferred Stock, Shares Issued Preferred Stock, shares authorized ( in shares) Preferred Stock, Shares Authorized Customer Relationships [Member] Customer Relationships [Member] Long-term Investments [Member] Other Long-Term Investments [Member] Schedule Of Finite Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property and equipment, gross Property, Plant and Equipment, Gross U.S. International Tax (Sub F, GILTI, FDII) Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Schedule Of Deferred Compensation Arrangement With Employees And Non Employees Share Based Payments [Table] Schedule Of Deferred Compensation Arrangement With Employees And Non Employees Share Based Payments [Table] Schedule, table or text reflecting equity-based arrangements (such as stock or unit options and stock or unit awards) with individual employees and non-employees. State Current State and Local Tax Expense (Benefit) Right-of-use assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Industry Sector [Axis] Fair value of shares issued Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued Common shares repurchased (in shares) Treasury stock repurchased shares Treasury Stock, Shares, Acquired Business Acquisition, Acquiree Business Acquisition, Acquiree [Domain] Financial Instrument Financial Instrument [Axis] Maximum shares per purchase date (in shares) Employee Stock Purchase Plan E S P P Maximum Shares On Purchase Date The maximum number of shares that may be purchased on a given purchase date, under the plan. Restricted Stock and Units Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Shares withheld for employee taxes (shares) Stock Issued During Period Shares Share Based Compensation Shares Withheld For Employee Taxes Stock issued during period shares share based compensation shares withheld for employee taxes. Amendment Flag Amendment Flag State and foreign income tax returns subject to examination period maximum (in years) State And Foreign Income Tax Returns Subject To Examination Period Maximum State and foreign income tax returns subject to examination period maximum. Assumptions Used to Determine Benefit Obligation and Net Periodic Pension Cost Defined Benefit Plan, Assumptions [Table Text Block] Total credit carry forwards, Tax Benefit Tax Credit Carryforward, Amount Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Purchase of intangibles Payments to Acquire Intangible Assets Available-for-sale Securities, Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Accounting Standards Update Accounting Standards Update [Domain] Category of Item Purchased Category of Item Purchased [Axis] Balance Balance Unbilled Contracts Receivable Leases [Abstract] Future amortization expense, thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Performance-Based Vesting Requirement [Member] Performance Based Vesting Requirement [Member] Performance-based vesting requirement. Entity File Number Securities Act File Number Percentage of revenue recorded from sales of materials Percentage Of Revenue Recorded From Sale Of Materials Percentage of revenue recorded from sale of materials. Net change in accounts payable and accrued expenses related to purchases of property and equipment Other Significant Non Cash Transaction Increase Decrease In Accounts Payable And Accrued Expenses Related To Purchases Of Property And Equipment Other significant non cash transaction increase decrease in accounts payable and accrued expenses related to purchases of property and equipment. Descripion of Property Available for Operating Lease Descripion of Property Available for Operating Lease Deferred Tax Assets, Gross Deferred Tax Assets, Gross Number of board members elected by class A shareholders Number Of Board Members Elected By Class Shareholders Number of board members elected by class A shareholders. Actuarial gain Actuarial (gain) loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Goodwill and Intangible Assets Disclosure [Abstract] Minimum average closing price of common stock (in dollars per share) Debt Instrument, Convertible, Stock Price Trigger Other Liabilities Other Liabilities, Total Unrealized gain (loss) on available-for-sale securities, net of tax of ($351), none and $65, respectively OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR CASH AND CASH EQUIVALENTS, END OF YEAR Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Other Assets Other Assets, Total Share-Based Payment Arrangement [Abstract] Cash Distribution Cash Distribution [Member] 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year One Increases due to cash received Increases Due To Cash Received Increases due to cash received. Member stands for 2006 Research Agreement. Additional Funding Agreement2006 [Member] 2006 Research Agreement [Member] Motorola [Member] Motorola [Member] Information pertaining to the Motorola acquisition. Research and development agreements Accrued Research And Development Agreement Fees Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development agreements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Estimate of Fair Value Measurement [Member] Estimate of Fair Value Measurement [Member] Other Significant Noncash Transactions [Table] Other Significant Noncash Transactions [Table] Gain Contingency, Nature Gain Contingency, Nature [Domain] Deferred Tax Assets, Valuation Allowance, Total Valuation allowance Deferred Tax Assets, Valuation Allowance Property Subject to or Available for Operating Lease [Domain] Total operating expenses Operating Expenses Revenues and Accounts Receivable From Our Largest Customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Auditor Location Auditor Location Net change in employee benefit plan Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Net change in employee benefit plan Schedule Of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Preferred Stock, par value $0.01 per share, 5,000,000 shares authorized, 200,000 shares of Series A Nonconvertible Preferred Stock issued and outstanding (liquidation value of $7.50 per share or $1,500) Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Decrease (increase) in assets: Increase (Decrease) in Operating Assets [Abstract] Title of Individual Title of Individual [Axis] Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases Summary Of Operating Lease Cost And Supplemental Cash Flow Information Related To Operating Leases Table [Text Block] Summary of operating lease cost and supplemental cash flow information related to operating leases. Factor used to determine prorated benefit Defined Benefit Plans Factor Used To Determine Prorated Benefit The factor used to determine the prorated benefit. Net change Net Increase Decrease In Deferred Revenue Net increase (decrease) in deferred revenue. Minimum period of service (in years) Defined Benefit Plans Minimum Period Of Service The minimum period of service (in years) which a participant must accumulate in order to be eligible to receive a benefit. Restricted stock awards and units and performance units Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends Adesis, Inc. [Member] Adesis Inc [Member] Adesis Inc. Contract research services Contract Research Services [Member] Contract research services. Shares withheld for employee taxes (in shares) Shares withheld for tax withholding obligations (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Certificates of Deposit [Member] Certificates of Deposit [Member] Installment period (in years) Defined Benefit Plans Installment Period The installment period (in years) over which the benefit is payable, beginning at the later of age 65 or the date of the participant's separation from service. NET INCOME PER COMMON SHARE Earnings Per Share [Text Block] Trade Name/Trademarks [Member] Trademarks and Trade Names [Member] Accrued PPG Agreements Accrued PPG agreements. PPG Industries, Inc. agreement Entity Address, Address Line One Entity Address, Address Line One Total Revenue [Member] Revenue Benchmark [Member] Maximum value per calendar year, per employee Employee Stock Purchase Plan E S P P Maximum Value Per Calendar Year The maximum value of shares that may be purchased by a single employee during a given calendar year, under the plan. Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Cash and Cash Equivalents, Fair Value Disclosure Research and development arrangement, extension term. Research And Development Arrangement Extension Term Research agreement, extension term (in years) BASF [Member] B A S F S E [Member] BASF SE. Other Liabilities, Current, Total Other current liabilities Other Liabilities, Current Other assets Other Assets Disclosure [Text Block] Finite-Lived Intangible Assets, Gross, Total Acquired technology, gross Finite-Lived Intangible Assets, Gross Royalty rate for licensed products sold by the Company's sublicenses (in hundredths) Research And Development Arrangement Royalty Rate For Licensed Products Sold By Companys Sublicenses The royalty rate of revenues received by the Company for licensed products sold by the Company's sublicenses, under the specified arrangement. Schedule of Other Intangible Assets Schedule Of Other Finite Lived Intangible Assets Table [Text Block] Schedule of other finite lived intangible assets. Tax Loss and Tax Credit Carryforwards Summary Of Operating Loss And Tax Credit Carryforwards Table [Text Block] Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, and tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates and the related deferred tax assets. Subsequent Event Type Subsequent Event Type [Domain] Income Statement Location Income Statement Location [Axis] Short-term U.S. Government bonds Short-term contract assets Other Short-Term Investments Cash Equivalents, Gross Unrealized Losses Cash Equivalents Gross Unrealized Losses Cash Equivalents, Gross Unrealized Losses Issuance of common stock to Board of Directors and Scientific Advisory Board Issuance Of Common Stock To Board Of Directors And Scientific Advisory Board Value Equity impact of the value of new stock issued during the period to the Board of Directors and Scientific Advisory Board. Amortization of premium and discount on investments, net Amortization of Debt Discount (Premium) Deferred tax liability: Deferred Tax Liabilities, Net [Abstract] Deferred revenue Deferred Tax Assets, Deferred Income 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Major Customer B [Member] Major Customer B [Member] Single non-government external Customer B that accounts for 10 percent or more of the entity's revenues. Product and Service Product and Service [Axis] Common shares repurchased Treasury stock aggregate purchase price value Treasury Stock, Value, Acquired, Cost Method Title of 12(b) Security Title of 12(b) Security Less: Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Less: Accumulated amortization Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture, Total Issuance of common stock to employees Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Industry Sector [Domain] Schedule of Acquired Technology Schedule of Finite-Lived Intangible Assets [Table Text Block] Accounting Standards Update Accounting Standards Update [Axis] Quarterly Financial Information Disclosure [Abstract] Treasury Stock, Common [Member] Incremental Performance Based [Member] Incremental Performance Based [Member] Incremental Performance Based Member. Purchase commitments for inventory Purchase Commitment, Remaining Minimum Amount Committed CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary of significant accounting policies. Reported Value Measurement [Member] Reported Value Measurement [Member] U.S.Federal Government [Member] State [Member] State and Local Jurisdiction [Member] Adoption of Topic 606 on January 1, 2018 Cumulative Effect Of New Accounting Principle In Period Of Adoption For Deferred Revenue Cumulative effect of new accounting principle in period of adoption for deferred revenue. Commitment With Senior Level Employees [Member] Commitment With Senior Level Employees [Member] Commitment with senior level employees. Goodwill impairment loss Goodwill, Impairment Loss Portion at Fair Value Measurement [Member] [Default] Fair Value Disclosure Item Amounts [Default] Portion at Fair Value Measurement [Member] Concentration Risk [Table] Concentration Risk [Table] Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Number of patents acquired (more than) Number Of Patents Acquired Number of patents acquired. Common stock dividends declared per share CASH DIVIDEND DECLARED PER COMMON SHARE Common Stock, Dividends, Per Share, Declared Preferred Stock, liquidation value per share (in dollars per share) Preferred Stock, Liquidation Preference Per Share Total long-lived assets Long-Lived Assets Actuarial gain on retirement plan, net of tax of ($2,168), ($1,667) and ($1,336), respectively Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax Cash and Cash Equivalents Cash and Cash Equivalents [Axis] Current liability Liability, Defined Benefit Plan, Current Other Significant Noncash Transaction Other Significant Noncash Transaction [Axis] Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common Stock, shares outstanding (in shares) Common Stock, Shares, Outstanding STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Royalties Accrued Royalties, Current Supplier Concentration Risk [Member] Supplier Concentration Risk [Member] Stock-based compensation to Board of Directors and Scientific Advisory Board Stock Based Compensation To Board Of Directors And Scientific Advisory Board The fair value of restricted stock or stock options granted to the Board of Directors and Scientific Advisory Board as payment for services rendered or acknowledged claims. Supplemental Cash Flow Elements [Abstract] Retirement Plan Type Retirement Plan Type [Axis] Tax Credit Carryforward Tax Credit Carryforward [Axis] Schedule of other liabilities Other Liabilities [Table Text Block] Concentration Risk Type Concentration Risk Type [Domain] EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS Commitments Disclosure [Text Block] Income Statement Location Income Statement Location [Domain] 1997 Amended License Agreement [Member] License Agreement Terms [Member] Benefit percentage, tier two (in hundredths) Defined Benefit Plans Benefit Percentage Tier Two The second level of percentage of the participant's annual base salary for the life of the participant, on which the benefit is based, depending on the participant's benefit class. Document Type Document Type Weighted-Average Grant-Date Fair Value, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share Amortization of prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Other Other Deferred Tax Liabilities, Other Finite-Lived Assets Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Equity Compensation Plan [Member] Share-Based Payment Arrangement [Member] Components of Net Periodic Pension Cost Schedule of Net Benefit Costs [Table Text Block] Benefit Payments Employee Benefits and Share-Based Compensation GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Long-term Purchase Commitment [Line Items] Long-Term Purchase Commitment [Line Items] Adjusted net income Net Income (Loss) Available to Common Stockholders, Basic Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Other Asset Schedule of Other Assets [Table Text Block] Other long-term liabilities Other Long-Term Debt, Noncurrent Short-term Investments [Member] Short-Term Investments [Member] Entity Filer Category Entity Filer Category Office, Lab Equipment and Furniture and Fixtures [Member] Office Lab Equipment And Furniture And Fixtures [Member] Office equipment includes long lived, depreciable assets not directly used in the production process for inventories or facilities. Lab equipment includes tangible personal property, non-consumable in nature, with finite lives used to produce goods and services. Furniture and fixtures include long lived, depreciable assets, commonly used in offices and stores. Other than Temporary Impairment Losses, Investments Impairment of minority investments Patent Costs Patent Costs Policy Policy [Text Block] Disclosure of accounting policy for patent costs. Balance Sheet Location Balance Sheet Location [Domain] Other assets Increase (Decrease) in Other Noncurrent Assets Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Change in cumulative foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Components of Income (Loss) before Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Inventory Increase (Decrease) in Finished Goods and Work in Process Inventories Short-term Corporate bonds Short-term investments Short-term Investments, Total Short-Term Investments Proceeds from sale and maturity of investments Proceeds from Sale of Short-Term Investments Other Significant Noncash Transaction, Name Other Significant Noncash Transaction, Name [Domain] Retirement plan expense, net of benefit payments Pension and Other Postretirement Benefits Cost (Reversal of Cost), Total Pension and Other Postretirement Benefits Cost (Reversal of Cost) Patent Technology [Member] Patented Technology [Member] 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Deferred Revenue (Increase) Decrease Increase (Decrease) in Deferred Liabilities [Abstract] Unbilled Receivables Noncurrent Unbilled receivables noncurrent. Long-term contract assets Interest and other income, net Nonoperating Income (Expense) Minimum period of service for prorated benefit (in years) Defined Benefit Plans Minimum Period Of Service For Prorated Benefit The minimum period of service (in years) which a participant must accumulate in order to be eligible to receive a prorated benefit. Deferred Tax Assets, Tax Credit Carryforwards, Total Tax credit carry forwards Deferred Tax Assets, Tax Credit Carryforwards Total liabilities Liabilities Effect of foreign operations Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Purchases of investments Payments to Acquire Short-Term Investments OLED patents useful life Finite-Lived Intangible Asset, Useful Life Accumulated Other Comprehensive Income Loss [Table] Accumulated Other Comprehensive Income (Loss) [Table] Commitment With Executive Officers [Member] Commitment With Executive Officers [Member] Commitments with executive officers of the Company which provide for certain cash and other benefits upon termination of employment of the officer in connection with a change in control of the Company. Total shareholders’ equity BALANCE BALANCE Equity, Attributable to Parent Amortization period of acquired intangible assets (in years) Weighted average useful life , intangible assets Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Merck KGaA[Member] Merck KGaA[Member] Dividend payable date Dividends Payable, Date to be Paid Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary of significant accounting policies. Net income NET INCOME NET INCOME Net Income (Loss) Plan amendment Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Schedule Of Research And Development Arrangement Contract To Perform For Others [Table] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Minority investment, carrying value Minority Investment Carrying Value Minority investment carrying value. Cash and Cash Equivalents Cash and Cash Equivalents [Domain] State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Statement of Financial Position [Abstract] Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total Issuance of common stock to employees (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Weighted average common shares outstanding – Diluted DILUTED Weighted Average Number of Shares Outstanding, Diluted Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Increase (decrease) in liabilities: Increase (Decrease) in Operating Liabilities [Abstract] Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Cash Equivalents, Gross Unrealized Gains Cash Equivalents Gross Unrealized Gain Cash Equivalents, Gross Unrealized Gain Effective tax rate Effective Income Tax Rate Reconciliation, Percent Federal Deferred Federal Income Tax Expense (Benefit) Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total Accruals and reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Available-for-sale Debt Securities, Amortized Cost Basis Debt Securities, Available-for-Sale, Amortized Cost Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Total net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Maximum contribution percentage (in hundredths) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Management's Use of Estimates Use of Estimates, Policy [Policy Text Block] INCOME TAXES Income Tax Disclosure [Text Block] Deferred tax asset: Deferred Tax Assets, Net [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Schedule of Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Disaggregation Of Revenue [Line Items] Disaggregation of Revenue [Line Items] Income Tax Authority Income Tax Authority [Axis] Fair Value Disclosures [Abstract] Current Income Tax Expense (Benefit), Total Current income tax benefit (expense) Current Income Tax Expense (Benefit) Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Measurement Frequency Measurement Frequency [Domain] Royalty rate for licensed products sold by the Company (in hundredths) Research And Development Arrangement Royalty Rate For Licensed Products Sold By Company The royalty rate of net sales price for licensed products sold by the Company, under the specified arrangement. Increase in property and equipment Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Reclassification of Prior Year Presentation Reclassification, Comparability Adjustment [Policy Text Block] Number of Shares, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Business Acquisition Business Acquisition [Axis] Income Taxes [Table] Income Taxes [Table] Income taxes. Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Ending Balance Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Beginning Balance Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Deferred Revenue, Current, Total Short-term deferred revenue Deferred revenue Deferred Revenue, Current Income Tax Disclosure [Abstract] Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Finite-Lived Intangible Assets by Major Class Finite-Lived Intangible Assets by Major Class [Axis] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Common stock equivalents arising from stock options and ESPP Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Unfunded status of the plan, end of year Unfunded status of the plan, end of year Defined Benefit Plan, Funded (Unfunded) Status of Plan XML 15 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Feb. 22, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Trading Symbol OLED    
Entity Registrant Name UNIVERSAL DISPLAY CORPORATION    
Document Financial Statement Error Correction [Flag] false    
Entity Central Index Key 0001005284    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Large Accelerated Filer    
Entity Shell Company false    
Title of 12(b) Security Common Stock, $0.01 par value    
Security Exchange Name NASDAQ    
Entity Incorporation, State or Country Code PA    
Entity Interactive Data Current Yes    
Entity Small Business false    
Entity Emerging Growth Company false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 1-12031    
Entity Tax Identification Number 23-2372688    
Entity Address, Address Line One 250 Phillips Boulevard    
Entity Address, City or Town Ewing    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 08618    
City Area Code 609    
Local Phone Number 671-0980    
Entity Common Stock, Shares Outstanding   47,365,600  
Entity Public Float     $ 320,500,461
ICFR Auditor Attestation Flag true    
Documents Incorporated by Reference

Portions of the registrant’s Proxy Statement for the 2024 Annual Meeting of Shareholders, which is to be filed with the Securities and Exchange Commission no later than April 29, 2024 (the first business day after the 120th day following the end of the registrant's fiscal year), are incorporated by reference into Part III of this report.

    
Auditor Firm ID 185    
Auditor Name KPMG, LLP    
Auditor Location Philadelphia, PA, USA    

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash and cash equivalents $ 91,985 $ 93,430
Short-term investments 422,137 484,345
Accounts receivable 139,850 92,664
Inventory 175,795 183,220
Other current assets 87,365 45,791
Total current assets 917,132 899,450
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $143,908 and $117,118 175,150 143,445
ACQUIRED TECHNOLOGY, net of accumulated amortization of $186,850 and $189,671 90,325 [1] 38,382
OTHER INTANGIBLE ASSETS, net of accumulated amortization of $10,414 and $8,989 6,874 8,247
GOODWILL 15,535 15,535
INVESTMENTS 299,548 259,861
DEFERRED INCOME TAXES 59,108 58,161
OTHER ASSETS 105,289 109,739
TOTAL ASSETS 1,668,961 1,532,820
CURRENT LIABILITIES:    
Accounts payable 10,933 9,519
Accrued expenses 52,080 51,002
Deferred revenue 47,713 45,599
Other current liabilities 8,096 29,577
Total current liabilities 118,822 135,697
DEFERRED REVENUE 12,006 18,279
RETIREMENT PLAN BENEFIT LIABILITY 52,249 59,790
OTHER LIABILITIES 38,658 43,685
Total liabilities 221,735 257,451
COMMITMENTS AND CONTINGENCIES (Note 18)
SHAREHOLDERS' EQUITY:    
Preferred Stock, par value $0.01 per share, 5,000,000 shares authorized, 200,000 shares of Series A Nonconvertible Preferred Stock issued and outstanding (liquidation value of $7.50 per share or $1,500) 2 2
Common Stock, par value $0.01 per share, 200,000,000 shares authorized, 48,731,026and 49,136,030 shares issued, and 47,365,378 and 47,770,382 share outstanding at December 31, 2023 and December 31, 2022, respectively 487 491
Additional paid-in capital 699,554 681,335
Retained earnings 789,553 653,277
Accumulated other comprehensive loss (1,086) (18,452)
Treasury stock, at cost (1,365,648 shares at December 31, 2023 and December 31, 2022) (41,284) (41,284)
Total shareholders’ equity 1,447,226 1,275,369
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,668,961 $ 1,532,820
[1] During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $ 143,908 $ 117,118
Finite-Lived Intangible Assets, Accumulated Amortization 186,850 [1] 189,671
Other Finite-Lived Intangible Assets, Accumulated Amortization $ 10,414 $ 8,989
SHAREHOLDERS' EQUITY:    
Preferred Stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred Stock, shares authorized ( in shares) 5,000,000 5,000,000
Common Stock, par value (in dollars per share) $ 0.01 $ 0.01
Common Stock, shares authorized (in shares) 200,000,000 200,000,000
Common Stock, shares issued (in shares) 48,731,026 49,136,030
Common Stock, shares outstanding (in shares) 47,365,378 47,770,382
Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]    
Treasury Stock, Common, Shares 1,365,648 1,365,648
Treasury Stock, Preferred, Shares 1,365,648 1,365,648
Series A Nonconvertible Preferred Stock [Member]    
Shareholders' Equity A Nonconvertible Preferred Stock    
Preferred Stock, shares issued (in shares) 200,000 200,000
Preferred Stock, shares outstanding (in shares) 200,000 200,000
Preferred Stock, liquidation value per share (in dollars per share) $ 7.5 $ 7.5
Preferred Stock, liquidation value $ 1,500 $ 1,500
[1] During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
REVENUE:      
Total revenue $ 576,429 $ 616,619 $ 553,525
COST OF SALES 135,376 127,896 114,991
Gross margin 441,053 488,723 438,534
OPERATING EXPENSES:      
Research and development 130,481 117,062 99,673
Selling, general and administrative 67,387 77,886 80,372
Amortization of acquired technology and other intangible assets 15,993 17,459 21,994
Patent costs 9,356 8,329 8,160
Royalty and license expense 647 877 691
Total operating expenses 223,864 221,613 210,890
OPERATING INCOME 217,189 267,110 227,644
Interest income, net 28,166 7,811 505
Other (loss) income, net (184) (6,691) 98
Interest and other income, net 27,982 1,120 603
Income before income taxes 245,171 268,230 228,247
INCOME TAX EXPENSE (42,160) (58,169) (44,034)
NET INCOME $ 203,011 $ 210,061 $ 184,213
NET INCOME PER COMMON SHARE:      
BASIC $ 4.25 $ 4.41 $ 3.87
DILUTED $ 4.24 $ 4.4 $ 3.87
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME PER COMMON SHARE:      
BASIC 47,559,669 47,390,352 47,296,447
DILUTED 47,622,763 47,468,507 47,365,435
CASH DIVIDEND DECLARED PER COMMON SHARE $ 1.4 $ 1.2 $ 0.8
Material sales      
REVENUE:      
Total revenue $ 322,029 $ 331,081 $ 318,623
Royalty and license fees      
REVENUE:      
Total revenue 238,389 267,115 219,032
Contract research services      
REVENUE:      
Total revenue $ 16,011 $ 18,423 $ 15,870
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Comprehensive Income [Abstract]      
NET INCOME $ 203,011 $ 210,061 $ 184,213
OTHER COMPREHENSIVEINCOME (LOSS), NET OF TAX:      
Unrealized gain (loss) on available-for-sale securities, net of tax of ($351), none and $65, respectively 8,745 (7,745) (233)
Employee benefit plan:      
Actuarial gain on retirement plan, net of tax of ($2,168), ($1,667) and ($1,336), respectively 7,207 5,971 13,620
Plan amendment cost, net of tax of none, none and $79, respectively 0 0 (283)
Amortization of prior service cost and actuarial loss for retirement plan included in net periodic pension costs net of tax of ($299), ($569) and ($1,316), respectively 996 2,037 4,719
Net change in employee benefit plan 8,203 8,008 18,056
Change in cumulative foreign currency translation adjustment 418 (480) (39)
TOTAL OTHER COMPREHENSIVE INCOME (LOSS) 17,366 (217) 17,784
COMPREHENSIVE INCOME $ 220,377 $ 209,844 $ 201,997
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Comprehensive Income [Abstract]      
Unrealized gain (loss) on available-for-sale securities, tax $ (351) $ 0 $ 65
Actuarial gain on retirement plan, tax (2,168) (1,667) (1,336)
Plan amendment cost 0 0 79
Amortization of prior service cost and actuarial loss for retirement plan included in net periodic pension costs, tax $ (299) $ (569) $ (1,316)
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Treasury Stock, Common [Member]
Series A Nonconvertible Preferred Stock [Member]
Preferred Stock [Member]
BALANCE at Dec. 31, 2020 $ 912,714 $ 490 $ 635,595 $ 353,930 $ (36,019) $ (41,284) $ 2
BALANCE (in shares) at Dec. 31, 2020   49,013,476       1,365,648 200,000
Net income 184,213     184,213      
Other comprehensive income (loss) 17,784       17,784    
Cash dividend (37,931)     (37,931)      
Issuance of common stock to employees 34,472 $ 1 34,471        
Issuance of common stock to employees (in shares)   63,969          
Shares withheld for employee taxes (14,949)   (14,949)        
Shares withheld for employee taxes (in shares)   (29,179)          
Issuance of common stock to Board of Directors and Scientific Advisory Board 1,704   1,704        
Issuance of common stock to Board of Directors and Scientific Advisory Board (in shares)   8,502          
Issuance of common stock to employees under an ESPP 1,907   1,907        
Issuance of common stock to employees under an ESPP (in shares)   9,156          
BALANCE at Dec. 31, 2021 1,099,914 $ 491 658,728 500,212 (18,235) $ (41,284) $ 2
BALANCE (in shares) at Dec. 31, 2021   49,065,924       1,365,648 200,000
Net income 210,061     210,061      
Other comprehensive income (loss) (217)       (217)    
Cash dividend (56,996)     (56,996)      
Issuance of common stock to employees 27,907   27,907        
Issuance of common stock to employees (in shares)   72,769          
Shares withheld for employee taxes $ (9,209)   (9,209)        
Shares withheld for employee taxes (in shares)   (31,938)          
Common shares repurchased (in shares) 0            
Issuance of common stock to Board of Directors and Scientific Advisory Board $ 1,866   1,866        
Issuance of common stock to Board of Directors and Scientific Advisory Board (in shares)   12,218          
Issuance of common stock to employees under an ESPP 2,043   2,043        
Issuance of common stock to employees under an ESPP (in shares)   17,057          
BALANCE at Dec. 31, 2022 1,275,369 $ 491 681,335 653,277 (18,452) $ (41,284) $ 2
BALANCE (in shares) at Dec. 31, 2022   49,136,030       1,365,648 200,000
Net income 203,011     203,011      
Other comprehensive income (loss) 17,366       17,366    
Cash dividend (66,735)     (66,735)      
Issuance of common stock to employees 21,793 $ 1 21,792        
Issuance of common stock to employees (in shares)   145,428          
Shares withheld for employee taxes $ (8,206) $ 0 (8,206)        
Shares withheld for employee taxes (in shares)   (58,512)          
Common shares repurchased (in shares) 0            
Issuance of common stock to Board of Directors and Scientific Advisory Board $ 2,074   2,074        
Issuance of common stock to Board of Directors and Scientific Advisory Board (in shares)   16,808          
Issuance of common stock to employees under an ESPP 2,554   2,554        
Issuance of common stock to employees under an ESPP (in shares)   17,513          
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited   (526,241)          
Stock Issued During Period, Value, Restricted Stock Award, Forfeitures 0 $ (5) 5        
BALANCE at Dec. 31, 2023 $ 1,447,226 $ 487 $ 699,554 $ 789,553 $ (1,086) $ (41,284) $ 2
BALANCE (in shares) at Dec. 31, 2023   48,731,026       1,365,648 200,000
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income $ 203,011 $ 210,061 $ 184,213
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 27,409 24,815 19,968
Amortization of intangibles 15,993 17,459 21,994
Amortization of premium and discount on investments, net (11,603) (6,461) (373)
Impairment of minority investments 0 6,962 0
Stock-based compensation to employees 22,335 28,380 34,871
Stock-based compensation to Board of Directors and Scientific Advisory Board 1,774 1,566 1,404
Deferred income tax (benefit) expense (3,766) (26,946) 1,748
Retirement plan expense, net of benefit payments 3,129 5,276 8,875
Decrease (increase) in assets:      
Accounts receivable (47,186) 14,975 (25,378)
Inventory 7,425 (49,060) (42,569)
Other current assets (41,574) (24,843) (202)
Other assets 4,450 25,971 (32,369)
Increase (decrease) in liabilities:      
Accounts payable and accrued expenses 4,047 3,338 1,902
Other current liabilities (21,481) 20,917 2,105
Deferred revenue (4,159) (93,203) (5,220)
Other liabilities (5,027) (32,392) 20,136
Net cash provided by operating activities 154,777 126,815 191,105
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of property and equipment (59,792) (42,497) (43,161)
Purchase of intangibles (66,563) (4,709) (394)
Purchases of investments (531,103) (701,993) (642,180)
Proceeds from sale and maturity of investments 574,165 468,456 227,984
Net cash used in investing activities (83,293) (280,743) (457,751)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from issuance of common stock 2,012 1,570 1,507
Payment of withholding taxes related to stock-based compensation to employees (8,206) (9,209) (14,949)
Cash dividends paid (66,735) (56,996) (37,931)
Net cash used in financing activities (72,929) (64,635) (51,373)
DECREASE IN CASH AND CASH EQUIVALENTS (1,445) (218,563) (318,019)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 93,430 311,993 630,012
CASH AND CASH EQUIVALENTS, END OF YEAR $ 91,985 $ 93,430 $ 311,993
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS Non-Cash Activities - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Other Significant Noncash Transactions [Line Items]      
Unrealized (loss) gain on available-for-sale securities $ (8,938) $ (8,100) $ (295)
Net change in accounts payable and accrued expenses related to purchases of property and equipment 678 3,069 (3,526)
Cash paid for income tax 96,176 72,347 52,650
Common Stock Issued to Board of Directors and Scientific Advisory Board that was Earned and Accrued for in Previous Period [Member]      
Other Significant Noncash Transactions [Line Items]      
Other significant noncash transaction, value of consideration received $ 300 $ 300 $ 300
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BUSINESS
1.
BUSINESS:

Universal Display Corporation and its subsidiaries (the Company) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light and can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and as lighting products. OLED displays are capturing a growing share of the display market, especially in the mobile phone, television, monitor, wearable, tablet, notebook and personal computer, augmented reality (AR), virtual reality (VR) and automotive markets. The Company believes this is because OLEDs offer potential advantages over competing display technologies with respect to power efficiency, contrast ratio, viewing angle, video response time, form factor and manufacturing cost. The Company also believes that OLED lighting products have the potential to replace many existing light sources in the future because of their high-power efficiency, excellent color rendering index, low operating temperature and novel form factor. The Company’s technology leadership, intellectual property position, and more than 20 years of experience working closely with leading OLED display manufacturers are some of the competitive advantages that should enable the Company to continue to share in the revenues from OLED displays and lighting products as they gain wider acceptance.

The Company’s primary business strategy is to (1) develop new OLED materials and sell existing and new materials to product manufacturers of products for display applications, such as mobile phones, televisions, monitors, wearables, tablets, portable media devices, notebook computers, personal computers and automotive applications, and specialty and general lighting products; and (2) further develop and either license or otherwise commercialize the Company’s proprietary OLED material, device design and manufacturing technologies to those manufacturers. The Company has established a significant portfolio of proprietary OLED technologies and materials, primarily through internal research and development efforts and acquisitions of patents and patent applications, as well as maintaining long-standing, and establishing new relationships with world-class universities, research institutions and strategic manufacturing partnerships. The Company currently owns, exclusively licenses or has the sole right to sublicense more than 6,000 patents issued and pending worldwide.

The Company manufactures and sells its proprietary OLED materials to customers for evaluation and use in commercial OLED products. The Company also enters into agreements with manufacturers of OLED display and lighting products under which it grants them licenses to practice under the Company’s patents and to use the Company's proprietary know-how. At the same time, the Company works with these and other companies that are evaluating the Company's OLED material, device design and manufacturing technologies for possible use in commercial OLED display and lighting products.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

Principles of Consolidation

The Consolidated Financial Statements include the accounts of Universal Display Corporation and its wholly owned subsidiaries, UDC, Inc., UDC Ireland Limited (UDC Ireland), Universal Display Corporation Hong Kong, Limited, Universal Display Corporation Korea, Y.H. (UDC Korea), Universal Display Corporation Japan GK, Universal Display Corporation China, Ltd., Adesis, Inc. (Adesis), UDC Ventures LLC, OVJP Corporation (OVJP Corp) and OLED Material Manufacturing Limited (OMM). All intercompany transactions and accounts have been eliminated.

Reclassification of Prior Year Presentation

Certain prior year adjustments to reconcile net income to net cash provided by operating activities have been reclassified on the Consolidated Statements of Cash Flows to conform to the current year presentation. These adjustments have been consolidated into their respective operating assets and liabilities accounts, specifically, inventory, other current assets, other assets and deferred revenue.

Management’s Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The estimates made are principally in the areas of revenue recognition including estimates of material unit sales and royalties, the useful life of acquired intangibles, lease liabilities, right-of-use assets, the use and recoverability of inventories, intangibles, investments and income taxes including realization of deferred tax assets, stock-based compensation and retirement benefit plan liabilities. Actual results could differ from those estimates.

Cash, Cash Equivalents and Investments

The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of three months or less to be cash equivalents. The Company classifies its remaining investments as available-for-sale. These securities (excluding minority equity investments) are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.

Trade Accounts Receivable

Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. The Company’s accounts receivable balance is a result of chemical sales, royalties and license fees. These receivables have historically been paid timely. Due to the nature of the accounts receivable balance, the Company believes there is no significant collection risk. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their ability to make payments, allowances for credit losses would be required. As of December 31, 2023 and 2022, the allowance for credit losses was $166,000 and $279,000, respectively.

Inventories

Inventories consist of raw materials, work-in-process and finished goods, and are stated at the lower of cost, determined on a first-in, first-out basis, or net realizable value. Inventory valuation and firm committed purchase order assessments are performed on a quarterly basis and those items that are identified to be obsolete or in excess of forecasted usage are written down to their estimated realizable value. Estimates of realizable value are based upon management’s analyses and assumptions, including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. A 12-month rolling forecast based on factors, including, but not limited to, production cycles, anticipated product orders, marketing forecasts, backlog, and shipment activities is used in the inventory analysis. If market conditions are less favorable than forecasts or actual demand from customers is lower than estimates, additional inventory write-downs may be required. If demand is higher than expected, inventories that had previously been written down may be sold.

Property and Equipment

Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful life of 30 years for buildings, 15 years for building improvements, and three to seven years for office and lab equipment and furniture and fixtures. Repair and maintenance costs are charged to expense as incurred. Additions and betterments are capitalized.

Major renewals and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to current operations as incurred. Upon retirement or disposal of assets, the cost and related accumulated depreciation are removed from the Consolidated Balance Sheets and any gain or loss is reflected in other operating expenses.

Certain costs of computer software obtained for internal use are capitalized and amortized on a straight-line basis over three years. Costs for maintenance and training, as well as the cost of software that does not add functionality to an existing system, are expensed as incurred.

Impairment of Long-Lived Assets

Company management continually evaluates whether events or changes in circumstances might indicate that the remaining estimated useful life of long-lived assets may warrant revision, or that the remaining balance may not be recoverable. When factors indicate that long-lived assets should be evaluated for possible impairment, the Company uses an estimate of the related undiscounted cash flows in measuring whether the long-lived asset should be written down to fair value. Measurement of the amount of impairment would be based on generally accepted valuation methodologies, as deemed appropriate. As of December 31, 2023, Company management believed that no revision to the remaining useful lives or write-down of the Company’s long-lived assets was required, and similarly, no such revisions were required for the years ended December 31, 2022 or 2021.

Goodwill and Purchased Intangible Assets

Goodwill is tested for impairment in the fourth fiscal quarter and, when specific circumstances dictate, between annual tests. If after assessing the totality of events or circumstances as those described in the qualitative assessment, it is determined that it is more likely than not the fair value of a reporting unit is less than its carrying amount, then a quantitative goodwill impairment test will be performed. Under the quantitative test, the fair value of the reporting unit is compared to its carrying amount including goodwill. If the

fair value of the reporting unit exceeds its carrying amount, goodwill of the reporting unit would be considered not impaired. However, if the carrying amount of the reporting unit exceeds its fair value, an impairment loss would be recognized in the amount equal to the excess, limited to the total amount of goodwill allocated to that reporting unit. The Company performed its annual impairment assessment as of December 31, 2023 utilizing a qualitative assessment and concluded that it was more likely than not that the fair value of Adesis is greater than its carrying value. Future impairment tests will continue to be performed annually in the fiscal fourth quarter, or sooner if a triggering event occurs. As of December 31, 2023, no indications of impairment existed.

Purchased intangible assets with finite lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets.

Fair Value of Financial Instruments

The carrying values of accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value in the accompanying Consolidated Financial Statements due to the short-term nature of those instruments. The Company’s other financial instruments, which include cash equivalents and investments (excluding minority equity investments) are carried at fair value.

Fair Value Measurements

Fair value is defined as an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. The Company uses valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. Observable inputs are inputs that market participants would use in pricing the asset or liability and are based on market data obtained from sources independent of the Company. Unobservable inputs reflect assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.

Minority Equity Investments

The Company accounts for minority equity investments in companies that are not accounted for under the equity method as equity securities without readily determinable fair values. The value of these securities is based on original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment in the same issuer. Under this method, the share of income or loss of such companies is not included in the Consolidated Statements of Income. The carrying value of these investments is included in investments on the Consolidated Balance Sheets.

The Company’s policy is to recognize an impairment in the value of its minority equity investments when evidence of an impairment exists. Factors considered in the assessment include a significant adverse change in the regulatory, economic, or technological environment, the completion of new equity financing that may indicate a decrease in value, the failure to complete new equity financing arrangements after seeking to raise additional funds, or the commencement of proceedings under which the assets of the business may be placed in receivership or liquidated to satisfy the claims of debt and equity stakeholders. The impairment in the value of minority equity investments is included in the other (loss) income, net line item on the Consolidated Statements of Income.

Leases

The Company is a lessee in operating leases primarily incurred to facilitate manufacturing, research and development, and selling, general and administrative activities. At contract inception, the Company determines if an arrangement is or contains a lease, and if so recognizes a right-of-use asset and lease liability at the lease commencement date. For operating leases, the lease liability is measured at the present value of the unpaid lease payments at the lease commencement date, whereas for finance leases, the lease liability is initially measured at the present value of the unpaid lease payments and subsequently measured at amortized cost using the interest method. Operating lease right-of-use assets are included in other assets on the Consolidated Balance Sheets. The short-term portion of operating lease liabilities is included in other current liabilities on the Consolidated Balance Sheets and the long-term portion is included in other liabilities on the Consolidated Balance Sheets. As of December 31, 2023, the Company had no leases that qualified as financing arrangements.

Key estimates and judgments include how the Company determines the discount rate used to discount the unpaid lease payments to present value and the lease term. The Company monitors for events or changes in circumstances that could potentially require recognizing an impairment loss.

Revenue Recognition and Deferred Revenue

Material sales relate to the Company’s sale of its OLED materials for incorporation into its customers’ commercial OLED products or for their OLED development and evaluation activities. Revenue associated with material sales is generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties. Revenue may be recognized after control of the material passes in the event the transaction price includes variable consideration. For example, a customer may be provided an extended opportunity to stock materials prior to use in mass production and given a general right of return not conditioned on breaches of warranties associated with the specific product. In such circumstances, revenue will be recognized at the earlier of the expiration of the customer’s general right of return or once it becomes unlikely that the customer will exercise its right of return.

The vast majority of revenue attributed to material sales is determined through technology license agreements and material supply agreements the terms of which are jointly agreed upon with the Company’s customers. The remaining revenue recognized is in the form of contract research services revenue earned by the Company’s subsidiary, Adesis, Inc., and the Company’s occasional material sales to smaller customers. None of the revenue recognized during the years ended December 31, 2023, 2022 or 2021 resulted solely from royalty or license fee arrangements as to which there were not associated material sales.

The rights and benefits to the Company’s OLED technologies are conveyed to the customer through technology license agreements and material supply agreements. The Company believes that the licenses and materials sold under these combined agreements are not distinct from each other for financial reporting purposes and as such, they are accounted for as a single performance obligation. Accordingly, total contract consideration is estimated and recognized over the contract term based on material units sold at the estimated per unit fee over the life of the contract. Total contract consideration is allocated to material sales and royalty and licensing fees on the Consolidated Statements of Income based on contract pricing.

Various estimates are relied upon to recognize revenue. The Company estimates total material units to be purchased by its customers over the contract term based on historical trends, industry estimates and its forecast process. Management uses the expected value method to estimate the material per unit fee. Additionally, management estimates the sales-based portion of royalty revenue based on the estimated net sales revenue of its customers over the contract term.

Contract research services revenue is revenue earned by Adesis by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis. These services range from intermediates for structure-activity relationship studies, reference agents and building blocks for combinatorial synthesis, re-synthesis of key intermediates, specialty organic chemistry needs, and selective toll manufacturing. These services are provided to third-party pharmaceutical and life sciences firms and other technology firms at fixed costs or predetermined rates on a contract basis. Revenue is recognized as services are performed with billing schedules and payment terms negotiated on a contract-by-contract basis. Payments received in excess of revenue recognized are recorded as deferred revenue. In other cases, services may be provided and revenue is recognized before the customer is invoiced. In these cases, revenue recognized will exceed amounts billed and the difference, representing amounts which are currently unbillable to the customer pursuant to contractual terms, is recorded as an unbilled receivable.

Technology development and support revenue is revenue earned from development and technology evaluation agreements and commercialization assistance fees. Technology development and support revenue is included in contract research services on the Consolidated Statements of Income.

On December 2, 2022, the Company entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, the Company is being paid a license fee, which includes quarterly and annual payments over the agreement term of five years. The agreement conveys to SDC the non-exclusive right to use certain of the Company's intellectual property assets for a limited period of time that is less than the estimated life of the assets.

At the same time the Company entered into the current commercial license agreement with SDC, the Company also entered into a new supplemental material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the supplemental material purchase agreement, SDC agrees to purchase red and green phosphorescent emitter materials from the Company for use in the manufacture of licensed products. This amount purchased is subject to SDC’s requirements for phosphorescent emitter materials and the Company’s ability to meet these requirements over the term of the supplemental agreement.

In 2015, the Company entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display), which were effective as of January 1, 2015. The terms of these agreements were extended by a January 1, 2021 amendment through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under the Company's patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The OLED commercial supply agreement provides for the sale of materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the lives of the agreements as well as minimum royalty revenue.

In 2023, the Company entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, the Company has granted BOE non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company supplies phosphorescent OLED materials to BOE for use in its licensed products.

In 2019, the Company entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, the Company entered into long-term, multi-year agreements with CSOT. Under these agreements, the Company has granted CSOT non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company also supplies phosphorescent OLED materials to CSOT for use in its licensed products.

In 2018, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Visionox Technology, Inc. (Visionox). Under the license agreement, the Company granted certain of Visionox’s affiliates non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Visionox for use in its licensed products. In 2021, the Company announced that it had extended the Visionox agreement by entering into new five-year OLED material supply and license agreements with a new affiliate of Visionox, Visionox Hefei Technology Co. Ltd.

In 2016, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Micro-electronics Co., Ltd. (Tianma). Under the license agreement, the Company has granted Tianma non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Tianma for use in its licensed products. In 2021, the parties extended the terms of both the patent license and material purchase agreements for an additional multi-year-term.

All material sales transactions that are not variable consideration transactions are billed and due within 90 days and substantially all are transacted in U.S. dollars.

Cost of Sales

Cost of sales consists of labor and material costs associated with the production of materials processed at the facilities of the Company's manufacturing partner, PPG Industries, Inc. (PPG) and at the Company's internal facilities. The Company’s portion of cost of sales also includes depreciation of manufacturing equipment, as well as manufacturing overhead costs and inventory adjustments for excess and obsolete inventory.

Research and Development

Expenditures for research and development are charged to expense as incurred.

Patent Costs

Costs associated with patent applications, patent prosecution, patent defense and the maintenance of patents are charged to expense as incurred. Costs to successfully defend a challenge to a patent are capitalized to the extent of an evident increase in the value of the patent. Costs that relate to an unsuccessful outcome are charged to expense.

Amortization of Acquired Technology

Amortization costs primarily relate to technology acquired from Merck KGaA, Darmstadt, Germany (Merck KGaA), BASF SE (BASF) and Fujifilm Corporation (Fujifilm). The Merck KGaA acquisition was completed on April 28, 2023. The BASF and Fujifilm acquisitions were completed in the years ended December 31, 2016 and 2012, respectively. Acquisition costs are being amortized over

a period of 10 years for the Merck KGaA and BASF patents. The Fujifilm acquired technology was fully amortized over a period of 10 years that ended in July 2022.

Amortization of Other Intangible Assets

Other intangible assets from the Adesis acquisition are being amortized over a period of 10 to 15 years. See Note 7 for further discussion.

Translation of Foreign Currency Financial Statements and Foreign Currency Transactions

The Company’s reporting currency is the U.S. dollar. The functional currency for the UDC Ireland and UDC Korea subsidiaries are also the U.S. dollar and the functional currency for the OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries is its respective local currency. The Company translates the amounts included in the Consolidated Statements of Income from OMM and its Asia-Pacific foreign subsidiaries into U.S. dollars at weighted-average exchange rates, which the Company believes are representative of the actual exchange rates on the dates of the transactions. The Company's OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries' assets and liabilities are translated into U.S. dollars from the local currency at the actual exchange rates as of the end of each reporting date, and the Company records the resulting foreign exchange translation adjustments in the Consolidated Balance Sheets as a component of accumulated other comprehensive loss. The overall effect of the translation of foreign currency and foreign currency transactions to date has been insignificant.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than 50%. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties, if any, related to unrecognized tax benefits as a component of tax expense.

Share-Based Payment Awards

The Company recognizes in the Consolidated Statements of Income the grant-date fair value of equity-based awards such as shares issued under employee stock purchase plans, restricted stock awards, restricted stock units and performance unit awards issued to employees and directors.

The grant-date fair value of stock awards is based on the closing price of the stock on the date of grant. The fair value of share-based awards is recognized as compensation expense on a straight-line basis over the requisite service period, net of forfeitures. The Company issues new shares upon the respective grant, exercise or vesting of the share-based payment awards, as applicable.

Performance unit awards are subject to either a performance-based or market-based vesting requirement. For performance-based vesting, the grant-date fair value of the award, based on fair value of the Company's common stock, is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved, and compensation expense is periodically adjusted based on actual and expected performance. Compensation expense for performance unit awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.

Recent Accounting Pronouncements

Adoption of New Accounting Standards

In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with FASB ASC 606. The adoption of ASU 2021-08, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.

In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, Liabilities—Supplier Finance Programs (Subtopic 450-50): Disclosure of Supplier Finance Program Obligations, which require disclosures about a buyer's supplier finance program. The adoption of ASU 2022-04, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.

Accounting Standards Issued But Not Yet Adopted

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. Under this standard, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. The standard also requires certain disclosures for equity securities that are subject to contractual restrictions. ASU 2022-03 becomes effective January 1, 2024, and will not have a significant impact on the Consolidated Financial Statements and related disclosures.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard improves the reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 becomes effective January 1, 2024, and the Company is evaluating the potential impact of this standard on the Consolidated Financial Statements and related disclosures.

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The standard enhances to the annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity's worldwide operations. ASU 2023-09 becomes effective January 1, 2025, and the Company is evaluating the potential impact of this standard on its income tax disclosures.
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH, CASH EQUIVALENTS AND INVESTMENTS
 12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
CASH, CASH EQUIVALENTS AND INVESTMENTS
3.
CASH, CASH EQUIVALENTS AND INVESTMENTS:

The Company’s portfolio of marketable fixed income securities consists of U.S. Government bonds and corporate bonds. The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of three months or less to be cash equivalents. The Company classifies its remaining debt security investments as available-for-sale. These debt securities are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.

Cash and Cash Equivalents

The following table provides details regarding the Company’s portfolio of cash and cash equivalents (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Cash and Cash Equivalents Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Cash accounts in banking institutions

 

$

91,717

 

 

$

—

 

 

$

—

 

 

$

91,717

 

Money market accounts

 

 

268

 

 

 

—

 

 

 

—

 

 

 

268

 

 

 

$

91,985

 

 

$

—

 

 

$

—

 

 

$

91,985

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Cash accounts in banking institutions

 

$

86,268

 

 

$

—

 

 

$

—

 

 

$

86,268

 

Money market accounts

 

 

7,162

 

 

 

—

 

 

 

—

 

 

 

7,162

 

 

 

$

93,430

 

 

$

—

 

 

$

—

 

 

$

93,430

 

Short-term Investments

The following table provides details regarding the Company’s portfolio of short-term investments (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Short-term Investments Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

1,763

 

 

$

1

 

 

$

(5

)

 

$

1,759

 

U.S. Government bonds

 

 

420,769

 

 

 

303

 

 

 

(694

)

 

 

420,378

 

 

 

$

422,532

 

 

$

304

 

 

$

(699

)

 

$

422,137

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

150,698

 

 

$

—

 

 

$

(910

)

 

$

149,788

 

U.S. Government bonds

 

 

339,472

 

 

 

32

 

 

 

(4,947

)

 

 

334,557

 

 

 

$

490,170

 

 

$

32

 

 

$

(5,857

)

 

$

484,345

 

 

Long-term Corporate Bond and U.S. Government Bond Investments

The following table provides details regarding the Company’s portfolio of long-term investments (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Long-term Investments Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Government bonds

 

$

284,053

 

 

$

1,457

 

 

$

(8

)

 

$

285,502

 

 

 

$

284,053

 

 

$

1,457

 

 

$

(8

)

 

$

285,502

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

2,479

 

 

$

—

 

 

$

(28

)

 

$

2,451

 

U.S. Government bonds

 

 

247,464

 

 

 

52

 

 

 

(2,152

)

 

$

245,364

 

 

 

$

249,943

 

 

$

52

 

 

$

(2,180

)

 

$

247,815

 

Minority Equity Investments

The Company’s portfolio of minority equity investments consists of investments in privately held early-stage companies primarily motivated for the Company to gain early access to new technology and are passive in nature in that the Company typically does not seek to obtain representation on the boards of directors of the companies in which it invests. Minority equity investments are included in investments on the Consolidated Balance Sheets. As of December 31, 2023, the Company had minority equity investments in five entities with a total carrying value of $14.0 million accounted for as equity securities without readily determinable fair values as compared to four minority equity investments with a total carrying value of $12.0 million as of December 31, 2022.

During the year ended December 31, 2022, the Company recognized an impairment in the value of two of its minority equity investments, an impairment of an equity security investment in the amount of $3.0 million and an impairment of a long-term convertible note investment of $4.0 million which had been acquired during the year ended December 31, 2022. During the year ended December 31, 2023, the Company did not recognize an impairment in the value of its minority equity investments. The impairment in the value of minority equity investments are included in the other (loss) income, net line item on the Consolidated Statements of Income.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
4.
FAIR VALUE MEASUREMENTS:

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2023 (in thousands):

 

 

 

 

 

Fair Value Measurements, Using

 

 

 

Total Carrying Value
as of December 31,
 2023

 

 

Quoted Prices in
Active Markets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant Unobservable
Inputs
(Level 3)

 

Cash equivalents

 

$

268

 

 

$

268

 

 

$

—

 

 

$

—

 

Short-term Corporate bonds

 

 

1,759

 

 

 

1,759

 

 

 

—

 

 

 

—

 

Short-term U.S. Government bonds

 

 

420,378

 

 

 

420,378

 

 

 

—

 

 

 

—

 

Long-term U.S. Government bonds

 

 

285,502

 

 

 

285,502

 

 

 

—

 

 

 

—

 

 

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2022 (in thousands):

 

 

 

 

 

 

Fair Value Measurements, Using

 

 

 

Total Carrying Value
as of December 31,
 2022

 

 

Quoted Prices in
Active Markets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant Unobservable
Inputs
(Level 3)

 

Cash equivalents

 

$

7,162

 

 

$

7,162

 

 

$

—

 

 

$

—

 

Short-term Corporate bonds

 

 

149,788

 

 

 

149,788

 

 

 

—

 

 

 

—

 

Short-term U.S. Government bonds

 

 

334,557

 

 

 

334,557

 

 

 

—

 

 

 

—

 

Long-term Corporate bonds

 

 

2,451

 

 

 

2,451

 

 

 

—

 

 

 

—

 

Long-term U.S. Government bonds

 

 

245,364

 

 

 

245,364

 

 

 

—

 

 

 

—

 

 

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on management’s own assumptions used to measure assets and liabilities at fair value. A financial asset’s or liability’s classification is determined based on the lowest level input that is significant to the fair value measurement.

Changes in fair value of the debt investments are recorded as unrealized gains and losses in accumulated other comprehensive loss on the Consolidated Balance Sheets and any credit losses on debt investments are recorded as an allowance for credit losses with an offset recognized in other (loss) income, net on the Consolidated Statements of Income. There were no credit losses on debt investments as of December 31, 2023 or December 31, 2022.

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
INVENTORY
5.
INVENTORY:

Inventory consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Raw materials

 

$

113,400

 

 

$

115,448

 

Work-in-process

 

 

9,433

 

 

 

7,626

 

Finished goods

 

 

52,962

 

 

 

60,146

 

Inventory

 

$

175,795

 

 

$

183,220

 

 

The Company recorded an inventory reserve of $8.5 million, $3.6 million and $3.6 million for the years ended December 31, 2023, 2022 and 2021, respectively, due to excess inventory levels in certain products.

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT
6.
PROPERTY AND EQUIPMENT:

Property and equipment, net consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Land

 

$

12,230

 

 

$

2,642

 

Building and improvements

 

 

116,903

 

 

 

99,586

 

Office and lab equipment

 

 

148,465

 

 

 

129,697

 

Furniture, fixtures and computer related assets

 

 

18,970

 

 

 

18,071

 

Construction-in-progress

 

 

22,490

 

 

 

10,567

 

 

 

 

319,058

 

 

 

260,563

 

Less: Accumulated depreciation

 

 

(143,908

)

 

 

(117,118

)

Property and equipment, net

 

$

175,150

 

 

$

143,445

 

Depreciation expense was $27.4 million, $24.8 million and $20.0 million for the years ended December 31, 2023, 2022 and 2021, respectively. The increase in property and equipment, net for the year ended December 31, 2023 is primarily due to the purchases of two previously leased facilities for an aggregate cost of $23.4 million and ongoing renovation activities at our research and development center in Ewing, New Jersey.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]  
GOODWILL AND INTANGIBLE ASSETS
7.
GOODWILL AND INTANGIBLE ASSETS:

The Company monitors the recoverability of goodwill annually or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Purchased intangible assets subject to amortization consist of acquired technology and other intangible assets that include trade names, customer relationships and developed intellectual property (IP) processes.

Acquired Technology

Acquired technology primarily consists of acquired license rights for patents and know-how obtained from Merck KGaA, BASF and Fujifilm. These intangible assets consist of the following (in thousands):

 

 

December 31,

 

 

 

2023 (1)

 

 

2022

 

PD-LD, Inc.

 

$

—

 

 

$

1,481

 

Motorola

 

 

—

 

 

 

15,909

 

Merck KGaA

 

 

66,012

 

 

 

—

 

BASF

 

 

95,989

 

 

 

95,989

 

Fujifilm

 

 

109,462

 

 

 

109,462

 

Other

 

 

5,712

 

 

 

5,212

 

 

 

 

277,175

 

 

 

228,053

 

Less: Accumulated amortization

 

 

(186,850

)

 

 

(189,671

)

Acquired technology, net

 

$

90,325

 

 

$

38,382

 

 

(1)
During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.

Amortization expense related to acquired technology was $14.6 million, $16.0 million and $20.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. Amortization expense is included in amortization of acquired technology and other intangible assets expense line item on the Consolidated Statements of Income and is expected to be $16.8 million in each of the years ending December 31, 2024 and 2025, $12.0 million in the year ending December 31, 2026, $7.2 million in each of the years ending December 2027 and 2028, and $30.3 million in total thereafter.

Merck KGaA Patent Acquisition

In April 2023, UDC Ireland entered into a Patent Sale and License Agreement with Merck KGaA. Under this agreement, Merck KGaA sold to UDC Ireland all of its rights, title and interest to over 550 of its owned and licensed OLED-related patents and patent applications in exchange for a cash payment of $66.0 million. The Patent Sale and License Agreement contains customary representations, warranties and covenants of the parties. UDC Ireland recorded the payment of $66.0 million as acquired technology, which is being amortized over a period of 10 years.

BASF Patent Acquisition

On June 28, 2016, UDC Ireland entered into and consummated an IP Transfer Agreement with BASF. Under the IP Transfer Agreement, BASF sold to UDC Ireland all of its rights, title and interest to certain of its owned and co-owned intellectual property rights relating to the composition, development, manufacture and use of OLED materials, including OLED lighting and display stack technology, as well as certain tangible assets. The intellectual property includes knowhow and more than 500 issued and pending patents in the area of phosphorescent materials and technologies. These assets were acquired in exchange for a cash payment of €86.8 million ($95.8 million). In addition, UDC Ireland also took on certain rights and obligations under three joint research and development agreements to which BASF was a party. The IP Transfer Agreement also contains customary representations, warranties and covenants of the parties. UDC Ireland recorded the payment of €86.8 million ($95.8 million) and acquisition costs incurred of $217,000 as acquired technology, which is being amortized over a period of 10 years.

Fujifilm Patent Acquisition

On July 23, 2012, the Company entered into a Patent Sale Agreement with Fujifilm. Under the agreement, Fujifilm sold more than 1,200 OLED-related patents and patent applications in exchange for a cash payment of $105.0 million, plus $4.5 million in costs incurred in connection with the purchase. The agreement contains customary representations and warranties and covenants, including respective covenants not to sue by both parties thereto. The agreement permitted the Company to assign all of its rights and obligations under the agreement to its affiliates, and the Company assigned, prior to the consummation of the transactions contemplated by the agreement, its rights and obligations to UDC Ireland. The transactions contemplated by the agreement were consummated on July 26, 2012. The Company recorded the $105.0 million plus $4.5 million of purchase costs as acquired technology, which was amortized over a period of 10 years that ended in July 2022.

Other Intangible Assets

As a result of the Adesis acquisition in June 2016, the Company recorded $16.8 million of other intangible assets, including $10.5 million assigned to customer relationships with a weighted average life of 11.5 years, $4.8 million to internally developed IP, processes and recipes with a weighted average life of 15 years, and $1.5 million to trade name and trademarks with a weighted average life of 10 years.

At December 31, 2023, these other intangible assets consist of the following (in thousands):

 

 

 

December 31, 2023

 

 

 

Gross Carrying
Amount

 

 

Accumulated
Amortization

 

 

Net Carrying
Amount

 

Customer relationships

 

$

10,520

 

 

$

(6,801

)

 

$

3,719

 

Developed IP, processes and recipes

 

 

4,820

 

 

 

(2,388

)

 

 

2,432

 

Trade name/Trademarks

 

 

1,500

 

 

 

(1,118

)

 

 

382

 

Other

 

 

448

 

 

 

(107

)

 

 

341

 

Total identifiable other intangible assets

 

$

17,288

 

 

$

(10,414

)

 

$

6,874

 

 

Amortization expense related to other intangible assets was $1.4 million for each of the years ended December 31, 2023, 2022, and 2021. Amortization expense is included in amortization of acquired technology and other intangible assets expense line item on the Consolidated Statements of Income and is expected to be $1.4 million for each of the next three fiscal years (2024 - 2026), $1.3 million for the year ending December 31, 2027, $422,000 for the year ending December 31, 2028, and $1.0 million in total thereafter.

Goodwill

As a result of the Adesis acquisition, the Company recorded $15.5 million of goodwill. The Company performs its annual assessment of goodwill during the fourth quarter of the fiscal year unless events suggest an impairment may have been incurred in an interim period using Adesis’ standalone financial operating performance information. Application of the goodwill impairment test requires the exercise of judgment, including the determination of the fair value of each reporting unit, as Adesis is considered to be the reporting unit. As part of the annual assessment of goodwill completed during the fourth quarter ended December 31, 2023, there were no significant indicators to conclude that an impairment of the goodwill associated with the acquisition of Adesis had occurred.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER ASSETS
 12 Months Ended
Dec. 31, 2023
Prepaid Expense and Other Assets [Abstract]  
Other assets
8.
OTHER ASSETS:

Other assets consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Long-term taxes receivable

 

$

60,146

 

 

$

63,915

 

Right-of-use assets

 

 

24,910

 

 

 

31,486

 

Long-term unbilled receivables

 

 

9,074

 

 

 

—

 

Long-term contract assets

 

 

9,278

 

 

 

11,651

 

Other long-term assets

 

 

1,881

 

 

 

2,687

 

Other assets

 

$

105,289

 

 

$

109,739

 

See Notes 9 and 20 for further explanation on right-of-use assets and long-term taxes receivable, respectively.
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES
9.
LEASES:

The Company has entered into operating leases to facilitate the expansion of its manufacturing, research and development, and selling, general and administrative activities. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend or terminate the lease when those events are reasonably certain to occur. The interest rate implicit in lease contracts is typically not readily determinable and as such the Company uses the appropriate incremental borrowing rate based on information available at the lease commencement date in determining the present value of the lease payments. Current lease agreements do not contain any residual value guarantees or material restrictive covenants. As of December 31, 2023, the Company did not have any finance leases and no additional operating leases that have not yet commenced.

The following table presents the Company’s operating lease cost and supplemental cash flow information related to the Company’s operating leases (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Operating lease cost

 

$

4,639

 

 

$

4,436

 

 

$

3,637

 

Non-cash activity:

 

 

 

 

 

 

 

 

 

Right-of-use assets obtained in exchange for lease obligations

 

$

1,072

 

 

$

4,750

 

 

$

26,174

 

The following table presents the Company’s operating lease right-of-use assets and liabilities (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Right-of-use assets

 

$

24,910

 

 

$

31,486

 

Short-term lease liabilities

 

 

3,533

 

 

 

3,737

 

Long-term lease liabilities

 

 

22,855

 

 

 

29,039

 

 

The following table presents weighted average assumptions used to compute the Company’s right-of-use assets and lease liabilities:

 

 

 

December 31, 2023

 

Weighted average remaining lease term (in years)

 

 

6.7

 

Weighted average discount rate

 

 

3.7

%

As of December 31, 2023, current operating leases had remaining terms between three and eight years with options to extend the lease terms.

Undiscounted future minimum lease payments as of December 31, 2023, by year and in the aggregate, having non-cancelable lease terms in excess of one year were as follows (in thousands):

 

 

 

Maturities of

 

 

 

Operating Lease Liabilities

 

2024

 

$

4,267

 

2025

 

 

4,321

 

2026

 

 

4,401

 

2027

 

 

4,323

 

2028

 

 

3,996

 

Thereafter

 

 

8,083

 

Total lease payments

 

 

29,391

 

Less: imputed interest

 

 

(3,003

)

Present value of lease payments

 

$

26,388

 
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCRUED EXPENSES
 12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
ACCRUED EXPENSES
10.
ACCRUED EXPENSES:

Accrued expenses consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Compensation

 

$

29,456

 

 

$

31,751

 

PPG Industries, Inc. agreement

 

 

11,962

 

 

 

9,864

 

Consulting

 

 

2,121

 

 

 

910

 

Professional fees

 

 

1,124

 

 

 

906

 

Research and development agreements

 

 

822

 

 

 

662

 

Royalties

 

 

647

 

 

 

877

 

Other

 

 

5,948

 

 

 

6,032

 

Accrued expenses

 

$

52,080

 

 

$

51,002

 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS
 12 Months Ended
Dec. 31, 2023
Research and Development [Abstract]  
RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS
11.
RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS:

The Company has long-standing relationships with a number of academic institutions that undertake funded research projects, including Princeton University (Princeton) and the University of Southern California (USC).

Under the current license agreement among the Company, Princeton and USC, the universities have granted the Company worldwide, exclusive license rights, with rights to sublicense, to make, have made, use, lease and/or sell products and to practice processes based on patent applications and issued patents arising out of research performed by the universities for the Company. The Company recorded royalty expense in connection with this agreement of $575,000, $853,000 and $691,000 for the years ended December 31, 2023, 2022 and 2021, respectively.

The Company also makes payments under the current research agreement with USC on a quarterly basis as actual expenses are incurred. As of December 31, 2023, the Company was obligated to pay USC up to $2.0 million for work to be performed during the remaining extended term. The Company recorded research and development expense in connection with work performed under the agreement of $1.1 million, $905,000 and $1.3 million for the years ended December 31, 2023, 2022 and 2021, respectively.

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER LIABILITIES
 12 Months Ended
Dec. 31, 2023
Other Liabilities [Abstract]  
OTHER LIABILITIES
12.
OTHER LIABILITIES:

Other liabilities consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Long-term lease liabilities

 

$

22,855

 

 

$

29,039

 

Long-term taxes payable

 

 

15,749

 

 

 

14,592

 

Other long-term liabilities

 

 

54

 

 

 

54

 

Other liabilities

 

$

38,658

 

 

$

43,685

 

See Notes 9 and 20 for further explanation on long-term lease liabilities and long-term taxes payable, respectively.
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS
 12 Months Ended
Dec. 31, 2023
Long-Term Commitment (Excluding Unconditional Purchase Obligation) [Abstract]  
EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS
13.
EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS:

On September 22, 2011, the Company entered into an Amended and Restated OLED Materials Supply and Service Agreement with PPG (the New OLED Materials Agreement), which, effective as of October 1, 2011, replaced the original OLED Materials Agreement with PPG. The term of the New OLED Materials Agreement, by amendment in February 2021, runs through December 31, 2024, and thereafter is automatically renewed for additional one-year terms, unless terminated by the Company by providing prior notice of one year or terminated by PPG by providing prior notice of two years. The New OLED Materials Agreement contains provisions that are substantially similar to those of the original OLED Materials Agreement. Under the New OLED Materials Agreement, PPG continues to assist the Company in developing its proprietary OLED materials and supplying the Company with those materials for evaluation purposes and for resale to its customers.

Under the New OLED Materials Agreement, the Company compensates PPG on a cost-plus basis for the services provided during each calendar quarter. The Company is required to pay for some of these services in all cash. Up to 50% of the remaining services are payable, at the Company’s sole discretion, in cash or shares of the Company’s common stock, with the balance payable in cash. The actual number of shares of common stock issuable to PPG is determined based on the average closing price for the Company’s common stock during a specified number of days prior to the end of each calendar half-year period ending on March 31 and September 30. If, however, this average closing price is less than $20.00, the Company is required to compensate PPG in cash. No shares have been issued for services rendered by PPG since the inception of the contract.

The Company is also required to reimburse PPG for raw materials used for research and development. The Company records the purchases of these raw materials as a current asset until such materials are used for research and development efforts.

In February 2021, the Company entered into an amendment to the New OLED Materials Agreement extending the term of the agreement and specifying operation and maintenance services to be provided by PPG affiliate, PPG SCM Ireland Limited (PPG SCM), to UDC Ireland, at the Company’s manufacturing site in Shannon, Ireland that UDC Ireland’s wholly-owned subsidiary, OLED Material Manufacturing Limited (OMM), began leasing at such time for the production of OLED materials. OMM purchased the site in September 2023 and the Company amended and restated the February 2021 amendment to reflect OMM’s ownership and PPG SCM’s updated operation and maintenance services after such purchase. Facility improvements have been completed and operations commenced in June 2022. As with the initial New OLED Materials Agreement, the Company compensates PPG on a cost-plus basis for the services provided at the Shannon manufacturing facility.

The Company recorded research and development expense of $9.1 million, $7.3 million and $3.6 million for the years ended December 31, 2023, 2022 and 2021, respectively, in relation to the cash portion of the reimbursement of expenses and work performed by PPG, excluding amounts paid for commercial chemicals.
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
SHAREHOLDERS' EQUITY
14.
SHAREHOLDERS' EQUITY:

Preferred Stock

The Company’s Amended and Restated Articles of Incorporation authorize it to issue up to 5,000,000 shares of $0.01 par value preferred stock with designations, rights and preferences determined from time-to-time by the Company’s Board of Directors. Accordingly, the Company’s Board of Directors is empowered, without shareholder approval, to issue preferred stock with dividend, liquidation, conversion, voting or other rights superior to those of shareholders of the Company’s common stock.

 

In 1995, the Company issued 200,000 shares of Series A Nonconvertible Preferred Stock (Series A) to American Biomimetics Corporation (ABC) pursuant to a certain Technology Transfer Agreement between the Company and ABC. The Series A shares have a liquidation value of $7.50 per share. Series A shareholders, as a single class, have the right to elect two members of the Company’s Board of Directors. This right has never been exercised. Holders of the Series A shares are entitled to one vote per share on matters which shareholders are generally entitled to vote. The Series A shareholders are not entitled to any dividends.

 

As of December 31, 2023, the Company had issued 200,000 shares of preferred stock, all of which were outstanding.

Common Stock

The Company’s Amended and Restated Articles of Incorporation authorize it to issue up to 200,000,000 shares of $0.01 par value common stock. Each share of the Company’s common stock entitles the holder to one vote on all matters to be voted upon by the shareholders.

As of December 31, 2023, the Company had issued 48,731,026 shares of common stock, of which 47,365,378 were outstanding. During the years ended December 31, 2023 and 2022, the Company repurchased no shares of common stock.

Dividends

During the year ended December 31, 2023, the Company declared and paid cash dividends of $1.40 per common share, or $66.7 million, on the Company’s outstanding common stock.

 

On February 20, 2024, the Company’s Board of Directors declared a first quarter dividend of $0.40 per share to be paid on March 29, 2024 to all shareholders of record of the Company's common stock as of the close of business on March 15, 2024. All future dividends will be subject to the approval of the Company’s Board of Directors.
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS
 12 Months Ended
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE LOSS
15.
ACCUMULATED OTHER COMPREHENSIVE LOSS:

Amounts related to the changes in accumulated other comprehensive loss were as follows (in thousands):

 

 

Unrealized
Gain (Loss) on
Available-for-
Sale-Securities

 

 

Net Unrealized
Gain (Loss) on
Retirement Plan (2)

 

 

Change in Cumulative
Foreign Currency
Translation Adjustment

 

 

Total

 

 

Affected Line items in the
Consolidated Statements of
Income

Balance January 1, 2021, net of tax

 

$

91

 

 

$

(36,075

)

 

$

(35

)

 

$

(36,019

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

(233

)

 

 

13,620

 

 

 

(39

)

 

 

13,348

 

 

 

Plan amendment cost

 

 

—

 

 

 

(283

)

 

 

—

 

 

 

(283

)

 

 


Reclassification to net income (1)

 

 

—

 

 

 

4,719

 

 

 

—

 

 

 

4,719

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

(233

)

 

 

18,056

 

 

 

(39

)

 

 

17,784

 

 

 

Balance December 31, 2021, net of tax

 

 

(142

)

 

 

(18,019

)

 

 

(74

)

 

 

(18,235

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

(7,745

)

 

 

5,971

 

 

 

(480

)

 

 

(2,254

)

 

 



Reclassification to net income (1)

 

 

—

 

 

 

2,037

 

 

 

—

 

 

 

2,037

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

(7,745

)

 

 

8,008

 

 

 

(480

)

 

 

(217

)

 

 

Balance December 31, 2022, net of tax

 

 

(7,887

)

 

 

(10,011

)

 

 

(554

)

 

 

(18,452

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

8,745

 

 

 

7,207

 

 

 

418

 

 

 

16,370

 

 

 



Reclassification to net income (1)

 

 

—

 

 

 

996

 

 

 

—

 

 

 

996

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

8,745

 

 

 

8,203

 

 

 

418

 

 

 

17,366

 

 

 

Balance December 31, 2023, net of tax

 

$

858

 

 

$

(1,808

)

 

$

(136

)

 

$

(1,086

)

 

 

 

(1)
The Company reclassified amortization of prior service cost, actuarial loss and plan amendment cost for its retirement plan from accumulated other comprehensive loss to net income of $1.0 million, $2.0 million and $4.7 million for the years ended December 31, 2023, 2022 and 2021, respectively.
Refer to Note 17: Employee Retirement Plans
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION
16.
STOCK-BASED COMPENSATION:

Equity Compensation Plan

On June 15, 2023, the shareholders of the Company voted to approve the Universal Display Corporation 2023 Equity Compensation Plan (the “Equity Compensation Plan”), which replaced the Universal Display Corporation 2014 Equity Compensation Plan. The Equity Compensation Plan provides for the granting of incentive and nonqualified stock options, shares of common stock, stock appreciation rights and performance units to employees, directors and consultants of the Company. Stock options are exercisable over periods determined by the Company’s Human Capital Committee, but for no longer than 10 years from the grant date. The total number of shares that may be subject to awards under the Equity Compensation Plan is equal to the shares that were available for issuance and not subject to an award under the 2014 Equity Compensation Plan at the time it was replaced by the Equity Compensation Plan, subject to adjustment with respect to shares underlying any outstanding award granted under the Equity Compensation Plan or the 2014 Equity Compensation Plan that may expire, or be terminated, surrendered or forfeited for any reason, without issuance of such

shares. As of December 31, 2023, there were 1,519,235 shares that remained available to be granted under the Equity Compensation Plan. The Equity Compensation Plan will terminate on June 15, 2033.

Restricted Stock Award and Units

The Company has issued restricted stock awards and units to employees and non-employees with vesting terms of one to five years. The fair value is equal to the market price of the Company’s common stock on the date of grant for awards granted to employees. Consistent with the accounting for equity-classified awards issued to employees, our equity-classified nonemployee share-based awards are measured at the grant date fair value. Expense for restricted stock awards and units is amortized ratably over the vesting period for the awards issued to employees and using a graded vesting method for the awards issued to non-employees.

The following table summarizes the activity related to restricted stock unit (RSU) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

230,223

 

 

$

165.13

 

Granted

 

 

121,896

 

 

 

136.22

 

Vested

 

 

(132,010

)

 

 

163.85

 

Forfeited

 

 

(3,623

)

 

 

152.21

 

Unvested, December 31, 2023

 

 

216,486

 

 

$

149.68

 

The weighted average grant-date fair value per unit of RSU awards granted was $136.22, $140.37 and $208.67 during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSUs that vested during the year was $21.6 million for the year ended December 31, 2023, $18.0 million for the year ended December 31, 2022 and $12.5 million for the year ended December 31, 2021. The fair value of RSUs as of their respective vesting dates was $18.6 million for the year ended December 31, 2023, $15.3 million for the year ended December 31, 2022 and $15.1 million for the year ended December 31, 2021.

The following table summarizes the activity related to restricted stock award (RSA) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

33,637

 

 

$

178.37

 

Granted

 

 

2,366

 

 

 

126.87

 

Vested

 

 

(18,456

)

 

 

178.82

 

Unvested, December 31, 2023

 

 

17,547

 

 

$

170.96

 

The weighted average grant-date fair value per award of RSA awards granted was $126.87, $148.35 and $172.95 during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSAs that vested during the year was $3.3 million for the year ended December 31, 2023, $8.3 million for the year ended December 31, 2022 and $9.3 million for the year ended December 31, 2021. The fair value of RSAs as of their respective vesting dates was $2.6 million for the year ended December 31, 2023, $6.5 million for the year ended December 31, 2022 and $20.0 million for the year ended December 31, 2021.

For the years ended December 31, 2023, 2022 and 2021, the Company recorded, as compensation charges related to restricted stock awards and units issued to employees and non-employees, selling, general and administrative expense of $9.5 million, $14.3 million and $15.4 million, respectively, cost of sales of $1.9 million, $2.2 million and $2.5 million, respectively, and research and development expense of $5.8 million, $6.1 million and $5.2 million, respectively.

In connection with the vesting of restricted stock awards and units during the years ended December 31, 2023, 2022 and 2021, 53,162, 54,856 and 67,798 shares, respectively, with aggregate fair values of $7.4 million, $8.4 million and $14.1 million, respectively, were withheld in satisfaction of tax withholding obligations and are reflected as a financing activity within the Consolidated Statements of Cash Flows.

For the years ended December 31, 2023, 2022 and 2021, the Company recorded as compensation charges related to all restricted stock units to non-employee members of the Scientific Advisory Board, whose unvested shares are marked-to-market each reporting period, research and development expense of $248,000, $234,000 and $220,000, respectively.

The Company has granted restricted stock units to non-employee members of the Board of Directors with quarterly vesting over a period of approximately one year. The fair value is equal to the market price of the Company's common stock on the date of grant. The restricted stock units are issued and expense is recognized ratably over the vesting period. For the years ended December 31, 2023, 2022 and 2021, the Company recorded compensation charges for services performed, related to all restricted stock units granted to non-employee members of the Board of Directors, selling, general and administrative expense of $1.5 million, $1.3 million and $1.2 million, respectively. In connection with the vesting of the restricted stock, the Company issued to non-employee members of the Board of Directors 13,016, 8,784 and 5,412 shares during the years ended December 31, 2023, 2022 and 2021, respectively.

As of December 31, 2023, the total unrecognized expense related to all restricted stock awards and units was $21.7 million, which the Company expects to recognize over a weighted average period of 1.80 years.

Performance Unit Awards

Each performance unit award is subject to both a performance-vesting requirement (either performance-based or market-based) and a service-vesting requirement. The performance-based vesting requirement is tied to EBITDA and cash flow achievement, as measured over a specific performance period. The market-based vesting requirement is tied to the Company's total shareholder return (TSR) relative to the TSR of companies comprising the Nasdaq Electronics Components Index, as measured over a three-year performance period. The maximum number of performance units that may vest based on performance is three times the shares granted. Further, if the Company's performance falls below certain thresholds, the performance units will not vest at all.

The following table summarizes the activity related to performance unit awards (PSU) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

227,866

 

 

$

185.57

 

Granted

 

 

84,448

 

 

 

165.72

 

Vested

 

 

(11,970

)

 

 

155.85

 

Forfeited

 

 

(91,791

)

 

 

170.96

 

Unvested, December 31, 2023

 

 

208,553

 

 

$

185.86

 

During the years ended December 31, 2023, 2022 and 2021, the Company granted 84,448, 100,621 and 77,086 performance units, respectively, of which 63,335, 75,465 and 42,291 units, respectively, are subject to performance-based vesting requirements and 21,113, 25,156 and 34,795 units, respectively, are subject to market-based vesting requirements, and which will vest over the terms described above. During the years ended December 31, 2023, 2022 and 2021, there were none, 1,268, and none incremental performance-based shares, respectively, that vested resulting from an increased vesting factor based on Company performance. The weighted average grant date fair value per unit of the performance unit awards granted was $165.72, $186.66 and $214.70 during the years ended December 31, 2023, 2022 and 2021, respectively, as determined by the Company’s common stock on date of grant for the units with performance-based vesting and a Monte-Carlo simulation for the units with market-based vesting. The grant date fair value of PSUs that vested during the year was $1.9 million for the year ended December 31, 2023, $1.9 million for the year ended December 31, 2022 and $1.1 million for the year ended December 31, 2021. The fair value of PSUs as of their respective vesting dates was $1.7 million for the year ended December 31, 2023, $1.8 million for the year ended December 31, 2021 and $2.0 million for the year ended December 31, 2021.

For the years ended December 31, 2023, 2022 and 2021, the Company recorded, as compensation charges related to all performance stock units, selling, general and administrative expense of $2.6 million, $2.8 million and $8.0 million, respectively, cost of sales of $770,000, $940,000 and $1.3 million, respectively, and research and development expense of $1.2 million, $1.5 million and $2.1 million, respectively.

In connection with the vesting of performance units during the years ended December 31, 2023, 2022 and 2021, 5,350, 5,082 and 3,881 shares, respectively, with aggregate fair values of $775,000, $826,000 and $875,000, respectively, were withheld in satisfaction of tax withholding obligations and are reflected as a financing activity within the Consolidated Statements of Cash Flows.

As of December 31, 2023, the total unrecognized compensation expense related to performance unit awards was $12.9 million, which the Company expects to recognize over a weighted average period of 1.98 years.

Employee Stock Purchase Plan

On April 7, 2009, the Board of Directors of the Company adopted an Employee Stock Purchase Plan (ESPP). The ESPP was approved by the Company’s shareholders and became effective on June 25, 2009. The Company has reserved 1,000,000 shares of common stock for issuance under the ESPP. Unless terminated by the Board of Directors, the ESPP will expire when all reserved shares have been issued.

Eligible employees may elect to contribute to the ESPP through payroll deductions during consecutive three-month purchase periods, the first of which began on July 1, 2009. Each employee who elects to participate will be deemed to have been granted an option to purchase shares of the Company’s common stock on the first day of the purchase period. Unless the employee opts out during the purchase period, the option will automatically be exercised on the last day of the period, which is the purchase date, based on the employee’s accumulated contributions to the ESPP. The purchase price will equal 85% of the lesser of the closing price per share of common stock on the first day of the period or the last business day of the period.

Employees may allocate up to 10% of their base compensation to purchase shares of common stock under the ESPP; however, each employee may purchase no more than 12,500 shares on a given purchase date, and no employee may purchase more than $25,000 of common stock under the ESPP during a given calendar year.

For the years ended December 31, 2023, 2022 and 2021, the Company issued 17,513, 17,057 and 9,156 shares, respectively, of its common stock under the ESPP, resulting in proceeds of $2.0 million, $1.6 million and $1.5 million, respectively. For the years ended December 31, 2023, 2022 and 2021, the Company recorded charges of $136,000, $107,000 and $93,000, respectively, to selling, general and administrative expense, $167,000, $141,000, $119,000, respectively, to cost of sales and $240,000, $224,000 and $188,000, respectively, to research and development expense, related to the ESPP equal to the amount of the discount and the value of the look-back feature.

Scientific Advisory Board Awards

During the years ended December 31, 2023 and 2022, the Company granted a total of 2,366 and 2,024 shares, respectively, of fully vested common stock to non-employee members of the Scientific Advisory Board for services performed in 2022 and 2021, respectively. The fair value of the shares issued to members of the Scientific Advisory Board was $300,000 for both years ended December 31, 2023 and 2022.

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS
 12 Months Ended
Dec. 31, 2023
Defined Benefit Pension Plans And Defined Benefit Postretirement Plans [Abstract]  
EMPLOYEE RETIREMENT PLANS
17.
EMPLOYEE RETIREMENT PLANS:

Defined Contribution Plan

The Company maintains the Universal Display Corporation 401(k) Plan (the Plan) in accordance with the provisions of Section 401(k) of the Internal Revenue Code (the Code). The Plan covers substantially all full-time employees of the Company. Participants may contribute up to 90% of their total compensation to the Plan, not to exceed the limit as defined in the Code. Once an employee is eligible to participate in the Plan, the Company will make a non-elective contribution equal to 3% of the employee’s total compensation. For the years ended December 31, 2023, 2022 and 2021, the Company contributed $1.5 million, $1.4 million and $1.3 million, respectively, to the Plan.

Defined Benefit Plan

On March 18, 2010, the Human Capital Committee and the Board of Directors of the Company approved and adopted the Universal Display Corporation Supplemental Executive Retirement Plan (SERP), effective as of April 1, 2010. On March 3, 2015, the Human Capital Committee and the Board of Directors amended the SERP to include salary and bonus as part of the plan. Prior to this amendment, the SERP benefit did not take into account any bonuses. The purpose of the SERP, which is unfunded, is to provide certain of the Company’s key employees with supplemental pension benefits following a cessation of their employment and to encourage their continued employment with the Company. As of December 31, 2023 there were eight participants in the SERP.

The SERP benefit is based on a percentage of the participant’s annual base salary and in certain cases, the participant's average annual bonus for the most recent three fiscal years ending prior to the participant's date of termination of employment with the Company for the life of the participant. For this purpose, annual base salary means 12 times the average monthly base salary paid or payable to the participant during the 24-month period immediately preceding the participant’s date of termination of employment, or, if required, the date of a change in control of the Company.

Under the SERP, if a participant resigns or is terminated without cause at or after age 65 and with at least 20 years of service, he or she will be eligible to receive a SERP benefit. The benefit is based on a percentage of the participant’s annual base salary and bonus for the life of the participant. This percentage is 50%, 25% or 15%, depending on the participant’s benefit class.

If a participant resigns at or after age 65 and with at least 15 years of service, he or she will be eligible to receive a prorated SERP benefit. If a participant is terminated without cause or on account of a disability after at least 15 years of service, he or she will be eligible to receive a prorated SERP benefit regardless of age. The prorated benefit in either case would be based on the participant’s number of years of service (up to 20), divided by 20. In the event a participant is terminated for cause, his or her SERP benefit and any future benefit payments are subject to immediate forfeiture.

The SERP benefit is payable in installments over 10 years, beginning at the later of age 65 or the date of the participant’s separation from service. Payments are based on a present value calculation of the benefit amount for the actuarial remaining life expectancy of the participant. This calculation is made as of the date benefit payments are to begin (later of age 65 or separation from service). If the participant dies after reaching age 65, any future or remaining benefit payments are made to the participant’s beneficiary or estate. If the participant dies before reaching age 65, the benefit is forfeited.

In the event of a change in control of the Company, each participant will become immediately vested in his or her SERP benefit. Unless the participant’s benefit has already fully vested, if the participant has less than 20 years of service at the time of the change in control, he or she will receive a prorated benefit based on his or her number of years of service (up to 20), divided by 20. If the change in control qualifies as a “change in control event” for purposes of Section 409A of the Internal Revenue Code, then each participant (including former employees who are entitled to SERP benefits) will receive a lump sum cash payment equal to the present value of the benefit immediately upon the change in control.

Certain of the Company’s executive officers are designated as special participants under the SERP. If these participants resign or are terminated without cause after 20 years of service, or at or after age 65 and with at least 15 years of service, they will be eligible to receive a SERP benefit. If they are terminated without cause or on account of a disability, they will be eligible to receive a prorated SERP benefit regardless of age. The prorated benefit would be based on the participant’s number of years of service (up to 20), divided by 20.

The SERP benefit for special participants is based on 50% of their annual base salary and bonus for their life and the life of their surviving spouse, if any. Payments are based on a present value calculation of the benefit amount for the actuarial remaining life expectancies of the participant and their surviving spouse, if any. If they die before reaching age 65, the benefit is not forfeited if the surviving spouse, if any, lives until the participant would have reached age 65. If their spouse also dies before the participant would have reached age 65, the benefit is forfeited.

The Company records amounts relating to the SERP based on calculations that incorporate various actuarial and other assumptions, including discount rates, rate of compensation increases, retirement dates, and life expectancies. The net periodic costs are recognized as employees render the services necessary to earn the SERP benefits.

In connection with the initiation and subsequent amendments of the SERP, the Company recorded cost related to prior service of $1.9 million as accumulated other comprehensive loss as of December 31, 2023. The prior service cost is being amortized as a component of net periodic pension cost over the average of the remaining service period of the employees expected to receive benefits under the plan. The prior service cost expected to be amortized for the year ending December 31, 2024 is $43,000. In December 2022, one of the participants retired and monthly SERP benefit payments commenced in January 2023. The total SERP benefit payments for the year ended December 31, 2023 were $2.0 million.

Information relating to the Company’s plan is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Change in benefit obligation:

 

 

 

 

 

 

Benefit obligation, beginning of year

 

$

61,804

 

 

$

66,773

 

Service cost

 

 

951

 

 

 

1,287

 

Interest cost

 

 

2,898

 

 

 

1,383

 

Actuarial gain

 

 

(9,375

)

 

 

(7,639

)

Benefit payments

 

 

(2,015

)

 

 

—

 

Benefit obligation, end of year

 

 

54,263

 

 

 

61,804

 

Fair value of plan assets

 

 

—

 

 

 

—

 

Unfunded status of the plan, end of year

 

$

54,263

 

 

$

61,804

 

Current liability

 

$

2,014

 

 

$

2,014

 

Non-current liability

 

$

52,249

 

 

$

59,790

 

 

The accumulated benefit obligation for the plan was $52.5 million and $59.5 million as of December 31, 2023 and 2022, respectively. The actuarial gain of $9.4 million for the year ended December 31, 2023 was primarily due to a decrease in the total average annual bonus for each of the participants during the most recent three fiscal years. The actuarial gain of $7.6 million for the year ended December 31, 2022 was primarily due to an increase in the discount rate.

The components of net periodic pension cost were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Service cost

 

$

951

 

 

$

1,287

 

 

$

1,675

 

Interest cost

 

 

2,898

 

 

 

1,383

 

 

 

1,165

 

Amortization of prior service cost

 

 

815

 

 

 

1,119

 

 

 

1,099

 

Amortization of loss

 

 

480

 

 

 

1,487

 

 

 

4,936

 

Total net periodic benefit cost

 

$

5,144

 

 

$

5,276

 

 

$

8,875

 

 

The measurement date is the Company’s fiscal year end. The net periodic pension cost is based on assumptions determined at the prior year end measurement date.

Assumptions used to determine the year end benefit obligation were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Discount rate

 

 

4.74

%

 

 

4.94

%

Rate of compensation increases

 

 

3.50

%

 

 

3.50

%

 

Assumptions used to determine the net periodic pension cost were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Discount rate

 

 

4.94

%

 

 

2.16

%

 

 

1.54

%

Rate of compensation increases

 

 

3.50

%

 

 

3.50

%

 

 

3.50

%

 

Actuarial gains and losses are amortized from accumulated other comprehensive loss into net periodic pension cost over future years based upon the average remaining service period of active plan participants, when the accumulation of such gains or losses exceeds 10% of the year end benefit obligation. The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost or credit) is included in the Company’s results of income on a straight-line basis over the average remaining service period of active plan participants.

The estimated amounts to be amortized from accumulated other comprehensive loss into the net periodic pension cost in 2024 are as follows (in thousands):

 

Amortization of prior service cost

 

$

43

 

Amortization of loss

 

 

—

 

Total

 

$

43

 

 

Benefit payments, which reflect estimated future service, are currently expected to be paid as follows (in thousands):

 

Year

 

Projected
Benefits

 

2024

 

$

2,014

 

2025

 

 

5,097

 

2026

 

 

6,141

 

2027

 

 

6,489

 

2028

 

 

6,489

 

2029-2033

 

 

34,503

 

Thereafter

 

 

14,855

 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
18.
COMMITMENTS AND CONTINGENCIES:

Commitments

Under the current research agreement with USC, the Company is obligated to make certain payments to USC based on work performed by it under that agreement, and by the University of Michigan (Michigan) under a subcontractor agreement that Michigan has with USC.

Under the terms of the current license agreement among the Company, Princeton and USC, the Company makes royalty payments to Princeton. See Note 11 for further explanation.

The Company has agreements with five executive officers and 13 senior level employees which provide for certain cash and other benefits upon termination of employment of the officer or employee in connection with a change in control of the Company. If a covered person’s employment is terminated in connection with the change in control, the person is entitled to a lump-sum cash payment equal to two times (in the case of the executive officers) or either one or two times (in the case of the senior level employees) the sum of the average annual base salary and bonus of the person and immediate vesting of all stock options and other equity awards that may be outstanding at the date of the change in control, among other items.

In order to manage manufacturing lead times and help ensure adequate material supply, the Company entered into the New OLED Materials Agreement (see Note 13) that allows PPG to procure and produce inventory based upon criteria as defined by the Company. These purchase commitments consist of firm, noncancelable and unconditional commitments. In certain instances, this agreement allows the Company the option to reschedule and adjust the Company’s requirements based on its business needs prior to firm orders being placed. As of December 31, 2023, 2022 and 2021, the Company had purchase commitments for inventory of $29.8 million, $31.9 million and $25.7 million, respectively.

Patent Related Challenges and Oppositions

Each major jurisdiction in the world that issues patents provides both third parties and applicants an opportunity to seek a further review of an issued patent. The process for requesting and considering such reviews is specific to the jurisdiction that issued the patent in question, and generally does not provide for claims of monetary damages or a review of specific claims of infringement. The conclusions made by the reviewing administrative bodies tend to be appealable and generally are limited in scope and applicability to the specific claims and jurisdiction in question.

The Company believes that opposition proceedings are frequently commenced in the ordinary course of business by third parties who may believe that one or more claims in a patent do not comply with the technical or legal requirements of the specific jurisdiction in which the patent was issued. The Company views these proceedings as reflective of its goal of obtaining the broadest legally permissible patent coverage permitted in each jurisdiction. Once a proceeding is initiated, as a general matter, the issued patent continues to be presumed valid until the jurisdiction’s applicable administrative body issues a final non-appealable decision. Depending on the jurisdiction, the outcome of these proceedings could include affirmation, denial or modification of some or all of the originally issued claims. The Company believes that as OLED technology becomes more established and its patent portfolio increases in size, so will the number of these proceedings.
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONCENTRATION OF RISK
 12 Months Ended
Dec. 31, 2023
Risks and Uncertainties [Abstract]  
CONCENTRATION OF RISK
19.
CONCENTRATION OF RISK:

Revenues and accounts receivable from the Company's largest customers for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands):

 

 

2023

 

 

2022

 

 

2021

 

Customer

 

% of Total Revenue

 

Accounts Receivable

 

 

% of Total Revenue

 

Accounts Receivable

 

 

% of Total Revenue

 

Accounts Receivable

 

A

 

36%

 

$

38,105

 

 

41%

 

$

11,425

 

 

44%

 

$

10,850

 

B

 

23%

 

 

30,142

 

 

25%

 

 

24,440

 

 

26%

 

 

45,867

 

C

 

17%

 

 

38,529

 

 

16%

 

 

22,291

 

 

14%

 

 

18,557

 

Revenues from outside of North America represented approximately 98%, 97%, and 97% of consolidated revenue for each of the years ended December 31, 2023, 2022 and 2021, respectively. Revenues by geographic area are as follows (in thousands):

 

 

 

Year Ended December 31,

 

Country

 

2023

 

 

2022

 

 

2021

 

South Korea

 

$

322,509

 

 

$

360,640

 

 

$

334,835

 

China

 

 

229,727

 

 

 

230,582

 

 

 

192,079

 

Japan

 

 

6,971

 

 

 

5,579

 

 

 

7,358

 

Other non-U.S. locations

 

 

4,411

 

 

 

3,829

 

 

 

3,137

 

Total non-U.S. locations

 

 

563,618

 

 

 

600,630

 

 

 

537,409

 

United States

 

 

12,811

 

 

 

15,989

 

 

 

16,116

 

Total revenue

 

$

576,429

 

 

$

616,619

 

 

$

553,525

 

 

The Company attributes revenue to different geographic areas on the basis of the location of the customer.

Property and equipment, net by geographic area are as follows (in thousands):

 

 

 

December 31,

 

Country

 

2023

 

 

2022

 

United States

 

$

118,250

 

 

$

117,255

 

Ireland

 

 

42,203

 

 

 

20,270

 

Other

 

 

14,697

 

 

 

5,920

 

Total long-lived assets

 

$

175,150

 

 

$

143,445

 

Substantially all chemical materials were purchased from one supplier. See Note 13.
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES
20.
INCOME TAXES:

The components of income before income taxes are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

United States

 

$

71,514

 

 

$

77,205

 

 

$

60,066

 

Foreign

 

 

173,657

 

 

 

191,025

 

 

 

168,181

 

Income before income taxes

 

$

245,171

 

 

$

268,230

 

 

$

228,247

 

 

The components of the income tax expense are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Current income tax (expense) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

$

(15,848

)

 

$

(51,980

)

 

$

(16,433

)

State

 

 

(3,048

)

 

 

(1,833

)

 

 

(641

)

Foreign

 

 

(27,030

)

 

 

(31,302

)

 

 

(25,212

)

 

 

 

(45,926

)

 

 

(85,115

)

 

 

(42,286

)

Deferred income tax (expense) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

 

(460

)

 

 

25,916

 

 

 

(844

)

State

 

 

3,936

 

 

 

1,216

 

 

 

(734

)

Foreign

 

 

290

 

 

 

(186

)

 

 

(170

)

 

 

 

3,766

 

 

 

26,946

 

 

 

(1,748

)

Income tax expense

 

$

(42,160

)

 

$

(58,169

)

 

$

(44,034

)

 

Reconciliation of the statutory U.S. federal tax rate to the Company's effective tax rate is as follows:

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Statutory U.S. federal income tax rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

Effect of foreign operations

 

 

(4.0

)

 

 

(4.9

)

 

 

(5.0

)

U.S. International Tax (Sub F, GILTI, FDII)

 

 

2.9

 

 

 

4.2

 

 

 

2.1

 

Research tax credits

 

 

(2.4

)

 

 

(1.9

)

 

 

(1.4

)

Redetermination of foreign tax credit utilization

 

 

(2.0

)

 

 

—

 

 

 

—

 

Nondeductible employee compensation

 

 

1.7

 

 

 

1.9

 

 

 

3.0

 

State income taxes, net of federal benefit

 

 

(0.2

)

 

 

0.1

 

 

 

0.2

 

Stock based compensation

 

 

0.1

 

 

 

0.2

 

 

 

(0.3

)

Accruals and reserves

 

 

—

 

 

 

—

 

 

 

(0.8

)

Other

 

 

0.1

 

 

 

1.1

 

 

 

0.5

 

Effective tax rate

 

 

17.2

%

 

 

21.7

%

 

 

19.3

%

 

The following table summarizes Company tax credit carry forwards for tax return purposes as of December 31, 2023 (in thousands):

 

 

 

Tax Benefit

 

 

Expiration Date

Tax credit carry forwards:

 

 

 

 

 

State research tax credits

 

$

8,752

 

 

2034-2038

Foreign tax credits

 

$

186

 

 

2031

Total credit carry forwards

 

$

8,938

 

 

 

 

Significant components of the Company's net deferred tax assets and liabilities are as follows (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Deferred tax asset:

 

 

 

 

 

 

Capitalized research expenditures

 

$

39,459

 

 

$

38,485

 

Retirement plan

 

 

12,555

 

 

 

13,495

 

Tax credit carry forwards

 

 

8,938

 

 

 

8,100

 

Accruals and reserves

 

 

7,180

 

 

 

6,944

 

Lease Liabilities

 

 

6,671

 

 

 

7,230

 

Deferred revenue

 

 

1,741

 

 

 

2,077

 

Stock-based compensation

 

 

1,498

 

 

 

1,454

 

Other

 

 

1,362

 

 

 

3,400

 

 

 

 

79,404

 

 

 

81,185

 

Valuation allowance

 

 

(9,551

)

 

 

(11,087

)

Deferred tax assets

 

 

69,853

 

 

 

70,098

 

Deferred tax liability:

 

 

 

 

 

 

Lease Assets

 

 

(6,302

)

 

 

(6,944

)

Acquisition Goodwill

 

 

(1,549

)

 

 

(1,283

)

Other

 

 

(2,894

)

 

 

(3,710

)

Deferred tax liabilities

 

 

(10,745

)

 

 

(11,937

)

Net deferred tax assets

 

$

59,108

 

 

$

58,161

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent on the Company's ability to generate future taxable income to obtain benefit from the reversal of temporary differences, net operating loss carryforwards and tax credits. As part of its assessment, management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. At this time there is not sufficient evidence to release the valuation allowance that has been recorded for the New Jersey research and development credits and unrealized loss on investments. There are no indicators against the realizability of the remaining net deferred tax asset.

The U.S.-Korean Mutual Agreement Procedure (MAP) for the years ended December 31, 2010, to December 31, 2017, was closed in September 2022, resulting in a refund of the Korean withholding taxes previously withheld. The Company filed amended U.S. federal tax returns to reflect the refund and to redetermine the foreign tax credit amount. As a result, the Company has recorded a long-term asset of $3.0 million in the year ended December 31, 2022. There was no long-term asset recorded for the year ended December 31, 2023.

On December 27, 2018, the Korean Supreme Court, citing prior cases, held that only royalties paid with respect to Korean registered patents are considered Korean source income and subject to Korean withholding tax under the applicable law and interpretation of the Korea-U.S. Tax Treaty. The Company has incurred Korean withholding tax of $14.9 million for each of the years ended December 31, 2018, through December 31, 2022. Based on the Korean Supreme Court decision, a tax refund request on behalf of the Company was or will be filed with the Korean National Tax Service (KNTS) for the entire period from January 1, 2018, to December 31, 2022. The Company received a formal rejection from the KNTS; and in May 2022 filed an appeal with the Korean Tax Tribunal. On December 18th, 2023, the Company received a formal rejection from the Tax Tribunal. Anticipating the rejection of the appeal, in September 2023 the Company filed a petition to the District Court and is awaiting its decision. The Company has been advised by a prominent Korean law firm that there is a more-likely-than-not chance of success. As a result, the Company has recorded a long-term asset of $60.1 million and $60.9 million as of December 31, 2023, and December 31, 2022, respectively for the receipt of the Korean withholding tax. The Company also recorded foreign exchange loss of $732,000 during the year ended December 31, 2023, due to the fluctuation of the Korean Won to the U.S. Dollar and resulting remeasurement of this Won-denominated receivable. The Company will amend U.S. federal tax returns for the 2018 to 2022 years when the anticipated refund from KNTS is received to offset the additional tax liability. The Company has recorded a long-term liability of $15.7 million and $14.6 million as of December 31, 2023, and December 31, 2022, respectively, for the estimated amounts due to the U.S. federal government based on the amendment of the Company's U.S. tax returns, indicating that lower withholding amounts were required.

The Company is not subject to examinations by the federal tax authority for the years prior to 2017. The Company's state and foreign tax returns are open for a period of generally three to four years. The Company is under California tax audit for 2019 and 2020 years, which is in the information-collecting stage.

The above estimates may change in the future and upon settlement.
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
REVENUE RECOGNITION
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
REVENUE RECOGNITION
21.
REVENUE RECOGNITION:

The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (Topic 606). The standard establishes the principles that an entity shall apply to report useful information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows from a contract with a customer.

For each of the years ended December 31, 2023, 2022 and 2021, the Company recorded 97% of its revenue from OLED related sales and 3% from the providing of services through Adesis, respectively.

Contract Balances

The following table provides information about assets and liabilities associated with the Company's contracts from customers (in thousands):

 

 

 

As of December 31, 2023

 

Accounts receivable

 

$

139,850

 

Short-term unbilled receivables

 

 

21,084

 

Short-term contract assets

 

 

2,698

 

Long-term unbilled receivables

 

 

9,074

 

Long-term contract assets

 

 

9,278

 

Short-term deferred revenue

 

 

47,713

 

Long-term deferred revenue

 

 

12,006

 

Short-term and long-term unbilled receivables and contract assets are classified as other current assets and other assets, respectively, on the Consolidated Balance Sheets. Contract assets represent consideration related to the renewal of customer contracts which is recognized over the contract term based on material units sold. The deferred revenue balance as of December 31, 2023 will be recognized as materials are shipped to customers over the remaining contract periods. As of December 31, 2023, the Company had $25.2 million of backlog associated with committed purchase orders from its customers for phosphorescent emitter material. These orders are anticipated to be fulfilled within the next 90 days.

Significant changes in the assets and liabilities balances associated with the Company's contracts from customers for the years ended December 31, 2023 and 2022, are as follows (in thousands):

 

 

Year Ended December 31, 2023

 

 

 

Assets

 

 

Liabilities

 

Balance at December 31, 2022

 

$

38,457

 

 

$

(63,878

)

Revenue recognized that was previously included in deferred revenue, net

 

 

—

 

 

 

195,703

 

Increases due to cash received

 

 

—

 

 

 

(202,100

)

Cumulative catch-up adjustment arising from changes in estimates of
   transaction price, net

 

 

—

 

 

 

10,556

 

Unbilled receivables recorded, net

 

 

41,659

 

 

 

—

 

Contract assets recorded, net

 

 

(2,407

)

 

 

—

 

Transferred to receivables from unbilled receivables

 

 

(35,575

)

 

 

—

 

Net change

 

 

3,677

 

 

 

4,159

 

Balance at December 31, 2023

 

$

42,134

 

 

$

(59,719

)

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2022

 

 

 

Assets

 

 

Liabilities

 

Balance at December 31, 2021

 

$

8,127

 

 

$

(157,081

)

Revenue recognized that was previously included in deferred revenue, net

 

 

—

 

 

 

239,608

 

Increases due to cash received

 

 

—

 

 

 

(176,667

)

Cumulative catch-up adjustment arising from changes in estimates of
   transaction price, net

 

 

—

 

 

 

30,262

 

Unbilled receivables recorded, net

 

 

15,946

 

 

 

—

 

Contract assets recorded, net

 

 

14,384

 

 

 

—

 

Net change

 

 

30,330

 

 

 

93,203

 

Balance at December 31, 2022

 

$

38,457

 

 

$

(63,878

)

 

The cumulative catch-up adjustment arising from changes in estimates of transaction price, net was $10.6 million for the year ended December 31, 2023 as compared to $30.3 million for the year ended December 31, 2022. These adjustments resulted from an increase in the average price per gram that was primarily due to the decrease in anticipated demand by several of the Company's customers over the remaining lives of their contracts, resulting from changes in global macroeconomic factors.

XML 45 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET INCOME PER COMMON SHARE
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
NET INCOME PER COMMON SHARE
22.
NET INCOME PER COMMON SHARE:

The Company computes earnings per share in accordance with ASC Topic 260, Earnings per Share, which requires earnings per share (EPS) for each class of stock to be calculated using the two-class method. The two-class method is an allocation of income between the holders of common stock and the Company's participating security holders. Under the two-class method, income for the reporting period is allocated between common shareholders and other security holders based on their respective participation rights in undistributed income. Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and, therefore, are included in computing earnings per share pursuant to the two-class method.

Basic net income per common share is computed by dividing net income allocated to common shareholders by the weighted-average number of shares of common stock outstanding for the period excluding unvested restricted stock units and performance units. Net income allocated to the holders of the Company's unvested restricted stock awards is calculated based on the shareholders proportionate share of weighted average shares of common stock outstanding on an if-converted basis.

For purposes of determining diluted net income per common share, basic net income per share is further adjusted to include the effect of potential dilutive common shares outstanding, including restricted stock units, performance units and the impact of shares to be issued under the Company's Employee Stock Purchase Plan.

The following table is a reconciliation of net income and the shares used in calculating basic and diluted net income per common share for the years ended December 31, 2023, 2022 and 2021 (in thousands, except share and per share data):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income

 

$

203,011

 

 

$

210,061

 

 

$

184,213

 

Adjustment for Basic EPS:

 

 

 

 

 

 

 

 

 

Earnings allocated to unvested shareholders

 

 

(993

)

 

 

(1,215

)

 

 

(1,137

)

Adjusted net income

 

$

202,018

 

 

$

208,846

 

 

$

183,076

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – Basic

 

 

47,559,669

 

 

 

47,390,352

 

 

 

47,296,447

 

Effect of dilutive shares:

 

 

 

 

 

 

 

 

 

Common stock equivalents arising from stock options and ESPP

 

 

2,173

 

 

 

2,340

 

 

 

1,010

 

Restricted stock awards and units and performance units

 

 

60,921

 

 

 

75,815

 

 

 

67,978

 

Weighted average common shares outstanding – Diluted

 

 

47,622,763

 

 

 

47,468,507

 

 

 

47,365,435

 

Net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

4.25

 

 

$

4.41

 

 

$

3.87

 

Diluted

 

$

4.24

 

 

$

4.40

 

 

$

3.87

 

For the years ended December 31, 2023, 2022, and 2021, the combined effects of unvested restricted stock awards, restricted stock units, performance unit awards and stock options of 36,345, 122,843 and none, respectively, were excluded from the calculation of diluted EPS as their impact would have been antidilutive.
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Principles of Consolidation

Principles of Consolidation

The Consolidated Financial Statements include the accounts of Universal Display Corporation and its wholly owned subsidiaries, UDC, Inc., UDC Ireland Limited (UDC Ireland), Universal Display Corporation Hong Kong, Limited, Universal Display Corporation Korea, Y.H. (UDC Korea), Universal Display Corporation Japan GK, Universal Display Corporation China, Ltd., Adesis, Inc. (Adesis), UDC Ventures LLC, OVJP Corporation (OVJP Corp) and OLED Material Manufacturing Limited (OMM). All intercompany transactions and accounts have been eliminated.
Reclassification of Prior Year Presentation

Reclassification of Prior Year Presentation

Certain prior year adjustments to reconcile net income to net cash provided by operating activities have been reclassified on the Consolidated Statements of Cash Flows to conform to the current year presentation. These adjustments have been consolidated into their respective operating assets and liabilities accounts, specifically, inventory, other current assets, other assets and deferred revenue.
Management's Use of Estimates

Management’s Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The estimates made are principally in the areas of revenue recognition including estimates of material unit sales and royalties, the useful life of acquired intangibles, lease liabilities, right-of-use assets, the use and recoverability of inventories, intangibles, investments and income taxes including realization of deferred tax assets, stock-based compensation and retirement benefit plan liabilities. Actual results could differ from those estimates.
Cash, Cash Equivalents and Investments

Cash, Cash Equivalents and Investments

The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of three months or less to be cash equivalents. The Company classifies its remaining investments as available-for-sale. These securities (excluding minority equity investments) are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.
Trade Accounts Receivable

Trade Accounts Receivable

Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. The Company’s accounts receivable balance is a result of chemical sales, royalties and license fees. These receivables have historically been paid timely. Due to the nature of the accounts receivable balance, the Company believes there is no significant collection risk. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their ability to make payments, allowances for credit losses would be required. As of December 31, 2023 and 2022, the allowance for credit losses was $166,000 and $279,000, respectively.
Inventories

Inventories

Inventories consist of raw materials, work-in-process and finished goods, and are stated at the lower of cost, determined on a first-in, first-out basis, or net realizable value. Inventory valuation and firm committed purchase order assessments are performed on a quarterly basis and those items that are identified to be obsolete or in excess of forecasted usage are written down to their estimated realizable value. Estimates of realizable value are based upon management’s analyses and assumptions, including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. A 12-month rolling forecast based on factors, including, but not limited to, production cycles, anticipated product orders, marketing forecasts, backlog, and shipment activities is used in the inventory analysis. If market conditions are less favorable than forecasts or actual demand from customers is lower than estimates, additional inventory write-downs may be required. If demand is higher than expected, inventories that had previously been written down may be sold.
Property and Equipment

Property and Equipment

Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful life of 30 years for buildings, 15 years for building improvements, and three to seven years for office and lab equipment and furniture and fixtures. Repair and maintenance costs are charged to expense as incurred. Additions and betterments are capitalized.

Major renewals and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to current operations as incurred. Upon retirement or disposal of assets, the cost and related accumulated depreciation are removed from the Consolidated Balance Sheets and any gain or loss is reflected in other operating expenses.

Certain costs of computer software obtained for internal use are capitalized and amortized on a straight-line basis over three years. Costs for maintenance and training, as well as the cost of software that does not add functionality to an existing system, are expensed as incurred.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

Company management continually evaluates whether events or changes in circumstances might indicate that the remaining estimated useful life of long-lived assets may warrant revision, or that the remaining balance may not be recoverable. When factors indicate that long-lived assets should be evaluated for possible impairment, the Company uses an estimate of the related undiscounted cash flows in measuring whether the long-lived asset should be written down to fair value. Measurement of the amount of impairment would be based on generally accepted valuation methodologies, as deemed appropriate. As of December 31, 2023, Company management believed that no revision to the remaining useful lives or write-down of the Company’s long-lived assets was required, and similarly, no such revisions were required for the years ended December 31, 2022 or 2021.
Goodwill and Purchased Intangible Assets

Goodwill and Purchased Intangible Assets

Goodwill is tested for impairment in the fourth fiscal quarter and, when specific circumstances dictate, between annual tests. If after assessing the totality of events or circumstances as those described in the qualitative assessment, it is determined that it is more likely than not the fair value of a reporting unit is less than its carrying amount, then a quantitative goodwill impairment test will be performed. Under the quantitative test, the fair value of the reporting unit is compared to its carrying amount including goodwill. If the

fair value of the reporting unit exceeds its carrying amount, goodwill of the reporting unit would be considered not impaired. However, if the carrying amount of the reporting unit exceeds its fair value, an impairment loss would be recognized in the amount equal to the excess, limited to the total amount of goodwill allocated to that reporting unit. The Company performed its annual impairment assessment as of December 31, 2023 utilizing a qualitative assessment and concluded that it was more likely than not that the fair value of Adesis is greater than its carrying value. Future impairment tests will continue to be performed annually in the fiscal fourth quarter, or sooner if a triggering event occurs. As of December 31, 2023, no indications of impairment existed.

Purchased intangible assets with finite lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets.
Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying values of accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value in the accompanying Consolidated Financial Statements due to the short-term nature of those instruments. The Company’s other financial instruments, which include cash equivalents and investments (excluding minority equity investments) are carried at fair value.
Fair Value Measurements

Fair Value Measurements

Fair value is defined as an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. The Company uses valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. Observable inputs are inputs that market participants would use in pricing the asset or liability and are based on market data obtained from sources independent of the Company. Unobservable inputs reflect assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.
Minority Equity Investments

Minority Equity Investments

The Company accounts for minority equity investments in companies that are not accounted for under the equity method as equity securities without readily determinable fair values. The value of these securities is based on original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment in the same issuer. Under this method, the share of income or loss of such companies is not included in the Consolidated Statements of Income. The carrying value of these investments is included in investments on the Consolidated Balance Sheets.

The Company’s policy is to recognize an impairment in the value of its minority equity investments when evidence of an impairment exists. Factors considered in the assessment include a significant adverse change in the regulatory, economic, or technological environment, the completion of new equity financing that may indicate a decrease in value, the failure to complete new equity financing arrangements after seeking to raise additional funds, or the commencement of proceedings under which the assets of the business may be placed in receivership or liquidated to satisfy the claims of debt and equity stakeholders. The impairment in the value of minority equity investments is included in the other (loss) income, net line item on the Consolidated Statements of Income.

Leases

Leases

The Company is a lessee in operating leases primarily incurred to facilitate manufacturing, research and development, and selling, general and administrative activities. At contract inception, the Company determines if an arrangement is or contains a lease, and if so recognizes a right-of-use asset and lease liability at the lease commencement date. For operating leases, the lease liability is measured at the present value of the unpaid lease payments at the lease commencement date, whereas for finance leases, the lease liability is initially measured at the present value of the unpaid lease payments and subsequently measured at amortized cost using the interest method. Operating lease right-of-use assets are included in other assets on the Consolidated Balance Sheets. The short-term portion of operating lease liabilities is included in other current liabilities on the Consolidated Balance Sheets and the long-term portion is included in other liabilities on the Consolidated Balance Sheets. As of December 31, 2023, the Company had no leases that qualified as financing arrangements.

Key estimates and judgments include how the Company determines the discount rate used to discount the unpaid lease payments to present value and the lease term. The Company monitors for events or changes in circumstances that could potentially require recognizing an impairment loss.
Revenue Recognition and Deferred Revenue

Revenue Recognition and Deferred Revenue

Material sales relate to the Company’s sale of its OLED materials for incorporation into its customers’ commercial OLED products or for their OLED development and evaluation activities. Revenue associated with material sales is generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties. Revenue may be recognized after control of the material passes in the event the transaction price includes variable consideration. For example, a customer may be provided an extended opportunity to stock materials prior to use in mass production and given a general right of return not conditioned on breaches of warranties associated with the specific product. In such circumstances, revenue will be recognized at the earlier of the expiration of the customer’s general right of return or once it becomes unlikely that the customer will exercise its right of return.

The vast majority of revenue attributed to material sales is determined through technology license agreements and material supply agreements the terms of which are jointly agreed upon with the Company’s customers. The remaining revenue recognized is in the form of contract research services revenue earned by the Company’s subsidiary, Adesis, Inc., and the Company’s occasional material sales to smaller customers. None of the revenue recognized during the years ended December 31, 2023, 2022 or 2021 resulted solely from royalty or license fee arrangements as to which there were not associated material sales.

The rights and benefits to the Company’s OLED technologies are conveyed to the customer through technology license agreements and material supply agreements. The Company believes that the licenses and materials sold under these combined agreements are not distinct from each other for financial reporting purposes and as such, they are accounted for as a single performance obligation. Accordingly, total contract consideration is estimated and recognized over the contract term based on material units sold at the estimated per unit fee over the life of the contract. Total contract consideration is allocated to material sales and royalty and licensing fees on the Consolidated Statements of Income based on contract pricing.

Various estimates are relied upon to recognize revenue. The Company estimates total material units to be purchased by its customers over the contract term based on historical trends, industry estimates and its forecast process. Management uses the expected value method to estimate the material per unit fee. Additionally, management estimates the sales-based portion of royalty revenue based on the estimated net sales revenue of its customers over the contract term.

Contract research services revenue is revenue earned by Adesis by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis. These services range from intermediates for structure-activity relationship studies, reference agents and building blocks for combinatorial synthesis, re-synthesis of key intermediates, specialty organic chemistry needs, and selective toll manufacturing. These services are provided to third-party pharmaceutical and life sciences firms and other technology firms at fixed costs or predetermined rates on a contract basis. Revenue is recognized as services are performed with billing schedules and payment terms negotiated on a contract-by-contract basis. Payments received in excess of revenue recognized are recorded as deferred revenue. In other cases, services may be provided and revenue is recognized before the customer is invoiced. In these cases, revenue recognized will exceed amounts billed and the difference, representing amounts which are currently unbillable to the customer pursuant to contractual terms, is recorded as an unbilled receivable.

Technology development and support revenue is revenue earned from development and technology evaluation agreements and commercialization assistance fees. Technology development and support revenue is included in contract research services on the Consolidated Statements of Income.

On December 2, 2022, the Company entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, the Company is being paid a license fee, which includes quarterly and annual payments over the agreement term of five years. The agreement conveys to SDC the non-exclusive right to use certain of the Company's intellectual property assets for a limited period of time that is less than the estimated life of the assets.

At the same time the Company entered into the current commercial license agreement with SDC, the Company also entered into a new supplemental material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the supplemental material purchase agreement, SDC agrees to purchase red and green phosphorescent emitter materials from the Company for use in the manufacture of licensed products. This amount purchased is subject to SDC’s requirements for phosphorescent emitter materials and the Company’s ability to meet these requirements over the term of the supplemental agreement.

In 2015, the Company entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display), which were effective as of January 1, 2015. The terms of these agreements were extended by a January 1, 2021 amendment through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under the Company's patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The OLED commercial supply agreement provides for the sale of materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the lives of the agreements as well as minimum royalty revenue.

In 2023, the Company entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, the Company has granted BOE non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company supplies phosphorescent OLED materials to BOE for use in its licensed products.

In 2019, the Company entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, the Company entered into long-term, multi-year agreements with CSOT. Under these agreements, the Company has granted CSOT non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company also supplies phosphorescent OLED materials to CSOT for use in its licensed products.

In 2018, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Visionox Technology, Inc. (Visionox). Under the license agreement, the Company granted certain of Visionox’s affiliates non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Visionox for use in its licensed products. In 2021, the Company announced that it had extended the Visionox agreement by entering into new five-year OLED material supply and license agreements with a new affiliate of Visionox, Visionox Hefei Technology Co. Ltd.

In 2016, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Micro-electronics Co., Ltd. (Tianma). Under the license agreement, the Company has granted Tianma non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Tianma for use in its licensed products. In 2021, the parties extended the terms of both the patent license and material purchase agreements for an additional multi-year-term.

All material sales transactions that are not variable consideration transactions are billed and due within 90 days and substantially all are transacted in U.S. dollars.
Cost of Sales

Cost of Sales

Cost of sales consists of labor and material costs associated with the production of materials processed at the facilities of the Company's manufacturing partner, PPG Industries, Inc. (PPG) and at the Company's internal facilities. The Company’s portion of cost of sales also includes depreciation of manufacturing equipment, as well as manufacturing overhead costs and inventory adjustments for excess and obsolete inventory.
Research and Development

Research and Development

Expenditures for research and development are charged to expense as incurred.
Patent Costs

Patent Costs

Costs associated with patent applications, patent prosecution, patent defense and the maintenance of patents are charged to expense as incurred. Costs to successfully defend a challenge to a patent are capitalized to the extent of an evident increase in the value of the patent. Costs that relate to an unsuccessful outcome are charged to expense.

Amortization of Acquired Technology

Amortization of Acquired Technology

Amortization costs primarily relate to technology acquired from Merck KGaA, Darmstadt, Germany (Merck KGaA), BASF SE (BASF) and Fujifilm Corporation (Fujifilm). The Merck KGaA acquisition was completed on April 28, 2023. The BASF and Fujifilm acquisitions were completed in the years ended December 31, 2016 and 2012, respectively. Acquisition costs are being amortized over

a period of 10 years for the Merck KGaA and BASF patents. The Fujifilm acquired technology was fully amortized over a period of 10 years that ended in July 2022.

Amortization of Other Intangible Assets

Amortization of Other Intangible Assets

Other intangible assets from the Adesis acquisition are being amortized over a period of 10 to 15 years. See Note 7 for further discussion.
Translation of Foreign Currency Financial Statements and Foreign Currency Transactions

Translation of Foreign Currency Financial Statements and Foreign Currency Transactions

The Company’s reporting currency is the U.S. dollar. The functional currency for the UDC Ireland and UDC Korea subsidiaries are also the U.S. dollar and the functional currency for the OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries is its respective local currency. The Company translates the amounts included in the Consolidated Statements of Income from OMM and its Asia-Pacific foreign subsidiaries into U.S. dollars at weighted-average exchange rates, which the Company believes are representative of the actual exchange rates on the dates of the transactions. The Company's OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries' assets and liabilities are translated into U.S. dollars from the local currency at the actual exchange rates as of the end of each reporting date, and the Company records the resulting foreign exchange translation adjustments in the Consolidated Balance Sheets as a component of accumulated other comprehensive loss. The overall effect of the translation of foreign currency and foreign currency transactions to date has been insignificant.
Income Taxes

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than 50%. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties, if any, related to unrecognized tax benefits as a component of tax expense.
Share-Based Payment Awards

Share-Based Payment Awards

The Company recognizes in the Consolidated Statements of Income the grant-date fair value of equity-based awards such as shares issued under employee stock purchase plans, restricted stock awards, restricted stock units and performance unit awards issued to employees and directors.

The grant-date fair value of stock awards is based on the closing price of the stock on the date of grant. The fair value of share-based awards is recognized as compensation expense on a straight-line basis over the requisite service period, net of forfeitures. The Company issues new shares upon the respective grant, exercise or vesting of the share-based payment awards, as applicable.

Performance unit awards are subject to either a performance-based or market-based vesting requirement. For performance-based vesting, the grant-date fair value of the award, based on fair value of the Company's common stock, is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved, and compensation expense is periodically adjusted based on actual and expected performance. Compensation expense for performance unit awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

Adoption of New Accounting Standards

In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with FASB ASC 606. The adoption of ASU 2021-08, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.

In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, Liabilities—Supplier Finance Programs (Subtopic 450-50): Disclosure of Supplier Finance Program Obligations, which require disclosures about a buyer's supplier finance program. The adoption of ASU 2022-04, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.

Accounting Standards Issued But Not Yet Adopted

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. Under this standard, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. The standard also requires certain disclosures for equity securities that are subject to contractual restrictions. ASU 2022-03 becomes effective January 1, 2024, and will not have a significant impact on the Consolidated Financial Statements and related disclosures.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard improves the reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 becomes effective January 1, 2024, and the Company is evaluating the potential impact of this standard on the Consolidated Financial Statements and related disclosures.

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The standard enhances to the annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity's worldwide operations. ASU 2023-09 becomes effective January 1, 2025, and the Company is evaluating the potential impact of this standard on its income tax disclosures.
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH, CASH EQUIVALENTS AND INVESTMENTS (Tables)
 12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents

The following table provides details regarding the Company’s portfolio of cash and cash equivalents (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Cash and Cash Equivalents Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Cash accounts in banking institutions

 

$

91,717

 

 

$

—

 

 

$

—

 

 

$

91,717

 

Money market accounts

 

 

268

 

 

 

—

 

 

 

—

 

 

 

268

 

 

 

$

91,985

 

 

$

—

 

 

$

—

 

 

$

91,985

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Cash accounts in banking institutions

 

$

86,268

 

 

$

—

 

 

$

—

 

 

$

86,268

 

Money market accounts

 

 

7,162

 

 

 

—

 

 

 

—

 

 

 

7,162

 

 

 

$

93,430

 

 

$

—

 

 

$

—

 

 

$

93,430

 
Schedule of Investments

The following table provides details regarding the Company’s portfolio of short-term investments (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Short-term Investments Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

1,763

 

 

$

1

 

 

$

(5

)

 

$

1,759

 

U.S. Government bonds

 

 

420,769

 

 

 

303

 

 

 

(694

)

 

 

420,378

 

 

 

$

422,532

 

 

$

304

 

 

$

(699

)

 

$

422,137

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

150,698

 

 

$

—

 

 

$

(910

)

 

$

149,788

 

U.S. Government bonds

 

 

339,472

 

 

 

32

 

 

 

(4,947

)

 

 

334,557

 

 

 

$

490,170

 

 

$

32

 

 

$

(5,857

)

 

$

484,345

 

 

The following table provides details regarding the Company’s portfolio of long-term investments (in thousands):

 

 

 

Amortized

 

 

Unrealized

 

 

Aggregate Fair

 

Long-term Investments Classification

 

Cost

 

 

Gains

 

 

(Losses)

 

 

Market Value

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Government bonds

 

$

284,053

 

 

$

1,457

 

 

$

(8

)

 

$

285,502

 

 

 

$

284,053

 

 

$

1,457

 

 

$

(8

)

 

$

285,502

 

December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

2,479

 

 

$

—

 

 

$

(28

)

 

$

2,451

 

U.S. Government bonds

 

 

247,464

 

 

 

52

 

 

 

(2,152

)

 

$

245,364

 

 

 

$

249,943

 

 

$

52

 

 

$

(2,180

)

 

$

247,815

 
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2023 (in thousands):

 

 

 

 

 

Fair Value Measurements, Using

 

 

 

Total Carrying Value
as of December 31,
 2023

 

 

Quoted Prices in
Active Markets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant Unobservable
Inputs
(Level 3)

 

Cash equivalents

 

$

268

 

 

$

268

 

 

$

—

 

 

$

—

 

Short-term Corporate bonds

 

 

1,759

 

 

 

1,759

 

 

 

—

 

 

 

—

 

Short-term U.S. Government bonds

 

 

420,378

 

 

 

420,378

 

 

 

—

 

 

 

—

 

Long-term U.S. Government bonds

 

 

285,502

 

 

 

285,502

 

 

 

—

 

 

 

—

 

 

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2022 (in thousands):

 

 

 

 

 

 

Fair Value Measurements, Using

 

 

 

Total Carrying Value
as of December 31,
 2022

 

 

Quoted Prices in
Active Markets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant Unobservable
Inputs
(Level 3)

 

Cash equivalents

 

$

7,162

 

 

$

7,162

 

 

$

—

 

 

$

—

 

Short-term Corporate bonds

 

 

149,788

 

 

 

149,788

 

 

 

—

 

 

 

—

 

Short-term U.S. Government bonds

 

 

334,557

 

 

 

334,557

 

 

 

—

 

 

 

—

 

Long-term Corporate bonds

 

 

2,451

 

 

 

2,451

 

 

 

—

 

 

 

—

 

Long-term U.S. Government bonds

 

 

245,364

 

 

 

245,364

 

 

 

—

 

 

 

—

 
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY (Tables)
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Raw materials

 

$

113,400

 

 

$

115,448

 

Work-in-process

 

 

9,433

 

 

 

7,626

 

Finished goods

 

 

52,962

 

 

 

60,146

 

Inventory

 

$

175,795

 

 

$

183,220

 
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment

Property and equipment, net consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Land

 

$

12,230

 

 

$

2,642

 

Building and improvements

 

 

116,903

 

 

 

99,586

 

Office and lab equipment

 

 

148,465

 

 

 

129,697

 

Furniture, fixtures and computer related assets

 

 

18,970

 

 

 

18,071

 

Construction-in-progress

 

 

22,490

 

 

 

10,567

 

 

 

 

319,058

 

 

 

260,563

 

Less: Accumulated depreciation

 

 

(143,908

)

 

 

(117,118

)

Property and equipment, net

 

$

175,150

 

 

$

143,445

 
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]  
Schedule of Acquired Technology

 

 

December 31,

 

 

 

2023 (1)

 

 

2022

 

PD-LD, Inc.

 

$

—

 

 

$

1,481

 

Motorola

 

 

—

 

 

 

15,909

 

Merck KGaA

 

 

66,012

 

 

 

—

 

BASF

 

 

95,989

 

 

 

95,989

 

Fujifilm

 

 

109,462

 

 

 

109,462

 

Other

 

 

5,712

 

 

 

5,212

 

 

 

 

277,175

 

 

 

228,053

 

Less: Accumulated amortization

 

 

(186,850

)

 

 

(189,671

)

Acquired technology, net

 

$

90,325

 

 

$

38,382

 

 

(1)
During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.
Schedule of Other Intangible Assets

At December 31, 2023, these other intangible assets consist of the following (in thousands):

 

 

 

December 31, 2023

 

 

 

Gross Carrying
Amount

 

 

Accumulated
Amortization

 

 

Net Carrying
Amount

 

Customer relationships

 

$

10,520

 

 

$

(6,801

)

 

$

3,719

 

Developed IP, processes and recipes

 

 

4,820

 

 

 

(2,388

)

 

 

2,432

 

Trade name/Trademarks

 

 

1,500

 

 

 

(1,118

)

 

 

382

 

Other

 

 

448

 

 

 

(107

)

 

 

341

 

Total identifiable other intangible assets

 

$

17,288

 

 

$

(10,414

)

 

$

6,874

 
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER ASSETS (Tables)
 12 Months Ended
Dec. 31, 2023
Disclosure Text Block [Abstract]  
Other Asset

Other assets consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Long-term taxes receivable

 

$

60,146

 

 

$

63,915

 

Right-of-use assets

 

 

24,910

 

 

 

31,486

 

Long-term unbilled receivables

 

 

9,074

 

 

 

—

 

Long-term contract assets

 

 

9,278

 

 

 

11,651

 

Other long-term assets

 

 

1,881

 

 

 

2,687

 

Other assets

 

$

105,289

 

 

$

109,739

 
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES (Tables)
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Operating lease cost

 

$

4,639

 

 

$

4,436

 

 

$

3,637

 

Non-cash activity:

 

 

 

 

 

 

 

 

 

Right-of-use assets obtained in exchange for lease obligations

 

$

1,072

 

 

$

4,750

 

 

$

26,174

 
Schedule Of Operating Lease Right of Use Assets and Liabilities

The following table presents the Company’s operating lease right-of-use assets and liabilities (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Right-of-use assets

 

$

24,910

 

 

$

31,486

 

Short-term lease liabilities

 

 

3,533

 

 

 

3,737

 

Long-term lease liabilities

 

 

22,855

 

 

 

29,039

 
Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities

The following table presents weighted average assumptions used to compute the Company’s right-of-use assets and lease liabilities:

 

 

 

December 31, 2023

 

Weighted average remaining lease term (in years)

 

 

6.7

 

Weighted average discount rate

 

 

3.7

%
Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms

Undiscounted future minimum lease payments as of December 31, 2023, by year and in the aggregate, having non-cancelable lease terms in excess of one year were as follows (in thousands):

 

 

 

Maturities of

 

 

 

Operating Lease Liabilities

 

2024

 

$

4,267

 

2025

 

 

4,321

 

2026

 

 

4,401

 

2027

 

 

4,323

 

2028

 

 

3,996

 

Thereafter

 

 

8,083

 

Total lease payments

 

 

29,391

 

Less: imputed interest

 

 

(3,003

)

Present value of lease payments

 

$

26,388

 
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCRUED EXPENSES (Tables)
 12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Accrued Expenses

Accrued expenses consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Compensation

 

$

29,456

 

 

$

31,751

 

PPG Industries, Inc. agreement

 

 

11,962

 

 

 

9,864

 

Consulting

 

 

2,121

 

 

 

910

 

Professional fees

 

 

1,124

 

 

 

906

 

Research and development agreements

 

 

822

 

 

 

662

 

Royalties

 

 

647

 

 

 

877

 

Other

 

 

5,948

 

 

 

6,032

 

Accrued expenses

 

$

52,080

 

 

$

51,002

 
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2023
Other Liabilities [Abstract]  
Schedule of other liabilities

Other liabilities consist of the following (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Long-term lease liabilities

 

$

22,855

 

 

$

29,039

 

Long-term taxes payable

 

 

15,749

 

 

 

14,592

 

Other long-term liabilities

 

 

54

 

 

 

54

 

Other liabilities

 

$

38,658

 

 

$

43,685

 
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)
 12 Months Ended
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of Accumulated Other Comprehensive Loss

Amounts related to the changes in accumulated other comprehensive loss were as follows (in thousands):

 

 

Unrealized
Gain (Loss) on
Available-for-
Sale-Securities

 

 

Net Unrealized
Gain (Loss) on
Retirement Plan (2)

 

 

Change in Cumulative
Foreign Currency
Translation Adjustment

 

 

Total

 

 

Affected Line items in the
Consolidated Statements of
Income

Balance January 1, 2021, net of tax

 

$

91

 

 

$

(36,075

)

 

$

(35

)

 

$

(36,019

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

(233

)

 

 

13,620

 

 

 

(39

)

 

 

13,348

 

 

 

Plan amendment cost

 

 

—

 

 

 

(283

)

 

 

—

 

 

 

(283

)

 

 


Reclassification to net income (1)

 

 

—

 

 

 

4,719

 

 

 

—

 

 

 

4,719

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

(233

)

 

 

18,056

 

 

 

(39

)

 

 

17,784

 

 

 

Balance December 31, 2021, net of tax

 

 

(142

)

 

 

(18,019

)

 

 

(74

)

 

 

(18,235

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

(7,745

)

 

 

5,971

 

 

 

(480

)

 

 

(2,254

)

 

 



Reclassification to net income (1)

 

 

—

 

 

 

2,037

 

 

 

—

 

 

 

2,037

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

(7,745

)

 

 

8,008

 

 

 

(480

)

 

 

(217

)

 

 

Balance December 31, 2022, net of tax

 

 

(7,887

)

 

 

(10,011

)

 

 

(554

)

 

 

(18,452

)

 

 

Other comprehensive (loss) gain
   before reclassification

 

 

8,745

 

 

 

7,207

 

 

 

418

 

 

 

16,370

 

 

 



Reclassification to net income (1)

 

 

—

 

 

 

996

 

 

 

—

 

 

 

996

 

 

Selling, general and administrative,
research and development and
cost of sales

Change during period

 

 

8,745

 

 

 

8,203

 

 

 

418

 

 

 

17,366

 

 

 

Balance December 31, 2023, net of tax

 

$

858

 

 

$

(1,808

)

 

$

(136

)

 

$

(1,086

)

 

 

 

(1)
The Company reclassified amortization of prior service cost, actuarial loss and plan amendment cost for its retirement plan from accumulated other comprehensive loss to net income of $1.0 million, $2.0 million and $4.7 million for the years ended December 31, 2023, 2022 and 2021, respectively.
Refer to Note 17: Employee Retirement Plans
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Restricted Stock and Units Activity

The following table summarizes the activity related to restricted stock unit (RSU) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

230,223

 

 

$

165.13

 

Granted

 

 

121,896

 

 

 

136.22

 

Vested

 

 

(132,010

)

 

 

163.85

 

Forfeited

 

 

(3,623

)

 

 

152.21

 

Unvested, December 31, 2023

 

 

216,486

 

 

$

149.68

 

The weighted average grant-date fair value per unit of RSU awards granted was $136.22, $140.37 and $208.67 during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSUs that vested during the year was $21.6 million for the year ended December 31, 2023, $18.0 million for the year ended December 31, 2022 and $12.5 million for the year ended December 31, 2021. The fair value of RSUs as of their respective vesting dates was $18.6 million for the year ended December 31, 2023, $15.3 million for the year ended December 31, 2022 and $15.1 million for the year ended December 31, 2021.

The following table summarizes the activity related to restricted stock award (RSA) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

33,637

 

 

$

178.37

 

Granted

 

 

2,366

 

 

 

126.87

 

Vested

 

 

(18,456

)

 

 

178.82

 

Unvested, December 31, 2023

 

 

17,547

 

 

$

170.96

 
Schedule of Nonvested Performance-Based Units Activity

The following table summarizes the activity related to performance unit awards (PSU) share based payment awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested, January 1, 2023

 

 

227,866

 

 

$

185.57

 

Granted

 

 

84,448

 

 

 

165.72

 

Vested

 

 

(11,970

)

 

 

155.85

 

Forfeited

 

 

(91,791

)

 

 

170.96

 

Unvested, December 31, 2023

 

 

208,553

 

 

$

185.86

 
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS (Tables)
 12 Months Ended
Dec. 31, 2023
Defined Benefit Pension Plans And Defined Benefit Postretirement Plans [Abstract]  
Information Relating to the Company's Plan

Information relating to the Company’s plan is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Change in benefit obligation:

 

 

 

 

 

 

Benefit obligation, beginning of year

 

$

61,804

 

 

$

66,773

 

Service cost

 

 

951

 

 

 

1,287

 

Interest cost

 

 

2,898

 

 

 

1,383

 

Actuarial gain

 

 

(9,375

)

 

 

(7,639

)

Benefit payments

 

 

(2,015

)

 

 

—

 

Benefit obligation, end of year

 

 

54,263

 

 

 

61,804

 

Fair value of plan assets

 

 

—

 

 

 

—

 

Unfunded status of the plan, end of year

 

$

54,263

 

 

$

61,804

 

Current liability

 

$

2,014

 

 

$

2,014

 

Non-current liability

 

$

52,249

 

 

$

59,790

 
Components of Net Periodic Pension Cost

The components of net periodic pension cost were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Service cost

 

$

951

 

 

$

1,287

 

 

$

1,675

 

Interest cost

 

 

2,898

 

 

 

1,383

 

 

 

1,165

 

Amortization of prior service cost

 

 

815

 

 

 

1,119

 

 

 

1,099

 

Amortization of loss

 

 

480

 

 

 

1,487

 

 

 

4,936

 

Total net periodic benefit cost

 

$

5,144

 

 

$

5,276

 

 

$

8,875

 
Assumptions Used to Determine Benefit Obligation and Net Periodic Pension Cost

Assumptions used to determine the year end benefit obligation were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Discount rate

 

 

4.74

%

 

 

4.94

%

Rate of compensation increases

 

 

3.50

%

 

 

3.50

%

 

Assumptions used to determine the net periodic pension cost were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Discount rate

 

 

4.94

%

 

 

2.16

%

 

 

1.54

%

Rate of compensation increases

 

 

3.50

%

 

 

3.50

%

 

 

3.50

%
Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year

The estimated amounts to be amortized from accumulated other comprehensive loss into the net periodic pension cost in 2024 are as follows (in thousands):

 

Amortization of prior service cost

 

$

43

 

Amortization of loss

 

 

—

 

Total

 

$

43

 
Benefit Payments Expected to be Paid

Benefit payments, which reflect estimated future service, are currently expected to be paid as follows (in thousands):

 

Year

 

Projected
Benefits

 

2024

 

$

2,014

 

2025

 

 

5,097

 

2026

 

 

6,141

 

2027

 

 

6,489

 

2028

 

 

6,489

 

2029-2033

 

 

34,503

 

Thereafter

 

 

14,855

 
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONCENTRATION OF RISK (Tables)
 12 Months Ended
Dec. 31, 2023
Risks and Uncertainties [Abstract]  
Revenues and Accounts Receivable From Our Largest Customers

Revenues and accounts receivable from the Company's largest customers for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands):

 

 

2023

 

 

2022

 

 

2021

 

Customer

 

% of Total Revenue

 

Accounts Receivable

 

 

% of Total Revenue

 

Accounts Receivable

 

 

% of Total Revenue

 

Accounts Receivable

 

A

 

36%

 

$

38,105

 

 

41%

 

$

11,425

 

 

44%

 

$

10,850

 

B

 

23%

 

 

30,142

 

 

25%

 

 

24,440

 

 

26%

 

 

45,867

 

C

 

17%

 

 

38,529

 

 

16%

 

 

22,291

 

 

14%

 

 

18,557

 
Revenues by Geographic Area Revenues by geographic area are as follows (in thousands):

 

 

 

Year Ended December 31,

 

Country

 

2023

 

 

2022

 

 

2021

 

South Korea

 

$

322,509

 

 

$

360,640

 

 

$

334,835

 

China

 

 

229,727

 

 

 

230,582

 

 

 

192,079

 

Japan

 

 

6,971

 

 

 

5,579

 

 

 

7,358

 

Other non-U.S. locations

 

 

4,411

 

 

 

3,829

 

 

 

3,137

 

Total non-U.S. locations

 

 

563,618

 

 

 

600,630

 

 

 

537,409

 

United States

 

 

12,811

 

 

 

15,989

 

 

 

16,116

 

Total revenue

 

$

576,429

 

 

$

616,619

 

 

$

553,525

 
Long-Lived Assets (Net) by Geographic Area

Property and equipment, net by geographic area are as follows (in thousands):

 

 

 

December 31,

 

Country

 

2023

 

 

2022

 

United States

 

$

118,250

 

 

$

117,255

 

Ireland

 

 

42,203

 

 

 

20,270

 

Other

 

 

14,697

 

 

 

5,920

 

Total long-lived assets

 

$

175,150

 

 

$

143,445

 

XML 60 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Components of Income (Loss) before Income Taxes

The components of income before income taxes are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

United States

 

$

71,514

 

 

$

77,205

 

 

$

60,066

 

Foreign

 

 

173,657

 

 

 

191,025

 

 

 

168,181

 

Income before income taxes

 

$

245,171

 

 

$

268,230

 

 

$

228,247

 
Components of Income Tax Expense

The components of the income tax expense are as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Current income tax (expense) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

$

(15,848

)

 

$

(51,980

)

 

$

(16,433

)

State

 

 

(3,048

)

 

 

(1,833

)

 

 

(641

)

Foreign

 

 

(27,030

)

 

 

(31,302

)

 

 

(25,212

)

 

 

 

(45,926

)

 

 

(85,115

)

 

 

(42,286

)

Deferred income tax (expense) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

 

(460

)

 

 

25,916

 

 

 

(844

)

State

 

 

3,936

 

 

 

1,216

 

 

 

(734

)

Foreign

 

 

290

 

 

 

(186

)

 

 

(170

)

 

 

 

3,766

 

 

 

26,946

 

 

 

(1,748

)

Income tax expense

 

$

(42,160

)

 

$

(58,169

)

 

$

(44,034

)
Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate

Reconciliation of the statutory U.S. federal tax rate to the Company's effective tax rate is as follows:

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Statutory U.S. federal income tax rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

Effect of foreign operations

 

 

(4.0

)

 

 

(4.9

)

 

 

(5.0

)

U.S. International Tax (Sub F, GILTI, FDII)

 

 

2.9

 

 

 

4.2

 

 

 

2.1

 

Research tax credits

 

 

(2.4

)

 

 

(1.9

)

 

 

(1.4

)

Redetermination of foreign tax credit utilization

 

 

(2.0

)

 

 

—

 

 

 

—

 

Nondeductible employee compensation

 

 

1.7

 

 

 

1.9

 

 

 

3.0

 

State income taxes, net of federal benefit

 

 

(0.2

)

 

 

0.1

 

 

 

0.2

 

Stock based compensation

 

 

0.1

 

 

 

0.2

 

 

 

(0.3

)

Accruals and reserves

 

 

—

 

 

 

—

 

 

 

(0.8

)

Other

 

 

0.1

 

 

 

1.1

 

 

 

0.5

 

Effective tax rate

 

 

17.2

%

 

 

21.7

%

 

 

19.3

%
Tax Loss and Tax Credit Carryforwards

The following table summarizes Company tax credit carry forwards for tax return purposes as of December 31, 2023 (in thousands):

 

 

 

Tax Benefit

 

 

Expiration Date

Tax credit carry forwards:

 

 

 

 

 

State research tax credits

 

$

8,752

 

 

2034-2038

Foreign tax credits

 

$

186

 

 

2031

Total credit carry forwards

 

$

8,938

 

 

 
Significant Components of Deferred Tax Assets and Liabilities

Significant components of the Company's net deferred tax assets and liabilities are as follows (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Deferred tax asset:

 

 

 

 

 

 

Capitalized research expenditures

 

$

39,459

 

 

$

38,485

 

Retirement plan

 

 

12,555

 

 

 

13,495

 

Tax credit carry forwards

 

 

8,938

 

 

 

8,100

 

Accruals and reserves

 

 

7,180

 

 

 

6,944

 

Lease Liabilities

 

 

6,671

 

 

 

7,230

 

Deferred revenue

 

 

1,741

 

 

 

2,077

 

Stock-based compensation

 

 

1,498

 

 

 

1,454

 

Other

 

 

1,362

 

 

 

3,400

 

 

 

 

79,404

 

 

 

81,185

 

Valuation allowance

 

 

(9,551

)

 

 

(11,087

)

Deferred tax assets

 

 

69,853

 

 

 

70,098

 

Deferred tax liability:

 

 

 

 

 

 

Lease Assets

 

 

(6,302

)

 

 

(6,944

)

Acquisition Goodwill

 

 

(1,549

)

 

 

(1,283

)

Other

 

 

(2,894

)

 

 

(3,710

)

Deferred tax liabilities

 

 

(10,745

)

 

 

(11,937

)

Net deferred tax assets

 

$

59,108

 

 

$

58,161

 
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
REVENUE RECOGNITION (Tables)
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Assets and Liabilities Associated with Contracts from Customers

The following table provides information about assets and liabilities associated with the Company's contracts from customers (in thousands):

 

 

 

As of December 31, 2023

 

Accounts receivable

 

$

139,850

 

Short-term unbilled receivables

 

 

21,084

 

Short-term contract assets

 

 

2,698

 

Long-term unbilled receivables

 

 

9,074

 

Long-term contract assets

 

 

9,278

 

Short-term deferred revenue

 

 

47,713

 

Long-term deferred revenue

 

 

12,006

 
Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances

Significant changes in the assets and liabilities balances associated with the Company's contracts from customers for the years ended December 31, 2023 and 2022, are as follows (in thousands):

 

 

Year Ended December 31, 2023

 

 

 

Assets

 

 

Liabilities

 

Balance at December 31, 2022

 

$

38,457

 

 

$

(63,878

)

Revenue recognized that was previously included in deferred revenue, net

 

 

—

 

 

 

195,703

 

Increases due to cash received

 

 

—

 

 

 

(202,100

)

Cumulative catch-up adjustment arising from changes in estimates of
   transaction price, net

 

 

—

 

 

 

10,556

 

Unbilled receivables recorded, net

 

 

41,659

 

 

 

—

 

Contract assets recorded, net

 

 

(2,407

)

 

 

—

 

Transferred to receivables from unbilled receivables

 

 

(35,575

)

 

 

—

 

Net change

 

 

3,677

 

 

 

4,159

 

Balance at December 31, 2023

 

$

42,134

 

 

$

(59,719

)

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2022

 

 

 

Assets

 

 

Liabilities

 

Balance at December 31, 2021

 

$

8,127

 

 

$

(157,081

)

Revenue recognized that was previously included in deferred revenue, net

 

 

—

 

 

 

239,608

 

Increases due to cash received

 

 

—

 

 

 

(176,667

)

Cumulative catch-up adjustment arising from changes in estimates of
   transaction price, net

 

 

—

 

 

 

30,262

 

Unbilled receivables recorded, net

 

 

15,946

 

 

 

—

 

Contract assets recorded, net

 

 

14,384

 

 

 

—

 

Net change

 

 

30,330

 

 

 

93,203

 

Balance at December 31, 2022

 

$

38,457

 

 

$

(63,878

)

 
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET INCOME PER COMMON SHARE (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share

The following table is a reconciliation of net income and the shares used in calculating basic and diluted net income per common share for the years ended December 31, 2023, 2022 and 2021 (in thousands, except share and per share data):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income

 

$

203,011

 

 

$

210,061

 

 

$

184,213

 

Adjustment for Basic EPS:

 

 

 

 

 

 

 

 

 

Earnings allocated to unvested shareholders

 

 

(993

)

 

 

(1,215

)

 

 

(1,137

)

Adjusted net income

 

$

202,018

 

 

$

208,846

 

 

$

183,076

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – Basic

 

 

47,559,669

 

 

 

47,390,352

 

 

 

47,296,447

 

Effect of dilutive shares:

 

 

 

 

 

 

 

 

 

Common stock equivalents arising from stock options and ESPP

 

 

2,173

 

 

 

2,340

 

 

 

1,010

 

Restricted stock awards and units and performance units

 

 

60,921

 

 

 

75,815

 

 

 

67,978

 

Weighted average common shares outstanding – Diluted

 

 

47,622,763

 

 

 

47,468,507

 

 

 

47,365,435

 

Net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

4.25

 

 

$

4.41

 

 

$

3.87

 

Diluted

 

$

4.24

 

 

$

4.40

 

 

$

3.87

 
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS - Additional Information (Details)
Dec. 31, 2023
Patent
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of patents issued and pending application 6,000
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Jun. 28, 2016
Jul. 23, 2012
Summary Of Significant Accounting Policies [Line Items]        
Cash and cash equivalents maturity period three months or less      
Allowance for doubtful accounts $ 166,000 $ 279,000    
Goodwill impairment loss $ 0      
Recognized income tax positions measured at likelihood of realization description Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than 50%      
FUJIFILM [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Amortization period of acquired intangible assets (in years) 10 years      
Visionox Hefei Technology [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Additional agreement duration 5 years      
Patents [Member] | FUJIFILM [Member]        
Summary Of Significant Accounting Policies [Line Items]        
OLED patents useful life       10 years
Patents [Member] | BASF [Member]        
Summary Of Significant Accounting Policies [Line Items]        
OLED patents useful life 10 years   10 years  
Minimum [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Recognized income tax positions measured at percentage of likelihood of realization 50.00%      
Minimum [Member] | Other Intangible Assets [Member] | Adesis, Inc. [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Amortization period of acquired intangible assets (in years) 10 years      
Maximum [Member] | Other Intangible Assets [Member] | Adesis, Inc. [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Amortization period of acquired intangible assets (in years) 15 years      
Building [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Estimated useful life (in years) 30 years      
Building Improvements [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Estimated useful life (in years) 15 years      
Office, Lab Equipment and Furniture and Fixtures [Member] | Minimum [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Estimated useful life (in years) 3 years      
Office, Lab Equipment and Furniture and Fixtures [Member] | Maximum [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Estimated useful life (in years) 7 years      
Computer Software [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Estimated useful life (in years) 3 years      
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Cash, Cash Equivalents (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Cash And Cash Equivalents [Line Items]    
Cash Equivalents, at Carrying Value $ 91,985 $ 93,430
Cash Equivalents, Gross Unrealized Gains 0 0
Cash Equivalents, Gross Unrealized Losses 0 0
Cash and Cash Equivalents, Fair Value Disclosure 91,985 93,430
Cash Accounts in Banking Institutions [Member]    
Cash And Cash Equivalents [Line Items]    
Cash Equivalents, at Carrying Value 91,717 86,268
Cash Equivalents, Gross Unrealized Gains 0 0
Cash Equivalents, Gross Unrealized Losses 0 0
Cash and Cash Equivalents, Fair Value Disclosure 91,717 86,268
Money Market Accounts [Member]    
Cash And Cash Equivalents [Line Items]    
Cash Equivalents, at Carrying Value 268 7,162
Cash Equivalents, Gross Unrealized Gains 0 0
Cash Equivalents, Gross Unrealized Losses 0 0
Cash and Cash Equivalents, Fair Value Disclosure $ 268 $ 7,162
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Investments (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Available For Sale Securities [Line Items]    
Available-for-sale Securities, Fair Value Disclosure   $ 4,000
Short-term Investments [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Available-for-sale Debt Securities, Amortized Cost Basis $ 422,532 490,170
Available-for-sale Securities, Gross Unrealized Gains 304 32
Available-for-sale Securities, Gross Unrealized Losses (699) (5,857)
Available-for-sale Securities, Fair Value Disclosure 422,137 484,345
Long-term Investments [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Available-for-sale Debt Securities, Amortized Cost Basis 284,053 249,943
Available-for-sale Securities, Gross Unrealized Gains 1,457 52
Available-for-sale Securities, Gross Unrealized Losses (8) (2,180)
Available-for-sale Securities, Fair Value Disclosure 285,502 247,815
Corporate Bonds [Member] | Short-term Investments [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Available-for-sale Debt Securities, Amortized Cost Basis 1,763 150,698
Available-for-sale Securities, Gross Unrealized Gains 1 0
Available-for-sale Securities, Gross Unrealized Losses (5) (910)
Available-for-sale Securities, Fair Value Disclosure 1,759 149,788
Corporate Bonds [Member] | Long-term Investments [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Available-for-sale Debt Securities, Amortized Cost Basis   2,479
Available-for-sale Securities, Gross Unrealized Gains   0
Available-for-sale Securities, Gross Unrealized Losses   (28)
Available-for-sale Securities, Fair Value Disclosure   2,451
U.S. Government Bonds [Member] | Short-term Investments [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Available-for-sale Debt Securities, Amortized Cost Basis 420,769 339,472
Available-for-sale Securities, Gross Unrealized Gains 303 32
Available-for-sale Securities, Gross Unrealized Losses (694) (4,947)
Available-for-sale Securities, Fair Value Disclosure 420,378 334,557
U.S. Government Bonds [Member] | Long-term Investments [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Available-for-sale Debt Securities, Amortized Cost Basis 284,053 247,464
Available-for-sale Securities, Gross Unrealized Gains 1,457 52
Available-for-sale Securities, Gross Unrealized Losses (8) (2,152)
Available-for-sale Securities, Fair Value Disclosure $ 285,502 $ 245,364
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH, CASH EQUIVALENTS AND INVESTMENTS - Additional Information (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Investment
Dec. 31, 2023
USD ($)
Dec. 31, 2021
Investment
Cash and Cash Equivalents [Line Items]      
Number of minority investments | Investment     4
Minority investment, carrying value $ 12.0 $ 14.0  
Number Of Convertible Note Investments | Investment 2    
Available-for-sale Securities, Fair Value Disclosure $ 4.0    
Impairment in minority investment $ 3.0    
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 91,985 $ 93,430
Short-term Corporate bonds 422,137 484,345
Short-term U.S. Government bonds 2,698  
Long-term U.S. Government bonds 299,548 259,861
Fair Value, Measurements, Recurring [Member] | Reported Value Measurement [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 268 7,162
Short-term Corporate bonds 1,759 149,788
Short-term U.S. Government bonds 420,378 334,557
Long-term Corporate bonds   2,451
Long-term U.S. Government bonds 285,502 245,364
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 268 7,162
Short-term Corporate bonds 1,759 149,788
Short-term U.S. Government bonds 420,378 334,557
Long-term Corporate bonds   2,451
Long-term U.S. Government bonds $ 285,502 $ 245,364
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Fair Value Disclosures [Abstract]    
Credit losses on debt investments $ 0 $ 0
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY - Schedule of Inventory (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 113,400 $ 115,448
Work-in-process 9,433 7,626
Finished goods 52,962 60,146
Inventory $ 175,795 $ 183,220
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY - Additional Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]      
Change in inventory reserve $ 8.5 $ 3.6 $ 3.6
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 319,058 $ 260,563
Less: Accumulated depreciation (143,908) (117,118)
Property and equipment, net 175,150 143,445
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 12,230 2,642
Building and improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 116,903 99,586
Office and lab equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 148,465 129,697
Furniture, fixtures and computer related assets [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 18,970 18,071
Construction-in-progress [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 22,490 $ 10,567
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]      
Depreciation expense $ 27,409 $ 24,815 $ 19,968
Increase in property and equipment $ 59,792 $ 42,497 $ 43,161
Property Available for Operating Lease [Member]      
Property, Plant and Equipment [Line Items]      
Descripion of Property Available for Operating Lease The increase in property and equipment, net for the year ended December 31, 2023 is primarily due to the purchases of two previously leased facilities for an aggregate cost of $23.4 million    
Increase in property and equipment $ 23,400    
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Schedule of Acquired Technology (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
 [1]
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Acquired technology, gross $ 277,175 $ 228,053
Less: Accumulated amortization (186,850) (189,671)
Acquired technology, net 90,325 38,382
PD LD, Inc [Member]    
Finite-Lived Intangible Assets [Line Items]    
Acquired technology, gross 0 1,481
Motorola [Member]    
Finite-Lived Intangible Assets [Line Items]    
Acquired technology, gross 0 15,909
Merck KGaA[Member]    
Finite-Lived Intangible Assets [Line Items]    
Acquired technology, gross 66,012 0
BASF [Member]    
Finite-Lived Intangible Assets [Line Items]    
Acquired technology, gross 95,989 95,989
FUJIFILM [Member]    
Finite-Lived Intangible Assets [Line Items]    
Acquired technology, gross 109,462 109,462
Other [Member]    
Finite-Lived Intangible Assets [Line Items]    
Acquired technology, gross $ 5,712 $ 5,212
[1] During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Acquired Technology - Additional Information (Details)
€ in Millions
 12 Months Ended
Apr. 28, 2023
USD ($)
Board_member
Jun. 28, 2016
USD ($)
Patent
Jun. 28, 2016
EUR (€)
Patent
Jul. 23, 2012
USD ($)
Patent
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2029
USD ($)
Dec. 31, 2028
USD ($)
Dec. 31, 2027
USD ($)
Dec. 31, 2026
USD ($)
Apr. 30, 2023
USD ($)
Finite-Lived Intangible Assets [Line Items]                        
Amortization of Intangible Assets         $ 15,993,000 $ 17,459,000 $ 21,994,000          
Future amortization expense, 2023         16,800,000              
Future amortization expense, 2024         16,800,000              
Future amortization expense, 2025         16,800,000              
Future amortization expense, 2026                     $ 12,000,000  
Future amortization expense, 2027                 $ 7.2 $ 7.2    
Future amortization expense, thereafter               $ 30,300,000        
Patent Technology [Member]                        
Finite-Lived Intangible Assets [Line Items]                        
Amortization of Intangible Assets         $ 14,600,000 $ 16,000,000 $ 20,600,000          
Patents [Member] | FUJIFILM [Member]                        
Finite-Lived Intangible Assets [Line Items]                        
Number of patents acquired (more than) | Patent       1,200                
Assigned value of acquired intangible assets       $ 105,000,000                
Cash paid for OLED patents       $ 4,500,000                
OLED patents useful life       10 years                
Patents [Member] | BASF [Member]                        
Finite-Lived Intangible Assets [Line Items]                        
Number of patents acquired (more than) | Patent   500 500                  
Assigned value of acquired intangible assets   $ 95,800,000 € 86.8                  
Acquisition Costs, Period Cost   95,800,000 € 86.8                  
Cash paid for OLED patents   $ 217,000,000                    
OLED patents useful life   10 years     10 years              
Patents [Member] | Merck KGaA[Member]                        
Finite-Lived Intangible Assets [Line Items]                        
Number of patents acquired (more than) | Board_member 550                      
Assigned value of acquired intangible assets $ 66,000,000                      
Cash paid for OLED patents                       $ 66,000,000
OLED patents useful life                       10 years
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Other Intangible Assets - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2027
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]              
Other intangible assets $ 16,800,000            
Goodwill 15,535,000 $ 15,535,000          
Adesis, Inc. [Member]              
Finite-Lived Intangible Assets [Line Items]              
Other intangible assets 17,288,000            
Amortization expense related to other intangible assets 1,400,000 $ 1,400,000 $ 1,400,000        
Future amortization expense of other intangible assets, fiscal year 2024 1,400,000            
Future amortization expense of other intangible assets, fiscal year 2026           $ 1,400,000  
Future amortization expense of other intangible assets, fiscal year 2025         $ 1,400,000    
Future amortization expense of other intangible assets, fiscal year 2027       $ 1,300,000      
Future amortization expense of other intangible assets, fiscal year 2028       422,000     $ 1,400,000
Future amortization expense of other intangible assets, thereafter       $ 1,000,000      
Goodwill 15,500,000            
Adesis, Inc. [Member] | Customer Relationships [Member]              
Finite-Lived Intangible Assets [Line Items]              
Other intangible assets $ 10,520,000            
Amortization period of acquired intangible assets (in years) 11 years 6 months            
Adesis, Inc. [Member] | Internally-developed IP, Processes and Recipes [Member]              
Finite-Lived Intangible Assets [Line Items]              
Other intangible assets $ 4,820,000            
Amortization period of acquired intangible assets (in years) 15 years            
Adesis, Inc. [Member] | Trade Name/Trademarks [Member]              
Finite-Lived Intangible Assets [Line Items]              
Other intangible assets $ 1,500,000            
Amortization period of acquired intangible assets (in years) 10 years            
FUJIFILM [Member]              
Finite-Lived Intangible Assets [Line Items]              
Amortization period of acquired intangible assets (in years) 10 years            
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 16,800  
Accumulated Amortization (10,414) $ (8,989)
Net Carrying Amount 6,874 $ 8,247
Adesis, Inc. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 17,288  
Accumulated Amortization (10,414)  
Net Carrying Amount 6,874  
Customer Relationships [Member] | Adesis, Inc. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 10,520  
Accumulated Amortization (6,801)  
Net Carrying Amount 3,719  
Developed IP, Processes and Recipes [Member] | Adesis, Inc. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 4,820  
Accumulated Amortization (2,388)  
Net Carrying Amount 2,432  
Trade Name/Trademarks [Member] | Adesis, Inc. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 1,500  
Accumulated Amortization (1,118)  
Net Carrying Amount 382  
Other Intangible Assets [Member] | Adesis, Inc. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 448  
Accumulated Amortization (107)  
Net Carrying Amount $ 341  
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER ASSETS - Schedule of Other Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Other Assets [Abstract]    
Long-term taxes receivable $ 60,146 $ 63,915
Right-of-use assets 24,910 31,486
Long-term unbilled receivables $ 9,074 $ 0
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other Assets, Noncurrent Other Assets, Noncurrent
Long-term contract assets $ 9,278 $ 11,651
Other Long-Term Investments 1,881 2,687
Other Assets, Total $ 105,289 $ 109,739
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES- Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Lessee Lease Description [Line Items]      
Operating lease description As of December 31, 2023, the Company did not have any finance leases and no additional operating leases that have not yet commenced.    
Operating lease cost $ 4,639 $ 4,436 $ 3,637
Operating lease, option to extend     true
Minimum [Member]      
Lessee Lease Description [Line Items]      
Operating leases remaining term 3 years    
Maximum [Member]      
Lessee Lease Description [Line Items]      
Operating leases remaining term 8 years    
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]      
Operating lease cost $ 4,639 $ 4,436 $ 3,637
Non-cash activity:      
Right-of-use assets obtained in exchange for lease obligations $ 1,072 $ 4,750 $ 26,174
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Schedule Of Operating Lease Right of Use Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Right-of-use assets $ 24,910 $ 31,486
Short-term lease liabilities $ 3,533 $ 3,737
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current Other Liabilities, Current
Long-term lease liabilities $ 22,855 $ 29,039
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Noncurrent Other Liabilities, Noncurrent
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities (Details)
Dec. 31, 2023
Leases [Abstract]  
Weighted average remaining lease term (in years) 6 years 8 months 12 days
Weighted average discount rate 3.70%
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Lessee Lease Description [Line Items]  
2024 $ 4,267
2025 4,401
2026 4,321
2027 4,323
2028 3,996
Thereafter 8,083
Total lease payments 29,391
Less: imputed interest (3,003)
Present value of lease payments $ 26,388
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCRUED EXPENSES - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Compensation $ 29,456 $ 31,751
PPG Industries, Inc. agreement 11,962 9,864
Consulting 2,121 910
Professional Fees 1,124 906
Research and development agreements 822 662
Royalties 647 877
Other 5,948 6,032
Accrued Expenses $ 52,080 $ 51,002
XML 85 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS- Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Research And Development Arrangement Contract To Perform For Others [Line Items]      
Royalty expense $ 647 $ 877 $ 691
1997 Amended License Agreement [Member]      
Research And Development Arrangement Contract To Perform For Others [Line Items]      
Royalty expense 575,000 853,000 691,000
2006 Research Agreement [Member]      
Research And Development Arrangement Contract To Perform For Others [Line Items]      
Maximum obligation 2,000    
Research and development expense incurred $ 1,100 $ 905,000 $ 1,300
XML 86 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER LIABILITIES - Summary of Other liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Long-term taxes payable $ 15,749 $ 14,592
Long-term lease liabilities $ 22,855 $ 29,039
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Noncurrent Other Liabilities, Noncurrent
Other long-term liabilities $ 54 $ 54
Other Liabilities $ 38,658 $ 43,685
XML 87 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Long-term Purchase Commitment [Line Items]      
Percent of services payable in cash or shares 50.00%    
Issuance of common stock in connection with materials and license agreements (in shares) 0    
Charges to expense for cash portion of reimbursement of expenses $ 9.1 $ 7.3 $ 3.6
New OLED Materials Agreement and OLED Materials Agreement [Member] | Weighted Average      
Long-term Purchase Commitment [Line Items]      
Minimum average closing price of common stock (in dollars per share) $ 20    
XML 88 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY - Additional Information (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Feb. 20, 2024
$ / shares
Dec. 31, 2023
USD ($)
Board_member
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2021
$ / shares
Class Of Stock [Line Items]        
Preferred Stock, shares authorized ( in shares)   5,000,000 5,000,000  
Preferred Stock, par value (in dollars per share) | $ / shares   $ 0.01 $ 0.01  
Number of board members elected by class A shareholders | Board_member   2    
Common Stock, shares authorized (in shares)   200,000,000 200,000,000  
Common Stock, par value (in dollars per share) | $ / shares   $ 0.01 $ 0.01  
Common Stock, shares issued (in shares)   48,731,026 49,136,030  
Common Stock, shares outstanding (in shares)   47,365,378 47,770,382  
Treasury stock repurchased shares   0 0  
Common stock dividends declared per share | $ / shares   $ 1.4 $ 1.2 $ 0.8
Common stock dividends paid per share | $ / shares   $ 1.4    
Common stock dividends paid | $   $ 66.7    
Subsequent Event [Member]        
Class Of Stock [Line Items]        
Common stock dividends declared per share | $ / shares $ 0.4      
Dividend payable date Mar. 29, 2024      
Dividend record date Mar. 15, 2024      
Series A Nonconvertible Preferred Stock [Member]        
Class Of Stock [Line Items]        
Preferred Stock, shares issued (in shares)   200,000 200,000  
Preferred Stock, liquidation value per share (in dollars per share) | $ / shares   $ 7.5 $ 7.5  
Preferred stock voting rights   Holders of the Series A shares are entitled to one vote per share on matters which shareholders are generally entitled to vote.    
Preferred Stock, shares outstanding (in shares)   200,000 200,000  
Series A Nonconvertible Preferred Stock [Member] | One Nine Nine Five [Member]        
Class Of Stock [Line Items]        
Preferred Stock, shares issued (in shares)   200,000    
XML 89 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Roll Forward]      
BALANCE $ 1,275,369 $ 1,099,914 $ 912,714
Reclassification to net income 1,000 2,000 4,700
Other comprehensive loss 17,366 (217) 17,784
BALANCE 1,447,226 1,275,369 1,099,914
Unrealized gain (loss) on available-for-sale securities [Member]      
Accumulated Other Comprehensive Income (Loss) [Roll Forward]      
BALANCE (7,887) (142) 91
Other comprehensive gain (loss) before reclassification 8,745 (7,745) (233)
Plan amendment cost     0
Reclassification to net income [1] 0 0 0
Other comprehensive loss 8,745 (7,745) (233)
BALANCE 858 (7,887) (142)
Net unrealized gain (loss) on retirement plan [Member]      
Accumulated Other Comprehensive Income (Loss) [Roll Forward]      
BALANCE [2] (10,011) (18,019) (36,075)
Other comprehensive gain (loss) before reclassification [2] 7,207 5,971 13,620
Plan amendment cost [2]     (283)
Reclassification to net income [1],[2] 996 2,037 4,719
Other comprehensive loss [2] 8,203 8,008 18,056
BALANCE [2] (1,808) (10,011) (18,019)
Change in cumulative foreign currency translation adjustment [Member]      
Accumulated Other Comprehensive Income (Loss) [Roll Forward]      
BALANCE (554) (74) (35)
Other comprehensive gain (loss) before reclassification 418 (480) (39)
Plan amendment cost     0
Reclassification to net income [1] 0 0 0
Other comprehensive loss 418 (480) (39)
BALANCE (136) (554) (74)
Accumulated Other Comprehensive Loss [Member]      
Accumulated Other Comprehensive Income (Loss) [Roll Forward]      
BALANCE (18,452) (18,235) (36,019)
Other comprehensive gain (loss) before reclassification 16,370 (2,254) 13,348
Plan amendment cost     (283)
Reclassification to net income [1] 996 2,037 4,719
Other comprehensive loss 17,366 (217) 17,784
BALANCE $ (1,086) $ (18,452) $ (18,235)
[1] The Company reclassified amortization of prior service cost, actuarial loss and plan amendment cost for its retirement plan from accumulated other comprehensive loss to net income of $1.0 million, $2.0 million and $4.7 million for the years ended December 31, 2023, 2022 and 2021, respectively.
[2] Refer to Note 17: Employee Retirement Plans
XML 90 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Parenthetical) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Reclassification to net income $ 1.0 $ 2.0 $ 4.7
XML 91 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION - Equity Compensation Plan - Additional Information (Details) - Equity Compensation Plan [Member]
 12 Months Ended
Dec. 31, 2023
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares available for grant (in shares) 1,519,235
Maximum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expiration term (in years) 10 years
XML 92 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION - Equity Instruments Other Than Options (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Shares, Unvested, January 1, 2023 230,223    
Number of Shares, Granted 121,896    
Number of Shares, Vested (132,010)    
Number of Shares, Forfeited (3,623)    
Number of Shares, Unvested, December 31, 2023 216,486 230,223  
Weighted-Average Grant-Date Fair Value, Unvested, January 1, 2023 $ 165.13    
Weighted-Average Grant-Date Fair Value, Granted 136.22 $ 140.37 $ 208.67
Weighted-Average Grant-Date Fair Value, Vested 163.85    
Weighted-Average Grant-Date Fair Value, Forfeited 152.21    
Weighted-Average Grant-Date Fair Value, Unvested, December 31, 2023 $ 149.68 $ 165.13  
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Shares, Unvested, January 1, 2023 33,637    
Number of Shares, Granted 2,366    
Number of Shares, Vested (18,456)    
Number of Shares, Unvested, December 31, 2023 17,547 33,637  
Weighted-Average Grant-Date Fair Value, Unvested, January 1, 2023 $ 178.37    
Weighted-Average Grant-Date Fair Value, Granted 126.87 $ 148.35 172.95
Weighted-Average Grant-Date Fair Value, Vested 178.82    
Weighted-Average Grant-Date Fair Value, Unvested, December 31, 2023 $ 170.96 $ 178.37  
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Shares, Unvested, January 1, 2023 227,866    
Number of Shares, Granted 84,448    
Number of Shares, Vested (11,970)    
Number of Shares, Forfeited (91,791)    
Number of Shares, Unvested, December 31, 2023 208,553 227,866  
Weighted-Average Grant-Date Fair Value, Unvested, January 1, 2023 $ 185.57    
Weighted-Average Grant-Date Fair Value, Granted 165.72 $ 186.66 $ 214.7
Weighted-Average Grant-Date Fair Value, Vested 155.85    
Weighted-Average Grant-Date Fair Value, Forfeited 170.96    
Weighted-Average Grant-Date Fair Value, Unvested, December 31, 2023 $ 185.86 $ 185.57  
XML 93 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION - Equity Instruments Other Than Options - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of shares withheld for tax withholding obligations $ 8,206,000 $ 9,209,000 $ 14,949,000
Director [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted stock awards and units vesting terms 1 year    
Fair value of shares issued $ 1,500,000 $ 1,300,000 $ 1,200,000
Shares issued (in shares) 13,016 8,784 5,412
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant-date fair value of RSU awards granted (in dollars per share) $ 136.22 $ 140.37 $ 208.67
Fair value granted as of the respective vesting dates $ 21,600,000 $ 18,000,000 $ 12,500,000
Fair value as of the respective vesting dates $ 18,600,000 15,300,000 15,100,000
Grants in period (shares) 121,896    
Restricted Stock Units (RSUs) [Member] | Research and Development Expense [Member] | Non Employee Members of Scientific Advisory Board [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 248,000 $ 234,000 $ 220,000
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant-date fair value of RSU awards granted (in dollars per share) $ 126.87 $ 148.35 $ 172.95
Fair value granted as of the respective vesting dates $ 3,300,000 $ 8,300,000 $ 9,300,000
Fair value as of the respective vesting dates $ 2,600,000 $ 6,500,000 $ 20,000,000
Shares withheld for employee taxes (shares) 53,162 54,856 67,798
Shares withheld for employee taxes $ 7,400,000 $ 8,400,000 $ 14,100,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 21,700,000    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year 9 months 18 days    
Grants in period (shares) 2,366    
Unrecognized compensation expense related to performance unit awards $ 21,700,000    
Restricted Stock [Member] | Selling, General and Administrative Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 9,500,000 14,300,000 15,400,000
Restricted Stock [Member] | Manufacturing Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 1,900,000 2,200,000 2,500,000
Restricted Stock [Member] | Research and Development Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 5,800,000 $ 6,100,000 $ 5,200,000
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant-date fair value of RSU awards granted (in dollars per share) $ 165.72 $ 186.66 $ 214.7
Fair value granted as of the respective vesting dates $ 1,900,000 $ 1,900,000 $ 1,100,000
Fair value as of the respective vesting dates 1,700,000 $ 1,800,000 $ 2,000,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 12,900,000    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year 11 months 23 days    
Grants in period (shares) 84,448    
Shares withheld for tax withholding obligations (in shares) 5,350 5,082 3,881
Fair value of shares withheld for tax withholding obligations $ 775,000 $ 826,000 $ 875,000
Unrecognized compensation expense related to performance unit awards $ 12,900,000    
Performance Shares [Member] | Incremental Performance Based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grants in period (shares) 84,448 100,621 77,086
Performance Shares [Member] | Performance-Based Vesting Requirement [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grants in period (shares) 63,335 75,465 42,291
Performance Shares [Member] | Market-Based Vesting Requirement [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grants in period (shares) 21,113 25,156 34,795
Performance Shares [Member] | Company Performance-Based Vesting Requirement [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grants in period (shares) 0 1,268 0
Performance Shares [Member] | Selling, General and Administrative Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 2,600,000 $ 2,800,000 $ 8,000,000
Performance Shares [Member] | Manufacturing Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 770,000 940,000 1,300,000
Performance Shares [Member] | Research and Development Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 1,200,000 $ 1,500,000 $ 2,100,000
XML 94 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION - Employee Stock Purchase Plan - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Jun. 25, 2009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Proceeds from common stock issued $ 2,554,000 $ 2,043,000 $ 1,907,000  
Employee Stock Purchase Plan (ESPP) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Employee Stock Purchase Plan ESPP Purchase Period1 3 months      
Reserved for issuance (in shares)       1,000,000
Percentage of market value (in hundredths) 85.00%      
Maximum allocation of base compensation (in hundredths) 10.00%      
Maximum shares per purchase date (in shares) 12,500      
Maximum value per calendar year, per employee $ 25,000      
Common stock issued (in shares) 17,513 17,057 9,156  
Proceeds from common stock issued $ 2,000,000 $ 1,600,000 $ 1,500,000  
Employee Stock Purchase Plan (ESPP) [Member] | Selling, General and Administrative Expense [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Charges to expense 136,000 107,000 93,000  
Employee Stock Purchase Plan (ESPP) [Member] | Cost of Sales [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Charges to expense 167,000 141,000 119,000  
Employee Stock Purchase Plan (ESPP) [Member] | Research and Development Expense [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Charges to expense $ 240,000 $ 224,000 $ 188,000  
XML 95 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION - Deferred Compensation Arrangement - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Non-Employee Members of Scientific Advisory Board [Member]    
Deferred Compensation Arrangement with Employees and Non-Employees, Share-Based Payments [Line Items]    
Shares issued (in shares) 2,366 2,024
Members of Scientific Advisory Board [Member]    
Deferred Compensation Arrangement with Employees and Non-Employees, Share-Based Payments [Line Items]    
Fair value of shares issued $ 300,000 $ 300,000
XML 96 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS - Additional Information (Details)
 12 Months Ended
Dec. 31, 2023
USD ($)
Denominator
Multiple
Participant
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Defined Benefit Plan Disclosure [Line Items]      
Maximum contribution percentage (in hundredths) 90.00%    
Matching contribution limit (in hundredths) 3.00%    
Contributions to the 401(k) Plan $ 1,500,000 $ 1,400,000 $ 1,300,000
Benefit Payments (2,015,000) 0  
Prior service cost expected to be amortized in next fiscal year 43,000    
Actuarial (gain) loss $ 9,375,000 7,639,000  
Supplemental Executive Retirement Plan [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Number of participants | Participant 8    
Factor used to determine annual base salary | Multiple 12    
Annual base salary period (in months)     24 months
Minimum period of service (in years) 20 years    
Benefit percentage, tier one (in hundredths) 50.00%    
Benefit percentage, tier two (in hundredths) 25.00%    
Benefit percentage, tier three (in hundredths) 15.00%    
Minimum period of service for prorated benefit (in years) 15 years    
Factor used to determine prorated benefit | Denominator 20    
Installment period (in years) 10 years    
Benefit percentage for special participants (in hundredths) 50.00%    
Initial prior service cost for retirement plan $ 1,900,000    
Benefit Payments 2,000,000    
Prior service cost expected to be amortized in next fiscal year 43,000    
Accumulated benefit obligation $ 52,500,000 59,500,000  
Defined benefit plan threshold of benefit obligation at which actuarial losses are amortized (in hundredths) 10.00%    
Actuarial (gain) loss $ 9,400,000 $ 7,600,000  
XML 97 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS - Information Relating to the Company's Plan (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Change in benefit obligation:    
Benefit obligation, beginning of year $ 61,804 $ 66,773
Service cost 951 1,287
Interest cost $ 2,898 $ 1,383
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Non-current liability Non-current liability
Actuarial gain $ (9,375) $ (7,639)
Benefit Payments (2,015) 0
Benefit obligation, end of year 54,263 61,804
Fair value of plan assets 0 0
Unfunded status of the plan, end of year (54,263) (61,804)
Current liability 2,014 2,014
Non-current liability $ 52,249 $ 59,790
XML 98 R84.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS - Components of Net Periodic Pension Cost (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Components of net periodic pension cost [Abstract]      
Service cost $ 951 $ 1,287  
Interest cost $ 2,898 $ 1,383  
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Liability, Defined Benefit Plan, Noncurrent Liability, Defined Benefit Plan, Noncurrent Liability, Defined Benefit Plan, Noncurrent
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Liability, Defined Benefit Plan, Noncurrent Liability, Defined Benefit Plan, Noncurrent Liability, Defined Benefit Plan, Noncurrent
Supplemental Executive Retirement Plan [Member]      
Components of net periodic pension cost [Abstract]      
Service cost $ 951 $ 1,287 $ 1,675
Interest cost 2,898 1,383 1,165
Amortization of prior service cost 815 1,119 1,099
Amortization of loss 480 1,487 4,936
Total net periodic benefit cost $ 5,144 $ 5,276 $ 8,875
XML 99 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Benefit Obligation (Details)
Dec. 31, 2023
Dec. 31, 2022
Assumptions used to determine the year end benefit obligation [Abstract]    
Discount rate 4.74% 4.94%
Rate of compensation increases 3.50% 3.50%
XML 100 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Net Periodic Pension Cost (Details)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Assumptions used to determine the net periodic pension cost [Abstract]      
Discount rate 4.94% 2.16% 1.54%
Rate of compensation increases 3.50% 3.50% 3.50%
XML 101 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS - Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Estimated amounts to be amortized from accumulated other comprehensive loss in next fiscal year [Abstract]  
Amortization of prior service cost $ 43
Amortization of loss 0
Total $ 43
XML 102 R88.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE RETIREMENT PLANS - Benefit Payments Expected to be Paid (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Benefit payments currently expected to be paid [Abstract]  
2024 $ 2,014
2025 5,097
2026 6,141
2027 6,489
2028 6,489
2029-2033 34,503
Thereafter $ 14,855
XML 103 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES - Additional Information (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Multiple
Employee
ExecutiveOfficer
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Loss Contingencies [Line Items]      
Purchase commitments for inventory | $ $ 29.8 $ 31.9 $ 25.7
Commitment With Executive Officers [Member]      
Loss Contingencies [Line Items]      
Number of executive officers under agreement | ExecutiveOfficer 5    
Number of employees under agreement | Employee 13    
Commitment With Senior Level Employees [Member]      
Loss Contingencies [Line Items]      
Multiple of sum of average annual base salary and bonus agreement terms 2    
Commitment With Senior Level Employees [Member] | Maximum [Member]      
Loss Contingencies [Line Items]      
Multiple of sum of average annual base salary and bonus agreement terms 2    
Commitment With Senior Level Employees [Member] | Minimum [Member]      
Loss Contingencies [Line Items]      
Multiple of sum of average annual base salary and bonus agreement terms 1    
XML 104 R90.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONCENTRATION OF RISK - Revenues and Accounts Receivable From Our Largest Customers (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Concentration Risk [Line Items]      
Accounts Receivable $ 139,850 $ 92,664  
Major Customer A [Member] | Total Revenue [Member] | Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
% of Total Revenue 36.00% 41.00% 44.00%
Major Customer A [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
Accounts Receivable $ 38,105 $ 11,425 $ 10,850
Major Customer B [Member] | Total Revenue [Member] | Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
% of Total Revenue 23.00% 25.00% 26.00%
Major Customer B [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
Accounts Receivable $ 30,142 $ 24,440 $ 45,867
Major Customer C [Member] | Total Revenue [Member] | Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
% of Total Revenue 17.00% 16.00% 14.00%
Major Customer C [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
Accounts Receivable $ 38,529 $ 22,291 $ 18,557
XML 105 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONCENTRATION OF RISK - Additional Information (Details) - Supplier
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Supplier Concentration Risk [Member]      
Concentration Risk [Line Items]      
Number of suppliers from which chemical materials were purchased 1    
Excluding North America [Member] | Total Revenue [Member] | Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage (less than 1% for contracts with U.S. government agencies) 98.00% 97.00% 97.00%
XML 106 R92.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONCENTRATION OF RISK - Revenues by Geographic Area (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Concentration Risk [Line Items]      
Revenues $ 576,429 $ 616,619 $ 553,525
South Korea [Member]      
Concentration Risk [Line Items]      
Revenues 322,509 360,640 334,835
China [Member]      
Concentration Risk [Line Items]      
Revenues 229,727 230,582 192,079
Japan [Member]      
Concentration Risk [Line Items]      
Revenues 6,971 5,579 7,358
Other Non-U.S. Locations [Member]      
Concentration Risk [Line Items]      
Revenues 4,411 3,829 3,137
Total Non-U.S. Locations [Member]      
Concentration Risk [Line Items]      
Revenues 563,618 600,630 537,409
United States [Member]      
Concentration Risk [Line Items]      
Revenues $ 12,811 $ 15,989 $ 16,116
XML 107 R93.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONCENTRATION OF RISK - Long-Lived Assets (Net) by Geographic Area (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]    
Total long-lived assets $ 175,150 $ 143,445
United States [Member]    
Segment Reporting Information [Line Items]    
Total long-lived assets 118,250 117,255
Ireland [Member]    
Segment Reporting Information [Line Items]    
Total long-lived assets 42,203 20,270
Other [Member]    
Segment Reporting Information [Line Items]    
Total long-lived assets $ 14,697 $ 5,920
XML 108 R94.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Components of Income (Loss) before Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Components of income before income taxes [Abstract]      
United States $ 71,514 $ 77,205 $ 60,066
Foreign 173,657 191,025 168,181
Income before income taxes $ 245,171 $ 268,230 $ 228,247
XML 109 R95.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Components of Income Tax Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current income tax (expense) benefit:      
Federal $ (15,848) $ (51,980) $ (16,433)
State (3,048) (1,833) (641)
Foreign (27,030) (31,302) (25,212)
Current income tax benefit (expense) (45,926) (85,115) (42,286)
Deferred income tax (expense) benefit:      
Federal (460) 25,916 (844)
State 3,936 1,216 (734)
Foreign (290) (186) (170)
Deferred income tax expense, gross 3,766 26,946 (1,748)
Income tax expense $ (42,160) $ (58,169) $ (44,034)
XML 110 R96.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate (Details)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
Effect of foreign operations (4.00%) (4.90%) (5.00%)
U.S. International Tax (Sub F, GILTI, FDII) 2.90% 4.20% 2.10%
Research tax credits (2.40%) (1.90%) (1.40%)
Redetermination of foreign tax credit utilization (2.00%) 0.00% 0.00%
Nondeductible employee compensation 1.70% 1.90% 3.00%
State income taxes, net of federal benefit (0.20%) 0.10% 0.20%
Stock based compensation 0.10% 0.20% (0.30%)
Accruals and reserves 0.00% 0.00% (0.80%)
Other 0.10% 1.10% 0.50%
Effective tax rate 17.20% 21.70% 19.30%
XML 111 R97.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Tax Loss and Tax Credit Carryforwards (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
USD ($)
Tax Credit And Operating Loss Carryforwards [Line Items]  
Total credit carry forwards, Tax Benefit $ 8,938
Foreign Tax Authority [Member]  
Tax Credit And Operating Loss Carryforwards [Line Items]  
Total credit carry forwards, Tax Benefit $ 186
Tax credit carryforwards, Expiration Date Dec. 31, 2031
Research Tax Credit [Member] | State [Member]  
Tax Credit And Operating Loss Carryforwards [Line Items]  
Total credit carry forwards, Tax Benefit $ 8,752
Research Tax Credit [Member] | State [Member] | Minimum [Member]  
Tax Credit And Operating Loss Carryforwards [Line Items]  
Tax credit carryforwards, Expiration Date Dec. 31, 2034
Research Tax Credit [Member] | State [Member] | Maximum [Member]  
Tax Credit And Operating Loss Carryforwards [Line Items]  
Tax credit carryforwards, Expiration Date Dec. 31, 2038
XML 112 R98.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Deferred tax asset:    
Capitalized research expenditures $ 39,459 $ 38,485
Retirement plan 12,555 13,495
Tax credit carry forwards 8,938 8,100
Accruals and reserves 7,180 6,944
Lease liabilities 6,671 7,230
Deferred revenue 1,741 2,077
Stock-based compensation 1,498 1,454
Other 1,362 3,400
Valuation allowance (9,551) (11,087)
Deferred Tax Assets, Gross 79,404 81,185
Deferred tax assets 69,853 70,098
Deferred tax liability:    
Lease Assets 6,302 6,944
Acquisition Goodwill (1,549) (1,283)
Other (2,894) (3,710)
Deferred tax liabilities (10,745) (11,937)
Net deferred tax assets $ 59,108 $ 58,161
XML 113 R99.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Taxes [Line Items]      
Long-term asset $ 105,289 $ 109,739  
Current income tax expense $ 27,030 31,302 $ 25,212
State and foreign income tax returns subject to examination period minimum (in years) 3 years    
State and foreign income tax returns subject to examination period maximum (in years) 4 years    
Korean Government [Member]      
Income Taxes [Line Items]      
Long-term asset $ 0 3,000  
South Korea [Member]      
Income Taxes [Line Items]      
Current income tax expense 14,900    
Foreign exchange loss 732,000    
Allocation of Withholding to Non-Korean Patents [Member]      
Income Taxes [Line Items]      
Long-term asset 60,100 60,900  
Allocation of Withholding to Non-Korean Patents [Member] | U.S.Federal Government [Member]      
Income Taxes [Line Items]      
Estimated settlement amounts due (refunds) from withholding taxes $ 15,700 $ 14,600  
XML 114 R100.htm IDEA: XBRL DOCUMENT v3.24.0.1
REVENUE RECOGNITION - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disaggregation Of Revenue [Line Items]      
Backlog associated with committed purchase orders from customers $ 25,200    
Contract with customer liability, transaction price 10,600 $ 30,300  
Cumulative catch-up adjustment arising from changes in estimates of transaction price $ 10,556 $ 30,262  
Revenue from Contracts with Customers - ASU No. 2014-09 [Member]      
Disaggregation Of Revenue [Line Items]      
Percentage of revenue recorded from sales of materials 97.00% 97.00% 97.00%
Revenue from Contracts with Customers - ASU No. 2014-09 [Member] | Adesis, Inc. [Member]      
Disaggregation Of Revenue [Line Items]      
Percentage of revenue recorded from provision of services 3.00% 3.00% 3.00%
XML 115 R101.htm IDEA: XBRL DOCUMENT v3.24.0.1
REVENUE RECOGNITION - Schedule of Assets and Liabilities Associated with Contracts from Customers (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Disaggregation Of Revenue [Line Items]    
Accounts receivable $ 139,850 $ 92,664
Short-term unbilled receivables 21,084  
Short-term contract assets 2,698  
Long-term unbilled receivables 9,074  
Long-term contract assets 9,278  
Short-term deferred revenue 47,713 45,599
Long-term deferred revenue $ 12,006 $ 18,279
XML 116 R102.htm IDEA: XBRL DOCUMENT v3.24.0.1
REVENUE RECOGNITION - Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Deferred Revenue (Increase) Decrease    
Balance $ (63,878) $ (157,081)
Revenue recognized that was previously included in deferred revenue 195,703 239,608
Increases due to cash received (202,100) (176,667)
Cumulative catch-up adjustment arising from changes in estimates of transaction price 10,556 30,262
Net change 4,159 93,203
Balance (59,719) (63,878)
Unbilled Receivables Increase (Decrease)    
Balance 38,457 8,127
Unbilled receivables recognized 41,659 15,946
Contract Assets Recorded (2,407) 14,384
Transferred to receivables from unbilled receivables (35,575)  
Contract Assets Recorded (2,407) 14,384
Net change 3,677 30,330
Balance $ 42,134 $ 38,457
XML 117 R103.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET INCOME PER COMMON SHARE - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Numerator:      
Net income $ 203,011 $ 210,061 $ 184,213
Adjustment for Basic EPS:      
Earnings allocated to unvested shareholders (993) (1,215) (1,137)
Adjusted net income $ 202,018 $ 208,846 $ 183,076
Denominator:      
Weighted average common shares outstanding – Basic 47,559,669 47,390,352 47,296,447
Effect of dilutive shares:      
Common stock equivalents arising from stock options and ESPP 2,173 2,340 1,010
Restricted stock awards and units and performance units 60,921 75,815 67,978
Weighted average common shares outstanding – Diluted 47,622,763 47,468,507 47,365,435
Basic $ 4.25 $ 4.41 $ 3.87
Diluted $ 4.24 $ 4.4 $ 3.87
XML 118 R104.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET INCOME PER COMMON SHARE - Additional Information (Details) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]      
Antidilutive securities excluded from calculation of diluted EPS 36,345 122,843 0
XML 119 R105.htm IDEA: XBRL DOCUMENT v3.24.0.1
QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Quarterly Financial Information Disclosure [Abstract]      
Revenues $ 576,429 $ 616,619 $ 553,525
Net Income (Loss) $ 203,011 $ 210,061 $ 184,213
Net income per common share:      
Basic $ 4.25 $ 4.41 $ 3.87
Diluted $ 4.24 $ 4.4 $ 3.87
EXCEL 121 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %"!5E@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !0@598Q#M@P^X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2@,Q$(9?17+?G6PJ@F&;B^*I!<&"XBTDTS:XR89D9+=O[VYLMX@^@,?,_/GF M&YC61&GZA,^ICYC(8;X9?1>R-''-CD11 F1S1*]S/27"U-SWR6N:GND 49L/ M?4 0G-^!1])6DX896,6%R%1KC30)-?7IC+=FP@R4H:D;8&J> M&$]CU\(5,,,(D\_?!;0+L53_Q)8.L'-RS&Y)#<-0#ZN2FW9HX&V[>2GK5BYD MTL'@]"L[2:>(:W:9_+IZ>-P],26XN*VXJ(38B48V7/+[]]GUA]]5V/?6[=T_ M-KX(JA9^W87Z E!+ P04 " !0@598F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M %"!5E@CM4+XE @ )@T 8 >&PO=V]R:W-H965T&UL MM9MA=^D$$.S )RA8B3 M?]\CP!"V0I@9^4MB,.<5>BRD\TKB?,OX]\2G5*"7*(R3BYXOQ.9COY^X/HU( M&?@2?\B]ZXASRZ)FDH'MCV-UI4:"CU M7!8FV5^TS:\=GO:0FR:"144PW$$4Q/E_\E* >!,PMAH"+R:E"3'S*86314/XCE[[X4'+X-($Y9RW)_F['*,ORQEZ_^X#>H>"&#WZ+$W@TN2\+Z!TJ=%W MBY*N\I)P0TDV1I]9+/P$BO&H5Q?HPVV7]XYW]WZ%M8HSZIX@QSY"V,*.XH:F M^O ;NCI!&&?A T7X3!_^>QI#Z9:J]%IMG/*7<#(]IT%ORIXI1W]/5HG@\#3\ M7T4X5QBH%607\3'9$)=>]* /2"A_IKW+GW^R1]8O*CHFQ6:&Q&KD!B6Y@4Z] M:L./KQNJPJ8/MZWC3RH^VJBN? R)U?@,2SY#;04G ,?+ -V$Y$D%2!^_)F&B MXCK5AG4E9$BL1FA4$AKMUX(6E =,=H0>@NY4V9A:E'9]4F.GI(WO"LV06 W: M:0GM=#]H-T'BDA!]HX2C&SBI'!ST6DVPM%%=81D2J\$:E[#&G6 5#:T1EU[M MYIL*EC:F*RQ#8C589R6L,VWU'CGQ@O@)+5^C%0M5>/3Q][?7,Q4@;5170(;$ M:H!LJTK;+&T5BU3M@3X%,E^ AG5'(F5_U2+TY6[^]?IA.;E%L_ER<3OYAJ;W M#XO[A\GC_/Y.!5&OUY6B*;4ZQC?9K[WO8QF3V W@R5P*Z/BS<]><,XZFC//" MI/PMQT]E8M923.,(JH_K#-.06ATFKF#B?=KD%-AQ #F'-/\%?:*O2F!Z*Z8XI81DU!:;4ZK J6V#KL_E= MCU8\H@]TP[C(,A,8)-2)6XMB4Q,SZ@I,J=6I5;[ UB?S!;6L8:$I=&-/C*L' M ;W.+>%/%$UC;(/V(-B16X]/+ M-"<=1HV"*;4ZK,HJV"U>(1 A16R-;/Q^]0$& 3?E0$_)2Z\$I"-(\I:"N=^/ MT#OKQ++1!@;C9Q*F:HY&_80IM?I4:F4HL-X'[,"AZQ?7)S$\>$V&HD7H;K*< M3?Y03L<:=0ZFU.J\*N> ]2E].5?N,@ZC0C9;?I2;!Y2Y!AA>872=,D\-4:^^ MF"@!&G4+IM3J "NW@/=R"_-84)ZO_LB4E^P&6R4TO6+#V*J/ZDSM$&X!5VX! MZ]/[W=@0$1@;KM($ODZ4>4B+3N/@H(_K3.L0)@%7)@'O91*N(\J?9-KV*R@( M7S>FM@@V8S/J$4RIU;%5'@'K,_MR5F02QREXTCSO5>+2"PFN'CGU89UI'<(D MX,HDX#T7#QXYB9,@FRG2$-.+-340\-X. =VET4KMUEM$[&,; M6^J9#GUD9UB'L .XL@-X+SOP2%[0W(-V%JP#-U^#0>*^D9 M]0>FU.KT*G^ ]5E]06_B>:">'.T^H%NX#MW'ZN1,+XF'%EKX01@&FP1=L32D MSX1[2I)&'8(IM?KVA,HA.'LM.90DI_((4MU'MHV5FQ5:Y+8P(BOW)1BU":;4 MZM JF^#L91-*:*5!6'#V',2NLOVU:-[]KL1FU!R84JMCJ\R!LYD&9->8&2=*2&9W2QT M"%?@5*[ T2?QMRQ;@?=9K,L^6D1&I_:Q=3:VE+2,F@%3:G5:E1EP]EHPJ,^. M+7T"9:'[5,!S&7OJGOQ*K]QYOUJN-LS4Y'[6Y\O!J3,:CBSX$9YKQ YA")S* M$#A[K1HLTE48N.@F9$3I!/0JG>D8]0>%VN@-:P=;0\L:C.P2=AU/E?P[^KQ] M/KUY0)/4"P0,@Q,A*#2A+)UMVIW6HM=D,O5AG8D M6LDM(&O*:5,FH5==R.4L%B=R_ESX%/%R.\G//XVQ??I+(O.4E]$?CA!4!04_X.8[ MW/ -U&I!N$#S^3Q7@YKRS/F?*!ND45]E2JW>("M?Y>A-T.X!O@EXA.:J[597 M+0KV>*BD9-0SF5*K;TRN/-- ;W)VE)K64EK"/RT^_WJ$;F\7*E#ZV,X;E _A MDP:53QKH/DA-6R9@*6G'@TW/@! <R4F0:Y<3LK?ZBC/EJ_=3+*73?K5Y?D[.Y^)G/1.4$C7$&J=G$)6 MQ//78/(#P3;9BR$K)@2+LH\^!8)<7@#?KQD3NP-90/DRTN6_4$L#!!0 ( M %"!5EA>CZ7IBP@ !$@ 8 >&PO=V]R:W-H965T&UL MK5IK;]LX%OTKA">8[0!*+))Z4)DD@&.KC0''SMIN9XO!?%!D.A8JB:X>3C._ M?B\EQ[(E2LGL]D-;2;Z\//?R<_4LDF_IAO,,_8C".+WN;;)L>]GOI_Z& M1UYZ(;8\AE_6(HF\#%Z3IWZZ3;BW*AI%89_HNM6/O"#NW5P5WQZ2FRN19V$0 M\X<$I7D4>][9Z#_EYFHEHWQ@01$%<_NO]V"?BJ $V6AJ0?0-2;T!; M&M!] _K>'HQ] Z/(3!E*D8>1EWDW5XEX1HFT!F_RH4AFT1K"#V(Y[HLL@5\# M:)?=#&?3Q6PR'@V6[@C=#B:#Z=!%BSO772[0.?J\&*$/9[^A,Q3$:+D1>>K% MJ_2JGT'/LGW?W_=R6_9"6GH9@2>&/ MM@7]>3YWITLT6"P@SDM5/*4#0^U +L;+=.OY_+H'JRWER8[W;G[]!5OZ[ZKH M?I*SDUCI(5;:Y?UFZ*4;!*.&?/G O^?!S@MYG"E'L71E%:[DCK&[<;##S*O^ M[C@@UCT\PAEF6H(5H' MB%8GQ#&D+\Y$\J("9C6!V:;MU(=88<8H(2UC;!^0V9W(9MF&)["K)0D 1%Z: MF4VM.L:FE0&18#5$=H#(.B$N1>:%[X#(FB.';4Q)#6/3C#F.8;;D MT3F =#I!/LQG#^Y\^14-IB/D_OOS^.$>MC,-Q: 3Q!JXU,^C//0RO@(*A#W% M#[R"9.&W,VQ0S=%9L26<86QK&#-5@(YJHN#&#%:8P2)K6V58KVA)[UYG0PAK M#IRT=(=WT]ED]NFK,CXO@FTC^/LH/F9IL-#V\3%'LVRL)"R].8(Z);5)-GP# MYI_X+R6=-9U31AEIR/N!;2\<^=H/%T.II_&MQ-WSV#OS(RN&=@H$\,T MASG*M. &!4MXTXFO/DTFXW^&$\F2F"D.=-,D]8WA3?- M3J%5+(J[:70\_>(NEG*9+93H:*-;XCBFP>KP%':FPZR670M7[(F[Z7/D?G3G M *LP8;L59T2?NYL]R!I?35@E/P9RZ2>1D M/<6GLG-LZK0 K,@3=[/G0-BCO1B&'@/09AD 7J M=!(%#^F.58?:M"*.:;?0%3FJ(KOIZE0KO@5504R8,5)7C"H[:EI.&]J*P4@W M@QT88NY^<:>?727()CUA>8)4QZ@P8\1N&_N*Q$@WB#)S]!O;/@"EHV:;RQW7>9G![X52Q/NUE^**((0+^=T7W2VG)J,,VF6-.) M)9-C.!JFEJ;3@VV9.:U(G6%KU#(U:K/75]O6-2AY7Q-UE%HO0R/N\^@1D+P> M"A>MZE^)!D(EW?+B;B!4GF=1A0QA]:- E5';01&ME KM5BJ#U2J0LP.VUJT7 MK,Z#&/G>-H"M5@E445A#A6C62VN5'<.TK8*EE5JAW6IESC,//H$^]9(8AD%] M -Q4'S8#E'7UI["SH+AITU3TZ+2Z6Z4,CDXP1"D%101;ST9>->TX"D6J!MZ4 M).=0U=:5B]*,&6;;FJND"^V6+LN$>VF>O*"T7'4PQWV19N@#+M:%9;##"GOW M[%?N*;2I8\X-3%AC'KUI=QII)7AHM^ IQ401S$:$*YZDO_["0"C\7EPN9.I5 MJJC6#<,FI#$^"D-BF]1JT9:TTD#T/77]D4XK-,8QZ[Z&47*O,@RK==Z:.BEJ9!'Q_#].<@V1>.'T?EDI*%Q[%\4C>]%)A(1>K %9K(*VD+[M0@# MD:*-!^OUD7-Y/QR)'7A9)R(JO&2R@@?_Q4L.8)/P1090.MDWA17E;Z"5M.&2 MG=?R,4A0GO)U+O7LCJ<7*AG2/[H/C7CR5-PKIZ@X0"AOS@Y?R[OK6WPY+*YX M:]\'U+X

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end XML 122 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 123 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 125 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 316 489 1 true 97 0 false 14 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100050 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100060 - Statement - CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME CONSOLIDATED STATEMENTS OF INCOME Statements 4 false false R5.htm 100070 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 100080 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Statements 6 false false R7.htm 100090 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY Statements 7 false false R8.htm 100100 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 100110 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Non-Cash Activities Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities CONSOLIDATED STATEMENTS OF CASH FLOWS Non-Cash Activities Statements 9 false false R10.htm 100120 - Disclosure - BUSINESS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureBUSINESS BUSINESS Notes 10 false false R11.htm 100130 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 11 false false R12.htm 100140 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTS CASH, CASH EQUIVALENTS AND INVESTMENTS Notes 12 false false R13.htm 100150 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 13 false false R14.htm 100160 - Disclosure - INVENTORY Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORY INVENTORY Notes 14 false false R15.htm 100170 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT Notes 15 false false R16.htm 100180 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETS GOODWILL AND INTANGIBLE ASSETS Notes 16 false false R17.htm 100190 - Disclosure - OTHER ASSETS Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssets1 OTHER ASSETS Notes 17 false false R18.htm 100200 - Disclosure - LEASES Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASES LEASES Notes 18 false false R19.htm 100210 - Disclosure - ACCRUED EXPENSES Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCRUEDEXPENSES ACCRUED EXPENSES Notes 19 false false R20.htm 100220 - Disclosure - RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartners1 RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS Notes 20 false false R21.htm 100230 - Disclosure - OTHER LIABILITIES Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilities1 OTHER LIABILITIES Notes 21 false false R22.htm 100240 - Disclosure - EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTS EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS Notes 22 false false R23.htm 100250 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITY SHAREHOLDERS' EQUITY Notes 23 false false R24.htm 100260 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSS ACCUMULATED OTHER COMPREHENSIVE LOSS Notes 24 false false R25.htm 100270 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 25 false false R26.htm 100280 - Disclosure - EMPLOYEE RETIREMENT PLANS Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANS EMPLOYEE RETIREMENT PLANS Notes 26 false false R27.htm 100290 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 27 false false R28.htm 100300 - Disclosure - CONCENTRATION OF RISK Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISK CONCENTRATION OF RISK Notes 28 false false R29.htm 100310 - Disclosure - INCOME TAXES Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXES INCOME TAXES Notes 29 false false R30.htm 100320 - Disclosure - REVENUE RECOGNITION Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITION REVENUE RECOGNITION Notes 30 false false R31.htm 100330 - Disclosure - NET INCOME PER COMMON SHARE Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHARE NET INCOME PER COMMON SHARE Notes 31 false false R32.htm 100350 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 32 false false R33.htm 100360 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSTables CASH, CASH EQUIVALENTS AND INVESTMENTS (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTS 33 false false R34.htm 100370 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS 34 false false R35.htm 100380 - Disclosure - INVENTORY (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYTables INVENTORY (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORY 35 false false R36.htm 100390 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables PROPERTY AND EQUIPMENT (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT 36 false false R37.htm 100400 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETS 37 false false R38.htm 100410 - Disclosure - OTHER ASSETS (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsTables OTHER ASSETS (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssets1 38 false false R39.htm 100420 - Disclosure - LEASES (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESTables LEASES (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASES 39 false false R40.htm 100430 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESTables ACCRUED EXPENSES (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCRUEDEXPENSES 40 false false R41.htm 100440 - Disclosure - OTHER LIABILITIES (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesTables OTHER LIABILITIES (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilities1 41 false false R42.htm 100450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSTables ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSS 42 false false R43.htm 100460 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATION 43 false false R44.htm 100470 - Disclosure - EMPLOYEE RETIREMENT PLANS (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSTables EMPLOYEE RETIREMENT PLANS (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANS 44 false false R45.htm 100480 - Disclosure - CONCENTRATION OF RISK (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKTables CONCENTRATION OF RISK (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISK 45 false false R46.htm 100490 - Disclosure - INCOME TAXES (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTables INCOME TAXES (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXES 46 false false R47.htm 100500 - Disclosure - REVENUE RECOGNITION (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables REVENUE RECOGNITION (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITION 47 false false R48.htm 100510 - Disclosure - NET INCOME PER COMMON SHARE (Tables) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHARETables NET INCOME PER COMMON SHARE (Tables) Tables http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHARE 48 false false R49.htm 100530 - Disclosure - BUSINESS - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureBUSINESSAdditionalInformationDetails BUSINESS - Additional Information (Details) Details 49 false false R50.htm 100540 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Details 50 false false R51.htm 100550 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Cash, Cash Equivalents (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Cash, Cash Equivalents (Details) Details 51 false false R52.htm 100560 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Investments (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Investments (Details) Details 52 false false R53.htm 100570 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails CASH, CASH EQUIVALENTS AND INVESTMENTS - Additional Information (Details) Details 53 false false R54.htm 100580 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Details 54 false false R55.htm 100590 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSAdditionalInformationDetails FAIR VALUE MEASUREMENTS - Additional Information (Details) Details 55 false false R56.htm 100600 - Disclosure - INVENTORY - Schedule of Inventory (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails INVENTORY - Schedule of Inventory (Details) Details 56 false false R57.htm 100610 - Disclosure - INVENTORY - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYAdditionalInformationDetails INVENTORY - Additional Information (Details) Details 57 false false R58.htm 100620 - Disclosure - PROPERTY AND EQUIPMENT (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails PROPERTY AND EQUIPMENT (Details) Details http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables 58 false false R59.htm 100630 - Disclosure - PROPERTY AND EQUIPMENT - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails PROPERTY AND EQUIPMENT - Additional Information (Details) Details 59 false false R60.htm 100640 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Acquired Technology (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails GOODWILL AND INTANGIBLE ASSETS - Schedule of Acquired Technology (Details) Details 60 false false R61.htm 100650 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Acquired Technology - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails GOODWILL AND INTANGIBLE ASSETS - Acquired Technology - Additional Information (Details) Details 61 false false R62.htm 100660 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Other Intangible Assets - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails GOODWILL AND INTANGIBLE ASSETS - Other Intangible Assets - Additional Information (Details) Details 62 false false R63.htm 100670 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails GOODWILL AND INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Details 63 false false R64.htm 100680 - Disclosure - OTHER ASSETS - Schedule of Other Assets (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails OTHER ASSETS - Schedule of Other Assets (Details) Details 64 false false R65.htm 100690 - Disclosure - LEASES- Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails LEASES- Additional Information (Details) Details 65 false false R66.htm 100700 - Disclosure - LEASES - Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESSummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesDetails LEASES - Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases (Details) Details 66 false false R67.htm 100710 - Disclosure - LEASES - Schedule Of Operating Lease Right of Use Assets and Liabilities (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesDetails LEASES - Schedule Of Operating Lease Right of Use Assets and Liabilities (Details) Details 67 false false R68.htm 100720 - Disclosure - LEASES - Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesDetails LEASES - Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities (Details) Details 68 false false R69.htm 100730 - Disclosure - LEASES - Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails LEASES - Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms (Details) Details 69 false false R70.htm 100740 - Disclosure - ACCRUED EXPENSES - Schedule of Accrued Expenses (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails ACCRUED EXPENSES - Schedule of Accrued Expenses (Details) Details 70 false false R71.htm 100750 - Disclosure - RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS- Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS- Additional Information (Details) Details 71 false false R72.htm 100760 - Disclosure - OTHER LIABILITIES - Summary of Other liabilities (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails OTHER LIABILITIES - Summary of Other liabilities (Details) Details 72 false false R73.htm 100770 - Disclosure - EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS - Additional Information (Details) Details 73 false false R74.htm 100780 - Disclosure - SHAREHOLDERS' EQUITY - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails SHAREHOLDERS' EQUITY - Additional Information (Details) Details 74 false false R75.htm 100790 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Details) Details 75 false false R76.htm 100800 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Parenthetical) (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossParentheticalDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Parenthetical) (Details) Details 76 false false R77.htm 100810 - Disclosure - STOCK-BASED COMPENSATION - Equity Compensation Plan - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails STOCK-BASED COMPENSATION - Equity Compensation Plan - Additional Information (Details) Details 77 false false R78.htm 100820 - Disclosure - STOCK-BASED COMPENSATION - Equity Instruments Other Than Options (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails STOCK-BASED COMPENSATION - Equity Instruments Other Than Options (Details) Details 78 false false R79.htm 100830 - Disclosure - STOCK-BASED COMPENSATION - Equity Instruments Other Than Options - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails STOCK-BASED COMPENSATION - Equity Instruments Other Than Options - Additional Information (Details) Details 79 false false R80.htm 100840 - Disclosure - STOCK-BASED COMPENSATION - Employee Stock Purchase Plan - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails STOCK-BASED COMPENSATION - Employee Stock Purchase Plan - Additional Information (Details) Details 80 false false R81.htm 100850 - Disclosure - STOCK-BASED COMPENSATION - Deferred Compensation Arrangement - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails STOCK-BASED COMPENSATION - Deferred Compensation Arrangement - Additional Information (Details) Details 81 false false R82.htm 100860 - Disclosure - EMPLOYEE RETIREMENT PLANS - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails EMPLOYEE RETIREMENT PLANS - Additional Information (Details) Details 82 false false R83.htm 100870 - Disclosure - EMPLOYEE RETIREMENT PLANS - Information Relating to the Company's Plan (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails EMPLOYEE RETIREMENT PLANS - Information Relating to the Company's Plan (Details) Details 83 false false R84.htm 100880 - Disclosure - EMPLOYEE RETIREMENT PLANS - Components of Net Periodic Pension Cost (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails EMPLOYEE RETIREMENT PLANS - Components of Net Periodic Pension Cost (Details) Details 84 false false R85.htm 100890 - Disclosure - EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Benefit Obligation (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineBenefitObligationDetails EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Benefit Obligation (Details) Details 85 false false R86.htm 100900 - Disclosure - EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Net Periodic Pension Cost (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineNetPeriodicPensionCostDetails EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Net Periodic Pension Cost (Details) Details 86 false false R87.htm 100910 - Disclosure - EMPLOYEE RETIREMENT PLANS - Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails EMPLOYEE RETIREMENT PLANS - Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year (Details) Details 87 false false R88.htm 100920 - Disclosure - EMPLOYEE RETIREMENT PLANS - Benefit Payments Expected to be Paid (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails EMPLOYEE RETIREMENT PLANS - Benefit Payments Expected to be Paid (Details) Details 88 false false R89.htm 100930 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails COMMITMENTS AND CONTINGENCIES - Additional Information (Details) Details 89 false false R90.htm 100940 - Disclosure - CONCENTRATION OF RISK - Revenues and Accounts Receivable From Our Largest Customers (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails CONCENTRATION OF RISK - Revenues and Accounts Receivable From Our Largest Customers (Details) Details 90 false false R91.htm 100950 - Disclosure - CONCENTRATION OF RISK - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails CONCENTRATION OF RISK - Additional Information (Details) Details 91 false false R92.htm 100960 - Disclosure - CONCENTRATION OF RISK - Revenues by Geographic Area (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails CONCENTRATION OF RISK - Revenues by Geographic Area (Details) Details 92 false false R93.htm 100970 - Disclosure - CONCENTRATION OF RISK - Long-Lived Assets (Net) by Geographic Area (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails CONCENTRATION OF RISK - Long-Lived Assets (Net) by Geographic Area (Details) Details 93 false false R94.htm 100980 - Disclosure - INCOME TAXES - Components of Income (Loss) before Income Taxes (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails INCOME TAXES - Components of Income (Loss) before Income Taxes (Details) Details 94 false false R95.htm 100990 - Disclosure - INCOME TAXES - Components of Income Tax Expense (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails INCOME TAXES - Components of Income Tax Expense (Details) Details 95 false false R96.htm 101000 - Disclosure - INCOME TAXES - Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails INCOME TAXES - Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate (Details) Details 96 false false R97.htm 101010 - Disclosure - INCOME TAXES - Tax Loss and Tax Credit Carryforwards (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails INCOME TAXES - Tax Loss and Tax Credit Carryforwards (Details) Details 97 false false R98.htm 101020 - Disclosure - INCOME TAXES - Significant Components of Deferred Tax Assets and Liabilities (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails INCOME TAXES - Significant Components of Deferred Tax Assets and Liabilities (Details) Details 98 false false R99.htm 101030 - Disclosure - INCOME TAXES - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails INCOME TAXES - Additional Information (Details) Details 99 false false R100.htm 101040 - Disclosure - REVENUE RECOGNITION - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails REVENUE RECOGNITION - Additional Information (Details) Details 100 false false R101.htm 101050 - Disclosure - REVENUE RECOGNITION - Schedule of Assets and Liabilities Associated with Contracts from Customers (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails REVENUE RECOGNITION - Schedule of Assets and Liabilities Associated with Contracts from Customers (Details) Details 101 false false R102.htm 101060 - Disclosure - REVENUE RECOGNITION - Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails REVENUE RECOGNITION - Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances (Details) Details 102 false false R103.htm 101070 - Disclosure - NET INCOME PER COMMON SHARE - Schedule of Earnings Per Share (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails NET INCOME PER COMMON SHARE - Schedule of Earnings Per Share (Details) Details 103 false false R104.htm 101080 - Disclosure - NET INCOME PER COMMON SHARE - Additional Information (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREAdditionalInformationDetails NET INCOME PER COMMON SHARE - Additional Information (Details) Details 104 false false R105.htm 101090 - Disclosure - QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) (Details) Sheet http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDDetails QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) (Details) Details 105 false false All Reports Book All Reports oled-20231231.htm oled-20231231.xsd img34714927_0.jpg img34714927_1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 false false JSON 128 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "oled-20231231.htm": { "nsprefix": "oled", "nsuri": "http://www.udcoled.com/20231231", "dts": { "inline": { "local": [ "oled-20231231.htm" ] }, "schema": { "local": [ "oled-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 396, "keyCustom": 93, "axisStandard": 33, "axisCustom": 0, "memberStandard": 61, "memberCustom": 35, "hidden": { "total": 30, "http://fasb.org/us-gaap/2023": 24, "http://xbrl.sec.gov/dei/2023": 4, "http://www.udcoled.com/20231231": 2 }, "contextCount": 316, "entityCount": 1, "segmentCount": 97, "elementCount": 814, "unitCount": 14, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1148, "http://xbrl.sec.gov/dei/2023": 38 }, "report": { "R1": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS", "longName": "100010 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical", "longName": "100050 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:TreasuryStockCommonShares", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R4": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME", "longName": "100060 - Statement - CONSOLIDATED STATEMENTS OF INCOME", "shortName": "CONSOLIDATED STATEMENTS OF INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "longName": "100070 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R6": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical", "longName": "100080 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY", "longName": "100090 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY", "shortName": "CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "C_0c443285-233e-4dd9-9ec7-aaaf288ca2e3", "name": "us-gaap:StockholdersEquity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_6a6f6ec4-3513-4202-ae4b-1fa7f2efbe2f", "name": "us-gaap:StockholdersEquity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R8": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "100100 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R9": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities", "longName": "100110 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Non-Cash Activities", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS Non-Cash Activities", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureBUSINESS", "longName": "100120 - Disclosure - BUSINESS", "shortName": "BUSINESS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "longName": "100130 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTS", "longName": "100140 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS", "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS", "longName": "100150 - Disclosure - FAIR VALUE MEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORY", "longName": "100160 - Disclosure - INVENTORY", "shortName": "INVENTORY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT", "longName": "100170 - Disclosure - PROPERTY AND EQUIPMENT", "shortName": "PROPERTY AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETS", "longName": "100180 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssets1", "longName": "100190 - Disclosure - OTHER ASSETS", "shortName": "OTHER ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASES", "longName": "100200 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCRUEDEXPENSES", "longName": "100210 - Disclosure - ACCRUED EXPENSES", "shortName": "ACCRUED EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartners1", "longName": "100220 - Disclosure - RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS", "shortName": "RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilities1", "longName": "100230 - Disclosure - OTHER LIABILITIES", "shortName": "OTHER LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTS", "longName": "100240 - Disclosure - EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS", "shortName": "EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITY", "longName": "100250 - Disclosure - SHAREHOLDERS' EQUITY", "shortName": "SHAREHOLDERS' EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSS", "longName": "100260 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATION", "longName": "100270 - Disclosure - STOCK-BASED COMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANS", "longName": "100280 - Disclosure - EMPLOYEE RETIREMENT PLANS", "shortName": "EMPLOYEE RETIREMENT PLANS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES", "longName": "100290 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISK", "longName": "100300 - Disclosure - CONCENTRATION OF RISK", "shortName": "CONCENTRATION OF RISK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXES", "longName": "100310 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITION", "longName": "100320 - Disclosure - REVENUE RECOGNITION", "shortName": "REVENUE RECOGNITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHARE", "longName": "100330 - Disclosure - NET INCOME PER COMMON SHARE", "shortName": "NET INCOME PER COMMON SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "longName": "100350 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "32", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSTables", "longName": "100360 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS (Tables)", "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables", "longName": "100370 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYTables", "longName": "100380 - Disclosure - INVENTORY (Tables)", "shortName": "INVENTORY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables", "longName": "100390 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSTables", "longName": "100400 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsTables", "longName": "100410 - Disclosure - OTHER ASSETS (Tables)", "shortName": "OTHER ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESTables", "longName": "100420 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "oled:SummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "oled:SummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESTables", "longName": "100430 - Disclosure - ACCRUED EXPENSES (Tables)", "shortName": "ACCRUED EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesTables", "longName": "100440 - Disclosure - OTHER LIABILITIES (Tables)", "shortName": "OTHER LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSTables", "longName": "100450 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONTables", "longName": "100460 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "shortName": "STOCK-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSTables", "longName": "100470 - Disclosure - EMPLOYEE RETIREMENT PLANS (Tables)", "shortName": "EMPLOYEE RETIREMENT PLANS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKTables", "longName": "100480 - Disclosure - CONCENTRATION OF RISK (Tables)", "shortName": "CONCENTRATION OF RISK (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTables", "longName": "100490 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables", "longName": "100500 - Disclosure - REVENUE RECOGNITION (Tables)", "shortName": "REVENUE RECOGNITION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHARETables", "longName": "100510 - Disclosure - NET INCOME PER COMMON SHARE (Tables)", "shortName": "NET INCOME PER COMMON SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureBUSINESSAdditionalInformationDetails", "longName": "100530 - Disclosure - BUSINESS - Additional Information (Details)", "shortName": "BUSINESS - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:NumberOfPatentsIssuedAndPendingApplication", "unitRef": "U_Patent", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:NumberOfPatentsIssuedAndPendingApplication", "unitRef": "U_Patent", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails", "longName": "100540 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "oled:CashAndCashEquivalentsMaturityPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "oled:CashAndCashEquivalentsMaturityPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails", "longName": "100550 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Cash, Cash Equivalents (Details)", "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Cash, Cash Equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails", "longName": "100560 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Investments (Details)", "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - Schedule of Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "C_4c9cbe32-4beb-47ee-adab-2e91586138d2", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_77972243-b8f9-4c43-9a23-d3f0b71606f4", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R53": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails", "longName": "100570 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - Additional Information (Details)", "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "C_637e64e6-76b4-4134-b73d-5ae0cfc45d35", "name": "oled:NumberOfMinorityInvestments", "unitRef": "U_Investment", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_637e64e6-76b4-4134-b73d-5ae0cfc45d35", "name": "oled:NumberOfMinorityInvestments", "unitRef": "U_Investment", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "longName": "100580 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_1b15f0aa-2f95-401d-9ec8-3fd1fc79cd24", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R55": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSAdditionalInformationDetails", "longName": "100590 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails", "longName": "100600 - Disclosure - INVENTORY - Schedule of Inventory (Details)", "shortName": "INVENTORY - Schedule of Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYAdditionalInformationDetails", "longName": "100610 - Disclosure - INVENTORY - Additional Information (Details)", "shortName": "INVENTORY - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:InventoryWriteDown", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:InventoryWriteDown", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails", "longName": "100620 - Disclosure - PROPERTY AND EQUIPMENT (Details)", "shortName": "PROPERTY AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails", "longName": "100630 - Disclosure - PROPERTY AND EQUIPMENT - Additional Information (Details)", "shortName": "PROPERTY AND EQUIPMENT - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:Depreciation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_db792e64-12af-42c7-b3e1-81ab705d7079", "name": "oled:DescripionOfPropertyAvailableForOperatingLease", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R60": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "longName": "100640 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Acquired Technology (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Acquired Technology (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "longName": "100650 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Acquired Technology - Additional Information (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Acquired Technology - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R62": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "longName": "100660 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Other Intangible Assets - Additional Information (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Other Intangible Assets - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OtherFiniteLivedIntangibleAssetsGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_028d6963-f383-4bf6-bdce-59e77712b552", "name": "oled:OtherFiniteLivedAmortizationOfIntangibleAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R63": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "longName": "100670 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OtherFiniteLivedIntangibleAssetsGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_c1d0c4b8-95e7-4b16-8376-a9ef8c6f7151", "name": "oled:OtherFiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:ScheduleOfOtherFiniteLivedIntangibleAssetsTableTextBlock", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R64": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails", "longName": "100680 - Disclosure - OTHER ASSETS - Schedule of Other Assets (Details)", "shortName": "OTHER ASSETS - Schedule of Other Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:IncomeTaxesReceivableNoncurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:IncomeTaxesReceivableNoncurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "longName": "100690 - Disclosure - LEASES- Additional Information (Details)", "shortName": "LEASES- Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:LesseeOperatingLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:LesseeOperatingLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESSummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesDetails", "longName": "100700 - Disclosure - LEASES - Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases (Details)", "shortName": "LEASES - Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:OperatingLeaseCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:SummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:SummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R67": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesDetails", "longName": "100710 - Disclosure - LEASES - Schedule Of Operating Lease Right of Use Assets and Liabilities (Details)", "shortName": "LEASES - Schedule Of Operating Lease Right of Use Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OperatingLeaseLiabilityCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:ScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R68": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesDetails", "longName": "100720 - Disclosure - LEASES - Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities (Details)", "shortName": "LEASES - Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "oled:ScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "oled:ScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails", "longName": "100730 - Disclosure - LEASES - Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms (Details)", "shortName": "LEASES - Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails", "longName": "100740 - Disclosure - ACCRUED EXPENSES - Schedule of Accrued Expenses (Details)", "shortName": "ACCRUED EXPENSES - Schedule of Accrued Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:AccruedSalariesCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:AccruedSalariesCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails", "longName": "100750 - Disclosure - RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS- Additional Information (Details)", "shortName": "RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS- Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:RoyaltyExpense", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_710da636-4406-43e7-a479-1828f7e0bb05", "name": "us-gaap:RoyaltyExpense", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R72": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails", "longName": "100760 - Disclosure - OTHER LIABILITIES - Summary of Other liabilities (Details)", "shortName": "OTHER LIABILITIES - Summary of Other liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:TaxesPayableCurrentAndNoncurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "div", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:TaxesPayableCurrentAndNoncurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "div", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails", "longName": "100770 - Disclosure - EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS - Additional Information (Details)", "shortName": "EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:LongTermPurchaseCommitmentPercentOfServicesPayableInCashOrShares", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:CommitmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:LongTermPurchaseCommitmentPercentOfServicesPayableInCashOrShares", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:CommitmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "longName": "100780 - Disclosure - SHAREHOLDERS' EQUITY - Additional Information (Details)", "shortName": "SHAREHOLDERS' EQUITY - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "oled:NumberOfBoardMembersElectedByClassShareholders", "unitRef": "U_Board_member", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R75": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails", "longName": "100790 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Details)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "C_4c9cbe32-4beb-47ee-adab-2e91586138d2", "name": "us-gaap:StockholdersEquity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_d386bc44-7812-4521-97ba-c0ad47f6e0ea", "name": "us-gaap:StockholdersEquity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R76": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossParentheticalDetails", "longName": "100800 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Parenthetical) (Details)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Accumulated Other Comprehensive Loss (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "longName": "100810 - Disclosure - STOCK-BASED COMPENSATION - Equity Compensation Plan - Additional Information (Details)", "shortName": "STOCK-BASED COMPENSATION - Equity Compensation Plan - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "C_e68712cc-cbd1-4595-91a2-c0764337dfe3", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_e68712cc-cbd1-4595-91a2-c0764337dfe3", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails", "longName": "100820 - Disclosure - STOCK-BASED COMPENSATION - Equity Instruments Other Than Options (Details)", "shortName": "STOCK-BASED COMPENSATION - Equity Instruments Other Than Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "C_13b3c8d6-776f-4656-940e-68e9f8d33738", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4a021dcb-5d7c-4e94-90c3-91de7c9664df", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R79": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "longName": "100830 - Disclosure - STOCK-BASED COMPENSATION - Equity Instruments Other Than Options - Additional Information (Details)", "shortName": "STOCK-BASED COMPENSATION - Equity Instruments Other Than Options - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4e4ec51a-93a3-4d58-a5f0-87590f6fcec1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R80": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "longName": "100840 - Disclosure - STOCK-BASED COMPENSATION - Employee Stock Purchase Plan - Additional Information (Details)", "shortName": "STOCK-BASED COMPENSATION - Employee Stock Purchase Plan - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_dc3d4d2d-deff-404c-8bcb-ccecffb04801", "name": "oled:EmployeeStockPurchasePlanEsppPurchasePeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R81": { "role": "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails", "longName": "100850 - Disclosure - STOCK-BASED COMPENSATION - Deferred Compensation Arrangement - Additional Information (Details)", "shortName": "STOCK-BASED COMPENSATION - Deferred Compensation Arrangement - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "C_6a88a95b-2f53-442c-9896-7992ff00d211", "name": "us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_6a88a95b-2f53-442c-9896-7992ff00d211", "name": "us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R82": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "longName": "100860 - Disclosure - EMPLOYEE RETIREMENT PLANS - Additional Information (Details)", "shortName": "EMPLOYEE RETIREMENT PLANS - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R83": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails", "longName": "100870 - Disclosure - EMPLOYEE RETIREMENT PLANS - Information Relating to the Company's Plan (Details)", "shortName": "EMPLOYEE RETIREMENT PLANS - Information Relating to the Company's Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "C_4c9cbe32-4beb-47ee-adab-2e91586138d2", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_637e64e6-76b4-4134-b73d-5ae0cfc45d35", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R84": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails", "longName": "100880 - Disclosure - EMPLOYEE RETIREMENT PLANS - Components of Net Periodic Pension Cost (Details)", "shortName": "EMPLOYEE RETIREMENT PLANS - Components of Net Periodic Pension Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_42ed47f7-daad-44f9-a0ff-c5d57aaa211f", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R85": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineBenefitObligationDetails", "longName": "100890 - Disclosure - EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Benefit Obligation (Details)", "shortName": "EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Benefit Obligation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineNetPeriodicPensionCostDetails", "longName": "100900 - Disclosure - EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Net Periodic Pension Cost (Details)", "shortName": "EMPLOYEE RETIREMENT PLANS - Assumptions Used to Determine Net Periodic Pension Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R87": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails", "longName": "100910 - Disclosure - EMPLOYEE RETIREMENT PLANS - Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year (Details)", "shortName": "EMPLOYEE RETIREMENT PLANS - Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R88": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails", "longName": "100920 - Disclosure - EMPLOYEE RETIREMENT PLANS - Benefit Payments Expected to be Paid (Details)", "shortName": "EMPLOYEE RETIREMENT PLANS - Benefit Payments Expected to be Paid (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "div", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R89": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails", "longName": "100930 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R90": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails", "longName": "100940 - Disclosure - CONCENTRATION OF RISK - Revenues and Accounts Receivable From Our Largest Customers (Details)", "shortName": "CONCENTRATION OF RISK - Revenues and Accounts Receivable From Our Largest Customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_66298c99-3c2b-4398-85b5-f201a7c14354", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R91": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "longName": "100950 - Disclosure - CONCENTRATION OF RISK - Additional Information (Details)", "shortName": "CONCENTRATION OF RISK - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "C_ac793240-4697-4872-b683-3083dcd017f2", "name": "oled:NumberOfSuppliersFromWhichChemicalMaterialsWerePurchased", "unitRef": "U_Supplier", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ac793240-4697-4872-b683-3083dcd017f2", "name": "oled:NumberOfSuppliersFromWhichChemicalMaterialsWerePurchased", "unitRef": "U_Supplier", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R92": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails", "longName": "100960 - Disclosure - CONCENTRATION OF RISK - Revenues by Geographic Area (Details)", "shortName": "CONCENTRATION OF RISK - Revenues by Geographic Area (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_c8544620-61a0-4c87-9ff2-f88f85485ccf", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R93": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails", "longName": "100970 - Disclosure - CONCENTRATION OF RISK - Long-Lived Assets (Net) by Geographic Area (Details)", "shortName": "CONCENTRATION OF RISK - Long-Lived Assets (Net) by Geographic Area (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:NoncurrentAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:NoncurrentAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R94": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails", "longName": "100980 - Disclosure - INCOME TAXES - Components of Income (Loss) before Income Taxes (Details)", "shortName": "INCOME TAXES - Components of Income (Loss) before Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R95": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails", "longName": "100990 - Disclosure - INCOME TAXES - Components of Income Tax Expense (Details)", "shortName": "INCOME TAXES - Components of Income Tax Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R96": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails", "longName": "101000 - Disclosure - INCOME TAXES - Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate (Details)", "shortName": "INCOME TAXES - Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R97": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails", "longName": "101010 - Disclosure - INCOME TAXES - Tax Loss and Tax Credit Carryforwards (Details)", "shortName": "INCOME TAXES - Tax Loss and Tax Credit Carryforwards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:TaxCreditCarryforwardAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:SummaryOfOperatingLossAndTaxCreditCarryforwardsTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:TaxCreditCarryforwardAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:SummaryOfOperatingLossAndTaxCreditCarryforwardsTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R98": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails", "longName": "101020 - Disclosure - INCOME TAXES - Significant Components of Deferred Tax Assets and Liabilities (Details)", "shortName": "INCOME TAXES - Significant Components of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:DeferredTaxAssetsCapitalizedResearchExpenditures", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:DeferredTaxAssetsCapitalizedResearchExpenditures", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R99": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "longName": "101030 - Disclosure - INCOME TAXES - Additional Information (Details)", "shortName": "INCOME TAXES - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:OtherAssetsNoncurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "oled:StateAndForeignIncomeTaxReturnsSubjectToExaminationPeriodMaximum", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R100": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "longName": "101040 - Disclosure - REVENUE RECOGNITION - Additional Information (Details)", "shortName": "REVENUE RECOGNITION - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:BacklogAssociatedWithCommittedPurchaseOrdersFromCustomers", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "oled:BacklogAssociatedWithCommittedPurchaseOrdersFromCustomers", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R101": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails", "longName": "101050 - Disclosure - REVENUE RECOGNITION - Schedule of Assets and Liabilities Associated with Contracts from Customers (Details)", "shortName": "REVENUE RECOGNITION - Schedule of Assets and Liabilities Associated with Contracts from Customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2f516a1c-7dd7-49a3-94f8-a738d8c51576", "name": "us-gaap:UnbilledReceivablesCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R102": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails", "longName": "101060 - Disclosure - REVENUE RECOGNITION - Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances (Details)", "shortName": "REVENUE RECOGNITION - Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "C_4c9cbe32-4beb-47ee-adab-2e91586138d2", "name": "us-gaap:DeferredRevenue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:SummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_637e64e6-76b4-4134-b73d-5ae0cfc45d35", "name": "us-gaap:DeferredRevenue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "oled:SummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R103": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails", "longName": "101070 - Disclosure - NET INCOME PER COMMON SHARE - Schedule of Earnings Per Share (Details)", "shortName": "NET INCOME PER COMMON SHARE - Schedule of Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "unique": true } }, "R104": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREAdditionalInformationDetails", "longName": "101080 - Disclosure - NET INCOME PER COMMON SHARE - Additional Information (Details)", "shortName": "NET INCOME PER COMMON SHARE - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true, "unique": true } }, "R105": { "role": "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDDetails", "longName": "101090 - Disclosure - QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) (Details)", "shortName": "QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "C_359bf4f9-13c9-4748-a5b6-b60864ad73b6", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "oled-20231231.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingStandardsUpdate201409Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingStandardsUpdate201409Member", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contracts with Customers - ASU No. 2014-09 [Member]", "label": "Accounting Standards Update 2014-09 [Member]", "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606)." } } }, "auth_ref": [ "r443" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCRUEDEXPENSES" ], "lang": { "en-us": { "role": { "terseLabel": "ACCRUED EXPENSES", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r28" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Accounts Payable, Current, Total", "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r27", "r932" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable [Member]", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r873" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total", "verboseLabel": "Accounts Receivable", "terseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r327", "r328" ] }, "oled_AccruedConsultingFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AccruedConsultingFeesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consulting", "label": "Accrued Consulting Fees Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for consulting fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Accrued Expenses", "terseLabel": "Accrued expenses", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30" ] }, "oled_AccruedPpgAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AccruedPpgAgreements", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued PPG Agreements", "documentation": "Accrued PPG agreements.", "terseLabel": "PPG Industries, Inc. agreement" } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Professional Fees", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30" ] }, "oled_AccruedResearchAndDevelopmentAgreementFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AccruedResearchAndDevelopmentAgreementFees", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development agreements", "label": "Accrued Research And Development Agreement Fees", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development agreements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccruedRoyaltiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedRoyaltiesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Royalties", "label": "Accrued Royalties, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30", "r892" ] }, "us-gaap_AccruedSalariesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalariesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation", "label": "Accrued Salaries, Current", "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30", "r892" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gain (loss) on retirement plan [Member]", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r6", "r21", "r39", "r982", "r983", "r984" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance", "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance", "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total", "negatedLabel": "Less: Accumulated depreciation", "terseLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r67", "r229", "r747" ] }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain (loss) on available-for-sale securities [Member]", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r244", "r245", "r246", "r248", "r257", "r258", "r982" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r256", "r257", "r652", "r654", "r655", "r656", "r657", "r658" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r38", "r39", "r134", "r238", "r743", "r770", "r774" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r256", "r257", "r652", "r654", "r655", "r656", "r657", "r658" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss [Member]", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r21", "r39", "r616", "r619", "r683", "r765", "r766", "r982", "r983", "r984", "r989", "r990", "r991" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in cumulative foreign currency translation adjustment [Member]", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r4", "r21", "r39", "r257", "r258", "r654", "r655", "r656", "r657", "r658", "r982" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization period of acquired intangible assets (in years)", "terseLabel": "Weighted average useful life , intangible assets", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r158" ] }, "us-gaap_AcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquisitionCosts", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Acquisition Costs, Period Cost", "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties." } } }, "auth_ref": [ "r178", "r179" ] }, "oled_AdditionalAgreementDuration": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AdditionalAgreementDuration", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional agreement duration", "label": "Additional Agreement Duration", "documentation": "Additional agreement duration." } } }, "auth_ref": [] }, "oled_AdditionalFundingAgreement2006Member": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AdditionalFundingAgreement2006Member", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Member stands for 2006 Research Agreement.", "label": "Additional Funding Agreement2006 [Member]", "terseLabel": "2006 Research Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "periodEndLabel": "Additional Paid in Capital, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Beginning Balance", "totalLabel": "Additional Paid in Capital, Total", "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r125", "r932", "r1094" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital [Member]", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r560", "r561", "r562", "r785", "r989", "r990", "r991", "r1070", "r1095" ] }, "oled_AdesisIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AdesisIncMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adesis, Inc. [Member]", "label": "Adesis Inc [Member]", "documentation": "Adesis Inc." } } }, "auth_ref": [] }, "oled_AdjustedBalanceDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AdjustedBalanceDeferredRevenue", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Adjusted balance on January 1, 2018", "label": "Adjusted Balance Deferred Revenue", "documentation": "Adjusted balance deferred revenue." } } }, "auth_ref": [] }, "oled_AdjustedBalanceStockholderEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AdjustedBalanceStockholderEquity", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "periodStartLabel": "ADJUSTED BALANCE", "periodEndLabel": "ADJUSTED BALANCE", "label": "Adjusted Balance Stockholder Equity", "documentation": "Adjusted balance stockholder equity." } } }, "auth_ref": [] }, "oled_AdjustedBalanceUnbilledReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AdjustedBalanceUnbilledReceivables", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Adjusted balance on January 1, 2018", "label": "Adjusted Balance Unbilled Receivables", "documentation": "Adjusted balance unbilled receivables." } } }, "auth_ref": [] }, "oled_AdjustedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AdjustedSharesOutstanding", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "periodStartLabel": "BALANCE ADJUSTED (in shares)", "periodEndLabel": "BALANCE ADJUSTED (in shares)", "label": "Adjusted Shares Outstanding", "documentation": "Adjusted shares outstanding." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Standards Update", "label": "Accounting Standards Update [Axis]", "documentation": "Information by amendment to accounting standards." } } }, "auth_ref": [ "r217", "r218", "r219", "r220", "r221", "r276", "r277", "r278", "r279", "r288", "r333", "r334", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r401", "r560", "r561", "r562", "r589", "r590", "r591", "r592", "r603", "r604", "r605", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r642", "r643", "r647", "r648", "r649", "r650", "r660", "r661", "r662", "r663", "r664", "r665", "r679", "r680", "r681", "r682", "r683", "r721", "r722", "r723", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares withheld for employee taxes", "terseLabel": "Fair value of shares withheld for tax withholding obligations", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r555", "r567" ] }, "oled_AllocationOfWithholdingToNonKoreanPatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AllocationOfWithholdingToNonKoreanPatentsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allocation of Withholding to Non-Korean Patents [Member]", "label": "Allocation Of Withholding To Non Korean Patents [Member]", "documentation": "Allocation of withholding to non-Korean patents." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r239", "r331", "r377" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "oled_AmortizationOfAcquiredTechnologyAndOtherIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AmortizationOfAcquiredTechnologyAndOtherIntangibleAssets", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of acquired technology and other intangible assets", "label": "Amortization Of Acquired Technology And Other Intangible Assets", "documentation": "Amortization of acquired technology and other intangible assets." } } }, "auth_ref": [] }, "oled_AmortizationOfAcquiredTechnologyPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AmortizationOfAcquiredTechnologyPolicyPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of Acquired Technology", "label": "Amortization Of Acquired Technology Policy Policy [Text Block]", "documentation": "Amortization of acquired technology." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of premium and discount on investments, net", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r14", "r113", "r145", "r421" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Amortization of Intangible Assets, Total", "verboseLabel": "Amortization of intangibles", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r14", "r62", "r65" ] }, "oled_AmortizationOfOtherIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "AmortizationOfOtherIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of Other Intangible Assets", "label": "Amortization Of Other Intangible Assets Policy [Text Block]", "documentation": "Amortization of other intangible assets." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from calculation of diluted EPS", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r303" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r606" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r181", "r233", "r269", "r311", "r317", "r321", "r366", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r607", "r609", "r646", "r738", "r824", "r932", "r945", "r1027", "r1028", "r1077" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r223", "r243", "r269", "r366", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r607", "r609", "r646", "r932", "r1027", "r1028", "r1077" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT ASSETS:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "verboseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r950", "r951", "r952" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "verboseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r950", "r951", "r952" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r950", "r951", "r952" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-sale Securities, Gross Unrealized Gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r339" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Available-for-sale Securities, Gross Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r340" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Available-for-sale Debt Securities, Amortized Cost Basis", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r336", "r383", "r736" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Debt Securities, Available-for-sale, Total", "terseLabel": "Available-for-sale Securities, Fair Value Disclosure", "label": "Debt Securities, Available-for-Sale", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r337", "r383", "r726", "r1000" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r550", "r551", "r552", "r553", "r554" ] }, "oled_BASFSEMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "BASFSEMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "BASF [Member]", "label": "B A S F S E [Member]", "documentation": "BASF SE." } } }, "auth_ref": [] }, "oled_BacklogAssociatedWithCommittedPurchaseOrdersFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "BacklogAssociatedWithCommittedPurchaseOrdersFromCustomers", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Backlog associated with committed purchase orders from customers", "label": "Backlog Associated With Committed Purchase Orders From Customers", "documentation": "Backlog associated with committed purchase orders from its customers." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r104", "r105" ] }, "us-gaap_BuildingAndBuildingImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingAndBuildingImprovementsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Building and improvements [Member]", "label": "Building and Building Improvements [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing." } } }, "auth_ref": [] }, "us-gaap_BuildingImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingImprovementsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Building Improvements [Member]", "label": "Building Improvements [Member]", "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r162" ] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Building [Member]", "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r162" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r602", "r922", "r925" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r93", "r94", "r602", "r922", "r925" ] }, "country_CN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CN", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China [Member]", "label": "CHINA" } } }, "auth_ref": [] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reported Value Measurement [Member]", "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r109", "r110" ] }, "oled_CashAccountsInBankingInstitutionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CashAccountsInBankingInstitutionsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Accounts in Banking Institutions [Member]", "label": "Cash Accounts In Banking Institutions [Member]", "documentation": "Cash accounts in banking institutions." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAbstract", "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r43", "r226", "r890" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r226" ] }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH, CASH EQUIVALENTS AND INVESTMENTS", "label": "Cash and Cash Equivalents Disclosure [Text Block]", "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify." } } }, "auth_ref": [ "r226", "r740" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails": { "parentTag": "us-gaap_CashEquivalentsAtCarryingValue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash equivalents", "terseLabel": "Cash and Cash Equivalents, Fair Value Disclosure", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash And Cash Equivalents [Line Items]", "label": "Cash and Cash Equivalents [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "oled_CashAndCashEquivalentsMaturityPeriod": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CashAndCashEquivalentsMaturityPeriod", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents maturity period", "label": "Cash And Cash Equivalents Maturity Period", "documentation": "Cash and cash equivalents maturity period." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, Cash Equivalents and Investments", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r44" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total", "periodStartLabel": "CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR", "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF YEAR", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r43", "r149", "r266" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Ending Balance", "periodStartLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Beginning Balance", "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r43", "r149", "r266" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "DECREASE IN CASH AND CASH EQUIVALENTS", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r149" ] }, "us-gaap_CashDistributionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashDistributionMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Distribution", "label": "Cash Distribution [Member]", "documentation": "Distribution of cash made by the entity based on a contractual agreement such as a partnership or employment agreement." } } }, "auth_ref": [] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Cash Equivalents, at Carrying Value", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r974", "r1088" ] }, "oled_CashEquivalentsGrossUnrealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CashEquivalentsGrossUnrealizedGain", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails": { "parentTag": "us-gaap_CashEquivalentsAtCarryingValue", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Equivalents, Gross Unrealized Gains", "label": "Cash Equivalents Gross Unrealized Gain", "documentation": "Cash Equivalents, Gross Unrealized Gain" } } }, "auth_ref": [] }, "oled_CashEquivalentsGrossUnrealizedLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CashEquivalentsGrossUnrealizedLosses", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails": { "parentTag": "us-gaap_CashEquivalentsAtCarryingValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash Equivalents, Gross Unrealized Losses", "label": "Cash Equivalents Gross Unrealized Losses", "documentation": "Cash Equivalents, Gross Unrealized Losses" } } }, "auth_ref": [] }, "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowOperatingActivitiesLesseeAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESSummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash activity:", "label": "Cash Flow, Operating Activities, Lessee [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CertificatesOfDepositMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CertificatesOfDepositMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Certificates of Deposit [Member]", "label": "Certificates of Deposit [Member]", "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured." } } }, "auth_ref": [ "r19", "r939", "r940", "r941", "r942" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r216", "r234", "r235", "r236", "r269", "r293", "r297", "r300", "r302", "r309", "r310", "r366", "r411", "r413", "r414", "r415", "r418", "r419", "r423", "r424", "r426", "r427", "r429", "r646", "r778", "r779", "r780", "r781", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r812", "r833", "r851", "r866", "r867", "r868", "r869", "r870", "r958", "r986", "r996" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class Of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r234", "r235", "r236", "r309", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r778", "r779", "r780", "r781", "r909", "r958", "r986" ] }, "oled_CommitmentWithExecutiveOfficersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CommitmentWithExecutiveOfficersMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment With Executive Officers [Member]", "label": "Commitment With Executive Officers [Member]", "documentation": "Commitments with executive officers of the Company which provide for certain cash and other benefits upon termination of employment of the officer in connection with a change in control of the Company." } } }, "auth_ref": [] }, "oled_CommitmentWithSeniorLevelEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CommitmentWithSeniorLevelEmployeesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment With Senior Level Employees [Member]", "label": "Commitment With Senior Level Employees [Member]", "documentation": "Commitment with senior level employees." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES (Note 18)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r35", "r115", "r739", "r811" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r163", "r403", "r404", "r874", "r1021" ] }, "us-gaap_CommitmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS", "label": "Commitments Disclosure [Text Block]", "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights." } } }, "auth_ref": [ "r163" ] }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareCashPaid", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock dividends paid per share", "label": "Common Stock, Dividends, Per Share, Cash Paid", "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r167" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock dividends declared per share", "terseLabel": "CASH DIVIDEND DECLARED PER COMMON SHARE", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r167" ] }, "oled_CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock Issued to Board of Directors and Scientific Advisory Board that was Earned and Accrued for in Previous Period [Member]", "label": "Common Stock Issued To Board Of Directors And Scientific Advisory Board That Was Earned And Accrued For In Previous Period [Member]", "documentation": "The fair value of stock, restricted stock or stock options granted to the Board of Directors and Scientific Advisory Board as payment for services rendered or acknowledged claims in a previous period." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock [Member]", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r935", "r936", "r937", "r939", "r940", "r941", "r942", "r989", "r990", "r1070", "r1092", "r1095" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r124" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r124", "r812" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Common Stock, Shares, Issued, Total", "terseLabel": "Common Stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r124" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common Stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r22", "r124", "r812", "r830", "r1095", "r1096" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock, par value $0.01 per share, 200,000,000 shares authorized, 48,731,026and 49,136,030 shares issued, and 47,365,378 and 47,770,382 share outstanding at December 31, 2023 and December 31, 2022, respectively", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "totalLabel": "Common Stock, Value, Issued, Total", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r124", "r742", "r932" ] }, "oled_CompanyPerformanceBasedVestingRequirementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CompanyPerformanceBasedVestingRequirementMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company Performance-Based Vesting Requirement [Member]", "label": "Company Performance Based Vesting Requirement [Member]", "documentation": "Company performance-based vesting requirement." } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "COMPREHENSIVE INCOME", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r252", "r254", "r261", "r728", "r753" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r133", "r260", "r727", "r751" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r52", "r54", "r111", "r112", "r326", "r873" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable [Member]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r52", "r54", "r111", "r112", "r326", "r775", "r873" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk [Member]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r52", "r54", "r111", "r112", "r326", "r873", "r962" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISK" ], "lang": { "en-us": { "role": { "terseLabel": "CONCENTRATION OF RISK", "label": "Concentration Risk Disclosure [Text Block]", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r154" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r873" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Concentration risk, percentage (less than 1% for contracts with U.S. government agencies)", "terseLabel": "% of Total Revenue", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r52", "r54", "r111", "r112", "r326" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r51", "r52", "r54", "r55", "r111", "r177", "r873" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r52", "r54", "r111", "r112", "r326", "r873" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r102", "r896" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction-in-progress [Member]", "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "oled_ContractAssetsRecorded": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ContractAssetsRecorded", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "documentation": "Contract Assets Recorded", "label": "Contract Assets Recorded", "terseLabel": "Contract Assets Recorded" } } }, "auth_ref": [] }, "oled_ContractExpirationYear": { "xbrltype": "gYearItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ContractExpirationYear", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract expiration year", "label": "Contract Expiration Year", "documentation": "Contract expiration year." } } }, "auth_ref": [] }, "oled_ContractResearchServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ContractResearchServicesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Contract research services", "label": "Contract Research Services [Member]", "documentation": "Contract research services." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and Liabilities Associated with Contracts from Customers", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability." } } }, "auth_ref": [ "r1032" ] }, "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails": { "parentTag": "oled_NetIncreaseDecreaseInDeferredRevenue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative catch-up adjustment arising from changes in estimates of transaction price", "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price", "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained." } } }, "auth_ref": [ "r910" ] }, "oled_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangesInEstimateOfTransactionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangesInEstimateOfTransactionPrice", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with customer liability, transaction price", "label": "Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Changes In Estimate Of Transaction Price", "documentation": "Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Changes In Estimate Of Transaction Price" } } }, "auth_ref": [] }, "oled_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueDecreaseInEstimateOfTransactionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueDecreaseInEstimateOfTransactionPrice", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative catch-up adjustment arising from decrease in estimates of transaction price", "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Decrease in Estimate of Transaction Price", "documentation": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Decrease in Estimate of Transaction Price" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails": { "parentTag": "oled_NetIncreaseDecreaseInDeferredRevenue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized that was previously included in deferred revenue", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r441" ] }, "us-gaap_CorporateBondSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateBondSecuritiesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate Bond Securities [Member]", "label": "Corporate Bond Securities [Member]", "verboseLabel": "Corporate Bonds [Member]", "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount)." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Cost of Goods and Services Sold, Total", "terseLabel": "COST OF SALES", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r140", "r719" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Sales [Member]", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Sales", "label": "Cost of Goods and Service [Policy Text Block]", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r965" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "oled_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionForDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionForDeferredRevenue", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Adoption of Topic 606 on January 1, 2018", "label": "Cumulative Effect Of New Accounting Principle In Period Of Adoption For Deferred Revenue", "documentation": "Cumulative effect of new accounting principle in period of adoption for deferred revenue." } } }, "auth_ref": [] }, "oled_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionForUnbilledReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionForUnbilledReceivables", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Adoption of Topic 606 on January 1, 2018", "label": "Cumulative Effect Of New Accounting Principle In Period Of Adoption For Unbilled Receivables", "documentation": "Cumulative effect of new accounting principle in period of adoption for unbilled receivables." } } }, "auth_ref": [] }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Effect Period Of Adoption Adjustment [Member]", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "auth_ref": [ "r219", "r275", "r282", "r288", "r370", "r376", "r560", "r561", "r562", "r591", "r592", "r614", "r616", "r617", "r619", "r620", "r621", "r626", "r629", "r631", "r632", "r681" ] }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Effect, Period of Adoption", "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "auth_ref": [ "r219", "r275", "r282", "r288", "r370", "r376", "r560", "r561", "r562", "r591", "r592", "r614", "r616", "r617", "r619", "r620", "r621", "r626", "r629", "r631", "r632", "r681" ] }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Effect, Period of Adoption", "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "auth_ref": [ "r219", "r275", "r282", "r288", "r370", "r376", "r560", "r561", "r562", "r591", "r592", "r614", "r616", "r617", "r619", "r620", "r621", "r626", "r629", "r631", "r632", "r681" ] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r964", "r988", "r1068" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign", "terseLabel": "Current income tax expense", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r964", "r988" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Current Income Tax Expense (Benefit), Total", "negatedTotalLabel": "Current income tax benefit (expense)", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r175", "r588", "r596", "r988" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current income tax (expense) benefit:", "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "State", "label": "Current State and Local Tax Expense (Benefit)", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r964", "r988", "r1068" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk [Member]", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r53", "r326" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Relationships [Member]", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r96" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock in connection with materials and license agreements (in shares)", "label": "Debt Conversion, Converted Instrument, Shares Issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r46", "r48" ] }, "us-gaap_DebtInstrumentConvertibleStockPriceTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleStockPriceTrigger", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum average closing price of common stock (in dollars per share)", "label": "Debt Instrument, Convertible, Stock Price Trigger", "documentation": "Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the debt instrument to become effective." } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities Available For Sale [Table]", "label": "Debt Securities, Available-for-Sale [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346" ] }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Investments", "label": "Debt Securities, Available-for-Sale [Table Text Block]", "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ] }, "oled_DeferredCompensationArrangementWithEmployeesAndNonEmployeesShareBasedPaymentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DeferredCompensationArrangementWithEmployeesAndNonEmployeesShareBasedPaymentsLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Compensation Arrangement with Employees and Non-Employees, Share-Based Payments [Line Items]", "label": "Deferred Compensation Arrangement With Employees And Non Employees Share Based Payments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of shares issued", "label": "Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued", "documentation": "The total fair value of shares issued during the period under a deferred compensation arrangement." } } }, "auth_ref": [ "r85" ] }, "us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualSharesIssued", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued (in shares)", "label": "Deferred Compensation Arrangement with Individual, Shares Issued", "documentation": "Number of shares issued pursuant to the terms of a deferred compensation arrangement." } } }, "auth_ref": [ "r88" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "oled_DeferredIncomeTaxExpenseBenefitBeforeChangeinValuationAllowance", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r988", "r1067", "r1068" ] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "oled_DeferredIncomeTaxExpenseBenefitBeforeChangeinValuationAllowance", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign", "label": "Deferred Foreign Income Tax Expense (Benefit)", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r175", "r988", "r1067" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Income Tax Assets, Net, Total", "terseLabel": "DEFERRED INCOME TAXES", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r575", "r576" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax (benefit) expense", "totalLabel": "Deferred Income Tax Expense (Benefit), Total", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r14", "r175", "r212", "r595", "r596", "r988" ] }, "oled_DeferredIncomeTaxExpenseBenefitBeforeChangeinValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DeferredIncomeTaxExpenseBenefitBeforeChangeinValuationAllowance", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Deferred income tax expense, gross", "label": "Deferred Income Tax Expense Benefit Before Changein Valuation Allowance", "documentation": "Deferred income tax expense (benefit) before change in valuation allowance." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax (expense) benefit:", "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Liabilities, Gross, Total", "negatedTotalLabel": "Deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r121", "r122", "r183", "r582" ] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "negatedPeriodEndLabel": "Balance", "negatedPeriodStartLabel": "Balance", "totalLabel": "Deferred Revenue, Total", "label": "Deferred Revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r978" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Revenue, Current, Total", "verboseLabel": "Short-term deferred revenue", "terseLabel": "Deferred revenue", "label": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r977" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Revenue, Noncurrent, Total", "verboseLabel": "Long-term deferred revenue", "terseLabel": "DEFERRED REVENUE", "label": "Deferred Revenue, Noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r978" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": "oled_DeferredIncomeTaxExpenseBenefitBeforeChangeinValuationAllowance", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r988", "r1067", "r1068" ] }, "oled_DeferredTaxAssetsCapitalizedResearchExpenditures": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DeferredTaxAssetsCapitalizedResearchExpenditures", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized research expenditures", "label": "Deferred Tax Assets Capitalized Research Expenditures", "documentation": "The tax effect as of the balance sheet date of the amount of the estimated future tax deductions attributable to capitalized research expenditures." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsDeferredIncome", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Tax Assets, Deferred Income", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income." } } }, "auth_ref": [ "r92", "r1066" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Gross", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r583" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1065" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1065" ] }, "us-gaap_DeferredTaxAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNetAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax asset:", "label": "Deferred Tax Assets, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r92", "r1066" ] }, "oled_DeferredTaxAssetsRetirementPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DeferredTaxAssetsRetirementPlan", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement plan", "label": "Deferred Tax Assets Retirement Plan", "documentation": "The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from all currently nondeductible expenses reflected in retirement plan, which can only be deducted for tax purposes when benefit is paid, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total", "terseLabel": "Tax credit carry forwards", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r91", "r92", "r1066" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r92", "r1066" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total", "terseLabel": "Accruals and reserves", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals." } } }, "auth_ref": [ "r92", "r1066" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total", "negatedLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r584" ] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisition Goodwill", "terseLabel": "Acquisition Goodwill", "label": "Deferred Tax Liabilities, Goodwill", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill." } } }, "auth_ref": [ "r92", "r98", "r99", "r1066" ] }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesLeasingArrangements", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Assets", "label": "Deferred Tax Liabilities, Leasing Arrangements", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements." } } }, "auth_ref": [ "r92", "r1066" ] }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesNetAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability:", "label": "Deferred Tax Liabilities, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "terseLabel": "Other", "label": "Deferred Tax Liabilities, Other Finite-Lived Assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment." } } }, "auth_ref": [ "r92", "r1066" ] }, "oled_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansAbstract", "lang": { "en-us": { "role": { "label": "Defined Benefit Pension Plans And Defined Benefit Postretirement Plans [Abstract]", "documentation": "Defined Benefit Pension Plans and Defined Benefit Postretirement Plans." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated benefit obligation", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level." } } }, "auth_ref": [ "r478" ] }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanActuarialGainLoss", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Actuarial gain", "terseLabel": "Actuarial (gain) loss", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan." } } }, "auth_ref": [ "r453" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of loss", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r447", "r485", "r508", "r920", "r921" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of prior service cost", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r447", "r486", "r509", "r920", "r921" ] }, "us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amounts to be amortized from accumulated other comprehensive loss in next fiscal year [Abstract]", "label": "Defined Benefit Plan, Expected Amortization, Next Fiscal Year [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineBenefitObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan." } } }, "auth_ref": [ "r492" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineBenefitObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rate of compensation increases", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan." } } }, "auth_ref": [ "r493" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Discount rate", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan." } } }, "auth_ref": [ "r492" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rate of compensation increases", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan." } } }, "auth_ref": [ "r493" ] }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanBenefitObligation", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Benefit obligation, beginning of year", "periodEndLabel": "Benefit obligation, end of year", "label": "Defined Benefit Plan, Benefit Obligation", "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r448" ] }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in benefit obligation:", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit payments currently expected to be paid [Abstract]", "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedAmortizationNextFiscalYear", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Defined Benefit Plan, Expected Amortization, Next Fiscal Year", "documentation": "Amount of cost (credit) included in accumulated other comprehensive (income) loss expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position." } } }, "auth_ref": [ "r1035" ] }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails": { "parentTag": "us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of loss", "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year", "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position." } } }, "auth_ref": [ "r1035" ] }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails": { "parentTag": "us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAmountsToBeAmortizedFromAccumulatedOtherComprehensiveLossIntoNetPeriodicPensionCostInNextFiscalYearDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization of prior service cost", "terseLabel": "Prior service cost expected to be amortized in next fiscal year", "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year", "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position." } } }, "auth_ref": [ "r1035" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2029-2033", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year." } } }, "auth_ref": [ "r479" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year." } } }, "auth_ref": [ "r479" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year." } } }, "auth_ref": [ "r479" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year." } } }, "auth_ref": [ "r479" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year." } } }, "auth_ref": [ "r479" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year." } } }, "auth_ref": [ "r479" ] }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Defined Benefit Plan, Plan Assets, Amount, Ending Balance", "periodStartLabel": "Defined Benefit Plan, Plan Assets, Amount, Beginning Balance", "totalLabel": "Defined Benefit Plan, Plan Assets, Amount, Total", "terseLabel": "Fair value of plan assets", "label": "Defined Benefit Plan, Plan Assets, Amount", "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee." } } }, "auth_ref": [ "r459", "r470", "r472", "r473", "r918", "r919", "r920" ] }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFundedStatusOfPlan", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Unfunded status of the plan, end of year", "negatedTotalLabel": "Unfunded status of the plan, end of year", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status." } } }, "auth_ref": [ "r445", "r468", "r920" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r447", "r451", "r483", "r506", "r920", "r921" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total net periodic benefit cost", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r481", "r504", "r920", "r921" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Components of net periodic pension cost [Abstract]", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes amortization of gain (loss) component of net periodic benefit (cost) credit for defined benefit plan." } } }, "auth_ref": [ "r481", "r504" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes components of net periodic benefit cost (credit), excluding service cost component, for defined benefit plan." } } }, "auth_ref": [ "r481", "r504" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditIncreaseDecreaseForPlanAmendment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditIncreaseDecreaseForPlanAmendment", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan amendment cost", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Increase (Decrease) for Plan Amendment", "documentation": "Amount of increase (decrease) in net periodic benefit cost from effect of change in substantive term of existing defined benefit plan or initiation of new defined benefit plan." } } }, "auth_ref": [ "r79" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r481", "r504" ] }, "us-gaap_DefinedBenefitPlanPlanAmendments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAmendments", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan amendment", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment", "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan." } } }, "auth_ref": [ "r456" ] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r449", "r482", "r505", "r920", "r921" ] }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineBenefitObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assumptions used to determine the year end benefit obligation [Abstract]", "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAssumptionsUsedToDetermineNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assumptions used to determine the net periodic pension cost [Abstract]", "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]" } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansAgeOfParticipant": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansAgeOfParticipant", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Age of participant (in years)", "label": "Defined Benefit Plans Age Of Participant", "documentation": "The threshold age of the employee, at which the participant may be eligible to receive a benefit, if the participant resigns or is terminated without cause at or after this age, and with a defined period of service." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansAnnualBaseSalaryPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansAnnualBaseSalaryPeriod", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual base salary period (in months)", "label": "Defined Benefit Plans Annual Base Salary Period", "documentation": "The period (in months) immediately preceding the participant's date of termination of employment, or, if required, the date of a change in control of the Company, used to determine the participant's annual base salary." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansBenefitPercentageForSpecialParticipants": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansBenefitPercentageForSpecialParticipants", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit percentage for special participants (in hundredths)", "label": "Defined Benefit Plans Benefit Percentage For Special Participants", "documentation": "The percentage of a special participant's annual base salary for the life of the participant (and their surviving spouse, if any), on which the benefit is based." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansBenefitPercentageTierOne": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansBenefitPercentageTierOne", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit percentage, tier one (in hundredths)", "label": "Defined Benefit Plans Benefit Percentage Tier One", "documentation": "The highest level of percentage of the participant's annual base salary for the life of the participant, on which the benefit is based, depending on the participant's benefit class." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansBenefitPercentageTierThree": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansBenefitPercentageTierThree", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit percentage, tier three (in hundredths)", "label": "Defined Benefit Plans Benefit Percentage Tier Three", "documentation": "The lowest level of percentage of the participant's annual base salary for the life of the participant, on which the benefit is based, depending on the participant's benefit class." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansBenefitPercentageTierTwo": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansBenefitPercentageTierTwo", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit percentage, tier two (in hundredths)", "label": "Defined Benefit Plans Benefit Percentage Tier Two", "documentation": "The second level of percentage of the participant's annual base salary for the life of the participant, on which the benefit is based, depending on the participant's benefit class." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansExpectedFutureBenefitPaymentsAfterFiveFiscalYearsThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansExpectedFutureBenefitPaymentsAfterFiveFiscalYearsThereafter", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSBenefitPaymentsExpectedToBePaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Defined Benefit Plans Expected Future Benefit Payments After Five Fiscal Years Thereafter", "documentation": "The amount of the aggregate benefits expected to be paid in total, subsequent to the five fiscal years thereafter (the aggregate amount of benefits expected to be paid after years 6 through 10 after the date of the latest statement of financial position)." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansFactorUsedToDetermineAnnualBaseSalary": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansFactorUsedToDetermineAnnualBaseSalary", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Factor used to determine annual base salary", "label": "Defined Benefit Plans Factor Used To Determine Annual Base Salary", "documentation": "The multiple of the highest monthly base salary paid or payable to the participant during the defined period immediately preceding the participant's date of termination or employment, or, if required, the date of a change in control of the Company. This multiple is used to determine the participant's annual base salary." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansFactorUsedToDetermineProratedBenefit": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansFactorUsedToDetermineProratedBenefit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Factor used to determine prorated benefit", "label": "Defined Benefit Plans Factor Used To Determine Prorated Benefit", "documentation": "The factor used to determine the prorated benefit." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansInstallmentPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansInstallmentPeriod", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Installment period (in years)", "label": "Defined Benefit Plans Installment Period", "documentation": "The installment period (in years) over which the benefit is payable, beginning at the later of age 65 or the date of the participant's separation from service." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansMinimumPeriodOfService": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansMinimumPeriodOfService", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum period of service (in years)", "label": "Defined Benefit Plans Minimum Period Of Service", "documentation": "The minimum period of service (in years) which a participant must accumulate in order to be eligible to receive a benefit." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansMinimumPeriodOfServiceForProratedBenefit": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansMinimumPeriodOfServiceForProratedBenefit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum period of service for prorated benefit (in years)", "label": "Defined Benefit Plans Minimum Period Of Service For Prorated Benefit", "documentation": "The minimum period of service (in years) which a participant must accumulate in order to be eligible to receive a prorated benefit." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansNumberOfParticipants": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansNumberOfParticipants", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of participants", "label": "Defined Benefit Plans Number Of Participants", "documentation": "The number of participants in the defined benefit plan." } } }, "auth_ref": [] }, "oled_DefinedBenefitPlansThresholdOfBenefitObligationAtWhichActuarialLossesAreAmortized": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DefinedBenefitPlansThresholdOfBenefitObligationAtWhichActuarialLossesAreAmortized", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined benefit plan threshold of benefit obligation at which actuarial losses are amortized (in hundredths)", "label": "Defined Benefit Plans Threshold Of Benefit Obligation At Which Actuarial Losses Are Amortized", "documentation": "The threshold percentage of year end benefit obligation for which accumulation of actuarial losses in excess of this threshold are amortized from accumulated other comprehensive loss into net periodic pension cost over future years, based upon the average remaining service period of active plan participants." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contributions to the 401(k) Plan", "label": "Defined Contribution Plan, Cost", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r516" ] }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Matching contribution limit (in hundredths)", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay", "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum contribution percentage (in hundredths)", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Depreciation, Total", "verboseLabel": "Depreciation expense", "terseLabel": "Depreciation", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r14", "r66" ] }, "oled_DescripionOfPropertyAvailableForOperatingLease": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "DescripionOfPropertyAvailableForOperatingLease", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Descripion of Property Available for Operating Lease", "documentation": "Descripion of Property Available for Operating Lease" } } }, "auth_ref": [] }, "us-gaap_DilutiveSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DilutiveSecuritiesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of dilutive shares:", "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "DirectorMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Director [Member]", "label": "Director [Member]" } } }, "auth_ref": [ "r999", "r1093" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation Of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r440", "r911", "r912", "r913", "r914", "r915", "r916", "r917" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation Of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r440", "r911", "r912", "r913", "r914", "r915", "r916", "r917" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATION" ], "lang": { "en-us": { "role": { "terseLabel": "STOCK-BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r522", "r525", "r556", "r557", "r559", "r929" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisclosureTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureTextBlockAbstract", "lang": { "en-us": { "role": { "label": "Disclosure Text Block [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DistributionTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DistributionTypeDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Distribution Type", "label": "Distribution Type [Domain]", "documentation": "Types of distribution made by the entity." } } }, "auth_ref": [ "r75" ] }, "us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Distribution Type", "label": "Distribution Type [Axis]", "documentation": "Information by type of distribution." } } }, "auth_ref": [ "r75" ] }, "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendPayableDateToBePaidDayMonthAndYear", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend payable date", "label": "Dividends Payable, Date to be Paid", "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r46" ] }, "us-gaap_DividendsCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCash", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Dividends, Cash, Total", "negatedLabel": "Cash dividend", "label": "Dividends, Cash", "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred." } } }, "auth_ref": [ "r12", "r167" ] }, "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableDateDeclaredDayMonthAndYear", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend declared date", "label": "Dividends Payable, Date Declared", "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format." } } }, "auth_ref": [ "r46" ] }, "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableDateOfRecordDayMonthAndYear", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend record date", "label": "Dividends Payable, Date of Record", "documentation": "Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r950", "r951", "r952" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r950", "r951", "r952", "r954" ] }, "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Restatement Recovery Analysis [Flag]", "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)." } } }, "auth_ref": [ "r950", "r951", "r952", "r954" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r953" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Documents Incorporated by Reference", "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r948" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income per common share:", "terseLabel": "NET INCOME PER COMMON SHARE:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings Per Share, Basic, Total", "verboseLabel": "Basic", "terseLabel": "BASIC", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r262", "r280", "r281", "r282", "r283", "r284", "r290", "r293", "r300", "r301", "r302", "r306", "r632", "r633", "r729", "r754", "r900" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment for Basic EPS:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicOtherDisclosuresAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]", "terseLabel": "WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME PER COMMON SHARE:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings Per Share, Diluted, Total", "verboseLabel": "Diluted", "terseLabel": "DILUTED", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r262", "r280", "r281", "r282", "r283", "r284", "r293", "r300", "r301", "r302", "r306", "r632", "r633", "r729", "r754", "r900" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHARE" ], "lang": { "en-us": { "role": { "terseLabel": "NET INCOME PER COMMON SHARE", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r289", "r303", "r304", "r305" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Effective tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r578" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory U.S. federal income tax rate", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r271", "r578", "r598" ] }, "oled_EffectiveIncomeTaxRateReconciliationChangeInAccrualsAndReservesPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationChangeInAccrualsAndReservesPercent", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accruals and reserves", "label": "Effective Income Tax Rate Reconciliation Change In Accruals And Reserves Percent", "documentation": "Effective income tax rate reconciliation change in accruals and reserves percent." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. International Tax (Sub F, GILTI, FDII)", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates." } } }, "auth_ref": [ "r598", "r1064" ] }, "oled_EffectiveIncomeTaxRateReconciliationDeductionShareBasedCompensationCostPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationDeductionShareBasedCompensationCostPercent", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based compensation", "label": "Effective Income Tax Rate Reconciliation Deduction Share Based Compensation Cost Percent", "documentation": "Effective income tax rate reconciliation deduction share based compensation cost percent." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of foreign operations", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile." } } }, "auth_ref": [ "r1064", "r1069" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nondeductible employee compensation", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement." } } }, "auth_ref": [ "r1064", "r1069" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r1064", "r1069" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State income taxes, net of federal benefit", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r1064", "r1069" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Redetermination of foreign tax credit utilization", "terseLabel": "Redetermination of foreign tax credit utilization", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit." } } }, "auth_ref": [ "r1064", "r1069" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESReconciliationOfStatutoryUSFederalTaxRateToEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Research tax credits", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit." } } }, "auth_ref": [ "r1064", "r1069" ] }, "oled_EmployeeBenefitPlansAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeBenefitPlansAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Employee benefit plan:", "label": "Employee Benefit Plans [Abstract]", "documentation": "Employee Benefit Plans [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit Payments", "label": "Employee Benefits and Share-Based Compensation", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total", "verboseLabel": "Unrecognized compensation expense related to performance unit awards", "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r558" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r558" ] }, "oled_EmployeeStockPurchasePlanESPPCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanESPPCompensationExpense", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charges to expense", "label": "Employee Stock Purchase Plan E S P P Compensation Expense", "documentation": "Employee stock purchase plan ESPP compensation expense." } } }, "auth_ref": [] }, "oled_EmployeeStockPurchasePlanESPPMaximumAllocationOfBaseCompensation": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanESPPMaximumAllocationOfBaseCompensation", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum allocation of base compensation (in hundredths)", "label": "Employee Stock Purchase Plan E S P P Maximum Allocation Of Base Compensation", "documentation": "The maximum percentage of employees' base compensation that can be allocated under the plan." } } }, "auth_ref": [] }, "oled_EmployeeStockPurchasePlanESPPMaximumSharesOnPurchaseDate": { "xbrltype": "sharesItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanESPPMaximumSharesOnPurchaseDate", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum shares per purchase date (in shares)", "label": "Employee Stock Purchase Plan E S P P Maximum Shares On Purchase Date", "documentation": "The maximum number of shares that may be purchased on a given purchase date, under the plan." } } }, "auth_ref": [] }, "oled_EmployeeStockPurchasePlanESPPMaximumValuePerCalendarYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanESPPMaximumValuePerCalendarYear", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum value per calendar year, per employee", "label": "Employee Stock Purchase Plan E S P P Maximum Value Per Calendar Year", "documentation": "The maximum value of shares that may be purchased by a single employee during a given calendar year, under the plan." } } }, "auth_ref": [] }, "oled_EmployeeStockPurchasePlanESPPPercentageOfMarketValue": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanESPPPercentageOfMarketValue", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of market value (in hundredths)", "label": "Employee Stock Purchase Plan E S P P Percentage Of Market Value", "documentation": "The percentage of the lesser of the price per share of common stock on the first day of the purchase period, or the last day of the purchase period, at which eligible employees may purchase shares under the plan." } } }, "auth_ref": [] }, "oled_EmployeeStockPurchasePlanESPPSharesInESPP": { "xbrltype": "sharesItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanESPPSharesInESPP", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserved for issuance (in shares)", "label": "Employee Stock Purchase Plan E S P P Shares In E S P P", "documentation": "Employee stock purchase plan ESPP shares in ESPP." } } }, "auth_ref": [] }, "oled_EmployeeStockPurchasePlanEsppPurchasePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanEsppPurchasePeriod1", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Employee Stock Purchase Plan ESPP Purchase Period1", "documentation": "Employee Stock Purchase Plan ESPP Purchase Period1" } } }, "auth_ref": [] }, "oled_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Purchase Plan (ESPP) [Member]", "label": "Employee Stock Purchase Plan [Member]", "documentation": "Employee stock purchase plan." } } }, "auth_ref": [] }, "oled_EmployeesAndNonEmployeeMembersOfScientificAdvisoryBoardMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "EmployeesAndNonEmployeeMembersOfScientificAdvisoryBoardMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Employee Members of Scientific Advisory Board [Member]", "verboseLabel": "Non-Employee Members of Scientific Advisory Board [Member]", "label": "Employees And Non Employee Members Of Scientific Advisory Board [Member]", "documentation": "Individuals employed by the entity, and non-employee members of the Scientific Advisory Board." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r947" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r947" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r947" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r955" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r947" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r947" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r947" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r947" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r956" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r22", "r219", "r256", "r257", "r258", "r272", "r273", "r274", "r277", "r285", "r287", "r308", "r370", "r376", "r430", "r560", "r561", "r562", "r591", "r592", "r614", "r616", "r617", "r618", "r619", "r621", "r631", "r652", "r654", "r655", "r656", "r657", "r658", "r683", "r765", "r766", "r767", "r785", "r851" ] }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Other than Temporary Impairment", "terseLabel": "Impairment in minority investment", "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment." } } }, "auth_ref": [ "r1016" ] }, "us-gaap_EquitySecuritiesByIndustryAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesByIndustryAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Industry Sector [Axis]", "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate." } } }, "auth_ref": [ "r797", "r798", "r800", "r855", "r857", "r860", "r862", "r904", "r937" ] }, "us-gaap_EquitySecuritiesIndustryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesIndustryMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Industry Sector [Domain]", "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate." } } }, "auth_ref": [ "r797", "r798", "r800", "r855", "r857", "r860", "r862", "r937" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimate of Fair Value Measurement [Member]", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r420", "r645", "r907", "r908" ] }, "oled_ExcludingNorthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ExcludingNorthAmericaMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Excluding North America [Member]", "label": "Excluding North America [Member]", "documentation": "Excluding North America." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r636", "r637", "r640" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r636", "r637", "r640" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r420", "r472", "r473", "r474", "r475", "r476", "r477", "r637", "r688", "r689", "r690", "r907", "r908", "r918", "r919", "r920" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r23", "r108", "r420", "r907", "r908" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r636", "r637", "r638", "r639", "r641" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r420", "r907", "r908" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "FAIR VALUE MEASUREMENTS", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r635" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 1 [Member]", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r420", "r472", "r477", "r637", "r688", "r918", "r919", "r920" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 2 [Member]", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r420", "r472", "r477", "r637", "r689", "r907", "r908", "r918", "r919", "r920" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 3 [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r420", "r472", "r473", "r474", "r475", "r476", "r477", "r637", "r690", "r907", "r908", "r918", "r919", "r920" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r420", "r472", "r473", "r474", "r475", "r476", "r477", "r688", "r689", "r690", "r907", "r908", "r918", "r919", "r920" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Measurements, Recurring [Member]", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r635", "r641" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r16", "r25" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term lease liabilities", "label": "Finance Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r668" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability." } } }, "auth_ref": [ "r669" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r386", "r422", "r428", "r622", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r752", "r905", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r1012", "r1013", "r1014", "r1015" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "OLED patents useful life", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated amortization", "terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "verboseLabel": "Less: Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r231", "r398" ] }, "oled_FiniteLivedIntangibleAssetsAcquiredOtherAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "FiniteLivedIntangibleAssetsAcquiredOtherAcquisitionCosts", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for OLED patents", "label": "Finite Lived Intangible Assets Acquired Other Acquisition Costs", "documentation": "Finite lived intangible assets acquired, other acquisition costs." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future amortization expense, thereafter", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Future amortization expense, 2023", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r160" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Future amortization expense, 2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r160" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Future amortization expense, 2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r160" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Future amortization expense, 2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r160" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Future amortization expense, 2024", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r160" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r395", "r397", "r398", "r399", "r720", "r724" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Finite-Lived Intangible Assets, Gross, Total", "terseLabel": "Acquired technology, gross", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r159", "r724" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r720" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r63", "r64" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ACQUIRED TECHNOLOGY, net of accumulated amortization of $186,850 and $189,671", "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance", "periodStartLabel": "Finite-Lived Intangible Assets, Net, Beginning Balance", "totalLabel": "Acquired technology, net", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r159", "r720" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assigned value of acquired intangible assets", "label": "Finite-Lived Intangible Assets Acquired", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r396" ] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Korean Government [Member]", "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Translation of Foreign Currency Financial Statements and Foreign Currency Transactions", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r651" ] }, "oled_FujifilmMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "FujifilmMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FUJIFILM [Member]", "label": "Fujifilm [Member]", "documentation": "Fujifilm." } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and fixtures [Member]", "label": "Furniture and Fixtures [Member]", "verboseLabel": "Furniture, fixtures and computer related assets [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainContingenciesByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingenciesByNatureAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain Contingencies, Nature", "label": "Gain Contingencies, Nature [Axis]", "documentation": "Information by nature of gain contingency." } } }, "auth_ref": [ "r1026" ] }, "us-gaap_GainContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingencyNatureDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain Contingency, Nature", "label": "Gain Contingency, Nature [Domain]", "documentation": "Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization." } } }, "auth_ref": [ "r1026" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "totalLabel": "Goodwill, Total", "verboseLabel": "Goodwill", "terseLabel": "GOODWILL", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r230", "r391", "r725", "r906", "r932", "r1018", "r1019" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETS" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL AND INTANGIBLE ASSETS", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r157" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Purchased Intangible Assets", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r18", "r61" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment loss", "label": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r14", "r392", "r393", "r394", "r906" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r139", "r269", "r311", "r316", "r320", "r322", "r366", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r646", "r902", "r1027" ] }, "country_IE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "IE", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "label": "IRELAND", "terseLabel": "Ireland [Member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r950", "r951", "r952" ] }, "us-gaap_ImpairmentOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfInvestments", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "label": "Other than Temporary Impairment Losses, Investments", "terseLabel": "Impairment of minority investments", "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income." } } }, "auth_ref": [ "r195" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Long-Lived Assets", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r270", "r597" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 0.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r136", "r188", "r311", "r316", "r320", "r322", "r730", "r749", "r902" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r270", "r597" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeLossBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Components of income before income taxes [Abstract]", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r400", "r402", "r836" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r402", "r836" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority", "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r20" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority", "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXES" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r271", "r572", "r579", "r580", "r586", "r593", "r599", "r600", "r601", "r783" ] }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated settlement amounts due (refunds) from withholding taxes", "label": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority", "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recognized income tax positions measured at likelihood of realization description", "label": "Income Tax Examination, Likelihood of Unfavorable Settlement", "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority." } } }, "auth_ref": [ "r89", "r174" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESComponentsOfIncomeTaxExpenseDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Income Tax Expense (Benefit), Total", "negatedTotalLabel": "Income tax expense", "negatedLabel": "INCOME TAX EXPENSE", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r201", "r213", "r286", "r287", "r314", "r577", "r594", "r755" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r255", "r573", "r574", "r580", "r581", "r585", "r587", "r777" ] }, "oled_IncomeTaxesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "IncomeTaxesLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Line Items]", "label": "Income Taxes [Line Items]", "documentation": "Income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "totalLabel": "Income Taxes Paid, Net, Total", "terseLabel": "Cash paid for income tax", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r45" ] }, "us-gaap_IncomeTaxesReceivableNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivableNoncurrent", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term taxes receivable", "label": "Income Taxes Receivable, Noncurrent", "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r976" ] }, "oled_IncomeTaxesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "IncomeTaxesTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Table]", "label": "Income Taxes [Table]", "documentation": "Income taxes." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total", "terseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerAsset", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails2": { "parentTag": "oled_UnbilledReceivablesIncreaseDecreaseNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unbilled receivables recognized", "label": "Increase (Decrease) in Contract with Customer, Asset", "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r985" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r716", "r985" ] }, "us-gaap_IncreaseDecreaseInDeferredLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredLiabilitiesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Revenue (Increase) Decrease", "label": "Increase (Decrease) in Deferred Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Finished Goods and Work in Process Inventories", "documentation": "The increase (decrease) during the reporting period in the book value of finished goods inventory and work in process inventory." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease (increase) in assets:", "label": "Increase (Decrease) in Operating Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in liabilities:", "label": "Increase (Decrease) in Operating Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r985" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Increase (Decrease) in Other Current Liabilities", "documentation": "Amount of increase (decrease) in current liabilities classified as other." } } }, "auth_ref": [ "r985" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Noncurrent Assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r985" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other." } } }, "auth_ref": [] }, "oled_IncreaseDecreaseInUnbilledReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "IncreaseDecreaseInUnbilledReceivablesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unbilled Receivables Increase (Decrease)", "label": "Increase Decrease In Unbilled Receivables [Abstract]", "documentation": "Increase (decrease) in unbilled receivables." } } }, "auth_ref": [] }, "oled_IncreasesDueToCashReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "IncreasesDueToCashReceived", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails": { "parentTag": "oled_NetIncreaseDecreaseInDeferredRevenue", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Increases due to cash received", "label": "Increases Due To Cash Received", "documentation": "Increases due to cash received." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureNetIncomePerCommonShareScheduleOfEarningsPerShareDetails2": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock equivalents arising from stock options and ESPP", "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method." } } }, "auth_ref": [ "r294", "r295", "r296", "r302" ] }, "us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureNetIncomePerCommonShareScheduleOfEarningsPerShareDetails2": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock awards and units and performance units", "label": "Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends", "documentation": "Number of additional shares included in diluted EPS for potentially dilutive effect of nonvested equity-based payment award containing forfeitable rights to dividends or dividend equivalents, whether paid or unpaid." } } }, "auth_ref": [ "r49", "r993", "r994", "r995", "r997" ] }, "oled_IncrementalPerformanceBasedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "IncrementalPerformanceBasedMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental Performance Based [Member]", "label": "Incremental Performance Based [Member]", "documentation": "Incremental Performance Based Member." } } }, "auth_ref": [] }, "oled_InternallyDevelopedIPProcessesAndRecipesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "InternallyDevelopedIPProcessesAndRecipesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Developed IP, Processes and Recipes [Member]", "terseLabel": "Internally-developed IP, Processes and Recipes [Member]", "label": "Internally Developed I P Processes And Recipes [Member]", "documentation": "Internally-developed IP, processes and recipes." } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORY" ], "lang": { "en-us": { "role": { "terseLabel": "INVENTORY", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r387" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r156", "r893" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Inventory", "terseLabel": "Inventory", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r241", "r891", "r932" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r202", "r225", "r240", "r387", "r388", "r390", "r718", "r897" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r156", "r895" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work-in-process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r156", "r894" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in inventory reserve", "terseLabel": "Change in excess inventory reserve", "label": "Inventory Write-down", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r389" ] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNet", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Investment Income, Net, Total", "terseLabel": "Interest income, net", "label": "Investment Income, Net", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r143", "r145" ] }, "oled_IssuanceOfCommonStockToBoardOfDirectorsAndScientificAdvisoryBoardShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "IssuanceOfCommonStockToBoardOfDirectorsAndScientificAdvisoryBoardShares", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock to Board of Directors and Scientific Advisory Board (in shares)", "label": "Issuance Of Common Stock To Board Of Directors And Scientific Advisory Board Shares", "documentation": "Number of new stock issued during the period to the Board of Directors and Scientific Advisory Board." } } }, "auth_ref": [] }, "oled_IssuanceOfCommonStockToBoardOfDirectorsAndScientificAdvisoryBoardValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "IssuanceOfCommonStockToBoardOfDirectorsAndScientificAdvisoryBoardValue", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock to Board of Directors and Scientific Advisory Board", "label": "Issuance Of Common Stock To Board Of Directors And Scientific Advisory Board Value", "documentation": "Equity impact of the value of new stock issued during the period to the Board of Directors and Scientific Advisory Board." } } }, "auth_ref": [] }, "country_JP": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "JP", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japan [Member]", "label": "JAPAN" } } }, "auth_ref": [] }, "country_KR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "KR", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "South Korea [Member]", "label": "KOREA, REPUBLIC OF" } } }, "auth_ref": [] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land [Member]", "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r1034" ] }, "oled_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "LeaseLiabilities", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Lease Liabilities", "label": "Lease Liabilities", "terseLabel": "Lease liabilities" } } }, "auth_ref": [] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesOfLesseeDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASES" ], "lang": { "en-us": { "role": { "terseLabel": "LEASES", "label": "Leases of Lessee Disclosure [Text Block]", "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing." } } }, "auth_ref": [ "r198" ] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee Lease Description [Line Items]", "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r671" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee Lease Description [Table]", "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r671" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r670" ] }, "us-gaap_LesseeOperatingLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDescription", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease description", "label": "Lessee, Operating Lease, Description", "documentation": "Description of lessee's operating lease." } } }, "auth_ref": [ "r672" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Undiscounted Future Minimum Lease Payments Having Non-cancelable Lease Terms", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1075" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureLeasesScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNoncancelableLeaseTermsDetails2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureLeasesScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNoncancelableLeaseTermsDetails2": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r678" ] }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseOptionToExtend", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease, option to extend", "label": "Lessee, Operating Lease, Option to Extend", "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability." } } }, "auth_ref": [ "r673" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases remaining term", "label": "Lessee, Operating Lease, Term of Contract", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1074" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASES" ], "lang": { "en-us": { "role": { "verboseLabel": "LEASES", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r666" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r29", "r269", "r366", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r608", "r609", "r610", "r646", "r810", "r901", "r945", "r1027", "r1077", "r1078" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r129", "r185", "r745", "r932", "r987", "r1017", "r1071" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r32", "r224", "r269", "r366", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r608", "r609", "r610", "r646", "r932", "r1027", "r1077", "r1078" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT LIABILITIES:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "oled_LicenseAgreementExtendedOptionTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "LicenseAgreementExtendedOptionTerm", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "License agreement, extended option term", "label": "License Agreement Extended Option Term", "documentation": "License agreement extended option term." } } }, "auth_ref": [] }, "us-gaap_LicenseAgreementTermsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicenseAgreementTermsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "1997 Amended License Agreement [Member]", "label": "License Agreement Terms [Member]", "documentation": "Terms of the license agreements under research and development arrangements accounted for as a contract to perform research and development for others." } } }, "auth_ref": [] }, "oled_LicenseFeeAgreementTermOfAgreement": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "LicenseFeeAgreementTermOfAgreement", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "License fee agreement, term of agreement", "documentation": "License fee agreement, term of agreement.", "label": "License Fee Agreement Term Of Agreement" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermCommitmentExcludingUnconditionalPurchaseObligationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermCommitmentExcludingUnconditionalPurchaseObligationAbstract", "lang": { "en-us": { "role": { "label": "Long-Term Commitment (Excluding Unconditional Purchase Obligation) [Abstract]" } } }, "auth_ref": [] }, "oled_LongTermContractAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "LongTermContractAssets", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Long-term contract assets", "label": "Long-term contract assets" } } }, "auth_ref": [] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term U.S. Government bonds", "totalLabel": "Long-term Investments, Total", "terseLabel": "INVESTMENTS", "label": "Long-Term Investments", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r227" ] }, "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Category of Item Purchased", "label": "Category of Item Purchased [Axis]", "documentation": "Information by category of items purchased under a long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]", "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermPurchaseCommitmentLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Purchase Commitment [Line Items]", "label": "Long-Term Purchase Commitment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "oled_LongTermPurchaseCommitmentPercentOfServicesPayableInCashOrShares": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "LongTermPurchaseCommitmentPercentOfServicesPayableInCashOrShares", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percent of services payable in cash or shares", "label": "Long Term Purchase Commitment Percent Of Services Payable In Cash Or Shares", "documentation": "Long-Term Purchase Commitment, Percent Of Services Payable In Cash Or Shares" } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermPurchaseCommitmentTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long Term Purchase Commitment [Table]", "label": "Long-Term Purchase Commitment [Table]", "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount." } } }, "auth_ref": [] }, "oled_LongTermUnbilledReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "LongTermUnbilledReceivables", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term unbilled receivables", "documentation": "Long-term unbilled receivables" } } }, "auth_ref": [] }, "us-gaap_LongtermTransitionBondCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermTransitionBondCurrent", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Corporate bonds", "label": "Long-Term Transition Bond, Current", "documentation": "Long-Term transition bonds are bonds under the Competition Act in which the proceeds of Transition Bonds are required to be used principally to reduce qualified stranded costs and the related capitalization of the utility. This represents the current portion." } } }, "auth_ref": [ "r30" ] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Nature", "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r405", "r406", "r407", "r410", "r1022", "r1023" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r405", "r406", "r407", "r410", "r1022", "r1023" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r405", "r406", "r407", "r410", "r1022", "r1023" ] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Nature", "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r405", "r406", "r407", "r410", "r1022", "r1023" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office and lab equipment [Member]", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "oled_MajorCustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MajorCustomerAMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Major Customer A [Member]", "label": "Major Customer A [Member]", "documentation": "Single non-government external Customer A that accounts for 10 percent or more of the entity's revenues." } } }, "auth_ref": [] }, "oled_MajorCustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MajorCustomerBMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Major Customer B [Member]", "label": "Major Customer B [Member]", "documentation": "Single non-government external Customer B that accounts for 10 percent or more of the entity's revenues." } } }, "auth_ref": [] }, "oled_MajorCustomerCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MajorCustomerCMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Major Customer C [Member]", "label": "Major Customer C [Member]", "documentation": "Single non-government external Customer C that accounts for 10 percent or more of the entity's revenues." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer", "label": "Customer [Axis]" } } }, "auth_ref": [ "r326", "r913", "r1033", "r1089", "r1090" ] }, "oled_ManufacturingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ManufacturingExpenseMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Manufacturing Expense [Member]", "label": "Manufacturing Expense [Member]", "documentation": "Manufacturing expense." } } }, "auth_ref": [] }, "oled_MarketBasedVestingRequirementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MarketBasedVestingRequirementMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Market-Based Vesting Requirement [Member]", "label": "Market Based Vesting Requirement [Member]", "documentation": "Market-based vesting requirement." } } }, "auth_ref": [] }, "oled_MaterialSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MaterialSalesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Material sales", "label": "Material Sales [Member]", "documentation": "Material sales." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]" } } }, "auth_ref": [ "r406", "r407", "r408", "r409", "r519", "r715", "r762", "r801", "r802", "r854", "r856", "r858", "r859", "r861", "r884", "r885", "r903", "r909", "r928", "r934", "r1029", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084" ] }, "oled_MembersOfScientificAdvisoryBoardMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MembersOfScientificAdvisoryBoardMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Members of Scientific Advisory Board [Member]", "label": "Members Of Scientific Advisory Board [Member]", "documentation": "Members of scientific advisory board." } } }, "auth_ref": [] }, "oled_MerckKgaaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MerckKgaaMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails" ], "lang": { "en-us": { "role": { "label": "Merck KGaA[Member]", "documentation": "Merck KGaA[Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]" } } }, "auth_ref": [ "r406", "r407", "r408", "r409", "r519", "r715", "r762", "r801", "r802", "r854", "r856", "r858", "r859", "r861", "r884", "r885", "r903", "r909", "r928", "r934", "r1029", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084" ] }, "oled_MinorityEquityInvestmentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MinorityEquityInvestmentsPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Minority Equity Investments", "label": "Minority Equity Investments Policy [Text Block]", "documentation": "Minority equity investments." } } }, "auth_ref": [] }, "oled_MinorityInvestmentCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MinorityInvestmentCarryingValue", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minority investment, carrying value", "label": "Minority Investment Carrying Value", "documentation": "Minority investment carrying value." } } }, "auth_ref": [] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money Market Accounts [Member]", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r1036" ] }, "oled_MotorolaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MotorolaMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Motorola [Member]", "label": "Motorola [Member]", "documentation": "Information pertaining to the Motorola acquisition." } } }, "auth_ref": [] }, "oled_MultipleOfSumOfAverageAnnualBaseSalaryAndBonusAgreementTerms": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "MultipleOfSumOfAverageAnnualBaseSalaryAndBonusAgreementTerms", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multiple of sum of average annual base salary and bonus agreement terms", "label": "Multiple Of Sum Of Average Annual Base Salary And Bonus Agreement Terms", "documentation": "The multiple of the sum of the average annual base salary and bonus of the officer, which comprises the lump-sum cash payment to which each executive is entitled, under the agreement." } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer", "label": "Customer [Domain]" } } }, "auth_ref": [ "r326", "r913", "r1033", "r1089", "r1090" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureBUSINESS" ], "lang": { "en-us": { "role": { "terseLabel": "BUSINESS", "label": "Nature of Operations [Text Block]", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r204", "r214" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r265" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r265" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r149", "r150", "r151" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 0.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income", "totalLabel": "NET INCOME", "terseLabel": "NET INCOME", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r137", "r151", "r189", "r222", "r250", "r253", "r258", "r269", "r276", "r280", "r281", "r282", "r283", "r286", "r287", "r298", "r311", "r316", "r320", "r322", "r366", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r633", "r646", "r750", "r832", "r849", "r850", "r902", "r943", "r1027" ] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Adjusted net income", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r263", "r280", "r281", "r282", "r283", "r290", "r291", "r299", "r302", "r311", "r316", "r320", "r322", "r902" ] }, "oled_NetIncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NetIncreaseDecreaseInDeferredRevenue", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net change", "label": "Net Increase Decrease In Deferred Revenue", "documentation": "Net increase (decrease) in deferred revenue." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "oled_NewOledMaterialsAgreementAndOledMaterialsAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NewOledMaterialsAgreementAndOledMaterialsAgreementMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The aggregation of information pertaining to both the OLED Materials Supply and Service Agreement (OLED Materials Agreement), and the Amended and Restated OLED Materials Supply and Service Agreement (the New OLED Materials Agreement), with PPG Industries.", "label": "New Oled Materials Agreement And Oled Materials Agreement [Member]", "terseLabel": "New OLED Materials Agreement and OLED Materials Agreement [Member]" } } }, "auth_ref": [] }, "oled_NonEmployeeMembersOfScientificAdvisoryBoardMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NonEmployeeMembersOfScientificAdvisoryBoardMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non Employee Members of Scientific Advisory Board [Member]", "label": "Non Employee Members Of Scientific Advisory Board [Member]", "documentation": "Non-employee members of the Scientific Advisory Board." } } }, "auth_ref": [] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other [Member]", "terseLabel": "Total Non-U.S. Locations [Member]", "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r1097", "r1098", "r1099", "r1100" ] }, "us-gaap_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncurrentAssets", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total long-lived assets", "label": "Long-Lived Assets", "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets." } } }, "auth_ref": [ "r325" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Interest and other income, net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r144" ] }, "oled_NumberOfBoardMembersElectedByClassShareholders": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfBoardMembersElectedByClassShareholders", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of board members elected by class A shareholders", "label": "Number Of Board Members Elected By Class Shareholders", "documentation": "Number of board members elected by class A shareholders." } } }, "auth_ref": [] }, "oled_NumberOfConvertibleNoteInvestments": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfConvertibleNoteInvestments", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of convertible note investments", "label": "Number Of Convertible Note Investments", "terseLabel": "Number Of Convertible Note Investments" } } }, "auth_ref": [] }, "oled_NumberOfEmployeesUnderAgreement": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfEmployeesUnderAgreement", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of employees under agreement", "label": "Number Of Employees Under Agreement", "documentation": "Number of employees under agreement." } } }, "auth_ref": [] }, "oled_NumberOfExecutiveOfficersUnderAgreement": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfExecutiveOfficersUnderAgreement", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number Of Executive Officers Under Agreement", "documentation": "The number of executive officers under agreement.", "terseLabel": "Number of executive officers under agreement" } } }, "auth_ref": [] }, "oled_NumberOfMinorityInvestments": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfMinorityInvestments", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of minority investments", "label": "Number Of Minority Investments", "documentation": "Number of minority investments." } } }, "auth_ref": [] }, "oled_NumberOfPatentsAcquired": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfPatentsAcquired", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of patents acquired (more than)", "label": "Number Of Patents Acquired", "documentation": "Number of patents acquired." } } }, "auth_ref": [] }, "oled_NumberOfPatentsIssuedAndPendingApplication": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfPatentsIssuedAndPendingApplication", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureBUSINESSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of patents issued and pending application", "label": "Number Of Patents Issued And Pending Application", "documentation": "Number of Patents Issued And Pending Application" } } }, "auth_ref": [] }, "oled_NumberOfSuppliersFromWhichChemicalMaterialsWerePurchased": { "xbrltype": "integerItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "NumberOfSuppliersFromWhichChemicalMaterialsWerePurchased", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of suppliers from which chemical materials were purchased", "label": "Number Of Suppliers From Which Chemical Materials Were Purchased", "documentation": "The number of suppliers from which all chemical materials were purchased." } } }, "auth_ref": [] }, "oled_OfficeLabEquipmentAndFurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OfficeLabEquipmentAndFurnitureAndFixturesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office, Lab Equipment and Furniture and Fixtures [Member]", "label": "Office Lab Equipment And Furniture And Fixtures [Member]", "documentation": "Office equipment includes long lived, depreciable assets not directly used in the production process for inventories or facilities. Lab equipment includes tangible personal property, non-consumable in nature, with finite lives used to produce goods and services. Furniture and fixtures include long lived, depreciable assets, commonly used in offices and stores." } } }, "auth_ref": [] }, "oled_OneNineNineFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OneNineNineFiveMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "One Nine Nine Five [Member]", "label": "One Nine Nine Five [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "OPERATING EXPENSES:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "OPERATING INCOME", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r311", "r316", "r320", "r322", "r902" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESSummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r674", "r931" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureLeasesScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNoncancelableLeaseTermsDetails2": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating Lease, Liability, Total", "terseLabel": "Present value of lease payments", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r668" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r668" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r669" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r668" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability." } } }, "auth_ref": [ "r669" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r667" ] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r669" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r677", "r931" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (in years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r676", "r931" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets", "totalLabel": "Other Assets, Total", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r180", "r232", "r737", "r945" ] }, "us-gaap_OtherAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsAbstract", "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r242", "r932" ] }, "us-gaap_OtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssets1" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets Disclosure [Text Block]", "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Other Assets, Noncurrent, Total", "verboseLabel": "Long-term asset", "terseLabel": "OTHER ASSETS", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r232" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial prior service cost for retirement plan", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax", "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)." } } }, "auth_ref": [ "r8", "r134", "r489" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Actuarial gain on retirement plan, net of tax of ($2,168), ($1,667) and ($1,336), respectively", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax", "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r5", "r134", "r489" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Actuarial gain on retirement plan, tax", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax", "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r9" ] }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of prior service cost and actuarial loss for retirement plan included in net periodic pension costs net of tax of ($299), ($569) and ($1,316), respectively", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax", "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r11", "r134", "r249", "r489" ] }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of prior service cost and actuarial loss for retirement plan included in net periodic pension costs, tax", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax", "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r9" ] }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "totalLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax, Total", "terseLabel": "Unrealized (loss) gain on available-for-sale securities", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax", "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r244", "r245", "r247" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive gain (loss) before reclassification", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r24", "r39", "r257", "r652", "r655", "r658", "r982" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total", "terseLabel": "Change in cumulative foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "verboseLabel": "Other comprehensive income (loss)", "totalLabel": "TOTAL OTHER COMPREHENSIVE INCOME (LOSS)", "terseLabel": "Other comprehensive loss", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r22", "r24", "r251", "r254", "r260", "r652", "r653", "r658", "r727", "r751", "r982", "r983" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER COMPREHENSIVEINCOME (LOSS), NET OF TAX:", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Net change in employee benefit plan", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "totalLabel": "Net change in employee benefit plan", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r7", "r134" ] }, "oled_OtherComprehensiveIncomePlanAmendmentCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherComprehensiveIncomePlanAmendmentCost", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Plan amendment cost", "label": "Other Comprehensive Income Plan Amendment Cost", "documentation": "Other comprehensive income plan amendment cost." } } }, "auth_ref": [] }, "oled_OtherComprehensiveIncomePlanAmendmentCostNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherComprehensiveIncomePlanAmendmentCostNetOfTax", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "negatedLabel": "Plan amendment cost, net of tax of none, none and $79, respectively", "label": "Other Comprehensive Income Plan Amendment Cost Net Of Tax", "documentation": "Other comprehensive income plan amendment cost net of tax." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain (loss) on available-for-sale securities, net of tax of ($351), none and $65, respectively", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r244", "r247", "r365" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain (loss) on available-for-sale securities, tax", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax", "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r9", "r245" ] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Assets [Member]", "label": "Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r104", "r107" ] }, "oled_OtherFiniteLivedAmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedAmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense related to other intangible assets", "label": "Other Finite Lived Amortization Of Intangible Assets", "documentation": "Other finite lived amortization of intangible assets." } } }, "auth_ref": [] }, "oled_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails": { "parentTag": "oled_OtherFiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated Amortization", "terseLabel": "Other Finite-Lived Intangible Assets, Accumulated Amortization", "label": "Other Finite Lived Intangible Assets Accumulated Amortization", "documentation": "Other finite lived intangible assets accumulated amortization." } } }, "auth_ref": [] }, "oled_OtherFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future amortization expense of other intangible assets, fiscal year 2024", "label": "Other Finite Lived Intangible Assets Amortization Expense Next Twelve Months", "documentation": "Other finite lived intangible assets amortization expense next twelve months." } } }, "auth_ref": [] }, "oled_OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future amortization expense of other intangible assets, fiscal year 2028", "label": "Other Finite Lived Intangible Assets Amortization Expense Year Five", "documentation": "Other finite lived intangible assets amortization expense year five." } } }, "auth_ref": [] }, "oled_OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future amortization expense of other intangible assets, fiscal year 2027", "label": "Other Finite Lived Intangible Assets Amortization Expense Year Four", "documentation": "Other finite lived intangible assets amortization expense year four." } } }, "auth_ref": [] }, "oled_OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Finite Lived Intangible Assets Amortization Expense Year Three", "documentation": "Other finite lived intangible assets amortization expense year three.", "terseLabel": "Future amortization expense of other intangible assets, fiscal year 2025" } } }, "auth_ref": [] }, "oled_OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future amortization expense of other intangible assets, fiscal year 2026", "label": "Other Finite Lived Intangible Assets Amortization Expense Year Two", "documentation": "Other finite lived intangible assets amortization expense year two." } } }, "auth_ref": [] }, "oled_OtherFiniteLivedIntangibleAssetsAmortizationThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsAmortizationThereafter", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Finite Lived Intangible Assets Amortization Thereafter", "label": "Other Finite Lived Intangible Assets Amortization Thereafter", "terseLabel": "Future amortization expense of other intangible assets, thereafter" } } }, "auth_ref": [] }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherFiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails": { "parentTag": "oled_OtherFiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gross Carrying Amount", "terseLabel": "Other intangible assets", "label": "Other Finite-Lived Intangible Assets, Gross", "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other." } } }, "auth_ref": [ "r159" ] }, "oled_OtherFiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherFiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER INTANGIBLE ASSETS, net of accumulated amortization of $10,414 and $8,989", "totalLabel": "Net Carrying Amount", "label": "Other Finite Lived Intangible Assets Net", "documentation": "Other finite lived intangible assets net." } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Intangible Assets [Member]", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities", "totalLabel": "Other Liabilities, Total", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r114", "r733", "r805", "r806", "r945", "r1093" ] }, "us-gaap_OtherLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Other Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Other Liabilities, Current, Total", "terseLabel": "Other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30", "r932" ] }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilities1" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER LIABILITIES", "label": "Other Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for other liabilities." } } }, "auth_ref": [ "r31" ] }, "us-gaap_OtherLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESScheduleOfUndiscountedFutureMinimumLeasePaymentsHavingNonCancelableLeaseTermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Liabilities [Member]", "label": "Other Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other liabilities." } } }, "auth_ref": [ "r104", "r107" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Other Liabilities, Noncurrent, Total", "terseLabel": "OTHER LIABILITIES", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r34" ] }, "us-gaap_OtherLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of other liabilities", "label": "Other Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherLongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermDebtNoncurrent", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Other Long-Term Debt, Noncurrent", "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r33", "r809" ] }, "us-gaap_OtherLongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermInvestments", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsScheduleOfOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term assets", "label": "Other Long-Term Investments", "documentation": "Amount of long-term investments classified as other." } } }, "auth_ref": [ "r734", "r975" ] }, "us-gaap_OtherLongTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermInvestmentsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Investments [Member]", "label": "Other Long-Term Investments [Member]", "documentation": "Long-term investments classified as other." } } }, "auth_ref": [ "r1091" ] }, "oled_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other [Member]", "label": "Other [Member]", "documentation": "Other [Member]." } } }, "auth_ref": [] }, "oled_OtherNonUSMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherNonUSMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-U.S. Locations [Member]", "label": "Other Non U S [Member]", "documentation": "Other Non US." } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets [Member]", "label": "Other Noncurrent Assets [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Other Nonoperating Income (Expense), Total", "label": "Other Nonoperating Income (Expense)", "verboseLabel": "Other income (loss), net", "terseLabel": "Other (loss) income, net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r146" ] }, "us-gaap_OtherShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermInvestments", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term U.S. Government bonds", "verboseLabel": "Short-term contract assets", "label": "Other Short-Term Investments", "documentation": "Amount of short-term investments classified as other." } } }, "auth_ref": [ "r116", "r735", "r981" ] }, "oled_OtherSignificantNonCashTransactionIncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedToPurchasesOfPropertyAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "OtherSignificantNonCashTransactionIncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedToPurchasesOfPropertyAndEquipment", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Net change in accounts payable and accrued expenses related to purchases of property and equipment", "label": "Other Significant Non Cash Transaction Increase Decrease In Accounts Payable And Accrued Expenses Related To Purchases Of Property And Equipment", "documentation": "Other significant non cash transaction increase decrease in accounts payable and accrued expenses related to purchases of property and equipment." } } }, "auth_ref": [] }, "us-gaap_OtherSignificantNoncashTransactionNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSignificantNoncashTransactionNameDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Significant Noncash Transaction, Name", "label": "Other Significant Noncash Transaction, Name [Domain]", "documentation": "The name of other significant noncash (or part noncash) investing and financing activities required to be supplementally disclosed to enable users of the financial information to fully understand the period cash flows of the Entity in relation to the statements of financial position, income statement, and statement of changes in shareholders' equity. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r46", "r47", "r48" ] }, "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSignificantNoncashTransactionValueOfConsiderationReceived1", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Other significant noncash transaction, value of consideration received", "label": "Other Significant Noncash Transaction, Value of Consideration Received", "documentation": "The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r46", "r47", "r48" ] }, "us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSignificantNoncashTransactionsByUniqueDescriptionAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Significant Noncash Transaction", "label": "Other Significant Noncash Transaction [Axis]", "documentation": "Information by other significant noncash transactions." } } }, "auth_ref": [ "r46", "r47", "r48" ] }, "us-gaap_OtherSignificantNoncashTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSignificantNoncashTransactionsLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Significant Noncash Transactions [Line Items]", "label": "Other Significant Noncash Transactions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OtherSignificantNoncashTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSignificantNoncashTransactionsTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWSNonCashActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Significant Noncash Transactions [Table]", "label": "Other Significant Noncash Transactions [Table]", "documentation": "This table may contain information related to other significant noncash investing and financing activities that occurred during the accounting period and are not otherwise listed in the existing taxonomy. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r46", "r47", "r48" ] }, "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held, Ending Balance", "periodStartLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held, Beginning Balance", "terseLabel": "Credit losses on debt investments", "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held", "documentation": "The cumulative amount of credit losses recognized in earnings related to debt securities held for which a portion of an other than temporary impairment (OTTI) was recognized in other comprehensive income (a component of shareholders' equity)." } } }, "auth_ref": [ "r196", "r197" ] }, "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Earnings allocated to unvested shareholders", "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic", "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r299", "r957" ] }, "oled_PatentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "PatentCosts", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Patent costs", "label": "Patent Costs", "documentation": "Patent costs." } } }, "auth_ref": [] }, "oled_PatentCostsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "PatentCostsPolicyPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Patent Costs", "label": "Patent Costs Policy Policy [Text Block]", "documentation": "Disclosure of accounting policy for patent costs." } } }, "auth_ref": [] }, "us-gaap_PatentedTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentedTechnologyMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patent Technology [Member]", "label": "Patented Technology [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law." } } }, "auth_ref": [ "r97" ] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patents [Member]", "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r176" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of common stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r42" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Payments of Dividends, Total", "negatedLabel": "Cash dividends paid", "label": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r42" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock dividends paid", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r42" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of withholding taxes related to stock-based compensation to employees", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r264" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of intangibles", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r148" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in property and equipment", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total", "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r148" ] }, "us-gaap_PaymentsToAcquireShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireShortTermInvestments", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of investments", "label": "Payments to Acquire Short-Term Investments", "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r147" ] }, "oled_PdLdIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "PdLdIncMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PD LD, Inc [Member]", "label": "Pd Ld Inc [Member]", "documentation": "Information pertaining to the PD-LD, Inc acquisition." } } }, "auth_ref": [] }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitExpense", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement plan expense, net of benefit payments", "totalLabel": "Pension and Other Postretirement Benefits Cost (Reversal of Cost), Total", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits." } } }, "auth_ref": [] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANS" ], "lang": { "en-us": { "role": { "terseLabel": "EMPLOYEE RETIREMENT PLANS", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r444", "r469", "r471", "r477", "r496", "r498", "r499", "r500", "r501", "r502", "r514", "r515", "r516", "r920" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current liability", "label": "Liability, Defined Benefit Plan, Current", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current." } } }, "auth_ref": [ "r118", "r445", "r446", "r468", "r920" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSInformationRelatingToCompanySPlanDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-current liability", "totalLabel": "Liability, Defined Benefit Plan, Noncurrent, Total", "terseLabel": "RETIREMENT PLAN BENEFIT LIABILITY", "label": "Liability, Defined Benefit Plan, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent." } } }, "auth_ref": [ "r119", "r445", "r446", "r468", "r920" ] }, "oled_PercentageOfRevenueRecordedFromProvisionOfServices": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "PercentageOfRevenueRecordedFromProvisionOfServices", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of revenue recorded from provision of services", "label": "Percentage Of Revenue Recorded From Provision Of Services", "documentation": "Percentage of revenue recorded from provision of services." } } }, "auth_ref": [] }, "oled_PercentageOfRevenueRecordedFromSaleOfMaterials": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "PercentageOfRevenueRecordedFromSaleOfMaterials", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of revenue recorded from sales of materials", "label": "Percentage Of Revenue Recorded From Sale Of Materials", "documentation": "Percentage of revenue recorded from sale of materials." } } }, "auth_ref": [] }, "oled_PerformanceBasedVestingRequirementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "PerformanceBasedVestingRequirementMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance-Based Vesting Requirement [Member]", "label": "Performance Based Vesting Requirement [Member]", "documentation": "Performance-based vesting requirement." } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Shares [Member]", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "axisDefault": "Portion at Fair Value Measurement [Member] [Default]", "terseLabel": "Fair Value Disclosure Item Amounts [Default]", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r644" ] }, "us-gaap_PreferredStockLiquidationPreference": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreference", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, liquidation value per share (in dollars per share)", "label": "Preferred Stock, Liquidation Preference Per Share", "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share." } } }, "auth_ref": [ "r71", "r72", "r123", "r986", "r1030" ] }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreferenceValue", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, liquidation value", "label": "Preferred Stock, Liquidation Preference, Value", "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares." } } }, "auth_ref": [ "r268", "r426" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock [Member]", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r935", "r936", "r939", "r940", "r941", "r942", "r1092", "r1095" ] }, "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' Equity A Nonconvertible Preferred Stock", "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r123", "r423" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, shares authorized ( in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r123", "r812" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Preferred Stock, Shares Issued, Total", "terseLabel": "Preferred Stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r123", "r423" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred Stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r123", "r812", "r830", "r1095", "r1096" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, par value $0.01 per share, 5,000,000 shares authorized, 200,000 shares of Series A Nonconvertible Preferred Stock issued and outstanding (liquidation value of $7.50 per share or $1,500)", "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "totalLabel": "Preferred Stock, Value, Issued, Total", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r123", "r741", "r932" ] }, "us-gaap_PreferredStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockVotingRights", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock voting rights", "label": "Preferred Stock, Voting Rights", "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r71", "r123" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsAbstract", "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification of Prior Year Presentation", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r973" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ProceedsFromSaleOfShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfShortTermInvestments", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale and maturity of investments", "label": "Proceeds from Sale of Short-Term Investments", "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r41" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r323", "r719", "r756", "r757", "r758", "r759", "r760", "r761", "r887", "r911", "r933", "r963", "r1024", "r1025", "r1033", "r1089" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r323", "r719", "r756", "r757", "r758", "r759", "r760", "r761", "r887", "r911", "r933", "r963", "r1024", "r1025", "r1033", "r1089" ] }, "us-gaap_PropertyAvailableForOperatingLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyAvailableForOperatingLeaseMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property Available for Operating Lease [Member]", "documentation": "Property available for operating lease." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r15" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT" ], "lang": { "en-us": { "role": { "terseLabel": "PROPERTY AND EQUIPMENT", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r161", "r207", "r210", "r211" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance", "totalLabel": "Property, Plant and Equipment, Gross, Total", "terseLabel": "Property and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r162", "r228", "r748" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "PROPERTY AND EQUIPMENT, net of accumulated depreciation of $143,908 and $117,118", "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "totalLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r15", "r732", "r748", "r932" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r15", "r207", "r210", "r746" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r15" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r162" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful life (in years)", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property Subject to or Available for Operating Lease [Axis]", "documentation": "Information by property that could be leased or is available for lease." } } }, "auth_ref": [ "r199" ] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property Subject to or Available for Operating Lease [Domain]", "documentation": "A descriptive title of whether the property is subject to or available for operating lease." } } }, "auth_ref": [ "r199" ] }, "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase commitments for inventory", "label": "Purchase Commitment, Remaining Minimum Amount Committed", "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations." } } }, "auth_ref": [ "r120", "r184" ] }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "QuarterlyFinancialInformationDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "QuarterlyFinancialInformationTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "QUARTERLY SUPPLEMENTAL FINANCIAL DATA (UNAUDITED)", "label": "Quarterly Financial Information [Text Block]", "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information." } } }, "auth_ref": [ "r153", "r307" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r406", "r407", "r408", "r409", "r469", "r519", "r551", "r552", "r553", "r691", "r715", "r762", "r801", "r802", "r854", "r856", "r858", "r859", "r861", "r884", "r885", "r903", "r909", "r928", "r934", "r937", "r1020", "r1029", "r1080", "r1081", "r1082", "r1083", "r1084" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r406", "r407", "r408", "r409", "r469", "r519", "r551", "r552", "r553", "r691", "r715", "r762", "r801", "r802", "r854", "r856", "r858", "r859", "r861", "r884", "r885", "r903", "r909", "r928", "r934", "r937", "r1020", "r1029", "r1080", "r1081", "r1082", "r1083", "r1084" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossParentheticalDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Reclassification to net income", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r24", "r39", "r257", "r652", "r657", "r658", "r982" ] }, "us-gaap_RecognitionOfDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RecognitionOfDeferredRevenue", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognition", "label": "Recognition of Deferred Revenue", "documentation": "The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r194" ] }, "oled_RecognizedIncomeTaxPositionsMeasuredAtPercentageOfLikelihoodOfRealization": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "RecognizedIncomeTaxPositionsMeasuredAtPercentageOfLikelihoodOfRealization", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recognized income tax positions measured at percentage of likelihood of realization", "label": "Recognized Income Tax Positions Measured At Percentage Of Likelihood Of Realization", "documentation": "Recognized income tax positions measured at percentage of likelihood of realization." } } }, "auth_ref": [] }, "us-gaap_ReductionInTaxesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReductionInTaxesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction of Korean Withholding Taxes [Member]", "label": "Reduction in Taxes [Member]", "documentation": "A potential favorable financial consequence resulting from a ruling or change in tax laws." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentAbstract", "lang": { "en-us": { "role": { "label": "Research and Development [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type", "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]", "documentation": "Information by form of arrangement related to research and development." } } }, "auth_ref": [ "r570", "r1063" ] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expense incurred", "label": "Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross", "documentation": "The amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others." } } }, "auth_ref": [ "r571" ] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research And Development Arrangement Contract To Perform For Others [Line Items]", "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r570", "r1063" ] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type", "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]", "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others." } } }, "auth_ref": [ "r570", "r1063" ] }, "oled_ResearchAndDevelopmentArrangementExtensionTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ResearchAndDevelopmentArrangementExtensionTerm", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Research and development arrangement, extension term.", "label": "Research And Development Arrangement Extension Term", "terseLabel": "Research agreement, extension term (in years)" } } }, "auth_ref": [] }, "oled_ResearchAndDevelopmentArrangementMaximumObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ResearchAndDevelopmentArrangementMaximumObligation", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum obligation", "label": "Research And Development Arrangement Maximum Obligation", "documentation": "The maximum amount the Company is obligated to pay under the specified research agreement, as of the balance sheet date." } } }, "auth_ref": [] }, "oled_ResearchAndDevelopmentArrangementNewAmendmentExpirationDate": { "xbrltype": "dateItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ResearchAndDevelopmentArrangementNewAmendmentExpirationDate", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Research and development arrangement, new amendment expiration date.", "label": "Research And Development Arrangement New Amendment Expiration Date", "terseLabel": "Research agreement, new amendment expiration date" } } }, "auth_ref": [] }, "oled_ResearchAndDevelopmentArrangementRoyaltyRateForLicensedProductsSoldByCompany": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ResearchAndDevelopmentArrangementRoyaltyRateForLicensedProductsSoldByCompany", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Royalty rate for licensed products sold by the Company (in hundredths)", "label": "Research And Development Arrangement Royalty Rate For Licensed Products Sold By Company", "documentation": "The royalty rate of net sales price for licensed products sold by the Company, under the specified arrangement." } } }, "auth_ref": [] }, "oled_ResearchAndDevelopmentArrangementRoyaltyRateForLicensedProductsSoldByCompanysSublicenses": { "xbrltype": "percentItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ResearchAndDevelopmentArrangementRoyaltyRateForLicensedProductsSoldByCompanysSublicenses", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Royalty rate for licensed products sold by the Company's sublicenses (in hundredths)", "label": "Research And Development Arrangement Royalty Rate For Licensed Products Sold By Companys Sublicenses", "documentation": "The royalty rate of revenues received by the Company for licensed products sold by the Company's sublicenses, under the specified arrangement." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Research and Development Expense, Total", "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r117", "r569", "r1085" ] }, "oled_ResearchAndDevelopmentExpenseCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ResearchAndDevelopmentExpenseCredit", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charges to expense for cash portion of reimbursement of expenses", "label": "Research And Development Expense Credit", "documentation": "Research and development expense (credit)." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Expense [Member]", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development", "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r568" ] }, "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartners1" ], "lang": { "en-us": { "role": { "verboseLabel": "RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS", "terseLabel": "RESEARCH AND LICENSE AGREEMENTS WITH PRINCETON UNIVERSITY, UNIVERSITY OF SOUTHERN CALIFORNIA AND THE UNIVERSITY OF MICHIGAN", "label": "Research, Development, and Computer Software Disclosure [Text Block]", "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period." } } }, "auth_ref": [ "r190", "r570" ] }, "us-gaap_ResearchMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research Tax Credit [Member]", "label": "Research Tax Credit Carryforward [Member]", "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes." } } }, "auth_ref": [ "r90" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r226" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock [Member]", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r50" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs) [Member]", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r126", "r167", "r744", "r769", "r774", "r782", "r813", "r932" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings [Member]", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r219", "r272", "r273", "r274", "r277", "r285", "r287", "r370", "r376", "r560", "r561", "r562", "r591", "r592", "r614", "r617", "r618", "r621", "r631", "r765", "r767", "r785", "r1095" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r445", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r492", "r494", "r495", "r497", "r500", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r521", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r445", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r492", "r494", "r495", "r497", "r500", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r516", "r517", "r518", "r521", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "REVENUE:", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total", "terseLabel": "Total revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r312", "r313", "r315", "r318", "r319", "r323", "r324", "r326", "r439", "r440", "r719" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITION" ], "lang": { "en-us": { "role": { "terseLabel": "REVENUE RECOGNITION", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r215", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r442" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition and Deferred Revenue", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r834", "r886", "r898" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Revenues, Total", "verboseLabel": "Revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r259", "r269", "r312", "r313", "r315", "r318", "r319", "r323", "r324", "r326", "r366", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r646", "r730", "r1027" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESSummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets obtained in exchange for lease obligations", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r675", "r931" ] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "oled_RoyaltyAndLicenseFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "RoyaltyAndLicenseFeesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Royalty and license fees", "label": "Royalty And License Fees [Member]", "documentation": "Royalty and license fees." } } }, "auth_ref": [] }, "us-gaap_RoyaltyExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RoyaltyExpense", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "verboseLabel": "Royalty expense", "terseLabel": "Royalty and license expense", "label": "Royalty Expense", "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property." } } }, "auth_ref": [ "r141" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesAndAccountsReceivableFromOurLargestCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Revenue [Member]", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r326", "r961" ] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast [Member]", "label": "Forecast [Member]" } } }, "auth_ref": [ "r520", "r992" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r288", "r520", "r959", "r992" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Expenses", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Loss", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r1072", "r1073" ] }, "us-gaap_ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts to be Amortized from Accumulated Other Comprehensive Loss into Net Periodic Pension Cost in Next Fiscal Year", "label": "Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block]", "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year, including the net gain (loss), net prior service cost or credit, and net transition asset or obligation." } } }, "auth_ref": [ "r1035" ] }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Assumptions Used to Determine Benefit Obligation and Net Periodic Pension Cost", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate." } } }, "auth_ref": [ "r491" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Available For Sale Securities [Line Items]", "label": "Debt Securities, Available-for-Sale [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Cash And Cash Equivalents [Table]", "label": "Schedule of Cash and Cash Equivalents [Table]", "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash, Cash Equivalents", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of Income Tax Expense", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r173" ] }, "oled_ScheduleOfDeferredCompensationArrangementWithEmployeesAndNonEmployeesShareBasedPaymentsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ScheduleOfDeferredCompensationArrangementWithEmployeesAndNonEmployeesShareBasedPaymentsTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Deferred Compensation Arrangement With Employees And Non Employees Share Based Payments [Table]", "label": "Schedule Of Deferred Compensation Arrangement With Employees And Non Employees Share Based Payments [Table]", "documentation": "Schedule, table or text reflecting equity-based arrangements (such as stock or unit options and stock or unit awards) with individual employees and non-employees." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Components of Deferred Tax Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r172" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r17", "r80", "r81", "r82", "r83" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHARETables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r997" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of the Statutory U.S. Federal Tax Rate to the Effective Tax Rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r171" ] }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit Payments Expected to be Paid", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter." } } }, "auth_ref": [ "r168" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r636", "r637" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSAcquiredTechnologyAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfAcquiredTechnologyDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r63", "r64", "r720" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Acquired Technology", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r63", "r64" ] }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of Income (Loss) before Income Taxes", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions." } } }, "auth_ref": [ "r988" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINVENTORYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Inventory", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r26", "r130", "r131", "r132" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of Net Periodic Pension Cost", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r169" ] }, "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetFundedStatusTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Information Relating to the Company's Plan", "label": "Schedule of Net Funded Status [Table Text Block]", "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans." } } }, "auth_ref": [ "r78" ] }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Nonvested Performance-Based Units Activity", "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units." } } }, "auth_ref": [ "r85" ] }, "oled_ScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ScheduleOfOperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Operating Lease Right of Use Assets and Liabilities", "label": "Schedule of Operating Lease Right of Use Assets and Liabilities [Table Text Block]", "documentation": "Schedule of operating lease right-of-use assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherAssetsTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Other Asset", "label": "Schedule of Other Assets [Table Text Block]", "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets." } } }, "auth_ref": [] }, "oled_ScheduleOfOtherFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ScheduleOfOtherFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Intangible Assets", "label": "Schedule Of Other Finite Lived Intangible Assets Table [Text Block]", "documentation": "Schedule of other finite lived intangible assets." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Property Plant And Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureQUARTERLYSUPPLEMENTALFINANCIALDATAUNAUDITEDTables" ], "lang": { "en-us": { "role": { "terseLabel": "Quarterly Supplemental Financial Data (Unaudited)", "label": "Quarterly Financial Information [Table Text Block]", "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data." } } }, "auth_ref": [ "r203" ] }, "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureResearchAndLicenseAgreementsWithAcademicPartnersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]", "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]", "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements." } } }, "auth_ref": [ "r570", "r1063" ] }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues by Geographic Area", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r60", "r138" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Assets (Net) by Geographic Area", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r59", "r138" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r59", "r135" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r523", "r524", "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r550", "r551", "r552", "r553", "r554" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock and Units Activity", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Stock By Class [Table]", "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r68", "r69", "r70", "r71", "r72", "r73", "r74", "r165", "r166", "r167", "r234", "r235", "r236", "r309", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r778", "r779", "r780", "r781", "r909", "r958", "r986" ] }, "oled_ScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ScheduleOfWeightedAverageAssumptionsUsedToComputeRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted Average Assumptions Used to Compute Right-of-use Assets and Lease Liabilities", "label": "Schedule Of Weighted Average Assumptions Used To Compute Right Of Use Assets And Lease Liabilities Table [Text Block]", "documentation": "Schedule of weighted average assumptions used to compute right-of-use assets and lease liabilities." } } }, "auth_ref": [] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues and Accounts Receivable From Our Largest Customers", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r51", "r52", "r54", "r55", "r111", "r177" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r946" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r949" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r324", "r325", "r797", "r798", "r799", "r855", "r857", "r860", "r862", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r888", "r912", "r937", "r1033", "r1089" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Selling, General and Administrative Expense, Total", "terseLabel": "Selling, general and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r142" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Selling, General and Administrative Expense [Member]", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Series A Nonconvertible Preferred Stock [Member]", "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r979", "r980", "r1031" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total", "terseLabel": "Stock-based compensation to employees", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted stock awards and units vesting terms", "terseLabel": "Expiration term (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r929" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Shares, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r543" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant-Date Fair Value, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share", "documentation": "Per share or unit weighted-average intrinsic value of award forfeited under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r543" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Grants in period (shares)", "terseLabel": "Number of Shares, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r541" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average grant-date fair value of RSU awards granted (in dollars per share)", "terseLabel": "Weighted-Average Grant-Date Fair Value, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r541" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted-Average Grant-Date Fair Value, Unvested, December 31, 2023", "periodStartLabel": "Weighted-Average Grant-Date Fair Value, Unvested, January 1, 2023", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value", "documentation": "Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r538", "r539" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of Shares, Unvested, December 31, 2023", "periodStartLabel": "Number of Shares, Unvested, January 1, 2023", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r538", "r539" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Shares, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r542" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value granted as of the respective vesting dates", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r545" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant-Date Fair Value, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r542" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r523", "r524", "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r550", "r551", "r552", "r553", "r554" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares authorized (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r930" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares available for grant (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r84" ] }, "oled_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award Options Weighted Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award Options Weighted Average Grant Date Fair Value", "terseLabel": "Fair value as of the respective vesting dates" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation plan extended term description", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms", "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price." } } }, "auth_ref": [ "r87" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r526", "r527", "r528", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r550", "r551", "r552", "r553", "r554" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Awards", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r522", "r529", "r548", "r549", "r550", "r551", "r554", "r563", "r564", "r565", "r566" ] }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "SHAREHOLDERS' EQUITY", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)." } } }, "auth_ref": [ "r164", "r170" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "periodStartLabel": "BALANCE (in shares)", "periodEndLabel": "BALANCE (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares withheld for employee taxes (in shares)", "terseLabel": "Shares withheld for tax withholding obligations (in shares)", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Short-term Corporate bonds", "terseLabel": "Short-term investments", "totalLabel": "Short-term Investments, Total", "label": "Short-Term Investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r186", "r187", "r981" ] }, "us-gaap_ShortTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestmentsMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Investments [Member]", "label": "Short-Term Investments [Member]", "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet." } } }, "auth_ref": [ "r863", "r864", "r865", "r889" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "lang": { "en-us": { "role": { "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r152", "r267" ] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computer Software [Member]", "label": "Software Development [Member]", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "oled_StateAndForeignIncomeTaxReturnsSubjectToExaminationPeriodMaximum": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "StateAndForeignIncomeTaxReturnsSubjectToExaminationPeriodMaximum", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and foreign income tax returns subject to examination period maximum (in years)", "label": "State And Foreign Income Tax Returns Subject To Examination Period Maximum", "documentation": "State and foreign income tax returns subject to examination period maximum." } } }, "auth_ref": [] }, "oled_StateAndForeignIncomeTaxReturnsSubjectToExaminationPeriodMinimum": { "xbrltype": "durationItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "StateAndForeignIncomeTaxReturnsSubjectToExaminationPeriodMinimum", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and foreign income tax returns subject to examination period minimum (in years)", "label": "State And Foreign Income Tax Returns Subject To Examination Period Minimum", "documentation": "State and foreign income tax returns subject to examination period minimum." } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "U.S.Federal Government [Member]", "terseLabel": "State [Member]", "label": "State and Local Jurisdiction [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r216", "r234", "r235", "r236", "r269", "r293", "r297", "r300", "r302", "r309", "r310", "r366", "r411", "r413", "r414", "r415", "r418", "r419", "r423", "r424", "r426", "r427", "r429", "r646", "r778", "r779", "r780", "r781", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r812", "r833", "r851", "r866", "r867", "r868", "r869", "r870", "r958", "r986", "r996" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r22", "r37", "r219", "r256", "r257", "r258", "r272", "r273", "r274", "r277", "r285", "r287", "r308", "r370", "r376", "r430", "r560", "r561", "r562", "r591", "r592", "r614", "r616", "r617", "r618", "r619", "r621", "r631", "r652", "r654", "r655", "r656", "r657", "r658", "r683", "r765", "r766", "r767", "r785", "r851" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r324", "r325", "r797", "r798", "r799", "r855", "r857", "r860", "r862", "r872", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r888", "r912", "r937", "r1033", "r1089" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r272", "r273", "r274", "r308", "r719", "r776", "r796", "r803", "r804", "r805", "r806", "r807", "r808", "r812", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r825", "r826", "r827", "r828", "r829", "r831", "r834", "r835", "r837", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r851", "r938" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r288", "r520", "r959", "r960", "r992" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r272", "r273", "r274", "r308", "r719", "r776", "r796", "r803", "r804", "r805", "r806", "r807", "r808", "r812", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r825", "r826", "r827", "r828", "r829", "r831", "r834", "r835", "r837", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r851", "r938" ] }, "oled_StockBasedCompensationToBoardOfDirectorsAndScientificAdvisoryBoard": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "StockBasedCompensationToBoardOfDirectorsAndScientificAdvisoryBoard", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation to Board of Directors and Scientific Advisory Board", "label": "Stock Based Compensation To Board Of Directors And Scientific Advisory Board", "documentation": "The fair value of restricted stock or stock options granted to the Board of Directors and Scientific Advisory Board as payment for services rendered or acknowledged claims." } } }, "auth_ref": [] }, "us-gaap_StockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockCompensationPlanMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityCompensationPlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Compensation Plan [Member]", "label": "Share-Based Payment Arrangement [Member]", "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares." } } }, "auth_ref": [ "r998" ] }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock issued (in shares)", "terseLabel": "Issuance of common stock to employees under an ESPP (in shares)", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan." } } }, "auth_ref": [ "r22", "r123", "r124", "r167" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total", "terseLabel": "Issuance of common stock to employees (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r22", "r123", "r124", "r167" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited", "documentation": "Number of shares (or other type of equity) forfeited during the period." } } }, "auth_ref": [] }, "oled_StockIssuedDuringPeriodSharesShareBasedCompensationSharesWithheldForEmployeeTaxes": { "xbrltype": "sharesItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationSharesWithheldForEmployeeTaxes", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares withheld for employee taxes (shares)", "label": "Stock Issued During Period Shares Share Based Compensation Shares Withheld For Employee Taxes", "documentation": "Stock issued during period shares share based compensation shares withheld for employee taxes." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEmployeeStockPurchasePlanAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Proceeds from common stock issued", "terseLabel": "Issuance of common stock to employees under an ESPP", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan." } } }, "auth_ref": [ "r22", "r123", "r124", "r167" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures", "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period." } } }, "auth_ref": [ "r22", "r123", "r124", "r167" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture, Total", "terseLabel": "Issuance of common stock to employees", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r86", "r123", "r124", "r167" ] }, "oled_StockIssuedDuringPeriodValueShareBasedCompensationSharesWithheldForEmployeeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "StockIssuedDuringPeriodValueShareBasedCompensationSharesWithheldForEmployeeTaxes", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares withheld for employee taxes", "label": "Stock Issued During Period Value Share Based Compensation Shares Withheld For Employee Taxes", "documentation": "Stock issued during period value share based compensation shares Withheld for employee taxes." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleOfAccumulatedOtherComprehensiveLossDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders\u2019 equity", "periodStartLabel": "BALANCE", "periodEndLabel": "BALANCE", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r124", "r127", "r128", "r155", "r814", "r830", "r852", "r853", "r932", "r945", "r987", "r1017", "r1071", "r1095" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "SHAREHOLDERS' EQUITY:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Total", "verboseLabel": "Cumulative effect adjustment to reduction of retained earnings", "periodStartLabel": "ASC Topic 606 Adoption", "periodEndLabel": "ASC Topic 606 Adoption", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r100", "r101", "r103", "r219", "r220", "r257", "r272", "r273", "r274", "r277", "r285", "r370", "r376", "r430", "r560", "r561", "r562", "r591", "r592", "r614", "r616", "r617", "r618", "r619", "r621", "r631", "r652", "r654", "r658", "r683", "r766", "r767", "r784", "r814", "r830", "r852", "r853", "r871", "r944", "r987", "r1017", "r1071", "r1095" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r659", "r684" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r659", "r684" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r659", "r684" ] }, "oled_SummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "SummaryOfOperatingLeaseCostAndSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureLEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Operating Lease Cost and Supplemental Cash Flow Information Related to Operating Leases", "label": "Summary Of Operating Lease Cost And Supplemental Cash Flow Information Related To Operating Leases Table [Text Block]", "documentation": "Summary of operating lease cost and supplemental cash flow information related to operating leases." } } }, "auth_ref": [] }, "oled_SummaryOfOperatingLossAndTaxCreditCarryforwardsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "SummaryOfOperatingLossAndTaxCreditCarryforwardsTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Loss and Tax Credit Carryforwards", "label": "Summary Of Operating Loss And Tax Credit Carryforwards Table [Text Block]", "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, and tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates and the related deferred tax assets." } } }, "auth_ref": [] }, "oled_SummaryOfSignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Summary Of Significant Accounting Policies [Line Items]", "label": "Summary Of Significant Accounting Policies [Line Items]", "documentation": "Summary of significant accounting policies." } } }, "auth_ref": [] }, "oled_SummaryOfSignificantAccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "SummaryOfSignificantAccountingPoliciesTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Summary Of Significant Accounting Policies [Table]", "label": "Summary Of Significant Accounting Policies [Table]", "documentation": "Summary of significant accounting policies." } } }, "auth_ref": [] }, "oled_SummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "SummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesTableTextBlock", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Changes in Unbilled Receivables and Deferred Liabilities Balances", "label": "Summary Of Significant Changes In Unbilled Receivables And Deferred Liabilities Balances Table [Text Block]", "documentation": "Summary of significant changes in unbilled receivables and deferred liabilities balances." } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementalEmployeeRetirementPlanDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalEmployeeRetirementPlanDefinedBenefitMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEMPLOYEERETIREMENTPLANSComponentsOfNetPeriodicPensionCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental Executive Retirement Plan [Member]", "label": "Supplemental Employee Retirement Plan [Member]", "documentation": "Plan designed to provide limited group of employees with supplemental retirement benefits, in addition to other pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Concentration Risk [Member]", "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r53" ] }, "oled_TaxCreditAndOperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "TaxCreditAndOperatingLossCarryforwardsLineItems", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit And Operating Loss Carryforwards [Line Items]", "label": "Tax Credit And Operating Loss Carryforwards [Line Items]", "documentation": "Tax credit and operating loss carry forwards line items." } } }, "auth_ref": [] }, "oled_TaxCreditAndOperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "TaxCreditAndOperatingLossCarryforwardsTable", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit And Operating Loss Carryforwards [Table]", "label": "Tax Credit And Operating Loss Carryforwards [Table]", "documentation": "Tax Credit And Operating Loss Carryforwards." } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total credit carry forwards, Tax Benefit", "label": "Tax Credit Carryforward, Amount", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r91" ] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward", "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r90" ] }, "us-gaap_TaxCreditCarryforwardExpirationDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardExpirationDate", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credit carryforwards, Expiration Date", "label": "Tax Credit Carryforward, Expiration Date", "documentation": "Expiration date of the tax credit carryforward, in YYYY-MM-DD format." } } }, "auth_ref": [ "r91" ] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESTaxLossAndTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward, Name", "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r90" ] }, "us-gaap_TaxesPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term taxes payable", "label": "Taxes Payable", "totalLabel": "Taxes Payable, Total", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes." } } }, "auth_ref": [ "r118", "r182", "r1087" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual", "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r999", "r1076" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureStockbasedCompensationDeferredCompensationArrangementAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual", "label": "Title of Individual [Domain]" } } }, "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Trade Accounts Receivable", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r191", "r192", "r193", "r329", "r330", "r332" ] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSOtherIntangibleAssetsAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureGOODWILLANDINTANGIBLEASSETSScheduleOfOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade Name/Trademarks [Member]", "label": "Trademarks and Trade Names [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r95" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "oled_TransferredToReceivablesFromUnbilledReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "TransferredToReceivablesFromUnbilledReceivables", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails2": { "parentTag": "oled_UnbilledReceivablesIncreaseDecreaseNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Transferred to receivables from unbilled receivables", "label": "Transferred To Receivables From Unbilled Receivables", "documentation": "Transferred to receivables from unbilled receivables." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r422", "r428", "r622", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r752", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r1012", "r1013", "r1014", "r1015" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r76" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r76" ] }, "us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockPreferredShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockPreferredShares", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Preferred, Shares", "documentation": "Number of previously issued preferred shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r76" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Common shares repurchased (in shares)", "terseLabel": "Treasury stock repurchased shares", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r22", "r124", "r167" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost (1,365,648 shares at December 31, 2023 and December 31, 2022)", "periodEndLabel": "Treasury Stock, Value, Ending Balance", "periodStartLabel": "Treasury Stock, Value, Beginning Balance", "totalLabel": "Treasury Stock, Value, Total", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r36", "r76", "r77" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Common shares repurchased", "terseLabel": "Treasury stock aggregate purchase price value", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r22", "r76", "r167" ] }, "us-gaap_TypeOfAdoptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfAdoptionMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Standards Update", "label": "Accounting Standards Update [Domain]", "documentation": "Amendment to accounting standards." } } }, "auth_ref": [ "r217", "r218", "r219", "r220", "r221", "r276", "r277", "r278", "r279", "r288", "r333", "r334", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r401", "r560", "r561", "r562", "r589", "r590", "r591", "r592", "r603", "r604", "r605", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r642", "r643", "r647", "r648", "r649", "r650", "r660", "r661", "r662", "r663", "r664", "r665", "r679", "r680", "r681", "r682", "r683", "r721", "r722", "r723", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSHAREHOLDERSEQUITYAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r606" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKLongLivedAssetsNetByGeographicAreaDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCONCENTRATIONOFRISKRevenuesByGeographicAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States [Member]", "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/DisclosureCashCashEquivalentsAndInvestmentsScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Government Bonds [Member]", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r731", "r918", "r1091" ] }, "us-gaap_USTreasurySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasurySecuritiesMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureCASHCASHEQUIVALENTSANDINVESTMENTSScheduleOfCashCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Government Bonds [Member]", "label": "US Treasury Securities [Member]", "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)." } } }, "auth_ref": [ "r899", "r918", "r920", "r1086" ] }, "us-gaap_UnbilledContractsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnbilledContractsReceivable", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance", "periodStartLabel": "Balance", "label": "Unbilled Contracts Receivable", "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet." } } }, "auth_ref": [ "r717" ] }, "us-gaap_UnbilledReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnbilledReceivablesCurrent", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Short-term unbilled receivables", "label": "Unbilled Receivables, Current", "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "oled_UnbilledReceivablesIncreaseDecreaseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "UnbilledReceivablesIncreaseDecreaseNet", "crdr": "credit", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONSummaryOfSignificantChangesInUnbilledReceivablesAndDeferredLiabilitiesBalancesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net change", "label": "Unbilled Receivables Increase Decrease Net", "documentation": "Unbilled receivables increase (decrease), net." } } }, "auth_ref": [] }, "oled_UnbilledReceivablesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "UnbilledReceivablesNoncurrent", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Unbilled Receivables Noncurrent", "documentation": "Unbilled receivables noncurrent.", "terseLabel": "Long-term contract assets" } } }, "auth_ref": [] }, "us-gaap_UnbilledReceivablesNotBillableAtBalanceSheetDate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnbilledReceivablesNotBillableAtBalanceSheetDate", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONScheduleOfAssetsAndLiabilitiesAssociatedWithContractsFromCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term unbilled receivables", "label": "Unbilled Receivables, Not Billable", "documentation": "Amount of unbilled receivables under long-term contracts that have not been billed and were not billable." } } }, "auth_ref": [ "r200", "r237" ] }, "us-gaap_UnrealizedLossOnForeignCurrencyDerivativesBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedLossOnForeignCurrencyDerivativesBeforeTax", "crdr": "debit", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureINCOMETAXESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange loss", "label": "Unrealized Loss on Foreign Currency Derivatives, before Tax", "documentation": "Amount of unrealized loss recorded in accumulated other comprehensive income pertaining to the decrease in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments to the extent that a cash flow hedge is determined to be effective." } } }, "auth_ref": [ "r106" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Management's Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r56", "r57", "r58", "r205", "r206", "r208", "r209" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSTOCKBASEDCOMPENSATIONEquityInstrumentsOtherThanOptionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062" ] }, "oled_VisionoxHefeiTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.udcoled.com/20231231", "localname": "VisionoxHefeiTechnologyMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Visionox Hefei Technology Co. Ltd [Member]", "label": "Visionox Hefei Technology [Member]", "documentation": "Visionox Hefei Technology." } } }, "auth_ref": [] }, "srt_WeightedAverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "WeightedAverageMember", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureEQUITYANDCASHCOMPENSATIONUNDERTHEPPGAGREEMENTSAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average", "label": "Weighted Average [Member]" } } }, "auth_ref": [ "r884", "r885", "r1079", "r1081", "r1084" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureNetIncomePerCommonShareScheduleOfEarningsPerShareDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted average common shares outstanding \u2013 Diluted", "terseLabel": "DILUTED", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r292", "r302" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.udcoled.com/20231231/taxonomy/role/DisclosureNetIncomePerCommonShareScheduleOfEarningsPerShareDetails2": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails", "http://www.udcoled.com/20231231/taxonomy/role/Role_StatementCONSOLIDATEDSTATEMENTSOFINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "verboseLabel": "Weighted average common shares outstanding \u2013 Basic", "terseLabel": "BASIC", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r290", "r302" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.udcoled.com/20231231/taxonomy/role/Role_DisclosureNETINCOMEPERCOMMONSHAREScheduleOfEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Denominator:", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "68B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-68B" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB TOPIC 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "38", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "740", "Section": "25", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-8" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "740", "Section": "25", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-9" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "270", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//270/tableOfContent" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(f)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482669/740-10-15-2" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "932", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "932", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "985", "SubTopic": "730", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//985-730/tableOfContent" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-8A" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-8B" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-8B" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//840/tableOfContent" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-5" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-1B" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479719/606-10-65-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r886": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r887": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r888": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r889": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "SubTopic": "320", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r890": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r891": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r892": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r893": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r894": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r895": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r896": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r897": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r898": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r899": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r900": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r901": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r902": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r903": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r904": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12" }, "r905": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r906": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r907": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r908": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r909": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r910": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r911": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r912": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r913": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r914": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r915": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r916": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r919": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r920": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r921": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r922": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r923": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r924": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r925": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r926": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r927": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r928": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r929": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r930": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r931": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r932": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r933": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r934": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r935": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r936": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r937": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r938": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r939": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r940": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r941": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r942": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r943": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r944": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r945": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r946": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r947": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r948": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r949": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r950": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r951": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r952": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r953": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r954": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r955": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r956": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r957": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60" }, "r958": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r959": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r960": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org//705/tableOfContent" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 129 0000950170-24-018765-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-018765-xbrl.zip M4$L#!!0 ( %&!5E@U@)(@O P %4. 1 :6UG,S0W,30Y,C=?,"YJ M<&>EEGD\5'O_P,_8U]QAR#IJ*%O(3I:YI;FBNI:Q9:U$,5FGB1%-$6H*5ZXE M7!/24.*2/9G'%JDL"86+0<80C7W&C#G/]#R_W_/<7J_?^CR?\_K\<5Z?[_=\ MW^_O]WN^YX ?P6G@!X>?['\"('P .%= #@.V (B0D+"0H(BPL+"HJ(B8A(P M20EQ<0D%:1DIF(JB*EQ%45EYG[J>QC[$(35E94TSK4.'#8R-C54U+*S-#:WT MC(P-OST$(BHJ*B$N(2\I*6^X7WF_X?\[P+\ 4!'@&$2*'X( ^* 0?B@$[ 14 M>9R"D+\%\!\!X>,7$!02%A$5$^ M;W!42,;YG# B$F9X,Z-(1.U8=9NLRR!#W>A\5(*HF-Q>>07% P1_UD=\+> >WJYN[A><8KX$)@T,5+P2'8*[BKT3'XV,1;2ECT=G5VONGM>][X?^C \,OKQ MTQAU9G;N\SQM@;ZXNK:^L;FUS63M?/." /R0_XS_T@O*\^(3$. 7$/[F!>&+ M_M8 *B"XWT!(^JBS\+E(&83A31'8L8RBZC91-2,7ANSYJ$$Q.75CZH'5;VI_ M,_N_B27\2V;_$/NGUQ@@P0_A+1X_%$ "VSN:Q3?$2O"X^#!Q6_+=)!734_P! M"W;,X44M WO3VJL6%AS,5K $EH[NG&7Z,@A9=B @^@6Y/@T"VPQ"$@X[WH%5 M2(MQ<46V+XI4B'\5I#=88**V^@C-T?ISA%.)_]>Q;W!/F[KJJ, MP@X0L)$" 8(PT]UZ.['NI$^M0XZFY2L\)WWCW;F3L%].!&2;I7:[X?:EMU?C MM.VPR3$%;F;!P6N6_DS'&*L=7\O.V%S< M!0&!Z._&L@ MD&"9_C^@:6X-K:CZ54TQ["+_^ZGPD$+!Q^([EH;97)&5/[&4? =)72@9=VR, MCZ40VE2Z_TP#^Q.FCS7L6O"V5)7'5Z9:XY]1OH/422E.#[6A_N]3%AG19O(V MP1R!5^8!:!UL^-*B4#Y!)7^ZG,*FZ;*DEMP4LP*K'QF8/R'MH:B'@, _05S: M9FUQ&CGAI8XZ.VH7=]SR]86"LS\&=TPTQ]F55!0,+7_A MHL(\<=V?F/8:6VIHX"ZN)V)N[=[X@@#%N.>NX4[6\3-//4KO6?59[]2T[RJ9 M;)]#=U)GO60<=A77ZVD49S_]\%7Q3J< W '='Q&U;F=W"G"&;P.1Q'P6AJ5B8HN]&(J'O\E5RXI7.=KEUC!: M>[<%K_A;228'$=C_N6"880L<%8#/5-(+T&1-NDDX^D$K W6+A3FC7A_NV$+) MH&U6AK';CSPK/(/8*V+9'D70JZ-?<8\JD8OX\)?!PM[)E'O-5F'.PUDI3AT" M:,Q'O2^Z^IFAPRU1:>,Y&1O63PM:&28%31B+22'N4MP2%]GW>Y:H;IKB ]P) MSAZ:("K4/\;;K>8-'AXE-7-K9?<(-^M>KQOQ]WUI#[\!. M>@=QT]MNSR0MU*HY_,P+^+7 Z667)4GMTAKX&IRP?S?2]T!.0NWX99,.^ZA9 M=G<(UY:#>51B^"7=@+5E:IHZ=U&3K_3Q:\3QI#D<2N6D MLEAOT^K/B<$D2X_G CBW7PTXR:?#Y1V\4#X+V%MRS]3\B'-ZUP\P0Z8L]8(: MU;CX8U-L4QTX;6;Y/NU+LUMG8>%E(ND-[DHW_^WL 4+./+9?-3EYW9\T%VLM M.[<7*5<7;*A;<8@*KVKJV44%^'!L5TWZ[+92?B77.FMS&_N7?*&]D5+7U/+P MK7!+7TYZS,,?L(E#S^*FL%4AVP_8/Y/QFM9Y06IK?3HCW+W2Y!/C\_J\-MO\U2N[KO#-'0]V#0B85!VI0C&?<2D.('#5?[Z.YK:. M X';_<.&_MN*!.2[))BS9^%#9Q0,UA^V6K:/_(A2T0D,V_B2WE7QP\G3Z0ON0U @(R5^PC#A)7^"=JA%2+N%ESKNYW MHSAE;*U\4&*5D@<'R0=OSL]"8989P&A3V'WY#(]*O"EGA.[=N;33?:S@P; M0=[NTJ9'C'OG;C"R0W:>?]"F#]$]TS*J5,Z4 M>A6ULAYN,XE<6DXC?&WQ*+75+](G/N$0O*7I3RR=HS8;Z-BAZY^*+O6@ETWE M;N"$4"X$G[R^)N9-:KY/8GE%*AUV>:I,?A?3O=*R?T;)BM5L/2F,5@Q7S9NO M"4K 1'\R=E2*/?(+P6NS/-!5=9Q22IG.=7V'Z4 YYO!6DR'EU\2L+K'+" _& M&VQJER$+"0[=3R%;YNH9%W/G#KV9JE M#ND.5YUDXU,_P@*!0B?>EZ@HJ'HESG=&J875W#4IY70?IGI_IOI2Y6UJ60>5 MR$X+GGGJ.)//?GV@$),R95RE%OM"FN"51M2)OZ3.'LP,YIA+V9?TCX850? T(;%'[V,W1Z]&N7H4 M>\=I%TS_$9)!+B,BILH1=<]:Y2^MGNV/C#;8F(!=3T0^.Y!2MJ/DVA_A-.:Q M<6K-2V([GW*2O-K?/#5_ M$JDKRSA*\=9?MY(;_VE8WV K_LBBT[5'A^QH1-ZNWWM[Y?#UML]:7P\1*8^Q M.Q[USEZ'#L4^3R9+>Q $I-E3+#@ZE-& CE/*7_),84,*T@?<7S:TOX!UC^&4 M[L3'U;IR\95F6*[*FO2LB&\.-I?N/4[910AM?@O%I+3<.:@-AH_8#Q MM5-XQ8K,;ZDI>Q.Q'JK9;\V B*GLTGF.Z#_"@&\#^$U3J[8I/^<=[S MTO!$R0,Q!^+BM<,]Y,$?Y;?]8 /Z1K1@N0N%I>=%" :)GJ/^$G%FD20]I;MQ MO/\1K3L@,/#<-U6VUL"DB/%Z=UZFPYG4);@-Q^ 8R9]J0DV"T0,G?PC_ .7U M$]TLJPE=J:#!\Q\X+AKLC%8/^AY^NVK ]F I#_4RWK--687"N&E]&2_:U1RU M=,\'_L@;%A7>OQDYU?2/582=[?8W/>@_KT,/T7FL\ ZUBD)VW9C0/&C^=V"6?KLTM_"J6R9JIKFR%QP31--B6O0&36@J$4[,;E;D7 M8:0NN;3@N3J/#G40X&];J/)O9IXLM<\,)42+;L17"B_H*"Y197227$&6_F%91F>05 MDWY=]U)?#5&SJM#FGF8Q$?AW$OST5U!+ P04 " !1@598\QLZ.[.5 !6 ML0 $0 &EM9S,T-S$T.3(W7S$N:G!G[+L%5!Q=ERA:.,'=+7APU\:#A0#! M'8+3-!*\<8)#( 0($)P$#Q;<+7@([DZCP=T;>'S_^+QYLV;NG37OSEKW=._5 MNT[M.KNV[[.J^G'V<17 >Z6@K @(" ;Y\^P",,\58>"K8! %55@ T '0 M&4$<0'S"\ X54$&$!^PA&>OH89F7_] G0 @#B^2P6@/*_U>[_S3X>/@$Q'CXQ'AXZ7AYQ?A$Q'A%_\VY)SL 8, ) ML +< '/ ^\EME0!GX!T ^=OLDU6>?!^9WL[=_9T8-[>3&Y>YE;.%-9>ELR,W MU/P=-R\7#S< DH*^,[>$6+O365C;@ITD6(Z:VUGHP%82+'J"JCRJ[^2L[@]_ 6XG9F-L(6EA9 M"7):F/-;@X^;G9N-C86-G^VL1!#1T=(QG M&$28F$1L5&14;/_I\=@!X*,C*B'V(B'0 XCX"$CX"(_= .U374!!^-OXAP2) M@(B$C(**AOX, _.)H!8/0$1 0D)$1D)!07XJY0C^3^\,JB$&N9H M]"Y$?._COZ(SR%9V$FN.'3/R6[@&/\,@(24CIV!B9F%]P28@*"0L(BHF]U)> M05%)^966MHZNGKZ!H:65M8VM'=C>S=W#TPOJ[1,2&A8>$1D5G9#X.2DYY4MJ MVK?G)Z=7UQ>7=_<_B47 H"$\ _CWY0+_TDN1&1D)&2TO^1"0/3ZBP ?&>4Y M+RJ!C ::N0LA/=][="+9^*^5G<\8^#6/B2U!6(9HU!_'?!7;FKIX FBD/EHGS(=_7+:UQ MGG<0W_Z->,\,JB+&&)H:A#)Y6_L'^C&09"6UK_Z/">0Y?,J%O(C?O?SU+N2] MBNH::NFFXYPU.M-<@D:L-;TZ'JT),!*"4FE-JLP&QABW83O$>^),X<@:(W]B MP0^Q%C\Y^:0Q3%O'.3@3WT<]FW?UWRV;B6UAMZ1N25EF'CM(V.45P!:$*S'+ M=5@SM5FO%ZT%"?WY+N99GV]_B>V?M^OI-1WYJK:G]JCC0W]$G2H10 M(6]C_\ TVB(YANUK.''>)?1:]G+G^1EOS,&B@DO\Q*1631R^71:=@5I(J;Z] M!=4SU:1QUA$UE*$A)C/N0T)@4A]%;V\JCL$, M*U0&!H8R@T2]"?-QU#*AKQ":# N#L'6U;P01R)+P@WE7'K>/=HB;Q KKQN.. M AY3AQ?B(@+3+SU:DY\\HBRV],DC1,E$M^FK#^$>,&K)S;(*N-:W!;4$"L,&HW72O#64@MK53=7FO24YS0HTU,&7!I3N:QD MO9@WK2R ) ="QCPH51467-3%QCV2A'%R71/X^]>"N#2,5^ <@."#1/ MUFM!0;+ _76M3T;+OT+'U&)/JFIOVKD*C9W M+C;:.5LQDO=U+QTU OUB_,PZ2*SIVH'3L"--4O2='^*CT[IQF;CKZ6*\8)1> M#/,-Q25B*(W)VV"Y4XRVKHBL43E@=M0=U/_1,) =T2OD-#=AE3MXWV9.[$ M'L!NS$#H@>WX8E%HPA R;W5B,K1A!/**KQKBOL(+.1/^L56N4CPK5RQ7J.KO M2'WQL[K+_HPU6=XT7TN4SHL^B%-#QWU)LTN_4F6)_G;^86H 4Z)TD(T7#0TK M+R2D1[X$,J\0@JA:OEMGZ* IU)UP"GNNZV +5)*+Y&">ZP:45?RY1>8=+-^= M%K-RK9M=/MU\CN.S2L+ 7)U[';(ZH*OPH6>>,'+&-VGRJ[@>G15\$>L3_R$K MTM=OQ080,9M\-S?G0GNA%+?Y@[N7;]3*1P^1RU=Q]$1$1HQU5-I)KR'JPHB/ M0+>83G%=DGGV<&LLJ)B,H&C..2E2EXY&"6T\2(BUU%&X5Y)LND(^*VY-@OEA MY[TY2MFY9B-2\7RIJL%4[3VM=+BHQY)AW^N/N@N4R\9YST>,$;NM1E'#B&,+ MH%U=8E.K-6,M\GF[I$PJZ([S&)X3) TWUOR+!TCZ YWCX ]11,!L?+.;?_Z:7LOG/VCMR)(AHZB3A&KF5B^KA_K+9/,!9.D61K( M[PU_(XB-+6OYFQMW]I=H]">^K'JY>](4KJ?UJ>.<[HH(V&47USLAB8)=1.[- M]X1_8>Z/7%YBE+3AS6R.'.83\XFV25KS1S,AS"0TFJC%=T+X,K?4Q_T9YYT1 M6&08UTQ.FN*SGO C@$G;27LN"@U\!% _!9[H.&N_%:[33QC1VN)T:+4_<"M?D_T'>@5"E M)MI1]DS048Q:"3R^,I]_)FM+4L87]?KM:MOO;2=%T\\(3M';I&LLP9D_66($ M4&U$, 1%E%D>;LN\/?R%L VIN1QEIR5D89A==F=%R?+D@VRVC%@TTOM_A;DN MI]I/QU>.8I1[8.ZR*5.(=NKKRA)WCM1^M$I!SK*EUHOOQG/JQ-T$6'F5(A[F M^XJH04S?HEF!_TU &@Z0L-;!_]0AT?.]> MP6BCG:^/V Q1KQW?G"BWA+!_T,-3<86I37JC4LBZ-)Z0]4^OKS]LU"YY/>@32 M'>T4A/95.^GFRL/X44V&%;Z8(U;-WY+55-Y!K^J+ 8 MSP73E37G,!_A2/A+CSM_.?U106_Z4]NV,6[LFA3\&'/CU6#4J7U<)-&.;DT_ MVN-!/U#SL9_"*:7XG":DN?:+X%#W]U\+1+VT3:8XK1ZFCOVO8(90B,W8Q4^1% SPJL=MJ,%F#P M];OY3-Q_:]-:MP=3C"B'*Y;O.5U]\"X'.^8O[KO/QU>QD :2!1"U"0A343XG+R*^T_"YQ$_FKYXWOQY @@0",ZP]=%&8]V"I=DOA3 MDDNYN[IXZ@[+6CUU6XP+;+!) GW$F\O+"O,3W!#W1X 0DD:37ZSND4FPL62T MT/N+/L%4J#HX+Z&AOY,LU_38)GL-%]_.<+/[2O=JGFJ$LWJAJOQX%57Q5T8Q M$AD9*,L.:4N572M"\=K6F[GP>$)ELHS;N=QAHCM%L^>+E2<=":)0O"S-#;4( MW5HKC2I.(#:T>C4KSL.7^KPNWHQ!'?^7\*&EU(O#7!&TF" 1:O9Q@8KP6Y*4 M5:.19_@NOOG+-64\31YX MV\JF?^+%KK<;?H.4U+N62]_DV*07)RD"]1S4MYD28/5C2TO.= YH#NO^N.J= M\ +VI?"- E^FB. 4I!T%)%$.,0R[GKP8$I+0"-D5$O._2G*$=FRD$H('1+?C M]SH9I^NC LBAOMW)8E8H3C7%YZ'ZYWM+7&[(EY$ I4;C.H CT^= 8X912!NV MJ9U/7AES_%HKZ_).PH\U]KQW3!&2NU\CIJ0WTFZYNYZRG+L4;D^)V)*]87)N M28?CX87)J^V1)NBO W2J& "@;L;:1L+;-4-O$2WQ$ZHZUEE?%@Q[K^7L2BTY M1HZ<$3Y7STB .SCZ(( 0>) BYM6Y4C?KXN&8<_,#K_%F>H6]+T"Z'*W##!=$ M7 K'K&^?=E]@'XR5'38J6=*%R1ESA"8<;-.F>L9_1/_C-KD]Z^!@,7'>#$'_ M !(Z+F6SZF32D2:_ZJ@0;[C&AZ4R-T2/:)^@9N:9O&;.EJN:?.W)ER6,1/.L MRY&\RV6!C PX93VZ,'%[?2WCXI_3MY8^':$9Y;XWH$%R@+=O,D3'_K/(X9-; M_7+K'NP@HV[>8S'%%/''L?;I*Z*%.17D=KLW(IYVGW$P>3JO+DI(:8 QFYD6 MX>^RS#7.V(H'M-GO$P M$]=!F7'Z:"-5FY<-;UM^]YCK,@O?=9!BH.]DS)1>FQZIG'AU98I!:V9SQB^H M)=[LW"FF4#FDO]8'L'.LH8#ECU)G8CC#J)]1A4J)L>GNO/L5SP??C0DG^.>V M2,MG/)V+/+R](K=8GH;^8>5)!0NSX%&FUK(:"!$O'8Q8 : - Z!H$2TOBE?\ M%&@Q+WR3&H\KPIPH=>1MF XM_,N0N7>),[89T.(G'$E)KMS@T).CV0=J?>@* MN&JQOI[DQ#_E"BGI[/.V5_V5@J]>C0%47/W'R7+^6K]-(^3^U;*X=ZZ-V0L= MWN!<)YGU1L%A^T< K>9>JR4&@&PF)6 M09!H7!3%R7']_B,@6+-,4WWLL57]X@>%8W4?Q[L(RRTA"X"JNU0-#25HS^ 1 M0&Y1A)701MX^ F%PAF+_:OF68/8% @MHW:]( NNN(%>H\[>9' ,X^\1J^^CA M!79@-T5W&M/O>J&5>:\/DML>2%ROK [F,59CJ&[3YJ9!Y(5[IIQC($6.I[1S M^R*Q7^CPJ[4!@)6 F)?4ZX,_.8HVZ(/Z%2?]V&::4QW6ENCB_%U9,(;F17/: M\TVE_0[^-7YZY(M%R2/B"^[0FO1L++CD>$VQ$\G#NOH/I9;N 0.,"@3?]1^7 M/;;@0"QW;&%8:1:J<\TRF( ]7%BMX'7UT;".=+\#GDLG8CU(\*LB+!M[SF[4 MU&2YRYHVB6@FIHRY\TH[20<9(4CD#PK@3?IS! 6JU9N-NC'=HF<)\2Z&$)BH M%.UZ(;P>$TY;=^WOXH7IJ%-Y24 4'GX.*E\O'/_L4XG/JPQYW1(]-Z_%?([G MU\[+ K(\WNEQV&U'!HD7FYD..A?O->DD?V5)]\W?F7G0R1],3.:DF;AJ0$/& M$>F!0)Y"OD6T_$^:6B;%$EAJMH'"<3E5*DFBB R9_9//JJTH2X6I'5+0B:T4 M:0M4\;D?&@_+Z%;+0I<>WP[-L\9C*CX^Y77\_ '+CTJ$\!3L\_LY\H.T6TSY M:XVO?YH"&O%;ISS8ESR7RBH\)!3VAIOLHATPR&*P<#)\;.D 2MOCQ*XZP[YP M08&$2Y4XK/ET(W6^E_3:78#5SU,9"P6A,VD:AM79Y)6N;%Q+-8:XWJH@ M":C0/V&1JBD, 3;*4Z#J/SK+B*^%8=G7LK1=!,J!3/4+AK>4N7QE/2V_ ^!. MWX$^AY"CM'J863B%>ECMC4??9&VLFRY4* M$'(G^@@,X(^W[]7V/7RTAP4(7(?\O%WI?@2N%5MTOI?%AL?GJED&,BL'3A2^ M(7Q.E)WD*:3N-^-2 $?[,;:O.:AT,A*[S_DFX8?A[A[!"Q86C,H@/N_RKI_+ MZ!/P%T40TLL4O904GZ&?(QX2ZR6-\^@Z*-I^.80Q&V?30:+J$:1I4MT5(8:J MP^V%<[O5^C^GQS\LN*=;C94OK?"(,'G6PS%:JM5':T+O8P\O0L=+4[0]K" P MIV!/L[KW(U43-DX&##FK>'P=8E!@79 M-F8C*[AJ[5KG:]=Q,1RH-WP_GBWZI3\KD.^FW==FI;5O:>=F% W7HTCF>'L= M-;/"E.>#\@EM1/2B,.!].18Q,F/Q/,V9K.>[ M.I@!Q2B.UV:.Q(B.G94:2GE3X7[2WB5!V+=,637FD>I,']XKGT!>EDDB$\H> M;*#4B98E]E[SNAFVG+2.BPUN8AJ:NLQT+#"6=X$P9[/U,3I2\#&3)U4&+37V M4XVBXK[G<+8\84GU/0Y1/@XNY=#3K&VJ2;IZ)V3!B,7W;%MDK=G$5W9<< &) MIC[?P%X9W3;6F7/\3>S''!X1R8L1J!>L'LXPOR&6 F?.XIX"?>K:;\HJV9:^ MT92TFN>/V7";Q-C?D&%TB!U[CT:$<-J3E6UN>?=BYS:_-K,L_^(>5M4ZN5XO M(S6WO#G5F4)9]PDQ(\/R8](*W.Q8+\SO^7%^;04VN,Y'LCA7V>'6X^([VVMC MI0]G(ENRV@E>MI-7Y8^ _+5+CMTC@/,(P#"@6Y/N%E7L^>O!A]2#&54HGJ58XS_*@\!H622 M$'4G;==DW=$E,";UG%=)O7^7,+WIREA M6_V/,7?E_(>IJ9[,K%$87NGS9*9!)\?UPK>0.9 MC!*7ZEIWK^NVIAYOWH2( MZ_)W"=T\K!<34:SH0 .\C#%1LNNNJAK ?2%/5]S$FJU/")94$ M6$%RSQN;%_(7E2)3I!@#7]BB*%8PU%KZ281SX\-?3PL.NB:L)YS= MC71I',9Y67Q17IJTK1)^IE;@W3=<">40? 0([,2F-F9>N'U5X:@;(&15Y&/5 M:B%FC,'AD==NOO;/6[P^\3/!NDKV232LS>^O\\!?ZE7@I6-39L ,1K\K^<.* MU!5 ,K?+!Q<<7UY8+8A;@\9EUNLVME9_5(E;D=*)Q\1N]TH<\VB++#R*,N:=QFK-:9ZM].W67* J[QZE6%18Z1'_A34.I950X/Y1&#D.]_DB%\WB[] M%N\ ZP7ZJ@0R*FMU:<@LB!/&*?Z3Q,UPA]D2JYS,>]-D$@#,^"D7<18&\420 M60';:V=8;P3,C!0B^7QLJ-N+HA,5BLF=$"$>)4V$GY@X(.&K9R"-0J3Q7P_F MUR,FSCA0A3N-4-(F;7S#WLH4;E ,@2 & F>*]2JBJI..A)QRU93A6 7LK*W' MM?X-]C[BKYPP"X1MRC@T!A$):3JD(8$*LETQO0B<1'.)GH/[\GKGPCZW\@6U MA %GU[F/>HISS]D;$UDJ/ON[Z=8<1=+0A3\0EC.G"V9??OQ:T,]QL*%,7F:9 MK,&SQ "06[!OGLIL>P^C08J@6O)3'I&U1GO\G!N2:@/(P[E7FN0,O\*! QM& M*R^&K_21?B^^=;IAG1A8*#G;M,M:NT5MZ1K0(J]N*'6AO<\"UH)$Q$ M&%_0KK>?.J:.HI\J9PX.,[9VMO#BWKRBI_Q<&$];E!7 MCNA$P($((>?JRJJM!GKB M^'NOYRNN49L^_%KOG"%)X2.VXRK(Q(JPNG/(3(&B;5'^"&B9GHXMV E /RY/ MS5DV?J:Y9E./LL9DFV7C3>5X4U?,=/Q,A PYJY#/7[AC&3?!NH6_Z]*?3^&9 M1,_4KP5#$FT7/!MSBL1*S[Z0()&.5:3L0&IH&%R2<6I&W;-UO-1#);"2XYCL M93UZ+"5/BMN[73G$UDYDBK&FZ_BB6<.EEDO="=7-T)'YEYR:Z%^"9WDWYK%38P%7-CJBNRX#Q3-=:=1E MEQ7%E)@>*;JQ>AH),DF9^!A!JR>Q>2%]$G^00I[B\A'H<5FX3RWCG-^"+%#: M"3X[-QID]UL4531CL\$Y($>HHL0BP_V\55<&URA?N&ZM.0"?W]D)]\?G30OC M/4MZSKW5Y]&XYI!D80&+%R90EFMJCR@#(02Z.=OFYR]6*XV9S@\&. L;<9"U*^FP?V3>5#U1OH_AU/322O?+EA5; M%P'K&P7H-E+U20QVX%H%)KC*9$4&XB$QDE7G5;5 +M3Q.Z?F=5F0@DM:WZC M(Q#A$S-]Z>-?7F!Z.F59YZ\@(.8#\_'0 M5K5E(<12)U&CWJS&Z!&P9CI*Q6BS7!QQX,N!1?R67AU%$[ZO+;8+8*? 3E^T M_[$ "5#]OF3ZRQKCUCV%1D7):+OK(U;S,95+DB9-F\0)/=CNX[Q56D;*M%#! MB_/!$N;Z.SD^H>L\"P,9LV1YBXH(,DI7SX2%CI7YN@=*WIL9H1E-L:C04XX4 M;B1GO-3 MN'1D^_FO?F7.CKQ*5[X.*5?U]B<>-S+N*50M;.WN4F[\X4R_N1';'^VY=$JD MN]+/WF!)7V8FM\IN]"$68_WU9(55E8%%H[[ W=U$^F?=Q-])^%?5+[22+;H^ MRJNU$8UZF/!WB]F&.UG5M33&"@QI;AVK>S /I?_,%GVPQ1\YK5RJI\.3/0 H M^*')C\ #<5;)FKYY5/['\42*ADBYKZJ7"C M6W)%HF#!+MDB>@RF]?NC$#LK;@3*S+.!]41IZEAO[FY'K6X2&KH3M%E!+>(: M0\&8'T:]5I$EM3!-KP@ZPN!GF EYN+#M\>&4NM-I.ZYR_.=I!GFQ!?'P\55X M(6=L3L;[&"R@@4J/?VU]M;I4"LZHL:0.G;:OSL_PTMRO-Q N3GV+3!^!'.[G M[D#EE(.5_@C00II>7XD)KE:G:ZD:BI,=.0H,1N7BUU;,JZ3K+VW8 'PP,ZIP M1D#>?J1B-RVNLQ6BW5+?,"'(ZGXWUB#'6>T4:\S17Q&%)S2Z2[E%3I-:EIZ- M:4?QVXL4%RW]_JN 7JR;LQN]:#P>FS)59,?76> 7_B-0BB%-Z MTH?9-D"^AJ.#Y.2AXV5.)IYN]\854MLPZKY0['[#4K=X"Y:R?KN/@9B.D4&; M^NI8IPH'@8%.%T2+W<+N2!7?4SA4NVKDTG;KR:M07D6OH))(IB=O/1>;9^TB M328L*7!"\$?H2G?W0>/.,5:'^69#(O'CFI2*;]3N'8Z^VVK>%._C%:1$%U M]%+9X=J?O((SP7Y2WK[$D_-0W5@+ M=;87>='D) Q?NKI+":0C#L.U/DXB]$$)=2>=07:?3%:6U)]]T)3EZHQ.J43V_=2M6)UM56SVN7_$2/];)\=IK" MF3Q,%%])DP*KP-H3(E#$G:MPSF^HJQ7/\S]B%_Q=,OD^D5)(C3<&R[VP:[6, M8L4P7:?^82Q\:VW[0 O] I(?;? .=2M2^!/*=M2 M>X+YW3<[V)S=5PDJ JHN[J._Q_I_&PA_#T+\1+11CNTEQAP!\YR\8!^BGU4& MN:F"7:M 951J&\ILC$Z>=!:=Z6\1XEB8TQ[PC]NB8*UJ+PY,W&^>XWJ>+JKR ME[I@E<]PF,A:LN'%%B8!H\B2N(T-1F8$X%/C$9"A6B%G66D]H4"5MPU9/M#? M7>T(-I!AS$ 8(>X"/TB%.#+6)/=N"JR@S4.\-.V?<52;B)XA%9S0==*# MCI[_[H.9OV&VDPGXA.;:[DC6GS7I B,"V=+61;FY$HQM% M@M.ND<.U\B5+S3\N#]LB3E-WY@$(#LG#P ->(8LGFHR.8\V"BGAS>KI^ M2S%7G7>G_H%%20UUXSS.**KT $;.!FO/=X#U6_1_&YRU1PNYV7LUF61?4AF& MOJJ4 MB(U_[$@ MV4EK7]( /T12Z/,;';^6#;[DA;BTE+7VB*PK_4DN1P'EPT.G%@G!&F&2:4YV M\I?]GBDZXFI#LP/D&Q@7OUB1^I_VNY@FLRKE7+3#24=]"4 P*2-"V!33M/=L"@N&FDX8MG_\-;XSW=>M*ZZG^JG7KPC6 ME"#H)3Z2TIV G7H3!&2T8\[OB@D.7:87[/BT+J<4[0Q3/ (:$[;1OMZA3H-6 M1;)A8NCJSF/O("=B^.D0(/5#AGX1&.Z;4;=.UCIJ7OIBLOTGTHK# 8 99 M_$C\[MB&%^XW@V]YCX:LH=MJ+A5F9G\JK^/]5"7R6\0Y?!?F@%*^7Y, CX?*]$X7@X0C(SD/'RB +T>_1[Y%P00<4A=?T+.L1& M4<&=\S=H*<;I'W C)5F3';5Z#%_K\2^T2,V)D3='O^/,U5QX&.2F"^8A<]\Q M"* ;NU!IU=-M=)14'&<^(3!6IYZ.%]QWD[_/)LBMK:H"?6!N)/,WPY MB1#6Z]+(ZB9JOL!-;MKZDO:Z-KO MA1$]T7FLO@Z!J&1C2Y^:,E=:4HH?S*[_OJ+C[=,:J1Z3IF%P M^6K/;)07(M_VI'NX&DYE ,F,9MITJEI?DZ? MJ;MW[:)"T*RJ2N&XIKN7PBTLZ96WC(8*T4(,U\2'#WX/1"=QD8>"U.+:31&Z M"93IH@X<3$W85F -^W3\77DF['47!-]"0TO(HER)^,KY9 ]R'_#RFT^86JV(_A2])E#"SBKEF%A\6YJODG1P,WYV#=/3>Y7-\BY*(0Y"$U[[GBM.=\]S:G4;VQ21]>4_.;B4*3]= M9J%5LWVP1M34PNOZW]5&_J"JA1[FC':0-/>O;#L,%2RVIF"E7H7MG_<4T2H"HLX"5\Z*"DXQ!!Q S3_8$;?%$EAO^B)WK2)B4\C9/B5%* 5O?DAP0RE+)VVQ4C_F7I?V+)C2A3N^ M^%4?;\UHL%#21C4J8S6!!/M440XN3T1' '/]U->9@^$DXLVZ@JOD>;[%@4L1 M715+K/=6IR&HMC:?UT D+(V/9-3MDD\1!_6\&PI;I4DJ^@F $.55O> MSU\^O\"B%;F)/M@[0 MEFZ:XS_?\38>.!"97O-%3O:1;!WT05B;:V'5;I)Y_ F;#0*.9 M?F^ R_D0]#*S<&57S*.NN:P^4F!P;\A%D'*VIAWWU\K;!8>Q3CQER\$PP,DC M6J89Z2--KJ-4+T6>)BW>CG"$T739N1SRB6%]"J;1DD B.;6,/MES'!F&!.GM M:. J>OCX"OY!S.S>N^<1R,%H=*W'QN%DBG[!?Y4?T] WRO<(B!7^9XV&'/2, M!?!@_E'+30'U?=7?-$7')=;W[(QR)VQ8BD(UOS'S5-(_A6X?1#)<,8._RZ1YT-E-J_O M=2S,_7+EC]>D'DKSFO$CT%FP$+C"0CL"=.^@C$CHUL=.V- MY+^X7]D:OHQ>;1LXX93:>E[0#D<./$&,.\"-(C';T'ZPC6@E)D9_F8[)K!/E29VFQ1W:>&L;R2"DHQ7B(:[\=6X*M[Q> 0G.)F/EA\J^(HE M#G][JO$Q>Y>I/LV0C8A6KD&S]F\WF4[U:[$,72>)QEOQ[:L,-UGL M29)")Z21S]2?V7%5TJ1X^7'/5#T4U+J;11@*I= UM.A.'O$GI^W%9[]IE0)E M^^P!& 2\ XX>#61?$ON"S+QMU>)]S1L;X?';Z_#'BK*&E)ZENG2WJJIMM9C M2*:N!F :-7D%M0@7O.TI4.2/6V^XA\'C:#^5?XRVS] H Z%2I&]M-A]>!$9. MQM+',-H71?,0*P"%&O(&B_]03UQ7CLM:6)Y"HP*>FO((1)>IQ&'9U7OR&AKO M_%#!XBW5.#2N*B(#A)?_2$!TH[/TRR,$WC5 "W)5V6\80AJO'2X)TRO0=V:OL7USA^%;QH%4H!?C]DBWLYBT191T8[>Z>5,,$6+KMD5 MQ%K%AI-3NZ)?$8.2K]U%LQ"T_&;!(I(+?8>/ #NQ>ZNE^G09RG"*!W6W_V66 MWNS'G'O[@W?S%5V5*#.7*2&'*Z]:3?U^] T&.CM/^FJYM],:@Z]R54YJOTX< M-G'VTS8GKBSL\DE^=JO-"Q89T/3[4G1Z>/U7?;V MFC'!;-K%OB)H:E:?LE83)MD 2E_Q(T X4L ^ZK!?5G.G75?YGBZ<-TQI!M#E M^_"]F:&K>[0D388[^-F24&T@)T<[X9 D,=19I7U\:\JY3'=MBSV1*,"6+85D)\P\[%MQW]8!)(Q(0]X M51;#Q+M-]2()F5N=>=;%5 5^-3X]Q0SE/&ANKB=Q&G%; M4O@FMA$@@P)HUH)_3+.M1BKG!FP"KMA0UK0!4EQE%:3,/I @,-L?,L#93)9* M,KY[/WH7UR>8PA[75;EUAS&K^NZV[\;L8?X14/PZ,V;,'+=>DBEV#J81#MG7 MLPQM[F7X[)/Q3C(W+M_KU:]=%Y>"RCE74FF@Z4I [US;C8NS=_N[M.:PE3SXH MRZVRT>4G.2-F3,(,X^S?.]21(S?+>*E54Z5)775K%6D]362WM>($$8+]EFTP]8G1H.M<7PK^F\"3 M-;0];;C$(T __)3+3%T"_R#60,2[5DXY=@(OMDD?@EB1_N7_JMA33B)B+(_/ ME<%6V?93Y2+!2PHN64@\M#E'RC5)<['VHU_1-'.K7BZSG_@7ACL&(UQFRII' ML3PRF_@VXNHVBG.:;O;8A ?K8Y$[+LRW,@ *E%?U]NV(!P#RJ,. MJ<*9PO%6YF $,@:ZR5P.I:;21[BOX!O>YKQL( M$*[6G6CX_R@Z;QIZ=.]E 3VPJ1:F=^ZM\JX]>&NB$I5P47AKL8 9;8U>KO)) M6/NE34X#H@+91W6_R]OS*Z+/\^,*/#V_/B>!-#?]:><"-^"I"V-*I=1R+[#R MK/!\QJ_4"]NU%J9SICPR%?O2/J>QA)-_'5\7:6[K18J3.3B8O&UZRIPCR32F<]LY9:9A.5"BHU;FR:\P)U[]GP7^K[GGI O#9II^Z[ M:M01['P4LIYG_<*6]=Q2/ORJQ^'_?ACM1]F>.*:$&"%)-@2EU&$A6H9,6OWU MJM=J@,[947=VC%Y3>5Y=%LZD;>V$I4835"9:.7OW70?.E_7V6@]:9+_ TNOP MVROY&1;?"2Q:N_#-OM\Y/)JEOO>K"MZK=Y:L%B_.3E_>9E^X%A"B78014W(V MY=\[^1(3:9C8)ORGMH?_8H]"G/NO]C#2% +_2/S4?7X Z3G"8D&\B+YS;4:^ M+E,CQ9>/P,5?=<56MY2U<]AI .]ZL&?LVG7L;:V&RW=C>-TQ0I8Z921U]:B7 MH%;G,FZB>E)MF?_0<+7;&;_H2&)6UTI]O4P/_T\:HH:/)RUR:Y;;NU>T?"6/ MP&"#1.7L>IQYCV?2,U%),!416!U?PX*]Q @6YRR\??-4!@QIOOS'TZ?5GBG; M:(M86&V9[O3H^G,:F99[/+^^8Z)T99,4=+6\QK?E\%A[]@'!['DDQ7J;#UVW MUM,%ZWD)M$R2K9BTW1CK%0$ERT)PY8;G9WTB=S"_L?DENW22['0B(X-BU!I7S9^QRC874K[ 'R%E=)SJN M#F1Q/]OK,JRDVZ]KK/^$+*5)>J8IF90(.5GO&;/_N;53QE++G5Q]BEAD"M/W MZ[A+"*3XXZ>8 WVZRDS.'V:&NY,LJ<\W B;2Z,_A84 6%>U'6A&I8(I02##Z M'*.4)XY"+NZ6[=9Q.R/QNIYJ?T>0Z7[FV\7DN:N?+8[Y<\U,'=9+':[SAX/D M[&S+/V0!4M<*ZNVHQ:1WQ\\?U""Z(^O"[P^/<\;AZ6O9 M!% Y]>B)'E/2A#WU,%W6C02IB[?O2 /009Z@N^G/DAS7YA5^3>51$###.\.U M3K?LJU%">$E@T;IFD_(MY(9_I##-:LJD\%GGI:L>7*>=<+1FA6S1X<^K(P73A5;+;?^4 M%&MZ2>NY?$X0\@C(TEX?N#;JAM3D7@5VBB=AH5C[Z)0],-WV/@7&[KE>XB/P M4_G$J$OJE/+XH*W5J=6F4L033IH-=ZT 9U.U"()6;*=7V\;*$;K*NIF2U*>\ MX1UY)5U@\"[!KQ.AK;S/,]":1P#[$4 :+RH]8.\6DVRDN:?5JFTE&\#[1197 MM"M%,5:6J*[M7163'PJ?8C#G?AQ;:R>;=-]46N7E !SC$9AQ&WL8 MRF0:BDXK:%E:62Q_N*-Y7WX]TY5%B7U?7;)@U-]^VBUT(W44-G#//M"B<4*K M?W)^D'=-J]C64*F)7(X7\OP1L/M([!]%\Q!<'G(\\^H$I\YBS+S!D6^I4C(7 MNI"EM6*_RCIB'O-^0*)DR;V5;41^PN+'Q%M]SC4R;8W;;*TC@PJ(GC]^%Y6" MD8'(SXSOBBW9'&;?#&MWI^ C3.,M"">X6A.YU9.U#7["A0A#91%\M"8]ZHQW MC>5Q"MT/H?ZB7&MIQ,&WG!_I[E"' WTS!Y, 6>T=ZN!^A74T1UKKW+ M ?&O=NQ PA&0Y3%$YD0JGNF]"0E4:Q!U&N5TSM<:590F)ZXO!GR-!AM.7V4' M/PSR+RT;KZJXT8?=*,IKS/JVY6]6X64 M[ -JM?'9.%BRM2Z\.LWE0^+3QNX5VZFG &L%XXEP;ZRX^HEG1IK)R'S-K!SE M"N<[*\X.))&[5O^SF E!J8]<\:@3-3I15$X?(7,_(V@Z+*7>EX=%).ZV7+Q: MKI^-$&7W39AQ]FAS5N%4-RTZY'I;&SKH(?"N5ZPEA@BW>V8XQ8P$9+O&'E?U MYXA=:3W2?<$R>P2EW;#2^KBB;YDMU4EP[^O;V '?@9BJ]5E$]56E4JL_BFH! MMO=3@7WRU]5M9%1&QE/TQ>5GGH&L)8/'BB406F*_Y[F(3%.:FWW'AL6)4G)7 M@8;K3I*BR[LSS!.= :2-[=G5K\A/#C7$ SM*+&6N26&Q'*5-Q=GZ&:ZO#ZI MCT!#^V3:N3BUY,CK6B-'L7%*)=*\=PKXBJOLI"\&8<;M'^Y)5X?6?F@+.SV5 MXP[+VX'[/Z=FUXH/G- 66X-I\^.+7)JW]8X53PG3^%1]+*M\)QOPDW)Z<*HH M,MW53$P6Q2^A=1FXATS9Y5.XJ!WI;1=]MQ'_2E#>[1.3([@A^9'Q7%,+TB6C)YP207(NH@7\_:F*!:]^YOKI,'? MO1Z6P MA )1R]N[V_ G0*K.'QK@)4FTS8TQYC-[NQ)Q.\:U%9$>(TC&?>9KW;Y+ ID_ MS'J%B6D>VN5&"B!?+;_G#QI.F 9N-V[XLH0F?:]+.>M[ZF>=.=M\2=V=/U!@ MPU=LIEXV"R,@]TDP#EF2/<7!S%\<9G;13V\\A#;JOJ>*K@X76PZYP"W"7D MNOAVNN6+X>"27\6(SM6AS[NRZ%PPM[^7H=3IW9=[O=7 ,&?&L_/VVAU28--T MVD*;UE@H4)8=!!5?"XP(W# [<3Y#9NO)9+-7)7&@-N>H,;JJZ&:GM M.7=69JV26.NU[5 )P_6P(S#"VM)^CT;< M 5>ZYK>:9_0R11WOUGLGRF^45_JZ7]'QMX*"&$ZCY!2AQSK)U,<80=#W,KN? M:F#AZ>F;]FO4E(@ "6B@3J.=8#K8W2U84R]02*C/0AJ9MHOFH6G&C*(%VP%G M2%E,MV%KO49K?[N\A:Q'[QQY:/(SD[ M=[IJ!J&?2_1]--3R9UK;][F.&Z&-)_7)3:BUGCAWTW*EPNXD, @? <[R2*[V M$-K[A%8#'0W9;V$:'X-$&[.I#PR,MA@@65P/XB:T$0=IW3.TTS'*:L,I#P8+F<+9%\_NPE\;O+_ ML/>6074%[9KH)@2'$-PEP5V"NP0+[K*1$%PV+AL)EN . 8*[LW'7X!;<-^[N MMO'+]^/>J?.=>^N>4S-5\YV9^?'\6+6JW[6ZUVM/]]N]\C6G79D4:;OD1R3, M@I#[=%/O,-6/%54+R4"WR5HC')P_E+RKCB!X,!V7R=?^8C!#R.K*T.+ FN*& M'E0'HCAU5+B(\FP8BX.7HM*-QD_?F]\5IJD26QOAN'Y@W@!28/QY 3"ZV 2( M)C\AV3D;+"[MBY!/;899';L\Z"19,\/J9%6S8&:8W(I++)E9?16IQ,$^1 M:,/[C"-*>K@$=N[*- EL5O965E9-S[V;\W;0A'BP:NX6[KA^=\;$='IWLX_G M.W!5DEUDDZ+U"V6ZC@FH[Y9BIGZ'D[(NNHYRWMXT%O*H!\JUJ]0)@",/)I&Y M++WW[7P!H"W$S#DN'6!;T)334N) M\/Z.$3_J3!E/K*QVS?5YW;J^T8P(C!0?Y#?^,45J 7'/()O-/L<,/KJ6M\/? M8-=UOB5T&(:]E_+P#?5Y?P M:.&ZE[D1C@SI$G]34XPJ6(^3**Q,-U7G:H3Q M2%<.DT!K$=;:&/7B_RW_/D"&.7K\3,5!6O#FMCQ-2HAN)JDZJ;7NN;M4^%/?!2P1I*PR38?V$2KEP7IN M34W9B!'YEP^ 2&>YIFTL!7 :!V.O]"L %>GT9KEV@'>G/3=3,HVM97_WA@9, M7(;3$-4CX-,N=<^\:DJ$"P=6: =.0D01F62?@-E/: MVI:CP:Y@,R0IT M_T2Q??*]U&_RR*[]XZ&D[JR)9:V\^K4A3&COO.3\N(Y$(HW]O[+O,L<77E M^Q/!AA"@!$\,@ X05)N0LO;L_'\6H? PEI?;(DN75A1B)'XO4Z4A#/[9/;#* M6ZS&L6*JMJ8ON?4,S,@D?WAH9(E_F/KRWL=T/-YN@$3.()&^7%X%EKW.(DIY M4.JP"0/%YHUM(*[.5F'V-G$C,JUGHAWHA8["G_%C8Q-#S2]FVI/-7@F6>K<$\711TN8=*E]8 EG19+RO^V[%FJ?4$';](]H+H)=-2"_SSKOBU'+[*ON?S^7INQ^%BUA2U2' M^5Y)H,RL4GG:%NF2VZ>[QW-F!*2E=@GE#04-U' MSS=YKYMII(352H)K:X0NUAWLX)7]T9S+].@?KC 'R_@W=W\5,2//9%U] M0IX9$5TS"MI(/2:>&7FNXN=W:_Q=TO!T>>F[V9@:J'0 :B_S=UKY S*Z*A7H%-F.I.N MI EE[(YD+@EO$Q(5/.5972N+#G/]+G K-\M:YBJK0. PH*5!E7USTZ+G7;04WW2ZR1?@>C:1^T4HNE3YS%#*!H.S M_TL#_KU9>EL:U;-NYWNIQT#=G+#C^;M@.CHW7%6I-ZCT.7[_#F$[LVB+5BPG M&W+9,<:;CC%=^3G^7"DU0A>779[]/^U6UVSS\RD-O>&/?S^RD=1*S7;.H1MUFQ"_N-& M]V>?ZTRFJ*J':([UDO5,'@*[*B_O3.6!O:U(VLC,/_^/N)44>$!1+1M=J;@O"]2AVZGUW8;A7>M./6-(MV:4/KYZ M?GCE\]O .G:1$0BT6+1;T$-F/[C7[GO]XE&%$RN5)99\;=A:$< T+6RW#C.8 M'&?Z=RV4"ZOIFR,D^%N4Q0,TV$,KVI3O_;IZ4+ M,.D--X14A *+&]7)JGU?='JHG@HGN&!7C2#+YS9G?&AYEPDG#R_,([* MS91^U0.9K_,)/$PPV)]9/*ZXTSIU$ZDX.T,U7AA:WT=45-C M&-8+0)&4[;(L?(P$;/X'Q[E<)T"@S!D%T3\#-B-13K"FNW@=1=//_9T MD5/E"A+M%* 9GVH5S)8I.SAQ*^&*YOSP K!)PSD2Q6:*DT="\)#K^)QT8."M MZ]W $;7O=2Z1I?7N4]NU,Y?OMDA'153OM\VV0?AP MG,%+7[@VWU?[GHE0!B.TKPN6-$P^?+UZ,GU)W\IVCJ,9^*%C#E(+E%(I10A; MR[HB$7L--R7'T9W'J/S>3]]V;C73+OJLOI3ZZ#_7[>%J"H%L],@/+K1> 'N M,O R'JSVVKXP1+OD]6,*:16N-A[H=/1F%"7AJU> ,-*7ZWY1C6SO/_0$M _H^P4TW>@)O\%,)=F= ^ $(^>W?4'<;6^9KS_N,["0#3[S'R$ MIV$:YP"HX)VN8'VF.I21FR3+'H?HDY1FB^ ='00)Q=3(*$/U4D6E1E[@Y/M>BS8DKD2>$&Z>JL/8OI M2UD"PGJFA2S6V]@^WNK52).IFKWK?G[3Q/UW^='T[%YNVRKQ%AI1>!*2#<5\ MNG*^U_[,7G?@S6$AK*")ZHL[L<>EG2*W&4UJ+0N4.0NI#G_V7&T"8.K7=SX> M$M^JG=/T^38\?]AK%B"OA"Y]B/5%>$W*^DME K>>F3;("-94JHCCZ)Z]95U>*W>?[F9K*9Q(G,U'E>.ZM)&QO MOB!E7OWSH.+R)3957.4?L$K1>SQEDTT*A)Y%;X:SFP?M6&5$\.UK0KZEO*TK M\!O97G5XPM0\6CE#$O]'SH%>6FZ6!A1SN_$Y MX<_C9UAPV8';ILS,U=7DQZ7JVK=5"1W-),(MF_!5Y>44>-Y*'1%263#B.?G@ M!FC4 MY(SM\@M@C>RW(3$DHJ1HHPJ%KCD\\DG@E3IARIZY^%">/X=37\!6@/(V/.\' M2;WY5!#1OE:\=:?>12P;6S\-$F .4GX/SCIX)17$3Z4>+X!V$X0.O741G$?A M\+[[P$WK@@,6S@5$/42T=C6P?HQSWX;C\13W,=2BRPC!"LRQ%ZO/=S"G,+E[ M9A(]F6\.;JYJX\IIK7U,> %@;3@)%<+K3E;P:]A,G8,63V0P*7I$@P4TNBC0 M87J@+YLP(A8XNN>W6QW[>I)]OCC<,VCKJPC]^5U@;*,XU&C5QL(+[@-\-WQ/ M;T/-P#S\JA> $V$7YH!FV&X<1'4E;_&YW22*"D%<+XC,=W&DHU.77/4%@$S1 M _+-Q :O'JDVZ+A<4T5+-GQ]=G57@A&L ZV$CE5/ZW1#AU-#;P)\PG_^B"86*,6O*R))]M](1UM8=S_KR2"OO@"^NXJF MVZA*6*B[?!>*J*OC])^P7+EX2KX<%]SROJK&;JNA#<"-WC[7H M.Y\1%VCPC].MR?+[.V!H9%N;V,V6E[:KE$).?M.($8;\^PYP_<*U8<3EUOEH MT_J.CK=%KMSV+@6H'E#\ EA0WA%)F-KW81NO\T.(RD=Q?@$PYPE27-CBP+2& MD/@D\*0M+.S])#P_=%Q\SF=P)AVS+=@N$B7$:XUCQR M"T[*SP'#CZ5)YX4_A>21YG\V)#7#1,PG8P1_^YP:-HX]#ZLSC##-[_::5+E8 M-C$*5'#-/BM^FKRJ(-P36/X;8Y6TH4L5,;36L_Q=A8B\N3\[&A\]KJ&WUKZ'0,.*!?M;I.!RV8@["!W0S.:7A/KM^0 M:>8J&F4OA7RJPW2#&/,F(V(;?OZI[5#3$-8/BK#QIO?1[B@M%FW$H77R2;_&1V96+T-B,C^0HYL.,5,-#QS9FUZ>3-(' D M$D*?0\F#\1J>71>$>H%R/$9R#Z$)XU.0G4"BXUW=.,Z?E>)^!VYQR$0G'+IZ MOMULV/MZC'N^)L"?TQ N\&YKE"G6 G=^9Z+*T%^BZG>X1?S"CK-^PKQ]Y/R3 MK3@8M^3;2\?OB71 M%/O@H"1#H9YF I%[D(IENT%7K=__B-/2)Q (\J-X='F6;JWY Z4FISRO3RHT M @'ERG$5V\*"5 <5HL1M080G-E&UI25AJ +"K6/N:+^^.C:Y?JD[Y"ZOMW): M+!R;L3?U0$$/[^;3.R7:\JXM6<]$W.FN9R)0?H M!Q$E-*:YL(X9MC^7F\HL^7B$#+7-AAQ&\;ZA:\[>"K#("L?\_=NP2&A?3^8< MNJ]>+EV0#RTX.+6-234M/O/J,#W+YUU7>V).G>8YFM7B!,V]?M 9&?MK% Y3 M3UIWZ8#?7:3XV<[O1"B>,T^^XW;9(4&J+6=UEMJ[(\JZVX]A3/0PL5])./U@ M_ 5SLLTS;,C:53247WZFQM(DG6)-[:?P!XJ93\-4,(P\I0U%&X.9:R2ROR59 MS\;1AT!\(T1O3(L E\0FXT?U)=G5+$J?A.4)W1+(U: MX56X8.WV+)UKA;#$/Y8D)/]Q=^[MMS)5A5]0]\\\]8FS/(?V9O9XK4RW)H%O MZ._A>A6E<.%!+96O7O']_XR2Q/_QY8K_HE#M%-)F+YN=S)O@70;/-)+ESI"*Y-%Y@S]*!M:XT"1G(^SACVM.A#(/B!4&I M@V@>BHD#5:_>Y&4AE^NM&X_DJ!]IO_Z=*FOX+H*;U?Z'^7)Y& M>$:'UG:@ I=AQN6Y 8(QKD2VFL3;'SL7MTO/?+YG^8\*U^AO>DO,TOD>L_ : M (?QI) %MO6VW$;;?0%L_$-E1I^7:E_CK/;K7;;,%T!( M[H/3U+.'T2NC:?=]_NC'9?DO(B*Y;F]6YRU/PVCD!^RJRC1;@S+G6_Z[@.B^ M_']J^H_SO 7_3?/H?_MTP$1.3<>_?8-_"1&,-'.YO'%4>JO(;RW5E"N5$[\! M'?I&_[#MBA%/_U?6S_\W(8KU;20]BB.0*_L=/E1F.GZ5'H:']#FD\V+?_[(* M6IKNR56;#&&Q-TNC(LRU09D6-/&34^+TFH7\IV*J,:RP\UXF@CFK8?;;KU0/ MH7FZAN2<1-J^=W-JR&^QD?=DQK\ES/WP)LO_'J_17--0&2P?A1X7A[N6"!!<(27AD[G+5D8M2N MZ6["#T^]F0T@^P6]B;4OZ\[3MZY7M58OAY5EK.-;$61HHBS)#'F^ZY_,B]>< MV@ ,^UK[ER,4L7!&_%5Z^]WG3K1[MG6Q-TZ^Q%MCJK9VHH*9JX6I%"3QH/E# M)L-\VHYJA_!G;)_&1U,[-[MM<.>(HG;G'*^ ?0!W$W,="K=X.7!%?_'QJ#[ M:L4C.<8!F16W:N\]G/\T_-3ZW)57I+G!1PR]/@,EO&66./WL%(Y^&K@E)*JB M$R:)5B^)25?Z=C;J:LL&RZI#XH@38NCGNH8@63_YWSM[%_(708I_$8'(OT>\ M,/[=T(IS'T/:1MK:>O]R*+O\K?Q\@6 5HM9#+U2%BL)WA%)2G_%APOZD@L76 MU0LM-1Q;:DEE*;>MZ6T *7Q"YUOGJ*#&4VRP6>HF[X]6<7M[#X=AEFGW3V8K M3#K/0^O2(@>()G--5!D!322F'>>(=>4&DMD' J2*YO?D\07]N&SW8R0_%*$ 6:2:_F*=$6>\5M[Z"V4N"LLPF@1Y.7RQ2\#HE^U?=J1. MPM8L=/J3KH<6C>/7@L)?WGZ/9DGO4BB91[)BE$5Z2^HUE[X,^TCOPV*M+F51 M+&]6##,\6-E9)ZPGRH]@YJCQ#I& KP/O9ZHKPY0+K">LH1GYWJQ2N?NS^*HD M$):K.[)UF5%C-Y,$;15]LKPM-C0Q\LQ_WM&E23WC C-MCK)YL%P9_2 \5#N$ MCI46<_+IHF)H*8-/),&N-9$,41055KB!<91!,[[1CU[2W1C$=>XX^6YW: MG[B.Z"WM?^K&-6/I45W\.!1F*BJ %9'(T4"'6.5RJ*BN:;QA \%1F8*R !7- MQ]88E-HD&)O&[D:)KM 4 3X>/EORH*^>1\>8WN8AH7A3;P#?4.'N75 M_[1V4Y)2D$X.R5_2468^EW((XO7R4+##O>Y^)U,@!=!J.N?Y8580*7T)G((< M*13 N;(LV6#%8*/:TY'X:Q$>=EX5VW,O4RG5/TAGE^CJ=6Y[K-C>(H=O;[$^ MQDXD*&QK$KT M9BH!<)>()YSO4F7H@H28N$_2UY^CD:J:N1LC1()P&Q]0V.T]Y?>J>?J;Z M,9SH0&GD+$PU QOY[R)HU]-ET-'M!,HFG(HD)HZN0-OU4"& 0$J+(97CFIL] M/.S+CNBQ@;I:]=S7QE37M)N#:)K59*$."S,U7%._7FF"#$Z;Q:)_5V[/U-+B MA<9O5U'^L;X^4'Z8:Q2+2G4Z40CNQ#J_KR,7:LT#_3X+,4$XGD>$0N5_Z=(B M94O1L4S5.740MO*^ %#8NH6UW@9='&RL(*6LS,[\OIL,%!27VCY3$KL&W)1[ M]:[XY&\8\JVOPY_ M@2S5=%V;P 34B)*E=\DQGA:O_FMF6[!Z5*/Q :-X^3Z2G@#?C&U4$8%'U8.$ MQ[ICVIW'WA_UFFPL;>>;Z&U MR_\]0Q_J&\=.8L>@&1\6'3V97*-]8IY(]J:HO;W+H!D[* 6SX! 5M*3(07<> M6XQ, . Y\L^K_>*.7C96U%C+^MWP2X/;8M6RN$,P.NL?TVLX_O/$&:VW?2N$ M-A4A*QASQY!3NX*&::'B+TE@B/&%&4U]%(XS+D*T00D]?$W=G$OXL=JF8O6, M;3G;L4?&+,E/#^-="D[XA*VHG-R&UU%P+Y(TMH+L3ZWH?Z8+6F%JA,I1,34* M%/$S:L?($.ZTIF]/U_GB';J[Z>$]AS1_KUO)S(;21@J@)9<3>0\/4F.%="6B M=KJ;KO_>+&X3;H#ZT.OLG8$]+Q7':XFPUVG#97^E&QX.<%!>!GA8AP1;61AG M("EIP+\JG_V7V9_],M-'UW#P=\XDP)])P_8G]9,.WR,-*X3.J(&/H))5*RC> M3FK^2*%>7X=]E8T6]?' MDGVS]ZVQ>\3""3,A:-6ZIG"A_?R(4J<9TZG5'!!=U>A/BO=,SS*Z4AX4$=RK M9)UYGZ%U99X*M [X7@PW+3RS=W*Z*'V+X!(.Y'%IZB.11+OCD_' M%3-X,]V=\/'L!!*O)6P0/SP)5IJ[FLZJ#J,-5"0*_V7X$N#/%.< C%)]I^AY<"GS1MLA'.P[HUIHXL/-0EB5TL/*H#H$=_D7Y?"I67YX0;N1,>\MMVH0\:HI$EC-DC/7(Y>M8G+)T43\8'@;N*2L=:>S MIH)4,V'(+D)Y;1;6\[RN_\>9$ORIA*R^/\9_>3?SP5WI*$=9*TG M$BKP%HMD_5$977'H+M-'.DF4@8, D=W"*' '1$^MLV@A+GKMO]$DN>!"5<-!,TU2U:) M#OO0_#\9@FX)93NQ<8I=]'^BMTWC+5DU6'GK%3WI@NHB?=5AVAX;B+'EKB1[ MY14N\]X)Y/JF5?41"!2\0^\OX^2=4P#'>Q4\,-](19Z-^P#.6ZX'UK7]0 M3M< F>26[A?:*3.R<]>Y&/F<%'@[,\1;E3;Y;/=8A+DI2AG7SFOP><2:QWS1 M,^]KKY^["=$87>.=307,<:-_SN5ML,XTZ(3[U/6Y M[T055-/,:43<95TEQO%8!806?[_*7Q$*'\;ED?$[U6?F-BTHY123FZ9<:XG\ MR&F5EX&%;NA>52#*B518V]D?<1=71 [UDBK<;(7H20-LI1B=I!'A1AT5)UJ= M-RE@DMYRH")K:0H&&"Z-T>L0+U6#F\:'"3E'9#]"^1<6[.6\G?\YIZI M\^NKW,66!]%W:!!S,EG]%;2EA7F:)19<^F%D#]3%84). DX$+3/50'CJ]4>9 MZ8HZ+Z)K# .6R?O-/\:[^-5E5?B\9Z:Y#(P:UX1T%>IB%/*J^DD]PV,8^\_H M<9=]^)&^)F_/6]T8=9[*'7S=R?^(Q;.,S@Z=Q_%5<-:-LZTUG!D&;P+YI +_ M"K0=[L>MK]6#4K/#D2+ZHAYDSA[G'YH Y-=2WMWK#VU*+P!QD(WZ)>TY1L)8 M\/H4JSE1NG&L^K:$!Q/M/J^O+TO:G&9>[6:_%G&6^%.#XZ:!1-_.5U'/FW"T M#5IA!>MP$@"84(OT4HQ\_[\5[NT2C]:=?\.PNV AZ"96[,N(9Z]/E O:C19E MX$_VH)K74/(N-2G$#';=FHS3.IE\')/):27H-V2 5=ED(DQG LZ MQM(%E1X;VRQN:#W/>885&%=L MS[Z@%4/=UE" _'QDHL0;M8DO@)\6F_ K!XE:>L<95<7+/.D;9)R;O._YM=BL M!(J?UJ3$WL1(;%)E$("'DPW[$PQ_9(MH4S\1VYP)#X7==:^?-)%'G@MT:\Y^ M;0P3Q4,QDF9'7I'_U=@X^*"?3!+AI>$_"O_5-$+S2;!;6X1R6N@+E_([$^WH MOAHYBI!!?Y%!XB\1PRV^:3XJW99JA;Z&==)(X[C::=XJ$]2SU]^Q$B^[G[62 M,;8/]^__BEH2*'Q$S9-L:5BF^7<*[-HA [Q=%]3RJ5\E4.;_&% MV5U3OWBGT TE>8,4N"/$E20:"7RI,\W5)C ZNZMXABV'E]ZX_):U@9.4]'WZ]"B7.']LGOP$+Y&(+$8&!3S-'^)ANY_V M*?JWGQA2_82A5.EPT?#F:Z0[QR04*2IFS=T9,8\I5^U# !&Y> #WJ)&-XUEB+RIX@R(QM_&TP%ELBXNU\:=(*IQ+@ M-7A53Q@R8$8\:A:#HQ7'<^?R&D+M75/Y79%9OK*!ZZMZ)N0NJ2@_I"?4^[TC M\>]CM,I\SYVDZRUQKK>TVGOVY(K=-\D^QCE&29,&>! QZ(5'.!![.X[4HJI? M\<.L=7'[0(0EVC#1AH_U,QLZ Q?)7.+3[+B)R:U3$Z'H)[V$V-(JQT'!"_V8!9! MK:.+3N4K\-I_WE/$D\\;HZO[''ED?$7;P0;:D9SX_]!M=@\3,BBV(=8 ;7B% M?)M^E"RR I&ZN1 XUVJOB9MUK MHNCCR!:]8RB.,1F/AH/>&L_[ 1#_(?3NIKNOG;7CS""P]S7HV6486'0+I&_6 M:IU]_IJR%!E)POB&LPF)^IK&+>V;330N++=KA?BLLV:F\+F[YNPI?>1H=@*J MKPSG1O@)&%,^?MR%*/$3H%.#-8#4KJHH@RU=GE8*D);F*_Q/'!R4>1:Q)[J8 MN6@TG^)^4^[\JFS5,KN[=JO7OY=OP8=385,Y?O0\/W);(T[S=6KJAE8^D9A2 MCW:XJ?>O$A+:Y9)9&B#)R%(&==X=V MFQM8ZDG=%-L7&^YK:1/G-JG+\ Y"Z31B8F<9%$-]W*6?,ND1U%(BJ]4D'D M6L$\&^F#/!4[KB_3&LC\U?69O^&H7>QC7QS:I8)'$BX9V?'/M4;<6]WGX94^ MQQ;,%%B@&-/@U_2._@T_@)1OJ2I&.II_=MN=DKHWS)J)KN4I.'1F==9)O"B: M$JAK*-Q(M4,'3WHY8M.=M8_?AV.?K],#6N,9/ZJ7NM@0-M%_A[OFG1O%^(0+ M-W1@]$Z(WR/'P"K%]2\M/,?&3^UY4$@C/0\ MGOJJ,A6Q<%++-CRQ/_!["/)2 ',]F(U$U\EPU>9IJHG:J[;6R)RF)J &ME)D1&D]YY\U4PIQ/0T5)/XR M,*;X[,Z$SX(%Q8*+.MW"D1K]\^C0^>\A+C-91MPS1":MQ<^397D-<6,*-0U> M.HIM+5)V)<8A,5\8X+?U_?]LAK7]^^E@3IW<#((@\*QLGEIY5),64@"RL)3& M<_>D@AM'.NNP>9IXM5%- 8LL(;E._^ KCRB=5D'4[ A\%+4JJL^VRK:J-*QI M2?U=MJF+)KH*^F/!LG1[*I44Z"U996NRT();AZV,_0"0) MD.$NE0*8\/YH9;__8J6\/D)3NY4T"OQD@A5HVDG2!?ICB_TIXE*+34@XYP A M\CG:V$5O]6AD5R]WAZRSM5UF:0EN<8J2>.)5/0^:61,J]"#E306Z!UI[&U)A M%\OF4E^1T>'?? J0_CZB:8\,MKIRF33JAJI;%=.EU)L/?4+M$&57;!'?NHRX M!.*J(*"XL'S\KK:JGOJE.NYYA@>XW-9,9&SHH^EM)D/GYY6B,<%5=%W,'7(U MS#6]K[AC#2P^.+(L*^,QN,M5 M36^&-D@G)0ZR2TY1LO-Q-33CQQ8;Z!E8"Q@D+/>&V]KFX-]C^^$5MIJ1! M&N%"GN 3!LA]%YRW>(AC?7-OD*:7T&6;K"" M>W;2YI1$O/.CP%H]QU;.GGDS.<%):5P'&U&.[Q9B3?\FL.!'[KR <%2"B>V@ M'8MF=OUG)F2:UBK_+M/XA@*YD@FP9+?#/HZ5"LSK2[12>D_<0OZO;T2$)NB# M#5:B]%M1W9/U]%GH_6>S@320A-H4UK2;&W3R4=I:B<2_ H1][#\](]17N^^Y M4@@G3"=MC;X Z*ML3-F_\JP)M8+6_#Q==VKILU"Q+ 6$WOR5S-?I8U;=K$6Q M_7&TMXE>W#^$#'C/D:9JD6U%[!U*$Y1@9GV^&*YA"9I [4(Q)J1T2*8^WH_7 MWLM"?Z(3F[A"-@V7F+1U&=@&3=*D5TN07@VB(BIR'G;KX=U4X)=ZY>S/$4?0 M*&C'0:E&B-03H%MVA$(1Y$Q*88 Q17B9:.!WQ:#UG^UHQ3J!]"=VMT'6AU&XN/X^?E?O1H2[2IZ*QUM MJRM_K9=<_-&P72*V7L]L%2AVZQ)?.(W?BH(E8W=Z=B<_R_+^[^SD(;%BY&-B MF=[R"21.'86/.ONK6^8OERORA&PI@$JJ^,2):9-7)&.?=C-XJ]&*)39BC%RH M_IO,7VWXMU=_>M_O"4BUU_!4V.?K2A4KM="TR9OJYAGR6< [4M ?>&%^Z7CU M3=WKR]A009>&B2M8')0N""%J!E>*Y.E*'S,!V$A*?FWT_'X,[X$=*3G>6RR _<+S<[\"Y3!_!_\+P%MJHT6#.\#'&LM5 _/:?.7P@J/FB_WM%8HINM2HZL@TSG3 MBV]UEI,!(B[%<5]X <2 C5K^:YW6#QL0;FYAI7ZM2CFZ1-V*J*RBU%W-"YJD MW;=W-$K7A(N-;".-%,'#?47^\WODMPMJO=G[.A2W.2$>I&P3Z"A M04@D@X3,&&X"4G,!K:*%<@6]B+'K,#;6[9\+\MRUWW;4(P_K](-$.\VSZSA59W.]V3I@3]0$DVB>DRF\J%D_,F_Z8/VO6/\%)!HED?4;I7)H$J MBN2Z3!T01T% SF8TW4)R>*VIWYB(!$V@;WTY_5O^#HY*\>SVWC_ZT,VXM.'. M2PP7&52D>L8O 2H7%K\ C+A @[%!!-91C:/'R]Q!->M$WC(@UZR"= \O"-%' MD+(2EMP.H0J'+HUZO'\#?,8RTV>Z(.C94&D^27(Y34@CUFF_VTN/K^MM[HBQA1LJDM4#PSO,N.+9G3OT['O>OPMW%;0L#9PU0F9 M/_!$U5F@K"(X6Y+XV&#T*\3[CT/NB7!THAD6=5=^KR.$[4KDDKPQCG'$\V9%GD['NZ=&GSTB>^LS'U_? MQ&QQBS=WV[@H> 6O<9(KD>.Q;P%R-)R&]WQD%MK'-P*0A]BDY&>?G:3F#5M@ MK$!:25I@4)UQ&928R+ ]W2C15G9XP;>9V6G# $\LU_T#PE5^M3(EDF"K"PNHJ M"[5=)$FM_KDKHU\];G+UP7R483W082HX'7'6IX4CK0B>GXAO@!^:_#QRK@#M M#2HN&49,O@EO,Y<[)8,(53#4 ZF-#KI_5%6')V@(SB>1-#PJENONG^8#Y7/U M;9R-EEX V9VVE578TD$J=PD3TF^PWSG'<.C$B'8'1VT:SM2"T*1:@ LL=MLS M(%!6,JLL\\ D:9"YUG+,7R(@/^4XHL9@D64-S%ZU9=:>M3SN9G9.4VIZR^1M M//T;+)M;TD_RC37I>XU,,;AH!,2)-<;.FS96KE9V%810H-6N74]#XOH7VAXD M/Z+I##E!.;JILG1O.MX(4.3 1&9/^+M#$\J0%>3*I0*?[XTL4U'*;=+-JS_L M/C;.J*N/YT?Q)QT3!&S@HS R,#5==C-N1:3YIP"VK]MD5,YNVC:T6N;L%?,K M@H@/X$C%1ZJT7-\5*9]2WXG3I,8_3?QI6$LN/U+O(08=S_RM6>A'WR"J,&W1 M^='CH.4.VG7KZ@4C*Q%0!@D2&#*?Q;'TY2(\IQ8I)9Z'*N9-R//&G+R)_Y') MQI8!W@G'4/_3C!F4N"O?_JHRV4L**O+V7.\7Y1E((XI1@:C@P\";K'=LW2NB MY^@WGI_SN4Z/7@"P7T!%G+Q)I9T3PD%CIB'EH;',WQS&T[OQX^":WOO9X(UA MH(UE69+L"T :&![ZS2I,:+(:\ P\_?F^@^EW.E'4Y.!L R3G+&M:M.IH2IH@ M)B3_ 5>"C9,#N^+7(A+55XYCOCMQ?9.PH53=LY7L#5>05_<+P+QIZGBWM6:& M6U#'+<38%5N>))&-.&#(J9,3F8HJ!;!YE4D"SAGN5JCX7K"D#X5:>Y;=$HP/ M/L#66TS?%Y[Z*+T 1'0H.8 MCHKWP7KE73?/>(GFE_3^M!MBC(:?KR&U77Q>631K M'Y$6<_(@7+,I_)_9U&YBC)'KY>.^T$)Y=R^"6%=!J/2D,CE@_DA:UZ&$';SF MJ8+(3,[68@0X%*%MJ8_]D0+.;4_OI3I0QR9!7J$*29@=R?=C-%$4 \N;2T*N4=J?'' M^VFF[-,GV=%':EEUHEO=_#B] (SIT4%7PIPK]%S+!,HU040C/:J+T#P;TOPO MR;AP?HMR!MUII*]>?M,>[\ 3,PP;@X'E;S50+X]2]MM#].SI$K ML(U*;E\R<,:ES)Q+XPG7L. (K_+T5F.;[%;TZ'O1Q""L'7/:[CDM?LL7B=#1_@QP.!\E^(Y+_A)\M-00;B4V;H!19>H(F4?2^ MUD"EUV17/>XHP+?"B@"'%/NH5GFO=8X.JM\FHCTWHTBB.JB* :L0T%[Q@F8;X*<3?08]OU M,"\W:5VJ4,W?'YMSXB..C3@JX0@'CV0I2=TZ-M*_=??/"6A%WWR.[E5V$$H$ML7(T]Y-!EBIML/&-O*_(LWQO+%4CA6WB M4DBJ[TFC?RHS]X4%]\=66ROP*Z6Y@^L M:]N)QLWC)N5J%05DJF(+:BUJ(U+=S5=TWXEHL5QBLSN/Z0$N%3$W\"$FZZGY MR6M-7H+R_+DI1RVMD<)7XY4F+3%X!/8=%6^*P?%]T,?ZLX-C9QNRM,3[AEAC M>^;QYKMW5='<<6(&C:/:YEV.H\Z&$+9 (6&N^@O%K/TX.>M\T/+1)NU[.6J& M_B$4ZO,#R_BN#++$BYT3 R0%K]1*J9X1"R(/?\(/BT1VPI;P_M,^-(?W8M-L M)Z#:AU1D\YFO 5!"4SG_6FTS\YBFM^P*[W%-RKVTM=<-;+3;YKA!;,#&*=:, M+B8K_.\"=)' $>UOJ#7M[(!^H2BO-5M]2SWOV0MJGDK@EQ4;FAZM\Z0P.7', MCR=J+5%*+O(D:>$B#"@^X%;7OU:B=)AA$&XQAK4]"%9IAD$U%74 M*8 U8UCJ)A$7"^L!$P;/SL:A[/-"JJD\.@,!_# ;]Z1MYZ"5]%/VW!;?L*+C MYAB6C$>Q>"YK.DH@MWP?;RGWJ%1#;!TB+9SS3HQ;>FX DLG>)Q(7"?L3D;M1?Z4B# MH"UM;A%76>]0;S?,"RW(H.DB*_*E@AYU,OZ29#=HMM792$(=E3W;0?A'W4Z$,])1QJF 7]A;I2 MCKN]%G;Q'A]7_^K\XOV%\N%3=#.*D,M.35)G!H$BPU7MV4I,LW=<:,:X3L]' M*X[(;9ZU>L1/$>-(Z?/@Q9XDO;\-;KSW9G\%DB>S&R311Q Z,DD#\U1T=9N( M.C68 4AVG^1X>T5QK.[!3:VU4W:1/016;X 2>VJ6;+FU*XO;G1*FJPU,?HUL MCY)3_<%7QJYDXY.V/A/$.7FKYHH'."< QQ@".O+DC1]9EL=8D;6I."0R7%(8 MU5_S1IHU^P0$G;IAT71<<+O!_3X<;E%_%O=Y]'[:>$^U]4BH?,;J_O@#EY=M MF^,RA'&2XP_&^#$D&NXPI;P.8C/7'-C55BIIQMV69[G:>,F2*)&52/ET*AX_ M5GD \N;/T5GL14B,+ER41!V(E<$H^=A7;0)60038HOO/D4[?I"BE&CM'-P#6_IB\UQ# M-3E(3I<@EW:<'$Y\U*0[S7O>W-G IYJ!"9>]]F7*Q%.S',Q:/E!G)OS.A]!7 M2KV3/\,E3 >43=*;/*K#"[SM83V>5"7Q+%]S^-X+\(A*/X?7F.0Z+#[Y$+6# MF B418_[5?]]%4.PB?BT"FMVCM7<%UI>@+(5B3_#(1W5*:GKH1BY;YZWQ#EZ\T^5 M\DRT_<2+?F/J6^S/Y1=/R6:K;>7P-=C.VR%R3 -V74R8(<_T*62,:-FYX1"G M,<7FNG10O@Y$9'H241=W2.$W\IOU>.8_7G.YT>_V?J@K?K:\![='L=&PM@]E M6/='V&)&!/83CG)\SB"=H*WEJ;&\]T[<66918+$.1*=WBCWNXV'88A.'^@G5 MC_6+T$TO25#?7!JMUV#PT:9Z\E64SP!+3%1K(@2)KH] ;P@'>V"PP4<)D MNFT30U8H)L,69">A/\S(699_?^+T[F"@?B/;20VOYP#LM"VK'^]';:F-H%)I M28[2C1*,I3UU"';6/@-WS!XV2,11:R6@6.!7D)3D$%V^X M-0/YKN;0QNG"VM\8W+8)V>YN-';E9H.LGP)JZ-24Q+?6.$XMLS _9:ZWY].% MLIW Q5!PMN]1[PX!]I>N5;&EEUH7S]3!AP)C?T^VK13LLH\@URGRC^QJ51] MYY&K+17FY(.8)FQ&>; DKI-^>BNH;;N>$%"U](/2M4+Y]453AM?MZMY7/WQ. MT4,N_Y8BF^-.C^M:-MH&*@?FM M;@VJ1M.N":7>W-_SY4T$;H7*K_H M]' Y8PKRSUF?Y=W"'U.:^7O@^XZ[=+%W=EAOL$39U9E[YI<>9"8-SBR,?ISY MK,B-OOX\ -5O6/PVQ;MA8G^?)KWWQR>R+R?G^?).QS'F&QQ-%U4E MZTJG:;O1ZJ]]3E6!J98:6*%9H4/U.N*+^Y[-;Z1Y><^79&(;=N#>!Y$Z^W'R M%W.S!9-33G,G>XM35@$/PY,S%#E7M9OK_%77PBA7+4/QEFO>Q*$")&,?*3,U M<_SXE1' 7^S1%(L]"J;[G>I#D1O8+LIX)GID1N7AFD@ -:18\6E3+$+"97*; M\]52VF;91?1:COX1_5G,!03DP#*8#S"MY$'2:FE?FH M,8@WO=A0?V"?"2-VF*NZ '$UN=WLK0,2-8X?IN2_P/3._PTMI8J-[VR?FX-F M;^1#60ND8UG*CG::?V51$C!@UR"\]6^,,/5/2YDM5U;YH3'1ZNQXH>5\F7,/&%_?U W7!EN)2 M(#*0':",RBFL8)@5HME@4=8 EAZ_F_7:/X8@)"R7#<1:QN4=720L==ZI97)9 MR__J1.70/TE?W^H8WY[1ZV/!ALZX\K3,GM!%FPV'0V;OX!IB26.#[KH"%P-' M-\7(#YG#T=F8@AC#='Y*_!6[@J?.-![ATI<&(0PN51U=BK@P_C$1*B9"FH^8 M^_5*[W%\R[\':[=/S%J57[4I'7QN7&A>.5E?!^,@P6*UO]JMZ PBX8U*?DM< M8:Z^51=9L3*R4M@F&4BM(E8@DF\1Z?V0-@2+^*^T#NV8/; MD,1WT=NW2E]_FF3W>'+G.80Y;J N?C9:I&Z\C M.?YX0/64S?VS?I@Z#'R!E,J)ARYRZ>>C'M@I&(]-AF18?^!,MDV=A4]Z4I+JB68WS#R7RNQ-',;*@^(UE$CU@C84SM?D(OOS/UOK$ MF4WIM\%,C,50,3Y;DQ]CB'GAO<1<*WC*V#0'+P#304 Z*Q&1^X?]0"HW90 K MIQP /66+0976WU1+\78.Q MG4IE8PL4H B^!E($S#;3UN5UEQA)6E8-%N:] "R6X"VL!XC\8MY)(@(J20M5 MX-HL-@U0'YSZW9G5('_=( @S>;.7S''H61P#)6OLHR0D2IA"I/;:OT;6([W4 MXF;*KR(E=N6K9B"LMD>NJ>$VJ8T *_0CFDL2)^/5 MC@S[=_TV-[!$P<8UGBHIIOPK;'L2X%^';]J@BQI^T".M&"7YNJ,C&:2L@0"C MFEZEI1ZERS_.0;BX7CO&&A__MMY^![C44]T#HW)B'^ 3BL+TO&!Z 01# ]MZ M_UJM)TR[F&6J #$X4;)#089F/[L=_'\S(C"P;^Y*W&GRUX\SXO/J^^[[^?] M)XN4],X6&SQV$RM1KE/=!9[4Z\\WGX#6=$H!@ ##!^Z].QI\;D&+= W5(EQ) M9P>&+/<^]G./RUBXT0$.%14CH*5H:)E#7%3>^]F"TU\ZTPV>$D_K&QO:FQM, M'7Q%LB'R)%V0(4D/+2,=@1N@B51GRPPN _ST4M^RZ4$GO6H]N;0M M68/0+F0X&=:7,B_5U(Z0.*1*9 ^G7&; ]!\ZIG[9M;T!,J+/_^Z.UB+,[$P2 MD,H&""J0J3YGN_PE*C+RH$S]S"S%ZI3++*7;HX.?+]WX8:ED7G%8N=@%!CQY M)>8IS,U38$V\3WV9AN=+,8+3O)Z-)]S-=6*L8E/A:36I\C5B#CDGK/J&M7W\$MZ-4&,3H VJZ)![%4F0R MHF) BM)UP'7$U->SG9K]*]W/ZB:>D:=V(2XQ?WD:.=6A"IDK2+#DLVBZY<1)_2L'X[CXF;!Q )G0"-GJ2 M1I?:G$!W:YD_Z<\W5+.ZL9T^:*A3+X!,V'T_5B.&F2C%CR0NW?YZG_Y# 4;Y M6!0^ !0$'*O!WK>^&8EW>K$P$&\')TKW&@YV AU]?*-NZ6A>2?SOV&3QT>*% M>3)=C9)GE\1.-5W T:J?:I70?;;C;U7U%6GCB[#65QL6(OKY"#%T ^/:PFNG M=-YYL)<(K_W]F]2 #=>'1$PB@K#6JN,XL2FP*WY=L)+%USD]*ZQW:$!P M>X$HH>/4GY&Y0/_RQ5R;?N'(\A?J?CBGJ[VBS,NAC._<0.&N:I,H!E"$)AU' MKLQ8O?=51-^6T=Z*VZ'^QPZL9YCWM;Y4X8^Z@O?G43> 'K6 XF>1O_T$A.B] M)DG*93]FWG3*P[.8&#_5M\;\UB!*\1GW^S6Q@IVLU?M84O@ 3;2TW#1^]X5/ MPU9RBC^W-,#5!=8&UGXU6Y'PST93P-X>&>G\P'D&%2:72( MQ3]0!S!-YWH9S]IKT$2;%1FMXUYZ1-R":NL!ZJ8)/9^]&XC?0K%OZ^B8F.H8 MP:OO.U57I(SWZ./PD :&RJ/[-XWAN^E;QGR8@N]/ZBJ^JEQ9.BC]!TB/#')@ M3(;3$LJ+&TM<@DNM+6 C'>1>C!>7JQ 3GK** K[)5;1^COS1;NEY=W-R[*L1 MX>=L2S+BJ+8QI3TAT:?#3Z+N0781O2JK5AU[:\9*^')2-/[4[WOAK-+O=&@< MQ-:5;J*CFR=?UUGL$+W1A/I0K=JG!]@^EO5_.BGGX7DL5!QEI>7K[5&L?PB6 M4/WA>ZPJ H$F; C"G6;9T7UH@X#SZ!@ [;W*RR".CN**)\ZG9##UJ18X%CB M^4VR*)>[F7?)@H7K'LR" 4)I;5!A/JB+M]0;'.RP,$T"\II2%%&!!!5+/'RO*&OL&^XIDK_J+9[O81H97^A]W2^Q<+1Z!D-IU M?[#L J!*04S8"Z^^=NX+WX-;29E"6RWP'227MI"*Z,98B%8#.J>A<457/ ME1F^_>62&_KV2;&3]^7H\ZR+WJ63PL&$<9B0@(,^T[H8KRX]?)43)FS@;\TW M7AEJ4UA$0(NK_;1M;LIB9/;TQ,-P7?<;D08)5DZC*%DM=3WUX]Y<4Y*%.!A$C5O%)#0' S MM\!OT]%X;EY.)_&OJMB4HII*M?"8OZ!8_=;:IHD=VZGS/RJ?([,&\%5I*K\3 M!Y0/(X;QX"PES'[,P-4']"T3UOJ?SF^&:=HWSBK-<\XK(:E4Q[8L1DI-YH[ MB@RE_*."#$LKGQL;QCQRQ,"]LT-BIOZ/,-1J2K*EN:6Y.>_YE(?EJ"FK@QYU M3BA_@KV,@Y[?25'>AOR-'O=?)R&6Q(:C1:/FSU!XAS&QR#_:FJ;/T+\75B4: MVTF8OGN,PK: 6Z)70Y)R?%H6L#5ZXS!M9GTP<[]#,VO2.OP_10S_-ZP>,QX;N/2KW.5)K]% N]N5= <= M6&HS&?@M@(".1O2**N]VE0[V$F'W[.\I, 5_KZ)ZA19?T1=4[Q81 M0EX&UF)?.@!2>\U2R=''[6W!P=;"C^KRJ)("O/\ _CR-[R'#6Y3SPJ$E\1\? MM@E!JX(_*7M2,9^R)D;3XR#D)'YR@EF29)(R25#=K:YL_@M"#"[]##[W3[LE3U)/[)UKO6--$]U[:_L78" MG5AG)-#<<&!'W=#\X,@.#6< )F6-=87(XO/LW&9V5>8"UJ<<,!3/$::WAS1= M@/2#Z=39>_*IYC?W.A8->6%NXIO\2ENN*8XU34F!K@)B!^];E:@":HA%<3,0 M3:O -_K;;#U5//>C _@)7^?<@HU^-MT,\-+DN[4P+!%:FLA1I[ "8.?5TF0N MR?FO,84M&GDN*5,S28=A.W#:^_VI;B?I[AJ)^!$GQ#?[J:.M5^;%[EN% M@Q6[IM=NM6W/-P37*=,/)7J213D,R7&Z)UG@X#/<&D8XFRCQT,NN$?%@A/&V5P0N\]79ME>$J6YTY@U1-]R:;Y M3/\'^I+5TRVC5WB42RR*$)IZ13)0YM-Z*75;0*7,P+O M'+.Q]Y>[?H)# BYT3=B)$M;RO@J[VH_@R=?M'XR:/KJ]NVMCV/X [ M634P7.4Y',1E37P(1 &'RR39;UC-@3T)2*I51^QR^_WN&J40!QND1WFD7(-0 M8IJV=>0C?-?=?P!6M9"KFLMHL=#;O!&R]\D65S\6B;CO<;RY.9*SP,YF"5BN M7P*2YMP$,0F[SV?KBGDMXN7E6S+W>[ES"@R >A3,KXO@2,E=-IHVE+[GU<@[C^;IR M?BV+.T8W"2D.*?UKSU43.URI@/N%E:)S7$L-5=UK)20&56-^BGO30HFGZ2*7Q[VB2;HQD3G3/LA.'SN)S M'28PRD]$XCH@= Y,&TOVCK<6^SMTB(/L*-T@-[9#:@D#M8$J[T^%K*JX'5=!OY%S8!* J1H@U(\>&F20#@5@RY%A'N+ZK3 MV18)^+Q2JS'/SD,4ATSI@J;,$F9K_#OT9MPO6B/>LQTT;Y[@$'L666WICE@2 M7,0\LT[PX(D3PT\F.4;ZI!+3O1,L/NTNKBK7E!'7ORO@"QSDU?ZMMPD0V%2S M+U\\5>P^0^<OL$<*:45RY)7I:Z-C@TZ/:9'!K1!Q52L+[Y2_B3"5;PHAR M,:+16KC]\Q2U;5K%G?M ?N#5-RIL5E^D$@.G"T5D\M39+F.+;K+MVP M0&7&+=@+9JQ"X?5&B%T7,P/!JGDWU]\T\!W+1M9V,K146V',.T]Z;68-YIHL M4@Z.3SO)56CN G$J7 &HMJN03?8L&78<#(QE-?IV#HVF'P^X@A((6K$7PF3Z M40E7F0,YZAS(5NC$AKWJ2V.E$MI%*V'T;(=,NMH5MJZ#,;S<$_<'Y0:E]=@T MXU]E[R\.X-5@&P]8&\%G\TLN0ET.!8H.'3!-&A<]NY"%.F7SPQ0_-U0X:Z@B M;][)H[IF@ %PZ,ZT',M7)?@SY5''0V[I.D!!!$WVNXQ5VKSPA%\V=EEG-]DD MYN==]S?-:H7.E8SJ#Q]U\0W]GF-@HDFC!SNRJX0(DZ:53?VM7GY.XI=P!?M/ MO-#1/X_VW=IK>F 5Z(4R/&&HS&^(?:KO9-Z/5:ISVCM-@S[6T+W\VOJ"WC"X MT,)FP^RNYR;T7O&$]UV5G ';D<]XZCS3J/*;"-4^U7RV6U,=8!L;.)_(TU8' M9/A%R:7_V=6S\E6N9OE MVSU"-%*[I3YEB%)VS20:@/EP8Z4&CS7=Z\/@K6%6;NFY 3.MH9\X6QPXBPK% M]%ABXQE&0T1Z5@V973E^GEA:6MJ/?H6O-R:.A&,F?I6-^ODL_$BY3ALORGFL MAKCM]$:'[W #&A88(CG-*P\T>OR-4[P:_5MZCIF&!FEOH, 6%W*D$O+6V'7O M9;=&L;^+G3I6C-GX6E5NZ;>:#R6#W4BUVM<;P)EW"7]Y":>1UL(:9&$YH4@? M.9)#SJ?DEQH;#YQRS.@.>":F1;1.\/&AP@4WL7_?I I/+=Y0^'*V%O=U9+:% M4W[JPXKZ./VUY?"X,]Q(?ZS2B/]C-'C:PW/5_;?+#M,;H9@([D:*"RFGK ,X+^:K:Y LW M#U[\!/50C@$,7&4&^#9]X3Z6$>85VGIW]24L M3\.\)&4?+XLK)+ 7< YX%=$?*L=@)!X,_J@&<-EI7%<_(Y':2V)WY2"RB^8& MJ[[#6@- IP%G#GXMIR OSIH!43E6G>$\UO/;LN_F+2>WW)5PX$*CSUP&:YF/,Q2]5]K GR!^@GBS2[1'=#,,NLC8N0VW7 M/8+SF=5NQC4=$+HN"O)[/8/#63Z<>7 L95[^^E)C4@#EWE#([P*XU?4CJ\!S M_S6L51]/WAM9;LP 394XYJJN!^>(H<&8'R9:?=K>F&)^LW70%6I_C)*=;^'8 M";?"3TR]Y:MT>UO3!V]9D8.EP/5/(3,^I\'+/G)=4TRRDW<5[@U7ULBH8MZ" M&L5^=WJ3J!238UH R][3J@JW?AO!3?#S^P_QQ=6YW,='1Z :',855?_)E?SRW*FOE_T.;Z MOX7MW_Q_ %!+ P04 " !1@598ZSM@]=^* P";-"\ $0 &]L960M,C R M,S$R,S$N:'1M[+UIB>^53F M$>$!V97*5+^9HM#\^NOQIB0D$"!!BHQ4J:R[2E)&ODOX]KB'+S_]WW=[TYVW M-"PF\]G/_R9_$/^V0[,\+Y/9ZY__[>[N_<>/_^W__O(O/[U9\C)>.EO\?.O- M;A/MWDAS%8K M3YYJ,3GOF?@-Y.W_^O7);GY#>P@?OGJA#W9_0?F'U_.WM_D#_J[2QPL/%O : M"U8KC+Q"_C#J/MDKH'^$I2O5^< MYP>SY7!X_H8=?7AV']XM@3\_^I?WLYX&Q1Y\/>^&:-.2R(<.HI^3KG MO]GG+M)>58%TQQ=9#,N/J<=_/$OFY?!)JL7;_.FM7_YEYZ__7QKR:2] M/:J#V^VJMX\N^U.:E\.=Q?)P2C_?VL/A]61V9P'L_( E\=O^6[Y@BJ__V_:QE1-C2!UYNMZ$P!M]NT>SLM>>=8JO MO^[Q*DX7=*&'?P/C_=@-/' MLT+O_DJ'7_>0@A4>FP05S">>]-& N8G(T:.JHJI$IG-!#$SQ=D&;!5AET)H0 M;-+Z^%&;9KCS;/F&AD>3V61)3R9OJ3R>,4>^;OKI[F)!R\7=/>;1R?^,8OCP MW3[K+FJ,\8C7?OA&SEE72]40@N)M2KE"$C$"1>^"LX4"L7X_X%N-7WCUVZO= M![=V"N7)'I/BYUM@;^TTQN-'8UJOA/_G6ZPM[K"BA#)?PM':6[_('T[VXW@# MSB==3=%JJ2V8("J3#BT$UMC\4R$=8G$EE^/].-+]=YX0OSD]VQ]U\^SU$V)K M^6R_W>/E_&%3W^7#-T?K+)GBP?.V@V'E M&1!?0Q>)\03<9;ORR'@XOQ6ZHU M5LU$%$4Y,*0$!!L+V)"IQ& TVGB:WQ[,\\'>B=P^YRO-RR/^V^+K>.[1?U^, MU[PP%&Q18$PQ8)2+@"XEP"QM-#DHJ^2'>WM_OK8<9>TWH MHX=5U4J',O.F\LZ:R'HAFLI/['4H(5MIO?N8G1@XW)E-IJR.>;=967Z"2SYX M%8R5<2/-.)4I\#R+ @@D4:Q$; MG.074E_]*F=Y!]$'+W-B9D$)1B;#1#$"9/6%C.9WT>'#-WD^S)G9EX?/IVR, M^%T>LIW;;R_V:D'U8/ID4C^2]> )O?>&MTD6IGTCN^%["8>LJ1-)LN;6+\_U MIUCI SOEA5,DF1$KLI3Z(""A#5"E+,SK)C%G?OC09^7SQ>3UF^6SR@\\JJW= M)5NM]@;/*NLVAH@3EHOY8K+28L<([,EDL?PJKOOE<[#Q7T>5NM*>3^>SO+*I M%Q-\990QSH"U+/TLGQZ2U!*LU&P,9=5:N>^T#Q=BV:O:A\"&*]3,EL1D?@*= M%$3F-M"N,'X1QF-0G]^')Q-,DVFSPJO;;GXCCI^(U4Z--["$Z9J3OMAV;9VD;;29%#E 9AJ>B M.N8362$SRVBG&7^;C[;C =7)C,H]FO$/RX;JGM)RY19,\M%?[\\7R_L#E9 MD6&]#+%YV9X!?FC1L6Q9@PBMLNEF>T52TJ(3+#6A.<:LVZ)J8NVE3;Z2U^XC MO^IRV_OP79X>M.#9+@UO)YG^E%Q8:1C;RTXW4XW*HG(3BUK M[UXW>JM4!XF^9A/GV 4O@KL\47> M0,%#."0<;OTR'H^!$OI3ASMG7TX77VR.NNT_N_ND,V D!1%5\FBQJ'82_LTO M5]@-C4DA;]IX:!@2OYP-P(ZUL#YJ@RV"?/&7"Q=T^WSSWCT(;YERJ)$A#/LY MWF>=%9$(\2/;^A4O9U+-N8Q$8Z_6%*<@1>9K'SPZJ;Q7C4$N_G(7.]UDJ<'2 M3%@J[,FR+\G\,KJX+@:L!@5Y.G,J-PHNR\NC^4"3U[.5G/+KOJ#EP3!;[!ZD M?U!>MN,HW&./MKWM2C7\.IE-]@[VOLHLG7[M=M!_IQP,J]?5'[WE[;,GSP-5 M=G+8!5_\\E/+&+FS&!,T^.X[8P;)G9:P\/.MQ61O?]JR-<:_O1G:P[7WA>/< MA!_>+.WG#<8GY#IZT*5@#+'C5LQIY&8,+R M]HJ Q30=>^OXJS0>T![_-BGM]SJA86=\;#HWP^'^X[^>/8[]\,O'EUO0ZZ;7 M5K\6OMF[_>DD3Y:_TE[B6Y3)WDH=G@E??.KX]=[AK_B/^7!_BHO%W7>3Q:U? M1OX8G'#^@M3>?[_,WGSX=Y;L&L=ASU@O)DGQ:K>_YT^]Q'N<03WCM8 ML)+F1\C_/)BL B>GGN9NH<5DP4SZA=O=_F"#;I]'C?V1CT\V_']_D]AE6.I^SC$V9D%61M*H=RC#<0,4: MWWHK6#NQV@CE6G#6R7$@MH26[\0[CP[^P>\XW;M:UF%F$!Z4N@#K'"W5ZV = MI] 'DQ.XYL2PGBV PBLH2NE*[)KZF:9(<&;Q"9L-L?'4DJ%M*G*#X=BZ_/&P(?CX;TP[.B.W=G _V#J:\MK"G M\&HV$$XG_],$_RTMQCR%8[?@2HDFUDZ?S>,D21["=E: M8+J9E30'.1E,LYA2UGC%/2?(Z'?+?\XV ETU<,N=3%(9=:'^22NA F M8K254LMB]!%B*HE]EL!.;B[98;T^]'W9^3 MV>O'O%N3Y<&8MG^E5%+KHY((20:!%<@3 ]&H,C 8U8R&+%KM@M6H>J72R9%] MV_AA3'0]*TJO=E\RUED<#(=,S+_,W[)G? $)NO#]5W*\2_E@&$.2]PX?SPI+ M*=_NK$5],Q^6+7/D/>#:&OX(L9B@#8%"JF D!8C&(& HUF&JT3K?*W_\C3>; MQ?*4V#ZG80QES3+=PP65HQ4O6OW&*NB\+MZXVR*.K0[D U3W_@%VW^#PQ3C, MMUII>7$K+==HI1VB]HY5B8M'QZ%1YPHB^U I5:N2Z95I7IR<;WA'L/?A:$0VZ^[]'QX:@Y5M6= MW\H^BV%YYV4KGFXY)V7R=E(.<'J*<9[.9\> :O7E%I_,D]6KY[OE[60Q'P[O MS1E87S%*YVU8#I.\/ I^OF*16[S8?74ME6'T3K,VK,S$IM4LE Q1:0]!H,XR MJ""-[96G[\_9CVJE&(V37TP6O]\[_)B8]]DC9\X?/EJ\#GY>:=RC.YP.$)WY MX/ZZ^/6<%V8W([]I2.ZC*.(8G'I!F29OD8W$MD0<=!(U66L!$['S*&3DGY ! MN<28&*.3SOT?R&W\>*4#S7*Q_,"->Y0=Q$L*_\,>J 4=&88:)]CW)ETAEQ"U MTHJ"ZRZ1I&F_%XP_C[3M2AF^:REFZU)VGRP^/ZWE5ZTJ*@,$>H+I9$G+D#L8 MV&X?#&.VW.1=^^EJHZYK=#A%%L4K5)!M*Z*GR P13(2 P3LGC*ZFNWA$XX 3 M_?<7FK\>&.6+^.\5[O74N-%5$6JQ A*$_L',BK^J69@@L4VJ@]4;.E*^2,IVAT3[4/FN\GO7I7S/S: ^WUEYP^0TU'J^'9?%1,[]LU>T"K!8O%FLK\U^( Y03JL";1PK+-42UHT M;&UT=-FCKZ*6[@#C9J.'5W0Z'F)NA>#-S&/+0PR 0F3PKAI9)"6CNJ5#;P<# M5Y.%9&J4AC2!S[E5,AH)['<6<*UUA!316^J.0E^ 9$<=.._\]<4U0V+*D7:! MU1A*(]CD20^8H@>3HU(Z8$FINUR3KKR>S40OT)D46L%ML3F!$2UX["Q"0NW9 M1K$I4K(WLGT3=!CI^>'R=423KQ;2_YE+M2A:=O'8,NO83NZ4MJTX-H VT8ED M8E78;4;2Y^GVZWPY'^93W!;(A%*IK$4"5;,!HTE!\HQDE1'LT9#37G1GD/], M"9^)&!BQT@;A6H?%)"TDXPK8+$1,(:F0NXMA71+2MOZL\]G5U[6LT>%+[9A6 MLF4E5RL8$P5$41S85IN.GK05W9[2WD0#>K*$(K!Y;)?9FI;00@Z!B<6J MNW66!UVB:GWO1:)N8[B;SQ>[*:5HJ<=5H W6@':BL9!EYSH5#UE$K;+2-=@K MA\N74W9QCYNX0T)=R9[\Q878["1F(%: TK:ZLM>X(4K!ZD"W+ MK)(4J:!RW9K7[HO]KZC0RE<4(DJH137X6AW$4#5DFTHIR?IDNXL5?T;VVD:LA%-0A%L0WY*((@Y,"$86<327N&R-T> MSEP>48WGN.>T/=Z6W)8DL"CE&3W%U-JA!X38IBDX5H4L-+*&V"W^;=WFSDS& MNW?X%%N._FJZSNK/AZ<[[IP,U6MQW%V:3>;#DQ9S.JX9W-P)?$_BBUEA :2,DFC MZ2]$?,'\M,:?(O(-BJXBL;D3KG:;%])M-L(ZS[TU M2EE$ >M;MDCQ"E*;TBLH5)>*C])T2Y_M@/R;.1GSA>7+:$:66K0BWU@!M6+B MUJH*65]+W+8"MRNNE+JB]G^RF-A".Z)U_C"_:?]W M]?HW%I&<U>.8;^N>]8D3EY=O MMQ"F35C3Z,$$'T+.['6; M;F,BVTS-#O(#+C8)<..'91WL5*5:LC$L&C*RM4XB0(J\74YG!GY&UB*[57F; MM=;?H3/7&A'#O6T)BU:3%5HDUMHY@U&^=43"S))1H]8&:]#=Q0?6=+3Q\!U[ ME,O)6UIU-1JVQE<,.5 2F: 69UOC-E:\,24@:4PVII>Y2)OM)9+]I?-HCYHE!UI39N5,-Z9A@"*)D M"*1T99?!16EKMZ&M<>@S[IW&]\<<-!+N^0'S,B[H JEMZY6C79I.V<#]A68T M,(_/RMVR-YE-%B,P>DM' G4]2S5\IB*R4T#.:;9_R0(&ER%$PV901AW]#8B^ M8@![!7C]^X:\-I7F:Z12.H$LB5F7"K)]IP N&B^*O6/;H@U#X^NCM.U]Z[BCY_5^.\EMBJ4H* MK$L%XWV"4%H':YVCM;;JI+MMH;!&9+&=HB6]%*H2@I(MP]ZVH*$B P%SMM(F ME6VWQ-N\J]-9S>YF6*C47+%%FXLJK0UPM1!J=/P@.LNLO;"FVSJ%1K-G]=01 MP^D^9C-Z.EG]_Q&#^77Q2C]-\Z]HLEHQ01+J=NXDF1TD07"Z0&('TVF3L_#= M@:LM:!*YSG;KJ$L(A8"256!4Z[1>I&/%C\5Y!E-DNTU6V'@[U37204;C!)8, MSK63]R ,H"L:,J6D=4 GJ,OJT*^:@]#/KN>4T*@,53-(-;:.DQ\59&1W0E@K M G:; ]C#H$&S/E)0]#EF!@TIILR>@R-(IAU@5^6\KA)-O^GHWS$^>./-7#C( M+86K&9F-BF9O)F""A%E 2N1"3EDJU^TPI?XG\780N=,VIFIJ!/8MV-=H6=QH MDX/D1' &B]=7GZRV)6>82>D<6*,6+9%!GE 02XJ@?!$5?7*I/U'8?"?P#56$ MZ\2T*@[:5.;65]]!-():U_980]':]YL]O.FCU2N:=.!L5MHGB'XL+2VI^:\) M@G&JY!!EI=PK1?[&6]\2'M^#@%-QJ'ML_LO1BA?$*')E/FX"86L08Z%8AJ/3 M[%D$#295MDLE$]A(WGNIDNTWEMI'A[3-F$KM,3LT&50TK2%'RYF.%,%55;70 M1H7<[4GVA=R0^_/%\ED=3W:OH:NQ(:9Q*J7"@MS=J"[C7+:A"H!BS1MQ)1GQT*SYUA#S((AL[/=I?Q=$"Z_VNT_*%>R M+J;UR"O4&KX+5L8AY00Y4ZXU"1-$=Z'0&U5X+#NDK7=D@/]/[)07#2E;8MDQ MWF4CB_+=AO$Z:&BU1K?%, &R97\_:F0D4]J -EL%!&\CJ[#*TM2=&/61V+09 MR2G>R92#A6I:W0<&T>R/XZOK%$*TI?IN$YN^H=_'VE#H%V8%T9!__RLOO.*C M*6% BW6(K\C&:,7LH+2FUGX@0J26D8-850@9U=6W'[WQ20RLK )-E:T3@ M"U\]1&RM?BEW&W-]/LSY59>'#>,OF?+-L1[I?AY)'QT,K"X.AC;=^]'D7?MI M:ZH>HR+CR$NH0K.?W%!_8/@/J2B+TL4:^NV0LV4GK!NJC3JL\"HD^JWZW2GN?;K!$F%W0+A6I\A$F"42Q"%)"#V][*663O777+E M9AO)=>#E:5&Q!O;*RSC-T#%2"M$)T#FPH-F6(-VQSMQZ-+.9,_WJ@W$N14 ; M ICH Z J%6H)646?2JW=Y5]<4H]>*C_]\C>_IOGQUB>D(@O(FMI,&&$@.BE MM"AW-3&(V.V,D3Y.B3=T0A2CP]C"JHDD&.$CQ-I&')8J; -+G1.^[ MX]P[O,]4>ST?#I_5QTR^XQ7E="\-^N,9__=77CA,<+HX,:QLK\__X%O5]#D% M '^GR>LW2WZNMS3@Z^O9$H:R=S%J 2A;^PS2JG4[( A".R49D==^.W-?*CAQ M[V R;?WR'N_M#_.WJYF-VZ('0D9D%5" G&'?-3CV7=E;@NAET*8-T>QW0LC' M67ML2(>C:,2'"7S7+%UO0SU[T=AL<@6K&[=DA1!-85PF$T:!&(/OMA!H:QIX M;0:K^5HE*9DA5=7.DEP%K+Z LD6RVF9%T&\H^?*D?4K+5[.!<#KYGW;^=-QU M_2^,Y5ISOFW1WC;F0!$K./2,XDR+;1D&V,IHED49 HEN#P _->O]).0_'Q@D MS>ZO4K*VA2+!$WKO32L/9E=5I01HD@'AL%;';A#9[08]JSK_L?'D$TPG2]JY MS.7/:+X&.F_9Q*V0M!>QY298=$U$"[-&&RUMHC:.=*RAWWP5G Q_P^D!W6/Y M:_'_4UEY3)"=??S!9Y.F\?7];$M6<4S'D&$%GE<#H&"#89*$J(=%G:72_FF7; M.C!?KJ/;A;38Q;K7W;V6;H/4F$+6$JCXU!II6D@F$T3A93*I"MEOMQL'M+YFOMNI#5PTTLDB M@#R-DT<+TU>WU$5;4Z:0*'1[FK,=$_LV([=9*JD3"I E5& :6PC"!/9-K3(U MZY1$9Y/G_1K'A$I1T.F&\ 7_2S-GH_$19%"A>A+\\C<)"]=-DV5=?:"HH#I5 M6T'CV);'0\"4*^LUDUVWUFOH4@?+EO7(^XN/9_GVQARC7V'!;%2BC)# MQ58P@HRJ4^L*'4TU7DIF2M/M^ M@Q?;B36]$][7**"X!K]M_&B!ZRZ+ST;'AK_,9L6\W_$[+-AAQ M:]!'2[(K6B<0HA3V2[QK<10+ E5RV7IKL+L3W:9FGP_SJ^["Y5NI*E&!T:H5A&J M&S-;R3"::KU86;1 !Z>K(%VSZ?9H;_-HJEMX_V? 3ZQB*&D?P96BP>@L 5OV M"+()]]&:UF2X5];]?$;]&)?:%A/M)*MZDQ+H3&,/'PW!9M8@T5JEI6( U6W^ MSDW%RX>,L49'W617([5JTI1:.-DFB-FULW]M72@A!]>M:?F\?#XZ^ =??WH% M^3L=H+VB4OT;5FK5B(U8S%%O; MK&%5(&K6KX)$HE2B#*+;4-?'.0=-N^+L\$_7E79#A:A\-6.#A&JHM4RW&I*W M!+:P_&:EDL!N(QJ?[6YZA*]G!Q7S\J#EY3V\F>JUOM9D.?J(VD$K3V??W1!@ M1@_$($][+++H;MFFHY[DZQQ<8VIV.K+DILCV>.RPB"J-1CFG8J,TL3>*?"$$ M=GP6?WQH?[3B>D;#,/NHE1%@7*-?\ J2"QJT"+KD(J2OW1ZP7RC",O;/F5P^ MPK*=Y%352H;$#!TBQ"0T MD%:VIB 2FFWW]:^^&+X#<&@B*85. ,G0*GQ:'KZ2C!6U2J:D6#L>UKCYJ._- M&7HWC*RJ=)%*_Z#3ZNI0?U>GRJ]0ZNVTY6LM7+ MD#SCM-".PTI6P+BM)4*&K*0.5$NW*=V[!VDQ%K0M'[*X+\_#:&<67#$!#0@% M2ER$@!\L_::(AX[6^T8[)#9J-3EV7:.&G'(4)%!;VVT[F+X;B:ZS53VRT!8& MC[:TDP&*!J+(C*%E(9^CE*0$1^Q M.AMJ=QJXSW#PAK*^=0BIC8TCP\ZJ"26R1A:L\F-1R4J4&Y MHFVI&4EZ,$:S<5>$()U'X:LN'7=.6DN"S87O=H6#6K[)HC,K" ]*K\.B*W3) MV8R@0D$PV0E(,0>00M40K,I)=)=UW4=,]SM4SUW(1%XLF_C>MO@>9%2R*$L; M15_ ..=9/0565,(&&WRFE+L]^.RCX_6&$*9)I*-0D&6K^$U&00K10)4%A3;L M*V"W"*6;0[ZKF0.2=0R\^P(B.@5&VM;@4C.E0M9H9:DE=I<+Z("A9C22[>JJL$8^H MHEL!J08O6H%"&]V).K33!AUT8(0O?7='KGT&(S>5\V"M3@P@Y5@DH&(S/5& M-\(HEY6D?H^'+A0>/+\MV)H+!MJ!XE/<.\U%Q\T11VD^GN#2UEW+F+9+KA2G M"8IM,6U-K2UJ2F!R=;J=ZK/;WQL;G=>5&]]=H"OWA=FB->%OVH1=%YKEL3W9 M4VS)&L_J^S\?GBV0.IH!]/?)DA7/;#(?GC2N/>F\N2U("F,.6A0#46(;FZ,R M8RI6+C+EI*36,>LM+?W\=;Z<#_/I5<^67U^WK,A.A$H!BJ8 1K@(03*Z#3XG M[4O4UG>GX:]>-+_J/&"LRO]P^4W\X=O-AR\U!U2MKDG6=J0=F$=C 4JVV!J\ M=ZF[^$-GN0@;ZH+LK*NE:@A!M3+_7"&)&(&B=\'90H&VM /']RD57Z,G1B(: MK0R"3[X=L<3 %K=8*#(DUOJZS:3ME107;>,Z*N#CP8D7;^7:30S#%U52J 8T M10;'R"*;%$9 IEE1Y(KK-_?U@C&,3L93K9%HJ#4F+2U$;+-O4K20G"N0+%)- MUAFD4KJ%')?7H2\' MG"VFJ[C6R?'I]0PAH4Q:(0'EP'ZJ\DWA1@3%Z)]1I(ZQ="N=FZ](74_FT+>\ M)#%_?HJY]>?RT-D&6#Q)NR-%5$1QY<;6>IT09@NCJH)61!V:.G[BJ]+DO?4D9G%J?/<5(>S^[C M_F2)TVNI]Z,7LA)E2%XC&-=:2UBMP).W(2>!076;7;;&#(?U@I4_<_D7HP@= M9"T00E%',T:-\""]$PJ--2EU5_YUP;3=_WQ^S7Q$*P4;:"K@?)NR5SW[B-DF M8%4N8RG5FM!MV&K;BK.N[>#K#4T(2<5G%1-HIP*8UHDZD470R5=1D)3IV%_Y MFCR/EP,6:FS5!AV/OS33=Y/IL0Y>\I15$A4LUC;.26M(QK3)0(08$C$&ZM9E MZ6[,UCK'GX6$4?O*DHVM?Q9?.*HL05$)255=G-MV5^.[EORMD339DE,RM:;_ MMDW1"!I0-[DI0E=-)NE^O< +0?C[\\7R6;W(-+1-N"O;:;-M/\>3#/6SWSD;L[N>B"8)Z16+%E,S@B'G(%)"R+GPWZO# M7/N-ZERF(=X3G%U!7M 530VU6I3H!: U;#-=:@7S1)!2&/-2+>]EKT2YF9NS M6=.9JT^:I1IA^:;)],X\O5 XT64$.Y:ZO(8#.7(7I")U-1&&S9L6H=B MJ2W9B.A=MXD/&FQ_*NLV&&]N38'P'OD@$CM6D'SP4L MDL@U&UOTE6/@R[W\&D?/ZD FM6X&V8T3Z*GE6(4,[!^>[!\,Q]XGS^( M\36XPNYD"]U/__-@F"S*)#>S>"W9$B4E!B\:M$H,+"428&P@)N8@/!E%J5NS M\7'<:'4.>1,KNCIK%8/45D4/TBH'QAH-00C&6)YD5,5G(;IM<])EP[AU9D=7 MLJFRLX_C2"CI$((DQ1!01J.3+P6[3378KF+K->)V94*U7B1V6O1X;ED@V** M++N4CC&@$]T=EWVAG]RO3)YA@M.+''!OIQ8DX95)TK*M;"/#T3L(IB)X;814 M5O)GW99NWDR:WURT73DOHPP0LF;CF7WKJ: SE.*,\U%6IG6O;+-M*;&;G%=P M!5FQ5V-\O&+5U69@F:+9*;6D 85H)W^%6(\%'\*-'NNWFG-#F5;L%J;(X!*Q M94[&E" 9F\#:G%4J6H?2K0OP)>?_T7R@R>O9_551QK8$OF,KQT]60LXB@&$Y M!@R^LF=F;5*B&I.[/7^X5+[Z*-:\C(893J>'1R?^_,WG#$OQHOT=10JJ ,U:@6;Y898D(/5&J,TENI^ZWFOVEB>=4A!"U5%)XA1BJL MVQN;M!(%J+:P;\,?5M_M()Q+Y?;MSNN233B=2AK:&AH)9]ID=JC%AC9DBD$; MB@S6"65B,"UKIS<:;;X(C!;H=%7*=7NXUWU^ MU=6T%;79MYF"#&HQ*7:,JF)WB#&N%%Y0#-XP@UP?DGWW*&H'0NF=%U*65B#2 MHG=%%T@^U)89YXJ-0H72;0)[%W[G9LB6:ZGMH!Q\'E/<<_-R* 6@5H9%:KN M+I?Q"Y'R%_-#G+(/.BM/^(/9@AY=R<2##HAG/996" NM-1PPDM3L=3 991)2 M.^5EQ6Y=U MJU2L=9M1!]#HH69RP#J+.;?)131":[K0Z!++&*>N[-8R7\@WN M'4RFYNZ3SHPO>[:;'S M)47M$K:$65#):N8HU=(1:X822+#= D;FMF>]7JJHQ.@K+5@\EDV.EH\RRJ M",7ZG%!O.WCM)B2PF3--;"/:O!?@QKAW.\Z,;;2G#BKJ:JI,M=LXW58FX6^& MS(:*-YH\9"]9D%WQ$(N(8(LM)K.^+;+;!)P>3IKL&L.LMI+SH8E8;:T<6=B" MCAK0R)Q3#<+K;I-5MU+B-@1P7 ZU. ]!M59ZVCB6.,W:U63I*J:L3+>F<[,] ME=Z+'2LHX1A[K"56$'54(BBH;70=ZSS6@%0<:,%B)[*IJ;]ZC_/*D-@=_W(9 M4C< 4H14@E 19&M_;$H;21HU"X4+R@LOI<[=GCATYZEM*.LM,,K'("!F&=E> MM6F#PE5@JBH6*92^OP!VAZ=DZW B$Q%H0$K*+S9Y[5XSQ,!7HTB>H.AFH73,;62D@9JU(TU9YWY;EESL=/;5;+)B=DEF8QB\($:3&):A2"(9:QX)X1' M]-U6;/2 )*]H8JXM6;'W!%I1;6..+:3 7I4L5J!-T:/H]@3V\DIO3*ANZP9Z MTZ[VEE:GJMM2]22<8PB8F3Q.>/;&& A&S_H.12Q9.!^+[2Z!]DPR^^[D]8RO MDWD#GLYG&1=OQG-,'-M4+.X=,L#XYP$]H$4>)OL?! I/2=?CQ>* RLOY. #Y M67TP&2@OYT,KH?C$E.27;W#Y=URT5FM4VKEXS@-?XM%\>#Q[/M#;R?Q@\7RD MQ+4,9E63L=:B61_KOI7XU6+ 6455@+LB5KVEL*6PD3(2";4HE M95ER=[&F/HK\;\9Z;[K+K&)_OU0'5:0VKY%_PN 2),]_M%ZF8/H]D^TI]+:A M,&]_8,_GZAV.=8+7C%B*(]#.2S U50B!R6=D5;92]1&[I=>V M9;INZ !!Q#;MI4*T;3R7*!Y"3A(T%>VJB>4[S*.\''L;$ J46@=[2]] FQD@F6->?.OK"2==!N.NI0U_Q7SF\F,QNCER<)ML>'>>6\+>O#H6EF82("1)2PK89QSGERY M27+_#"G\&N&4,X6\"*!"9'N3V>*F[#PXUG\RQ&A8W6TG*7ZE(?_^5UZX+5*! MCFP@&2%3;-7K0K/)$2P5F**L.7HCNPW+7O2X8_?-?%A>[JCCPL_PQ2.?^_-A M?SZP:;DWGY7WS[HM_)%5"5HFOF)"MFU),4(F2T!1.G0^4ZG=VK8_]R"$#0W. M4.B,96/A5:1:U*VAJJ M=]T5/5W]Q*M/&,WCJ9/9_L%R,:Z0 M:PM_O'^87\?$UE&JV<&>?'"\^)"][3T6G6?UY"LG/SR8+/)TWKY\M8_U:&!G MG^'DA\,MCA>?6MIPY<$P7'6WPW4&\H1KE80(D;)I(^T+1$844,A[Q2 SD;E) M%>F#5*[DP%"?(;_(@4G%'D!H\ZY,,I1#K"[VFT]XH?J%X]FT=]EU&I>'VM!EA\?VN[QK)63%E@C J*:AE[B24JR.! ZAQR*!&# MZ X8;=Y'WHSV,ZGF7)I-2S6T;#0%*2*"#QZ=5(QDL5OMM^D9>AW@$B=R<@$E M6/X/DZ\H""%9R,:$4)P(/G8[ O&K9J@]YYU:8S+!QG)+/N0= RI5P-3!69,I )H51,81 ,Q)@GH3"[H2L+:;<[C39SS M^L0YUYHCCR44K'PY>)=GYM\[1W%#7J:OAI)!B$ED,(;_A I%L3I25H(2A@7> MD(28JP%A18A1!*G-]0AO/F'9WI;P6!(ER\)7M*$%,UOWTDBJ\-6#BJWG@_!= MIL]^!M/]RE(T3' Z=D>ZGDHN55FT*U!S5&"R9:)EVV98).NS8E@7NI.DS9_G M;J8S0D'T53&9K/0)3#0*V"CQLT2?O3%5%=MM_+FUNF'4VP + ]VQO/@I+@\& M>E;?__GP@Q;2DQ$7_7VR?+-+L\E\&*/0QVT\M^>0AZP-;1H,*90M/9J-E2\2 MJ,ALLJ[:A>[TXDTG\ [DW0G25-OP!?+L9TO-?G9K+D!69:N9IV*_+>0O%9Q? M.1/3Z5'4]EEM(O]F/C8X>SEGGOOK?""IJ9SF"U-RAEB2!6,0M4*RJM2W;K%:QR+>$F&^$(V]OWY8OFL M7E] :,DX+$&"E]@.N3.##'9U(0D9A1?%)7]S"G230O]!%782U6GK0)=D6=V$ MEL>BF2MC:):*??.M'>YTA:/O-D,KT\922X_LYSD/1@<%,4D+45!L'H0NOCM4 ML1%:75$24;+1DX^@JG0M,]%8F;R?E MX$Q'PA.7C-$2H[7C7U<76K"U/!_>7TO0[J/22K39G[J!+E9]$!(%L+:&E)TQ MU&]&S>;+T;[$:>OCKC6;]6O>\]^'*-&"R"*R(YH3I)@\9&.-\EH$J;H-/%WP M).1XDM!QBY2][7'S6EM[FRI"T,2^GLV:3;LW$(T1*&*62M\4P'Y/AW,[A9PH M4M3>@Q;(P 2I,"Z,&8)W154D&URWAFLMKM=ZF;:/J7.;P4"M&YRLR'JHYI82 M*#.DK 60ET)2"L'$;NW%GUX/%"-L9LC:SFTU&%*9R6@%R-P ;$F"0G>I>=VE M/70@A!@-UD(:M$\)3,D6@B0/5?I@B#2FLO5M#4H94Y)P^APGY?'L/NY/ECC= MEBP6JWSPN53(N11@)!T E=5@O<_H=(A8NPVU_KF[ 6]&,[,35I)Q?+FB6*)M M&P">K&&LYD1,Y!WE;@^2NVV3T %=9=0N:27 MGZZII;8!L8@D,VFU.*1:K+*P1M39TH9B)G;H#+)SKMI9K72 )00=5@_2;M=O,F(V0, MC*4LNKHPM@ M;I5 R7DGH@\N=8OCMZ2_VQJI%5!8JZ)MGK&%EB<+T?L*-L58G779I>X\X\T. M[NY!Y>I<@[4(M8BQ_;]GHA%!5E8:W\HB:W=$6_-IUGH=PC]SX@J6$:3QY41% M,)[Q6W2.0!"2JB8FA]WEQF^\W>W5*&-%-,YI QI)(4L&%.P[NYH)&4S5:+I+ M7SAOL!^+SI<'^VVGHXQ*YF@KRU]M:%=7 ;$RQ"$7JK#>DS#=E3)LWE'N1L*\ M=[)$6T 9F5H;+P7HE06=J9)K'6VIVRR];6OC-=:+OF"/>G9 3^F;SUDWVL.K M ]"'-IEHJ7G71H!1M0"K' =5:BPFZ42JVW/7S;+N%_R%56C^79X>--WV=#XL MW]SEQ^ %OV M)7C=:E&KP @R6':G/5\[:B^A8$:2#,-%OZ"@G_/.+G)K-E3_2DZH&"IDZ2H8 MFW(;T5O9*:B:A"XI]YM>\BW MH%I@C9J9?)5$I$#5U@TJ% =I' =5425M166AZY5"7\Q'O3\?]N=LP^G>?%;> MYW?=Y*->\@3#F52L-N #$L/)&"%89T$D)20SBB/5;43FXXH2MN>KZA&6V _: M\M_4DZQ!YPL3E'6I@FUE8D;%5K#)T,];:[*36=5^^TEVC_7^'',<_/7SUXH0O]E9#WGZ9+.9&27^' M/SN^P/%'Q[^W*YQSM7U>\]'ECIZ(?[SDU5J[H>:.\HLMGM6C$.V#^72*PV*D MQ\FMQB9*=/H23QE_,]2>#Y]ZN5>[#S[W.!]]O_WQ XSRS[GL$<5&+OG< M=<]<$5MWU"WK[, MBN=<\=>#Z7*R/_W$EAY_>EDZO6.7M&75/*MUDC_%8Q^NNJRNV'WP23WV!5$_ MYVJ[!_NLV3_UJ,>??OZBDW=W!EJ5=B_>3/9WII/9[R_X^V?,:_O"#_/A]6TE MA+X]\,>WV[I;.XSHA\\O/EIQNW5ZA3J?+V?S)=W:6_I:BL MCTE 16)/.;+;DX1TX%OR6- N2:=N[=1AOG?TG=]ADEEI.,E[9=S5GE$ -(V]H] MQ]I&-]HV+]S)6ITVB5R[FG R6<$ J+4E--%KP,#&$FW./LFH1/:\+).KJ (C M)I]#NQI"E+;RHYI0LLJ1K\?+@K6V-7B%&%P!PYXDOV1.?$GG19$I.-MN6AQJ M?IL,OM3V;!DA$#)*;NVI0[1&CPEZMS]@BBZXA!^9M\!7X&WDG0C!0 N%@@I9 M.T_%9QG/2+]SKF*,C*3EC*08UCN^)*&3&--(R&@*RXA\WEH&R*MKFZ;>QMIZ%NR@J4*L*E;'GV"2C0K\ MH)I?"KR03%YK"X3D!(0VE3!IBF[LG-F:B[.T5;(MLX[5LR76;M'S2WMF-V3&9]YR[-BQRF95V51.D8AM13#, M0L84"9%8)R9L]3?!HM.--L?D.HK/A1*Y8NW2(CAN6)'4.K_<7E02H?I&:&S%*TF_)&(_\-O,R\8](6 MYI,FTLC2F$B!$VUFKY5\^YP(2O#&Y1JU^^?[Q12I[9&T) MW9%B?_GC'@ZO^2+C)7\WGG)SNIBYRG]L?-BSH[H\<(T7R[G>[RV MN76 T\GKV9TIU66[QX*Q]/%M_GC#+A3P7S+=V1\(_AAP_\=3]^9;?_9N?*L_ M)F7YYDZ=+&'T(F?M'O_?OTHG?OSI=KL5;]+^J8TZ><.C%V^OI'Y0=G^Y4^8' M:4H_GMZ_DP??EP]]2NG=FO*^"(KC9A]^']5R\>OWS\<'?G M[M,'.P__Z_Y_W'WZEX<[]Y_]^NOCW=W'SYYN^\ZHK]R9OR/KH=GKY7SV?W8> M_'#_AQTEK(F?VHVCMVK2?L>(_W4B3D>O^7F)NMR&G>BNU>\_-"%>S*>3A/<47]_8+FLBM2Q-M)>=\K4P]>O;BUYWCES_]/)>X]JT1ZC\E;Y+6/#65\\=<39CJS+;_\ MN>3Q:S?PN\OC>:CGVY@G?.6K_^_6''+GV8S^_5.O/S[V9-;.3.Z ^<&;^)Y= M5OSS@]7Z?ZV-7TYM4^LM.*F''^[4!W?Z"CTAA&=](-B1]FTJ#NH6%? 2M&7/ MVE3)'HY:EYZX.YL=X/0%[<^');M][6AF^?.M";_D@C*3<3Y-.)W.EPRVUZM. MOK0WGY:&R"[*CU_0*!T\Z/]S]^G35W>?[+QX^/S9BY<[SU^]V'UU]^G+G9?/ M=ABWO61PMB/USK,7.]+^[_+O.\\>[;S\CX<[IR#="9R[>_]E^UA&;2ZO!3H# M_/%KS?)\V%F^H9TZ662<[AP2#CO$8E^^8*N_=+]/B* DEB9#$536;*H]R96I MKLFZY,@CB^BZ1' UB?+AZKCQC S>:8/988_O\J9]#0H>0GMSH%D71'E >77^ MJ^7_N1HZ9*.0O/%0K*/65+Q"B,J!E0R86+NT]W'X^0X 8MK$,7'*.%Y0G?[JS2 M=\:#C9W?3OVSLYR?_OU/NV7CW/1%R^':>329T@[+2;/LG[?J7[K9)U27,=JI MW)K3YN#;(;J!6%D766-,E*HX(?*WJJZ'8X98>Y75FW2QR2T)6[04LYMPR)VO M#>UV$I[\PMOY[7N[R=[KG<60V:;OO=;&2Q.5_TW\\(_]U[=V<+H\]^_'FS&^ M"7^R_^['HU,[[?CG6[=/7FASO15R_H]=@Q:;9L;6_["."^>OKX;P]?[-Y]LO/@\>[S)W?_>^?^LQ>,4NZ^ M/'W ]*U>2%>G!U\=KWSX#O-RI.K.O.X,)]32RU;.?YY^X4'R_GQ6[5':7D#S#9M.4SQ<'ZPY,N_H_+C MD>H2X@=^MZ,OY)80O;^@.PO:QU9=>'87QFO?:O?G!QB.[_YVLIBDR92%^,[Q M]X\6\:IR5E,V#Y1UX_D?JL]\=NJ+/]U>#A\^PY'N;>Q[+A7^X/>#-!#^?F?\ M-[0_G!/Z__#F;ZEE%./T:-6*33YB&G_"-3O'@G=^?D;X_I;YXFD7WU]7G=V8 M3]B@4LA$*SRH//;_+JJE"AH0_/?@2C$J^_78H%8BMZJJG;31.\S^]UOXC]#;R,KK MV8'/BG(/HE&-212=@II+2U#,'E(5")*BU(6RJ^MR)U_BN\='Y5FKNM&U^9:? M# !K4-HK%\(E./XSIL%]']-P/K.X[B#?)X'OTR6;H/UW4Y1;S]B/?WCQP^X/.T>U7,.U MX>2S>GGGZ?R'<]GW!C7_J5"S*:F4'#T$*PF,R %B:A4G):H8DM+5K DUWRUE M:%V45_]Y,IF1O$I88,7.\S>3Z72RO]BY-S^8TEL[SC\^&E_,_KM)M>?C'9/9ZVTFC M4ZY>M7'3-@@PD3*$VNJI\/]G[]V[VD:VM/&OHG5F>EY8R^;8!G/I7K]9BP!) MZ$X"@TGW>W[_L,I6&:LC2SZZ0#R?_MV7NDHRD 02@C5K9CK8LE2JVK5K7Y[] M[' J^SVQ#?_SJ$M#!MA9=@Z.)1@I/]3O1"7UN\QRN6R]SM;KU#M"3@2XEKN3 M;CC>W>ON[..ILBLFW8$X&,O]01_VQ?!1=\1Y"B(?___1@N(P3R?N,)1^ZVU^ M5Z-) ZO)]^!CK]_/6'WL>+_>H2P_[.< -?:>W O_%S,6: M05)L,O2__@,4ZMYO>5#(6"YF:2*#A")OG0!V"Y..!P(4">C;4/X:;#P);&5W MVA<[6((K]WM8]SL4W8/)#MA !WL'DW!G. ['WVP#H45Z""_R2#K^VQ=AMW?P M76W7KQGCYM/ E$(AAML2/9%I#_[?0&QW#_H[PVYO<""EZ.]*T?OF]:86=>3HI?'YKX[__R!6G_@X,[L_[?E./?WMO:V;TK MS;\UO"O3/^AM]7;N^'Y[:_O.KW>W=G=^"%; 0];#2^PA>T/%> .AOF,+ZSMD MBOZ!;_$C/.''M/0NHR(F5) 4DUDPP2Y1]YF\WSR53B#A^4SJ$_@&K12&#KO.0U;J.40F]W?!$0WW][K;_7WP4\/!H M3-L46TG)_6PXGP]XW%Z\J M2V[9'XSI8'M"D<+*%! @ZJ'2"?X3YK\?@($6W(BXE%\9D7_H]GT^F_0'Z;"? M= M,]G;D?K@WZ>[VMO>Z.WV!+49W!]U^3_;Z!\/MX?#@FX/SZG#EL_4)Y?_L MW2Q-?Z(. MO3OZBGS5>@;5OR@$<^V% M8((/:2+7*_CW-!QJ3QC\>S0BIV\2LM,D1"">#,;+8#*3L%.QK680L2PY95%1 M'HC@5L9Q]U.2WL(@I]O[_3YRU$YW0HT0H-U0^8"]#&SVY"=GZXREM!M_+LM%Z2 M%O )==T)\="=(N="1N0J>?-IO(WP?/,7L8#8LQE4'VS89RP//V*#/,EA,!Q, MY"#<&W?E-.QU=Z0XZ!Z 4]GM'^R-A\.^V-O>?21$\9]I7":%R(C$(OM:/JIO MFL0/:7L&/)R*L%5Y6N7=SB25357TWD9_,YB!18?*+@Q$'!N-YZK"L507P#U] M[>=I/'FS _<")#?)R,@OR M68J5^)HDJ)B)HCKV6Y'7%3;]6+W#)ABK21AL#/@=Q^ *P_?CO^$-\'JZ%'Z$ MH\ALN[61 M8-2]##8PRK+W6S#8'FR9H$!$O"H+Y%5YZB. !VPTN\PWGTIO"]#-X2 4W5#T_)M-$'&HFZ M#J/M#G<#@Q>G[3JXSM+;8J:_W0)37M+0*-)+=)U4"H.H_T'OMU4#I*_[O^G+ M[KU@Y?#,A6B_JXM7C%5?J6/1_<&X.] >B>N&;+T,HJK!_MTPT^%="-9O^>W! M5O\N\.R.^_7CP8:^'LWZ0S+'3?F=!^6-Q^/^<"JH-]S^=G=GT-_OC@^P$=QD M>S <3J;]WO";\\8GAH U.P+)O$ZS94/:F"ZB[3I1%WU-!GF5.GS7K#H>D"Q^ M0N##5V;E5L?H&M3QTP)#&E[FIP8MU@-Y+^!]=AX-P_HCT$&/O$D.[]H@/\]K MC%:9,.U^_\;]\4P!7MN[XN+W?W1]BNW&Q!X?NSJ[L3B=[P_%D/(43^)$< M?Q*M5V4>)3+/G[Z_P[-,PS%_D1,][J3H1"P"?:V MNP>]R4XW'/9WL/WR03C]YAYJO''T0KRA=3CB9?B9-M"=>,B7#U6;WA&:0'J! M!V(Z, I.L6^P,!#<4:1!F7-8 ]Z26Y4UM"-),WI6O,2'WT;P:(R7)##L%(]Y M\-7)8DE$,HE$C*X,;AL>*:TLV&2$/D.9SS^)&6#3F=2HK[)XJ) M!G\9H0).0/!PG%D:!RF<%8X\6D.TA-6Q^*2=WHY3OST2V5C ;;MGGV.YI"P] MO*1](P5!'L>@OAT)GT;9G!,Q,,T+@1?!IB!D:$BC$V48%6H,3Y5ZV3D8#.3! MSG:W/QQ0HGR[NQ].!MVA& Z0H6Y[.OGF-ENGDVEVB.^29H=V]5['XOI[-MIZ M+!C,P\@BUN%@R2U$!:3W2RD/5AX^KDJP6Y'X\!A2DM81A\22PR!J_ID"HDQC MPJ? 1Y,TRZ0F.*8S,YU^^$4 MB0=[8?=@<+#3[8_#G5YON-_;W?[F4*7M )F,BGEQ@B]^9*;CZ?;AHQZ9[;9[ MR#%*V2C<'BD89RSA5O#U-G6V$AT_)NF/9^TD)4@#'*GQ,H_XI$S04X&CLSL6 M:*^A12>3G,]@!![ 5P1G,T]W-Z[N MH#?IRC$FLR:[X^YXW!]T>[MA+^SOB>UA[Y&262.4B28/GU.T,.XX?QZL;:U- MMK* 5%Q?PUY'93#GZE'B$=#[^"8EUP,=*<0YJ#\G3$& QT"Q#$ *2)L3$&** MIA3[^9&^GN[/;&QR(Z7A[?U]6=^]D*@="B''W MH#>&*_>VA[!Q8?=,"VZZHI__'=G>]#K#'N]SLYN7^\Q M_7H_#J6V%8S26(*QCL$E, X68.KD%APIXHD"478(@M]@=:#TAQ$:16G6)-<4 M9H"?CF4"9R+Y >EM(OG:>9IAV M>NM_[Y:$BO8&WA LCL-#,CMH,;F'+X-KG M44AND_VNBJ_Y.AWV937=P^>#\SJDJ7XMQUDIP!+L[](>W^G4PT1AD)8%Q0I1 MV3RSS;\C=W9W=Z?#[OZ>A,V_-T56^>U^5^Z-97]\$&[O'8CJYC_H'>R-MZ?3 M[L%0A-V=7K@'"F/<[V[+<'MWNG,0[@^:ZA%(VH@U8#0#*S\_L[/B:8.GUR@ MW^^"M7K0/>AO[PTGNT+LR=W'"F/DMH.?#%\M+[3E<0FW?A6#$/PCD'#>+5!; M9J5TDWCKX R>8\1:04Q7G$WG6?IY&8QT&,#4:*&.#0Z3I(03[[V49!O"74BC MS$!,X0CL**8S.&K=6C9*[53*UO#,,WZCTW\]20,XH,DOA:DY!-LP#@8'K.&# M#0[?97D1C%6V'DO&X&@LE"?;'_2^4NM4\L!YN8#-:R=\N+7]M7P8Q>S'*4*< MG6D:Q^FM#J5(F/C:XO\?3*B@&1@LIH%:>O"ERDX?U/7F.?U*X8Q;R-/SUH%\-A-YRBCSX&0WL\ MG(#PA,.#GISL#,;C;R;24S.-$WT:/MX"]O>'WP@C6R,I1U:W7[_RC%YY\J[G MEMD=ACO3_8->=[@+NP6*?_S= SM6S$Q?=HZ_7'^?LW MG>#=N_-VVSQTVV#[#G0F7M[I\,6V^;U:X(LWTL'><*\W'0ZZ4F#J?XP8SGZX M!^\(CG0XG?1[X3?W]58+J=?Q\20$NW.*4,:+620ZP?EA)_@X.GPL5.9W(U=$ M>WA1!&%:PAB^T<&@<3V:A^$&9V+YN!2_XK=5-LK> M%J*9\7G*4N8/U%;0CZ:?=L%9A$GYC.^ SHJ9G\\_HKKOOBE^K!FV7NHLLT)W M+=EIZ%*PX5<1WXIEKOP0=T%\9=7AZ_>G01G MKX.CLP^7&'K]\N#SS[G6/W,(I'='Z&'_KIKM!X4D:(X?M2+[&9E2#Y:YQR4T M_Y(9^&$5/"*896BB_0>(;7$5/6$%S/GAQ65P:B91?--$JC:C]\VE?<^GG$T= ME7L* 6O:L^T^_6'[=&UF8*TWV+H>BM_@5Y]>GKP/^ELO8.^9$Q'>?MZ_TMG< MQYNJ5Q]'IQ].1J.U.0J_8:ZVVRW[Q%OV\,7MV:N^N,JB_-/55!!2\O%F[.)T M]$?P^O#H\NRBW;T/2?7MM=OWB;?OJQ>X?<=799+)/(UO9'B5%V(ZO4*L)$+H M'F_Z/GZX.!F=O?OSY#@871Z^QF#8^_=>,*S=V"LG;[#;;NPGWMA'+W!C3ZXF MR[',5/WU\O&F[.A?KTXN1B=''R].+__5;N ';.#V9'[B#3QX>?MW<+7(T@6. M4#[B07Q^<79^M*>O.W&?08;=_OE;=SMJUA>BQBW[T12NX5'W+_O3MX< MO@M@%Q^=G!R??GC3;N.';./]=AL_[3;>>7G;>.<*WEA>Y6(JB^55&.58JUYF MCWD8OS_] M/:CIZ5%-+:RIA37]S#MU;69@K3?8NAZ+W^I*#E^>*SF\8I:UJVF:75FRA?R* M26FNY+_+1W0J#R_^.+D,7I]=!!''RX5J<>(\JYG'X*3__EX>OFO M#ESQC@A@1I=G1W^\/7MW?'(1O#^\O#RY& 6''XZ#T]'H(WQT_O'BZ.WAZ&2$ M=0S\VT E@-I(\L/\U8-6;SRMWMA]>7IC%Y1%+K,;^8B$ !IMV[LITF_K/$]KL\,$[_;>3= H.7YU]O R4]X#8ZU8!/$ !M)GE)U8 ^R]O_^]?F=8Q M5[;+QE5>+A8Q_5MDCS>)]LP?P:8_8?)7U .CC^?G[^COPXM_!<>'EX?MAF\W M_(_?\ '1T]A&V/7Z '@#_>?KA#?W *@QK';2:H=4,ST SO$!? MX$!%F"'IT,79.S[R"39ZW$+,V@W]3#;T"ZRG/!A?I1F<\]PK MXU'9%,\NWYY0]M59X@<68!Q.*[&'R M/PNOIEER]7>976%/65 5^4).BL>;1&NV(P#@\ ++1! .<'+ZYD/P^\>+T]'Q MZ1&%^(/+MX>78!6<_ G. 2B6T?G)41O[?W1%L$Z;OX7:M5"[%FKWHD7M^2/0 MOP,$O<6@MQCTGWFOKLT,K/4&6]>#\9OY@'HOSP7M]ZY,.^,KT^_XBKL=7U&' MO\?T02].B+BO$YS\WY.CCX0V.7O]^O1((\M-]]'@S=F?)Q>8 MN_F?>/._/&+=JW[?V?*3=+Z02?[(T6F[SX_.WI^??!C50M3MEFZW] _:TB^0 M'ZP_N-+4?E?I;0*'^"Q:7,%A7H@HN1K+1#XBSERS_05G?WV $_SMZ3EUM#FY MN#P\_1"\.OEP D<[8D;X>SKA+39=@<8^HH>!H["L'IA^,3L!J. M3UH_H-4'ST,?O$!2L_[.U2*+DDFT$#'"3M,R*4127$VES*^PU#1Z1"3J^<7I MAZ/3<[ *+.(T>'URHO#G)Q=_GAZU4+3'W>SKM,';D'H;4F]#ZB]:U)Y]KOGF MR5/-?Z[- =EFFE_B3EV;&5CK#;:NQ^(W.YDOD.ZL/[R2GV?1."KRIDKGJWPR M>\RTT]O35Z>JIKFAV#D8';T].?[XKG4T'^1HMHQ'3[WA7R!/67\7F0T18O+I M*B_G\/M'[#:%U4Y!O]?](QA]?/_^\*+M./60??S@5J[KM'=;R[BUC+^+90S_ M%>-8TC^?Q1)7GGWGXQ[ZUNW+_G]PWVL_)&SW-3&Z;YOUR%,0,-TT[;/,ZLUKR6=L5TQAE+^*^%8L\]_^ M\<_J^NC))X%KGOEOF>"?4X;ME'Z?N.^W!GD?80Z.#C\B<@+INHQ[^QU5UO.: MB[,/1R<7'U1I\U^'%\?==V=G?^#?EN=LU>302T5)B#IJ9VNXO?U+=4B/I'^4 M0OPQ"NAR%N5!)A=I5@0B"8-B)H,PG91$/!5$"4'^,T0!!>,E7#B5F4PF$KZ! M2^U/\88"/LO3N0R097: $I3="G 1XC3]!#HGL"QV=$'_MP!YK>A&,IA+D>!% MZ308\1$3#/8.\4_\=L08Q@A>Z7!2X*?]@^UM&K"YNG_29Y!-99D&:!R,%?A0F8ED69R4#>X)4=>/6\C.$G.(IQF4>) MS/,@+8L)S$&^%5S.9"[=6Z>@P!.TR6_@VCU9_"_.41B*3( G@-F#.D.6Z:'@%3.Q8YS#.L)DWY@I!HL*2B"&YE M,!,W("BNQP":]602O&I2@4#(:XB3*8)O!!,"P\ZWUUD*'>;!,2]A1(J3IA&_R MB"?*Z)@.79+/TC(.@R0M I#G"4UH*>&2.,*))-E)EL%JW;,5_,O>AE8#ER!D M*2NJ0ADE-VD,RYB78[RLB$!0LBC_1*,L$P6;+);T-ZXU#NRZ%-BY0TH2,24R M('C$]D.#S+3RH'VP!'E:R(0$?TZC5W)$8\*[*H)P$L",1(WEZ!3&&?0/@XT+ M'--K_MDF"E]ZVU&J!LV]U6:]D@CRRP^V>GL[O_@VO2-=N["XC<8[S$Q6_$9B MU,507_XK[N,8%&)-X*P H##O_?(#)7!GZV#_8&^O?] ;[ QV^SO[]LVC! ?? MI0FXXXW1X 0EMVLL3F=>^1G]7J]ZUQ^SP>"< 2V33\LXP'8RH 1!DJ/_):PO M'NQI=@WG[T2I53F/B@*W31BEH&XWSMZ='&^B:)8HF2#-&4DV:+6PG'AF AWA MH&;Q%T$A)[,$7N\:3V+<('C2@!J,1%AE3F& M6)*#KG.O9 #DF _3<+>0V2Y55%4M2R[@R1BZ(]HE;*6BFS#LE" M+.>>C\'A1)2Z3$XDZD$.YWAG+C&^"W2O2>!(OGRIT[X)>,%SDD'[D_J3*"^# MIW>Z\GXJ=LH'?2O"K0@[(ISB'QC]M.$CC&N#FRQ,,-VQ$D,YI[_2["'QFP[' MT"M*%.7Q6B8R$W$KC*TP6F&$0:MS6R7\KN-T#/(HX;)TONQ0^J $*0WRA8K% MH'RIJZB#UA*]G0A3.TY^Z";%8YYN'"4\RW8MEL M3*;3*4@?*35T>. 54Q#'7+5?K4:ZC<6)X: R \G,.>QMX^7J:*;4,XJBFX^* MDDDFX2=\E=<$=,LW1.SGR6D :G#"@F5^&7 MUS)=I/ NE!?%Z2T+V0I[*^R.L!N9_C]N,IS3HBB]TV">(E9B.HTF$7YC34V4 M/NIBE.<50T!_K*XH4G@?9$'%ML"NA715D0;113D;Y$FH9 $^^I&@]Z,9"3#ZUQVTK9(Z0 M_;N$0A N)3D"9HLN0:6!!BR2;]VY8ZI]E# MBZ0)7$"I TSHSL4R&,NMX"_\+=4)$NBK$)\D+5Q8LGM8+O"I"&+(\+SH!/,4 MA H4I:M*FDRK0YDGC'>Y'#.47 MBI@V+-$ZZ1G="U M96(+D4/UC*JHM4?A$POWH#T*7PZ/2!"%N [('/T\>#3.#R_T9#R#T5P&IP\Y MR;K]_M;.3O^7WSSNL7YO:["[]^0''"TANIC]*^TF/(^E9'K)K> 'K"=?BH_Z M-2HPV+ERD*\^/NOAC4X_G(Q6\L:LEJS='V8Y/;(0G8&5>X1PB&3Y*#;ECYN8 M;YN'OQ2_1Q!+$1*ZGNPCG6COU*!1]=I[] <>4'M_!XX$HVKH.\##E17%.=8T MCL(N&8)\9XKI.8CM+8K#<P$&/I5A<0MP6LWRQ ,XV(=2B(&%U'(8,9T7S.P=@5GU01V#R8P1W! M',_+B(@2W3>=EG'5F-(^<7=:[+T")?*"2:"*XS+CS+9R*3 MQO)74\FAITX@P3^8L -F,&CC" :UF*4)6.N%C&%&D-L&#?8D*M*L$]R"&.#( MX6O\#]P&S'XY!B.=YU=F.<65,&E9PGJ"PU!>S[GB%VPU2AAM'%YL=H*;*%.> MH?KTSXM-?N$2MD1*J7$%2B8/0]//*%83L.;A?\>2O4Q>=\:H6F"_BV"ZD9F# M0=)SX0FA3J7J^A(2%H/)FS *N\"454#>+KZ#O.7 \C5.">8F=#(,!E7 GNMP M%1;3GR@Q=U&#B :@UP.Y3_UWI"6N+3US!OD%#.3,,'<,D:T8 !8+L,X->\4P M9NI8.J*,9+-;?V?Y>8+5L40?%)/;CSX>A2GA'Y]ACZ6W.@! Z*XY_;M4P(@$ M9CYV)P%D%W2M&Y\G38.%:!V%+6:VHN:R7%U>V3%89$).4KY[T N6()_DZSH$ M2K=I1CMP$J>Y!&FG=<:GXH?N1JH6(\%]B?U+;2 7M.&(%BV68M^1"6WKL@:" MYIUHM*G*.E#@H[*5X:WJB\Y>]S) " ",'S6SF"#K$[J[:QX%07%:9!&R;UO2 M,E7IN$0E =._T=_4)U>0P!T;<#HYEDQXT$6\T%[#Q :X'!4QF5J-[9U&'4.% MYNK5W%6LN=&LN56MN=:M\ \,5Y!$S648"7U$.4I7ZUF\MJI[\ZHZ]4='+\U' M@,K)ZTQ%3?XHH15L##8-69.>3/Q<1O21YA?!E!A^(P6>!R M>'#+W5(%U**E)B34TQ@$U2)A%"=A5.THP> M44914=IXKBT;KD#>P:%7#9AYXI7JAOE);Q,Z.F+8D#>H=!WI,"<86%^2>19( M199C?9%5Z;L=4!UFCJ(\+Q67B"Z#HO=!C;CF6O O;R-8C7;GEN-CRD"]4)/) M&Q&7;,CKR@>"BYD22:^@T9HN3C&NN,ZD"M7>45CN6O;U X^KAV&R0!YO)1BT MN'')A%8RHA0R GTG;K&QNYV(W*BN=3XEZ6UWEMYN!8<<_/HFD0V.GI\LE"?M*A8:S;S@Z5\S[G9.V<@?<(>[[+\6!?\\)];,; M;.8J;W]R)_[) SZ7(/;'2IC.10(F.D_@3SYOW\P<$WG*FQD$Q.PD0#6%WFNG#;<[H)L^>!&H&IB=C=M\)F"7XDN4 96XB0W M.WVE:7EX\<\_+X(9^#8YV8]A=(V" ,.%6XE&(U-Y:55[3" ::0B'>QJ5I MB1*AQ1.W5)R1-'^+WL4BL=K70HZ0BEX1B%_T52Y6K2607.5#8* M?DE]&G2*VOBFVAYO1:L5+1:M*9Q>,O-3V!R9Y-PV'5=PR^2ZK7%JY<;*34S^ M%E$;^!'NN2QF:5A)I*TJ+UJSV,TKW1J*\PP3L!!AWF"*8$P3RC8VI9LI>R;" M=(&0FGPNXKB+51N5"(L#+*H'&6U(T6:4=< -[I@5.IQHHH4<=>. X5;PO@:3 M4(1ML.)8J>OD?"E3B8&^>P;I1/185E2XKP[]B72%@$FJ(DS#-(/I<.B(2U L MQ1:N%"?2&5)$S_9&TP+\O[/X;[< _[;6[2GP0 I\:I/<R$ ]1 2M2J=>SIT@03W: )X"8(L!!9)G17GEH68RL8D5)U.85UKT0=!@%\)7ACN$#U-Y(I)'/Q$)99!:*F:5QS/]230(I0(Y@U/+Z6H8P MFV%E8*<)DG0H(%UH$CWP>PR28JH]$PDL#99$&4[:M#:Q="J8*PM]L(32RVQW M%#R3"JE*6@"L'%/>"4$9>?84>MB]8],B&)" /K,6POMP;WNI%8"TGEH>.T+(+A+WJGJ\R(OA 3T0SM M01,--VW,25^-DB%&7MA>$F?K&K?D3(IB*W@=EZ:G22SFBYRVL/P\B=!XO4:& M7U)TL!G![L0<#;*JS;C-:*"BJC9-0V UT!$6GDP<[33X0>\7)V_)<-T&N#+3 MN,)@I[6A$95Q_S?4, SWH7ZV?*]_E\)AYZ8>?W&J $&95,1' 9C9&CVI0-?V MIJCZIS 0KCTE=4_\\O[RX<(U31M!K!:(=I3)302FN^H;,^'>OKF_ML5RH0XZ ME!B$#*,]7F;+-4^6CYH*2+#/*A8() JJ@%:^*VS&7P*1XW)F;Q,$)5'+Y$C, MD29X+J4.W^Y6\ IVUTT:A;H/$&X,!C"2S'?Y,/,)A.&1-:G(5>BN(AD=7;! M*,M.M M#G M(B'[7((<;II.OC"5R P-(Q\3ZA84IKC!QX^E3+0=C+8B:]2AJJ88,\WT&8_, M#$/$V-QX2=$%N"6R-J1+9A<4;K2A)H8VV "6'DH87^+ E1 N"=X?]R&'%QFG M@E2QJG*QY-;ULX_ T&,Q^<3WI*N\F,:]B**.+KMB1Y':I4^\!S@'S5RQ>6J4 M)D84"+8"EZFZ+!/6^5\F4\#=UEPPPT.A5N>@RGF-J)J!P_ES0NA\D@H'BU\@ MLC0SE614_--<&;?>FU>)KM+Q?+K/8*X[&L?'"%T^R$%,,=B-+$SP+^D ;2L1 MNHI!Q7=2J#:],:E$DK_!=![Y'GC"H*Y&ZPDW&I\@2(L"-W-[9"LN=QH5BXEA M<*H("&PS5A;L::DG3L48&\$7%&4D$\4I/^OR[<4EAT M.KG@Y>EZ6I&F>OR')I;I]RE<9AC00"4!Y^ B M\)WO"T V@N8:#F,UE]<8_L3:/S2.F5+.&Y0];Q2O)JL1EF*_U*^**?>*1_#& M%+-P;\[5E$38H@%UV@F@87N%>Z<)T\Y.2I!R-HR=MC55WCU3,(7P_(ANY$XD MEV2*;!S!*8 '&D>@S14 0MV_0D#JV(?2_>=V:3S#Q5]W5K# MY76]NZYG'(%ED%P7LWRMW>IJKN'6M?:HE#HQV\-@>ZS$:PO*-IXC&3:"J<\+ M+#*1"AL]C3+%!X[:F3K;VLHZOWJ.^WZRT2C=$EHNJ;45KU1F J)NBO1-:59O 8K#E^Q\B+. MKTS!CT(MDWN22_F)^_W-L-Q58::P?NJD8#P9VO,='A,=IEP&R,O]GR02+51DNAN?28 R&8XWM0WPW]RF"Q,)66(6*@(D%LINB^L6$_=?A,=>4A M_%.71]F&\::>BP7M$T6%K.[(M>[0T>TJ#+N-;=:\2:LTWIGR]W57O4P\ M9Q M>IV0LU0C"6A4JZ@&P-!!4:^7N(J)8,Y47:L*F@GVAI1D5M>S/[C=/G)9K(A9 M3_W7?_3W=GZKMFBN[4F]R97M3;:<8P*Q,6I,^W+!'7J1"H%FJ-+_B8I?W6B/ M8C;!LDY;RHR9E(;?:08%+K_@85$P6)M?,E1.AW64ZXEV')O2U'?H'FS\YM68 MC"597UUT-)0Y:P[ ,F<#3-,I5'2P4EH/($3X^1,W/ZLK?=E0^(X^9)+><-F/ MI0IBP9L)7;>F=MQ<_)UFRF=@_@XT@#)%8.Q(A;^[\-*&>G8ZPR*W.->&E\[/ MWX#/PAE1_/PTF6P%&_#IIF4/J3$^-&B,JD.']@EN,T?JR7OB)FRNVKI59 0Z M5N;$V*KF7:@[%?$#:OL*-L2$729++J"<0#CWL6RP62LYWA!SL?@5X!WU1'P< MV!_HS6'L4O,\D!'B-*'3>>BZ6@"7M-&3WPHN4^;KD1AP@5?CV)>D\"E%2KOI MM M/Z\*$@U4T1M[1E%<,E,>A=5>#(X*K(/\%B!B-1X5;; V[4BZ'>22ZY_ ^ M4VIV?DV>^R6Y[0TWY$52@1_4C?5&ES;7Y?2](.7[[S(");K4I>"RXYGPXTP5 M *@Z-[PIB!GFR^YI%F1KZRF,"+*B@L4NEX7M_%*DSTGD$Y@\4YL*8$H)R@>8"G>D9:0^(,IH M)NOASK8S#18$AFMRA'I?NQ$>+!GB/Z43[C%Q/F-$<3< >(O5 3NTNE7,"52 MNL[YGGTYEP;')02X@PV'\U_$T(YZQRPC&\2ALH=(7\%B*/]#J@3JC52LBC6' MU@8[?18PAS5HQ>RP<8@()C8%13,?8'.(XOF89JV[&C=1LW4\7C8648]AK>X?7A>3&+VYX7'=O6VNK1D7'W;QC[LSQ MJO/9=+=6)W U,(-0W\IO=-@NRCU0C(DPQQ8ZK&&1V-M, 89A'S(F"7YU"ZHK MIL2008%UB(X5GJI32&DBB>D7\Y#.0-EP:22;)$L PV":[+>#83Y+*S+":F7KXBE[OE#'*D/DX@S MWU36"4)+Z&BAQ0J<5(F2H6%<@IZG]D!1$LW+.3;.>S)?M"LT TV'.^/E5M" M"XPF^/0UAI%BCMPSOY0.JRCL0$Z_:^Q':MHM.AVT-#S0UV$9D[EZ'*!(H5=O M#' *=B><$&182LO)BJ:0,3'=EJCNA-*$K)R*#N-+86>HC"+5).C]5-G6Y' M M!*;\@FGTF=!Z;*].)2M5=(6S,B$.N"Q=BI@4Q-BIB8X<-:9^'38A-Y0RKRY/ MQ7)5=G'%+<0> EHZYFDH8Y:JW%*XHPJA=(72K!.TMRWD 35+#0%D@#V]<"6T$TM;98/6J#HC:I3@UP8SCM M7-E=4>;EIH6'S'#4W7BI(7;N3':UL8M!"Q4!F5(I'AQ+:$JJYAU+20=X0U01 M(=LIR$<+]/CQNT60L"!\/Q.33]KK &%P5QZ6.,H+BN=X.$N_V[IRCNR)@[*N MRRT\%TB9>]4?*%K[#(>%ECX%Q52EI99@4PBC0\8:6>(4Y35%ALL$/$PX_,%G MK=*TV_!>(JA\BCQ._!$AG=Q.$VK@8!,AE30919A4@+<""=>S4LB\,$T;E-G" M%0QY7F84B,.\1 H+K<@+$)& &8>IS-"UUKZPS@/X$T05!%@)1+PK.;R[]"U' M5RDH^(=0C575HN(_O87TNX;+).S6[88?L$77?(^>XMDPV.Y8* Q"J;Q^#@Z* MSSU_"*<;!B,QSTN0<$T%?Y1N=8)W1;@5;(R.CS;AWV^:OK.?PB6OSD[<@-V; M+"T7[L7P/5QU&8ED+H+WT21+NRZGN7,E7P,7_TF5>.EGY[X:O:6_@JO^*O%P M/)J!SQZ 50:G[*)(W5N/O*)<_1[.6)UG'XW.+N&>OPM<1'4I/[,3C)"[$R[F MELBF^=3A1WRB>0WS;;#A?K.Y%9RY_7%"9X&4BG).U(A7U*[0'R*1GX3_\'-& ML-9'A,O\%Y@$>?!NZ]W6T7/:F2TDZ(EG?-A"@IXUG=(+]HN//!! )>'SC-HL M<^[I>7OH;Q$-K;-BP2L5FUIKO]TAJ](>@1OG:TXP-A67^3EO%:OKN&50W'&" M. /0:IY@V^ M9A+N7@"RTH?+=\;TSVTH8YI.2A5]Y51(4U353S6J.^,0%26^MT/D.GN_:3RU]J(4SLB-JGO> MGLJ83+55K@A*L.BP6W*B%1>%P)0*[YIMQ5N38G!YY05BZ8Y:"R ML8A5 P%:Q@KN>#$N8Z!HR[H- 225.LO*34-FE=$ M;+:W41J^*E%L*[>S-)9>R"VMSZ#2Y+D[<_=!\'R%Y^2 B<#,2NHX2(@!0]6^.IF#$KE=8U5+ZT1&LW0*\@VGSZB0"YRVBZW@ M=9H10: :ZD?==I9BM.^C"4@U[.(-_2\FK+)W0K['X 2%'$[67'&$UNXS2DL\ MD)+@")$X:99$(MCX.#I:75CPDO3]7=I*.Q%(\D%-L==>?^L"Z57MPETW :S* M>:J0Y:"=3,C>A8_?5R1-=+V8Y%]@&:CFL7U(G3/J356'X_2-MT02XR4A0YHL M]8;B 'O&-,-=NO6C[F.)=93>I+(#%0C;K#HVKROSK_!PFP8%4].+^/M]U*(## M5_0PVH6F#N%U8NZ:$TN=K6&YG&D@%J_(0OQO;2+8P>[EF%4VA0D^5B%O CHHSL"PB%_=T/PT. M6X:-P2\XIT'A_[M4_&36C?0(SE09DK(P"=9IYZ=X6+C M>J9@RX)?[)J@F,N(-TM7I/ M+QX5D?4/#GHZ*M'1O']\R*+MO0RN4UQWC+<0>[+VSDT-RKBQNPC--@*#-;GL M0QB6*-A##9;@!WY38U6X%RI"^FLQ+POEJA3(?(_;8BJ)8LIE@J(U*(C%G&Z/ M!*G<^*.Q?1?RBIOC:NE17,&D:DX8__RC\ *%D6V7% ^%]$*)G5[P2:B\!?@M M#/F-98?0'7?< W#=CSPWA* P2"N+8!UKV*M)K;)PU#7% T]"E^09;QH\*K4' MTG0)G2A9+5C-IOD?%Y=1\_Q:T@M,*#@G.'67C*M/ANFVKX8BF#0V3 M3-U$AA[&)$L<1B72>(W%G9PB\(I1?\.;M@+;"BP)K $?&>=;=<*H$P9.9NBR M(UQYF6"N+LH=7O#59ZR61FI5E"9=]H@;^YCYPKAF=7_O&1+^=28Q[4H+?R4>OA6LRUWDG7;3FP@"4@/ M?LWM9^Y. SN >JXJ1(>0F_R,%^54U@!U5 M6(AO_!:S57^D5+%KV=2Q586"O@C%43F-&/%Y*:);D=A2_B;*<;C,W)[W3,%&1?=P:;<'T9EG$S/8_?YKC9U6=IF3ZEAC49(1) M.%%K2E&))612.MCH,(7#+8I94:Y08%07[=5/$Z+^^*C#]]3DQ"9L/A.&RPUO M"R*LBC3ZO5\<^EMJ,$MZ5EW,F]%(8$2]MV\0&QA*)/ZDQ&.RJGV&JLNQC PC MKS,PRJ\>%$=90ELVXS1=P"!XDNK>,C!\$O@0[=1'(Q;Z627.(#AQ0AU*+MN; MJUJH58&BV^ZO"H =;/0WF:]N%5$?*3@JIS+\7%/#05CK (*2N3'8?& 3,%U$ M16ERU8;1(RN;-J=X51?DK<"AZ*Y0<]S[63YHK%4P M+(7$KKC(\%S&]JG7F9@SOZ*>5K2 BKB!QE!K>.J[4O)M:WWA_(13,]//'/M0 M.1V.5)<5 WT37([E/'):TD16$7^G3LU<+B7VM>"N]%E=?R]'X*,2,V(;5>:,PE3E5^LVE+(((!.:N M]^@X.Q)[[1#SNJ%:-BS+H/DB>6OF%45/+4W%]%"(#D2SL$$PA>$F#,B3"5/; M/5 +]E^H%L1#ZH'ZQ:X--3+'PAEQ(Z*8,JLU2B"MZ2HJR %F-E3<4@H:-:I^ MO+L!]-KJIIQ.I:PC'.[S]$^KH%M=6>NSY.L:9K^"N%:PK/L5J2'FNO^Q(@8Q M']-8/DFN8C7>'CG6GI%*;-C^,YLID:("#W3V 2U'4:WJ=HPE/=II9+RM[1_5 M 'UZZ+PX[=,1&,P.$"&!&[AF57>]2A<\9="K]2&Y4:)@#]C:/*^(JF&GSNB3 M9#8J4XJAIH=R?\*ZDQ\L.J9K(AF M_/X2!-URI+;C38,!O%N >FTT@B")7KB0]1]S;M66UT+O>#:X^H=7593VC9X-.C%"RL=M%11#2_FL$RF+-(M[ZF$30C^$*:W)$9V^M&M^ #R-0L. M8W]9JN?33GJ,6.9=*W#(>SW)08S8>#V63 $Q4[!'/8YF*><:UPHR%#>H4?T M?[/J6\:YO,6QL!E%(0[<7=^Y6K$)S?$#2Q4=;BZRJ6 >=5V3X=2H7#,JLI+T MV5JC(%QSAW0O;8HNM5>$O>+RH.FKR+!2\0UT.J)XSL5&"G=F:1M1GZ-YPKX< M7J,AOY;C/^5)RMV*&?!^]F^D.\/Z33UMZ\]F/N;'W.L)$VYW:P2+"DUL)-&7A-^49^-$$QJVCND,@KO3 M %6)EE5WV'"Y7GA/8#&HB79B.PXOSZ.B.[;.&&WM>_P5!P*L/0E^7S3-N3_( M'?VM&WJ74%,TE&MF/39S(ZOHGUFBL:[:^O$ M*[! .]2:)B06#FF^MQBF[3R%%5+LKGG/&:;ZEJBH$A'6,TN](JZW&8WN."ZE M[FKE%=:-HX3/][ M,6H="JW95BAB3EC.;5ZK^SY.4D7*;\HRP64@P(UU<7(;!*>74]M-(0A)Q>C; MJ=:TR FO;^B4V7*36D7!)="7*O+&K:]4&0+ (APS#T+ES3P#USA]26.36-.8 M38=M3>O6*AV8C;UZS&N:B('"H5ZYEH$;N?ET6QQL[DVC:JHF6WNFJ08BA+6. MRC05=RN/CP,/'-:NG(5JK]C=JB+J! +#&^;F(&0/J&X@8'J-*@V] P\-FLM, MF,R%ZW_Q?9MNBO&,F=0@/[R[=>/4\V@O:JH[IO"CK$^.&3X:/,\$\B3,HG%4 MZ'=TB]F#A!TP0CVR%WJ$A40$;]G#5>;?A;P;G_NASN,&@6;HW%>;Q% M>DLUH3;9S#EL6X4981,PR:0L%ELYI::\20C^0*R7RB$^ .,N*V $"=?;8WQW M+-#&6*HG4O"XD,2]%\%L4]Y(8&!NS4__ZM)A7S,\H'Q.6^YI@CACNR2&!U?& ML!PY)_AY[I4$5:5-F5^T(#,IO'IHM#G5L8 ('6F[LQ@F!0V>U(P,?G!CLESS ME;2=@Q312S.DTM*;Y&#TI:H6G+NG:I:=>\DQ'DH%8T)3;&H[Z-1F^O!Q!O=A M!FEY0_1_KBYQ\Z T8)4LMJSB7&E?X?IHX-%NU/R>E51KG:4=$G) 5(J\D'7 M@X$Y6LZ;"MQ*H:P:8(&6HT5O+D(S8I,4%]/884 C]VUAJ(!IW0)S4:J^D+5W MK< G/.:Q%?3HR+ZE/#F76@$_]AFY;#;=:<:&/U,M>N\@-??%RIFH,D>L$AP# M#^):H#6A'"@YT#ZH+=+P,G84W?GQ.=45+*I.,[^::'WM[<]#B\HXK_))M4:I M,U&-&KGS134Z!B"#AS2<>J@QL$+=R2 Y,JHU6U+MK>;J=B>]U*$L'*(VR$JB MV$_G[J+NEJ^G!N9X9OU7 CAL8SE%RK#"VG;(U7N6)2],"==W)+A]%U-L%P\)S!:J-Q6DMN*QA1H^G8 ME)K8:A!W\,?K"HML044V<#GBM$I$:I^X#?IF MV&H;9N0=3.Z?\EK $?#A3\Y6..87G%86/J^#M:_=2F4'-.H,EQ?L)M)+H_CW M= C>=-UT"DRM)T]>)[Q2AUZNR\2%\S+15_KN)EV*QA^BS,9I^HE,Z+(P34O= MN( #/5,"E.LR@FD9)ZKNAP:BHZ$P1UEY?2U#C!=U3.\'U>#^%DYM)7'X4*K_ MII!NOE4E?=; YS$LG,)3ZW2'VC3<3;V"J%4V=UHR)I^FI$B[^-^.C@(YA(&F M-H#@\ERB9(@K5]*@N9A;C")-"DVJ-3,DP)J.W=[=ZU$ST6+&+KJ9I=>>>]1: M#O<<@DCIICQA3>[WIX =$?P.OO.Y8H-;Z[.1]\J$*D?&7O5!J'80GV"@[1:F8\2(5I+_IW"?H'KW(Q18TG$7'GKS<'&.MGYD#RKV6WCN MG&R7;OA%BV6X"]TYA(]E/&5@I;&G&.2(Z[*Y%;Q:JG9C4[) MDND;4Q]X/H.W>#1, 7F31F'NQE[QU%,_H>E2V !\2&+.$*GF,9BUN& M.YG+X#"B;%CD=N!R[H8:'9.[1$J.$+7P1FA&]T8^JEI'$U]QDMT$EQV#?TDA MB>U^1^4\[#.Y=1KI=FJ/!]I<709ZQ]DU.D6TJBV4-.Y0%Q=V%L1-* M>,6Z0PRR-)'9H$Q2\PC52="YV[V9$:^X_)DRF;PDG^VN*/[(M&%H:/[4V/1I MK5VVOQJ(H=P&%4YC(]@"2!61UQ,AE3Y&]L(*6ZA7@DH+XF>0;1RUPN/E[L\: MQ=<#&BB8P@ZND*WWS&1KC)0PZ#/D2 MAY**A!US,H#'?W-!F.JTITN;5].-(7*RB5EC11:L67OC0HSA\COJK M#4.I&6I0:[1XFE*I4;<]RS=YG+7^B37O_1O=(([3%=1V3J>YIHYGFCCU0\%*&K![T &8W6 MO0C FU.=>:39U$DKRW&["EN$5U8Z%>;4/6K0Z_6W@H\&^X7L6XS[U-PT-;(. M"K&XPFOPYA5#V'TP\0\Y "<231&3,!R^IP%O4,\7V86!9]%G4W3-M26$!.)6 MX&DH-ZL9JWS%.Y#T2]4 R_ >^:^R8H?<-8WX-FK?^=B-&M&(;>_B!L#4(_%V MAAK"?78%@==@7\"3<1!-N2(&\@E:VN#O-$HJ[2?UR__\Y_S/NJ//$NNC#\A% M'W!;LZ&KPZ:,1IC24Z B$("EAN^(/U6IG7[OV$68)R* 59Q MMBW$4D'@];M;)D%B*(2Q3W$V^82JS1UN]QNYU$J#V5:2+M&P4CF482]5P5I@L Q86I#23B,-63>ES+DI050+DWI&OP:WO=+R%[\?0 M@GND2A<"*5XCQ2.GIZJ)%H]2$ Q.Y3+!>^H,.2U1>@JN@<.L0;_B\/6(+.4A M46V4Y%JI-3 ,-EZ% S7BO:\$4A-^:=0$@G615$_[DV[%Q(US".F9]F;7ZE^2 M#.S(:0BCF1LXNY85,FOGE/3*+AP,A0.!Q>ZZM(ELGRROADRA&W+_7LU$%P[. MAA-/E3M67-OUUNNK+;4*Z2T>W6(Z!6DRV6@2G/Y0ZQ/.QPWKQX*NQUEEG6GJ M$[KH+C[4RK@L5P6C7-1AP>3UWE'1'_*F,V96506K>^AVFV-X:N6PZ0=8+1FR M-FT\%-0S5KZE44CNS/HJMJ.8X!#9([A2TM17."2'Q!1HPBK^'K.4=6H@Y@Z- MP\,B]-QATF9^.D0#23J'+#,=(<1J?'5(7].LX.Y=34]!D\[1[7T:8U/U=7=) M?)H5(H_:+_/ET:T@I?7)%K6.=D\)M[4C =,P&>I# C2=:!%-H@6SZ6L5ZQUF M#F.>Q9+I9VI!, 31CM1\DP)V,"0.^*U1R^HTQ&I=:^_0:M45_.0U"]E01G=< M#N2J.?SJ[.1.>Y&T]G4&4@;WAHLKMIK>S62S::V@:[^U]\MIPY0;:B,*D%5? M6:OM:=0U#0ZCVN.5S5AW2G&\%;>PKD5:$=+HENIIZH1$*@F+AF(P%BI,5+L47^0^V!!3[2]B M][TJW!0NWZO&U5G8Y^!;DJ1EPB13;OB.#75S4_N.8]4$1/4:8L,.@VN.L-3Z M8"1A?;8,K(#JS/6RNHO>L<]_*ZP3_E%C XRWOIC[E\U65^V>^3@"E;.J@U=6HDTZ M9NU<394\4?Y@:CZB,1[=Z+$F8HY^$SY1(E\P0,9"*87+VV MY0R(D\P?[]X_4J>VF+ZOQ?2]TTC6%M3WTVC6+P+U.6RWSQK5-_)0>W?J+\5, M_Q E]@*4TD]L K@G1TUHE8SR,5.QYFIG.3>A^2O-/GFBJQIO56GGV+YK\!KN ML/7R0+%=,S/PL,)!;#+-IAM=;MGL*HTZW<&^F8_?L.-(>S7$P/8^:7 B[SWG[/YX/47$/;#V26]]D27-^_AC&>IG;[VL+?D:8 ME2.[NJIX<+WK!1L(^1MTN=$!Q&:T4H_P >YWNJSKH0?7 CKLJE]2L&?P20VF MMJ6^@JM$B8<0%^I1MB+-=,-']=?:DXW27+\W4_O>BY.\4OT#UGH#_;6RW*29 M=-D[FU9LI15'KL$#&W2ZWW7-L-\AB:\H0,[_72+,CC(4XV5P?OY&[W'Y&4MS MK!5O6@0J&)]B=Z+V' V=*0*WO379[HIXF'OZ\,-MVY]2,V?($>L*$Q5GF4BI6RJJYWP])CJ;($_CUR3]@^D$[;;VJ= MXP514^J[*JLLV,C#0*%1R\TP*K,;&<4Q,5$32;D0 M*E?T5HJX8)J\D9C*QL>WH*+OK-3ZO195]*Q113^=D?%P8QY.J74W*,B.G@LP M2@7U61/,_F\*4.KX53S:3?ZVIXM-^HWPV$K!"/RTX]4WT1'3H2(/4](!)\]K M.;Z 68^(,==6DICCI\/%=)[%1#E*9-9M8GNJQ$)TGI(-2OQU:1HE MI'FU99MJ\.69@9K>"#LCK:2@=UM1'DUZR!61<.X2[SBHKS@FH_H)>,:9?*<<> K= M66C238X0H)>?D!E,=&%,28W"@XU+QR:H:)2% 1RR!A@=O==-%X-W"H*PH;[8 MI+2)TY91NSP5;8!=;&#'C&:(J02%89HX.GVEL9=B+ 6Y8' 7BEA0+;#V!WRJ MG[I_0<*LH5J<1#$/EHM"E:F#T\ 1FCGG6@C9AI"#0OW&6[+[E@<^S.04BTFU M H)]AN<3WE9-D@''E8N0"[_N7R ^.6@.]!O!ZQ%;;(E'B+D%TMLQ*;]*\T2Y M1[ =IB4J!Z6#]?Q-! B[IK3G[G.VBRFZ[]9/55/M+^@8P7"K2XX5NG :97D! MEPAF$;9#Y*Y)'!Q#>),":FDOCAPH_8*J"V^B/'Q-D#H@DD!#.@$JBD)I3:>\ M/;(:U[RRS,J?!"V+&@Z7D+3F),V+[B*&DXD4IRU/U"MF=A%[\%K6*Q.GYZ#E M*;_/(#YRSTV-)K%=9W1TKB7!:TJ&+U\*26)]BQ9 M"1R\\YH,JSX/?%"-LU00J-;I"N$L;D58VO:])D_H>$3'UB-::V5Y1BF_5:XB M-L\FK@?L>G$PT&"_:@HU:AQ2C%U M@-XI&)AXOFLD4H=\A#_YRSQX]^[("Z4@D;'\Q+3(-TA9$"6.8M>>KE: Q'1J M>W'F2VS2&NGN3FQ&4GA>$SD[X!E8K)87]#F;?:>ZE9"CJ((3/M[60F$]?*KJ MS2I>*^]B+2;J;C.8VW_=U=E7MPUIU/KLSI.'V$VG7=#175"!-)A&T-"92')L<&1\^=I!M.9AQ#/=F,:*V0R.<_BM"1 K M63;-H7*=B[924:N(?*@UP4:==A?,,;V&X/Z!Z0[6+>C9O3:UK%FA( M@P/^B>8&4Y2)>$F9'=@#8"R1M^+>W,,O:,U4<6<] X^(O/(YV'(NDD5U.'2 M-,HL*C J6"BKZ47UPGOL _/0&MG!$<7AU\.D^ (4I-,#Q0$H-9UJ%OK8,*WX MB[<(%/HC56[.N4BNEVDG&*4EHN333 H-YV+(1U[A,ZWO.R[$<'96!UP"#EGD M>93SD7V81Z([I@2 #<,8U+;*?55R>M5XPEUUOAT# *N#\\UC,&.J> ?5[T&1 MP'(WI2A@(N* 8]&DUG6$K#ZK>/^&:<2/WXLE1^1:R-!WA@SU6\A0"QGZ+J<7 MFBA'*;;!!OOAN.*(^!!E;NS*AOBOP2$J'U!G,;5X[E(% M&_P7HF-5__-)W0/UG;;46?A@X^CX_=DFVXF&5E47.EDH0&JB[1W,U69S >=J ME.+)!FZ=@#5<8L+3QBIU[V5)G"XX1(=X5 %T<\W2,I,B5,3D>VIQ$J(1WE*15T!UF. HN@<8V9@]QYVOF>9 K;$:" IAR[;'9OL]> MN)[OZ?[D@7!51P/RTATA_#+%\T&G\M;BY/P"TRB+8*3@1QWJA-6Y"AVNQ43= MAZDFQCL,@X=5&+5I*(D@:CCT BMUP8;Y=),.J(^C(Z.Y=!B+NF,H]>9RH!MU M9JT&'0,L9C#:*1RS]^5+W92H 1$8TG*W0R(&$IPL:<=MF.$AOSWL)?H5]V*@US@T5*XWS5 M>X KV"3.[[V_N9RE\T6>)@KKW@/[L7Y#'5)7X [=8!RM+FQH4"E]GY;(AN_, MWYJ'VT>ZH&"WPWGH)%$K07OE.-O2$VV G7K"&P"^%+3-C0*W@5X?J&@7WX2* MR3XM><_JS6.#V$[,F!L$J2W),-YCA&"Z\J7E)MA X<*7,V>)(]-; 7*#$ ZX M)E11KAXT57V>%;B L'^%>;5,I MQKVBEN1^3FB')KF"R,">01_%FMRT\O)#03ZLF MSG1'&"K+&,6B")H,*)4)/#R;7 MV-^;*H_4$'7A/7W_T&E(@YF,%T&$ H8%_8Y&Q?-.J')O'T[&R-JT:$:^T;'EH>!TIY4JN]1,8=E0%%7"D#+^8( M4WK?2-P;#D^9#@XWM'Q4#IJ!5,Q3+F!,@EV*QG[<&FWIZDI8^,2[KZ+8 M\]Q!C7U(;Y'R5I!#%16LAP\8&Z5W5$6ZMA+AW<.E[QP)@B5$%:AHN\[K6Q+ MVW*N234TAJ%6AYHT",6PV5K- K=:X'1@^%W,45VRBL,(UC5AZY+T1CUU+)>I M:BV0ZF"DJS.580 3-Y$+UHV5!YIV"U@&A ,O;2C.+(K%X8.VFF31&)< EN@6 M;"N=KYA[)-VF2X([FH9AT J J85IR(YIWDM(;/-T766D$3I8%L1+XDZ%-2EU M(9++B0HRE;1J;LQTR?/V4>Y_":1Q/N/:"'V#I'/4=U+FN1'V M9VA%MX>I)K)1$O"7-$%S6ET39VI3,YR::=H':LLH[F>:-[?%ZEU'PE;PAM2M M::[#,6>-/9@27;'G(7N^,>:S,3!84*P0WC0$AS9Q/7]]@!N !;S #$DN\6D9 M**.&%D84X7/..6S..S;56W!W&XS4MZ*]0Y>,!!D^'SW2 C6?&J@Y:(&:WQFH^?*TMNL#93*:C\LL MEZ;V12MOUBW$&,+FBZ:=8K5%.314S"ESV\R=?FFJ*/B?7$EC/Z,>;$Y3-K^" M"C5KE#M&-KRD)@M3S%@^YZX77H]%.I>\$%ECK>MJ:RK4D="%\,8]H=KC-HHS9!#4OX)PX')TU MK +,+$I=/>Y(6#E=X=1Q=I?U*A3GZ5UGM)XPST ?['ZI40XO_W>917D839JM M=$WH5AE/M5F%WZ89XWG7VH2 =Y+2#Y>QN>^X[?S*&5%_.;653@?$L&K0I/6& M]Y5+J:F6(4]3OR-F-(OIT/QV.DLH$&PQ*5%Z3849B@NR\2+][524<<'[ 6O1 M@FC*0C;!'3@6R:>L7!3T!>R!&$O86P=36V 5$5HA.\JNL"+)L47W-?(;<3Y]T8'BWU'CN+6#H8'MOJTE.^ACX& MQ*6B:-TWT+$E>QT,*,N!3O2*D'V]6M^YY;6OK4H-S MY[!A>$";)*M.UFL\V(F#$#46_M<6:SPT]U4S:K1!8]L(F8+WE%S6,E$FIL.< M9.P OW@>+Y^F<91Z521DC[Q/BS1+8Q&,P(%4M/%<5C+]YZ=_"O,]?[H9;.@/ M-E4E1M\0V<+.1HI ,D?T U5TXG7Y=T1@SJ,T6R@VJD[PZG#TFG_]'I3SI^"/ M-^+PUU8K/!LXD!.C._2$IFDYUUH#<)76H G8R9,8C)!%V!Z(A*\TT^C A2GM MI;]P;93ZQ1W[&1W[UEGH=P9PT*(/HT-8]T;&#O$0$!)B6F\P/8B(*:W1B$S03\Q42096C9)YR*:/,]L=J1BR'1 M+J%4HG8MB#Z[2%<.;8$N0('OSXW/L0+\.F&/9.JY#JB=&7'(+3[NF'?31$P3 MX-I.&WQ_3(TQB[:R8+%.K9S/A>O[$!A83#1W*0C-?!%K,NY5"W['B'V"79Z1 MKW@&@R_-@)G.[/<27+W!;H>$O$5-/E1-XOG6JD4L7G6IGWW]F 2GY\&E)O>I M*$BA?Q%8%*\32A1 -'T4C'NQ:Z/$#]Y@_OA7["]F*]VE_[;;[ MZZ'[RUJ-[2[#2.3J7>99(P7OL2JO.Y^L6-O* MYU0''*)"/92@(E1YE'*T>#CLZ:L9D&!)9>&/+]JM;J*1=^Y$Y#/30 KW[FYM M[]X_*_?;-IV5AHT^Z96QLN5-5"8GF/$)U17-H^0R"AUU,OZ;=SQ(63G+>[?*4N4G^YU&0IF?3F<]>4#E@PL.O33@T#\0 M'/HVO5UK!?97'1-;;WYLO^Q4@'XJ6OH !*X+^KL7\/<754&JGG:"NMH@7F)& M@&;.8Z@M3IAE(@.W]7^-S0N=(%"-O5#W#TBF7%V R0G3>X4K.X@^PI1NS&4Q M2\-^ M<,INI.+RQK\Q:886!]8<$+*6HB%:G;@*B^J.2?8F)0KJNZ-C'TBPBN7>[A'U M1(6)XVVWX E"!+BW"]5GQ*7I]3(NX[$!@^D"91B2 M^DP_ RP-7-#K%8]X(&%_BX]Z:GS4=HN/:HGL?HP)?:QTX+E(9!R<:B6K3YYT MS;'"'PQS,YA>N>8=UJ5RMD\"F=H66HN^LM\I@50U]=["O^!4J5"NYLPW7,[A M206=.L$&7\"M"<%\I"%GTI*+@ K_'U3ZFQW'!@:_-%XBX\SUZ@-.9P; /LS2 MJOI7;66HMV&!OJPV[O7!9@H7F5VUX1E;J[_R[\*G*[V$\PJ-OU-]+I>&_MR+ M5*CV(,R3@)"^]!9;#='_9R=[P>E1Q5K+I!EP1%*>#<8PA3_@<\P.IT'&^0>" M,Z.?D:K./'2[2K^A-"^V@K>Z(P^_@)4+!.=0;QTNK5*^EYI0U8O-Z:8D::Z; MEXTP4JY((?2N^5*S@'E)08O,^&:-4PNWM6U**%>D^J 8:Q_1;IQ@B>;,B:(! M1'!C%E,R*KSN\8'P3MNK[5FPBI60G6C3/%$$F;:N9P]6(*/UMUN$ YBQON:PJS M.RZ1']5"H"E6TORJ[$Z=T6!0=>FAL_L#KJ8JIE55,CS)>$I-L)('!F5;37D- MILQ9X4>QX- RQ^#J-:B<)Y2)H]9L6/\;"G56$Q&Z&1.LA5;OC4-B!&A!6'&\ MOU+:SH'DKKJY19V/H^G$P9HB]$8ISEYU58UVD\7)>"^;HH1ULF0&YW(V^!G(= Z=M.2%Z,*Z4 M2<7X$]IF"UBI3X^T_(]5DFRW,D;%>YU*'KRBXCMQQF#IY2FT2JJULK^#Q]*H MI$1BZR3\"?>/GY8M6_SSD"WZAM:L-&4ZE*97KA.<8MB]R$N0M1PD M[BC=TBOO?[/IIGT[P1_+,BX_$QZT@W?#Q1S!ZX)UX,K0Q],_%5WXX74L(D%? M=H+?D:Z!W^)\EA8IMV M,"V4]9_#:12S_Z,/B4I;'708M11YHF5["Z8VD(NWOK?_QYI7AB!%2+TY+"6L MA6J12>5FZ-JF,7-WD&W@0)7A0P\!H/J5N4" 6E3;-K^%1]E;F<"%RVZA;Z0+ M@K$RC+@)_%[E%5E1?">X^[Q8N[:DG!HWO\5D0QC^T*4L(/[MCA?T;PZ%U]2[ M[LCK-)^1GZ-->;HB%55LU ]]%V2D@IVL9N&'JJU^B1WZ#, M8X_36'FT;F$5$JQ1,US?PFC+6A]1F38OBI(]>'^&]6!V] M;IPT/#8H!P-+!?6,M:.K MYFF]]='ES-\ ",'))V*AO#L52M+[HM)QVU5?3O]"MH,$W"N[!C&S5:O8I6D< M1SFZM!,M0G9?&7F]G:4.\396*S:1;FN>'NJ]C=NZTCK<(J:D6[4;&_)_!3!0 MC7R5FFIHC Z7.A:#U_*<)L0H!#U-SIGI*$)S\M8GTKBC;":A-O=L%$^%\_E@ MEXS:*5.HV/0LI%?K6%:84,H%I>=CB8:M;M/E;XD&;6F#U_[^TUYSY?TK)XUJ M DJ(<<.>7E=9=74D$U1TN8*F(\"AJ'1[=^=EQ$N-#=L5_(L MS#I/J/,A"F7M\>:.AF&IRL!4@,^Q=-3_+76IE[IBVLJE6VJDX2R:5T^9WA41 MTB5#S9O2,@#B0SA,Y&XJ([/&IOU"C0Y_E9]06W^0*=JRSF6^.OG&R?O+YE ?R3F M>8FW/SZUA\AE9;/2[+J1)A S6(F)=E0(?D-GS/4U?*4JT1?@'I629\UJ-67_ ME+@)U_R<.'.5K)FA!JT\.CYRLD ZS^.'R?+R^IK0KEI%W.,&=APP1[QL),=M M^ TM\F3&+<\]D8C1$\4MJLTNF<@B\UAPPB97VVW+O&)#M,R0>%MEB+3? MB]?-F>0/G6=ENL-#I!L)!M6_<7EX_'JS4XT35K)&M??O5(QQUV"NJ$N^\T)I M-_0%QYI5F)]%U XZ;N#FD<:X23)#/E!-(#6O]VV$)R"&>FO@15VB_@ I,.P' MZB&J9,B) #0VM[ QZ182\YTA,3LM).;94 ;]?!'TNXZB/^&?J(:.Q *CZ\$K M=2+]2J4$ZML\>/?N:*U#YCA5X$S!F=/E,A)$AT=A!#9\IS93'8(4@S[ERF7P MOM4D3]0D([Q8U^-CO"AWS"XGH%$!S6AJTQLGPU;K_.N2V^7+!!&/!-3A"*_C M>2@/RU@@BNS)_*U) 63.&2D\E BS@*?O;91;^H"IN$DYH!(E-V"-\$GH$@BL M-6SY;8FY%K6_UGH3W<46BSVL=H:[;-%)W<<2;;$D3_VGASVH(&7;+F7RZ M)EHNG6$B;'@7]C?1:L($@L5I MBF%L?W5 ^LW\TD78SEF:,S\;^8HZA4IN';@A$_)=,CF-I<+4W41C+'74_.W1 M#6, ->V7IP\4H@8HKC$< F^X1-Q$"*[9B"G=XO-M I)R7I&EA$,)\9 ML03;&)12WUP52X$Q-_#*@XUCU3*W%VON?P1MCE"N.' M,@6+0%>3&2+$4 ITPQ$T=5W,* [*5;4*CU/&8,U0\9C1+$&()5FF_S"O@;4E MT/?.<]4J<+#-X@V^H3)%RBRA-R1C"6$ ![^8]\&# ;]$$3)WAZ?>8E =KX?W M&/R"_9]-5BP4A7"3K*"@879)<9I'4>S92)53@.67MU"$6)MQBS0&+2GKS/YF M7 P),-G^&1W]RNICT$"Y"'5]*ZV?!#,27_KV=BN-X4@#P>Y8]1#:'@0B24J" M0.C17$BBRHS&W#+Z0N(V7FM+B_O2LS9\2VN^WJ1A9X[T4M4H2C3W9?<(KV-Q M:RK)8?[F:7(KL6*36F+)),F7\0W\2"C\S!#L+M=SN!6*\35AM",R]>UPXDJ? M304"VC!M0O7FJK6K,"E.G[.+E;EI:@H;05=X;CHL%V!AF 5J1KES'W<"N< ]+[,;/I7?R 8\FA4J< M B&1%"2".=[ IU0L::-H#@I7))*3PR9C5&?\,8]G>*&Z*RH/<]>[9G[+>2AX MI9K1->>^C[JK]XIWF#D !52PL5@L.$LUC2;:Y@WK!QTEJ%4[12PLT/@OMD2: M9Z]2MW'G2P5OL5W*'RD:T.^B.26R-@:]WOYFYYX?_@%6,1PC_]IZNX6_Z/?N M_<7O K?XFS_H\OZFSY;A/+P_N/=6E-O14"FD;-G4C=)<$2S-.) M[MXPJ[\VV)!=3I@?T8KDOKRH+11TI)&6?ZA+/: M"H>G&\QZ!!%$L:[+PK26QO%_R0C,7@M3GHB$,4P%/5TGP=* ^L3I%A.P"R4% MW^[)KJ[+ECNE0(TLX-PLY%IO*6\V1!AF"F#TE?5F]%HA<@J1M/Y*IE@,&^0Q MQNKZ/S^N'L[VJ!8W(HH52# S)/!F-I7;UF%R>LR=SA"BU7$]M8P<,BK&?(VE MD_U>]X^.T\6ZX?O_Z02D6PALX7^[W_V#(PY(@,T5A&2LIAQSH6NG4M/8V5BLUV'2>A>]DGH?.1Y3GD>X./SHY MVF2C&_X58$$7,V4)XS>KTT!]SK%@/1U^OXO/2SX?H16RG>]712+^*WE+/=3_E#WF\V!/(&/8T$S0#ZJO\;.T8SVF(&Y7 (;D+!LE444JX.OW4: M?^[E;[[^-A]2[A2![R'FB]^"IM=XV.U3LBQ#NN8$W+Y)KFZID[?P+54OT,-/ M;&K$_:%[B7-ORB;090VCH_@TBBB;1+8)=D5GKEI2-(C83''U&*87!3E#.I[V M%2_G#/R.]V-EXF[\54.-F!38MO^*GIY]" Y?G7V\#,X^7@0G__?DZ./EZ9\GP=GKUZ=')Q>C]4YB7GH] M%PK2[M1S'?OO6JQ_C9NP4NY@DVTV'DC1V]=RG)482QP," RP\^NCS/=7;\05 MD_W=]B*^LIIE?K(:Z_]C[\V;VS:V?=&_W_L4J)R;<*OVMO='>Y^KS=0#^Q%97ZJ M#!QJ<+#K-!")+C_[.WP_#,!JULM4\TL_Z?UR$5R5V-FAU^WO#A_>O_^]:-V. M"_8^\+>#X>ZC#[UW;[C_:,//#P^&CQ^[,?_S'W79G@(Y'%#MN7SGCNR^"?VO M>_==P;SSJ?03GTWXAX[9 \,'/:A,))"E\HD]>]1,6-1,/!#IEN\^DAY]QA/I M0S3U6BHI, "#,ZA./GYF>#EV[WV%N>F4FMLP69]2CC9.R-W>(ENM.U\559L%U\[.AB.,K)35,VP, MLC\9W_BXZAQZ:QU@]KZ&QW2#.5XWI>W/>=AXU;[FZ0/MVZK>CG\]-C@S)=1 M0\_*8I)Z9_.3+=?3,H7GO$BS+"Z3?HOVJO:;.DSO[_4KO'T[]=O1SN$IJI'8 M9RGB@U/G7M+Q>8%U LA;USN;GVS^7\1-6> "S,'C'Q?]KNNUYS=U/CYXU*_P M]NW4;T<_=SJ;@^A5%N/:/#>'Q[OM;Y@AAV!M!_A M0G"=Q$!)%8G'Z92IPWAHCO-FY2LW)@%;@4PM^?8"H,]M)Z7C%(L^BOSNMZ7] MAG50B,@!^V(V//Z:"R9T5Z@(U@IBFD>'BQ).H?W=?=@&"^V+*0V3D5G+:I0X MZH[:LT+ZMI?+?[GQWZ\Y]VA9_%42 VA";(OT$._21:K2- M"8-CU]=/MCUN;OP2 MRM.PSPQ6/:JJ/,WAIKIAECEOR$1?80DB*OL)5?3#Z6]X>7BRGF*KUY6;\1E?5TNN\1,_ M84JRK6^I0:KK,1=:;^^9'!5E&N=4N@L:[V"PSL[P6LQ8,KK60,.G>3:@6G]B M^56R@AUF'[[I_/#G$]V+8[ LYT2FK39=/8-5F:397/E#+9"?*6G-A+O!,,MX.M)GD2T54]9 I13Z?F# M5JOTR*JLM4FUX"^.0CI*]W1[A" I)*I_E&[;._'$-\1Q3E^#+0M6<0P7ORJR MI5"M>TJ<2$H/'K/4TK'T='@HY\DO<7F)GI [3X3W]/YP97F-[@. M]XZ[8XO4>M0S1S,X\$%:*B46E1:0AU4%QQ>K !W$XQUX^?W^%+KN%.J$-7R] M@,$'Y?$X "#?$%K/YV91JP^_OR]M)8M2>JSN/8B68-AR_U1]QT!)92PF<(TXT >X$""@>%G M@2I(B?QRP]=P" ?5 S[">V(H1\0 +-\ DF3E0^B6<%T]%GYX@2%WX)%W!*\8F2E((5(XC>/2\!P\W,7%0Q?N;>_0?G:12$S!(T'>CI>LK8^@5^JT4PR M&9%YZ,\XJ]$WSLW2$OM;PP/?C4/A>5K]2@R@9FCK-TRU#">*[$.U8TP[C$HO M?FYRL'VCG\&T6C !M[[R ;]R]_&P]:$NPA']BF$-NN%I@5%E7P>= 8[_L06'E6]SK#MN>F^-#=="([ON>GN*C<=?V64)O_Z M#CYM_F8O?E.FU=LWZ"B#KW1+..LN3EY$>Z P/N:\^^QG\^M;/;K3\]^B9X=' M%V>?B-KOKK*#_[MHHFI6-%E"1C'V^%I2AC-5VEW'^X<[@2V")A?*OUHR$]0J MC(),1)%ZR-S7W(PHH+YFZE7W3-E88;LE:OHAOT0Q,?YK$S+7@00.^283"\5Y M"S!T)1H>RU=ALWHBY&8;0)AGK[F=FYEA+RS+7IV)U<%LVXNR^(MR!EM-M?^: M1.(U-L+B!G#*-K]BDTET'Z]41OXH/4K-;ZH&I3Y3^-YWE6=B!J*NBYJYN*Z M1NHIY@ 6)F>?0QJU24.V&J,:8^*Z_L@%)I!MY:WS,#K,0!EAZ!>D"=.MWW$)V^]&5"O;Z4%ES(B9\0KSEU,@,JNFI(" M:-QMT+7@T_?#UV88XD#!)#&#&UGL\7F4&< ;HWJT=D%J4G!+\98U ?M!#>P"98;H "D29123P=8"^RAA?-=%?K]1 W>_O8K M8Q\C^#HX43%"E)@)R 7O9]EK):JH8713TJ2. MC:'0&OB]16DP'>'8_)TBPT@6#Z^U#E4QO_F.RJE9*#:V@84-&UXR4H2>8!M@ M%Z5W\QPW"BZ!E^*BAA@5*/0['U3[Z 9+06M0E$9M\=F6QC7GC(B$#P%6QFA*\\+G)A+T&?2 M'T]8IMU"-S7HV/]PP)BUAEP_C(ZT"9VV>66X1SB"CA?JJ,R[!36@DPY+O^?4 M*8TZ#)(0VA X]EE[HOV2]1;>2DYJ)7U&B$*Y^Y'TF(]4ZEMY5[8ZD3D7RU[FI6^D8?T56+7T#JY"$/A7$%IL[ M_,"=4KBE15S1N#H&( J:;_H1)&U9\$?>&_"!1 V\:L?7KURH9;O=@4X,,!O$].KC MY*-6G EPC3FH6PM]>;L D7!R>$SW.AU\$(!"MFN4=CP*4T 2T,=4>DVEJU@5=F98(%8 M>1MB.,Q3!TL(/,(?C7FF)C(W17N56WG3V@3N7 M3F,-#LE^Q*4T.;=4IX5X'U^.E ,\F=L.*0;BHL3.6%X3-,_TIK4)JET M]P--CC8KYTW$3@IM]BQ]:^#%= _.FKN-[O+]$^N.#+@AIN>J!%,PXF/;MI%[ MY::)(DE2RK=9/ E&@RL3666Z\5'/;D3R. /2+L4-PQ[VP'H+ M9^UUCF2A)W/P,1RMZ34=6@O+ 0498&-BK,4BK,#FWK$'F'^\!).-5AH)A6FU MRCW#%:U(.'$>)3@&FD!/?G(\"0>-2 88=UR&CU:QN$HK8V.D)&9J&WHG;&@A M/FM*O!/-SH&U"4O*5>" Y&%KHA1HZ+B#'R=GEHY2CIV5A*\PC/1I!/XES2\U MMN/N!2/$.R=@P#5I]HJ (:!/WN;%U\"XMGY2EQ:3 MB^-2&F#FI)7B/!VV#B-20DA[!^8I-6XH>.XXG-@4=3B>:[.:5\T][54VJ&- ME:!>B[WP>(W>#L4@YHQCE>ZOL'_X\*OBB9DV5/Y#YAWM<] Q<0,/*2G,!#:^ M7WTY0K? 3-CT &.-?A9[H/LLX^J+-;NZGJ5E$B@J/(_G"VZ?1CH+-_EBB882 M'N!F1VM/!^Q^E"2F<+SB,.'MTUA$WRK2 >NW]QX=-?HD1PK'-4&S1097X304 MK.UAG%/4K,&DJ7QGP=])BO;P+S==O! G^2EN+$ M3 6C=W;UN"D['#Y, J.'KV'UVGJ-8>S:BV=T>L/M4.S[I:DIH;K: K05FEJG MO;8.<%#R">)7*&L2"8\==6R+<@K_\1\)2;L\O9>?#\/?&,Y(,Q<979\ONC9% M;@T?CH04#9:=S]-:3J;?BB1^&_W@R2,2RG#8@Y-+](:XHL:Q5U1:B>DNC&A% M4X)9(R3Z9^^+*5.V^_C'071T?!']$(_)YTGPI#YOX,W%O)!K#O":.'?T'>=8 M%,BV.U4AFA+I+?QZ^J,"+CM-X+JZ:F#T5^Y9IEZ M<41=U#%[RZM"T>EJ0Y;?S]/CJ+#:M!G]Y6%3W"2B&56 RT5M<"TY@0Q17SL7 M3@D7=QR";,#L9_$5W]2.0(4O&1FJ+$K)<,/G)_$+R8I;2U(ABZQ2PR] 9?0&9^9 @"J<@B.Y3_ M_J]'^WL'3\!SR63Y:4(IRU,LP?EIS;A<2)Z-@CX\S=@K("V.*KP>0X:UGO/HBG'L[@*4$GN:)@499A? M07,]1O\"9E+3L>,L3N=^,#&0"Y)(3W0'[2.0'0>)&ZR>I^1!R:F*+ROR7 (9 M=+0%F!Z81?=E+F7& ]SR0..9GVAP.3D5LOBR2'&-E@S08'BN%>"1]8.M1W89 M!LT3 [/,R M&;7'Z3=(RM+/Q(0QD&D:KHQE)BEJ2%1@T2DGIC&?R<#PTEM93 MI&00.IN2#*8TQ'D#4S;'Q V\1;8FC8TKV^&>SQ\5>H_*.9.<(F&+D3K)RR%5 M0>6HK>E/7R^$-8Q^D!/=3ZOSO HXC^&"=A6C'+4,ITDGJ,\HT[3TA(CP0U39 M[K0ANF;CF:ZAXB9M>%.S02/4)XR_$P$@;#C+G%_)^3O(P-#IH36BN.6JH'U, MR/:3HS:1NN,:G@;?N8/_')"*J)"2:$/01+R.$:IQKH+CBN$I7V2=&CU .&)% M82V!86/(&)$+)KD&RLF+J:>6!]3$Z) U.^3;Z 3+QV"5'--I$?O7.@>L=34' MY=M9Y96@H*F0"!1,51YQD$A$B(S((,:X*#KEBR%8'@U!H10EW!J.'0J;)%A[ MS:9Z8F#_V,0LOS@G%Y5T:"L?VAI':PRG$^9DD2-ZR3-MB(') [3B5*]]Q8#' MP/=;YU3M/DV!TXUL1Z67J.15$)J*3P0/KYV ?KA4C<"E)FPQ:;['@4X#XY:0 MC-80]H!(;"PK#D6L.AP#C><;8-O\R#SDS)"K&UJA1$H:H*99"5B<'4C-#J_Z MYERY+#1;WAIPP#.A3&EU.R!]G@_CIP(QIB%^.@]%BY*N\IN-@453@O#>?A/P M% IK9MX-R.3$! :&D0F:PP<)4KIA"C6MRF9!:"^)JK3C0^H9V(2WR]RC=%+^ MO[;3:K/^3&<)KK)@5GUH /R$^?;:DMLP,TQNLE57,^)T[UC2;NS$%$T]%F<9 ME4[W?(48&VN>K\2_8L+)D>,H&UTFI>N3!P%ZBLQ\ IS@4%;#9Y0FE4JK MT3ORB@W0=43-0>Z%&A0\*87/2 H9H'\(H#XW(J$3@N-S' MUO:2>1;*%$5MZ\)527F!LR#RPLMO4YB:$VB9>_Q%\1SK)/P/(A0UIW,=<'#I MI-57VO(E6*N+.)!:DO<(S4:;F[5EXJ2R\YRTHNJD5%7I&K$4FVYSI,Y&R]1^ MA"DS'EC91@U]92Q#Y4L#;+/$^3Q$SI^T'EAQC8; & XVSA"SR:[02SEV/ OW MA_1'#6(B[MA%0^3$O>;;&.94SFUABWYH7%+5"J.#KM1W\.!%=+[A\1^\EF&: M/Z0PJ@I!BCA:H4"),S[+_ON_]@[N/PE!S79B\&Y\H%W7 )Y>2)6&9*^6@<,A M 40R-I56%Q-6=+QG?.:ZEU:-%#*"$=58')I];9='*X)H6.0-RTWR5#I3,NRO% MVV$X.[U,DX8TP:Q@Q>AQ+PDL+T&D+EM@74\D@* GG+3;%="GKG.1"25:J;30 M,>HTB8&A':SHR4*@W?Q[6)-" [1/B]4=0F2)L2\-)5B-8$0%>B)%,N9&R3X1 MZ@JT"4A7U(ST#'%'3<4UF(I08FICK(?!W%$ " S2T9W8/%$[[=$/H^?NQ).O MR V&;@BX6H@_:;>!'Z$G7HJUV]*SQP5\K"!F.=K&94HM:V[JD1D-4.1F&DM( M(@6Q$%"B/3&"%(WU;3!"':=9C_GYTIB?1SWFI\?\? GR)$,ER5QZKSDDTNFV M2P@';=G71%U'Y7R8WRC(EE%S&$WSQL]:AP0#@\XXLXN9^8E_U&GRC/@2;&2T M_/]JDJFMH./!,&TVA8&\(+"\YA/%.N\JTD?7%2,X67QUW<+)(L^HJK#R:D1; M+!%@'?[#*T1;K89\AK^^B]'Y&]RV5.1OYZ];%7!'Q3"ZQ"/9@#:B@.@M24AV M)WLQ3IJ0N1!+GN$=C+$BGG?D[( O(! +<;Y@A) L$PTT9D M2$I1':5!@BBK35JB,8"E[DGP<(Q.5QP,Y >AT3#8Q$&B.]LOQ?8SXU8LM]Q9 M6*.7+:1!3#BRZ7DS:CC$4Z^M[=A=MF)R9%2U0!??9VVJ5H - Q,@1%C]Z>6@ M?(7N"-"+:GW:R+C=F_C/J T< MF:,XP\(K>)2RZ/DX.E79QEB$")7 PIT#61I^:]GQN_:#8:+HE0N&T9G=PR:? M<<\>C10H\Q+GL-?.&]RQ&<9<]3B#=.HE;O54PI >)\,K!J=)F)LQ#AD@=4%'YS"L2850ME*\@ M":P1V5ET4]UTQ*5G#F/>];'=:R/&+L**0&SF(UV*W$,]X99G*4+J3KU$[Y!!Y\VF:,4I2X9P]05 M+-HNQ^NLI!DQU0*,SC8+)@V;6*U)KO M$D-R)EQ$RSSC .+*H411+V[:5Q#J<$Z,9*YH$L BT5P&!IFOOKXR;SO&#"@=AGXP@_2$UQ0:+!U6(6IQ/'[N3S7>@-(<=% M]Y30(K*A2[7V'RY"S;:G;5X(&1=E-ATEP09Y1/W*# 1YMK3R2'Q("9OGA#9E M @C%4W9,/4M-^&RAO4,"0#!(,BYX%F'!&HHKW$/,G] ].)4B^A2MO+BRC&0= MZ\\^AP!WZ-R(JU3J/9;N.0G915187J:O#QI$7+0%WM?U3KJ.89H.G_)A^E?]!VNW!7+> MNA37ABV+#EYH"OQJ@,<1MMCL)QS 5(/6MU-%E0+] M.LZ^PC\V\=R&4VY1MT0;]4>6#:-G8%,VI:=C","^FJNTQM::I.4WZ3N]KU. M$Q/);E<<)HF'D!166KE(II!# H!O1$0TBF!FX*L.R"+R6S@8^ MY.0)EHLH+'%Q\63"@*25/!KMER617WH*TO_*C<.SMO3GEIL[?2"MG3Z#A/9$ M?HN'B@^\<8Z*=E_IA(P%*T$1+4T-V/"TP?Z5>L"E( Z73/#NK]BU-?Y-CJA+ MI7UTM0 ^8 =.BWGE8M7JEJ6YY;4=D^&.=*RVRG>1,?5KIU!YU=*N^D!?%-(? M)G">+:7+%+#"'IG%&V3\RT,T;X2;JP(^6 M>_:BU^]4/H0=69V=CWTM1W;)/7980L\*"JF\';4:E2JQ%8%./7<"=&!&FDR8 M6B35ZK!->Z32UT J/>Z12CU2Z0O8KT=%/H'?6ZA-IYNQRLXX^\35$L#EF/:M M T6F5LO XQ\GZ*N& .@8TLKM,O)+48O)@!O@6 AH:7,4@\XX$8<(+M@*HA+- M5FEF@,7<;LMWTSHSDI57>F3J*V2W$?3*>ZVYDNG8NC_N'D#08$NRF>:7IJH5 MGF<&^JYAO7_*U@5LM!QYYM!8+6 &.'XZ@O:_@ MRG#X"SCS75QQD&HF?7 ),;SJ>W67\'#M5*7OPHQ^4RJ. V$H7"K UKGSYY3R1I0&)%6UU;XT&(.\!?Y[HV?+9ZF5YI.:=TLW+B4-E'_PRL? M2;V=Z6]JL_(CFBQ,64Q.CWJX1'?FUZ&X,K4UW#=>:>0(ACA):^N#V;<-HY.4 MKN "5)KP]Y@,!MG4IE73ZH!?WGK /I)+$)!IJ_JO(U@#'8EX?OD0-)F:VI8. MM;[EO%URK%@6KC56FO \L<6R0965K1$.RH+5/B:I:?*0)Z%5Y#QP!4%VO;PI M6+L, ^K!XNK,7+C+5L'DFI<7LYUI/[OFSD7(I V&AL/9&6>_"RO1>"[[6%4[ M5G43-T/#WA/PIE)=ME%9Q,D.NZ,:^&ZU#NK$P?D1,1QZ MICB%4.#Q4T%4"6T:5 E3T@Q'@[7Q\-:_&\H@L_FFP3)-U4L,32/J' ?+$-Z4 M2TPM'%I+FD1U#_RK6)?@;'3DCTFG3+MJ0_MH5RAP3YDZJ3O!Q3T<-3])6.GD M>N; U4C&%;4HKL9PL'>LEE!JFV70AT3/-L6WS4'(:"NXRO<*UK>:*-.3YH%O MHO/>2]]IS,"D)5494\91^[AEYI)9QF2+K1(+S1 <=FET+&2$T(>2<_W6("/3 *522>&UXT8ZFS1R[&N7\:7U 238% MA@=^>CS'C1X_W#Q[M/GAP\.#^WNYC]^5ICH/?H0G8\,48Z7BTO__0ACJ\>>5W M[.WNMI_ZE0ZU\*@BD4GG!#W&XV5B$,Z!YK1&G1T/7$9!YZ),R,M@;0+^W]00 M459,+2-V^#+N0BF[BFYG(R1;/<%<> A#0RY U(OFMHDF :K+ JRMNHO55$+P M#+LV6#Q$9! H@#M\G+D#D\'\EVE9Y!3&H%:CO:#U@D:"AM)"CA+KM:K>L11W MMB)HI=.KML^:Q*-2SFNB@T?YBP25VN$'V"S<&NG;,A-W4U:=Z *<+8.^%7.S M$(D;4X_=P*;TO.' M/3LMVNM3&E,'!-6K@]G!$MX(K#>-8YON#*EL1?(7']-UZ[ *"03S>9*.L4J M513!"A"(Z@T44KSV==Q6C5"^&BK HV6EDT0V9D0O*US%U(;>23JPJ&RJB:E MN3*K4TP1<4X(RU@]6 )&QYM2G%LW)R'@13IH2H<$+ILCC&\&WQ5S6+$TW(&X M1=[/4&O?4".B80I ,^;$$=YU=K+>[AC1L>#VT:,&QR M;"PXR@5KPD;+09=[K88B 3>&2[5]2;=EM5;;#X)FR>0Z5K8AL\TM*E=T:8A$ M*E'*>14[JR&P^D3(#GSXU7(8Z7F$^2;*9FQ0"([]2<-5!5,"Y)O7Y:P3K38I+- 85*K+M6]>@E:-05=:/DRWKC; )C)+:1[! M>VN&*Q)PPZF*H I2^!G^'_0!E1ACQY?:!(U(6+<500\'G!^#"21Z_>8W;OE6 M?A%7E1=W51#B/"8$&)VP(5,M;1:?E#>^A#WIG>;(H4Y'6\L3ACL6G!3$G57D M1COG>(LYE\H@SL%3-0D_'4]*+/VALKCN$CJB]RO;0EK[W7-66S2M;LQ6#8GT M0%&99!"V)2FP,K]ZT%'#;4KF%MR'0(Y6VRS>94\*V>$XVTKN;MH&[HI)&Y,1 MA0ZDKY-\$T)Y10@=.EECRH9UV"O->@EG;-=.+8G*>(LX:"F[U9EM6=K^!K_V M:.WAAI]9 ^SO]G##'F[X!7SV"]LJ+T=?@@KWK._@*;%*>Z15MCUL+$6?[3*L MO@3FO9UR]2OE<&>_&DTU-AT3;C(@21-;@O#\Z#BP=U_J"GH]#NF5P@2X^+K0%!"8MC%U3BBQ,&]<$3H4!H !]*!'M.NR&+K,P?+;IGT# M;:9"?>,&#I8WH QS-$_'90'2,XP.+2]KE=92SDY5@K::IBJR-,&8,V'$Q#GG M&5693?TJ^F!V0Y* 0R^-*]8/'[!:W!I\#>X$I(FB=@SLTZHO[K*Q$O1%;Z"V M1O?(Z#W4$&8EFI"JCSS!4B(P0!A U^J(P+NP#H([(DG"[2/]#.B(#]K#;6IX MV,IX,Z*7JT"ZK1;;>FQM67YGX;46@#I/"2N0R45Q)=O=!:'7UNYOIU(_J[M[ M5/C\1!ZV4%QP+]O>E5_ ]R8\C,5I:A!AT06+=P&5'6A MQ- I0H8I6&;RO@I]L-G@_I 7YJJ0!IZ6GF2-]>?%G2CG4K,,$D%:DD(:)O&N M'9O62Y8B8J35UOE"'2&$UE-\NOFB-6?X J_Z5N8(O\$Z<5W^HQT5"7]+W E, M?HE9H2O$O'HZ6S="YV2ND7@^3H-JK^L_>=#R^7PY&,<+QM(%9SC&Y3WN[A:3 M$9]ZW87CZXK(MEQK7O@=>BA2518YFCJ@EF#HY=*K)ZR"R'A27.5X2%:NVQX= M:,1_$D1/J(*G713#:*PY<9L28UJB;6![K7I#K=J&LFH6* "S>I7Z+5SK2D>J M3@CK&D-J$\8O:'VQ/G;*]X4Q4))]()9Z0&MERO\M&P_N-WTI;-*K(-4:Z7]2]"BV74!.^L: MC3]<'QR[870AV0CU'8LQVX&Y@:!CD^S601!V'5@=[E=VBSLUMX%6GZ]Q)>O) M)*V\<)P@F&34FS$W68BB6\5_XWDB#>Z\=U#A"FT5F0?/48 /W8%I\3P&>W@J M4OMF0 LB//50Y3)EFN05J03UFJUN/FKPNM(/:[P<9S1_O!DQ20+_ 3:%M&[B MK)<,7^?+YJ^\1O*FO#0!]-8J=Q^+"*9"#M[AF)SB]!,B!^YL2L*70VWG.@.K ME1(Y,&L,^E8"*CDEP_PQ,X/!I-KC^#VEYOJWY(1-,L40/ ;IQ4?BX_[M1^@ZOX=^LE?=> MDTM?-0=M@:GS8MWKU:8ANS2@^G3WCX(/902.*!7-'&=,,6*1!EASLL":H+\; M"B1CJ2W3(I)^AB?.0:%/EG)*IVOP.Y9\JS5JKS[)LWI7(YN$BP ](ZEMV][0 M RA@)M/.*SEA3:59VXWV'<89I60*(61EH6ZU)(!=;EJ8PAB5816?I\!MDP"O M?YW H3Q&'?Z29/VH5J I'/%TL1/[^/]9=5,0[.[CR*C6W[6RNW[/;Z<./EG MX0@6!+'TY/JO:%2-K02X'MNNU=9JKA;1X(?> KQ862U V:2Y[''W+.C1]+@OX-O'&DK10+;'02:M6?..DY8: M4,7)YG.O%:KHR-OX;0H$.;+RP=)*Y^;BEAOKD8OGXGI]8W>@G+$/"V9[\ET9 MOYT! J/=?>01.!=*X> K2*J/# 0=A:MB%\59"G)T=Q:Y2)A4403:THK745P? M,HS1GBAS%R>W)L,59ISAM[* R9D/HJD!7RN3+K^VA(BYEM6J"WBE-)A&_;G$ MEA(C1L5)83HK@UC3T9Y%L[6J_ B]<]Q*47C&XTWS);H!VHF*[8XH_T+GCD&- ME&%<0EBF)IDS*D-(TQ4LA\DE*SJ/QV6QTW%V^)F#BB.[T[*XJF<<1J!8#F+0 MP7K/IPQKG*25IA;F( O4'1M%,& ,BI,_TX]XI@?CUT @GR- MET&,=4"*D5 57%/#]>K*OR/P>/NQUVT]%_0F^(&;+44,@F*PT#.>5,XHLYF? MV/X<$E_GE%AEZ=]:_;_\'G1S)A[C& QO @5G5))M$@.?:[7HR2W:2?^0H.!7 M66#I'6+544:59[B:P1P65VW*7$I1*0QLDKXSR0X%VUU+AXY:&*LU+#];>RNC MD]E.0GG$P:,FF2*4PLXU2H='V,1*DNQACR\^/KVF&XJ\>?PK""S>/Z/YOYUINI@9;K3"MY&@]78"5A M)UL,+LTX-9U+[0LEN8M<"F+7"<[(4(P]1\& $Z&8YBY2HD)E(RD#OW"1@S64 MZ@<%46'.,M, "R.F,4U(^7_!GN6H5I-">[?.'9IX_J&BNF)G^*%$7V!I.U3: M@$EJ?? (9*R!F9B25!RI([K*O2[F#MA2@^\QZ-MQ9O$5T0IC0R,7QPS*."G- MCF,:1D^-M#)1^XK1BX2E4!W,%58E>V M%9(\6YMG8G*7H%J][EW?7?&M,0L2OK<@1F:^R(HENBX(G,3$D527Q1EZ/XGL M#5U_-+_:-/;M1BK;K10Q!>S71*>5C_2TS10%,Z#P&886(:(%$0>J[@Z+Q XB+J+V=U<5@VFFOJ9E4F M41E+ M6"V>H8H-M5"1,F1&C- O7,O8JEWV]'C'EUD[+/PP)A)8^:XPV:DU&#[2EGJW MR%FNS6L%PF=-YXA"&AZ] :E6-B_;3,O>AVF7.2*(6++"B0Z#TAGO!*.W"WJK M>IMF60 B6[=P*#AR''8WN"*]5Y.Q/*"="Z,O8ZP *HVH3_2!&/%-@M8:@]OZ M5\;6X8Y\!:T4QDH*(*^3PT%8??!>O!YMZ9O(8]@X&(N=A9^8;J&O[ '-791* M2.Z--A;^ Z3JU:N?V^A6BQWW4)F,CK2X5XJ7=!3\]$K;RB3,#Y%K*KS+]R=X MZMNZE&NZ$7 "I1"#AW,=J0\KW*['/@WRO&O71+"G3F"=](ZN.I,>(-<+ZI8 M(_::E+XLX,LA])>CJ!CX/60%M&KI89MR451F_9M=P5W9$."D+)KI3!&;J-SW M=_?OL[3-8B;]B!M8Z[@6W+0VB&QQ=16YV5F"U:V]]+1/J.I@92F2QIHIF[.I M0*=S$]'-/D4'W8%C[KREOBKH%OE4N,.O>=66EK2NCEF@O:AH:N,;Z'#ALTO6 M 4,W6)82 H)3]6O?XR7$%6]1-G\W:$;42BZ-'"T2>UD5G_\)2(0D.LYA3AD% M;(Z:F7*OWB-#'2"V-1XR+1!,!$=]\&^C$AILT+_$!9N3J*C^R3N98$:"1X:1.MB3M3;*E=1$7)84Q]5:/&L!KSC4]INLR'WY MY8YZ,REP=/W(K@WH:KEVE58U'U]H"OL:V>:L5MAVRO@J)&QB,4GS18/50Y4] MFM1!LID BP^6 MN=)V&VNG?E">U]!/ M%,5.*:QFH3H#]4S1OGFAM4YB994M8W&@S%:1V6&6YEI9( 6922$QT9%YKBWR M"^ _)8'E53=P F<%B-I*IJ#3:CLZ!IF-TF):V_M@7$IZ=]6J;9DL O?=/,9A M).UB!][>$S">XM?:CU1 'UG29;@,&C]U=L+MT_C;K8&_W=5C M1;SXEN:A7AWH*6':/,YSCE.1]1>H.56GB:JWGWU(C/0G)G!Q2DGZH'C+J3Y" M%PO2JGU)^]!"+7X%(FUQ%!;VE109<4*X8+$%5S"AK(Y+@3%TVC#NN?O$$4RT MEK+;Y/_JP>G>R2>G0LW2;LN,9M%CIKF!]8-U,Y1_ZFZ*M4!F1;78\33D I"5 M/H4:.PY/TN$'XQK4;V7\L-7_EKM1W4) 7Q MM95Q^)BTEC%B$%,3BV/#F<6T3':XR^H*M9=$D%O1(&YSB=&1BH/+Z&H4.;;^ M\>:>@!"I:VT91VS/!F\9>+@.CAIN7B4A;&?-WV)]$-(";4"/%E>E]4.FTQO2;6AJAL#=?AC'V7 ]!',],S7KY2L^QS;?+ )>I8+ M=5%&Y!7N$=BI"[OU6;Q%^Z!WC5XM*'BTM 0(PJBV[D8O^NN0AX[;8Q4T8[FQ M'>\O#^P389GN;-RT6^NQW89@?(=PO<)8)\'%L8-"Y6/,LAB?V#$VUQT"ITC0Y!>6)GLJFTHX[+%3R3*IHFMYL7C7)!"*_CMVG5.L-A M)I0*.E>_!X_3=:"\MPTNZ5]U->@'4BED<+(VDF 4&=AT,/'4,I6U97@T:L!P M"+'C+!E&)VT3I_LP90!*UQ1UZV**%=FR/U$8Z]C*BL97IUS07LGC:C- J^JF MU8\F+G/J#I(T5EDZQ+$@DZNJ&*>T!-JDWM?F<(: ).&H$6:H[8_=!5_M#2%KF.H# ,N M?9?\>TNFH$&P:84\9JDM-" SQ5IA&UM<738T?O&@?_AK$JU#0U1EZX0 M6$Y3)/E7E8>J$I%>S+'!LT;F:4X BM:$= \:GYFIF'#MN*4KENB.SO6MY#LJ7 (2/(6481C# M_6)M(K?^XCVZ(H "R'0;'3 5R :K0*K31+"'@FA>) /I<)(P"KDHS12[E:U MQD@\F46-G'W$;T\/(HPJ^<+T58SJI>$KS;K[#)5B?;>&KOW7#Z/7['NU+#Y\ M>5)0LS=5.IL>(WEAT]53NV^3O>TM8BEBG)(_*CA*(M9#B34LZ[:*'N'AV.8. M*V5D ]EB&1]]H->AJP1OTMIFB4D3[HB+;[ MTZYB?!';V_?8[N6:Y9J/\J .'ZWV2VX.#O<>[^_?W M'^[=?_0MRZW-4K=0<^P>61&=M),N:% S$:+&V@C%9"TH+Z+8BK2+2\?E/YRH M(&)J>$\OEKU8LE@Z?VBC7,(?A"+-*$:D!3H@L]ZL6NKG8)C.HM\*3*SZ>6XL MP,,):&IC2^C(F7B'1BSYY"]!QBE)79,9C/ M-\2S_R3J);274))02^DAVAG>BJ)&(/$Q"5,E24AN;82.%\,=NGY>Q%S\B^T+ M;F0=]%C?SX+UO==C?;\,UK=7F-NF,-N(8PUF63HT\TZ *$R5IK0*MB246+T6 M[.YCRBDQN6W,J6RA#$ZN/N"<[L-5WZ;8V9QE9MM=8)2)G7,*,Q$GJ/F[(8JA M)_A#+SR]\+ ;0K%$^.])EA)VTM17R)E+A%ES=(0U 160E&)>5;M"*D;)HW6E MAP8%PM346!ER6VS%0;^&=0U90D'=,G3EH=]X.:1C9=16&VL@4>,-=+A$9])5 M9TGQO!&C_15^[!K*';5R/A8,WI79$7#E99%=A@T!I++$59%X $./2 2%C%#Q M'3*FA98WJ^S=3JR$LMX46/U$E%KHL\73#8A7+>:>!#\BI7LV*NQ4@X7*WD5@B& M(.E36TU;.MYCBB':?'][J-N-IQ!<8D"8]NG$ .%EY"8B'A1#3I>QL G;K"WV M&X(C0/'1WK+)6EF4V#7#&GE$>P.6- WH-B!73(89C[7!DB=Z^-8F]ZY2/KZU M9 %>3Q !\A)D&A%_<$_),NS:C&#!"L=%!K"ZA30?@@,PK[!?$SP5@7S8&!=# M=A0OKJG:2C]=*^.3(JH*1J959LQ4[%0OZ9<""=_=)$W8XM..*MR34@ FW+S$ MS6B;6^V*82L,UM-$97N9KQ>48!\'9"*RRRO[&F())=R+5U4#/D^B7:QM/2AC M>H*5]+\W&-8\?DO,UOBY.J[+)D-.Z%%FAM$QSC@K)'/#[PHUU9H1#VC(6.6C M3-:TAA5"#@BB1$LM!"I<#D1%")UR:!E2I(W2,/ISEF94G#D"2]E<&M=C$N>F MQH+5*%XP$I70DB@MN/1S$W-1*%-=].G=9LUP2^VN$HN]:.AD:D M?[QPS#LD-@0B]G$*\@)A2$TI%6[2B%2Y_8G";E$R6MXJ%)H8NW92=O!^B^19 M#9U==?L>C)VGQDML)!M32]VXJ@-FR08E BQ0;!P*,@6JO5C,TG'87 HNBB\+ MW(+O-]M;<22O3*[C2I\U98G&,8%#*M 5W4B> M C W?2I&J=UT*J9A,5M6=,XF\1Q[T^*ALM+C@B$-F#Q+I8H,]".>W$)P#[_ M*RA[D165]%GV'X,53[7;+RC]SPR!WP_B/N:C=NA[P-&GF=BF#< M[FNA,P)Q?8YHM '\A=SJ0MIS7\3OHAJ0 MK-W272^PRH6(UE+K;<5)?^0"6INECX)@+F+6+DIOA[V$#TS<5&G&ZZYB+QMY2K\ T^L4.E=\GX@S"B.V\^\-/]?4<_ M^W"JULD9-HSM(*0<<#%%2#(D3<2]#8BUK1610# 9WFIY.)(U>%1O(5F/D,WQ M$E PUM(LH(>S[N/;RP7#0;\-K!^I/N]YNH>-=7BK7S=/SA[N4ZPT? T*9D5_N"Q\%!( MDU;UHU=K%6836D(?H/R;!9=RMHR*@)Q^LV)%1.P"U5NP/-K J=4ZMF7-VNY; M6V'$W/PX.&.77XJX,#U)4<86-PEL/?[W[783_^RH0:1>]U0\8"F&M;@FQUZ& M!?=I(,#!7Z FJT0V"_9\=)F7OYIDROK.TE,D7,_+U-^:\;DJRBRAY6N^9!''#U8MD9&GK3V4KA(Y^?"ZOK@(X$SSNZE>%X%"RMX0%QB97'&59-97)[< [[[TBYAZ>I]4>< M$&E7.T_?X6LL\X2ZKS 76?H?C_PTP?Y**&@TFJHRY);FG3M?@WT=RF(S%8;K MHXJWOU_[[Y[L='L D/=[ .07)CO=#HQ&2!'M6AL-^*">F 2;E9(V4_L8E66< MX*G+Y:N7IJUOV1LHU!L(K7]7-"ZMR:25+YYQS W-7%LENW4P)FI]6DMT#X^' MSJ$-VFY9:TA@V#<9:7Q*WF#OXZIJ<#Q!1P$/T]$] YML<>?@BL8>K%7IKI+= M*G1I^-?N5$Q)I!D2M<00#HU5M'QG-:4LD@,L4Z2YF<#[V:C%@UZQL,1HX[IGS)N^ MH\IVN?9:(0,GLL;REDL9TN2=E=,X!Y/0]G,[T5+58]=^1LCDJN@IKMQ)69#3 M\8KP72 IZ834P:L4\<_1_G W^N'IR:MS[P\_PH3#BL32+TBZ/(&I"'^>-W,U M6ZT]"2*P]^![&L^<\B.6X\4;KNT1I7?'#S8A7=DF:1\ M,"/$[( (EJ-F 0SGQFC"6*+ZC),BE$0]@RV#&LG51!+P#B5[&+UN,K,:!JJ: M$CR^W+H,K9GP)X+:QA;$14U.B$$X'MQ'Y(GT.NESQ(=5[7K(2Y<41)A*I/V:RF;!0*ZJG5B4BX M:G'N6*45Z6$?L!YCX+/;2?PR"(PZ: \*))EN/D?]*(#HQCDFV70/Y!X'#()JJ1;B7-[RB(C4J48(V;877$AE=I M0AI[H1%KG$RE>X>V^1.@ "M(P("L&WC4'.-:+'F'4]7-&[4=9=1ALRY,Z"1?P+6,)DL+3)DC1KA+,? M^[SM6$+"&[DBW]+9>?,SX<+F++E%5=>RJUTN?7EAQ4"I9%N>.OB(B:.^D;.X MXC."+$,TQ"UO7/ (T?T+9&#TVDT2Q,?N#L$\<1MZL*A7$&S:#=O@9$YWL#UZ M/7-7ZUL\L"JL'TPO\C<_D]BY(K[H*"JRK+C"O<7]*BA2[!>>N"!Q?9.)"DZX MGO!NVXOE_/ZM@Q!JL1*OZNGD>JEAJ4&;"7.5;(53M\N!@NJY3H_PZAXAEU(? M>8TGT+*P5BOA69UQ70W\E@E8' "/=<%:HI2+V20FLXB[,_0EY+V(=HNH#[R" M,6/QC?2\)HL5J6VEDT5?3-Z+D7\^DCFGH 9&.Z@3)>-C,2JR--GA+$.&G@1' M$\BR$[-O:K".*[NV_GL[W:.SK@R9LWE]BY=;/,&,[/"_!7T1M1\!-[#'K@18 MGAC$+#2GZ$4?_(J-K7:VCEVK%0VB5]BU@=G6/C38I8^:KK3 Y&@#H7H-P;Y& MG(<(HCC@#V'1R:2A\%Z%V# ')^8F!D&+Y6 H##X/*=9M=R2;H&"_B<@\,;5UM)>XS-L*!:/9X3F MTO D8MHJ$((X8=15M7%IB/:L/8GJ<@K' M%E7GOAS?^G<#:MZ0.[RRI5="B+H=-61X26$M-V_PE$E9S/6A>(O\ZY:G(?]L M ?M6]"+WT$LK#X7?O1X8 26BT91"I3!S:&T7I=ZUJB4CJI+%5!\,=A@=$J_* MNL.20,OMP5D0A',:!+#O0B/^CID8VG*U8?E-*PI+4\?!+I-W6-\]3''4+=3;?*M M2J+*7W")4#@CI);A[I1^IMQ@Y[K=Y>%%O7DUMJT9-IV@RDK7T8QKV+A W18/ MNNML;1W'K5?"NCV\[W/#^Q[T\+X>WO/?L7ZS7 [4O@O-RN_H*FSU:!J:5G M(P^V6&#%3I-+-LO3F'CZJ!6A2G79 K1S.-UQ1*R\).UJ"TK:U#]2V(AQ+1+A MR2-J!H]H(8OZ\YY 9UKBT'X>=BVH?B:(NKQN7H AE1IG:N-%J,=M*^/T[\9: MX[ZQB0ZUW#[^E(V:[NQ>.)T063HU2W763EI([G?UH"W*H-]05A1O(X3]H4E6 M7'$-&H&C'.K5RR+!NF?+2B%U6+%' 5/:<92FX03.E59<9.E;W$T8O3)C6CSM M8UE)M45W2DP3Y-)<#H$,6:9'/"=T8Z+IYATFDJ9-76D0P^AI6<2)>$@#FZZB M$0B"S+9IT*U+[8^Y#[+=64QO=J,LU4"ZBV1BDX1+MS+T'H%B/ M-1#0.OG;C!QOV'"VY;K$ MQ2C$9?TVKRP8K05B$>4^R@CZ)J,JSK@L3ZHB$&]+I7Y8R&Z+S((>8A29)D,# M#RZU1!")&^W=OQ\U.:$/0<;/W2%UR)0J>X_OW2,@13Q'LR]Y H_H\R-]?H2D M_$HJ96YXU'!)!>'G1E0CN4:P7?6H/(Q#HFH.<7$.U\7#6+ FQHMYMJ!S6I9D MWF% 66MY:ZH;Y0)2NFC1,H/[[$P8:D26#%YJM[[MF;85,ROT=-QRF3"K"GP4 MF&"7G&RWJ8&IL$.$E&4\RZ?YN"B1BXKKPY1Q45AD>4V:!?[[@P&,"_]_PQI1 MT)'Y0-37E(7A5E)X-;&JV_)TN)4"\!AA11<:_ZGN\=,"S'1\S3&%_0IT[ _' M8RJ?GR(DMOLBK!]!?JTK>%?B6K%ZD:L(/%\0?C"/,32KIUVLA![O-VV MGY>=BE'DD[:#-BV^3@[MMW[X-UP;JUGS#?]/WT^K]W%($A1>0643+JE+76"B MH!U<$4VYK2SU@D6!;OI^FKTA,\L, H M[J<0TT'JL;&$)3U]1F2ES5!BQ@1=JSBZ2EDH+*+$0T>*A1?QDBMCJYF'#]?& M&[XISI%^Y.+N2&5UGELN:;?=88W3''3%WL':D,#(3..,.-!M+ %!B/)C*XCX04HW*&:,)Q8B[CK*%OP-D)>_KP^S%H M3QO3@LE]7:I @R1 )'SA$XRQ9U&:_.L[M._?[(W>-#D, SN\)6_@%)Y,WA : M'7;7[>!E.;TX>1'M/1U&'Q,"^NPG[^\O7Y^+DY<7Y5I_08*^OV"@]O/=SPWL?]O#>+PSO_4('R?@-=934;F:WZ? XNN6' MQ]&_GY[&W&Q33GZCMAV:/>D((^K"K&(H,13=T. M)TLOGI''4V8U$>@RE0-RHCG8-D0F&->5N!YB8L:MBQ9E,2WCN;2EJ:+,(;@] MD'5MX!+R@RA."#8KTJG#P ^)6_T(S+RT1@MXK;LVQ!9%-QNPZ_;(E(G2&"!K M$LP;>P53]8S]N: W!!='=I-_P5V3>@"OCIL$23M@8)STQ@;'U!U(6XN27^8Z MI<&77Z9%9HLWJ8\B6.J7\9C:7-E/0&K4+4>$7Q16:IW$&@&R7">JM.Z= BH2 M4-ENM-(HD@HF!H2Y&/O4[@N,9%P:VPKSVEY.'F703U'4,*H!I U)-Y36S;VE M*B;U%7JK/L4&C#^?%GBQ"E*$OFQLQX6<;[9T +'C,(@U,U'";XA7M[](*U3X MZM1<>96R*0(JYCP3+)VVT=U*/U".1PCQO^VJ31I"R?W\!IJ5*2_1&Q4"5>WR MB1O2X.8J87;&7/V!=B#2*3%%5$E$=ADSG;ENJ$'74:^7;0"_=(/VRD1$"*0O M45Z0=#55*\@PH;#(VQRQV+@KFTI85FF.40!(,K=\@[YPR8 .-8_5,56-4TQ] M%O&*HUEJ)M$S6WUSAOEJYA0O**BOVTW",<2BJ^<4/N#46_<+5Z6*JWFNJSUI M/8L74A; MWMQDON; 6W_!@G&"EW5]%<]*:1;4TE:.LK4S2)&KL4&Y;Q:)I;BF\P4QFL&7 M>A^'&_=2"K7% 36*<4JALWP\,](;CL-KD M[(;3@4+"HU_?>IAUC9#+6*G Q !2+.\_8'KO@2WN7S.G030MI3Y4J'0IR,=@ M;Z:=2Q>Q<(UH#TO;+Y0CCJ3& ^U=ES%UQ1FT6RCO8 ".XHYP@H!6MVW#E90? M&?/)^/*UJS]A=AM0$3,WZ)RD;)3$R26A;WD0O,;=^P /"%/QE?8H&L55NO4V MR?N8JB2M9.@2WKI#N5VCA-9))B[?YMVB)ZW4T*5CJQ6XKJM; U+C<4\Y4/&" M$06KN]AI#"T:;4W(0'"L/ #ET'6CA$EA5E>F_L<"2=$.DWB,6]$ MJR?@E_?H,#&ZCQSUH9$(0SFG=X(P')$9@_3BT<_4W8\\1OSV(P$ZFR -3VLX M#X_[29-E'4*OB4!15W0D54X,1R6(-/7YZ#B5:FY?3;=2%E'N)VF:H"M+G]JM M3-<>,U^S$],GZEAZ9_7E,>B\5(B*P3)74Z;ERET?=/!XK"T3$>TM.G(%6SZ7 MWF5HP+2>IA:[WPEW7=,O(QW!L>,CHEE,= J[)MH['$:$R-I]0AM'N&+I3WM/ M!'(Y:4K:*YAO;"J_)F954]VF%F%?"J3B@K/[;UQ[]%L4F-V_Y7'95[=Z=*_/ M7IV\OC@]V>XL'@/YCN'L(M*->WL$Y+M'JHQ#C%C0P[9.R@0 (=$T=D@BP[]= MKO)A\_C!::,UL_C%,D?XR<2 IF^6C!F^&J-K,%C\=2>+ET53P]/>F>0)/_GQ M@^'N]T_D>O*F%I7YJ3+@,<'TP\O^7SR;:YOC0VXU-LQ_TJOE(K@J"7&W]_>' M>[L/OI?\7\<%>\/=!_\,]_U&7[@R3IB$I[ M%(_?3JFUSXYL@ G]KWL#7,&<<;;S)\YYXA\ZYH)0I6"5BJRP_#RQ.4U-/R]J MIN:,=-=UISH??<9,YX>HQW4R^ERV9I#?K)./GQU>DMU[7V%^.F?D/=*[G^+S M97$Z1OH9)^/C4 HHJ>9I?),#JYHI KCN97 M=,4ZI_MZ6;PM4)U/NL_NW@*[0!5'13E6]EH:A47_'<\73_Q.D-%SCJ<76!K3 MK_P=7OG?_CNS>O^@]UK5>8-@B,4*X(OO,9+?#@\@(NH MBQIB696Q_W<[]K/KY^IM;2//U&-W:_O'5[?WFK^3%;S0?1B?-1D&4'"CHG#%\=Q%%_>>[P(A\B75^UR7+M@PO?QDKWQNOGF=?S&?:#S*-3Z<@79]$) M42(/(OEI$%$4?!D=98B1^WJ&['YOR-YE20L5\S.&6?2Q_KN\I*>X:;V>L+W5 M^K$S^C1#0I'#073P;!C]5L"W1D_3(GH5EV^C?X[*?_SO@]W=Z#@V5W$^A3=. ME\5.60RBIS"/\%\[TX:O.C=%/LWC.7SL(/IYB?\U37<2N'+OWOU'CT"W%TT] MDQ=\/8U^K]?H=UE8#UUE9'1$D(U^.>_PC]X8/]1UM$ M*7KP8'_OX-'#^X_W[QWJU^OQC$HK!NTF[)I_LFC:AO;N*@M+'40 M\9LQW_9B^OYBNG\'Q/2Y(>JTD8&ER*4$=']W?X_$4[H%HFR.EM&K5S]K([MU9>=L[6)6@%_%29.=Z MR>E)Q3X+J=A!3RKV39"*=92NW7N3F6FW^!"U$ETC52V(2NBC)+E!&MPD;0"YK62MD1 MJ@@^:>8U:E%>%2&#RJDIF-=0FRB**V/>>K7&3.3$I$7*@\_O82X$Y1*8.+H% MI:'2GM?$3H"L)4(*A01N1&,P2V*3FY*( MG9+"5%3$K<00.)QQ%J?S2OBQ3(UM#Y)X'D^9-RWV/LV.QMV2YA,<.%%5".M# M@0PVS#2OS="IQIP>0Q^=P%)*4\Y+^+U(B,=":,A'Q,)EN =B:_SH>Q+-%UM8 MU;A8&'^I'(,T-8]J#124U0@+"/#7.N638-$@-_BR$!"'>>]U^<$Y,VM5*292.J'9'M MA.C"B&=#^9_PO8Z=@\BEIBTZ>-M-3 6B+07,EN'MH:NXDIU%M#^T >#GRH33 M@4PNDTRHSG WP+NF14S]/(I1+9P8^-P1=@\'4>/1(1T_-A6LF!)+7CI&%A"D M9*#?:A%R@^K-'_ P.D.BD-@;"JH*>%>-C.0)=ZG572.,'@-FE_,5DR7\KV3; M+9AV/4%"\S2)&O@U6]$ZE@9&MQQNTI4-O51="QHR1;J0O,AWO&VMS2B&T3'Q M_1-Y1+[R,AYUT=34'I57L;4&3",A?(+8\"85EAAD$ERI MK5=8=-,ICC1;ZBRQ^-'Z!R(*LTO! X^%AONW5BRVL,KPC6DUTZXHM1XY$9X@ MDR)+"QPP-:;*IZ8>OD& M63:R@BC$;H?51 ;X_5MN@+\X?7D2G1\^N]6#/+GX=W1\>G[T_.S\]]=;SB?Q M$HX=I_)Z?O@O'DL03OP39K>CD/CU>'KBZ^@B]=&/TY/ M/^"8_XB]W:;M?_!F3AUTWH"'^*8T4[+NP)1^P\UPWH!U?3L6CD[[![?]M#]\ M_=O)1?3L['7T^N3GT_.+UXN*V7)R\/H\.7QY'I^?GO\.?7OW^^NB7P_.3\^CLF7Q8 M)+T"-A!3W4:KX1.+*S&*2FEN3?+^>P3DH0B$[:4)D!6WT]]QYJ7\^: M>G]=&29_]Q /^P_W(J_S.+(J,\OF^LZI6QDZ.F;8!N;<:4[WR>FU7&OI!>'T?0_"Y9VEFPO:$V))0J+^]CG/N.4&[PKY+X>?L4GA[*#-[O^MS^UV/ M>[_KUOA=7_&,^-3NEBF)SAL#V3_#2V9;;0=1@M";D2G." :=BRNF%,=&VC4S MJN=3V^IZW,P;1MW[#46Q/4%3YEV6"E,\MSA1]Q[AZ=I%E*K9%1@:JB#,3*P= M0%WPZ<:OOE2#+)XK^SV>\S^D/]*?7S=59> 4W4=(Z2DL[CM.5/Z0R@7GQ!SU M*GH OY_8WC056LYPXE)*AV[#C&-:=,R+(%/U)9RP:A/\KSUX M- QI=3(TY=(Q?X,UH[?=>VX^[F<"GD6.^QWNU=&Q!)X)O.EQE*[*BR@K8''* M:-&,X!#/M,D0I9@P8^TWG25+AO)7<#QB!L^N]DV_03GFO58%FLDFWONL@%E: M[B@A?$K??4NW^1/_@S=[PK\7T MNRC.ZLZ_!XC+ QC4NR=R/#]X=!_^ \YT_:+/_RE?]5A>(3WVH;UQ4Q=/;LZ" M#)IF(PVR/+JDB:9G?QPQ\N[PX>ZC3;S%'_C;P^&C1Q]Z;__._IW\SLW_X^]1[WJZ3=)OTDV;Y+'_2;I-TF_239NDOW= M?I/TFZ3?))LWR5Z_2?I-TF^2S9MDO]\D_2;I-\GF37*OWR0?%S.\AJ3XAO'! MSG'>>6:ZW_,46X#'673,V+T(NR(,KQ.YFTS&-T5!Z#\R+V[7YX;+O^X[_]YL7_=.)<[]_^_U[U_;O_O[N\.!:P^@V+_H7 MV[^W8ZW[+=UOZ6NV]/V#X>ZU2]"^1+5"(\59G"_QBS#[$ M^$WOD&W5AGUFH-^VM^9S^VU[XVV[_V#XX%HX4;_6MV:M^YW\+:_NQ^SD![O# M!WT>X.ZL=;^3O^75_:CP__[P<6]*WYVU[G?RM[RZ'[.3[QT,'VQ9B/!.KW6_ MD[_EU?V8G?QP=_CHP7:M=5\:\&%-ZSNI"3UFPCZ4^$UOFZU5D7T&H-^VM^5S M^VW[/LBDZZDI^K6^-6O=[^1O>74_9B???S \Z*,-=V>M^YW\+:_N1V4 '@_W M^P* N[/6_4[^EE?WH[+RCX;74XCV:WUKUKK?R=_RZG[,3GZ\.]S=T@P _!/[ MAM"_WJ0#V*,/[WWS@<%X>MLG;O]U;L9-F=8I7'S8U+.BA*LE1?A-7E%;Q>A5%N=^I#^8.OK>;>@7EN;4\HIF1)I*)M@4LL:& M6/#:.7=T*DVUP)ZI=4'=K S/Y]B?SP7.IVV'69D:%P)N3;FU96(FU$+KTD2O MRN+=,CJOXYK[/4VDB15V4HT.\QS;6+XPIL9^H,4D.O<:3G&#+^RU"H\=82?/ M"?P[+'2[)53?T?$S"\^],"+9=W3\JAT=/T*?6Q7DNK8_? /[W927)KD=>O[T MXBLT,%\WF),7T<-@.-ZTP73=GH%^5'_=3SR6Z"N,A2_%5UW7@?[_>WUR?O+Z MCY/C_W^K[8&71=Z?HU_\'-WKS]%;3%RGA\^CH[.7QZ<7^@%P"/W^ M_ +''YV].GE]B#^<;\6!=//)0Y=U4F19<87.H=M4Y!;JQM*>R^!PQOD8FS;# M Y*TUNO N&VRFB];F)+B[@J[%1L-XUU]-3J>=ZVM<\?$7P7C2 M.@-G&>5Q?_?)N4$D(?SW,_O6X[B.Z=>])]SJ.J5&R> 5TS!PB$?P9J2NCL,[ MK6]U#!OX(-[CY+>U>NF JLOWPPR;$L>(<9QA= 9CB,=U0VW >9W&M#!).@%?/\(7ES!'V9+; MD->SHL(P1I*.I4$T+M/F0<3869J?CD(@[X\F\-Z"8@Q5-"]*>$2#KY&IY6>? M8DAD[Q!O\Q9AL"(.K^'[HF?\P*$(P?LWX0)&9IW7-RK!(3/3#V?.3XQ^CVHQG.7S3-)5=JMN&%$'4T):)Q':/ MXL4BP^W#V[MJQC/> J,T,]%B!FX!_+D&!8<-I.F:>9&GO%>N8.@8>L8K\)\U M_ MN">IZ/3=)&N-7I6.\ /77"+8C!0Z;FN)YH("K(B<=+7]C!=; TA44+@Q' M!P.[0J86^">&).&3ZB7=,34YZ/*,IP4G!!13THQKT"GG*8:"]QX_OH_CC68Q M/'5D#"KQ*5AH"=W/"@^U*RY8FC?4[1Z.@T4)VJZ$==;+!SAWDR9'8YM5H"DQ MBHK_J6M)?P^6$U3D)<>J29WCQ?!\7*X-JS58$0.ZCQ3<^KN&$4@:"!C.'NKT M$L:!W^.^1%2G=YC^M-[QD^U$3\/'S]ZO'_P:/?!@X,']_=V'[LO3W,<_ Y- MP(8O1H\$E/]#J_R]>95>U;N[[:=^'>U4Q;"+4<&03(8*PUS&64-;<).2@IOR M!D_1I@2)F#.#ULO60?WMTNR#@[V'N_NW]]_N'?_T;;GJYL7+C24=;Z53-@@UO.-JS)N%3,05S?Q&7E)G, MLGA4L&\7F0FF(JV[E3CX@D^M!?8 M7F!)8/'?2CC_G!F(:30T?M76!_L_ID-V/ /+?4QGIAZTU3)'RXZ\RIM[!"BM M>9'OD%CZMO)PC5A^F,_U,?'UK^ITO9#YC=B^X5B* AGP;VM,'E L1;E0%0)' M6"'QD0J^#]P4B4/ZYD^@&)A7$QS M KK$-8E4#1,14?0!-%A5H:,%1PPPM9/">B4 M2U,N4?@6AKV<9E&P_*J$XTD>3TO#"(Z1J:_0G\(K1(NV$TE;)G5_HEL_-NB! ML6%C.))7+,EA7<1+#D4Q/DDC4$Z65G>^=QCZ)Y<(BK)Q.CN*>;R4@]38(>([=>@38_ B^'71E(BLHE/3?I@= [ON656$ M=\JC$W3:43S\H)NW??! 1DFUCUL9)WZ3?9AH5(U&T@%=U!SM92T,_U*EB41X M$2ZDFU>BJFXG5=9'+D#T TF'B2_G+D:J2@)6+H41545F-Z*.A ("]#M^OGMB MEDZ,F!'VZ5N^3<[RZ!BVR7P$4[0_0 38/H5H*"%+:PQR%OM"LHCQUE79XPC] M>3RO&M!7KN??@JX\D[&[O4)T[QM6N:(F=,\Q[7\\:"EM-4O@Z/A1DJ%[, MYPKD$6Q6C*IC_(OLA5_A:7&YC/9HEN[Q]HRK&M]5%LV4LQ,&\PH3O.* )P06 M%+/"N %@\NJK8F<)ED4$RX_.%IJU"VM%P P-H]])(=7MC^/(YFU7T-XP5/B=;2C:",'UV&]L=X4TX;C(8^02_&(?(F]^[ H3FTBPI M_0$#I=M1O9EW\,HJI90"QD/A9XQNJGJ15- :#Q1.RYI/>_R<>2I[-RUH%OE@ M14F R8"3&*8IE MG48Y/F+QQU.MI9;L60"GXG@6K[N9M@;O586Z\A!1YN-*SH;VVW'C@-Q5S>@O MB4O;&]N[5Y11#A.T:4BL^_"XER=UXE&8(DX8'SHVI)6P?/,]J M0M5_M,9H!]$%OI&]Y9;":8ZR]Z##.LC%[UIG&/ )Q!=ML#9YQS[_N2[Z;,$"M1+8%CT?36F63YY1:LW\%Q=>YMN[? M6ST]T6;,"I03.*4&T;P!#(QZRC,X6=6$L76,5G6,"I50+U?4V0O.D,A MW?[">SD'AS8(FBUI9FZZ*>PZ7+LQ1+OL<;@HSPM$-I/KZ<5KV JW#_52:$N6 M)_P8>S)C--03)&?LBUOCI6C:\A/3 ^RR^HL^<.__Q4Q,VM*9I#+[&.9753 / M/[^"N4CC?!Y'+])Q6>SXYZIW;/(U[ZMGY,EW7X_PAU@=:4,%GU*_R&2]GW:9 M-YC(T,!&@L_A,)*-)=(X0;AGDI-_/P&AC$B0.?)$#A_?6P%VD\9C8/$C6:87S0U1K!*N-+CN(*41NX''^F&>+':P38'H,M?!679BB/Q.!T M[/+1;6! +J5Z@#!!OUP=/SB[$>.Z-O(E^+>+#0)C?( V#&*\:V*BU-(G0)? M--B.LCP 8_+>3R(1FF!"(4!;+)::H\H#DXQ+1 (N+LD=,LAB:;-^MZ3A.9 M/];,%UFQI"Q%;6(*BN_=>^0AJL8I%MM4:'(3B(K^S>0@*$:#;X+]*\HEPR92 M<#6P/.D5J)M2L3^T<%6JX#Y=/EC2IH9#$W$!5 5$2;\'N]^[BQ3ZXT$R9#(5 M8HA[EI[;U(NF)E/;C]^'(,L8TY!PY3$ 7'/AJGAT35<*$4RA!J88>(6P.*WS ML[^FA=6;6+\VN9%00 PJ&BR-Y0X;'U4SJD!T8L2_G?WQZRN0/8<"_,'^Y4=& M:6#9#^.'8JNV(P\W.(R>QE(Y> 1?#I?G:>P]6![24 ((0R6,T!*(4%?Q%^98 MRF(!^Z+&/-&9%(/]$<,KHU]-C3HNIUP!#=8K!5MNT+UN0!WJ=_^1MU/F\#A\ M(T+4V&JD[44&63&I:0)NIHP/<=(XA8"523QHON+OQLB8/%TVDU3YHL!U1-,% M-145A<[ J$2T8B'JO"1'E@P]D$&S@ZA;THUL1ZE=L_H..,<;U"JANP6+1,JP M*L8II5;(@$9S#68'=/@L3@I,O5=OHQ_2H0'S&\F@H$!5?%FE2"9A5)5IOH>GB$1E\24YK2">#,T/AD@7#!.:@ MX;G>+DU0Z>IC;&6;(F[AE*#S=P1/!2TO&?8QSLVDR:)TKKEV#^5_,]E+\S&B MN8T.$L92<=EC7+YE_C.1/]17ZJKE!J855%NFT3D\R6B-V59RKYB6Q54]\Y_6 MWOVO?FDM5P 4[5&XL->?F5%)&?6.T(P@N6#-TFK&:.B)!$Y"HQK$FURS\QG> M#'KC%./5>:+8@E4D]._'1_:BY[)E\-]?O?K9VFZ^G>B9;V$9I[IG/%H:2,*# M.C>+6I"3H,/A8M(:5+)N70W4TH24PV 2F'>$1T%3B8I=^'D!B^1#"L,^&RY4L3%L3"1:)(UZ+78N 1YQHS7QX>9UY7R3W;1;)2:T1"<@845(H9P[19*.LJP=B M7QG2^XKT']@#Z$?D8+9=)03F'#&>4.FQN(8 ^-^RS0 MN'L]-.[+0.-Z;;K%VI032M,\K1'@#,H4/44DSP,-65'JD?'/5%.%4>_<> 1Y MJ(C!XBLV,R%ABH02DCM*;.>JGWL^A5XPUPIF0.A8F;\;]/D=W:-M9 !_P(#' MJ*E@Y%45@ NU1CE+N13Z.I*$;2#G.\(F&AC%/QR/L1 +Y_M5 6:4EF"<*./C M5M/W75#LZQ-2CJ8M[LUKV4 '%DZ@#'94,L,8(="B8[!5*,Q!VOCWX?G08XZ MGS%BF-!ULLJ8-ABGBTPX >1Q?B@<[6@[$H]#4\K8*@O.>6M:Q*!_-;+B=;" 0K-3.R(I82)GNZQG4I$2=:R#QUY:92X%AB%DR;5&7JN@V!H6$_8 M%NR.2+!S"PJN7D#UKOD8.2SJ^)WX:HFIQF4ZPGP3V ]7 TI#X5N%9G6LFJMC M%$J]&S,++B8V8Y>YBLY/CBR_A-RQNKVP3-9<:<8/7WS8@"A@)R&*8QL>44 1 M.P4?! M"$U/':<8#7RLWW]+QPI?>A,;YM:SYZY90'*M0R 5;?=RL)2[2LL7N M(-E7)B_2I6UGRUN%BFEU%SF-[-?AR3(RP< QYJ"X54TC.Y E?82EK+GD@EX8 M7QGG5

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�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

?$\"[WDJYKQ(LW4*6(GG:3(WU2EM M[.-2, ')=N&+OTV]1=/825I5#KN4C?-GTODFQM1C\TFG)'5DZ,SSJ%,-*EF3 M6,).,7[+F(L+3UX,:3%:O(0-N)8,#9L<0R671)@N2JB IPV_8I])FO # _P7 M=Z6__/RWP$(K8\Z2J8[=\6QR9'21UB4R;I"+ ZIM=[3'?JRO!1:-2EZ0N+WK MW8EBS1-GM2V !M''RAOK$KA#5=.H& .EEX#4@AJ2FFX9R-Z$;3B'KT4:\XK2 MWC*C LB(9O>CA?ZVR=.3T@'!BH1*8(!EXMC]IG[4,1,K[^5SK70+,="^F:S\ M$+EDHF41D(V=H*Z?H3HM:'#/T4)20X1LD.1%AH\B;T[)8,!/X:EI'<12TDD; MV;/-.P9%0[FH#7)?HJ, VF8W?/63+99IDI_319I17?Q&\TO^15XTXW2[!93N MN2C!\52XY\5&^=#E(>D,=+Y3S1)*+3%ZR1TJ)J:J#WHBE7*GZY9BN./CXC)'CQ7D;56'L1U"U-(>.K M,18G%RG9H >@4!D.C5"#S#UW2KXH3_:29BM\Q!S# M>JN\)+B:6\(.&.$RY'"1\JVN(3@!RO!(F/<\&O(F<^D%).2>9I@CF^V"9F7S MTK(Y+&GIII'LQ<_4.710FBPAJJ$@_B N%^/Y\H)OP\LTVXX6@%"B?C]O5#R( MC7881-&0AD9A0)1*; GA2O6GYMZX3R409]-J0BGF#8^6E0;JJ9!0IJBM7CZ< MY+K9:32:WO@CV! M$?<;Z"ZD-L"%M8X.CAADGK'!7VT(.Y8-:HZ*@FZ=TN-3!E T)S1*DRAF,4X. M_D-1LI]?I1F-E\_?"FHO>!,ZIPI 1R*9+(1U;P0X]"P\]S5+G\%K("Z612'YT_5NA5,(> M7_D(4=42R@JVV%XRYTL"@#X]8&5>"Y4B>TEVW4,(N#>4';#1XAH^0HG(JVF# MH4NCV%J%+KAOS%:A]%R.#,*Y@HMOG5ZX7"FN"9A#2<"\! 7OD05R8DM"G%?B,U1PZ,Y3QL(L!ZQ4D?)SGL;KK.?MMU8)?U\BOGY?(;X.Q(_=]\UV MUJ.=$.3O M6-=DX,SOF"&H*$L]MOVOT0JFUC"\;YA4$_*($DA XENW@!UC\-7D6(.RKO(N MB/DO+)&^_7[Z/?D,V>I$K!G0/]4!>^P@B+'&$N@I!M*&*=;+,1C^UI_.;OK# MF?-@6PLCW\FF>JP*Q+WJ*H8*8D1,'20%EP0%BJ(/]56(%N6W!$68KF(_*.9. M[-KM-(ZU6)_-QFW;Q6R3A'")GVO$Z[YD+X@BLRR<4WX9%+W5.WA6S:^_J( < M 6?,B64FK+A+^7V$.Z[&"*P',6@1*M'"!P0EP0ZB0;=M9?5FUF(W' '\< <. MO!X-O%!5S+-4IOHN8)IF,AD-6YD5&B2 +ROR&/ MU,P=.::]X.EF7%"9+T=&]-!J_'F$25>A24P3_F5$K=XR\=^69E*$5WV;2])6 MV'5;Y1S9X??7)M\I3.X8Y$NS_O]T\LE!+)V?DN,_M]88^\>R,8/?U MFF*3FU#!/Y:OXG4;($<*N;,DUQ\64'M6L3=A$-Z*:D(JS9]4;72KHW:5[NNU M82-OAID#[X&@Q*O8?VKO>:.%C$^0/?$)7U0_[NRN.;H"%&4694D]&G7RW2+JPV&Z7?)[-WKLGVS6[?/)^CL&> MSM^M&EFF&4?):!TUUBU]!$[;-8L]_[&]A3+V"\PE#I)^$D)-E_Q,(V@5R.LA M&94HYP\95F&>33=WY(I;/KB>#0)R=3D8.#^8^W. ?.K/+^87:N&2(A7KCSJO MZ4\!OF.7E&9/.0I0Q^UA?\QW"E7:/;9H^IJ]=28P.+*?0#,7ER92JD)QOOF_ M.?]6CT?_=FUKKJU@#JFA!:3 &&^:D0)"?_PNSV!AX <2BL5/[^_0;Z$9;$[. M\@U0&>0"Z0/^=L//L$3PB0CBIO)O1(W@.\&F&&N65$W\GN_0HN;.Z4YESR4" M:R&G:12RG5[/9@US*+M;=M3WI:)P2;\:R6URIT'5.8\'E-2-%K>YN("-[HH0 M:K[YABCKC("V0_3%)LMKRJ>MIOILE"8 M>_3Q?M-KNH 2"IUPZY(5943M.0P M4,M_S>*E"+"K\/(5KET%@.M\.DODF M+[)M@_Y[)0*0G8K4%Z'/,[8.PSMMX3.VE76X*E5\EU(.IVBZ?-9/'SMP+S/J M U+&K_2:P"@!"SE]E=!XQ'Z5S[UC*XUR(?';%.+UI6KA&R\LI)Q MPK .V<4J)I4R,0%18MT#YN=\'\B%&7F,[ZM039MS]2GAQ)*N37-^S&K=-/8< MJ[QAZ=2@^3;%U:E#\.V(&6R_!8YW?;PWJKL?OL4*5PE;**?C\4WX-;[?W$N, M]T3]^K)A,$R*54L]M&ZI]9!@YY>'!=^K\2H0)M7)KE^-=86T#7TR)6/^/^4< MA7V?F,]=.KSB>?5')4 P6U%R+\U.-$"QG!W%*BSX;[?DCA*S:_*#0DB6\0-- MRE,G()MDCDU3@@?"^=7>Q%W0,7?5'K8)!>Q5B&6B4_FMN?(3 -WF*WW!SW;% MMKV*5J-%SC8!!]MFC.T6]_OCV MBH$0,1+%4BU=9H2U+Z- M_Q 1T8]L3^9/3DJG%$V:C.J*A8W8F S/%DAZLT-F/DB>F1@ R<4(H#>!FC&H^:M. MHG )V=(P<[XV^O46LQT%"4S5GF$GYZ6CI'(R2XFE7BV9<@ GY9V=9:ZMZ>3Q M(M+CJ_*]R(_>YE"\T=:=PA),0#)8?"E!*@WBT4AGI-!Q@#DF'DD<\2^2''X! M1( ==8@)VM>@0-D>\M_1I-$WL4>:SUA(A8LVZ4;!:RBC4X"C$8@F4G8N\#>E M#SIDGHIA:_!08LL,//666S,TBC)^DE(YRYBVV-LJ9:LDNL=.UK:M4EN75=&L MC+-T'.'%T]4RJ0RF5PNX&S+?J@@7-]@ !7@@-VK+JBI:CJR+XMN'E+Q;C.X< MI_,AC!G,$WZRF(:,7M*[PN3P+5Q-+$J]33(:,N@O0MXFY(=K3&BLA_">BWN? M\T&4>)P$W(713$"U^Z?NUS'53?6N*/F@["(8#H3=#.9IK8\"1>#GD/-8[TG\ M0WRAFXMZM.;=15;W[!0H;Q'O[G8]]U#0A__>@J]7;< Z2Y3CT%)!J*(;@W92 M&H*J$[)>/N"#+906#+2M/B#H#/<0T!@R&].,GW[N807 G("DF;!VEQ9C0Y3=&(].U5S*A@ M/&XAK0W"B)#VED>N(ASZ"@1%!CX&KR88M-B%2P,[!1UZV9S. 7X*KE^CQ0T_ M_&5QR)JUMFI-<(;,))Q4)I4)7"FX$.?PZWNEL\@4?"(XW +!U-@ 15A2!5B1Z7 M#15BXUJ,25"CRN"H/)A!43U3=.FJ:@[?L'5MI_F__5Z+DV(-&IL_$3_1&C=1 M R=JY/PG!B%4#AY3K]70/)$&0,)5FP!K@88"Z-D=\_]^0'O6&?&@I!S=6#9?$:N$^,,ZTH;KDG[]6A6:4$S#3S4>FI MZ\'KL-65"?66K*]VK &+6 ,H:@M513>B05[4*TQS.[:P8YF!$U(+\S3, MYN(FEO<91@/.MQ-4(])&>*+:3 M*CML/2L9SC=$5$.D'B(5D?,M055D>AIF5U:A5SYWYZ5'N_QK_-:Z">'T_CF, MD^N7O,KUF5(ECBRYO"Z94YOB4\:<@37O"/.SP+9MDUEM:PJA=HO!L%]"&@XJ M)2FE:\,_I^G\,68,">'*$>++.(^X[S<9;1CT5SKPT+<+JV?T>,P+0"K==!)> MI,D#/[' J$1O5Q9'=);%RV6SZ-I-G&"MK&)O SNQ%!SDPT(5R:9N+!<_#E^; M.T_H-^"NL+HV V+I"%2O'SI$ZO$#$FHJHIK!@AHY;WW<]EEV9_">X #WD?Z: M&I4O?%>&/B>Y[(X2J[HFB^'UL3L\%%%P(_ Y4Q^SQ)67(=J*5 M4@^F)BFI_JST!UY>;*]NVJWIN.A-OY#>\)+@%_V_WPY^ZUT#+QD_:_4_#X;# MP? S&5V1?_1[DQ-TA2G0.>"(/O_I*;J O>A]"9YZ8;RLTHTJA,7F[:<0N,%H M=\\;*MKD944R]XK1HMQ7C[%IZ+')3>>]JKIN>-=YD@K;VPT'IC5W@6 ::J7X M%E\46V0W3&![1N\-NW\WN*#*H$29F/J%G(%#^K68/5+V0&_2I%@U"J9\^O#I MKR=FWL&XBJXODP5X^K=">2!JS$:)V]R+ROSEEQLZ2V'BB3+-%X")U<;YM%PR MWU#(K6'*+I.RW[I)501'90N7" E=?#\GW;*E$H ^_'S<9CE[\WDLD-.O-DC> MT%MF%/<&O+.V8=6K:MT'E&%X/?@B!UAB MVK#00"4D?*$NQH$3/Z2O:#"%(OR5P9YP;!214&MSF3]U9 MJ58\6;ECE@-NJ*7#6AY 2T>-K*)89>EFN1+X>W,%@Z&*HF!SS)Z>.]]KG @)]H^CB"34^QI:)$1) M#?R863W<9W# (B@F/\ZH0C$ A#_\D?P\01>5T927743;2,^LGA!6,IOH]D[ MYWGO2KF;1+!O$D6H5@D&1 KU%%)HR:+=AE9=3M<-"]@3C\,YIGQ>Q% /5IH MJ'']A0G[-#]B*#U(#FS-65M371N5JVN;LP;5EBM'E6IE M;ZQ_KBQF;]%82.Y!#RO?EF@2;8(,'V*DX MA;5 L#XPEC["*:GU4EJM@F@=OE(%+5I;&[DSIH5*8)=L>D8!<F"'X"> *J]X0LB-'H&(>]MYC'7"A1M,*IF MS#]2&%'2WO# F=\1/U7X!N5C$E.SE\SQ4^,T+S):R#Y]*VF9F^JR%]>]E??\ MF;6>EMM0-8[SGR> F]W6J?65_8]V.7>C.'C3-X' ML)0?8T:-L"^4.,6%?/GS_X:-IC0C(C\&'#Q_@_PHU/]P4JS2#0N( MDM/VKX (D&:(&8*Q#].$0"HJ%6X_G+#238'Y;CA1GK'X7YMX+M8=3]#QA0S8 M(2RB/*(%O?/SLN$-? M4<;:HVY"^LD#:?B(:^>5,88R\0VP15/ ? MG351/C8-<'.F-*!U)C0E&U_=UX+G6?%?L[B 0ZFA1VX*XXL"$=M6BWSSXV=[ MA^Z#1'2ZN;\/ 6&X')*&#@1^39QNUFN&M\.003'J%4L?K6HKC0E4_N,6&1#D M\, OU1@V#!'/P?8@1:DN#)/856$3@_E3$>.8^^OM>9>5'3O:X]C>RQP[VW4L M$5'-/SR$-=^JKZN41&8RFRP&0Y]':C+GML\Q";X G\>6SRT JXH8QX![-<$# M$<%&:IY4\PF-LS2#$#V/1C28O>!%X":/%E&8/\2M*8VHP M8R0_'C!]"Z&^&!>=67EPZ55F2_+$$49K04LW;:VC<'_&@R6/JQ@JQB'H7<11 MO(9*O?L-G%LTK0_,>P $SF")OJ.$LEC@*6$9.?::<0&N%^G295H>^1#,2/#J M]@K19XM'NW0(P?8<>,LUZ>Y5FBUHC+^_A*L83>9-.S540[] 4PJ1@0_/>QOD M=U\-?8T&S^QQP[ [,>K*"FA&[W:/5M0X MJHM(KM]Y"_ '4K)I[)'KM]N9WZY!K&*+[OM28OW,K7:-JK9W[7U0[EF&<9$< MAS$P,L_"KT@O+Q"M@"^PEHB^667Q]$FZ>#Q>B"2X\Y2T4_OK0IM1D\=E"5-7HN-=_%W.=_7^?BF3\;]">%?W(R&9/JE-^EWQA[Y&BAY,-O%YN,E1:6I>K-P3N_#[,^\E\SQ MFV%XW\85 &41$/:_C0YO&TRK9C'+(F$&Q$>,@9XN A+S8;PV(#=-H2S&X\\& MM<(+8D6CT5?OR985%E#$FS>C5,++QSY(YAN(R%$5:='&N"^]ZLWG_#.Y_.>: M;X8?6Z@?D^("]04!P2ZQY%HUB!W7%GTK M9"F18:TA9._:)A45$%^EJ*6S&# MJO5:ZN@)J70/6TJPK%&O%J#_8:F=F[4 ,PT%T M%\;;0J0QNCIK-'M;]N(:L =XS002^U\+T=PXH]E]PS=_/[*>';BD2B.!2B2W MIV"WYNO-?A_.G@42KA41T-1AH^NA%-5%H/IX?<7_SGO3JVF_^=$3Y/@YJS49 ML9QXYZ3'CQE7_/_]MS_FREJ!CI[VG>_<58*E%A +:WB6_$(6MF73#G":0JED MQR/ :H9>N/_1>.34,%M[*S%D85/HFQFD!2M*#Z6&&=!C^/@J3N*"7@-F>Y43 ML3&'L)#]'H7OA,VL8NY(F2LTDCV[ M@?>N3$_NJ+9:6K,@1;?KW@6TM<(.P_ M?\FQ,:"]EP$*Z4"52*#S;X0V4E)W.J:K=Z*VMQG7.FPF:]VHHW%M&%0*Q E[0"*Q1+IM#2KG6C&N8OCA8?M^P>VPMF5F-]>*2FP6 M>J&F.W;69)4MV2=CWPZ/UUMXD(!$" W%R#(-';Y00C-+SU-^E!HM+N., J@& M'#JG440-1. YZ:$0 M-1;QT1-T%:MX:;30?=#HI9GRTLCV4N^0ET1AQ@GZJO*&PO\M^0DNZ5T!R2:XP(PS M>A]O&I4ZV,+QSB=$BE(7J8;P7\5F2PW@(ME$HVZA\*T:XMNZ9<+RVC]JDYLY4-QT"F#@7!5_%#HZ?VZ<.G7[IN MCWQT0DU0!6T,]/NV#22$#W2)!UCD34"?\Q2YJE\=).M-D5]#XNY3\WHX4[$* M+3\@F9L*LLDG;XT9+9K&CF\5'@1OPG^FF2)Q.F^!-QWD:58HPP#?#,,I,_RB2$2]/ K90GK@=N$>#:&C[;.W)/$=I9AA2]6T.VH,JO M )CWAA:K%S3\UX?,9%1!=.9D5/?C=,JTVHYN(5^!QBV7&1JN.X[XY0T>Y(/+ M^[Y+8UG%SC*+AI(?"$!JH<)E/^N41AM(;7[\=(=@[*T T7_\=';WCBC1;WGX M["@C?T9I9$_#2\[MVWRS50,.P/]!+-&0(]:R.VQMW>'WB?I0VPN]D_("^]8= M4$X!'G?2X_(NN)$N,1@KX'YPN6\)?LVJ9I>X8HI:2FXJ H[L;C\!IE""B MF\P7R[<'WSPS*:,:E]U3\CHWF3T]$PX TU5G@G.@(\QGR/TVIKE$*=DVNH\J M(;"/(]6PI](94_;IO>A7MW?,='O'"5C+=@T]O*MY9)76.1S-&IOSUV9('R4' M.+S;69KP+R,!X-/T(F[D0ND1P"G,9".#Q(=0@W;>V_.+$("D/E/[C"^>7:--4 MX09>U=%BS&^DD&:6U0Z-V+U0)':#"J'\^"UK*,ZP>K]8A8E;[,.6K&(E@_@M M2\K312%=,*)R5MS_=-P',DUWMZ;25CQLES1BX2NLJS!%V-5G$<"1= MPF?3:@I0>&: ^:0X4* M]ZN_# C@:*YC_K[,\742OZ!\MVW6"*3B#=):9C18!$(X<1%"=IXR;G=N?NJ\ MX=R!!]@>XRWAQ$@WC]UYDO7_9^_=NQO'C7W1KZ*5<]<]R5J=9,\D>Y+<<_? @^1)2L7BN9[K8!$%4 M"H5Z_(HJ3QP^#2_9%<(5SY$BIT%(&DI"4S4Y+M)I!=D)0G03\@S5,MX( MS_I6E'F](]EC),+-R?8CU9,8W&$20,&D<@ P;;C:;;ROPP($L[V70#S9$_T0 M&*83D@7BM0.5ECYP<$*.,TC_^.W_]?V'[W[XZ^\^T+]]]^&''_[R.V;MAW_\ MZ4\_T!]31KP2\)V3\.AQ(IBX*G86A]RJS$DD^,]^"U_\'4O\;]07_C"#*8DF M,S&M&9^7L(7+0&LZ-S<5DX8&HVKK))T..6$+)1-%G=[S@CN4)K;=[N,T*XZM M8O.+DA@EB)!!ZU@K&G+\<+#)R9771('QH#ZT4]8:*06'P"U(=]XFH<1ZS+>: M7AP>(ZI>4-&7^DGP.@;\ID /+,6(B._.2A]^/Z2'':B>Z)R7'B$\-V>USU(( M=*>W0C_?]"*J98,+U90/_V%6^L"'V8+].;OP0HAX/3UBRXYX"W(O\E+V)TAQ MW25:T"KR_>-B;/;2XC\^^O-J3!J5[V?%4AX=)"IW-S!2-2U[H MGC(>W@R"NI&CW 4%=5A4)?VZ2&3W2]]'AZL[/9O"$H=$/E/YTWTP==\9AQ05 MJ780&9"CY]+I9DG@0[PU=\W$B?P+>XBDLR=Z7<&O>X+H0CV15W'U00!?RD&I M +\)"E;1@>D//?_7*/Y"6?0$FSST@IS] % MT50Y.AE:0B,94Y87*=G;C@-8P>N3.:Q5/ HR1:-DL0, BF9,UBA!3 H-)NLSXM__64V?P%%?2OK_<[RCTQF5AB1NMPO5J>%C3F-.4'A\)-_ MYUC*WA/9!"39?(F'+)YT]+WF@WZ896!&R;[$DU:[/B*]8CE5OLVT^%?^E1E\ M9D:_D5D!QOWI)%OC!*WW&_T]XK$=[^BH%>](L M]4)(X81G.30,@YVJTP>(JOGR'/C/[#>?!5N#E VR_3#;DE?"_3)@E6I\47:@ M[_KT>,]Z ,:]$NP!5:?O5A)#'%7O&SK72H&1*2:%$F<,S MCD,>+J,T2]AL4_:(V#Q[T8J;F0KTQ71)]=8@2@-_<$FR3R1X>L[(]O?S-Y+ MB?@(MJS?7[$2]J6*"N+CQX]6/0'^*3Q7%9MJV7WU^: &UX09?YB)LEVE28NZ MY9!D,!/S_E#"W4RAMH68>XX-SJ&+)@LQ;0KO:KVJ^R2()4P_. VYR6+<.EU! M82:=^?0;[X-FPUW]859G OMD7L" P<+_EG_640&O>DW[CM&[2F1R-N9)DJ,+ MMCIE8HK]J:E)QH57!8MUFMAK>VRQ(3#: "S&PL3V'$M,% 9D1=7S#YPNJ6%! M94?XM$G@L!4D](>8 M!_/#CP[)GRL^(L;L9(D2BRC'EZLGX@$T[X>IX$$HE758]I$=$1]7JZM/RYL; MYHI8WFWF=Q^7%S>+V7R]7AS?XW!<.L72YA@OL*)-W'E'3@G(?0-S;1-D]V8, M:%&66D=_\#)3H.M.@JEY1$+#$HT;##12L<_=)RR;[V3J2CIM)45OEG\*HK;*X>;B:Q]F['LG;^Z" MMP'7BX:]Q OD!1F-_WY,@CUXY-@4R)^??,Z.'IRB3,71WM8[.;[[M_4(I-J] MK?,/3?FVSM\O;+^-78V(;^))8(Z.0(GB%58BR,4#C,>K";7GBGS."KB$XL]/9U$)+DDNHX3W%R&&1'9,/-V'@S.2#R^8<.ILYB/U:[ M7> #YW(4.OI O]XG$7-PPM^#K\S5.?S$\$]]F-%_SO*OL9=Z_CW^+_'%:8*; MCLR L$Q[C?1YA?3Y>R.]%OLC6$!R\NF+-MQO*;%PS\T8IA$+S4F('[![G ,< MS:(XFVU9[DYXR/51%K7#2\>#9D__ZI.T6C0) KWI/W>>+Z[./S#^*R:0VXE> MZ7:-(R^$\1A&XP?Z]>CW/E7V]R]L3O33D<>KKS)XY!WSKK'9IWQR] '+)T9F M3W&\Y=9%F43TA]I>W\D%%W-IX<4'41.UQ(B8L55\A5(] 39S 3V\VI7NBD'J M 7M7;=XSXR M-P6K;G/@_QWE3<''YCZ0DR(B;,Z?UR(ZR#^FL!(?A;2:["T9OJ$^0:WP$ ^H MY!">+'[G^")$X'VLGPD9,4A?C#ICPTX6H3\>+:&)C,EB\UG]12\%T$WVYS)B M(KHW$* ^E&@B",.Q"5)4Y 2'Q&_E^+^#>YD36'S#,>PAW*+75#L(GB(.'4&% M2X&N1'4]]J^0VW+S0L*] 0]+ID0+?#XQL9F<607X"12;TN1FQ>P^,!\\U/GQ MOGZ8,7S,,V%O.>[B&4S:L./\HF+-3C#4EPS-2@ST\N^?![?"*??A=%95/O<+ M FO-_TX_3Z\(" ?SX?'&B3E6A$_5?_>934/^D$YD2DOY))Q0V)X%M0W:/\SD MQ[D]0^RJZ:W3S8L/@D%32@$$2D!@S:@$"K MRUY^=?8Q?_'#AYE74%@F2M]V81L>AH5?,G9?Q@F\T3.Z[^-H>Q*T:,SV$[R] M1Z6BI%.IG0\3Z4!C$&-T.DQ0@,4G9)M>)_'+VH,;9.Q=)K\PV]%/0-8BM_:] M@.40S#[T\IAP]QV'WE!%*@S/HU)<+&P[=.V=]S("ZH858BW5"KWC!VP=D^2P M,[63V2B, -4BKG?Q%2)_!N5C/E2A^6>$#YE#],M,X=>)0J./27;I>I$!^R"S M^.I7OS3+(Z=YHAM47$VHE .6P$]^-]%-=$1VA"-QXN@L8%9;LMT0_SF*P_CI M,-Q1*PSBQ9"3136,14W%L@^I<=.3TLQ1A9T(N(77>W#YR5\(R?$+\9+-(DEA].CYIU+&88 M=(-T)KG#OPI(VA*5@WYX)K\L.[T7EBB MEZTVZ38$0(FRRLC8,U>]B :?.%/ M9+[%.-E"D%9,-]6,A &/EJ/_Y$*>P "U;7?T$)(2M(;,+5 _ XRLU:@->8B M D^#^SN5]?589-< FGU.H0]CSN2@)TI;V&,UCP\1V;\R7&F'BJ*@TZ6'C%?B M;8+)+G8[7A@S]PH_4!'U "$$!/,9*7PSE9:7 4[5BHV"[QP4"8"^SY(7AF0 M(125.'J7M(=ELDOQ%7#(8.Q9]?-%P$6]77D2'R0>YG0!!?"QKPV5BS*W@_R M?BD#'B0H03JU9V]4TNK&4SXVJ'EB=$=NO1)26@TZY#$ENWUX$^P&')* MA#^S' XZ)(.6/46ZQ.)50-_J0"@?9GS\VQ$M8C2.S+=[,U;P+)\"K+GQ5?B[T$5X-E?R0AIA"7<%_C"+/_$ M3'YCFNRYHQ :G@&--5-%N6H$2ZDC.;&Q)%9@?,/>]J*#,%J\F?WKX#T3>^M(,HA6PG# 9,I63"^^!X+IHZCB/# 7S8I;^87 M@=9@ H[#VJR.7_^KA(?#\4F&OQQ935HQYO_]/_[Z_7=_^5\L0?+X)<:'4],L M.7PQOYG?72Y.9>I%:>B3F;A\X;'.'V;S+$N"S_M,(C?=>U, .@AM=*O7GU() MI"YPU/OK4]4XV KJ>P*PO:="S#TV6 MO"<^Y%J86'^CVIU^F.6\DOC^$RCB["*_)8G_ZT^4/X/4$C;*[*>/WGP2[6/@ MI&MZQG23+TIX@WX2 0@:"$BHXK")+\B]%VROO,,MU2*>Y]$60E4&Q86(KT 0 M(I/#6_J=TR4MK%*5SL0G/LQ8%0SN@H+O3%'K)(7WD\AWV%X<'@BS2OKCY%/E M'YF5OP(09/EW3I+&T)J\Z?+KU_N7%R\YK':E,.9YG@;/DNUEM9T M+L5+%U^:R4]-\A8_(M7AN1%!5+Q%>AU8()H!CJ6"V#M-O[]P S0Y" MJEQL9LN[R]7MT5]/PZ9'.C5* MY,VJC(F6_UI]#H,GX5]5Q=*"N8RQ83X5&PHGXP-)J4KH@VYX!?7_8HXZ5L#R M7HKHRDU\3Q(ZTY?K.&%V[1'NYI+K56&-;W&);YZ>;Q\*QF4%XW:3,8X_'07 5N&E9-$]]%X>7*/OMHG=]8'' M2<&M_P;#GQ)I88VJ8MB9')>7MCLEHNI/_^:2U5;LZ$H:/3E9$D#."@!.TR,, M?X 9E7X>K@+U3T?PEDF'"/M+:>CW1'#80NMD::DV05>LZC:E''"]PKQ=CS# M\MV6\3A=IJ5E,%J>HKHC6Y) _=SCQCN[X(!T1EB'FW$VP0YAGZ[ U4P69@9U M7)E0NZ7ZV)ZGD8Z.R5@4BYV5/G/\2)UCT1::R/J0PS6*/R>$V&%;BB.%BG(! M7G@?IP&#KAJ6")[;,T\U@5^B%GI>%]E5N"LRHNOC)C\1W?_:^9F,:I,Z'L25G>/&X65R=. M45A;4>DCKM=ZFI6^\6&JU524W"Y"#\5/"\O36(&<,H4QSD<^;3J-!KPRX4UC MG@.07)E4.S*006&4W)83_$M)3/_/:1,;UNFL @/GN.6V9@?!)#-75JXDZ, MMGHTM]T*NC%#@6,BB/94]J[R/,PARG=Q2#-Z.I,)I-+QZ.IL3)O(7":SML7- MD-,M #ZZPB4HT_?$V"=&BB:[75ZAI?43'YC]5GQB"A=^(Y%?_DQ,!ER)R1L! MC&:J^"9[+SP.5$/^BX7$;I1?9H9@^6V'Z U'8$SU.<7&8-0F8NSW069]Y_=< M^J,'I,O:UM=Q OBX4/]R37Q H9'!D\I /M8FD&1ZT''(/_6[W=Q\GL&/ R? MFQ7?H^],^46.6>H\R+="G=8*/^#+=?J/#M";/RSA!5@S(3T0<$O*7T)> M]7>CIF(D M1UO*C.QYLG#-*;E1VQ_ET<4FD3SBGZ^T2&'WS.0,)GO'/*9@2DJSX(4^/ 9I M=+=>Y''/UO],(8&,F8ODP+C)$ M7G[1+!WY1,"BOD3B*N9,'>,\V\W\LUJ=$ M0V&\EJ_'4O'(*?)UM&\(*OA'Q5$&FPU+23VZNV%,4DR/'K@:IW,D&!)L;ZA< M7F;D99"<,R?3SOX_^,B,?>4D20W145ER>7@):,MP5 MXJ/L?F:??2<$J]P[#5H_L(V8A[_.O/0Q*56>]U /R,4^#BJ8BDP]' M+TDZX/%O#1D-6VA00V,*2@&PI4$GO/1Y:=1L)-]%V98A1C;Z+2:RTH]$9-77 MM%'06D3L%VCMY,C(]<=9R=!^$2<[=A>'_*\_!B2!Q+7##22M#16*I5.8#\PN M[KOYSZ=)75.\- B;6FB6 ORO$_+?>RC(/+QT7VG463[L"=(4&L@Y>KH3"R5I M34=]B ]>F!T@>. Z3FX"'\3 ]CZ)MWL_2]=QN+TX".R\07%E_#,L_(*EF8;B M2P 0R#XU2^FW 'BDC"$XD974.:O$1K'*>):L9/$>D.HL9S*34YG!7&87!\G& M=\LV13V-I+S1J((/;A?PL*9TH\GB*U9[[\.,[CLHIT%_E+X2/]@%X+,KZ#IZ M-FH#-UJ+_CU*H"\]:J\2[!QN$R)'/V$ZR^4R%4C9->3S#U7H\ZGJ8XY/?CO\ M^7M;Z;#O(A^=Y"2($^X)?2!^Z*4I0R%BF8?;?^UYGOL52?TD>!V:E%'_ "PT M^SZOM'@/@45"6)XZV:&:X@]<>B<\9/\P*[[E).U4F597NAHO#D43L77G4-B& M(['R85ZYM*'&1_][+BC2&,4^8KE M"59T,:HR*/,:89H?9GRBL]),!?Q[1N/_*7&BIS_,3R'9P M>@)\]$,#WX4%]HIIS7@3T,1J/ZSVR.<[DQ.>L1D+!UPQYUDQZ7->@#IDO=N5 MH#<@3VJ_\$+OB$"YI[,RY3H(KM?F@CP%4?1M>9H^+L<+,VF.BW" 7_:LOJU* M[A%#4A;R04^*HBK4+B^EQ@+RMY*\A(]_&N0H8^I.BH*P97)PZ_TK3B[!$#;89VZ. M<_Q\F+%OS=C'3ICFL >Y$[G6ER^O7I PL+I$:@VKW4T,H"=TFGQJN6)19\SH M&(7%=,!""-,0[)I/4B<( 3?")B.20I]3,:6L^"GJ"SE-H^!A")#L PADW.); M+A"VB2^],!2V2:I>?V(>SV%X[I=E #Q2@M;PDB %)NV2^$7\.N9?YDZ:]?W] M.V))@A07!\\2OD.@EOIP>_6O+#$6+/P),"GG-?L\G*[J#'.)UE^94>F=Q M5WMR1V>]^4+"-\**GJ4J^ON.Y901S)O!5>$]O3]?2#+GX.QE"K6- M4*QAR9T*E^M=')5BK#;T;ZG'*ORF3<)Z#N&4[')1-S8UYFE\(*]QDM7EC*X= MBG5KWAR%,>-&YNFH5LNJ(PH2"Y%(M]0;\]*+2BE@+F$OM7V+US-?DS!_D 5;Q]@ M7^G5T "8E98[N]T^QI=0,)'%LD!H3$*>"150$N\.ZH_5H81*,$)Y2-8%H1L? M+*LJOHTVN%-6I518YQ4"/I+X*?%>GP/?8^D?9;*-#=VK&!*(@Z'(RT!2V,SP M1+_/44U6.W[<61I%0P7I,PB*C5X4IUP#HK>7;-/'5RC@^_U_?/?G__B;03&Q MZ8B"Q-[!>.P_$,&6EQ3X3GGQC3@^"H;I95 5-4VY+2S[HB"4"V+N:^,63/U^ MU[7%0PA$B6[("]0Y3@Z%29<[>.!N(2E J#Y% #VWC"0"0/GWJZBZ2C^2<*ME MQI&^AX*A?]][24:2\)"7O5E&3)5E6-LF-=BN)PHBV2J6,."IWN[S#:Y=5!KI:Z.6'5 05(1?\/4"O9Z>E@_ZF64L0,*D@Q^ M3X&*RGGW-A2,ZXU!8ZV$8JU48$1&1?%V $% M27G\9"T,1T6-KBT*0K2YRH\IV>W#FV!'5#19=$-!GHBKO:8_E*7A/P79LW09 M+KZ*B";0'^G_MAJ[;8]A4)"O*#96,F:4GG2:?6O7V;TN<^'YOX8QL#^F[VXJ M!-GJQ"\O00;.*&&5725;DJ1L$<7"I0WUI?=(*-8[-T:3Y"WPB=H^F3OIF!4R M90$\Y=_#\^$NSGXA66'$4>V/HWT,!2L;BL'%84,_J+,I&)J[/QZW=",G@1>" M659AZ-2U0;$.I:Q6ND-(\ 8F9K.]JJ6+\[?%TM\E(MIJ3J5*RC-NKT/OJ?[( MT+=TKI-N@@P\_LMH&[P%V[T7@J!\("'/]WH.7C@"/"U1*9[6.NL3VC/ !%"S3 : M7"!MG5"0)F+]P0-0G$X!*PYYO/=>H-3D;/JA(+#8C6RR%P>6P\0VF7GS-IJC M($=AYX XP?D+Q%>DS8NS2S\4!-9JK=4B!+3K9M$-!7G;KBT*0F2&N"; "+3F0H?F&5?+--VK M7^R]!T/!"JYW7.K/5J4!BBF+$"^])*\T0#'EDE)'53QVM)_C$,Q='/A-Z3%J MZ>/\Q"M$IXMK!DCY?72Y%N 5(FR,:H! M*>8EI:H@Q+T 'JLP/X,AF0<8TE^L=GT"\*>;FGN3<#..*-T\4XD' _]Y[F=[#ZS$/(ASGI"\HG%;(,CP+Z#8VXJ]8]IOAN8HR%E&;W3[QLG! M,ES"U!X%01_C>/LE"$-Z3M6X&4;R['N[/\&5)V3-A:MLX%P+VR0>.,G7AY?/ M<5A7NRJ_1+&55*4SK;0LU__[+H#Q^_W(?M.))HFZ&8BU:_ )Y M%O5JEV>7T2=HP#-=,GA?4#EU$ZA%_6B#HV 55:]*CW:#44C9$ 4)FX3YRP\\ M:3P_6$P145%B:H^"H.9C7^(M7>\ALZZ&NG1-U8YK^H+T0@@/23=4.!)OEVFM MF*.,C8)15)4@P1-5E_94%!T,J4.*=B@(X)MNM<]22/ZG=X!6#R@W0C'U+HDM M8*I2JCB=!T%!^MSW]R^ OT*V.A.H$?#!KC,*4DTFWKZF850V.RD:V.7M'\I0 M8/-HR_XIPB@M+%Z]!T/!"HN="%-U:_A-[+3&!O=4)"G MS:(SBNSV7BB(TPG3QXCJXR$X]'Z,0] - 8X#).PJ*L7\<0SMJWV2(R1UO+8' M? 8%^Z0JN=KE(;DEF[5R7QA[N#?2W'K1?D=U"\9L84S6)B/IFJ)8F_7^<\H* MWF<+<(?J-6=E0XPDF%+;-$W=;RAV]+O!P9@PD\<:$\7Z%D@J$+P/^)NO0>:% MAD>>J0,*D@K'#(C[..*R3A/QU26SI?-P*-@!W@0#:EWIU^Y/JA$DL^PJ$EQO M',NN Z!8H5+LA80/-%BK]:W=KY\BEFL>17LO!$?>V@N]Y,"U)YLH,'5/%"M6 MB2 W+9:R(0X2PC#^ MZ>ZSBYBO>?L]T^%(BMI6QH4Q1]EP%0D%SU3-Y[R2IA M#_PM\P[+1+9VGZ:N)PHB12G16@%16Y0CV\XH2"U99YJY!*93:=71O32M5*VX MM"EM<8G@(F\QKADDBKD'"J(D1*T\\I"\[+.W0 F"RK3U.@W@?@OJ]:GT]37_ M=Q/YNG-G%*NKM9AI(CI-[5$0M*;,I=NI>GT9S!#ZYNZWH@S*H9I[P%-SZH@3 MAF8H5J.CN_]Y O( ETN62PBN$RVI*O/Y$*_H"V$8KU M9DI171-J*3.C;NY><5!#H0EC.\]M;N@&%GU0K),^OKBLJZYV,H _'U%@+'= M.>PR(@JFL,H2W@O1OV>J+5!,VHQ8S$^4BA2;?N[/8.&PK!K46!+.:D?ENPJ9 M3^\('6U0%&O_N):W/YWJQ_B-)-&+,3;#V $%20 C#(Q_I"V3C!XR%K)D JPT M=4!!4A%/*['4Z[ LO,1E"<*7OA3CA"4'9H2J2P#LK/"1-9">K#BAVE"H?@^>,@M4A(Y$R_;N]E_OU MNHFCIPU)7J1%G:/0LU(Y/$1WM1, ,]+V!%$[Z?,J:;Z01AD0Q7I7C=A6V4@M M75"0)70-84=KQ!\I#<9@'83!1PCLHD@N.,#R*;=M#/Z"W1N+%"14H4!,5$H4@W02<5G%( MO_ D]8:1U!';SZ%@I_%I,6:J3^^A4; I!]<"3UI*WV4 1\5S#\&6DKSIZO2T M=G,O@Q1Q@,8L[CED;%NEB1]A>"2[(8]$SGUG-\&O) R>Z?K231[MO+2S+FSZ'5KO$ OPK"/6U6+69AM-^-,[)[":-06_+"R>PU M1(D#\#F(+8#$+"I%_.#5BQ0RIO]0[ME0,S3*4R^J;K;9)6O-W9/3D&0BEPX. MK'2*,HFV#4 U5:YEIP%0G'8[I^=8SE.$+E/Z;@<5AIDYEM%]$C\!\H9>IIO: MHR"(F4LY+FHY0Y[EQFACP-7A7ST&0L$"II95ZIP9PS<:+=T+(VGTM\'\-;1% ML1KLK65*5:\T0#%EE:/)7/SKY(&V5 M.UO$NH^>#6.8,]AX,!2MD=)).4I1_[UY(:RJ-%H:G6^\K MA,NK88]Z#N$^RIH\L99IZND7,:E*DRTCX.N@[@70SUPZ\!P"B$0#=DS8"P4 M>Z"^54WV"55+%$3DL4MEW M1*.N,0I2\@"E!^_++9THE'?L$-:D[86"N..5 M/+J+F0I'MLV@T\D_CH/5#4PGJAR%>W#TWH-$@G3Z+ D^[S/VI(CM S#'&1D/ MDYJ^%NX:USI;-%*EUU#.[4H"6Z(I]AN_=']O4\6>I\)"#%"N5\1I>NDER6$7 M)W!:U04,^O1'L46ES4!](_/?H9AH!4^@&F3"WUK,N0'Q?G8@84/&0\&0=? 4 ML2!'>HUP2$@F(4.J_K=XM>QZHB!2 U?7;IO(FSJ7@!*6!'*#?"]59,'J6Z%8 M@\+ 2#6^ZSU4(64(.9ULD\:N*,@4T@[,.O1X,'2D]I(]K9U0D,;5J!Q:6Q\S MK&R(@@01B<3\,:#[ :>I@@-&?\'\?ZN+"UMU1$$BF.>I\OK" K?97KJ(HZTI M5<_4 0=)7K35O_B+WZ*8;,?:AJRHW)?8L.&W-F!9ZAJC((6' MIO($AUA:ZTFE$.DFAA"2^R0&W,#MQ0%PF991KDG,P>H?M"$]'.,[*!B8%W6^ M.-PR99F9,:X35H#$/^@,8!;=4)!76K<'PHSGFY@^X3X%V?,S+U,$,=I*JT[+ M-N@Z' IV7.P#-DM(YA!_7;Z\TBW+EL]@N+7JB,3[)2['!_(*IJ3HB6NC:B^8 MNBV*M2K5DA)/UGWV'"#ZP-BHFS_5,M*15M&UNNQ0W6 M<0SWBB(<-B^"(GV[.'F!JXK-]&>2@N!]("PP7FVRZ],?Q4K+# RPH\A@]MRY M5W6_:%^_749PO\HR\U/.6P-DHFZ&8LVN]TG$LN&A&DGPE>7%Z^U'^M;NUZ)P M8)HUH$TLDO%46,UE?W07%.AC?1+%'JD"@=X$5/9L>4T:]@M"!]!>2;9]41#* M,@+(U@Y]4]O8N?U4(ISF. ^+:'M5JWUA:H=B+>RM^0@-]<#=^7X;9'&B2MTH M_0H%KW/O5N$&,X;M%,U03+]AB+(W\&"V['0@!S,91@> $0.AK1L*\NX!#I7A MJC$[[WV<9@G)A'*N0)^=347% MQYX'&GM%!R#9Z M$]TS^S:=- ]J]H-7U4NL1W?WY-X$/DCM^5-"")?B4"J";$7I"/HR;CZ96[N@ MV)0/4+(T37,$6_!-E%(\>3VDIFP0FC>7.RPYB][=ZEMPO/%1,$Q$L/89!0?XE- %; M&.QI*+]4@&U^IZ+3U-Z]>&O%$+HC7^;TSZW08$4A[OJ3?.A8*%9V'M(S!J)) M_2HW! K9]41!I/0WC!&+V'J+[Q)-1] MX6]@!EDU.?KV[H62#;#Q)H#D9:IA-<10I][NB:5"<47_S//=<[417L_*7V@T MZ[X#H=C C5ORQAC#J&V-@AC[(#N['NXW*0L:%3KK,KKPHE^9*37-@HSE.NE> M>Y;]4*R: 8-:.CS^%NR* M07;@\U>+N99.*+:?SN@"3_"RP;A8%V:U65TNC2;]LJY%M7XP2U.2$U%:M+!) M:TP![F>%8G'4&6WT]12DW9+@\BXHR#)BRJ@?B'2U=H0J1,I JR'CH6 (VZIW M<117?=(&^X*YAWNA62O/8E-XH+T+CK62'!>\-AH)M(U1D"(A#D$>PIL0;BIN MH3.0U-K)_>93O/=E_'?7\DFJ?NX)Y*H18/SY >'%AN?;MR"-D\-%["4*Z(,. MW=R3M_@J<-?NZ$W_/*?OCL#W-#09VCH/FN+IO#_'(7WL>E":-:3/2PM B1D89&P:8K\CDK&8%+J25KJO6W8Q5UZ8^"X!Z5JH4K M3Q_MU6 MKT_7%@4A\^V6@=)!A=N Y8BSPJG*@ZINBH(,)L)+D*EPA7KI,P/=\QA"K!G6 MI4M_% 375=^:8EP$"GY,J+981(M!)+,QL&R4@5&PJ,B]E$IC_OY]!#3R?#<+ M+.ZBT)M)!1T^*@KF- '<343K6Z,@)K?C%[F5Y;JRS+*_744/L(T3#H)&#W@B M_\D,_D;Q,.H'4+!,54TOS[>6D6E7E.!=1A)5X9-! Z%@P1643Q)HL^8;7-T2 M!Q$-,ZPLK@ >.DT4AJ$'"J(8''_Y<7]QD*DIQ8^UT);VO5$0"UQ?[3[&\1;D MBG"OIFLJ;-46$%UK][8"G:$2]E@>N5S?EMUZHE@Q6?SHGO (7=/-J6N+@A"C M[);Q%^U&V1[#X""_+BBT ;_JEBB(D"Y&?;TU?::M;5\4A#:K8!BA[[2M$-6\82.A8((1L*@(W+OT,O_Y\;6(O0+T<18V*HN1 M+M(L>*$/ZM6N9&VX3^BUKK[_C_Y9%.Q5UP75"VA]L*=M(S .EK N'3#BSSJ%%"PG7E 19:H<"SPI[G!$=?6!P5A MIA7A5KAZ_G!J2C8>,)SS(.L] MZ)[.6PGLWZ<_BJW;&Y;4:*$;/BH*YLA052%KN"JD5^ -S=UO;CHO6?.R9PQ> MYQ%0K*&BL)#0M=25A;I=VG9CH6"$=)5(5TCA,C$\M(U=G$2'.:1%Q[2(+T.O4IV5??>"$ZP".A=?"4^R]]>[>BYH\?P M,=J2)$^$;9Y;NW[N"=36Y%VL[^]OO:]0^+9\QU[P+:E,ZQ]E0/*SB11 M_ Z%@.&NR%N2/J(@D1I;FS 1^C?)RU=W N7 E(^#YF_CWF9 MUCRN8UY"/EGM;H)?21@\QY"'_ MO[Q0M8 ^28NX06Y=3Y>1(B.3 7MQ!(Q2])#(X&P%G#_BQU#L,-"\HHP^YS\E M]'*^BK]H$F#JK5!,WI"7HG;B:)NC((>?N=QF:E(D-4W=G\XNFMZ&-B4>!*@- M4AB+85"LHM+A4P,U3D&P:HO\V79'0:XVU]H25+1+?Q0$TZ.7<("B M:@YQCY%0,*%4)HE#6!BB7=1-49"A)NMG/MA M'T 95>-8E7Z%@L>-<+X;DVM1WQH%,0KEWY!MJ6^-@I@[DH']@][%@..VO3CP MRJ4*,Z6*./O>[J5>2QT:'G7!7WA!!'8N[M .P_@+W& -P3=P/!2KS_7L4*EG M^ZSNX58)$F[3#P6!Y422]-;;DDW,Q>(JN0E> &(+L',BDEP3Q'.,[:%S2',=-4_!-V0B'RJ *U\I_@6)[ M,AG"3;>@::EK3]?:N+]@Z!4@2AE%VT)=!%T&G"?T-H MW?1+=.V+8H6L<&%: M7DY=1D!!M/ P<&N,!?RRJ3T*@NHN2U8U0(UBJ6GJ7*)1U7.[][-R;E[S.C(V M1+$2S.HI8[&*F @]=(*B+0I">+HDX!@8#$.-1DBF7O.94DW>?W[QDE_U"DY; M'Q2$<2SKW+5'[YH'JHR =*+B-N081OD%E,JR.$HIT&LD%$QHP8XWN5PLN[K7 M0&08X'K_^AH&)&&@=9^> __Y\IF\!+X7YD4U/I&$R'"Y)D!XWX'0V:4D+73_(<_TE6$LWC0R[). [A?:6/D)_M723?P6Q/N4F\YTE9JF_+I39K.X "J(+^_*3"A^BN(\*W6'')U+ M_Q*TZ8>"P%+(I.(J-=45ZC<""J(?")A,J-Q91BQ)6T^W_V:Y>LY&@IF*$(?[N+L@OZ,A;AE(CAZ_4Q(5O>A]1T# M!>$R.9@J% _D5>*2[DHZBU)Y;^WE7NF[#:(8P,5X"E_)^-QF5+'MB&+]#.'' MM]Z_XN02D#G,GN^.0Z @F\J1E*[&EEF^+&Y+4WL4!-F8J_D+.=>^E/:#/N.X M/ZNVA:574?^BU+0OBI4NZ37P[.N$M6S;%P6AFFJ"[ T%\ 9)X$,Q66C%0FA$ M*4'ZM%*CN/0?#@4[-!B8(L(RSY)9[:@\IGI"X(4R)W#Q-8-\-RJ5;P*;D-_^ M8[N7!/6?L"K6>[5)HM= M*%C0&[!./EGI\3T'<$TS$1];VD:H_"Y_/2@\KG\](!B0[>74&)J/"O"D 9;4;"2&](T>1T# MAT2R_>"5G@"$%$R.Z>F7?.7T.J"Q"XK55H/5V%AI;#JB(%&)H-2EUD.E@WO- M]WY[ ]EA&@]VY;>J* EHH *&MI"B(8,B8(M>GB%PHUD%R?6[(>"P*9Y-@^D M6.T80:E"TV3'M+6 M%L6*Y@$6=N7'#*A8Z%8UQ*V'*]QP42G%4?5 M-;2[ _N/CX)A3<5%"TQDI_=HN[L7NR:7I=K.QI575JZ#A.#"E D@+%2Q(8O' M_@"*'7(\"^3/5,$ D<*Y](D$3\]PD#@.%#-/0EQ6KF1.:Q[M.#GG!JR;F(J5 M^V?ZBN::7-U:5?\]BKUUL0]8%9PEO63C-Q[#K8_@U+=&08P6E?#&!%G5W@L% M<5!;GHIVNOU3AIL!?V/G0QX@D?W&A)_20MQM!!1$"T_X-0%[==@ :E+:3,U= M4) ELZM-0?GE%B@F#764OP1AJ)JN_)U[%2,OIR*N<>OR*^KV[@GZF66/Q5]_ M)#L2%$$3&LNTL36*;50*OI*%-8Q&35-[% 25$C5*9F=Y(NB%4G^RF0Y2[\&< MH[G(W#TUJF7UMRC6+0>[*.,TTEM1L*\A3U0-)T_\(- MFP#;<^F%/IP=*LE$H]7G,'CB*J0(Q'W0:*"C#8Z%565P37.]>6UC]YJJ-"2( M(N+*)E=PXO]K-MS';?RJ 8IL^ M*+9B#B[&W89JU\9=S.(R"(>Y3C=QYH7EWX.S\2[.?B%9X9[F%+/D\!Q65FFB MG78&*)BNU5XO#B8H=XMN[F7"0WSPPNS "LKX8(2^)BJ C+:V*-:IMZ.O&HWLKT=&,8]3A#HV!3$0S4O_: 1>G8 M@8,[OX)%972UG;7R2QRK>K0 @?P>7 *&3I0&OH,H!DKXGF#PTUX0;8UP4# +_WCD+[[ZK-X8Z&A3; M,W\4G)7D30>%W=K-_4TM+70:/0L";?-0&RX.\W\V-#"U6#GB9U#L#E%&.)7@ MQEYH3OK3-W>_&YK"1@$*J?7G=^J-8NUT_N:F3*+'MIZBD(HR8DF04G%;N/_$D4;-4G?5SO =!,_D*<9U6JUL"AT'C[KH-HG;UDBR2)Z:HG$%5%1=]U MZ#WI?'_Z'BC6EL'0T%<01Z>QS AM[82"M,+FE%_=(CJY2V:LP]YABX F@4O:-4*"7EWZ%8K0'O,;-/9I2!4;#H M*@=2H(\A>-9#[HZF6K3)3VW3'P7!N9#1H-&7?X]BPO;ERTW*<_=1W.O4"AVX MKBC7%K%#-Q1KJU9=F5H:^.*G14YOG0HJ4UA,#!4XVWK*QW&^@()IA<+P][V7 M9"0)#WFL;RE8LHOFT6$@]\="E?9< OZ5(2B74'CA\;4(4]S$(ICHDEF_H'Q< MF@641LJ $G@:?3GY3:SM*3Z*8G?9OS+!(/48>3P9GVP_>D$$T=:*)^;@!VVG M3Z%@8Y?0/;5$>F![I&SVDM)I:*A@U^\A92@_42QG?0QO]I5K9L<9& M 6OZORLU48N?HEC%-0GI3Y\^T@.3>)"M.-^^!%&0LBCZ-R+>/0: @4X#H""Y MADM1C4-;[;,T\U@0+\.W5)'<:8!WH&85QOPI]2R;KZ+83P-L*&!!T>=XCC(P M"A9I'NWBD3+PZ6\8!07QZF44@I'';=FO?J6;>]G2*'E8M?QJG<":]NX)Z@D- MN/D2-VCM/Q2*;:NJ/7!%4C\)7NLI,99=W*]N[Z!2$3K:"6]KFB^Z9RHD/T%5 MR$KQQ"X%HKGBU(PE&&=<]PP2!:\ARW\?PL& /!%%=:'6QBCD0HY"H _DFLK0Q2UK9%@4A=N"1N:*M=@QU&L*YI[:(B@ 44)D6Y^\K$L/8$,7*&6OY MR."5*W4RA&U?][+NUDM^)1F[S0 -DD[V@;#J86ID ML^[@G+\SQ9)KNH%PPZ MJX:HEO8HMN2@M/3CF;4[?,K]OJBG2J]V=^2+N$+ F9$$]&WZ&A*)BEHD4=/' MNL+#VS2DC/P!%#O/5J IWE8]AT!!ME#N $R&SIXND1=J=$&['BB(RM6]&R,: M4*,5BLGS0M+\/=Y6([':S+WH4;A7YT]05\1+LH#*!$_QO+#H@V)=YE2X;8-P M#W)O#=E7S*ZW^ J9+V1[3=O"=;"7&&GUVE3ZDHJC#(R"1;>>_TS7,CF4/5[Z M9XVAN?NMK,G\X--+5SO-"[]%]^HU&HJU+2)ZA#@/(-QI+7XSI MWIN9I/.(74#"M:]PCDGKA*>UJA=JFZ!8HL-B*Y@>9A+#F2X9?"P(X=O-#^ M@F4E/YS^G=%HA&/JRKK,P_U*%H"4>5V<#4E>J/:@+:O3W@7%J2K53R[E..5@;_IX.JN.*$@L M"AYP,)S[C2R#JR]Y[3-X8-[%&;&IRJSO M@F*5Y/^6MFA82FUP^@C#HF#/)F%@; 4]@6KGBB(!),V7&8R#@,N[X#)@DNJ M03[%R6&U Y^D_/U6'Y3?3,4:ZE&O:Y"6^=UVM)KJHX$3\KSUVL@%"Q0/(M +VE!^#7W M04%827&\]X*M%H^DW@K%Y#N6'C-)F)Y#H6##?9+CWQBM>ZIV* CH@Q)'E\7. M9V8U% HVJ/-->#()JT4*%;+H9%GDC_ZQW&,8Q.2/@1K/,F]2Z]KV]DQU,#D4 M2R5*)QE$3;F!RT>+QFQB:(9B^FV9E%H7G%5' M%"1N$F\+L'/S3U.O.I@NY9>;HV6&'.5,7,/%$3)T_5 >%G=]#EX-?FO]*(BR,?])%+A%Y,&C7;3I:TQ4 MC^;>,]H,[QRELD9C]Q_]8RCVE? .5-"?K7"CK3JB(/$!K *KW6/*)=7J<^:! MF8ON;/%J%![RB\,RVM)+.3GH_&/F'BB(LCB==,Y0 MO6[OA:6(F#:%%'^CI%7*8C'?O)(M>U4H/L=NIB)QO^>B%/!7,J-W76L;_@?.WS"&I5 M\:C*+S&L+U>(A7VQ>&"1;)]$Z7K_^5\$4E]*F;9\?80T4RSGL &1B<(:_$T7 MJ6;LBH+,/ "'90Z%@@P3^DCFF)9>PBE1#Y;B*.05T"ZVDDWFJ[*C?O9 MN%\, 0O/,-;R&9:TJ*KGH,&];MU1W 8-$!:M&U;=TOV:R<3*$EA:N@A98#15 MB$(OY5:5YSCM];.]!P)-EJ[3+&!;-Q3D?8SC[1>J][&( M[JI&413H-BE=G09 03*\S HO02E%F%O6H:C0)@F>GM2O'OO>*(CE$3F%M4$? MM5.TP3-Q1?I,\7+^,6;(&?(XK:+2<[M93%*%5W'L;Z%@)*@4M2#9PM:2=CB3T!XV(@JFP+[* M$0V,=BIU2Q1$=$PSNR-?L\T7$KZ1VSC*GBT5CTY#NE-T15 MHS-:FKHG8[[=LK *+[S>,T2@'$.'#O.#QM)AT\D]:;=Q%M.&GJZ61^77[JHS#R++_U+<6WIQWZ4_"H(5 M9B"_:@;2QZ/;]D5!*&C/'&3CB43^XP< S^%@HV5])1Z?9OBWK=)[;(8 7)U8Q( M+>:$HIGS<\H]H>L7+PQE*+K:65II@F7:SR0,C0&WY18HMDK3D9A?7>V5KZP[ M.T>BWP09'. B#T4%1J]LY/Z9NMZ_O'@03515B< 6!_6-]Z^OO,J,%X*AXYJJ MBLN(A464#'=4NZIT-H0F3O5-]XQ5B'.NMK#(V?B*9"1YH2VHI@I@XEM%IM^0 M<=PS@-[3S2,LGR$B;*/IJK7HY)XTQ9KLM:&:*,C,5WXA%5G]ZO=6FY-E*B,(\CI::QQM^[NR;V8 MKZ_7"XV.6/XEBDU8CS)L*U#6;(J'C'I\JU%E,/= 050?8%74F*IVYUD4?P4P M+_J8$-6OMO=)O-W[6;JFSXR+@[#B0G)YR!LT-9!C?<@]"PNG2!N.;INEL>= M"%C0M)'2W0WJLBIEO8?%U7XT%+*"[L^4_/<>KL,W*!!'/Z;W_FL;HR"%>S_S MZM;2+:Q+!C8T1T$.#P9ZCI/, NA;V]C]B:NIFHJ$>84,MNGDGC3 HH$('Q9V M+8M';F*6#[7:704) 8<"R(.U'T!]A5W@S[=O01HG!]:HX>4=<5@4F[B@B@ICW0D%::7(KY)R2U_+QE#]MD[82!.:KO@!EYDMA*FZ MH"#KAM"9$0V$I0RAO]H34\Y^US%0$)X_[Y?1ZSY+;T"K_5YO_3$T=R]S*\7G M+W1!ZXI&SL,9Q -AE0@'CRJ:0=4&Q19JUN64L)D07G!+LN>X'6]3T\^Y>5>6 M>?GN^\\LG*1NU:W_'L6*F-!#"GRB\EW:\=VO&04%\1HH0+;!.K@C.X^"@O@Z M;+$$+39D41A[H"#*'HO?$IOM-(P2N2S*2 MA(<2VF\>CF8'5]!Q"!1D5VY$_L S>70UC=TK8J4@HSJDDT8K:^V!8GV:X' / M!&Q<]"")D#(.9,E_GVG*VW0=! 7I]!T*AAQ-$!- !%=#$W?JC6&UFFF;(:Z]4NR," MG[53=F;'(5"072GL\;^I0I1N ]^,.=#2Q?WVO>2*.M5U> &J6*(C05APS>Q8M MNKD7'1+O3M0Q5I69,;5#L3XECU(>XB^C7Z^('WJ:NCDV_5 06,V/O DH[[>\ M=@#[!='D\5MT0T$>0$+P^"D]XE6]#8J)Z[*5%8'E] 'Q&'G4C?&@4QQGQUQ9*)&,(6*,3AHZ)@C@4L#'UD1U1F$0&C:XI[ MZ3\:"F:4+B)1'VN?I9G'\+5:+JY&>Q0$6:/W50MMFHS@ X=$P18)UL5B+!#?GW"A0F/,]TUHVZ)@@AU=2H-'=K&*$BIYU:T.TC-/5 0U31O&&T' MAN9(R)&&0]L<$W,/%$1IHJ?UJV3L@((DD6G&O:FR:^M M;8Z#G#R8CZZ#.&W,>-$E#M#8%069TH$LILD>N=8QK-:=49!J55_(N+#=1D!! MM+[LZ(TJH*A#-Q3D<6PY 3R;HT%OXI+E590 HWLR\#5BMLL0*,@^NAH%%TT3 MCXHC<*8FOY]=V#W[7=4)#';5!"O$%^9^&QUINLE,U1 MD*/*NS8H7=K6SE_3B[RB;2++8= MHO#WX"M[E6I"^SKV1['IBG@] #\V@@-HFKI?-QX@Q=1R%B)]X/_5XVVT=4"Q M,A=>"'D-ZV="+.RB^M8HB%&@A8,TM@E#LNR*@DQ3+06J#Y'@*>)>9;K9BD ) MCK(8I2'7O097;>C_)11,+-0/3M(%V5&"^-_I'.FN!J.)#_*4$]I%H^DU) JV M-,\!6,I22AB\9>'!_BE.?J7*=A+[)$U!0D=9G&@TV?ZCH6"&+: -.BR;4J2R M3\@VO:8_!9C,U*(ALCQ$#8%G]I=:E/PJ";>KEB*I0RJ6U[XZ#7*9' MD>V&^,]1',9/AMQQ75L4A'2LCPJH+)OGA.@@;'J-A8(1^NH.)3=-M[(PA@'< M/QT>(SJG$/+*H$0L7/JIVHC0WAK%^M'IQ!)4B*LW!G&C;>Q^7:P+<5!]K4>) M%MNQ4*QI Q-+C0K9XF8U=45!9DL0/K9H>I[$FK^[*&,!R)5*!MJ5SM,3B:OP MF*BTN IV+!$H"[Q01><8XZ)@4/'FTF?EM9?=,_=%06@>^!Z+%#UK3=ZF(PH2 M]2 XCRG9[<.;8*=<1YM^* @L@529+"O:#=NEO_O;M9J#OOA*_#U('&Z_3NPR MUS6]4*QFV=/+_93:L)5**Q23EWF^!N"I3U3Z/P-.QAO5WIZ(^0P.&<_]5KTE MB?_K3Y00'41C]?!PM/4!:O:NM#PK""A6XM9#$I:C\MXD%'AI]'S MQ*:N]=#1W9]0^IB/$Q:+ M))5FB2>EQD5O:8]B]>FJ9$D 1D-UQKWZIWKKZY#Q4##$YEES$T5@[0>0^E,,%78DJ'M>B'A$ E@# ' M&AB,0VP:!@7YM>>'Q#VZ"L)]7E>X!9ZAXQ HR%:D_Q16!/'3U>

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oled-20231231_htm.xml IDEA: XBRL DOCUMENT 0001005284 oled:AdesisIncMember oled:InternallyDevelopedIPProcessesAndRecipesMember 2023-01-01 2023-12-31 0001005284 oled:FujifilmMember us-gaap:PatentsMember 2012-07-22 2012-07-23 0001005284 oled:FujifilmMember 2023-12-31 0001005284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001005284 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001005284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-12-31 0001005284 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001005284 oled:CashAccountsInBankingInstitutionsMember 2022-12-31 0001005284 us-gaap:ShortTermInvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001005284 us-gaap:PerformanceSharesMember oled:PerformanceBasedVestingRequirementMember 2021-01-01 2021-12-31 0001005284 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2023-12-31 0001005284 2022-12-31 0001005284 oled:AdesisIncMember us-gaap:TrademarksAndTradeNamesMember 2023-12-31 0001005284 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001005284 oled:BASFSEMember us-gaap:PatentsMember 2016-06-28 2016-06-28 0001005284 oled:NonEmployeeMembersOfScientificAdvisoryBoardMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-12-31 0001005284 oled:MajorCustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001005284 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-12-31 0001005284 2021-01-01 2021-12-31 0001005284 srt:MaximumMember oled:OfficeLabEquipmentAndFurnitureAndFixturesMember 2023-12-31 0001005284 oled:OtherNonUSMember 2023-01-01 2023-12-31 0001005284 us-gaap:NonUsMember 2022-01-01 2022-12-31 0001005284 srt:MinimumMember us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2023-01-01 2023-12-31 0001005284 oled:AdesisIncMember us-gaap:CustomerRelationshipsMember 2023-12-31 0001005284 oled:BASFSEMember 2022-12-31 0001005284 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001005284 country:KR 2022-01-01 2022-12-31 0001005284 oled:OtherNonUSMember 2021-01-01 2021-12-31 0001005284 srt:MinimumMember oled:AdesisIncMember us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-12-31 0001005284 oled:MotorolaMember 2022-12-31 0001005284 us-gaap:ShortTermInvestmentsMember 2022-12-31 0001005284 us-gaap:CommonStockMember 2023-12-31 0001005284 oled:AdesisIncMember us-gaap:CustomerRelationshipsMember 2023-01-01 2023-12-31 0001005284 oled:AllocationOfWithholdingToNonKoreanPatentsMember 2022-12-31 0001005284 country:KR 2023-01-01 2023-12-31 0001005284 us-gaap:PerformanceSharesMember us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001005284 2029-12-31 0001005284 us-gaap:AccountingStandardsUpdate201409Member oled:AdesisIncMember 2022-01-01 2022-12-31 0001005284 oled:MembersOfScientificAdvisoryBoardMember 2022-01-01 2022-12-31 0001005284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001005284 srt:DirectorMember 2021-01-01 2021-12-31 0001005284 us-gaap:StockCompensationPlanMember 2023-12-31 0001005284 2026-12-31 0001005284 us-gaap:PatentedTechnologyMember 2021-01-01 2021-12-31 0001005284 us-gaap:RestrictedStockMember 2023-12-31 0001005284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001005284 srt:MinimumMember oled:CommitmentWithSeniorLevelEmployeesMember 2023-12-31 0001005284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001005284 country:IE 2023-12-31 0001005284 us-gaap:ShortTermInvestmentsMember 2023-12-31 0001005284 us-gaap:PatentedTechnologyMember 2023-01-01 2023-12-31 0001005284 us-gaap:NonUsMember 2022-12-31 0001005284 us-gaap:ShortTermInvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001005284 oled:CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember 2023-01-01 2023-12-31 0001005284 oled:MajorCustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001005284 oled:AdditionalFundingAgreement2006Member 2023-12-31 0001005284 oled:AdditionalFundingAgreement2006Member 2022-01-01 2022-12-31 0001005284 2022-01-01 2022-12-31 0001005284 oled:MajorCustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001005284 oled:CommitmentWithExecutiveOfficersMember 2023-12-31 0001005284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001005284 oled:NonEmployeeMembersOfScientificAdvisoryBoardMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001005284 us-gaap:SellingGeneralAndAdministrativeExpensesMember oled:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001005284 oled:MajorCustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001005284 srt:DirectorMember 2022-01-01 2022-12-31 0001005284 us-gaap:TreasuryStockCommonMember 2021-12-31 0001005284 oled:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001005284 us-gaap:PerformanceSharesMember us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001005284 us-gaap:SeriesAPreferredStockMember oled:OneNineNineFiveMember 2023-12-31 0001005284 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001005284 oled:BASFSEMember 2023-12-31 0001005284 srt:MaximumMember 2023-12-31 0001005284 oled:AdesisIncMember 2024-12-31 0001005284 us-gaap:SellingGeneralAndAdministrativeExpensesMember oled:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001005284 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2021-01-01 2021-12-31 0001005284 2023-01-01 2023-12-31 0001005284 country:KR 2021-01-01 2021-12-31 0001005284 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001005284 us-gaap:PerformanceSharesMember oled:PerformanceBasedVestingRequirementMember 2022-01-01 2022-12-31 0001005284 oled:AdesisIncMember 2023-01-01 2023-12-31 0001005284 us-gaap:CostOfSalesMember oled:EmployeeStockPurchasePlanMember 2023-01-01 2023-12-31 0001005284 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001005284 country:US 2023-12-31 0001005284 oled:EmployeeStockPurchasePlanMember 2023-01-01 2023-12-31 0001005284 us-gaap:RestrictedStockMember 2022-12-31 0001005284 srt:DirectorMember 2023-01-01 2023-12-31 0001005284 oled:MerckKgaaMember us-gaap:PatentsMember 2023-04-30 0001005284 2020-12-31 0001005284 oled:BASFSEMember us-gaap:PatentsMember 2016-06-28 0001005284 us-gaap:LicenseAgreementTermsMember 2022-01-01 2022-12-31 0001005284 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001005284 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2022-01-01 2022-12-31 0001005284 us-gaap:TreasuryStockCommonMember 2020-12-31 0001005284 us-gaap:NonUsMember 2023-01-01 2023-12-31 0001005284 us-gaap:LicenseAgreementTermsMember 2021-01-01 2021-12-31 0001005284 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001005284 oled:AdesisIncMember 2022-01-01 2022-12-31 0001005284 us-gaap:RetainedEarningsMember 2023-12-31 0001005284 srt:WeightedAverageMember oled:NewOledMaterialsAgreementAndOledMaterialsAgreementMember 2023-01-01 2023-12-31 0001005284 us-gaap:BuildingImprovementsMember 2023-12-31 0001005284 us-gaap:PerformanceSharesMember oled:IncrementalPerformanceBasedMember 2023-01-01 2023-12-31 0001005284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001005284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0001005284 us-gaap:ForeignCountryMember 2023-12-31 0001005284 srt:MinimumMember oled:OfficeLabEquipmentAndFurnitureAndFixturesMember 2023-12-31 0001005284 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001005284 oled:MajorCustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001005284 us-gaap:PerformanceSharesMember oled:IncrementalPerformanceBasedMember 2022-01-01 2022-12-31 0001005284 oled:EmployeesAndNonEmployeeMembersOfScientificAdvisoryBoardMember 2023-01-01 2023-12-31 0001005284 us-gaap:PatentedTechnologyMember 2022-01-01 2022-12-31 0001005284 2027-12-31 0001005284 us-gaap:LicenseAgreementTermsMember 2023-01-01 2023-12-31 0001005284 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateBondSecuritiesMember 2023-12-31 0001005284 oled:MajorCustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001005284 oled:ExcludingNorthAmericaMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001005284 us-gaap:PerformanceSharesMember 2022-12-31 0001005284 us-gaap:MoneyMarketFundsMember 2023-12-31 0001005284 oled:MaterialSalesMember 2023-01-01 2023-12-31 0001005284 country:US 2022-01-01 2022-12-31 0001005284 oled:MajorCustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001005284 oled:OtherMember 2023-12-31 0001005284 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001005284 oled:FujifilmMember 2023-01-01 2023-12-31 0001005284 oled:AdesisIncMember 2023-12-31 0001005284 us-gaap:PerformanceSharesMember oled:CompanyPerformanceBasedVestingRequirementMember 2021-01-01 2021-12-31 0001005284 us-gaap:PerformanceSharesMember oled:ManufacturingExpenseMember 2022-01-01 2022-12-31 0001005284 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001005284 oled:ContractResearchServicesMember 2023-01-01 2023-12-31 0001005284 us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-12-31 0001005284 2023-12-31 0001005284 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001005284 oled:ExcludingNorthAmericaMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001005284 us-gaap:RestrictedStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001005284 us-gaap:SubsequentEventMember 2024-02-20 2024-02-20 0001005284 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001005284 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001005284 us-gaap:BuildingAndBuildingImprovementsMember 2023-12-31 0001005284 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001005284 us-gaap:PerformanceSharesMember 2021-01-01 2021-12-31 0001005284 oled:ContractResearchServicesMember 2022-01-01 2022-12-31 0001005284 us-gaap:RestrictedStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-12-31 0001005284 oled:FujifilmMember us-gaap:PatentsMember 2012-07-23 0001005284 oled:MajorCustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001005284 oled:AdesisIncMember 2021-01-01 2021-12-31 0001005284 us-gaap:RetainedEarningsMember 2020-12-31 0001005284 us-gaap:AccountingStandardsUpdate201409Member oled:AdesisIncMember 2023-01-01 2023-12-31 0001005284 country:IE 2022-12-31 0001005284 oled:PdLdIncMember 2023-12-31 0001005284 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001005284 us-gaap:CommonStockMember 2020-12-31 0001005284 oled:ContractResearchServicesMember 2021-01-01 2021-12-31 0001005284 us-gaap:ResearchAndDevelopmentExpenseMember oled:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001005284 srt:MaximumMember oled:CommitmentWithSeniorLevelEmployeesMember 2023-12-31 0001005284 oled:MotorolaMember 2023-12-31 0001005284 srt:MaximumMember oled:AdesisIncMember us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-12-31 0001005284 us-gaap:PerformanceSharesMember 2023-01-01 2023-12-31 0001005284 oled:AdesisIncMember 2020-12-31 0001005284 us-gaap:OtherLongTermInvestmentsMember 2022-12-31 0001005284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0001005284 oled:MembersOfScientificAdvisoryBoardMember 2023-01-01 2023-12-31 0001005284 oled:VisionoxHefeiTechnologyMember 2023-01-01 2023-12-31 0001005284 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0001005284 oled:MajorCustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001005284 us-gaap:PropertyAvailableForOperatingLeaseMember 2023-01-01 2023-12-31 0001005284 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001005284 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001005284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-12-31 0001005284 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001005284 us-gaap:SellingGeneralAndAdministrativeExpensesMember oled:EmployeeStockPurchasePlanMember 2023-01-01 2023-12-31 0001005284 country:JP 2022-01-01 2022-12-31 0001005284 oled:MajorCustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001005284 oled:AdesisIncMember us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-12-31 0001005284 us-gaap:MoneyMarketFundsMember 2022-12-31 0001005284 us-gaap:RetainedEarningsMember 2022-12-31 0001005284 us-gaap:CostOfSalesMember oled:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001005284 oled:PdLdIncMember 2022-12-31 0001005284 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2023-01-01 2023-12-31 0001005284 us-gaap:LandMember 2023-12-31 0001005284 us-gaap:PerformanceSharesMember oled:CompanyPerformanceBasedVestingRequirementMember 2022-01-01 2022-12-31 0001005284 oled:AdditionalFundingAgreement2006Member 2023-01-01 2023-12-31 0001005284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-12-31 0001005284 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001005284 us-gaap:TreasuryStockCommonMember 2022-12-31 0001005284 oled:OtherMember 2022-12-31 0001005284 2021-12-31 0001005284 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001005284 us-gaap:AccountingStandardsUpdate201409Member 2023-01-01 2023-12-31 0001005284 srt:MaximumMember us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2023-01-01 2023-12-31 0001005284 us-gaap:PerformanceSharesMember oled:MarketBasedVestingRequirementMember 2022-01-01 2022-12-31 0001005284 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001005284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0001005284 oled:MaterialSalesMember 2022-01-01 2022-12-31 0001005284 us-gaap:PerformanceSharesMember oled:ManufacturingExpenseMember 2023-01-01 2023-12-31 0001005284 oled:MajorCustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001005284 us-gaap:RestrictedStockMember oled:ManufacturingExpenseMember 2022-01-01 2022-12-31 0001005284 us-gaap:ForeignCountryMember 2022-12-31 0001005284 oled:AdesisIncMember oled:InternallyDevelopedIPProcessesAndRecipesMember 2023-12-31 0001005284 oled:AdesisIncMember us-gaap:OtherIntangibleAssetsMember 2023-12-31 0001005284 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001005284 country:JP 2021-01-01 2021-12-31 0001005284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001005284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-12-31 0001005284 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001005284 oled:RoyaltyAndLicenseFeesMember 2021-01-01 2021-12-31 0001005284 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001005284 us-gaap:BuildingMember 2023-12-31 0001005284 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-12-31 0001005284 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001005284 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001005284 oled:CashAccountsInBankingInstitutionsMember 2023-12-31 0001005284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-12-31 0001005284 us-gaap:AccountingStandardsUpdate201409Member 2022-01-01 2022-12-31 0001005284 oled:AdesisIncMember 2025-12-31 0001005284 us-gaap:AccountingStandardsUpdate201409Member 2021-01-01 2021-12-31 0001005284 oled:EmployeeStockPurchasePlanMember 2009-06-25 0001005284 srt:MinimumMember 2023-12-31 0001005284 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001005284 oled:RoyaltyAndLicenseFeesMember 2022-01-01 2022-12-31 0001005284 country:US 2021-01-01 2021-12-31 0001005284 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001005284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001005284 country:KR 2023-01-01 2023-12-31 0001005284 us-gaap:CommonStockMember 2022-12-31 0001005284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001005284 oled:CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember 2021-01-01 2021-12-31 0001005284 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001005284 us-gaap:OtherLongTermInvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001005284 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2022-12-31 0001005284 oled:MajorCustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001005284 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001005284 oled:MajorCustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001005284 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-12-31 0001005284 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0001005284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-12-31 0001005284 2024-02-22 0001005284 us-gaap:NonUsMember 2023-12-31 0001005284 oled:OtherNonUSMember 2022-01-01 2022-12-31 0001005284 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001005284 oled:AdesisIncMember 2027-12-31 0001005284 oled:MerckKgaaMember 2022-12-31 0001005284 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001005284 us-gaap:PerformanceSharesMember oled:MarketBasedVestingRequirementMember 2023-01-01 2023-12-31 0001005284 oled:MajorCustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001005284 oled:MajorCustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001005284 srt:MaximumMember us-gaap:StockCompensationPlanMember 2023-01-01 2023-12-31 0001005284 us-gaap:RestrictedStockMember oled:ManufacturingExpenseMember 2021-01-01 2021-12-31 0001005284 country:CN 2023-01-01 2023-12-31 0001005284 us-gaap:PerformanceSharesMember 2023-12-31 0001005284 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001005284 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001005284 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-12-31 0001005284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001005284 us-gaap:ConstructionInProgressMember 2022-12-31 0001005284 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001005284 country:CN 2021-01-01 2021-12-31 0001005284 us-gaap:ForeignCountryMember 2023-01-01 2023-12-31 0001005284 oled:MerckKgaaMember us-gaap:PatentsMember 2023-04-28 2023-04-28 0001005284 us-gaap:ConstructionInProgressMember 2023-12-31 0001005284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001005284 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001005284 oled:BASFSEMember us-gaap:PatentsMember 2023-12-31 0001005284 us-gaap:PerformanceSharesMember oled:ManufacturingExpenseMember 2021-01-01 2021-12-31 0001005284 us-gaap:PerformanceSharesMember oled:PerformanceBasedVestingRequirementMember 2023-01-01 2023-12-31 0001005284 oled:RoyaltyAndLicenseFeesMember 2023-01-01 2023-12-31 0001005284 oled:MajorCustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001005284 us-gaap:AccountingStandardsUpdate201409Member oled:AdesisIncMember 2021-01-01 2021-12-31 0001005284 us-gaap:RetainedEarningsMember 2021-12-31 0001005284 us-gaap:LandMember 2022-12-31 0001005284 oled:MaterialSalesMember 2021-01-01 2021-12-31 0001005284 country:CN 2022-01-01 2022-12-31 0001005284 oled:CommitmentWithSeniorLevelEmployeesMember 2023-12-31 0001005284 oled:CommonStockIssuedToBoardOfDirectorsAndScientificAdvisoryBoardThatWasEarnedAndAccruedForInPreviousPeriodMember 2022-01-01 2022-12-31 0001005284 oled:AllocationOfWithholdingToNonKoreanPatentsMember us-gaap:StateAndLocalJurisdictionMember 2023-12-31 0001005284 us-gaap:CostOfSalesMember oled:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001005284 us-gaap:RestrictedStockMember oled:ManufacturingExpenseMember 2023-01-01 2023-12-31 0001005284 country:US 2023-01-01 2023-12-31 0001005284 country:US 2022-12-31 0001005284 oled:EmployeesAndNonEmployeeMembersOfScientificAdvisoryBoardMember 2022-01-01 2022-12-31 0001005284 oled:NonEmployeeMembersOfScientificAdvisoryBoardMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001005284 us-gaap:TreasuryStockCommonMember 2023-12-31 0001005284 us-gaap:ResearchAndDevelopmentExpenseMember oled:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001005284 us-gaap:RestrictedStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001005284 oled:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001005284 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001005284 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001005284 us-gaap:PerformanceSharesMember oled:MarketBasedVestingRequirementMember 2021-01-01 2021-12-31 0001005284 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001005284 us-gaap:CommonStockMember 2021-12-31 0001005284 us-gaap:OtherLongTermInvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001005284 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001005284 2028-12-31 0001005284 us-gaap:OtherLongTermInvestmentsMember 2023-12-31 0001005284 oled:FujifilmMember 2022-12-31 0001005284 us-gaap:ResearchAndDevelopmentExpenseMember oled:EmployeeStockPurchasePlanMember 2023-01-01 2023-12-31 0001005284 country:JP 2023-01-01 2023-12-31 0001005284 oled:AllocationOfWithholdingToNonKoreanPatentsMember us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001005284 oled:AdditionalFundingAgreement2006Member 2021-01-01 2021-12-31 0001005284 us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2023-12-31 0001005284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001005284 us-gaap:NonUsMember 2021-01-01 2021-12-31 0001005284 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001005284 oled:MerckKgaaMember 2023-12-31 0001005284 srt:MinimumMember 2023-01-01 2023-12-31 0001005284 oled:AllocationOfWithholdingToNonKoreanPatentsMember 2023-12-31 0001005284 oled:MajorCustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001005284 oled:ExcludingNorthAmericaMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001005284 oled:MajorCustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001005284 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001005284 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001005284 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001005284 us-gaap:OtherLongTermInvestmentsMember us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001005284 us-gaap:PerformanceSharesMember oled:IncrementalPerformanceBasedMember 2021-01-01 2021-12-31 0001005284 us-gaap:PerformanceSharesMember us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-12-31 0001005284 2023-06-30 0001005284 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001005284 us-gaap:PerformanceSharesMember oled:CompanyPerformanceBasedVestingRequirementMember 2023-01-01 2023-12-31 iso4217:EUR pure iso4217:USD shares oled:Investment oled:Board_member oled:Participant oled:Employee oled:Denominator oled:Patent shares oled:Multiple oled:ExecutiveOfficer iso4217:USD oled:Supplier --12-31 false 0001005284 1400000 true FY P3Y http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent P3Y http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent 2034-12-31 2038-12-31 2031-12-31 P3Y 10-K true 2023-12-31 2023 false 1-12031 UNIVERSAL DISPLAY CORPORATION PA 23-2372688 250 Phillips Boulevard Ewing NJ 08618 609 671-0980 Common Stock, $0.01 par value OLED NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false false 320500461000 47365600 <p style="text-indent:4.533%;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Portions of the registrant’s Proxy Statement for the 2024 Annual Meeting of Shareholders, which is to be filed with the Securities and Exchange Commission no later than April 29, 2024 (the first business day after the 120</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.36pt;font-family:Times New Roman;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> day following the end of the registrant's fiscal year), are incorporated by reference into Part III of this report.</span></p> 185 KPMG, LLP Philadelphia, PA, USA 91985000 93430000 422137000 484345000 139850000 92664000 175795000 183220000 87365000 45791000 917132000 899450000 143908000 117118000 175150000 143445000 186850000 189671000 90325000 38382000 10414000 8989000 6874000 8247000 15535000 15535000 299548000 259861000 59108000 58161000 105289000 109739000 1668961000 1532820000 10933000 9519000 52080000 51002000 47713000 45599000 8096000 29577000 118822000 135697000 12006000 18279000 52249000 59790000 38658000 43685000 221735000 257451000 0.01 0.01 5000000 5000000 200000 200000 200000 200000 7.5 7.5 1500000 1500000 2000 2000 0.01 0.01 200000000 200000000 48731026 49136030 47365378 47770382 487000 491000 699554000 681335000 789553000 653277000 -1086000 -18452000 1365648 1365648 1365648 1365648 41284000 41284000 1447226000 1275369000 1668961000 1532820000 322029000 331081000 318623000 238389000 267115000 219032000 16011000 18423000 15870000 576429000 616619000 553525000 135376000 127896000 114991000 441053000 488723000 438534000 130481000 117062000 99673000 67387000 77886000 80372000 15993000 17459000 21994000 9356000 8329000 8160000 647000 877000 691000 223864000 221613000 210890000 217189000 267110000 227644000 28166000 7811000 505000 -184000 -6691000 98000 27982000 1120000 603000 245171000 268230000 228247000 42160000 58169000 44034000 203011000 210061000 184213000 4.25 4.41 3.87 4.24 4.4 3.87 47559669 47390352 47296447 47622763 47468507 47365435 1.4 1.2 0.8 203011000 210061000 184213000 -351000 0 65000 8745000 -7745000 -233000 -2168000 -1667000 -1336000 7207000 5971000 13620000 0 0 79000 0 0 283000 299000 569000 1316000 996000 2037000 4719000 -8203000 -8008000 -18056000 418000 -480000 -39000 17366000 -217000 17784000 220377000 209844000 201997000 200000 2000 49013476 490000 635595000 353930000 -36019000 1365648 -41284000 912714000 184213000 184213000 17784000 17784000 37931000 37931000 63969 1000 34471000 34472000 29179 14949000 14949000 8502 1704000 1704000 9156 1907000 1907000 200000 2000 49065924 491000 658728000 500212000 -18235000 1365648 -41284000 1099914000 210061000 210061000 -217000 -217000 56996000 56996000 72769 27907000 27907000 31938 9209000 9209000 12218 1866000 1866000 17057 2043000 2043000 200000 2000 49136030 491000 681335000 653277000 -18452000 1365648 -41284000 1275369000 203011000 203011000 17366000 17366000 66735000 66735000 145428 1000 21792000 21793000 58512 0 8206000 8206000 -526241 -5000 5000 0 16808 2074000 2074000 17513 2554000 2554000 200000 2000 48731026 487000 699554000 789553000 -1086000 1365648 -41284000 1447226000 203011000 210061000 184213000 27409000 24815000 19968000 15993000 17459000 21994000 -11603000 -6461000 -373000 0 6962000 0 22335000 28380000 34871000 1774000 1566000 1404000 -3766000 -26946000 1748000 3129000 5276000 8875000 47186000 -14975000 25378000 -7425000 49060000 42569000 41574000 24843000 202000 -4450000 -25971000 32369000 4047000 3338000 1902000 -21481000 20917000 2105000 -4159000 -93203000 -5220000 -5027000 -32392000 20136000 154777000 126815000 191105000 59792000 42497000 43161000 66563000 4709000 394000 531103000 701993000 642180000 574165000 468456000 227984000 -83293000 -280743000 -457751000 2012000 1570000 1507000 8206000 9209000 14949000 66735000 56996000 37931000 -72929000 -64635000 -51373000 -1445000 -218563000 -318019000 93430000 311993000 630012000 91985000 93430000 311993000 -8938000 -8100000 -295000 300000 300000 300000 678000 3069000 -3526000 96176000 72347000 52650000 <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BUSINESS:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Universal Display Corporation and its subsidiaries (the Company) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light and can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and as lighting products. OLED displays are capturing a growing share of the display market, especially in the mobile phone, television, monitor, wearable, tablet, notebook and personal computer, augmented reality (AR), virtual reality (VR) and automotive markets. The Company believes this is because OLEDs offer potential advantages over competing display technologies with respect to power efficiency, contrast ratio, viewing angle, video response time, form factor and manufacturing cost. The Company also believes that OLED lighting products have the potential to replace many existing light sources in the future because of their high-power efficiency, excellent color rendering index, low operating temperature and novel form factor. The Company’s technology leadership, intellectual property position, and more than 20 years of experience working closely with leading OLED display manufacturers are some of the competitive advantages that should enable the Company to continue to share in the revenues from OLED displays and lighting products as they gain wider acceptance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s primary business strategy is to (1) develop new OLED materials and sell existing and new materials to product manufacturers of products for display applications, such as mobile phones, televisions, monitors, wearables, tablets, portable media devices, notebook computers, personal computers and automotive applications, and specialty and general lighting products; and (2) further develop and either license or otherwise commercialize the Company’s proprietary OLED material, device design and manufacturing technologies to those manufacturers. The Company has established a significant portfolio of proprietary OLED technologies and materials, primarily through internal research and development efforts and acquisitions of patents and patent applications, as well as maintaining long-standing, and establishing new relationships with world-class universities, research institutions and strategic manufacturing partnerships. The Company currently owns, exclusively licenses or has the sole right to sublicense more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> patents issued and pending worldwide.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company manufactures and sells its proprietary OLED materials to customers for evaluation and use in commercial OLED products. The Company also enters into agreements with manufacturers of OLED display and lighting products under which it grants them licenses to practice under the Company’s patents and to use the Company's proprietary know-how. At the same time, the Company works with these and other companies that are evaluating the Company's OLED material, device design and manufacturing technologies for possible use in commercial OLED display and lighting products.</span></p> 6000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Consolidated Financial Statements include the accounts of Universal Display Corporation and its wholly owned subsidiaries, UDC, Inc., UDC Ireland Limited (UDC Ireland), Universal Display Corporation Hong Kong, Limited, Universal Display Corporation Korea, Y.H. (UDC Korea), Universal Display Corporation Japan GK, Universal Display Corporation China, Ltd., Adesis, Inc. (Adesis), UDC Ventures LLC, OVJP Corporation (OVJP Corp) and OLED Material Manufacturing Limited (OMM). All intercompany transactions and accounts have been eliminated.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassification of Prior Year Presentation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain prior year adjustments to reconcile net income to net cash provided by operating activities have been reclassified on the Consolidated Statements of Cash Flows to conform to the current year presentation. These adjustments have been consolidated into their respective operating assets and liabilities accounts, specifically, inventory, other current assets, other assets and deferred revenue.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Management’s Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The estimates made are principally in the areas of revenue recognition including estimates of material unit sales and royalties, the useful life of acquired intangibles, lease liabilities, right-of-use assets, the use and recoverability of inventories, intangibles, investments and income taxes including realization of deferred tax assets, stock-based compensation and retirement benefit plan liabilities. Actual results could differ from those estimates.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash, Cash Equivalents and Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to be cash equivalents. The Company classifies its remaining investments as available-for-sale. These securities (excluding minority equity investments) are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Trade Accounts Receivable</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. The Company’s accounts receivable balance is a result of chemical sales, royalties and license fees. These receivables have historically been paid timely. Due to the nature of the accounts receivable balance, the Company believes there is no significant collection risk. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their ability to make payments, allowances for credit losses would be required. As of December 31, 2023 and 2022, the allowance for credit losses was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">166,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">279,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventories</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consist of raw materials, work-in-process and finished goods, and are stated at the lower of cost, determined on a first-in, first-out basis, or net realizable value. Inventory valuation and firm committed purchase order assessments are performed on a quarterly basis and those items that are identified to be obsolete or in excess of forecasted usage are written down to their estimated realizable value. Estimates of realizable value are based upon management’s analyses and assumptions, including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. A 12-month rolling forecast based on factors, including, but not limited to, production cycles, anticipated product orders, marketing forecasts, backlog, and shipment activities is used in the inventory analysis. If market conditions are less favorable than forecasts or actual demand from customers is lower than estimates, additional inventory write-downs may be required. If demand is higher than expected, inventories that had previously been written down may be sold.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful life of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years for buildings, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years for building improvements, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_aa7871cb-58a1-41b4-a640-1f7de43bfd38;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">seven years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for office and lab equipment and furniture and fixtures. Repair and maintenance costs are charged to expense as incurred. Additions and betterments are capitalized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Major renewals and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to current operations as incurred. Upon retirement or disposal of assets, the cost and related accumulated depreciation are removed from the Consolidated Balance Sheets and any gain or loss is reflected in other operating expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain costs of computer software obtained for internal use are capitalized and amortized on a straight-line basis over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Costs for maintenance and training, as well as the cost of software that does not add functionality to an existing system, are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company management continually evaluates whether events or changes in circumstances might indicate that the remaining estimated useful life of long-lived assets may warrant revision, or that the remaining balance may not be recoverable. When factors indicate that long-lived assets should be evaluated for possible impairment, the Company uses an estimate of the related undiscounted cash flows in measuring whether the long-lived asset should be written down to fair value. Measurement of the amount of impairment would be based on generally accepted valuation methodologies, as deemed appropriate. As of December 31, 2023, Company management believed that no revision to the remaining useful lives or write-down of the Company’s long-lived assets was required, and similarly, no such revisions were required for the years ended December 31, 2022 or 2021.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Goodwill and Purchased Intangible Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Goodwill </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">is tested for impairment in the fourth fiscal quarter and, when specific circumstances dictate, between annual tests. If after assessing the totality of events or circumstances as those described in the qualitative assessment, it is determined that it is more likely than not the fair value of a reporting unit is less than its carrying amount, then a quantitative goodwill impairment test will be performed. Under the quantitative test, the fair value of the reporting unit is compared to its carrying amount including goodwill. If the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">fair </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">value of the reporting unit exceeds its carrying amount, goodwill of the reporting unit would be considered not impaired. However, if the carrying amount of the reporting unit exceeds its fair value, an impairment loss would be recognized in the amount equal to the excess, limited to the total amount of goodwill allocated to that reporting unit. The Company performed its annual impairment assessment as of December 31, 2023 utilizing a qualitative assessment and concluded that it was more likely than not that the fair value of Adesis is greater than its carrying value. Future impairment tests will continue to be performed annually in the fiscal fourth quarter, or sooner if a triggering event occurs. As of December 31, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> indications of impairment existed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchased intangible assets with finite lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The carrying values of accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value in the accompanying Consolidated Financial Statements due to the short-term nature of those instruments. The Company’s other financial instruments, which include cash equivalents and investments (excluding minority equity investments) are carried at fair value.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fair value is defined as an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. The Company uses valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. Observable inputs are inputs that market participants would use in pricing the asset or liability and are based on market data obtained from sources independent of the Company. Unobservable inputs reflect assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Minority Equity Investments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for minority equity investments in companies that are not accounted for under the equity method as equity securities without readily determinable fair values. The value of these securities is based on original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment in the same issuer. Under this method, the share of income or loss of such companies is not included in the Consolidated Statements of Income. The carrying value of these investments is included in investments on the Consolidated Balance Sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s policy is to recognize an impairment in the value of its minority equity investments when evidence of an impairment exists. Factors considered in the assessment include a significant adverse change in the regulatory, economic, or technological environment, the completion of new equity financing that may indicate a decrease in value, the failure to complete new equity financing arrangements after seeking to raise additional funds, or the commencement of proceedings under which the assets of the business may be placed in receivership or liquidated to satisfy the claims of debt and equity stakeholders. The impairment in the value of minority equity investments is included in the other (loss) income, net line item on the Consolidated Statements of Income.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is a lessee in operating leases primarily incurred to facilitate manufacturing, research and development, and selling, general and administrative activities. At contract inception, the Company determines if an arrangement is or contains a lease, and if so recognizes a right-of-use asset and lease liability at the lease commencement date. For operating leases, the lease liability is measured at the present value of the unpaid lease payments at the lease commencement date, whereas for finance leases, the lease liability is initially measured at the present value of the unpaid lease payments and subsequently measured at amortized cost using the interest method. Operating lease right-of-use assets are included in other assets on the Consolidated Balance Sheets. The short-term portion of operating lease liabilities is included in other current liabilities on the Consolidated Balance Sheets and the long-term portion is included in other liabilities on the Consolidated Balance Sheets. As of December 31, 2023, the Company had no leases that qualified as financing arrangements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Key estimates and judgments include how the Company determines the discount rate used to discount the unpaid lease payments to present value and the lease term. The Company monitors for events or changes in circumstances that could potentially require recognizing an impairment loss.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition and Deferred Revenue</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Material sales relate to the Company’s sale of its OLED materials for incorporation into its customers’ commercial OLED products or for their OLED development and evaluation activities. Revenue associated with material sales is generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties. Revenue may be recognized after control of the material passes in the event the transaction price includes variable consideration. For example, a customer may be provided an extended opportunity to stock materials prior to use in mass production and given a general right of return not conditioned on breaches of warranties associated with the specific product. In such circumstances, revenue will be recognized at the earlier of the expiration of the customer’s general right of return or once it becomes unlikely that the customer will exercise its right of return.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The vast majority of revenue attributed to material sales is determined through technology license agreements and material supply agreements the terms of which are jointly agreed upon with the Company’s customers. The remaining revenue recognized is in the form of contract research services revenue earned by the Company’s subsidiary, Adesis, Inc., and the Company’s occasional material sales to smaller customers. None of the revenue recognized during the years ended December 31, 2023, 2022 or 2021 resulted solely from royalty or license fee arrangements as to which there were not associated material sales.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The rights and benefits to the Company’s OLED technologies are conveyed to the customer through technology license agreements and material supply agreements. The Company believes that the licenses and materials sold under these combined agreements are not distinct from each other for financial reporting purposes and as such, they are accounted for as a single performance obligation. Accordingly, total contract consideration is estimated and recognized over the contract term based on material units sold at the estimated per unit fee over the life of the contract. Total contract consideration is allocated to material sales and royalty and licensing fees on the Consolidated Statements of Income based on contract pricing.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Various estimates are relied upon to recognize revenue. The Company estimates total material units to be purchased by its customers over the contract term based on historical trends, industry estimates and its forecast process. Management uses the expected value method to estimate the material per unit fee. Additionally, management estimates the sales-based portion of royalty revenue based on the estimated net sales revenue of its customers over the contract term.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Contract research services revenue is revenue earned by Adesis by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis. These services range from intermediates for structure-activity relationship studies, reference agents and building blocks for combinatorial synthesis, re-synthesis of key intermediates, specialty organic chemistry needs, and selective toll manufacturing. These services are provided to third-party pharmaceutical and life sciences firms and other technology firms at fixed costs or predetermined rates on a contract basis. Revenue is recognized as services are performed with billing schedules and payment terms negotiated on a contract-by-contract basis. Payments received in excess of revenue recognized are recorded as deferred revenue. In other cases, services may be provided and revenue is recognized before the customer is invoiced. In these cases, revenue recognized will exceed amounts billed and the difference, representing amounts which are currently unbillable to the customer pursuant to contractual terms, is recorded as an unbilled receivable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Technology development and support revenue is revenue earned from development and technology evaluation agreements and commercialization assistance fees. Technology development and support revenue is included in contract research services on the Consolidated Statements of Income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On December 2, 2022, the Company entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, the Company is being paid a license fee, which includes quarterly and annual payments over the agreement term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The agreement conveys to SDC the non-exclusive right to use certain of the Company's intellectual property assets for a limited period of time that is less than the estimated life of the assets.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At the same time the Company entered into the current commercial license agreement with SDC, the Company also entered into a new supplemental material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the supplemental material purchase agreement, SDC agrees to purchase red and green phosphorescent emitter materials from the Company for use in the manufacture of licensed products. This amount purchased is subject to SDC’s requirements for phosphorescent emitter materials and the Company’s ability to meet these requirements over the term of the supplemental agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2015, the Company entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display), which were effective as of January 1, 2015. The terms of these agreements were extended by a January 1, 2021 amendment through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under the Company's patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The OLED commercial supply agreement provides for the sale of materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the lives of the agreements as well as minimum royalty revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2023, the Company entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, the Company has granted BOE non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company supplies phosphorescent OLED materials to BOE for use in its licensed products.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2019, the Company entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, the Company entered into long-term, multi-year agreements with CSOT. Under these agreements, the Company has granted CSOT non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company also supplies phosphorescent OLED materials to CSOT for use in its licensed products.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2018, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Visionox Technology, Inc. (Visionox). Under the license agreement, the Company granted certain of Visionox’s affiliates non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Visionox for use in its licensed products. In 2021, the Company announced that it had extended the Visionox agreement by entering into new five-year OLED material supply and license agreements with a new affiliate of Visionox, Visionox Hefei Technology Co. Ltd.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2016, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Micro-electronics Co., Ltd. (Tianma). Under the license agreement, the Company has granted Tianma non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Tianma for use in its licensed products. In 2021, the parties extended the terms of both the patent license and material purchase agreements for an additional multi-year-term.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All material sales transactions that are not variable consideration transactions are billed and due within 90 days and substantially all are transacted in U.S. dollars.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cost of Sales</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cost of sales consists of labor and material costs associated with the production of materials processed at the facilities of the Company's manufacturing partner, PPG Industries, Inc. (PPG) and at the Company's internal facilities. The Company’s portion of cost of sales also includes depreciation of manufacturing equipment, as well as manufacturing overhead costs and inventory adjustments for excess and obsolete inventory.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and Development</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expenditures for research and development are charged to expense as incurred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Costs associated with patent applications, patent prosecution, patent defense and the maintenance of patents are charged to expense as incurred. Costs to successfully defend a challenge to a patent are capitalized to the extent of an evident increase in the value of the patent. Costs that relate to an unsuccessful outcome are charged to expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amortization of Acquired Technology</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amortization costs primarily relate to technology acquired from Merck KGaA, Darmstadt, Germany (Merck KGaA), BASF SE (BASF) and Fujifilm Corporation (</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fujifilm). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Merck KGaA acquisition was completed on April 28, 2023. The BASF and Fujifilm acquisitions were completed in the years ended December 31, 2016 and 2012, respectively. Acquisition costs are being amortized over</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years for the Merck KGaA and BASF patents. The Fujifilm acquired technology was fully amortized over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years that ended in July 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amortization of Other Intangible Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other intangible assets from the Adesis acquisition are being amortized over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. See Note 7 for further discussion.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Translation of Foreign Currency Financial Statements and Foreign Currency Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s reporting currency is the U.S. dollar. The functional currency for the UDC Ireland and UDC Korea subsidiaries are also the U.S. dollar and the functional currency for the OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries is its respective local currency. The Company translates the amounts included in the Consolidated Statements of Income from OMM and its Asia-Pacific foreign subsidiaries into U.S. dollars at weighted-average exchange rates, which the Company believes are representative of the actual exchange rates on the dates of the transactions. The Company's OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries' assets and liabilities are translated into U.S. dollars from the local currency at the actual exchange rates as of the end of each reporting date, and the Company records the resulting foreign exchange translation adjustments in the Consolidated Balance Sheets as a component of accumulated other comprehensive loss. The overall effect of the translation of foreign currency and foreign currency transactions to date has been insignificant.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties, if any, related to unrecognized tax benefits as a component of tax expense.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share-Based Payment Awards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes in the Consolidated Statements of Income the grant-date fair value of equity-based awards such as shares issued under employee stock purchase plans, restricted stock awards, restricted stock units and performance unit awards issued to employees and directors.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The grant-date fair value of stock awards is based on the closing price of the stock on the date of grant. The fair value of share-based awards is recognized as compensation expense on a straight-line basis over the requisite service period, net of forfeitures. The Company issues new shares upon the respective grant, exercise or vesting of the share-based payment awards, as applicable.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Performance unit awards are subject to either a performance-based or market-based vesting requirement. For performance-based vesting, the grant-date fair value of the award, based on fair value of the Company's common stock, is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved, and compensation expense is periodically adjusted based on actual and expected performance. Compensation expense for performance unit awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Adoption of New Accounting Standards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with FASB ASC 606. The adoption of ASU 2021-08, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liabilities—Supplier Finance Programs (Subtopic 450-50): Disclosure of Supplier Finance Program Obligations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which require disclosures about a buyer's supplier finance program. The adoption of ASU 2022-04, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Standards Issued But Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In June 2022, the FASB issued ASU No. 2022-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Under this standard, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. The standard also requires certain disclosures for equity securities that are subject to contractual restrictions. ASU 2022-03 becomes effective January 1, 2024, and will not have a significant impact on the Consolidated Financial Statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The standard improves the reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 becomes effective January 1, 2024, and the Company is evaluating the potential impact of this standard on the Consolidated Financial Statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Improvements to Income Tax Disclosures (Topic 740)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The standard enhances to the annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity's worldwide operations. ASU 2023-09 becomes effective January 1, 2025, and the Company is evaluating the potential impact of this standard on its income tax disclosures.</span></p></div> <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Consolidated Financial Statements include the accounts of Universal Display Corporation and its wholly owned subsidiaries, UDC, Inc., UDC Ireland Limited (UDC Ireland), Universal Display Corporation Hong Kong, Limited, Universal Display Corporation Korea, Y.H. (UDC Korea), Universal Display Corporation Japan GK, Universal Display Corporation China, Ltd., Adesis, Inc. (Adesis), UDC Ventures LLC, OVJP Corporation (OVJP Corp) and OLED Material Manufacturing Limited (OMM). All intercompany transactions and accounts have been eliminated.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassification of Prior Year Presentation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain prior year adjustments to reconcile net income to net cash provided by operating activities have been reclassified on the Consolidated Statements of Cash Flows to conform to the current year presentation. These adjustments have been consolidated into their respective operating assets and liabilities accounts, specifically, inventory, other current assets, other assets and deferred revenue.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Management’s Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The estimates made are principally in the areas of revenue recognition including estimates of material unit sales and royalties, the useful life of acquired intangibles, lease liabilities, right-of-use assets, the use and recoverability of inventories, intangibles, investments and income taxes including realization of deferred tax assets, stock-based compensation and retirement benefit plan liabilities. Actual results could differ from those estimates.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash, Cash Equivalents and Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to be cash equivalents. The Company classifies its remaining investments as available-for-sale. These securities (excluding minority equity investments) are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.</span></p> three months or less <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Trade Accounts Receivable</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. The Company’s accounts receivable balance is a result of chemical sales, royalties and license fees. These receivables have historically been paid timely. Due to the nature of the accounts receivable balance, the Company believes there is no significant collection risk. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their ability to make payments, allowances for credit losses would be required. As of December 31, 2023 and 2022, the allowance for credit losses was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">166,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">279,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span></p> 166000 279000 <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventories</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consist of raw materials, work-in-process and finished goods, and are stated at the lower of cost, determined on a first-in, first-out basis, or net realizable value. Inventory valuation and firm committed purchase order assessments are performed on a quarterly basis and those items that are identified to be obsolete or in excess of forecasted usage are written down to their estimated realizable value. Estimates of realizable value are based upon management’s analyses and assumptions, including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. A 12-month rolling forecast based on factors, including, but not limited to, production cycles, anticipated product orders, marketing forecasts, backlog, and shipment activities is used in the inventory analysis. If market conditions are less favorable than forecasts or actual demand from customers is lower than estimates, additional inventory write-downs may be required. If demand is higher than expected, inventories that had previously been written down may be sold.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful life of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years for buildings, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years for building improvements, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_aa7871cb-58a1-41b4-a640-1f7de43bfd38;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">seven years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for office and lab equipment and furniture and fixtures. Repair and maintenance costs are charged to expense as incurred. Additions and betterments are capitalized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Major renewals and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to current operations as incurred. Upon retirement or disposal of assets, the cost and related accumulated depreciation are removed from the Consolidated Balance Sheets and any gain or loss is reflected in other operating expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain costs of computer software obtained for internal use are capitalized and amortized on a straight-line basis over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Costs for maintenance and training, as well as the cost of software that does not add functionality to an existing system, are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> P30Y P15Y P7Y P3Y <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company management continually evaluates whether events or changes in circumstances might indicate that the remaining estimated useful life of long-lived assets may warrant revision, or that the remaining balance may not be recoverable. When factors indicate that long-lived assets should be evaluated for possible impairment, the Company uses an estimate of the related undiscounted cash flows in measuring whether the long-lived asset should be written down to fair value. Measurement of the amount of impairment would be based on generally accepted valuation methodologies, as deemed appropriate. As of December 31, 2023, Company management believed that no revision to the remaining useful lives or write-down of the Company’s long-lived assets was required, and similarly, no such revisions were required for the years ended December 31, 2022 or 2021.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Goodwill and Purchased Intangible Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Goodwill </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">is tested for impairment in the fourth fiscal quarter and, when specific circumstances dictate, between annual tests. If after assessing the totality of events or circumstances as those described in the qualitative assessment, it is determined that it is more likely than not the fair value of a reporting unit is less than its carrying amount, then a quantitative goodwill impairment test will be performed. Under the quantitative test, the fair value of the reporting unit is compared to its carrying amount including goodwill. If the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">fair </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">value of the reporting unit exceeds its carrying amount, goodwill of the reporting unit would be considered not impaired. However, if the carrying amount of the reporting unit exceeds its fair value, an impairment loss would be recognized in the amount equal to the excess, limited to the total amount of goodwill allocated to that reporting unit. The Company performed its annual impairment assessment as of December 31, 2023 utilizing a qualitative assessment and concluded that it was more likely than not that the fair value of Adesis is greater than its carrying value. Future impairment tests will continue to be performed annually in the fiscal fourth quarter, or sooner if a triggering event occurs. As of December 31, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> indications of impairment existed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchased intangible assets with finite lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets.</span></p> 0 <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The carrying values of accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value in the accompanying Consolidated Financial Statements due to the short-term nature of those instruments. The Company’s other financial instruments, which include cash equivalents and investments (excluding minority equity investments) are carried at fair value.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fair value is defined as an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. The Company uses valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. Observable inputs are inputs that market participants would use in pricing the asset or liability and are based on market data obtained from sources independent of the Company. Unobservable inputs reflect assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Minority Equity Investments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for minority equity investments in companies that are not accounted for under the equity method as equity securities without readily determinable fair values. The value of these securities is based on original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment in the same issuer. Under this method, the share of income or loss of such companies is not included in the Consolidated Statements of Income. The carrying value of these investments is included in investments on the Consolidated Balance Sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s policy is to recognize an impairment in the value of its minority equity investments when evidence of an impairment exists. Factors considered in the assessment include a significant adverse change in the regulatory, economic, or technological environment, the completion of new equity financing that may indicate a decrease in value, the failure to complete new equity financing arrangements after seeking to raise additional funds, or the commencement of proceedings under which the assets of the business may be placed in receivership or liquidated to satisfy the claims of debt and equity stakeholders. The impairment in the value of minority equity investments is included in the other (loss) income, net line item on the Consolidated Statements of Income.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is a lessee in operating leases primarily incurred to facilitate manufacturing, research and development, and selling, general and administrative activities. At contract inception, the Company determines if an arrangement is or contains a lease, and if so recognizes a right-of-use asset and lease liability at the lease commencement date. For operating leases, the lease liability is measured at the present value of the unpaid lease payments at the lease commencement date, whereas for finance leases, the lease liability is initially measured at the present value of the unpaid lease payments and subsequently measured at amortized cost using the interest method. Operating lease right-of-use assets are included in other assets on the Consolidated Balance Sheets. The short-term portion of operating lease liabilities is included in other current liabilities on the Consolidated Balance Sheets and the long-term portion is included in other liabilities on the Consolidated Balance Sheets. As of December 31, 2023, the Company had no leases that qualified as financing arrangements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Key estimates and judgments include how the Company determines the discount rate used to discount the unpaid lease payments to present value and the lease term. The Company monitors for events or changes in circumstances that could potentially require recognizing an impairment loss.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition and Deferred Revenue</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Material sales relate to the Company’s sale of its OLED materials for incorporation into its customers’ commercial OLED products or for their OLED development and evaluation activities. Revenue associated with material sales is generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties. Revenue may be recognized after control of the material passes in the event the transaction price includes variable consideration. For example, a customer may be provided an extended opportunity to stock materials prior to use in mass production and given a general right of return not conditioned on breaches of warranties associated with the specific product. In such circumstances, revenue will be recognized at the earlier of the expiration of the customer’s general right of return or once it becomes unlikely that the customer will exercise its right of return.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The vast majority of revenue attributed to material sales is determined through technology license agreements and material supply agreements the terms of which are jointly agreed upon with the Company’s customers. The remaining revenue recognized is in the form of contract research services revenue earned by the Company’s subsidiary, Adesis, Inc., and the Company’s occasional material sales to smaller customers. None of the revenue recognized during the years ended December 31, 2023, 2022 or 2021 resulted solely from royalty or license fee arrangements as to which there were not associated material sales.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The rights and benefits to the Company’s OLED technologies are conveyed to the customer through technology license agreements and material supply agreements. The Company believes that the licenses and materials sold under these combined agreements are not distinct from each other for financial reporting purposes and as such, they are accounted for as a single performance obligation. Accordingly, total contract consideration is estimated and recognized over the contract term based on material units sold at the estimated per unit fee over the life of the contract. Total contract consideration is allocated to material sales and royalty and licensing fees on the Consolidated Statements of Income based on contract pricing.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Various estimates are relied upon to recognize revenue. The Company estimates total material units to be purchased by its customers over the contract term based on historical trends, industry estimates and its forecast process. Management uses the expected value method to estimate the material per unit fee. Additionally, management estimates the sales-based portion of royalty revenue based on the estimated net sales revenue of its customers over the contract term.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Contract research services revenue is revenue earned by Adesis by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis. These services range from intermediates for structure-activity relationship studies, reference agents and building blocks for combinatorial synthesis, re-synthesis of key intermediates, specialty organic chemistry needs, and selective toll manufacturing. These services are provided to third-party pharmaceutical and life sciences firms and other technology firms at fixed costs or predetermined rates on a contract basis. Revenue is recognized as services are performed with billing schedules and payment terms negotiated on a contract-by-contract basis. Payments received in excess of revenue recognized are recorded as deferred revenue. In other cases, services may be provided and revenue is recognized before the customer is invoiced. In these cases, revenue recognized will exceed amounts billed and the difference, representing amounts which are currently unbillable to the customer pursuant to contractual terms, is recorded as an unbilled receivable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Technology development and support revenue is revenue earned from development and technology evaluation agreements and commercialization assistance fees. Technology development and support revenue is included in contract research services on the Consolidated Statements of Income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On December 2, 2022, the Company entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, the Company is being paid a license fee, which includes quarterly and annual payments over the agreement term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The agreement conveys to SDC the non-exclusive right to use certain of the Company's intellectual property assets for a limited period of time that is less than the estimated life of the assets.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At the same time the Company entered into the current commercial license agreement with SDC, the Company also entered into a new supplemental material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the supplemental material purchase agreement, SDC agrees to purchase red and green phosphorescent emitter materials from the Company for use in the manufacture of licensed products. This amount purchased is subject to SDC’s requirements for phosphorescent emitter materials and the Company’s ability to meet these requirements over the term of the supplemental agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2015, the Company entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display), which were effective as of January 1, 2015. The terms of these agreements were extended by a January 1, 2021 amendment through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under the Company's patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The OLED commercial supply agreement provides for the sale of materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the lives of the agreements as well as minimum royalty revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2023, the Company entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, the Company has granted BOE non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company supplies phosphorescent OLED materials to BOE for use in its licensed products.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2019, the Company entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, the Company entered into long-term, multi-year agreements with CSOT. Under these agreements, the Company has granted CSOT non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The Company also supplies phosphorescent OLED materials to CSOT for use in its licensed products.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2018, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Visionox Technology, Inc. (Visionox). Under the license agreement, the Company granted certain of Visionox’s affiliates non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Visionox for use in its licensed products. In 2021, the Company announced that it had extended the Visionox agreement by entering into new five-year OLED material supply and license agreements with a new affiliate of Visionox, Visionox Hefei Technology Co. Ltd.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2016, the Company entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Micro-electronics Co., Ltd. (Tianma). Under the license agreement, the Company has granted Tianma non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the Company supplies phosphorescent OLED materials to Tianma for use in its licensed products. In 2021, the parties extended the terms of both the patent license and material purchase agreements for an additional multi-year-term.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All material sales transactions that are not variable consideration transactions are billed and due within 90 days and substantially all are transacted in U.S. dollars.</span></p> P5Y <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cost of Sales</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cost of sales consists of labor and material costs associated with the production of materials processed at the facilities of the Company's manufacturing partner, PPG Industries, Inc. (PPG) and at the Company's internal facilities. The Company’s portion of cost of sales also includes depreciation of manufacturing equipment, as well as manufacturing overhead costs and inventory adjustments for excess and obsolete inventory.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and Development</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expenditures for research and development are charged to expense as incurred.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Costs associated with patent applications, patent prosecution, patent defense and the maintenance of patents are charged to expense as incurred. Costs to successfully defend a challenge to a patent are capitalized to the extent of an evident increase in the value of the patent. Costs that relate to an unsuccessful outcome are charged to expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amortization of Acquired Technology</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amortization costs primarily relate to technology acquired from Merck KGaA, Darmstadt, Germany (Merck KGaA), BASF SE (BASF) and Fujifilm Corporation (</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fujifilm). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Merck KGaA acquisition was completed on April 28, 2023. The BASF and Fujifilm acquisitions were completed in the years ended December 31, 2016 and 2012, respectively. Acquisition costs are being amortized over</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years for the Merck KGaA and BASF patents. The Fujifilm acquired technology was fully amortized over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years that ended in July 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> P10Y P10Y <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amortization of Other Intangible Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other intangible assets from the Adesis acquisition are being amortized over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. See Note 7 for further discussion.</span></p> P10Y P15Y <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Translation of Foreign Currency Financial Statements and Foreign Currency Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s reporting currency is the U.S. dollar. The functional currency for the UDC Ireland and UDC Korea subsidiaries are also the U.S. dollar and the functional currency for the OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries is its respective local currency. The Company translates the amounts included in the Consolidated Statements of Income from OMM and its Asia-Pacific foreign subsidiaries into U.S. dollars at weighted-average exchange rates, which the Company believes are representative of the actual exchange rates on the dates of the transactions. The Company's OMM subsidiary and each of the Company's other Asia-Pacific foreign subsidiaries' assets and liabilities are translated into U.S. dollars from the local currency at the actual exchange rates as of the end of each reporting date, and the Company records the resulting foreign exchange translation adjustments in the Consolidated Balance Sheets as a component of accumulated other comprehensive loss. The overall effect of the translation of foreign currency and foreign currency transactions to date has been insignificant.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties, if any, related to unrecognized tax benefits as a component of tax expense.</span></p> Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than 50% 0.50 <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share-Based Payment Awards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes in the Consolidated Statements of Income the grant-date fair value of equity-based awards such as shares issued under employee stock purchase plans, restricted stock awards, restricted stock units and performance unit awards issued to employees and directors.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The grant-date fair value of stock awards is based on the closing price of the stock on the date of grant. The fair value of share-based awards is recognized as compensation expense on a straight-line basis over the requisite service period, net of forfeitures. The Company issues new shares upon the respective grant, exercise or vesting of the share-based payment awards, as applicable.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Performance unit awards are subject to either a performance-based or market-based vesting requirement. For performance-based vesting, the grant-date fair value of the award, based on fair value of the Company's common stock, is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved, and compensation expense is periodically adjusted based on actual and expected performance. Compensation expense for performance unit awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.</span></p> <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Adoption of New Accounting Standards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with FASB ASC 606. The adoption of ASU 2021-08, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liabilities—Supplier Finance Programs (Subtopic 450-50): Disclosure of Supplier Finance Program Obligations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which require disclosures about a buyer's supplier finance program. The adoption of ASU 2022-04, beginning on January 1, 2023, did not have a impact on the Consolidated Financial Statements and related disclosures.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Standards Issued But Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In June 2022, the FASB issued ASU No. 2022-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Under this standard, a contractual restriction on the sale of an equity security is not considered in measuring the security's fair value. The standard also requires certain disclosures for equity securities that are subject to contractual restrictions. ASU 2022-03 becomes effective January 1, 2024, and will not have a significant impact on the Consolidated Financial Statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The standard improves the reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 becomes effective January 1, 2024, and the Company is evaluating the potential impact of this standard on the Consolidated Financial Statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Improvements to Income Tax Disclosures (Topic 740)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The standard enhances to the annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity's worldwide operations. ASU 2023-09 becomes effective January 1, 2025, and the Company is evaluating the potential impact of this standard on its income tax disclosures.</span></p> <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CASH, CASH EQUIVALENTS AND INVESTMENTS:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s portfolio of marketable fixed income securities consists of U.S. Government bonds and corporate bonds. The Company considers all highly liquid debt instruments purchased with an original maturity (maturity at the purchase date) of three months or less to be cash equivalents. The Company classifies its remaining debt security investments as available-for-sale. These debt securities are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides details regarding the Company’s portfolio of cash and cash equivalents (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:43.1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:13.9%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cash and Cash Equivalents Classification</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gains</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Losses)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Market Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash accounts in banking institutions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,717</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,717</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market accounts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,985</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,985</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash accounts in banking institutions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">86,268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">86,268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market accounts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Short-term Investments</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides details regarding the Company’s portfolio of short-term investments (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:43.1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:13.9%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Short-term Investments Classification</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gains</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Losses)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Market Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,763</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,759</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,769</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">303</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">694</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,378</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">422,532</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">304</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">699</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">422,137</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">150,698</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149,788</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">339,472</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,947</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">490,170</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,857</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">484,345</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Long-term Corporate Bond and U.S. Government Bond Investments</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides details regarding the Company’s portfolio of long-term investments (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:43.1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:13.9%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Long-term Investments Classification</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gains</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Losses)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Market Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">284,053</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">284,053</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,479</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,451</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">247,464</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,152</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,364</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">249,943</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">247,815</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Minority Equity Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s portfolio of minority equity investments consists of investments in privately held early-stage companies primarily motivated for the Company to gain early access to new technology and are passive in nature in that the Company typically does not seek to obtain representation on the boards of directors of the companies in which it invests. Minority equity investments are included in investments on the Consolidated Balance Sheets. As of December 31, 2023, the Company had minority equity investments in five entities with a total carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million accounted for as equity securities without readily determinable fair values as compared to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> minority equity investments with a total carrying value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of December 31, 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended December 31, 2022, the Company recognized an impairment in the value of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of its minority equity investments, an impairment of an equity security investment in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and an impairment of a long-term convertible note investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which had been acquired during the year ended December 31, 2022. During the year ended December 31, 2023, the Company did not recognize an impairment in the value of its minority equity investments. The impairment in the value of minority equity investments are included in the other (loss) income, net line item on the Consolidated Statements of Income.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides details regarding the Company’s portfolio of cash and cash equivalents (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:43.1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:13.9%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cash and Cash Equivalents Classification</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gains</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Losses)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Market Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash accounts in banking institutions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,717</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,717</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market accounts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,985</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,985</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash accounts in banking institutions</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">86,268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">86,268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market accounts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 91717000 0 0 91717000 268000 0 0 268000 91985000 0 0 91985000 86268000 0 0 86268000 7162000 0 0 7162000 93430000 0 0 93430000 <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides details regarding the Company’s portfolio of short-term investments (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:43.1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:13.9%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Short-term Investments Classification</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gains</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Losses)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Market Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,763</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,759</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,769</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">303</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">694</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,378</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">422,532</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">304</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">699</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">422,137</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">150,698</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149,788</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">339,472</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,947</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">490,170</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,857</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">484,345</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides details regarding the Company’s portfolio of long-term investments (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:43.1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:10.040000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:13.9%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Long-term Investments Classification</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gains</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Losses)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Market Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">284,053</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">284,053</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,479</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,451</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">247,464</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,152</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,364</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">249,943</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">247,815</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 1763000 1000 5000 1759000 420769000 303000 694000 420378000 422532000 304000 699000 422137000 150698000 0 910000 149788000 339472000 32000 4947000 334557000 490170000 32000 5857000 484345000 284053000 1457000 8000 285502000 284053000 1457000 8000 285502000 2479000 0 28000 2451000 247464000 52000 2152000 245364000 249943000 52000 2180000 247815000 14000000 4 12000000 2 3000000 4000000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FAIR VALUE MEASUREMENTS:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:32.993%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:12.045000000000002%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:15.186%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements, Using</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total Carrying Value<br/>as of December 31,<br/> 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices in <br/>Active Markets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash equivalents</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,759</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,759</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,378</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,378</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:32.993%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:12.045000000000002%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:15.186%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements, Using</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total Carrying Value<br/>as of December 31,<br/> 2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices in<br/>Active Markets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash equivalents</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149,788</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149,788</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,451</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,451</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,364</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,364</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on management’s own assumptions used to measure assets and liabilities at fair value. A financial asset’s or liability’s classification is determined based on the lowest level input that is significant to the fair value measurement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in fair value of the debt investments are recorded as unrealized gains and losses in accumulated other comprehensive loss on the Consolidated Balance Sheets and any credit losses on debt investments are recorded as an allowance for credit losses with an offset recognized in other (loss) income, net on the Consolidated Statements of Income. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> credit losses on debt investments as of December 31, 2023 or December 31, 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:32.993%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:12.045000000000002%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:15.186%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements, Using</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total Carrying Value<br/>as of December 31,<br/> 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices in <br/>Active Markets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash equivalents</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,759</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,759</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,378</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420,378</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">285,502</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:32.993%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:13.826%;"></td> <td style="width:1%;"></td> <td style="width:1.04%;"></td> <td style="width:1%;"></td> <td style="width:12.045000000000002%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:15.186%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value Measurements, Using</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total Carrying Value<br/>as of December 31,<br/> 2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Quoted Prices in<br/>Active Markets <br/>(Level 1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Significant Unobservable<br/>Inputs<br/>(Level 3)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash equivalents</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,162</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149,788</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149,788</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term Corporate bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,451</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,451</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term U.S. Government bonds</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,364</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,364</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 268000 268000 1759000 1759000 420378000 420378000 285502000 285502000 7162000 7162000 149788000 149788000 334557000 334557000 2451000 2451000 245364000 245364000 0 0 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">5.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INVENTORY:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventory consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Raw materials</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">113,400</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115,448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Work-in-process</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,433</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,626</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finished goods</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52,962</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,146</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inventory</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">175,795</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">183,220</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recorded an inventory reserve of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the years ended December 31, 2023, 2022 and 2021, respectively, due to excess inventory levels in certain products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventory consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Raw materials</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">113,400</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">115,448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Work-in-process</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,433</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,626</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finished goods</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52,962</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,146</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inventory</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">175,795</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">183,220</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 113400000 115448000 9433000 7626000 52962000 60146000 175795000 183220000 8500000 3600000 3600000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">6.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PROPERTY AND EQUIPMENT:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Land</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,230</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,642</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Building and improvements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">116,903</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99,586</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Office and lab equipment</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148,465</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">129,697</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Furniture, fixtures and computer related assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,970</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,071</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Construction-in-progress</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,490</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,567</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">319,058</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">260,563</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: Accumulated depreciation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">143,908</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,118</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property and equipment, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">175,150</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">143,445</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">27.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">24.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the years ended December 31, 2023, 2022 and 2021, respectively. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The increase in property and equipment, net for the year ended December 31, 2023 is primarily due to the purchases of two previously leased facilities for an aggregate cost of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and ongoing renovation activities at our research and development center in Ewing, New Jersey.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Land</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,230</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,642</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Building and improvements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">116,903</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99,586</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Office and lab equipment</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148,465</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">129,697</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Furniture, fixtures and computer related assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,970</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,071</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Construction-in-progress</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,490</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,567</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">319,058</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">260,563</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: Accumulated depreciation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">143,908</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,118</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property and equipment, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">175,150</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">143,445</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 12230000 2642000 116903000 99586000 148465000 129697000 18970000 18071000 22490000 10567000 319058000 260563000 143908000 117118000 175150000 143445000 27400000 24800000 20000000 The increase in property and equipment, net for the year ended December 31, 2023 is primarily due to the purchases of two previously leased facilities for an aggregate cost of $23.4 million 23400000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">7.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GOODWILL AND INTANGIBLE ASSETS:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company monitors the recoverability of goodwill annually or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Purchased intangible assets subject to amortization consist of acquired technology and other intangible assets that include trade names, customer relationships and developed intellectual property (IP) processes.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Acquired Technology</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Acquired technology primarily consists of acquired license rights for patents and know-how obtained from Merck KGaA, BASF and Fujifilm. These intangible assets consist of the following (in thousands)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">:</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:61.832%;"></td> <td style="width:1.38%;"></td> <td style="width:1%;"></td> <td style="width:15.143%;"></td> <td style="width:1%;"></td> <td style="width:2.501%;"></td> <td style="width:1%;"></td> <td style="width:15.143%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023 </span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">PD-LD, Inc.</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,481</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Motorola</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,909</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Merck KGaA</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66,012</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">BASF</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95,989</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95,989</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fujifilm</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">109,462</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">109,462</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,712</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,212</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">277,175</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">228,053</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: Accumulated amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">186,850</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">189,671</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Acquired technology, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90,325</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,382</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:83.333%;text-align:justify;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.</span></div></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amortization expense related to acquired technology was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the years ended December 31, 2023, 2022 and 2021, respectively. Amortization expense is included in amortization of acquired technology and other intangible assets expense line item on the Consolidated Statements of Income and is expected to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in each of the years ending December 31, 2024 and 2025, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the year ending December 31, 2026, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in each of the years ending December 2027 and 2028, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">30.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in total thereafter.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Merck KGaA Patent Acquisition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In April 2023, UDC Ireland entered into a Patent Sale and License Agreement with Merck KGaA. Under this agreement, Merck KGaA sold to UDC Ireland all of its rights, title and interest to over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">550</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of its owned and licensed OLED-related patents and patent applications in exchange for a cash payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">66.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Patent Sale and License Agreement contains customary representations, warranties and covenants of the parties. UDC Ireland recorded the payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">66.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as acquired technology, which is being amortized over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">BASF Patent Acquisition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 28, 2016, UDC Ireland entered into and consummated an IP Transfer Agreement with BASF. Under the IP Transfer Agreement, BASF sold to UDC Ireland all of its rights, title and interest to certain of its owned and co-owned intellectual property rights relating to the composition, development, manufacture and use of OLED materials, including OLED lighting and display stack technology, as well as certain tangible assets. The intellectual property includes knowhow and more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> issued and pending patents in the area of phosphorescent materials and technologies. These assets were acquired in exchange for a cash payment of €</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">86.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">95.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million). In addition, UDC Ireland also took on certain rights and obligations under three joint research and development agreements to which BASF was a party. The IP Transfer Agreement also contains customary representations, warranties and covenants of the parties. UDC Ireland recorded the payment of €</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">86.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">95.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million) and acquisition costs incurred of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">217,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as acquired technology, which is being amortized over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fujifilm Patent Acquisition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 23, 2012, the Company entered into a Patent Sale Agreement with Fujifilm. Under the agreement, Fujifilm sold more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,200</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> OLED-related patents and patent applications in exchange for a cash payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">105.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, plus $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in costs incurred in connection with the purchase. The agreement contains customary representations and warranties and covenants, including respective covenants not to sue by both parties thereto. The agreement permitted the Company to assign all of its rights and obligations under the agreement to its affiliates, and the Company assigned, prior to the consummation of the transactions contemplated by the agreement, its rights and obligations to UDC Ireland. The transactions contemplated by the agreement were consummated on July 26, 2012. The Company recorded the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">105.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million plus $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of purchase costs as acquired technology, which was amortized over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10 </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">years that ended in July 2022.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Intangible Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a result of the Adesis acquisition in June 2016, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of other intangible assets, including $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million assigned to customer relationships with a weighted average life of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11.5</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to internally developed IP, processes and recipes with a weighted average life of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to trade name and trademarks with a weighted average life of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At December 31, 2023, these other intangible assets consist of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:54.882%;"></td> <td style="width:1.301%;"></td> <td style="width:1%;"></td> <td style="width:12.485000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.661%;"></td> <td style="width:1%;"></td> <td style="width:11.665000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:10.824%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gross Carrying<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Carrying<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,520</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,801</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Developed IP, processes and recipes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,820</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,388</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,432</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trade name/Trademarks</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,500</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,118</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">382</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">341</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total identifiable other intangible assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,288</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,414</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,874</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amortization expense related to other intangible assets was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for each of the years ended December 31, 2023, 2022, and 2021. Amortization expense is included in amortization of acquired technology and other intangible assets expense line item on the Consolidated Statements of Income and is expected to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for each of the next three fiscal years (2024 - 2026), $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ending December 31, 2027, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">422,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for the year ending December 31, 2028, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in total thereafter.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Goodwill</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a result of the Adesis acquisition, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of goodwill. The Company performs its annual assessment of goodwill during the fourth quarter of the fiscal year unless events suggest an impairment may have been incurred in an interim period using Adesis’ standalone financial operating performance information. Application of the goodwill impairment test requires the exercise of judgment, including the determination of the fair value of each reporting unit, as Adesis is considered to be the reporting unit. As part of the annual assessment of goodwill completed during the fourth quarter ended December 31, 2023, there were no significant indicators to conclude that an impairment of the goodwill associated with the acquisition of Adesis had occurred.</span></p> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:61.832%;"></td> <td style="width:1.38%;"></td> <td style="width:1%;"></td> <td style="width:15.143%;"></td> <td style="width:1%;"></td> <td style="width:2.501%;"></td> <td style="width:1%;"></td> <td style="width:15.143%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023 </span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">PD-LD, Inc.</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,481</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Motorola</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,909</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Merck KGaA</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66,012</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">BASF</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95,989</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95,989</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fujifilm</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">109,462</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">109,462</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,712</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,212</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">277,175</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">228,053</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: Accumulated amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">186,850</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">189,671</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Acquired technology, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90,325</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,382</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:83.333%;text-align:justify;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives.</span></div></div> 0 1481000 0 15909000 66012000 0 95989000 95989000 109462000 109462000 5712000 5212000 277175000 228053000 186850000 189671000 90325000 38382000 14600000 16000000 20600000 16800000 16800000 16800000 12000000 7.2 7.2 30300000 550 66000000 66000000 P10Y 500 86800000 95800000 86800000 95800000 217000000 P10Y 1200 105000000 4500000 105000000 4500000 P10Y 16800000 10500000 P11Y6M 4800000 P15Y 1500000 P10Y <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At December 31, 2023, these other intangible assets consist of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:54.882%;"></td> <td style="width:1.301%;"></td> <td style="width:1%;"></td> <td style="width:12.485000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.661%;"></td> <td style="width:1%;"></td> <td style="width:11.665000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:10.824%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gross Carrying<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Carrying<br/>Amount</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,520</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,801</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Developed IP, processes and recipes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,820</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,388</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,432</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trade name/Trademarks</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,500</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,118</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">382</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">341</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total identifiable other intangible assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,288</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,414</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,874</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 10520000 6801000 3719000 4820000 2388000 2432000 1500000 1118000 382000 448000 107000 341000 17288000 10414000 6874000 1400000 1400000 1400000 1400000 1400000 1400000 1300000 422000 1000000 15500000 <div style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">8.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OTHER ASSETS:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other assets consist of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term taxes receivable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,146</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63,915</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_d7062e16-bfaf-4780-ba58-f11da594bd73;"><span style="-sec-ix-hidden:F_b2424464-5561-4747-b131-5137561f3326;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right-of-use assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,486</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,074</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term contract assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,278</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">11,651</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,881</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,687</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">105,289</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">109,739</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See Notes 9 and 20 for further explanation on right-of-use assets and long-term taxes receivable, respectively.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other assets consist of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term taxes receivable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,146</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63,915</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_d7062e16-bfaf-4780-ba58-f11da594bd73;"><span style="-sec-ix-hidden:F_b2424464-5561-4747-b131-5137561f3326;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right-of-use assets</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,486</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,074</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term contract assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,278</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">11,651</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,881</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,687</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">105,289</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">109,739</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 60146000 63915000 24910000 31486000 9074000 0 9278000 11651000 1881000 2687000 105289000 109739000 <div style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">9.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LEASES:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has entered into operating leases to facilitate the expansion of its manufacturing, research and development, and selling, general and administrative activities. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend or terminate the lease when those events are reasonably certain to occur. The interest rate implicit in lease contracts is typically not readily determinable and as such the Company uses the appropriate incremental borrowing rate based on information available at the lease commencement date in determining the present value of the lease payments. Current lease agreements do not contain any residual value guarantees or material restrictive covenants.</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> As of December 31, 2023, the Company did not have any finance leases and no additional operating leases that have not yet commenced.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the Company’s operating lease cost and supplemental cash flow information related to the Company’s operating leases (in thousands):</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.19%;"></td> <td style="width:1.1%;"></td> <td style="width:1%;"></td> <td style="width:13.837%;"></td> <td style="width:1%;"></td> <td style="width:1.1%;"></td> <td style="width:1%;"></td> <td style="width:13.837%;"></td> <td style="width:1%;"></td> <td style="width:1.1%;"></td> <td style="width:1%;"></td> <td style="width:13.837%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating lease cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,639</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,436</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,637</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-cash activity:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right-of-use assets obtained in exchange for lease obligations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,072</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,750</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,174</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the Company’s operating lease right-of-use assets and liabilities (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:59.24%;"></td> <td style="width:1.32%;"></td> <td style="width:1%;"></td> <td style="width:17.06%;"></td> <td style="width:1%;"></td> <td style="width:1.32%;"></td> <td style="width:1%;"></td> <td style="width:17.06%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right-of-use assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,486</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_849b8fc3-84c2-43b2-9777-36db41047a82;"><span style="-sec-ix-hidden:F_b9eeac63-aefc-4cf1-85b9-e4c000d4224a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term lease liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,533</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,737</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b56dc050-69c8-4bfe-b430-9c90d87d7801;"><span style="-sec-ix-hidden:F_b35feecb-730d-4f13-88a0-65b6f5b1009c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,039</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents weighted average assumptions used to compute the Company’s right-of-use assets and lease liabilities:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:74.415%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:22.404%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average remaining lease term (in years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.7</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average discount rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, current operating leases had remaining terms between </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_178ad16e-50fe-44be-8110-16a8500a5e74;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three </span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">eight years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> with options to extend the lease terms.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Undiscounted future minimum lease payments as of December 31, 2023, by year and in the aggregate, having non-cancelable lease terms in excess of one year were as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:74.355%;"></td> <td style="width:1.58%;"></td> <td style="width:1%;"></td> <td style="width:22.064%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Maturities of</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating Lease Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,267</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,321</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,401</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,323</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,996</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,083</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,391</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: imputed interest</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,003</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Present value of lease payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,388</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> As of December 31, 2023, the Company did not have any finance leases and no additional operating leases that have not yet commenced. <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.19%;"></td> <td style="width:1.1%;"></td> <td style="width:1%;"></td> <td style="width:13.837%;"></td> <td style="width:1%;"></td> <td style="width:1.1%;"></td> <td style="width:1%;"></td> <td style="width:13.837%;"></td> <td style="width:1%;"></td> <td style="width:1.1%;"></td> <td style="width:1%;"></td> <td style="width:13.837%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating lease cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,639</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,436</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,637</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-cash activity:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right-of-use assets obtained in exchange for lease obligations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,072</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,750</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,174</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 4639000 4436000 3637000 1072000 4750000 26174000 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the Company’s operating lease right-of-use assets and liabilities (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:59.24%;"></td> <td style="width:1.32%;"></td> <td style="width:1%;"></td> <td style="width:17.06%;"></td> <td style="width:1%;"></td> <td style="width:1.32%;"></td> <td style="width:1%;"></td> <td style="width:17.06%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right-of-use assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,486</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_849b8fc3-84c2-43b2-9777-36db41047a82;"><span style="-sec-ix-hidden:F_b9eeac63-aefc-4cf1-85b9-e4c000d4224a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term lease liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,533</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,737</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b56dc050-69c8-4bfe-b430-9c90d87d7801;"><span style="-sec-ix-hidden:F_b35feecb-730d-4f13-88a0-65b6f5b1009c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,039</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 24910000 31486000 3533000 3737000 22855000 29039000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents weighted average assumptions used to compute the Company’s right-of-use assets and lease liabilities:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:74.415%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:22.404%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average remaining lease term (in years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.7</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average discount rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table> P6Y8M12D 0.037 P8Y <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Undiscounted future minimum lease payments as of December 31, 2023, by year and in the aggregate, having non-cancelable lease terms in excess of one year were as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:74.355%;"></td> <td style="width:1.58%;"></td> <td style="width:1%;"></td> <td style="width:22.064%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Maturities of</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating Lease Liabilities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,267</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,321</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,401</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,323</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,996</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,083</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,391</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: imputed interest</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,003</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Present value of lease payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,388</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 4267000 4321000 4401000 4323000 3996000 8083000 29391000 3003000 26388000 <div style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">10.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ACCRUED EXPENSES:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,456</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,751</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">PPG Industries, Inc. agreement</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,962</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,864</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Consulting</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,121</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Professional fees</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,124</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">906</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development agreements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">822</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">662</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Royalties</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">647</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">877</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,948</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,032</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52,080</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51,002</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses consist of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,456</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,751</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">PPG Industries, Inc. agreement</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,962</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,864</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Consulting</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,121</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">910</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Professional fees</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,124</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">906</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development agreements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">822</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">662</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Royalties</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">647</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">877</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,948</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,032</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52,080</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51,002</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 29456000 31751000 11962000 9864000 2121000 910000 1124000 906000 822000 662000 647000 877000 5948000 6032000 52080000 51002000 <div style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">11.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RESEARCH AND LICENSE AGREEMENTS WITH ACADEMIC PARTNERS:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has long-standing relationships with a number of academic institutions that undertake funded research projects, including Princeton University (Princeton) and the University of Southern California (USC).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the current license agreement among the Company, Princeton and USC, the universities have granted the Company worldwide, exclusive license rights, with rights to sublicense, to make, have made, use, lease and/or sell products and to practice processes based on patent applications and issued patents arising out of research performed by the universities for the Company. The Company recorded royalty expense in connection with this agreement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">575,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">853,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">691,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for the years ended December 31, 2023, 2022 and 2021, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company also makes payments under the current research agreement with USC on a quarterly basis as actual expenses are incurred. As of December 31, 2023, the Company was obligated to pay USC up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for work to be performed during the remaining extended term. The Company recorded research and development expense in connection with work performed under the agreement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">905,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the years ended December 31, 2023, 2022 and 2021, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 575000000 853000000 691000000 2000000 1100000 905000000 1300000 <div style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">12.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OTHER LIABILITIES:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other liabilities consist of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cb8b14c1-8ba8-46e0-b73e-af8f1208d29a;"><span style="-sec-ix-hidden:F_74476b3e-ee9c-4e2f-8e76-f7d3a28a6613;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,039</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term taxes payable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,749</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,592</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,658</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43,685</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See Notes 9 and 20 for further explanation on long-term lease liabilities and long-term taxes payable, respectively.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other liabilities consist of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_cb8b14c1-8ba8-46e0-b73e-af8f1208d29a;"><span style="-sec-ix-hidden:F_74476b3e-ee9c-4e2f-8e76-f7d3a28a6613;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29,039</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term taxes payable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,749</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,592</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,658</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43,685</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 22855000 29039000 15749000 14592000 54000 54000 38658000 43685000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">13.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EQUITY AND CASH COMPENSATION UNDER THE PPG AGREEMENTS:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On September 22, 2011, the Company entered into an Amended and Restated OLED Materials Supply and Service Agreement with PPG (the New OLED Materials Agreement), which, effective as of October 1, 2011, replaced the original OLED Materials Agreement with PPG. The term of the New OLED Materials Agreement, by amendment in February 2021, runs through December 31, 2024, and thereafter is automatically renewed for additional one-year terms, unless terminated by the Company by providing prior notice of one year or terminated by PPG by providing prior notice of two years. The New OLED Materials Agreement contains provisions that are substantially similar to those of the original OLED Materials Agreement. Under the New OLED Materials Agreement, PPG continues to assist the Company in developing its proprietary OLED materials and supplying the Company with those materials for evaluation purposes and for resale to its customers.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the New OLED Materials Agreement, the Company compensates PPG on a cost-plus basis for the services provided during each calendar quarter. The Company is required to pay for some of these services in all cash. Up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the remaining services are payable, at the Company’s sole discretion, in cash or shares of the Company’s common stock, with the balance payable in cash. The actual number of shares of common stock issuable to PPG is determined based on the average closing price for the Company’s common stock during a specified number of days prior to the end of each calendar half-year period ending on March 31 and September 30. If, however, this average closing price is less than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company is required to compensate PPG in cash. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares have been issued for services rendered by PPG since the inception of the contract.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is also required to reimburse PPG for raw materials used for research and development. The Company records the purchases of these raw materials as a current asset until such materials are used for research and development efforts.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2021, the Company entered into an amendment to the New OLED Materials Agreement extending the term of the agreement and specifying operation and maintenance services to be provided by PPG affiliate, PPG SCM Ireland Limited (PPG SCM), to UDC Ireland, at the Company’s manufacturing site in Shannon, Ireland that UDC Ireland’s wholly-owned subsidiary, OLED Material Manufacturing Limited (OMM), began leasing at such time for the production of OLED materials. OMM purchased the site in September 2023 and the Company amended and restated the February 2021 amendment to reflect OMM’s ownership and PPG SCM’s updated operation and maintenance services after such purchase. Facility improvements have been completed and operations commenced in June 2022. As with the initial New OLED Materials Agreement, the Company compensates PPG on a cost-plus basis for the services provided at the Shannon manufacturing facility.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recorded research and development expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the years ended December 31, 2023, 2022 and 2021, respectively, in relation to the cash portion of the reimbursement of expenses and work performed by PPG, excluding amounts paid for commercial chemicals.</span></p> 0.50 20 0 9100000 7300000 3600000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">14.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SHAREHOLDERS' EQUITY:</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s Amended and Restated Articles of Incorporation authorize it to issue up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> par value preferred stock with designations, rights and preferences determined from time-to-time by the Company’s Board of Directors. Accordingly, the Company’s Board of Directors is empowered, without shareholder approval, to issue preferred stock with dividend, liquidation, conversion, voting or other rights superior to those of shareholders of the Company’s common stock.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 1995, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">200,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of Series A Nonconvertible Preferred Stock (Series A) to American Biomimetics Corporation (ABC) pursuant to a certain Technology Transfer Agreement between the Company and ABC. The Series A shares have a liquidation value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. Series A shareholders, as a single class, have the right to elect </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> members of the Company’s Board of Directors. This right has never been exercised. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Holders of the Series A shares are entitled to one vote per share on matters which shareholders are generally entitled to vote.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Series A shareholders are not entitled to any dividends.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, the Company had issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">200,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of preferred stock, all of which were outstanding.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s Amended and Restated Articles of Incorporation authorize it to issue up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">200,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> par value common stock. Each share of the Company’s common stock entitles the holder to one vote on all matters to be voted upon by the shareholders.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, the Company had issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">48,731,026</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, of which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">47,365,378</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> were outstanding. During the years ended December 31, 2023 and 2022, the Company repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dividends</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended December 31, 2023, the Company declared and paid cash dividends of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per common share, or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">66.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, on the Company’s outstanding common stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 20, 2024, the Company’s Board of Directors declared a first quarter dividend of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share to be paid on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 29, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to all shareholders of record of the Company's common stock as of the close of business on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 15, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All future dividends will be subject to the approval of the Company’s Board of Directors.</span> 5000000 0.01 200000 7.5 2 Holders of the Series A shares are entitled to one vote per share on matters which shareholders are generally entitled to vote. 200000 200000000 0.01 48731026 47365378 0 0 1.4 66700000 0.4 2024-03-29 2024-03-15 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">15.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ACCUMULATED OTHER COMPREHENSIVE LOSS:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amounts related to the changes in accumulated other comprehensive loss were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:28%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.52%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.06%;"></td> <td style="width:1%;"></td> <td style="width:1.14%;"></td> <td style="width:1%;"></td> <td style="width:15.02%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:6.2%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:18.06%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized<br/>Gain (Loss) on<br/>Available-for-<br/>Sale-Securities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Unrealized<br/>Gain (Loss) on <br/>Retirement Plan </span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;min-width:fit-content;">(2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Change in Cumulative<br/>Foreign Currency<br/>Translation Adjustment</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Affected Line items in the <br/>Consolidated Statements of <br/>Income</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance January 1, 2021, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36,075</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36,019</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive (loss) gain <br/>   before reclassification</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">233</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,620</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,348</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Plan amendment cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">283</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">283</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><br/>Reclassification to net income </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative,<br/>research and development and<br/>cost of sales</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change during period</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">233</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,056</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,784</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance December 31, 2021, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,019</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">74</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,235</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive (loss) gain <br/>   before reclassification</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,971</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">480</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,254</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><br/><br/>Reclassification to net income </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,037</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,037</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative,<br/>research and development and<br/>cost of sales</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change during period</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,008</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">480</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">217</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance December 31, 2022, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,887</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,011</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">554</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,452</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive (loss) gain <br/>   before reclassification</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,207</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">418</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,370</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><br/><br/>Reclassification to net income </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">996</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">996</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative,<br/>research and development and<br/>cost of sales</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change during period</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">418</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,366</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance December 31, 2023, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">858</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,808</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">136</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,086</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:83.333%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Company reclassified amortization of prior service cost, actuarial loss and plan amendment cost for its retirement plan from accumulated other comprehensive loss to net income of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> million for the years ended December 31, 2023, 2022 and 2021, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></div></div></div><span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Refer to Note 17: Employee Retirement Plans</span></span> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amounts related to the changes in accumulated other comprehensive loss were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:28%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.52%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.06%;"></td> <td style="width:1%;"></td> <td style="width:1.14%;"></td> <td style="width:1%;"></td> <td style="width:15.02%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:6.2%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:18.06%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized<br/>Gain (Loss) on<br/>Available-for-<br/>Sale-Securities</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net Unrealized<br/>Gain (Loss) on <br/>Retirement Plan </span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;min-width:fit-content;">(2)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Change in Cumulative<br/>Foreign Currency<br/>Translation Adjustment</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Affected Line items in the <br/>Consolidated Statements of <br/>Income</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance January 1, 2021, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36,075</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36,019</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive (loss) gain <br/>   before reclassification</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">233</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,620</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,348</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Plan amendment cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">283</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">283</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><br/>Reclassification to net income </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative,<br/>research and development and<br/>cost of sales</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change during period</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">233</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,056</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,784</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance December 31, 2021, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,019</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">74</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,235</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive (loss) gain <br/>   before reclassification</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,971</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">480</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,254</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><br/><br/>Reclassification to net income </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,037</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,037</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative,<br/>research and development and<br/>cost of sales</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change during period</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,008</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">480</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">217</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance December 31, 2022, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,887</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,011</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">554</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,452</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive (loss) gain <br/>   before reclassification</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,207</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">418</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,370</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><br/><br/>Reclassification to net income </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">996</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">996</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative,<br/>research and development and<br/>cost of sales</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change during period</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">418</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,366</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance December 31, 2023, net of tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">858</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,808</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">136</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,086</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:83.333%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Company reclassified amortization of prior service cost, actuarial loss and plan amendment cost for its retirement plan from accumulated other comprehensive loss to net income of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> million for the years ended December 31, 2023, 2022 and 2021, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></div></div><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Refer to Note 17: Employee Retirement Plans</span> 91000 -36075000 -35000 -36019000 -233000 13620000 -39000 13348000 0 -283000 0 -283000 0 -4719000 0 -4719000 -233000 18056000 -39000 17784000 -142000 -18019000 -74000 -18235000 -7745000 5971000 -480000 -2254000 0 -2037000 0 -2037000 -7745000 8008000 -480000 -217000 -7887000 -10011000 -554000 -18452000 8745000 7207000 418000 16370000 0 -996000 0 -996000 8745000 8203000 418000 17366000 858000 -1808000 -136000 -1086000 -1000000 -2000000 -4700000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">16.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">STOCK-BASED COMPENSATION:</span></div></div><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equity Compensation Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 15, 2023, the shareholders of the Company voted to approve the Universal Display Corporation 2023 Equity Compensation Plan (the “Equity Compensation Plan”), which replaced the Universal Display Corporation 2014 Equity Compensation Plan. The Equity Compensation Plan provides for the granting of incentive and nonqualified stock options, shares of common stock, stock appreciation rights and performance units to employees, directors and consultants of the Company. Stock options are exercisable over periods determined by the Company’s Human Capital Committee, but for no longer than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">from the grant date. The total number of shares that may be subject to awards under the Equity Compensation Plan is equal to the shares that were available for issuance and not subject to an award under the 2014 Equity Compensation Plan at the time it was replaced by the Equity Compensation Plan, subject to adjustment with respect to shares underlying any outstanding award granted under the Equity Compensation Plan or the 2014 Equity Compensation Plan that may expire, or be terminated, surrendered or forfeited for any reason, without issuance of such</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shares. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,519,235</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares that remained available to be granted under the Equity Compensation Plan. The Equity Compensation Plan will terminate on June 15, 2033.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restricted Stock Award and Units</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has issued restricted stock awards and units to employees and non-employees with vesting terms of one to five years. The fair value is equal to the market price of the Company’s common stock on the date of grant for awards granted to employees. Consistent with the accounting for equity-classified awards issued to employees, our equity-classified nonemployee share-based awards are measured at the grant date fair value. Expense for restricted stock awards and units is amortized ratably over the vesting period for the awards issued to employees and using a graded vesting method for the awards issued to non-employees.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the activity related to restricted stock unit (RSU) share based payment awards:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.327%;"></td> <td style="width:1.46%;"></td> <td style="width:1%;"></td> <td style="width:12.817%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:12.917%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br/>Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, January 1, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">230,223</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">165.13</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">121,896</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">136.22</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">132,010</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.85</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,623</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">152.21</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">216,486</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149.68</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average grant-date fair value per unit of RSU awards granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">136.22</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">140.37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">208.67</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSUs that vested during the year was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021. The fair value of RSUs as of their respective vesting dates was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the activity related to restricted stock award (RSA) share based payment awards:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.327%;"></td> <td style="width:1.46%;"></td> <td style="width:1%;"></td> <td style="width:12.817%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:12.917%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br/>Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, January 1, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33,637</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">178.37</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,366</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">126.87</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,456</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">178.82</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,547</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170.96</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average grant-date fair value per award of RSA awards granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">126.87</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">148.35</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">172.95</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSAs that vested during the year was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021. The fair value of RSAs as of their respective vesting dates was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the years ended December 31, 2023, 2022 and 2021, the Company recorded, as compensation charges related to restricted stock awards and units issued to employees and non-employees, selling, general and administrative expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, cost of sales of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, and research and development expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the vesting of restricted stock awards and units during the years ended December 31, 2023, 2022 and 2021, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">53,162</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">54,856</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">67,798</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares, respectively, with aggregate fair values of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, were withheld in satisfaction of tax withholding obligations and are reflected as a financing activity within the Consolidated Statements of Cash Flows.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the years ended December 31, 2023, 2022 and 2021, the Company recorded as compensation charges related to all restricted stock units to non-employee members of the Scientific Advisory Board, whose unvested shares are marked-to-market each reporting period, research and development expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">248,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">234,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">220,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has granted restricted stock units to non-employee members of the Board of Directors with quarterly vesting over a period of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The fair value is equal to the market price of the Company's common stock on the date of grant. The restricted stock units are issued and expense is recognized ratably over the vesting period. For the years ended December 31, 2023, 2022 and 2021, the Company recorded compensation charges for services performed, related to all restricted stock units granted to non-employee members of the Board of Directors, selling, general and administrative expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. In connection with the vesting of the restricted stock, the Company issued to non-employee members of the Board of Directors </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">13,016</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8,784</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5,412</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares during the years ended December 31, 2023, 2022 and 2021, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, the total unrecognized expense related to all restricted stock awards and units was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, which the Company expects to recognize over a weighted average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.80</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Performance Unit Awards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each performance unit award is subject to both a performance-vesting requirement (either performance-based or market-based) and a service-vesting requirement. The performance-based vesting requirement is tied to EBITDA and cash flow achievement, as measured over a specific performance period. The market-based vesting requirement is tied to the Company's total shareholder return (TSR) relative to the TSR of companies comprising the Nasdaq Electronics Components Index, as measured over a three-year performance period. The maximum number of performance units that may vest based on performance is three times the shares granted. Further, if the Company's performance falls below certain thresholds, the performance units will not vest at all.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the activity related to performance unit awards (PSU) share based payment awards:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.02%;"></td> <td style="width:1%;"></td> <td style="width:13.323%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br/>Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, January 1, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">227,866</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">185.57</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">84,448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">165.72</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,970</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">155.85</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,791</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170.96</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,553</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">185.86</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the years ended December 31, 2023, 2022 and 2021, the Company granted </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">84,448</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100,621</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">77,086</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> performance units, respectively, of which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">63,335</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">75,465</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">42,291</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> units, respectively, are subject to performance-based vesting requirements and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21,113</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25,156</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">34,795</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> units, respectively, are subject to market-based vesting requirements, and which will vest over the terms described above. During the years ended December 31, 2023, 2022 and 2021, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ne, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,268</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ne incremental performance-based shares, respectively, that vested resulting from an increased vesting factor based on Company performance. The weighted average grant date fair value per unit of the performance unit awards granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">165.72</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">186.66</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">214.70</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> during the years ended December 31, 2023, 2022 and 2021, respectively, as determined by the Company’s common stock on date of grant for the units with performance-based vesting and a Monte-Carlo simulation for the units with market-based vesting. The grant date fair value of PSUs that vested during the year was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021. The fair value of PSUs as of their respective vesting dates was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the years ended December 31, 2023, 2022 and 2021, the Company recorded, as compensation charges related to all performance stock units, selling, general and administrative expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, cost of sales of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">770,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">940,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, and research and development expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the vesting of performance units during the years ended December 31, 2023, 2022 and 2021, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5,350</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5,082</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,881</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares, respectively, with aggregate fair values of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">775,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">826,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">875,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, were withheld in satisfaction of tax withholding obligations and are reflected as a financing activity within the Consolidated Statements of Cash Flows.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, the total unrecognized compensation expense related to performance unit awards was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, which the Company expects to recognize over a weighted average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.98</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 7, 2009, the Board of Directors of the Company adopted an Employee Stock Purchase Plan (ESPP). The ESPP was approved by the Company’s shareholders and became effective on June 25, 2009. The Company has reserved </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock for issuance under the ESPP. Unless terminated by the Board of Directors, the ESPP will expire when all reserved shares have been issued.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Eligible employees may elect to contribute to the ESPP through payroll deductions during consecutive </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> purchase periods, the first of which began on July 1, 2009. Each employee who elects to participate will be deemed to have been granted an option to purchase shares of the Company’s common stock on the first day of the purchase period. Unless the employee opts out during the purchase period, the option will automatically be exercised on the last day of the period, which is the purchase date, based on the employee’s accumulated contributions to the ESPP. The purchase price will equal </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the lesser of the closing price per share of common stock on the first day of the period or the last business day of the period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Employees may allocate up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of their base compensation to purchase shares of common stock under the ESPP; however, each employee may purchase no more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares on a given purchase date, and no employee may purchase more than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of common stock under the ESPP during a given calendar year.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the years ended December 31, 2023, 2022 and 2021, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">17,513</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">17,057</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9,156</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares, respectively, of its common stock under the ESPP, resulting in proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. For the years ended December 31, 2023, 2022 and 2021, the Company recorded charges of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">136,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">107,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">93,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, to selling, general and administrative expense, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">167,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">141,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">119,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, to cost of sales and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">240,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">224,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">188,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, to research and development expense, related to the ESPP equal to the amount of the discount and the value of the look-back feature.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Scientific Advisory Board Awards</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the years ended December 31, 2023 and 2022, the Company granted a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,366</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares, respectively, of fully vested common stock to non-employee members of the Scientific Advisory Board for services performed in 2022 and 2021, respectively. The fair value of the shares issued to members of the Scientific Advisory Board was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">300,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for both years ended December 31, 2023 and 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> P10Y 1519235 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the activity related to restricted stock unit (RSU) share based payment awards:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.327%;"></td> <td style="width:1.46%;"></td> <td style="width:1%;"></td> <td style="width:12.817%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:12.917%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br/>Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, January 1, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">230,223</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">165.13</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">121,896</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">136.22</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">132,010</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">163.85</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,623</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">152.21</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">216,486</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">149.68</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average grant-date fair value per unit of RSU awards granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">136.22</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">140.37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">208.67</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> during the years ended December 31, 2023, 2022 and 2021, respectively. The grant date fair value of RSUs that vested during the year was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021. The fair value of RSUs as of their respective vesting dates was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2021.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the activity related to restricted stock award (RSA) share based payment awards:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.327%;"></td> <td style="width:1.46%;"></td> <td style="width:1%;"></td> <td style="width:12.817%;"></td> <td style="width:1%;"></td> <td style="width:1.48%;"></td> <td style="width:1%;"></td> <td style="width:12.917%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br/>Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, January 1, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33,637</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">178.37</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,366</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">126.87</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,456</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">178.82</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,547</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170.96</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 230223 165.13 121896 136.22 132010 163.85 3623 152.21 216486 149.68 136.22 140.37 208.67 21600000 18000000 12500000 18600000 15300000 15100000 33637 178.37 2366 126.87 18456 178.82 17547 170.96 126.87 148.35 172.95 3300000 8300000 9300000 2600000 6500000 20000000 9500000 14300000 15400000 1900000 2200000 2500000 5800000 6100000 5200000 53162 54856 67798 7400000 8400000 14100000 248000 234000 220000 P1Y 1500000 1300000 1200000 13016 8784 5412 21700000 P1Y9M18D <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the activity related to performance unit awards (PSU) share based payment awards:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.02%;"></td> <td style="width:1%;"></td> <td style="width:13.323%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br/>Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, January 1, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">227,866</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">185.57</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">84,448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">165.72</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,970</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">155.85</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91,791</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170.96</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested, December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,553</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">185.86</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 227866 185.57 84448 165.72 11970 155.85 91791 170.96 208553 185.86 84448 100621 77086 63335 75465 42291 21113 25156 34795 0 1268 0 165.72 186.66 214.7 1900000 1900000 1100000 1700000 1800000 2000000 2600000 2800000 8000000 770000 940000 1300000 1200000 1500000 2100000 5350 5082 3881 775000 826000 875000 12900000 P1Y11M23D 1000000 P3M 0.85 0.10 12500 25000 17513 17057 9156 2000000 1600000 1500000 136000 107000 93000 167000 141000 119000 240000 224000 188000 2366 2024 300000 300000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">17.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EMPLOYEE RETIREMENT PLANS:</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Defined Contribution Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company maintains the Universal Display Corporation 401(k) Plan (the Plan) in accordance with the provisions of Section 401(k) of the Internal Revenue Code (the Code). The Plan covers substantially all full-time employees of the Company. Participants may contribute up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of their total compensation to the Plan, not to exceed the limit as defined in the Code. Once an employee is eligible to participate in the Plan, the Company will make a non-elective contribution equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the employee’s total compensation. For the years ended December 31, 2023, 2022 and 2021, the Company contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, to the Plan.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Defined Benefit Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On March 18, 2010, the Human Capital Committee and the Board of Directors of the Company approved and adopted the Universal Display Corporation Supplemental Executive Retirement Plan (SERP), effective as of April 1, 2010. On March 3, 2015, the Human Capital Committee and the Board of Directors amended the SERP to include salary and bonus as part of the plan. Prior to this amendment, the SERP benefit did not take into account any bonuses. The purpose of the SERP, which is unfunded, is to provide certain of the Company’s key employees with supplemental pension benefits following a cessation of their employment and to encourage their continued employment with the Company. As of December 31, 2023 there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">eight</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> participants in the SERP.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The SERP benefit is based on a percentage of the participant’s annual base salary and in certain cases, the participant's average annual bonus for the most recent three fiscal years ending prior to the participant's date of termination of employment with the Company for the life of the participant. For this purpose, annual base salary means </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> times the average monthly base salary paid or payable to the participant during the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">24</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-month period immediately preceding the participant’s date of termination of employment, or, if required, the date of a change in control of the Company.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the SERP, if a participant resigns or is terminated without cause at or after age 65 and with at least </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years of service, he or she will be eligible to receive a SERP benefit. The benefit is based on a percentage of the participant’s annual base salary and bonus for the life of the participant. This percentage is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, depending on the participant’s benefit class.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If a participant resigns at or after age 65 and with at least </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years of service, he or she will be eligible to receive a prorated SERP benefit. If a participant is terminated without cause or on account of a disability after at least 15 years of service, he or she will be eligible to receive a prorated SERP benefit regardless of age. The prorated benefit in either case would be based on the participant’s number of years of service (up to 20), divided by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In the event a participant is terminated for cause, his or her SERP benefit and any future benefit payments are subject to immediate forfeiture.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The SERP benefit is payable in installments over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, beginning at the later of age 65 or the date of the participant’s separation from service. Payments are based on a present value calculation of the benefit amount for the actuarial remaining life expectancy of the participant. This calculation is made as of the date benefit payments are to begin (later of age 65 or separation from service). If the participant dies after reaching age 65, any future or remaining benefit payments are made to the participant’s beneficiary or estate. If the participant dies before reaching age 65, the benefit is forfeited.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the event of a change in control of the Company, each participant will become immediately vested in his or her SERP benefit. Unless the participant’s benefit has already fully vested, if the participant has less than 20 years of service at the time of the change in control, he or she will receive a prorated benefit based on his or her number of years of service (up to 20), divided by 20. If the change in control qualifies as a “change in control event” for purposes of Section 409A of the Internal Revenue Code, then each participant (including former employees who are entitled to SERP benefits) will receive a lump sum cash payment equal to the present value of the benefit immediately upon the change in control.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain of the Company’s executive officers are designated as special participants under the SERP. If these participants resign or are terminated without cause after 20 years of service, or at or after age 65 and with at least 15 years of service, they will be eligible to receive a SERP benefit. If they are terminated without cause or on account of a disability, they will be eligible to receive a prorated SERP benefit regardless of age. The prorated benefit would be based on the participant’s number of years of service (up to 20), divided by 20.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The SERP benefit for special participants is based on </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of their annual base salary and bonus for their life and the life of their surviving spouse, if any. Payments are based on a present value calculation of the benefit amount for the actuarial remaining life expectancies of the participant and their surviving spouse, if any. If they die before reaching age 65, the benefit is not forfeited if the surviving spouse, if any, lives until the participant would have reached age 65. If their spouse also dies before the participant would have reached age 65, the benefit is forfeited.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company records amounts relating to the SERP based on calculations that incorporate various actuarial and other assumptions, including discount rates, rate of compensation increases, retirement dates, and life expectancies. The net periodic costs are recognized as employees render the services necessary to earn the SERP benefits.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the initiation and subsequent amendments of the SERP, the Company recorded cost related to prior service of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as accumulated other comprehensive loss as of December 31, 2023. The prior service cost is being amortized as a component of net periodic pension cost over the average of the remaining service period of the employees expected to receive benefits under the plan. The prior service cost expected to be amortized for the year ending December 31, 2024 is $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">43,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2022, one of the participants retired and monthly SERP benefit payments commenced in January 2023. The total SERP benefit payments for the year ended December 31, 2023 were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Information relating to the Company’s plan is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change in benefit obligation:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Benefit obligation, beginning of year</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,804</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66,773</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">951</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,287</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_595ce2e6-a243-40f6-8b1f-c14c36385d43;"><span style="-sec-ix-hidden:F_b8d39f40-22aa-4365-a1c8-cbbdfcb1a9c5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest cost</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,898</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,383</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Actuarial gain</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,375</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,639</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Benefit payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,015</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Benefit obligation, end of year</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,263</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,804</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fair value of plan assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unfunded status of the plan, end of year</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,263</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,804</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current liability</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,014</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,014</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-current liability</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52,249</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,790</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accumulated benefit obligation for the plan was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">52.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">59.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of December 31, 2023 and 2022, respectively. The actuarial gain of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023 was primarily due to a decrease in the total average annual bonus for each of the participants during the most recent three fiscal years. The actuarial gain of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022 was primarily due to an increase in the discount rate.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The components of net periodic pension cost were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">951</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,287</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,675</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,898</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,383</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,165</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0b215a60-ad8a-40e0-929c-4715b7fe7367;"><span style="-sec-ix-hidden:F_f966a4b8-fe34-4e25-b8b6-9bf88648e730;"><span style="-sec-ix-hidden:F_a4f55512-8f20-4f83-86fa-77d7f7473808;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of prior service cost</span></span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">815</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,099</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_445cf9f1-3df4-4736-bc83-ed920e93053c;"><span style="-sec-ix-hidden:F_cf394d41-4323-48c1-af23-25e55959da24;"><span style="-sec-ix-hidden:F_bc791219-6f7b-460d-8636-04fe09dc06a4;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of loss</span></span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">480</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,487</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,936</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total net periodic benefit cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,144</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,276</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,875</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The measurement date is the Company’s fiscal year end. The net periodic pension cost is based on assumptions determined at the prior year end measurement date.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assumptions used to determine the year end benefit obligation were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.34%;"></td> <td style="width:1.021%;"></td> <td style="width:1%;"></td> <td style="width:13.31%;"></td> <td style="width:1%;"></td> <td style="width:1.021%;"></td> <td style="width:1%;"></td> <td style="width:13.31%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Discount rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.74</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rate of compensation increases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assumptions used to determine the net periodic pension cost were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.683%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.045%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.045%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.225%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Discount rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.16</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.54</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rate of compensation increases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Actuarial gains and losses are amortized from accumulated other comprehensive loss into net periodic pension cost over future years based upon the average remaining service period of active plan participants, when the accumulation of such gains or losses exceeds </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the year end benefit obligation. The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost or credit) is included in the Company’s results of income on a straight-line basis over the average remaining service period of active plan participants.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The estimated amounts to be amortized from accumulated other comprehensive loss into the net periodic pension cost in 2024 are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.236%;"></td> <td style="width:1.92%;"></td> <td style="width:1%;"></td> <td style="width:15.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of prior service cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of loss</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Benefit payments, which reflect estimated future service, are currently expected to be paid as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.46%;"></td> <td style="width:1.76%;"></td> <td style="width:1%;"></td> <td style="width:15.780000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Projected <br/>Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,014</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,097</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,141</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,489</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,489</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029-2033</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,503</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> 0.90 0.03 1500000 1400000 1300000 8 12 P24M P20Y 0.50 0.25 0.15 P15Y 20 P10Y 0.50 1900000 43000 2000000 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Information relating to the Company’s plan is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change in benefit obligation:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Benefit obligation, beginning of year</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,804</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66,773</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">951</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,287</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_595ce2e6-a243-40f6-8b1f-c14c36385d43;"><span style="-sec-ix-hidden:F_b8d39f40-22aa-4365-a1c8-cbbdfcb1a9c5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest cost</span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,898</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,383</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Actuarial gain</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,375</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,639</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Benefit payments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,015</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Benefit obligation, end of year</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,263</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,804</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fair value of plan assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unfunded status of the plan, end of year</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,263</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,804</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current liability</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,014</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,014</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-current liability</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52,249</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,790</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 61804000 66773000 951000 1287000 2898000 1383000 9375000 7639000 -2015000 0 54263000 61804000 0 0 54263000 61804000 2014000 2014000 52249000 59790000 52500000 59500000 9400000 7600000 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The components of net periodic pension cost were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">951</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,287</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,675</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,898</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,383</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,165</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0b215a60-ad8a-40e0-929c-4715b7fe7367;"><span style="-sec-ix-hidden:F_f966a4b8-fe34-4e25-b8b6-9bf88648e730;"><span style="-sec-ix-hidden:F_a4f55512-8f20-4f83-86fa-77d7f7473808;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of prior service cost</span></span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">815</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,099</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_445cf9f1-3df4-4736-bc83-ed920e93053c;"><span style="-sec-ix-hidden:F_cf394d41-4323-48c1-af23-25e55959da24;"><span style="-sec-ix-hidden:F_bc791219-6f7b-460d-8636-04fe09dc06a4;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of loss</span></span></span></span></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">480</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,487</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,936</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total net periodic benefit cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,144</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,276</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,875</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 951000 1287000 1675000 2898000 1383000 1165000 815000 1119000 1099000 -480000 -1487000 -4936000 5144000 5276000 8875000 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assumptions used to determine the year end benefit obligation were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.34%;"></td> <td style="width:1.021%;"></td> <td style="width:1%;"></td> <td style="width:13.31%;"></td> <td style="width:1%;"></td> <td style="width:1.021%;"></td> <td style="width:1%;"></td> <td style="width:13.31%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Discount rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.74</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rate of compensation increases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assumptions used to determine the net periodic pension cost were as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.683%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.045%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.045%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.225%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Discount rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.16</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.54</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rate of compensation increases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table> 0.0474 0.0494 0.035 0.035 0.0494 0.0216 0.0154 0.035 0.035 0.035 0.10 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The estimated amounts to be amortized from accumulated other comprehensive loss into the net periodic pension cost in 2024 are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.236%;"></td> <td style="width:1.92%;"></td> <td style="width:1%;"></td> <td style="width:15.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of prior service cost</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of loss</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 43000 -0 43000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Benefit payments, which reflect estimated future service, are currently expected to be paid as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.46%;"></td> <td style="width:1.76%;"></td> <td style="width:1%;"></td> <td style="width:15.780000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Projected <br/>Benefits</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,014</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,097</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,141</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,489</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,489</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029-2033</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,503</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 2014000 5097000 6141000 6489000 6489000 34503000 14855000 <div style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">18.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">COMMITMENTS AND CONTINGENCIES:</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Commitments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the current research agreement with USC, the Company is obligated to make certain payments to USC based on work performed by it under that agreement, and by the University of Michigan (Michigan) under a subcontractor agreement that Michigan has with USC.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the terms of the current license agreement among the Company, Princeton and USC, the Company makes royalty payments to Princeton. See Note 11 for further explanation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has agreements with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">five</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> executive officers and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> senior level employees which provide for certain cash and other benefits upon termination of employment of the officer or employee in connection with a change in control of the Company. If a covered person’s employment is terminated in connection with the change in control, the person is entitled to a lump-sum cash payment equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> times (in the case of the executive officers) or either </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> times (in the case of the senior level employees) the sum of the average annual base salary and bonus of the person and immediate vesting of all stock options and other equity awards that may be outstanding at the date of the change in control, among other items.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In order to manage manufacturing lead times and help ensure adequate material supply, the Company entered into the New OLED Materials Agreement (see Note 13) that allows PPG to procure and produce inventory based upon criteria as defined by the Company. These purchase commitments consist of firm, noncancelable and unconditional commitments. In certain instances, this agreement allows the Company the option to reschedule and adjust the Company’s requirements based on its business needs prior to firm orders being placed. As of December 31, 2023, 2022 and 2021, the Company had purchase commitments for inventory of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">29.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">31.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Patent Related Challenges and Oppositions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each major jurisdiction in the world that issues patents provides both third parties and applicants an opportunity to seek a further review of an issued patent. The process for requesting and considering such reviews is specific to the jurisdiction that issued the patent in question, and generally does not provide for claims of monetary damages or a review of specific claims of infringement. The conclusions made by the reviewing administrative bodies tend to be appealable and generally are limited in scope and applicability to the specific claims and jurisdiction in question.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company believes that opposition proceedings are frequently commenced in the ordinary course of business by third parties who may believe that one or more claims in a patent do not comply with the technical or legal requirements of the specific jurisdiction in which the patent was issued. The Company views these proceedings as reflective of its goal of obtaining the broadest legally permissible patent coverage permitted in each jurisdiction. Once a proceeding is initiated, as a general matter, the issued patent continues to be presumed valid until the jurisdiction’s applicable administrative body issues a final non-appealable decision. Depending on the jurisdiction, the outcome of these proceedings could include affirmation, denial or modification of some or all of the originally issued claims. The Company believes that as OLED technology becomes more established and its patent portfolio increases in size, so will the number of these proceedings.</span></p> 5 13 2 1 2 29800000 31900000 25700000 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">19.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CONCENTRATION OF RISK:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenues and accounts receivable from the Company's largest customers for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:30.52%;"></td> <td style="width:1%;"></td> <td style="width:10.58%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.56%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:10.58%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.56%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:10.58%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.620000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Customer</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">% of Total Revenue</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accounts Receivable</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">% of Total Revenue</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accounts Receivable</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">% of Total Revenue</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accounts Receivable</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">A</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,105</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,425</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,850</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">B</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,142</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,440</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45,867</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">C</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,529</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,291</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenues from outside of North America represented approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">98</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">97</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">97</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of consolidated revenue for each of the years ended December 31, 2023, 2022 and 2021, respectively. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenues by geographic area are as follows (in thousands):</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Country</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">South Korea</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">322,509</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">360,640</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,835</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">China</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">229,727</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">230,582</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">192,079</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Japan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,971</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,579</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,358</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other non-U.S. locations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,411</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,829</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,137</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total non-U.S. locations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">563,618</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">600,630</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">537,409</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,811</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,989</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,116</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">576,429</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">616,619</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">553,525</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company attributes revenue to different geographic areas on the basis of the location of the customer.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net by geographic area are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.673%;"></td> <td style="width:1.52%;"></td> <td style="width:1%;"></td> <td style="width:13.143%;"></td> <td style="width:1%;"></td> <td style="width:1.52%;"></td> <td style="width:1%;"></td> <td style="width:13.143%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Country</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">118,250</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,255</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ireland</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,270</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,697</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,920</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total long-lived assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">175,150</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">143,445</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Substantially all chemical materials were purchased from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> supplier. See Note 13.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenues and accounts receivable from the Company's largest customers for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:30.52%;"></td> <td style="width:1%;"></td> <td style="width:10.58%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.56%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:10.58%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.56%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:10.58%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:8.620000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="4" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Customer</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">% of Total Revenue</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accounts Receivable</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">% of Total Revenue</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accounts Receivable</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">% of Total Revenue</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accounts Receivable</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">A</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,105</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,425</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,850</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">B</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,142</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,440</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45,867</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">C</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,529</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,291</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,557</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 0.36 38105000 0.41 11425000 0.44 10850000 0.23 30142000 0.25 24440000 0.26 45867000 0.17 38529000 0.16 22291000 0.14 18557000 0.98 0.97 0.97 <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenues by geographic area are as follows (in thousands):</span><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Country</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">South Korea</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">322,509</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">360,640</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">334,835</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">China</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">229,727</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">230,582</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">192,079</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Japan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,971</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,579</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,358</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other non-U.S. locations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,411</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,829</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,137</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total non-U.S. locations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">563,618</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">600,630</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">537,409</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,811</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,989</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,116</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">576,429</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">616,619</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">553,525</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 322509000 360640000 334835000 229727000 230582000 192079000 6971000 5579000 7358000 4411000 3829000 3137000 563618000 600630000 537409000 12811000 15989000 16116000 576429000 616619000 553525000 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net by geographic area are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.673%;"></td> <td style="width:1.52%;"></td> <td style="width:1%;"></td> <td style="width:13.143%;"></td> <td style="width:1%;"></td> <td style="width:1.52%;"></td> <td style="width:1%;"></td> <td style="width:13.143%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Country</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">118,250</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,255</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ireland</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,270</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,697</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,920</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total long-lived assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">175,150</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">143,445</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 118250000 117255000 42203000 20270000 14697000 5920000 175150000 143445000 1 <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">20.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INCOME TAXES:</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The components of income before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71,514</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">77,205</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,066</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">173,657</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">191,025</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">168,181</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income before income taxes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,171</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268,230</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">228,247</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The components of the income tax expense are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current income tax (expense) benefit:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Federal</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,848</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51,980</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,433</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,048</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,833</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">641</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27,030</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,302</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,212</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45,926</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">85,115</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,286</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred income tax (expense) benefit:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Federal</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">460</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,916</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">844</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,936</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,216</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">734</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">290</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">186</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,766</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,946</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,748</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,160</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44,034</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reconciliation of the statutory U.S. federal tax rate to the Company's effective tax rate is as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.731%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.022%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:11.022%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:11.022%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Statutory U.S. federal income tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effect of foreign operations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. International Tax (Sub F, GILTI, FDII)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research tax credits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Redetermination of foreign tax credit utilization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nondeductible employee compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock based compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accruals and reserves</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effective tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes Company tax credit carry forwards for tax return purposes as of December 31, 2023 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.3%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.84%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:14.86%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Tax Benefit</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Expiration Date</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tax credit carry forwards:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State research tax credits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,752</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_e0cb93c6-e773-4637-905b-0268cb5781ac;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2034</span></span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="-sec-ix-hidden:F_3d7d5c93-96ed-4e3c-a9e2-9a2b7a5ad2ce;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2038</span></span></span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign tax credits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">186</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_747178a7-0753-4a3a-b81f-77c3c2ee0898;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2031</span></span></span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total credit carry forwards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,938</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant components of the Company's net deferred tax assets and liabilities are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax asset:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized research expenditures</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39,459</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,485</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Retirement plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,555</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,495</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tax credit carry forwards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,938</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accruals and reserves</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,944</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease Liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,671</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,230</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,741</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,077</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,498</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,454</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,400</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">79,404</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">81,185</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,551</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,087</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">69,853</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">70,098</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax liability:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,302</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,944</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Acquisition Goodwill</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,549</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,283</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,894</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,710</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,937</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net deferred tax assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,108</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58,161</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent on the Company's ability to generate future taxable income to obtain benefit from the reversal of temporary differences, net operating loss carryforwards and tax credits. As part of its assessment, management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. At this time there is not sufficient evidence to release the valuation allowance that has been recorded for the New Jersey research and development credits and unrealized loss on investments. There are no indicators against the realizability of the remaining net deferred tax asset.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The U.S.-Korean Mutual Agreement Procedure (MAP) for the years ended December 31, 2010, to December 31, 2017, was closed in September 2022, resulting in a refund of the Korean withholding taxes previously withheld. The Company filed amended U.S. federal tax returns to reflect the refund and to redetermine the foreign tax credit amount. As a result, the Company has recorded a long-term asset of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the year ended December 31, 2022. There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> long-term asset recorded for the year ended December 31, 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On December 27, 2018, the Korean Supreme Court, citing prior cases, held that only royalties paid with respect to Korean registered patents are considered Korean source income and subject to Korean withholding tax under the applicable law and interpretation of the Korea-U.S. Tax Treaty. The Company has incurred Korean withholding tax of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for each of the years ended December 31, 2018, through December 31, 2022. Based on the Korean Supreme Court decision, a tax refund request on behalf of the Company was or will be filed with the Korean National Tax Service (KNTS) for the entire period from January 1, 2018, to December 31, 2022. The Company received a formal rejection from the KNTS; and in May 2022 filed an appeal with the Korean Tax Tribunal. On December 18th, 2023, the Company received a formal rejection from the Tax Tribunal. Anticipating the rejection of the appeal, in September 2023 the Company filed a petition to the District Court and is awaiting its decision. The Company has been advised by a prominent Korean law firm that there is a more-likely-than-not chance of success. As a result, the Company has recorded a long-term asset of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">60.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">60.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of December 31, 2023, and December 31, 2022, respectively for the receipt of the Korean withholding tax. The Company also recorded foreign exchange loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">732,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> during the year ended December 31, 2023, due to the fluctuation of the Korean Won to the U.S. Dollar and resulting remeasurement of this Won-denominated receivable. The Company will amend U.S. federal tax returns for the 2018 to 2022 years when the anticipated refund from KNTS is received to offset the additional tax liability. The Company has recorded a long-term liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of December 31, 2023, and December 31, 2022, respectively, for the estimated amounts due to the U.S. federal government based on the amendment of the Company's U.S. tax returns, indicating that lower withholding amounts were required.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is not subject to examinations by the federal tax authority for the years prior to 2017. The Company's state and foreign tax returns are open for a period of generally </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_400adc83-bd76-4be8-bb3e-e698af4a0e7e;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">four years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company is under California tax audit for 2019 and 2020 years, which is in the information-collecting stage.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The above estimates may change in the future and upon settlement.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The components of income before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">United States</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71,514</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">77,205</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,066</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">173,657</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">191,025</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">168,181</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income before income taxes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">245,171</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">268,230</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">228,247</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 71514000 77205000 60066000 173657000 191025000 168181000 245171000 268230000 228247000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The components of the income tax expense are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current income tax (expense) benefit:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Federal</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,848</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51,980</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,433</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,048</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,833</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">641</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27,030</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,302</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,212</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45,926</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">85,115</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,286</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred income tax (expense) benefit:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Federal</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">460</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,916</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">844</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,936</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,216</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">734</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">290</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">186</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">170</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,766</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,946</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,748</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,160</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44,034</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table> 15848000 51980000 16433000 3048000 1833000 641000 27030000 31302000 25212000 45926000 85115000 42286000 460000 -25916000 844000 -3936000 -1216000 734000 290000 186000 170000 -3766000 -26946000 1748000 42160000 58169000 44034000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reconciliation of the statutory U.S. federal tax rate to the Company's effective tax rate is as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.731%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.022%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:11.022%;"></td> <td style="width:1%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:11.022%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Statutory U.S. federal income tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effect of foreign operations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. International Tax (Sub F, GILTI, FDII)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research tax credits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Redetermination of foreign tax credit utilization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nondeductible employee compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock based compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accruals and reserves</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effective tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table> 0.21 0.21 0.21 -0.04 -0.049 -0.05 0.029 0.042 0.021 0.024 0.019 0.014 0.02 0 0 0.017 0.019 0.03 -0.002 0.001 0.002 0.001 0.002 -0.003 0 0 -0.008 0.001 0.011 0.005 0.172 0.217 0.193 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes Company tax credit carry forwards for tax return purposes as of December 31, 2023 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.3%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.84%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:14.86%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Tax Benefit</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Expiration Date</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tax credit carry forwards:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State research tax credits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,752</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_e0cb93c6-e773-4637-905b-0268cb5781ac;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2034</span></span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="-sec-ix-hidden:F_3d7d5c93-96ed-4e3c-a9e2-9a2b7a5ad2ce;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2038</span></span></span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign tax credits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">186</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_747178a7-0753-4a3a-b81f-77c3c2ee0898;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2031</span></span></span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total credit carry forwards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,938</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table> 8752000 186000 8938000 <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant components of the Company's net deferred tax assets and liabilities are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax asset:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized research expenditures</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39,459</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,485</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Retirement plan</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,555</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,495</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tax credit carry forwards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,938</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accruals and reserves</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,944</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease Liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,671</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,230</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,741</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,077</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,498</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,454</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,400</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">79,404</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">81,185</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,551</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,087</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">69,853</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">70,098</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax liability:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,302</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,944</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Acquisition Goodwill</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,549</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,283</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,894</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,710</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,745</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,937</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net deferred tax assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,108</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58,161</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 39459000 38485000 12555000 13495000 8938000 8100000 7180000 6944000 6671000 7230000 1741000 2077000 1498000 1454000 1362000 3400000 79404000 81185000 9551000 11087000 69853000 70098000 6302000 6944000 1549000 1283000 2894000 3710000 10745000 11937000 59108000 58161000 3000000 0 14900000 60100000 60900000 732000000 15700000 14600000 P4Y <div style="display:flex;margin-top:18pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">21.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">REVENUE RECOGNITION:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes revenue in accordance with ASC Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The standard establishes the principles that an entity shall apply to report useful information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows from a contract with a customer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For each of the years ended December 31, 2023, 2022 and 2021, the Company recorded </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">97</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of its revenue from OLED related sales and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% from the providing of services through Adesis, respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contract Balances</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides information about assets and liabilities associated with the Company's contracts from customers (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:72.96%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:23.24%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts receivable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">139,850</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,084</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term contract assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,698</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,074</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term contract assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,278</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term deferred revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,713</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term deferred revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,006</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Short-term and long-term unbilled receivables and contract assets are classified as other current assets and other assets, respectively, on the Consolidated Balance Sheets. Contract assets represent consideration related to the renewal of customer contracts which is recognized over the contract term based on material units sold. The deferred revenue balance as of December 31, 2023 will be recognized as materials are shipped to customers over the remaining contract periods. As of December 31, 2023, the Company had $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of backlog associated with committed purchase orders from its customers for phosphorescent emitter material. These orders are anticipated to be fulfilled within the next 90 days.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant changes in the assets and liabilities balances associated with the Company's contracts from customers for the years ended December 31, 2023 and 2022, are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:62.76%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:15%;"></td> <td style="width:1%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:15%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2022</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63,878</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized that was previously included in deferred revenue, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">195,703</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Increases due to cash received</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">202,100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cumulative catch-up adjustment arising from changes in estimates of<br/>   transaction price, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,556</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unbilled receivables recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,659</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contract assets recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,407</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Transferred to receivables from unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,575</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net change</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,677</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,159</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,134</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2021</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,127</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">157,081</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized that was previously included in deferred revenue, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">239,608</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Increases due to cash received</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">176,667</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cumulative catch-up adjustment arising from changes in estimates of<br/>   transaction price, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,262</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unbilled receivables recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,946</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contract assets recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,384</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net change</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,330</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93,203</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2022</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63,878</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The cumulative catch-up adjustment arising from changes in estimates of transaction price, net was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2023 as compared to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">30.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended December 31, 2022. These adjustments resulted from an increase in the average price per gram that was primarily due to the decrease in anticipated demand by several of the Company's customers over the remaining lives of their contracts, resulting from changes in global macroeconomic factors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 0.97 0.97 0.97 0.03 0.03 0.03 <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table provides information about assets and liabilities associated with the Company's contracts from customers (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:72.96%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:23.24%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts receivable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">139,850</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,084</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term contract assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,698</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,074</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term contract assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,278</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term deferred revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,713</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term deferred revenue</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,006</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 139850000 21084000 2698000 9074000 9278000 47713000 12006000 25200000 <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant changes in the assets and liabilities balances associated with the Company's contracts from customers for the years ended December 31, 2023 and 2022, are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:62.76%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:15%;"></td> <td style="width:1%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:15%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31, 2023</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2022</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63,878</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized that was previously included in deferred revenue, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">195,703</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Increases due to cash received</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">202,100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cumulative catch-up adjustment arising from changes in estimates of<br/>   transaction price, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,556</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unbilled receivables recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,659</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contract assets recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,407</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Transferred to receivables from unbilled receivables</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,575</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net change</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,677</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,159</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,134</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,719</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31, 2022</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2021</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,127</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">157,081</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized that was previously included in deferred revenue, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">239,608</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Increases due to cash received</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">176,667</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cumulative catch-up adjustment arising from changes in estimates of<br/>   transaction price, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,262</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unbilled receivables recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,946</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contract assets recorded, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,384</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net change</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,330</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93,203</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2022</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,457</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63,878</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 38457000 63878000 195703000 202100000 10556000 41659000 -2407000 35575000 3677000 4159000 42134000 59719000 8127000 157081000 239608000 176667000 30262000 15946000 14384000 30330000 93203000 38457000 63878000 10600000 30300000 <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">22.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NET INCOME PER COMMON SHARE:</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company computes earnings per share in accordance with ASC Topic 260, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnings per Share</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which requires earnings per share (EPS) for each class of stock to be calculated using the two-class method. The two-class method is an allocation of income between the holders of common stock and the Company's participating security holders. Under the two-class method, income for the reporting period is allocated between common shareholders and other security holders based on their respective participation rights in undistributed income. Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and, therefore, are included in computing earnings per share pursuant to the two-class method.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net income per common share is computed by dividing net income allocated to common shareholders by the weighted-average number of shares of common stock outstanding for the period excluding unvested restricted stock units and performance units. Net income allocated to the holders of the Company's unvested restricted stock awards is calculated based on the shareholders proportionate share of weighted average shares of common stock outstanding on an if-converted basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For purposes of determining diluted net income per common share, basic net income per share is further adjusted to include the effect of potential dilutive common shares outstanding, including restricted stock units, performance units and the impact of shares to be issued under the Company's Employee Stock Purchase Plan.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table is a reconciliation of net income and the shares used in calculating basic and diluted net income per common share for the years ended December 31, 2023, 2022 and 2021 (in thousands, except share and per share data):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Numerator:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net income</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">203,011</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210,061</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">184,213</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Adjustment for Basic EPS:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnings allocated to unvested shareholders</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">993</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,215</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,137</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjusted net income</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">202,018</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,846</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">183,076</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Denominator:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average common shares outstanding – Basic</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,559,669</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,390,352</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,296,447</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effect of dilutive shares:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common stock equivalents arising from stock options and ESPP</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,173</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,340</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,010</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock awards and units and performance units</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,921</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">75,815</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">67,978</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average common shares outstanding – Diluted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,622,763</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,468,507</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,365,435</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net income per common share:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.25</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.41</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.87</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Diluted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.24</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.40</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.87</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the years ended December 31, 2023, 2022, and 2021, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the combined effects of unvested restricted stock awards, restricted stock units, performance unit awards and stock options of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">36,345</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">122,843</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">none</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> excluded from the calculation of diluted EPS as their impact would have been antidilutive.</span></p> <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table is a reconciliation of net income and the shares used in calculating basic and diluted net income per common share for the years ended December 31, 2023, 2022 and 2021 (in thousands, except share and per share data):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Numerator:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net income</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">203,011</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210,061</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">184,213</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Adjustment for Basic EPS:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnings allocated to unvested shareholders</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">993</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,215</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,137</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjusted net income</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">202,018</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,846</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">183,076</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Denominator:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average common shares outstanding – Basic</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,559,669</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,390,352</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,296,447</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effect of dilutive shares:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common stock equivalents arising from stock options and ESPP</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,173</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,340</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,010</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock awards and units and performance units</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60,921</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">75,815</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">67,978</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average common shares outstanding – Diluted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,622,763</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,468,507</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,365,435</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net income per common share:</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.25</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.41</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.87</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Diluted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.24</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.40</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.87</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 203011000 210061000 184213000 993000 1215000 1137000 202018000 208846000 183076000 47559669 47390352 47296447 2173 2340 1010 60921 75815 67978 47622763 47468507 47365435 4.25 4.41 3.87 4.24 4.4 3.87 36345 122843 0 During the year ended December 31, 2023, the gross value and accumulated amortization associated with the PD-LD, Inc. and Motorola patent portfolios have been removed from the table as the underlying patents have reached the end of their useful lives. The Company reclassified amortization of prior service cost, actuarial loss and plan amendment cost for its retirement plan from accumulated other comprehensive loss to net income of $1.0 million, $2.0 million and $4.7 million for the years ended December 31, 2023, 2022 and 2021, respectively. Refer to Note 17: Employee Retirement Plans

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